Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Neurons,0.7750191360904816,2.049959037499806,0.0,0.0,0.0,82/259,10.71%,NPY;CDH22;SLITRK1;SLC32A1;CCK;SPOCK3;CA10;IGF1;PROX1;RGS7BP;TAGLN3;STMN2;TESC;NCALD;SH3GL2;VSTM2B;TMEM191C;PCSK2;CNTN2;RIT2;SNCB;SYT4;GAP43;ZDHHC22;SCN3B;SCN1A;NRGN;C11ORF87;SYT5;RIMS3;CNTNAP2;STMN4;OPCML;PCP4;SCN2A;ELAVL4;OLFM3;ATP2B3;GAD2;VSNL1;KCNK1;SRRM4;SYNPR;ARHGDIG;GABBR2;RAB3C;GNG2;CDK5R2;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;PDE1A;SYP;VGF;ZIC1;MAP7D2;MEG3;TCEAL5;NRN1;RYR2;GRIA3;LUZP2;VSTM2A;SULT4A1;MATN2;GABRG2;NECAB2;KIF5A;CELF3;PCLO;KCNC1;TMEM130;CPLX1;BEX1;KCNQ2;PACSIN1;LY6H;DNER;NWD2;ADAM12
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.8178145903201404,2.0401820119477914,0.0,0.0,0.0,44/117,8.58%,NPY;CDH22;SLITRK1;CCK;CA10;RGS7BP;TAGLN3;STMN2;ZNF536;SH3GL2;VSTM2B;CNTN2;RIT2;SNCB;SYT4;GAP43;SCN3B;PLP1;KCNC2;PLPPR4;NRGN;C11ORF87;STMN4;OPCML;SCN2A;ELAVL4;OLFM3;ATP2B3;GAD2;SYNPR;ARHGDIG;RAB3C;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;TCEAL5;VSTM2A;GFAP;SULT4A1;GABRG2;CELF3;KCNC1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7190683187722989,-1.9744798050015224,0.0,0.014661480168057217,0.02,29/87,14.26%,TMA7;RPL35A;RPS24;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;FTSJ1;RPL14;RPL15;RPS2;RPL11;RPL23A;RPS21;RWDD1;RPS23
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.7766735401410862,1.9669809778606597,0.0,0.0,0.0,54/143,10.46%,CDH22;SLITRK1;SLC32A1;CA10;SLC24A2;PCDH8;STMN2;VSTM2B;CNTN2;RIT2;SNCB;GRID2;SYT4;GAP43;ZDHHC22;PLP1;SHISA8;C11ORF87;CNTNAP2;STMN4;OPCML;PCP4;ELAVL4;OLFM3;ATP2B3;GAD2;IGSF21;SRRM4;SYNPR;RAB3C;HPCA;ITPR3;CPLX2;GABRA1;ST8SIA3;GRM5;PDE1A;SYP;TCEAL5;GRIA3;GRIN1;VSTM2A;SULT4A1;HIVEP2;GABRG2;KIF5A;CELF3;KCNC1;HCN1;CPLX1;KCNQ2;NRIP3;LY6H;PDE1B
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7918823178693983,1.9590424272015485,0.0,0.0,0.0,38/114,8.58%,NPY;RIMBP2;CDH22;SIX3;CA10;CHGB;PROX1;STMN2;SH3GL2;NPTX2;PCSK2;CNTN4;SYT4;SCN3B;KCNB2;ABCC8;PLPPR1;PCP4;ELAVL4;PAK3;GAD2;IGSF21;FGF12;UNC5D;RAB3C;NKX6-2;CPLX2;ST8SIA3;SYP;ROBO2;MEG3;TCEAL5;VSTM2A;SYT13;PIR;SULT4A1;CELF3;KCNC1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.7886523701158508,1.940256379354754,0.0,0.0,0.0,46/123,9.05%,SLITRK1;CA10;SLC24A2;PROX1;STMN2;ZNF536;VSTM2B;PCSK2;CNTN2;CNTN4;SYT4;ZDHHC22;SCN3B;VWC2L;SCN1A;C11ORF87;CACNG3;CNTNAP2;CNTNAP5;STMN4;OPCML;SV2B;SCN2A;OLFM3;ATP2B3;PAK3;GAD2;SRRM4;SYNPR;B3GALT2;RAB3C;NTRK3;GABRA1;ST8SIA3;GRM5;SYP;TCEAL5;VSTM2A;GABRG2;FAM135B;CELF3;KCNC1;TMEM130;GRIA1;GRM6;HCN1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7818214441104041,1.9379627613706507,0.0,0.0,0.0,51/155,10.71%,SLITRK1;ELAVL2;CNR1;FLRT3;EDIL3;PCDH8;TAGLN3;EPHA7;STMN2;ZNF536;SH3GL2;KCNH7;NLGN1;ATRNL1;CNTN2;SNCB;GRID2;CAMKV;NEFL;SYT4;PLPPR5;SYT1;GAP43;ZDHHC22;RELN;CLSTN2;SLITRK5;LINGO2;CNTNAP2;STMN4;ACHE;OPCML;EFNB3;OLFM3;TCEAL7;NAP1L3;FSD1;ST8SIA3;NRG1;MAP1B;SULT4A1;KIF5A;CELF3;KIF5C;KCNC1;KCNQ2;PNMA2;RGMB;HMGCLL1;SMAD1;ADAM12
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.8070045405781892,1.9321099296658448,0.0,0.0,0.0,40/104,11.36%,RIMBP2;MYT1;CDH22;SLITRK1;PCDH8;STMN2;ATRNL1;CNTN2;SNCB;SRCIN1;CAMKV;SYT4;GAP43;ZDHHC22;PRKCG;KCNB2;ABCC8;STMN4;SCN2A;OLFM3;GAD2;PRR36;CDK5R2;HPCA;CPLX2;ST8SIA3;SYP;VSTM2A;SYT13;SULT4A1;GABRG2;KIF5A;CELF3;KCNC1;SMAD3;KCNQ2;HMGCLL1;LY6H;MAPT;NR4A2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.7228783603301139,1.9218758040643569,0.0,0.0,0.0,82/265,10.56%,NPY;CDH22;SLITRK1;CCK;L1CAM;SPOCK3;CA10;SHISA9;RGS7BP;PCDH8;TAGLN3;STMN2;NCALD;SH3GL2;GRIN2D;ZIC4;ELMO1;VSTM2B;PCSK2;PTPRO;CNTN2;RIT2;SNCB;CAMKV;SYT4;PLPPR5;SYT1;GAP43;PRKCB;ZDHHC22;PRKCG;SHISA8;RELN;KCNC2;NRGN;C11ORF87;STMN4;OPCML;SV2B;ELAVL4;OLFM3;ATP2B3;GAD2;IGSF21;VLDLR;FGF12;SYNPR;GABBR2;RAB15;KCNQ5;RAB3C;CDK5R2;LHX6;HPCA;CPLX2;ST8SIA3;PDP1;GRM5;PDE1A;SYP;VGF;TCEAL5;NRN1;VSTM2A;SYT13;RAMP3;SULT4A1;HIVEP2;GABRG2;ADGRL2;GABRA5;KIF5A;CELF3;CACNA1E;KCNC1;CPLX1;KCNQ2;NRIP3;GDA;PACSIN1;LY6H;CDKL5
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7993181137674117,1.9182177312000286,0.0,0.0,0.0,37/101,8.77%,CDH22;SLITRK1;CA10;GRIN2A;STMN2;GRIN2B;CNTN2;RIT2;GAP43;SCN3B;KCNC2;SCN1A;C11ORF87;CACNG3;CNTNAP5;STMN4;OPCML;SCN2A;OLFM3;ATP2B3;GAD2;SRRM4;SYNPR;HPCA;NTRK3;CPLX2;GABRA1;ST8SIA3;GRM5;DIRAS2;GRIN1;VSTM2A;GABRG2;CELF3;KCNC1;TMEM130;GRIA1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6756999893640518,-1.8993136097452985,0.0,0.0952996210923719,0.18,48/179,12.26%,IMP4;PAK1IP1;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL13;RPL37;ZNF658;RPS28;RBIS;RPL18;POP5;DDX52;RPL12;RPL23;RPL31;PIH1D2;MRPL36;NOP56;NOC2L;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;RPL29;RPL30;NOL8;SNU13;RIOK1;RPL14;URB2;EXOSC5;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A;NIP7
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7957958795477547,1.8912344690797271,0.0,0.0,0.0,45/97,12.25%,CDH22;CCK;MOBP;ST18;MOG;SLC24A2;PROX1;SLC4A10;PCSK2;CNTN2;XKR4;PRKCB;SCN3B;KCNQ1;KCNC2;SCN1A;CACNG3;RPH3A;CNTNAP5;STMN4;SV2B;GAD2;KCNT1;SRRM4;SYNPR;UNC13C;CPLX2;GABRA1;ST8SIA3;SYP;KCNH2;ADCY2;VSTM2A;FAM135B;CELF3;CACNA1E;MYT1L;MYO15A;HCN1;CNDP1;PDE1B;FGF13;TCEAL6;SLC7A14;CABP1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6983242888556821,-1.8860602741118384,0.0,0.08308172095232423,0.23,31/97,14.26%,RPL35A;RPS24;RPL34;SRPRA;RPL39;RPL13;RPL37;SRPRB;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;SPCS1;RPL15;RPS2;ZFAND2B;RPL11;RPL23A;RPS21;SPCS2;RPS23
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7800165117669373,1.8798357116683884,0.0,0.0,0.0,38/116,11.44%,NPY;RIMBP2;CDH22;CHGB;TTLL7;RGS7BP;TAGLN3;STMN2;PLD1;SERPINE1;DOC2B;CNTN2;SYT4;GAP43;PLPPR4;OPCML;ELAVL4;TCEAL7;SYNPR;UNC5D;RAB3C;CPLX2;ST8SIA3;GUCY1A2;PHYHIP;TCEAL5;VSTM2A;MAP1B;SULT4A1;CELF3;PTPRD;PCLO;KALRN;PLD2;NACAD;ASXL3;CRMP1;FAM13C
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.7833184510603437,1.8703437109643266,0.0,0.0,0.0,49/121,8.77%,CDH22;SLITRK1;SHISA7;SLC32A1;CCK;CA10;GRIN2A;SPINK8;TAGLN3;STMN2;GRIN2D;GRIN2B;VSTM2B;CNTN2;RIT2;SNCB;SYT4;GAP43;KCNC2;KCNB2;NRGN;C11ORF87;CACNG3;STMN4;OPCML;PCP4;ELAVL4;OLFM3;ATP2B3;GAD2;IGSF21;SRRM4;SYNPR;RAB3C;OXTR;KCND3;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;TCEAL5;GRIA3;VSTM2A;GFAP;GABRG2;CELF3;KCNC1;GRIA1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7586914751957512,1.856705520919501,0.0,0.0,0.0,46/133,11.67%,SLITRK1;SCN9A;CA10;RGS7BP;TAGLN3;STMN2;ZNF536;SH3GL2;CNTN2;SYT4;GAP43;SCN3B;PLP1;PLPPR4;C11ORF87;ADD2;STMN4;OPCML;SCN2A;ELAVL4;OLFM3;ATP2B3;TCEAL7;PIEZO2;SYNPR;RAB3C;ST8SIA3;GRM5;TCEAL5;VSTM2A;MAP1B;SULT4A1;KIF5A;CLGN;PTPRD;KCNC1;DHCR24;LY6H;VWA5A;NACAD;ASXL3;FGF13;TCEAL6;CRMP1;FAM13C;NEFM
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7435141343034114,1.849826037576092,0.0,0.0,0.0,35/121,9.36%,SLITRK1;PROX1;PCDH8;EPHA7;STMN2;ZNF536;ATRNL1;CNTN2;CAMKV;SYT4;GAP43;ZDHHC22;SCN3B;STMN4;OPCML;ELAVL4;OLFM3;ATP2B3;PAK3;GAD2;SRRM4;SYNPR;RAB3C;LHX6;NTRK3;ST8SIA3;ROBO2;VSTM2A;SULT4A1;HIVEP2;KIF5A;CELF3;PCLO;KCNC1;KCNQ2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.7238081311509774,1.840433084039407,0.0,0.0,0.0,59/229,10.44%,NPY;RIMBP2;SLC32A1;HTR2C;GRIK1;GRIN2A;HRH1;CHRM3;TBC1D24;CHRM1;CHRNA5;GRIN2D;NPTX2;GRIN2B;NLGN1;GRIK2;MBP;RIT2;SNCB;GABRB2;GRID2;SYT1;PLP1;RPS6KA1;GLRA2;NRGN;SYT5;GABRG3;APBA2;CBLN2;CDH8;GAD2;KCNMB4;GABRD;GABBR2;PRKAR1B;UNC13C;PTCHD1;GABRA1;DVL1;GRM5;HCRTR2;DTNA;SNCA;GRIA3;GRIN1;GABRG2;GABRA5;KIF5A;CACNA1E;NPTX1;GRIA1;CPLX1;PDLIM4;KCNQ2;DNAJC5;MINK1;FCHSD1;HOMER1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.7762034463373195,1.8386509795715558,0.0,0.0,0.0,40/100,11.44%,KCNT2;RIMBP2;CDH22;CHGB;PROX1;RGS7BP;STMN2;NPTX2;PCSK2;RCAN2;CNTN4;SYT4;SHC2;PLPPR4;KCNB2;ABCC8;PLPPR1;ELAVL4;GAD2;IGSF21;BAIAP3;UNC5D;RAB3C;CPLX2;ST8SIA3;TCEAL5;MAOB;GRIA3;VSTM2A;SYT13;GABRG2;CELF3;PTPRD;KALRN;ATP1B1;HMGCLL1;LY6H;SORBS1;ASXL3;FAM13C
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6600743145617002,-1.8375843986596867,0.0,0.14294943163855786,0.44,40/149,11.83%,IMP4;RPL35A;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL13;RPL37;NIFK;RPS28;RPL18;POP5;DDX52;RPL12;RPL23;RPL31;PIH1D2;NOP56;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;RPL29;RPL30;NOL8;SNU13;RPL14;EXOSC5;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7452336821130933,1.8292810117975256,0.0,0.0,0.0,48/146,11.98%,RIMBP2;CCK;CA10;RGS7BP;TAGLN3;STMN2;ZNF536;NMNAT2;ATRNL1;CNTN2;CASZ1;SYT4;GAP43;PLPPR4;STMN4;OPCML;ELAVL4;OLFM3;ATP2B3;TCEAL7;GFRA2;CDK5R2;CPLX2;ST8SIA3;GUCY1A2;TCEAL5;VSTM2A;MAP1B;SULT4A1;CELF3;CACNA1E;PCLO;KCNC1;KALRN;ARHGAP26;AHDC1;RGMB;HMGCLL1;LY6H;SCN3A;NACAD;MFSD6;ASXL3;VSTM2L;CRMP1;FAM13C;NEFM;SLC7A14
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6991946723357501,-1.827426448906494,0.0,0.13781791357973783,0.51,25/88,11.83%,RPL35A;RPS24;RPL34;SRPRA;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7842159038164976,1.8272297201640109,0.0,0.0,0.0,36/103,8.71%,NPY;ENPP2;RIMBP2;CDH22;CCK;CA10;CHGB;VWA5B2;TAGLN3;STMN2;SH3GL2;PCSK2;SYT4;GAP43;KCNB2;ABCC8;OPCML;PLPPR1;ELAVL4;OLFM3;GAD2;UNC5D;RAB3C;CDK5R2;HPCA;CPLX2;ST8SIA3;SYP;TCEAL5;VSTM2A;SYT13;GLP1R;SULT4A1;CELF3;KCNC1;SCG5
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7309493126035143,1.8255372999095336,0.0,0.0,0.0,33/105,12.80%,RIMBP2;FLRT3;PROX1;RGS7BP;STMN2;RCAN2;CNTN4;PDZRN4;SYT4;SHC2;PLPPR4;ABCC8;PLPPR1;PCP4;FGF12;ATP9A;ST8SIA3;ABCC9;GUCY1A2;MAOB;SYT13;SYBU;LIMCH1;ADGRL2;PTPRD;PCLO;KALRN;ATP1B1;HMGCLL1;ASXL3;FAM13C;PXK;TMEM196
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.665109483477816,-1.8234625036406735,0.0,0.12095721138647204,0.52,45/161,12.22%,IMP4;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL13;RPL37;NSA2;RPS28;RPL18;POP5;DDX52;RPL12;RPL23;RPL31;PIH1D2;NOP56;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;THUMPD1;RPL29;RPL30;NOL8;SNU13;RIOK1;RPL14;EXOSC5;RRP15;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A;SRFBP1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7335284743519407,1.8200816893332485,0.0,0.0011837006252739318,0.02,47/178,9.61%,NPY;HTR2C;GRIK1;GRIN2A;HRH1;CHRM3;CHRM1;CHRNA5;NPTX2;GRIN2B;NLGN1;GRIK2;MBP;RIT2;SNCB;GABRB2;SYT1;PLP1;RPS6KA1;GLRA2;NRGN;SYT5;GABRG3;APBA2;GAD2;KCNMB4;GABRD;GABBR2;PRKAR1B;UNC13C;PTCHD1;GABRA1;GRM5;HCRTR2;DTNA;SNCA;GRIA3;GRIN1;GABRG2;GABRA5;KIF5A;CACNA1E;NPTX1;GRIA1;CPLX1;KCNQ2;MINK1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7012697234273654,-1.8186775423573933,0.0,0.11100834984386176,0.54,25/85,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;ZFAND2B;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.736873898405766,1.8185572118920446,0.0,0.0011273339288323159,0.02,53/160,11.41%,ENPP2;CDH22;ANLN;MOBP;ST18;HAPLN2;MYRF;CA10;MOG;ADAMTS4;TMEM235;RGS7BP;CREB5;VSTM2B;MBP;FAM163B;CNTN2;SNCB;SRCIN1;ZDHHC9;ADCY5;FA2H;OPALIN;PLP1;STMN4;OPCML;BCAS1;EFNB3;IGSF21;VLDLR;SYNPR;NINJ2;MCAM;PLLP;NKX6-2;FAM107A;HPCA;CPLX2;ST8SIA3;GRM5;PHYHIP;TCEAL5;GFAP;MAG;TF;TPPP;SLC25A29;LY6H;KLK6;SORBS1;KIF13B;LGI3;TCEAL6
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.7756007630894346,1.817326744661912,0.0,0.001076091477521756,0.02,42/105,11.41%,CDH22;SLITRK1;SLC32A1;CA10;RGS7BP;STMN2;ZNF536;SH3GL2;VSTM2B;CNTN2;SNCB;GAP43;KCNC2;PLPPR4;C11ORF87;ABCC8;STMN4;OPCML;SEMA3C;OLFM3;ATP2B3;GAD2;IGSF21;SYNPR;GABBR2;CDK5R2;HPCA;ST8SIA3;GRM5;PHYHIP;TCEAL5;VSTM2A;GFAP;SULT4A1;GABRG2;CELF3;KCNC1;HMGCLL1;LY6H;SYN2;LGI3;TCEAL6
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8842393449340732,-1.8002655710725877,0.0,0.1301206364915078,0.6,1/16,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6729271532632072,-1.7941098795139954,0.0,0.12788068813249906,0.62,69/191,18.61%,TMA7;MRPL10;RPL35A;RPS24;RPL34;RPL39;MRPS21;RPL13;RPL37;MRPL52;RPS28;AIMP1;MRPS7;RPL18;KARS1;VARS1;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;RPS26;RPL6;MRPL47;FASTKD2;RPL41;RPS13;RPL22;GATC;RPL29;RPL30;ASMT;RPSA;FTSJ1;EEFSEC;RPL14;RPL15;EEF1A1;RPS2;IGF2BP3;EPRS1;APEH;NOA1;EEF1B2;RPL11;RPL23A;NARS1;WARS2;MRPS18B;RPS21;MRPS34;MRPS33;RWDD1;RPS23;YARS2;MRPS12;RPS25;MRPS5;RARS1;MRPL27;RPL10;MRPL3;AIMP2;TNIP1;LARS1;RPL8;PTCD3;RPL32
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.8450930870913416,1.7919067516076923,0.0,0.003087914674627648,0.06,13/35,6.17%,HLA-DRA;GPNMB;TLR2;CTSS;MYO1F;PLEK;NAPSB;PRKCB;SIGLEC1;ACHE;PTPRC;AHR;CIITA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6671357248522999,-1.7909029698289975,0.034482758620689655,0.12169028539487489,0.63,31/105,15.97%,RPL35A;RPS24;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RBM8A;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;PYM1;RPL11;RPL23A;RPS21;RPS23;EIF3E;PNRC2;RPS25
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7558291469568391,1.7907493766687708,0.0,0.00295925156318483,0.06,34/96,11.74%,STMN2;SH3GL2;CNTN2;GRID2;NEFL;GAP43;ZDHHC22;SCN3B;PLP1;OPCML;PAK3;TCEAL7;SRRM4;UNC5D;RAB3C;SEMA5B;GJC1;NTRK3;ST8SIA3;GUCY1A2;ROBO2;TCEAL5;MAP1B;SULT4A1;PTPRD;GRIA1;KCNQ2;PNMA2;DCX;NACAD;ASXL3;CRMP1;NEFM;RUNX1T1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.7491029711357657,1.7833088558340022,0.0,0.003787842000876582,0.08,20/63,13.49%,NR4A3;HPN;IGF1;SGPP2;NR4A1;ZFP36;DAB2IP;DUSP10;TGFA;EPB41L4B;LAMB1;CDK6;NLRC3;YAP1;TGFB2;CDKN1C;B2M;DEAF1;FUT2;FGF2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.6926937386291545,1.7810607879183162,0.0,0.003642155770073636,0.08,50/211,10.76%,TGFBR2;IL1RAPL2;SIX3;COL4A1;C3;HAPLN2;MYRF;CHST8;CA10;MOG;GRIK1;GRIN2A;PROX1;PCDH18;TAGLN3;EPHA7;SH3GL2;GRIN2D;GRIN2B;ZIC4;MBP;SH3GL3;CNTN4;UGT8;RELN;LSR;CNTNAP2;SHROOM4;CIC;SOX4;APOD;MFSD2A;ZBTB16;NNAT;ZIC1;ROBO2;EIF2B2;SYNJ2;GLIS2;GRIN1;AATK;ADGRL2;THOC6;NPTX1;PBX3;TPPP;STAT3;KLK6;DNER;DCX
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.7784971612591753,1.7756286009761097,0.0,0.003507261111922761,0.08,35/94,10.64%,SLITRK1;SHISA7;SLC32A1;PCDH8;TAGLN3;STMN2;GNG3;VSTM2B;CNTN2;SNCB;ARHGAP39;CAMKV;GAP43;PRKCG;C11ORF87;OPCML;CAMK2N2;EFNB3;PRR36;B4GALNT4;CDK5R2;HPCA;GRM5;PHYHIP;GRIN1;SULT4A1;NYAP1;MAPK8IP1;KIF5A;CELF3;KCNC1;SRRM3;KCNQ2;LY6H;DNER
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.8197546942561775,1.7717955569502188,0.0,0.0038047520098090665,0.09,2/52,0.12%,LEF1;CDKN2A
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.7271779626158232,1.7704167800165274,0.0,0.00408172629404804,0.1,25/117,10.27%,LEF1;GGT5;ANXA1;IL1RAPL1;SP100;TIMP2;IRAK2;APP;NLRP12;IL1R1;PLSCR1;OSMR;CIITA;PID1;CDK9;SNCA;PML;MYD88;BCL2L1;CHI3L1;SMAD3;PTPN9;IKBKE;HDAC4;STAT3
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.7349182762273134,1.7637224137212262,0.0,0.005523936251278349,0.13,16/92,9.00%,LEF1;TGFBR2;CACNA1H;IL1RAPL1;SLIT2;NLRP12;SLIT3;PID1;CDK9;ROBO2;GHR;RAMP3;CYP1B1;CTNNB1;SMAD3;PTPN9
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.7428578109181867,1.7445639079409119,0.0,0.010691489518603254,0.23,36/111,11.67%,MYT1;ELAVL2;CNR1;PCDH8;TAGLN3;EPHA7;STMN2;DRAXIN;GRID2;CAMKV;SYT4;PLPPR5;GAP43;ZDHHC22;EFNB3;PRR36;VLDLR;UNC5D;B4GALNT4;SEMA5B;CDK5R2;GRM5;CCKBR;MAP1B;SULT4A1;NYAP1;KIF5A;CELF3;KIF5C;KCNC1;C2CD4C;KCNQ2;EPHA4;DCX;CRMP1;NEFM
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.706586850208335,-1.74207815198991,0.0,0.231917959021996,0.87,31/84,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTRF1L;APEH;MRPS26;MRPL21;MTRF1;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.8264995019852034,1.7414662149624442,0.0,0.011097193361943111,0.24,11/26,11.38%,NPY;PROX1;DRAXIN;GRID2;MDGA2;SOX4;CTNNB1;AGTPBP1;MAPT;NR4A2;OPHN1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.739999537379191,1.7393602486095159,0.0,0.011478309093565398,0.26,38/110,11.74%,KCNT2;RIMBP2;CHGB;PDGFRA;PCDH18;STMN2;ZNF536;ZNF385D;PCSK2;SULF1;CNTN4;PDZRN4;SYT4;GAP43;PLPPR4;C11ORF87;THY1;OPCML;OLFM3;PAK3;GAD2;TCEAL7;UNC5D;RAB3C;ST8SIA3;ROBO2;TCEAL5;CACNA1C;GRIA3;CELF3;PTPRD;TMEM130;GRIA1;SCN3A;ASXL3;FAM13C;NEFM;RUNX1T1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.6747429387504611,1.7286836449089786,0.0,0.01740736213638135,0.34,58/211,11.69%,SLITRK1;CCK;L1CAM;SCN1B;ANK3;EPHA7;DRAXIN;PTPRO;CNTN2;CNTN4;SHTN1;EPHA2;SLIT2;RELN;IRS2;SLITRK5;APP;PLPPR4;DOK6;NRP2;EPHA5;EFNA1;EFNB3;SEMA3C;PAK3;SH3KBP1;VLDLR;EMB;SHANK3;FYN;SLIT3;UNC5D;GFRA2;SEMA5B;SEMA3D;ANOS1;BAIAP2;RAP1GAP;PARD3;SEMA3B;ROBO2;NEXN;MAP1B;DCC;NPTN;LAMA5;KIF5A;NRXN3;KIF5C;GAB2;GLI2;EPHA4;SLITRK4;LAMA2;VSTM2L;OPHN1;ENAH;B4GALT5
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.7249202815096031,1.7188722831889873,0.0,0.0192774101830326,0.37,25/118,7.97%,TGFBR2;SIX3;COL4A1;CA10;GRIN2A;PROX1;PCDH18;EPHA7;GRIN2D;GRIN2B;CNTN4;RELN;CNTNAP2;SHROOM4;CIC;SHANK3;APOD;MFSD2A;NNAT;ZIC1;ROBO2;SYNJ2;GRIN1;AATK;ADGRL2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6297294588594764,-1.7178380688833084,0.0,0.3109455585642135,0.95,42/188,11.83%,IMP4;RPL35A;RPS24;FCF1;TRPT1;RPL34;RPL39;EXOSC8;RPL13;RPL37;RPS28;RPL18;POP5;DDX52;KARS1;RPL12;RPL23;RPL31;PIH1D2;NOP56;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;RPL29;RPL30;NOL8;SNU13;METTL3;RPL14;EXOSC5;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.7701909086637527,1.717738816304366,0.0,0.018741926566837253,0.37,2/54,0.12%,LEF1;CDKN2A
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.8413017161885012,1.716935601182589,0.0,0.019195145274712406,0.37,3/30,8.12%,LEF1;GNG2;CTNNB1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.8140655555001398,1.7164288201371922,0.0,0.018690009872746292,0.37,23/53,9.70%,SHISA7;SHISA9;GRIN2A;NPTX2;GRIN2B;NLGN1;PSCA;NEFL;SHISA8;RELN;DLGAP3;APP;CACNG3;NETO1;CACNG8;GRIA3;GRIN1;SHANK1;NPTX1;CAPN1;GRIA1;MINK1;CACNG4
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.7518399790411652,1.714564927192185,0.0,0.01881780481204712,0.38,17/65,7.85%,ENPP2;CSPG4;IGF1;IL15;EPHA7;DMTN;RELN;TEC;APP;EFNA1;PTPRC;FYN;TNFRSF14;CD44;GHR;PDGFA;RAP2B
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.7465068514345268,1.7103186491053266,0.0,0.02101068609861229,0.42,26/80,8.95%,ECM2;COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;ABCA8;SULF1;ITGA8;COL4A2;SLIT2;ASPN;THY1;PODN;ANGPTL2;MYH11;POSTN;SLIT3;COL12A1;FAP;SEMA3D;C1R;ITGA11;BGN
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7343922463016282,1.7083180260190858,0.0,0.02165306021842558,0.42,32/101,8.75%,KCNT2;RIMBP2;CHGB;EDIL3;PROX1;RGS7BP;STMN2;SH3GL2;DEPP1;PCSK2;RCAN2;CNTN4;SYT4;SHC2;PLPPR4;KCNB2;ABCC8;PLPPR1;TCEAL7;RAB3C;FAP;ST8SIA3;RAI2;PGR;LDB2;GRIA3;SYT13;GLP1R;CELF3;PTPRD;SCG5;PKDCC
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.7149360257293218,-1.7047242425953069,0.0,0.34285307469918413,0.98,30/78,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTRF1L;MRPS26;MRPL21;MTRF1;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6950781504901564,-1.7034866447653632,0.0,0.3215053151138261,0.98,23/74,16.25%,NDUFAF3;UQCRFS1;NDUFS5;COX18;DMAC2;TMEM126A;NDUFA12;NDUFB4;NDUFB1;COX20;NDUFAF4;NDUFV3;NDUFA8;LYRM7;FOXRED1;COX19;NDUFS3;NDUFC1;SAMM50;SLC25A33;SMIM20;OXA1L;NDUFAF8
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.8161972924128023,1.7017006895360454,0.0,0.024801346434310954,0.48,11/29,12.55%,SCN1B;ANK3;YWHAH;SCN3B;FGF12;HECW2;NETO1;PRKCE;FGF13;HECW1;FXYD7
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.8358072692537393,1.6991574802310885,0.0,0.02532568779655854,0.5,7/29,7.47%,TLR2;CTSS;P2RY13;MYO1F;PLEK;SIGLEC1;SLC7A7
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.8774018492099214,1.6985988064365438,0.0,0.025288149721761268,0.51,2/27,0.25%,LEF1;HPN
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.6593853426642865,1.6955930437325464,0.0,0.027356636672997536,0.56,48/186,11.08%,CACNA1H;SLC6A15;HPN;SCN1B;SCN9A;CACNA1G;SLC24A2;KCNH8;KCNJ2;KCNV1;KCNH7;TRPC3;KCNK10;SCN3B;KCNQ1;SLC39A14;KCNC2;SCN1A;KCNB2;ABCC8;KCNF1;SCN2A;KCNK1;ASIC3;TRPM4;KCNQ5;SLC9A9;ASIC4;KCND3;SLC39A11;ABCC9;KCNH2;CACNA1C;ATP1A1;SLC9A1;KCNC1;LRRC55;HCN1;KCNQ2;KCNK12;ATP1B1;ORAI1;ATP1B3;SLC4A11;MCOLN2;SCN3A;GAS6;KCNAB3
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.8221733569940783,1.6930485996832751,0.0,0.027019253402991918,0.56,12/34,10.44%,GRIN3A;GRIK1;GRIN2A;GRIN2B;GRIK2;GRID2;APP;GRM5;GRIA3;GRIN1;GRM6;HOMER1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6869645618618648,1.6890407771073446,0.0,0.029214738836548106,0.6,41/126,13.35%,TGFBR2;CDH6;CDH22;SLITRK1;L1CAM;FLRT3;CDH9;IL1RAPL1;CDH19;CDH23;NLGN1;CNTN2;GRID2;CLDN16;CNTN4;ICAM1;CDH8;IGSF21;EMB;CDH7;UNC5D;CDH18;FAT2;KIRREL3;ROBO2;NEXN;NPTN;TENM4;MAG;PTPRD;TGFB2;LRRC4;CLDN18;VSTM2L;ITGAL;CLDN20;SDK2;ROBO4;CDH4;PCDHB2;HMCN1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.831015947831619,1.6878315232382453,0.0,0.02885270274105209,0.61,2/32,0.06%,LEF1;TGFBR2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.7126122718137764,-1.68420222143399,0.0,0.37924362034708,0.99,18/44,16.95%,TIMM8B;ATP5PF;ATP5MC1;TIMM13;APOO;ATP5PB;ATP5PD;DMAC2L;MICOS10;ATP5MC3;SAMM50;ATP5F1B;TIMM10;ATP5F1A;TMEM11;LETM1;ATP5MC2;AFG3L2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7868030644757423,1.683447461924409,0.0,0.03188744541554265,0.67,14/25,7.50%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNQ1;KCNE4;SCN1A;FGF12;GJC1;KCNH2;CACNA1C;RYR2;ATP1A1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7009302578587853,1.6776921608112656,0.0,0.03598449900832753,0.72,33/112,11.98%,KCNT2;EDIL3;RGS7BP;PCDH18;STMN2;RCAN2;GAP43;ADCY5;SHC2;SLIT2;PLPPR4;THY1;OPCML;EFNB3;TCEAL7;COL23A1;SEMA5B;CCDC3;GUCY1A2;LDB2;MAP1B;BOC;ADGRL2;PTPRD;RASL12;TGFB2;PCDHB15;NACAD;ASXL3;CRMP1;FAM13C;RUNX1T1;PRICKLE2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.8694269745083424,1.6769160699011292,0.0,0.03620731324367321,0.72,11/26,9.70%,CALD1;DMTN;ADD2;BAIAP2L1;NEDD9;BAIAP2;FAM107A;RHOD;PAWR;MYO1B;FSCN1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.8701418758797166,1.6752324223556503,0.0,0.03596628822947716,0.72,11/26,9.70%,CALD1;DMTN;ADD2;BAIAP2L1;NEDD9;BAIAP2;FAM107A;RHOD;PAWR;MYO1B;FSCN1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.6921392197382965,1.674516648449723,0.0,0.035734358498835675,0.72,24/99,12.43%,GGT5;CXCL2;TLR2;ANXA1;HRH1;ADGRE5;THBS1;TRAF3IP2;NOD1;SIGLEC1;ACKR1;TPST1;CIITA;CD44;TNFRSF1A;CHI3L1;HDAC4;STAT3;APOL3;HDAC9;CCL2;ITGAL;PXK;RELB
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7185871449546809,1.672499733102025,0.0,0.03682624167518899,0.74,22/95,9.36%,SIX3;PCDH8;TAGLN3;ZNF536;SNCB;CAMKV;GAP43;ZDHHC22;OPCML;EFNB3;LGR5;UNC5D;SEMA5B;CDK5R2;HPCA;MAP1B;SULT4A1;CELF3;PCLO;KCNC1;SRRM3;KCNQ2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.7059475785896377,-1.6719012950177177,0.0,0.4137286434923646,1.0,33/78,21.93%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MRPS26;MRPL21;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3;MRPL54;TSFM;MRPL9;MRPL24;MRPL58
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6924247281703766,1.6668400191367323,0.0,0.04239800421435719,0.77,33/101,14.64%,CACNA1H;ANK3;RAPGEF5;CD24;SRCIN1;ADCY5;SHC2;KCNQ1;PLPPR1;CP;BAIAP3;EPB41L4B;ATP9A;ZNF704;FAAH;RAP1GAP;RAI2;MAOB;SYT13;SYBU;HOOK1;ZBTB7C;KALRN;SLC22A23;TPPP;PODXL;SORBS1;PLEKHH1;DLG3;NEBL;COBL;PATJ;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.847591343713742,1.6659359592259042,0.0,0.04248639744286791,0.78,8/21,11.24%,TLR2;THBS1;DMTN;APOD;FAM107A;ROBO2;DUSP22;PHLDB2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.7146757041021781,1.6647745927262767,0.0,0.042571689154588775,0.79,18/74,11.04%,OPTC;COL4A1;COL11A2;P4HA2;COL4A2;TLL1;COL8A1;COL21A1;COL23A1;COL12A1;COL27A1;SCX;CYP1B1;LOXL1;TGFB2;COL9A1;P3H2;COL4A4
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.8407726651888803,1.664669640722411,0.0,0.04183769451399242,0.79,6/24,3.47%,CACNA1H;CACNA1G;DOC2B;SYT4;SYT1;SYT5
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.7120071096104513,1.6628929356805724,0.0,0.04353610774312597,0.81,35/106,15.65%,LEF1;ARHGAP39;CEP170B;APP;DAB2IP;EFNB3;ARHGEF17;NUAK1;PTPN21;SEMA3B;PHYHIP;LARP6;MAP1B;GFAP;SCARA3;NYAP1;MAPK8IP1;SH3PXD2B;SRRM3;YAP1;EPB41L1;CMTM4;TEAD1;NACAD;TNFRSF19;LGI3;MEIS3;CAP2;SLC13A4;GPR37;RBFOX2;BCAR1;MTCL1;SEZ6L2;NGEF
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.7296259504954687,1.6627755742931045,0.016666666666666666,0.04300778938495286,0.81,6/63,3.55%,GGT5;NPNT;ZFP36;YBX3;DAB2IP;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.7335947350419869,1.662033044856498,0.0,0.043078940788657843,0.81,19/84,10.44%,ARHGAP4;SPOCK3;TMEFF2;SERPINE1;SULF1;SLIT2;WAS;THY1;DUSP10;PODN;CLIC4;FOXO3;LIMCH1;CYP1B1;RAP2B;DUSP22;LDLRAD4;DLG5;EPHA4
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.7032117259729509,-1.6602454683044017,0.0,0.4463127051158593,1.0,38/93,20.22%,MRPL10;MRPS21;MRPL52;MRPS7;MTIF2;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;FASTKD2;MRPS9;MTRF1L;GATC;MTIF3;MRPS26;NOA1;MRPL21;MTRF1;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3;QRSL1;MRPL54;TSFM
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.8576176672386866,1.6594656849060958,0.0,0.04429331371992777,0.82,4/23,3.05%,NR4A3;C3;IGF1;IRS2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.7553255276731394,1.6591032288461522,0.0,0.043778134236321604,0.82,19/62,7.53%,SHISA7;SLC24A2;GRIN2A;RIMS2;PLK2;GRIN2D;GRIN2B;NLGN1;GRIK2;SYT1;RELN;CLSTN2;APP;CACNG3;RIMS3;BAIAP3;SHANK3;CACNG8;NPTN
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7997441995631001,1.6586702156699105,0.03508771929824561,0.04346400733427719,0.83,9/31,7.99%,GRIN2A;GRIN2D;GRIN2B;GRID2;GABRG3;GABRA1;GRIN1;GABRG2;GABRA5
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.8213811714513249,1.6576413964729413,0.0,0.04370586924088363,0.84,7/28,7.91%,CDKN2A;THBS1;SERPINE1;DMTN;APOD;FAM107A;DUSP22
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.8036272609752529,1.6576390344228746,0.0,0.04304365910087024,0.84,1/38,0.01%,LEF1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.6587923753167132,1.6574682304586466,0.0,0.04275455989795396,0.84,57/175,15.21%,L1CAM;SCN1B;EPHA7;DRAXIN;PTPRO;CNTN2;CNTN4;GAP43;EPHA2;SLIT2;RELN;IRS2;DOK6;NRP2;EPHA5;EFNA1;EFNB3;SEMA3C;SH3KBP1;VLDLR;EMB;SHANK3;FYN;SLIT3;UNC5D;GFRA2;SEMA5B;SEMA3D;ANOS1;RAP1GAP;SEMA3B;ROBO2;NEXN;DCC;NPTN;LAMA5;KIF5A;NRXN3;KIF5C;GAB2;GLI2;EPHA4;LAMA2;VSTM2L;OPHN1;ENAH;PLXNA4;KLF7;ROBO4;GAB1;PALLD;NTN4;PIK3CD;PLXNA1;NOTCH3;LAMA3;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.8947723362290839,1.65720933558805,0.0,0.04229988999140668,0.84,4/13,4.64%,SHISA7;RELN;APP;SHANK3
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.7246650696559043,1.6566328693531183,0.0,0.04185839892273034,0.84,28/73,12.58%,SHISA7;ANK3;SHISA9;CTSS;GRIN2A;GRIN2B;NLGN1;NEFL;SHISA8;RELN;APP;CACNG3;FGF12;NETO1;HPCA;JPH4;CACNG8;GRIA3;GRIN1;SHANK1;CAPN1;GRIA1;MINK1;CACNG4;HOMER1;FGF13;CAMK2B;DLG3
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.8117852432942715,-1.6563289936225405,0.0,0.4439170384217324,1.0,3/31,2.65%,ACP3;ATP10B;TPP1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.6746880297384188,1.6556938125778984,0.0,0.0424441224205367,0.85,34/146,18.66%,TGFBR2;VRK2;SBK1;PLK2;CAMKV;PRKCB;PRKCG;RPS6KA1;STK32B;GRK2;PRKCE;PRKCH;IKBKE;HIPK3;GAS6;STK32A;CDC7;PRKCD;HIPK1;MAPKAPK5;RPS6KA6;STK32C;RPS6KB2;HIPK2;NEK6;PINK1;CDK2;MAPK9;CAMK1D;PDK3;CAMK2A;PRKCA;CAMK1G;RPS6KA4
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.7057583569882068,1.6555627275703126,0.0,0.04184631787940238,0.85,35/118,11.43%,C1QL1;CSPG4;HAPLN2;CA10;PDGFRA;TAGLN3;STMN2;ZNF536;VSTM2B;CNTN2;SNCB;GAP43;ADCY5;PLP1;PLPPR4;C11ORF87;STMN4;OPCML;IGSF21;TCEAL7;FYN;LHFPL3;NKX6-2;HPCA;ST8SIA3;NNAT;PHYHIP;TCEAL5;GFAP;NYAP1;LY6H;NACAD;LGI3;TCEAL6;CRMP1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7267330830914104,-1.6554986618402914,0.0,0.4244112680227089,1.0,13/38,13.47%,RIOK2;RPS24;RPS28;MRPS7;DDX52;RPS27L;SNU13;RIOK1;RPSA;RRP36;LOC102724159;SRFBP1;NOM1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.8109777375246537,1.654655921601722,0.0,0.04208713334307313,0.85,6/26,2.82%,TGFBR2;MET;COL4A1;NPNT;EPHA2;SLIT2
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.8101848991830845,1.6539805588891332,0.0,0.04215920035222223,0.87,12/26,10.76%,CACNA1H;SCN1B;SCN9A;CACNA1G;YWHAH;SCN3B;SCN1A;SCN2A;KCNH2;CACNA1E;CACNG4;SCN3A
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.7799611045575364,1.651709757884326,0.0,0.04590838911535384,0.88,8/35,10.25%,CLIC1;SLC4A10;CLIC4;SLC26A8;ANO9;TTYH3;CLCN4;SLC4A11
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.8169727543429627,-1.649115974914062,0.02702702702702703,0.4402109420459179,1.0,4/21,3.99%,AR;CEBPA;ZC3H8;BRF2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.6904195282545039,1.6485514987617038,0.0,0.04845281226121294,0.89,45/118,15.20%,COL4A1;EDIL3;CALD1;COL4A2;GAP43;ADCY5;SHC2;SLIT2;PLPPR4;DAB2IP;ABCC8;THY1;IL1R1;EFNB3;TCEAL7;ANGPTL2;ASIC3;ARHGEF17;NUAK1;GFRA2;PTPN21;TNFRSF1A;GUCY1A2;LARP6;MAP1B;LIMCH1;SCARA3;BOC;ADGRL2;PKDCC;SRRM3;BGN;EPB41L1;HMOX2;TEAD1;NACAD;CRMP1;FAM13C;PRICKLE2;MEIS3;CAP2;RBFOX2;BCAR1;PDZRN3;SMARCA1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6633127406870444,1.646970430029947,0.0,0.04952852616277768,0.89,32/119,12.93%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTN4;BICDL1;PLP1;APP;CNTNAP2;EPHA5;STMN4;SRRM4;LAMB1;UGDH;TENM4;MYT1L;MICALL1;PBX3;TGFB2;GLI2;GPRIN1;HS6ST1;DCX;FRY;MAPT;OPHN1;B4GALT5;ATP8A2;ALK
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.8464186503537444,1.646377397917436,0.0,0.04965393531993247,0.89,6/20,8.06%,NR4A3;KCNQ1;GNG2;SNCA;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.7920134506303989,1.6462500790758268,0.0,0.0491691028959941,0.89,9/34,13.04%,GGT5;ANXA1;WNT8B;CYP1B1;CTNNB1;STAT3;ABCA2;CCL2;ALPL
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.795324310502881,1.645172433741658,0.0,0.04959555784375587,0.9,4/35,2.65%,CDKN2A;THBS1;PTPRO;DMTN
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.7426440426328167,1.6451316083853171,0.0,0.049123575948868174,0.9,2/53,0.86%,TGFBR2;SBK1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.9162637519101724,1.6427032414599818,0.0,0.05114755788220693,0.91,2/16,0.25%,LEF1;HPN
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.6125028505065331,1.6422202680135474,0.0,0.050812514645905374,0.92,52/304,10.44%,LEF1;ENPP2;ARHGAP4;GPNMB;ANXA1;IGF1;KIF14;PDGFRA;EGF;TMEFF2;THBS1;SERPINE1;SRCIN1;SULF1;FLT1;SLIT2;MGAT3;TMSB10;THY1;DUSP10;PODN;SEMA3C;NEDD9;CLIC4;SEMA5B;LAMB1;SEMA3D;FAM107A;NTRK3;DOCK10;LDB2;SEMA3B;FOXO3;RHOD;NEXN;LIMCH1;CYP1B1;PDGFA;MYO1C;RAP2B;DUSP22;MGAT5;LDLRAD4;LMNA;GNA12;MMP14;CYRIB;MINK1;DLG5;STAT3;PODXL;EPHA4
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.9126646426510415,-1.6410473939925208,0.0,0.4552040509320621,1.0,3/10,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.7115690405574039,1.6376133418508183,0.0,0.05362306447024076,0.94,9/50,8.06%,S100A10;THBS1;DMTN;THY1;APOD;FAM107A;LIMCH1;DUSP22;SLC9A1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.9437010032637183,1.637156850658388,0.0,0.053407444878430965,0.94,2/11,0.06%,LEF1;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.9257003752248695,1.6359949398728475,0.0,0.05417171096841875,0.95,3/13,1.50%,NR4A3;C3;ACSL5
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.6737542690421524,1.635644879162249,0.0,0.054092365782866886,0.95,21/74,11.44%,COL4A1;CSPG4;PRRX1;TEAD2;PCDH18;CALD1;COL4A2;SLIT2;DAB2IP;COL12A1;LAMB1;PTPN21;RHBDF1;PDGFRL;SCARA3;BOC;YAP1;PPARG;GLI2;TEAD1;ENAH
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.6954439160737631,1.6347255119667743,0.0,0.05523936251278348,0.95,22/87,11.07%,ENPP2;CSPG4;SOCS3;IGF1;IL15;PTK6;SRCIN1;RELN;TEC;EFNA1;PTPRC;TNFRSF14;NEDD9;GRM5;CD44;TNFRSF1A;GHR;STAT3;EPHA4;DOK7;PARP9;GAS6
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.9042484089792785,1.634489479869543,0.0,0.05501517678829978,0.95,3/13,3.52%,HPN;CCBE1;MYH9
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.8449506723890308,1.6343101390077528,0.05454545454545454,0.05466302887500966,0.95,7/17,4.33%,CACNA1H;SCN9A;ANK3;CACNA1G;SCN1A;SCN2A;KCNMB4
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.7811857519603442,1.6342421277222878,0.0,0.05405566188750955,0.95,8/25,10.32%,MET;COL4A1;SLIT2;TBX20;RYR2;CTNNB1;GLI2;PODXL
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.618835704892889,1.6327240122351214,0.0,0.05593310646898799,0.95,36/175,14.40%,TGFBR2;BOK;TLR2;ELMO1;SEPTIN4;APP;FOXO1;SCN2A;PLSCR1;FAS;AHR;FAP;ZBTB16;CASP10;PAK4;PAWR;DCC;MYD88;DAPK2;HK2;BCL2L1;CSRNP1;DHCR24;PRKCE;PDE1B;BBC3;TNFRSF19;GADD45A;MX1;PRKCD;BCL2;TNFRSF10B;FADD;RNF152;TRAIP;IKBKG
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8271929351132217,1.6308898268461531,0.0,0.0578984001492684,0.96,8/27,1.52%,NPY;CNR1;NPY1R;HTR2C;ANXA1;HRH1;CHRM3;CHRM1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.6152455827721063,1.626516390316854,0.0,0.06211246291759986,0.97,57/290,13.49%,LEF1;CXCL2;IL13RA1;TLR2;ANXA1;SOCS3;IL1RAPL1;NPNT;STAT4;NUMBL;ZFP36;DUSP1;SLA;ICAM1;CSF2RA;TEC;IRAK2;PIM1;YBX3;DAB2IP;FOXO1;IL27RA;ERBIN;NLRP12;IL1R1;MYLK3;OSMR;FYN;BCL6;TNFRSF1A;PID1;CDK9;GHR;FOXO3;LAMA5;BCL2L1;CHI3L1;SMAD3;PTPN9;GAB2;FSCN1;SHMT1;STAT3;SYK;PDE1B;INPPL1;GAS6;TYK2;CCL2;STX4;CDKN1B;BCL2;FN1;IL4R;CDKN1A;CCND1;FGF2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.933574224875843,-1.6243562322566634,0.0,0.5288129324251546,1.0,1/12,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.7698685264665329,1.6240589115043924,0.0,0.06459983199633267,0.97,8/29,13.56%,LZTS1;YWHAH;IL1RAPL1;HECW2;PTPRD;CDKL5;HECW1;SS18L1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.8427278229998532,1.6240563740301772,0.0,0.06391983376479232,0.97,1/27,0.01%,LEF1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5804163256341863,-1.6234472589692464,0.0,0.5099645275845989,1.0,52/179,16.95%,SLC25A5;UQCRFS1;TIMM8B;PHYH;LRPPRC;COX7C;NDUFB4;OAT;RETSAT;UQCRB;MRPL15;MRPS22;NDUFB1;ATP5PF;ALAS1;SLC25A4;VDAC2;ATP5MC1;TIMM13;GLUD1;COX7B;NQO2;ATP5PB;ATP6V1G1;ATP5PD;NDUFA8;ECH1;COX5B;ETFB;PDHA1;COX11;CS;MPC1;ISCU;ATP5MC3;HTRA2;MTRF1;NDUFS3;NDUFC1;ETFDH;ATP6V1F;ATP5F1B;TIMM50;TIMM10;MRPS12;SUCLA2;ATP5F1A;ECHS1;OXA1L;IDH3G;ATP5MC2;AFG3L2
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6856639429786953,1.6231753353689296,0.0,0.06387051290540591,0.97,34/137,11.99%,LEF1;COL4A1;TEAD2;CD24;COL4A2;FBLIM1;EPHA2;THY1;FRAS1;LAMB1;GJC1;PARD3;PTPN21;ZIC1;PAWR;PML;MYO1B;ADGRL2;CTNNB1;SH3PXD2B;KITLG;SMAD3;YAP1;LMNA;GLI2;RBPMS;STAT3;PODXL;SMAD1;TEAD1;NR6A1;CTNNA1;ENAH;CD276
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.7482846757384283,1.623030168585332,0.0,0.06333408500177017,0.97,1/66,0.01%,LEF1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6857135221718641,-1.6223500941841966,0.03333333333333333,0.47649810546185956,1.0,13/50,13.26%,NDUFAF3;NDUFS5;DMAC2;TMEM126A;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;NDUFA8;FOXRED1;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6857135221718641,-1.6223500941841966,0.03333333333333333,0.47649810546185956,1.0,13/50,13.26%,NDUFAF3;NDUFS5;DMAC2;TMEM126A;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;NDUFA8;FOXRED1;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.9303392721155487,1.622175147833135,0.0,0.06353331927490695,0.97,1/11,0.53%,PTP4A3
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.8451800919409107,1.6219018492705684,0.0,0.06301113429488506,0.97,7/18,9.61%,PTK6;SRCIN1;THY1;PTPRC;DUSP22;MVP;ZFYVE28
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.8523800806063742,1.6216246563762409,0.0,0.06285450320204578,0.98,6/25,10.27%,GGT5;ANXA1;WNT8B;RAMP3;CTNNB1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.8310156117784342,1.6214596099479324,0.0,0.06246657755158472,0.98,4/24,2.65%,ANXA1;THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.6415145172006315,1.6209395023964126,0.0,0.062434405529154434,0.98,31/157,14.91%,LEF1;GPNMB;IGF1;PDGFRA;EGF;THBS1;FLT1;SEMA3C;NEDD9;SEMA5B;LAMB1;SEMA3D;FAM107A;NTRK3;SEMA3B;RHOD;PDGFA;MYO1C;MGAT5;MMP14;STAT3;PODXL;STX4;CFAP20;PAK1;PDPN;CEMIP;WASHC1;TRIM32;PIK3CD;BCAR1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.8519024136878627,1.620824140460451,0.0,0.061828246252172356,0.98,5/15,7.26%,GRIN2A;GRIN2D;GRIN2B;GRID2;GRIN1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.8328050867671165,1.620270093699647,0.018867924528301886,0.06294100440158504,0.99,11/21,7.01%,CACNA1H;SCN1B;SCN9A;CACNA1G;YWHAH;KCNJ2;SCN3B;SCN1A;SCN2A;KCNH2;CACNA1C
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7948251119494076,-1.6191530959902178,0.0,0.47734396008693974,1.0,5/16,10.54%,RTRAF;TRPT1;C2ORF49;CPSF1;CLP1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.73395154031406,1.617313335035389,0.0,0.06549810126515757,0.99,14/58,9.55%,CLIC1;SLC4A10;GABRB2;GLRA2;GABRG3;GABRD;CLIC4;GABRA1;GABRG2;GABRA5;SLC26A8;ANO9;TTYH3;CLCN4
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.7486368240644112,1.6172124574748163,0.0,0.06488019464944852,0.99,8/31,11.07%,TLR2;IL15;SFTPD;DYSF;PTPRC;PLSCR1;SYK;GAS6
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.6313106406179115,1.6130420258105467,0.0,0.07002640147648587,1.0,30/202,10.32%,LEF1;ENPP2;GPNMB;IGF1;PDGFRA;EGF;THBS1;FLT1;SHTN1;DMTN;DAB2IP;SEMA3C;PTPRC;NEDD9;SEMA5B;LAMB1;SEMA3D;FAM107A;NTRK3;SEMA3B;RHOD;PDGFA;MYO1C;MGAT5;PRKCE;ARHGEF7;MMP14;TGFB2;STAT3;PODXL
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.8743288862050254,1.6120675094885535,0.0,0.07080283369694074,1.0,2/13,0.90%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.6676321599358939,-1.6103488775116546,0.0,0.5142378414500067,1.0,35/92,20.22%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;EEFSEC;MTRES1;EEF1A1;MRPS26;MRPL21;EEF1B2;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3;EEF2;MRPL54;TSFM
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9112845061821901,-1.610337062320156,0.0,0.49587220425536366,1.0,2/9,3.59%,H1-2;H1-4
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.7118993594730487,1.6101879855428982,0.0,0.07330256165687193,1.0,15/56,12.85%,ANK3;YWHAH;KCNJ2;CHRM1;SYT4;SYT1;SYT5;SNCA;SYT13;ATP1A1;TF;PXK;SYT12;PER1;B2M
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.7539456648751147,1.6098864073412373,0.016129032258064516,0.07295900217597506,1.0,15/32,12.58%,PTK6;SRCIN1;RELN;APP;THY1;EFNA1;PTPRC;NEDD9;GRM5;RAP2B;MVP;EPHA4;DOK7;GAS6;DLG3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6887982574951503,-1.6097045374294858,0.0,0.4805426517151168,1.0,16/56,13.47%,PAK1IP1;RPL35A;RIOK2;RPS24;ZNF658;RPS28;RBIS;MRPL36;NOC2L;RIOK1;RPL14;URB2;RRP36;RPL11;NIP7;NOM1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.8161997392048368,1.609020912124497,0.0,0.0735813902197309,1.0,8/18,16.03%,TRPC3;THY1;SNCA;APLNR;GRIN1;RAMP3;CEMIP;P2RX7
prerank,PanglaoDB_Augmented_2021__Podocytes,0.645390627925233,1.6087599930659622,0.0,0.07334716374465255,1.0,47/163,15.20%,MET;COL4A1;CALD1;PTPRO;SULF1;COL4A2;DAB2IP;ANGPTL2;TDRD5;ARHGEF17;NUAK1;COL12A1;LAMB1;PTPN21;RHPN1;RHBDF1;LIMCH1;SCARA3;MYO1B;ENPEP;ADGRL2;KITLG;ITGA3;YAP1;TANC1;EPB41L1;PODXL;TEAD1;MAPT;CDKN1C;COL4A4;ENAH;WSB2;PRICKLE2;PARD3B;STARD13;CAP2;OPTN;COL4A5;NEBL;PALLD;PLOD2;NTN4;RBFOX2;LAMA3;BCAR1;SMARCA1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.8068695466051202,-1.6086814627045065,0.023809523809523808,0.46965608138343284,1.0,5/20,7.16%,ASIP;BLOC1S4;BLOC1S2;PMEL;SNAPIN
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.9290756147840149,-1.606674331072857,0.024390243902439025,0.4646743311327811,1.0,3/10,3.12%,AR;CEBPA;ZC3H8
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7993723652267014,-1.6033903728226582,0.0,0.4680219372397014,1.0,5/15,10.54%,RTRAF;TRPT1;C2ORF49;CPSF1;CLP1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.9243787306863963,1.6024110159737808,0.0,0.08285904376917523,1.0,3/6,7.04%,CCBE1;PROX1;APLNR
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.9435867876595412,1.601532807938583,0.0,0.08462421136826793,1.0,3/11,1.87%,APOLD1;MAFF;CD24
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.9555823233786216,-1.6012499864700278,0.022222222222222223,0.4647244925996317,1.0,3/9,2.08%,ACP3;TMEM100;SCN11A
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.8698898439419928,1.6006801879742316,0.0,0.08440300110648905,1.0,5/16,5.13%,GRIK1;GRIK2;GRID2;CDH8;UNC13C
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.7729643568191935,1.6006107377122696,0.0,0.08398151850003843,1.0,1/46,0.01%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.8689890889392742,1.599606178005328,0.0,0.08589417357756993,1.0,3/15,2.60%,NR4A3;IGF1;TRPC3
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.9568555612763097,-1.597957649019869,0.02127659574468085,0.4708922453976023,1.0,3/8,2.08%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7792484614234878,1.5970154340808398,0.01694915254237288,0.08827597883398813,1.0,9/32,7.26%,HTR2C;SLC24A2;GRIN2A;GRIN2D;GRIN2B;PTPRC;ITPR3;RYR2;GRIN1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.8459336178205624,1.5968534255489217,0.0,0.08793204644892064,1.0,11/23,9.70%,SHISA7;SHISA9;NLGN1;SHISA8;RELN;CACNG3;SHANK3;CACNG8;SHANK1;MINK1;CACNG4
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.6954681904568257,1.5954431003890603,0.015384615384615385,0.09005988923959166,1.0,25/80,9.70%,RIMBP2;CACNA1H;TMEM74B;STMN2;FAM163B;SYT4;SYT1;ADCY5;SHC2;ABCC8;PLPPR1;PRR36;DUSP8;SEMA5B;CPLX2;ST8SIA3;FAAH;RAP1GAP;KCNH2;SYT13;CELF3;C2CD4C;CPLX1;FTCD;CACNG4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.6422920062968237,1.5951412199426882,0.0,0.09000037812000142,1.0,28/145,12.93%,SCN1B;IL1RAPL1;STMN2;PTK6;CSMD3;PTPRO;RIT2;SRCIN1;PLPPR5;RELN;RTN4RL1;DAB2IP;PAK3;SHANK3;NTRK3;MFSD2A;DCC;NPTN;MAG;ZNF804A;PTPN9;SIPA1L1;EPHA4;CDKL5;KIF13B;CRMP1;CAMK2B;PAK1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.8972765441966524,-1.5944397246726918,0.0,0.47440360829499423,1.0,3/8,8.80%,HEY2;HEYL;HEY1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6596224598121209,1.5935733511738963,0.0,0.09227043398651714,1.0,38/124,11.44%,NPY;HAPLN2;RCAN2;CNTN2;GAP43;ADCY5;SHC2;PLP1;PLPPR4;DAB2IP;THY1;OPCML;BCAS1;CTHRC1;TCEAL7;PRIMA1;APOD;SEPTIN9;FAM107A;TMEM132C;SEMA3B;PHYHIP;NRN1;APLNR;GFAP;MATN2;MAG;BAG3;RASL12;EPB41L1;ART3;NDRG1;ZCCHC24;NACAD;SORBS1;LGI3;TCEAL6;FAM13C
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.7942099592092802,1.5929621838923238,0.0,0.0930600410276335,1.0,7/29,7.50%,SCN1B;ANK3;YWHAH;PKP2;SCN3B;FGF12;ATP1A1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.6731268533065592,1.5920386658045345,0.0,0.09431421111053585,1.0,16/85,6.63%,CDH6;CDH22;SLITRK1;FLRT3;CDH9;CDH19;PKP2;NLGN1;FBLIM1;ACHE;CDH8;SHANK3;CDH7;CDH18;GJC1;KIRREL3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7783922247232824,1.5917828012707131,0.0,0.09403317767176116,1.0,3/27,7.04%,TGFBR2;TBX20;APLNR
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.7726272111015782,1.5908944272587706,0.0,0.09460210552784518,1.0,5/30,4.42%,SCN1B;YWHAH;CHRM3;SCN3B;FGF12
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.8535183805736897,1.5896405083993905,0.0,0.09571329274675933,1.0,6/15,11.24%,THBS1;DMTN;APOD;FAM107A;DUSP22;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.8535183805736897,1.5896405083993905,0.0,0.09571329274675933,1.0,6/15,11.24%,THBS1;DMTN;APOD;FAM107A;DUSP22;PHLDB2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.8203374784433363,1.587319391951637,0.03389830508474576,0.09900875772640096,1.0,5/16,9.86%,THBS1;SLIT2;SLIT3;YAP1;TGFB2
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.9500667174487653,1.5866218014294893,0.0,0.09943085252301026,1.0,1/10,0.01%,GGT5
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8784074448358132,-1.586145242824828,0.017543859649122806,0.5050065391219708,1.0,2/10,0.96%,EYS;REEP6
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.7460072887348329,1.5848442358444752,0.01639344262295082,0.1013826031723169,1.0,10/37,9.58%,HPN;ADAMTS4;CTSS;TIMP2;TLL1;CD44;CAPN1;SH3PXD2B;SCUBE3;MMP14
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6934111441808455,1.5836365242164536,0.015384615384615385,0.10303575897270814,1.0,22/73,11.67%,MYT1;PCDH8;STMN2;CAMKV;SYT4;PLPPR5;GAP43;ZDHHC22;KCNB2;ACHE;EFNB3;CDK5R2;VGF;SULT4A1;NYAP1;KIF5A;CELF3;C2CD4C;KCNQ2;CACNG4;CRMP1;NEFM
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8578374442518922,-1.5833451854789196,0.0,0.5074060906810072,1.0,4/14,6.53%,H1-2;H1-4;M1AP;NOC2L
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.8852513638493107,-1.5830995088685977,0.02631578947368421,0.495789526735619,1.0,3/12,4.40%,ID2;TNFAIP3;FOXJ1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.7844049916668883,1.5825188260107195,0.0,0.10350705467620923,1.0,4/38,2.75%,LEF1;PDGFRA;NR4A1;EPHA2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.9254184813405741,1.581700975580969,0.0,0.10476633892349874,1.0,5/10,2.67%,CACNA1H;CACNA1G;DOC2B;SYT4;SYT1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.604701717850613,1.5795112878140214,0.0,0.11004031738657662,1.0,62/268,15.18%,OPTC;COL4A1;KIF14;COL11A2;STMN2;ELMO1;CORO6;CORO7;P4HA2;MYO1F;NEFL;COL4A2;APP;TLL1;STMN4;SHROOM4;COL8A1;MYH11;COL21A1;COL23A1;COL12A1;COL27A1;FSD1;SNCA;RHOD;POF1B;TPM4;SCX;GFAP;CYP1B1;CLIP2;MYO1B;MYO1C;CLRN1;HOOK1;MYO15A;LOXL1;TGFB2;COL9A1;TPPP;P3H2;INPPL1;TLE6;MAPT;COL4A4;ACTN1;B4GALT7;FGF13;TSPAN14;B2M;COL4A5;KATNAL1;MTM1;PPP1R9B;COL5A1;PLOD2;ARHGAP17;RHOBTB2;CAMSAP3;LAMA3;BCAR1;CGNL1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.7825325273792039,-1.5793959232569614,0.023809523809523808,0.4999940672696435,1.0,2/29,2.65%,ACP3;TPP1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.9305540535819469,1.5790257392405869,0.01818181818181818,0.11001452870193014,1.0,3/6,3.05%,ACSL5;THBS1;IRS2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.6962761310615337,1.578948109012181,0.0,0.10938430595597062,1.0,20/70,12.25%,SLITRK1;CCK;ANK3;CNTN4;SHTN1;SLITRK5;APP;PLPPR4;PAK3;BAIAP2;MFSD2A;DVL1;PARD3;MAP1B;DCC;MINK1;SLITRK4;OPHN1;CDHR1;KLF7
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7237383853458405,-1.5774828801511838,0.03125,0.4994066682244489,1.0,2/19,1.88%,BUD23;TFB2M
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.7076402504047726,1.57550852916547,0.017241379310344827,0.11313776266205189,1.0,16/61,11.38%,KIF14;PROX1;TMEFF2;ATRNL1;SRCIN1;ITGA8;EPHA2;RELN;EFNA1;LAMB1;POF1B;LAMA5;RADIL;ACTN1;PXN;OPHN1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.7664665167501019,1.5748461503538216,0.0,0.11368635501731647,1.0,16/34,18.27%,LZTS1;CSMD3;DAB2IP;VLDLR;HECW2;MFSD2A;DCC;PACSIN1;CDKL5;HECW1;ALK;COBL;BCL11A;KIAA0319;CAMK1D;SEMA4D
prerank,PanglaoDB_Augmented_2021__Macrophages,0.6983431850801584,1.5745746621562142,0.0,0.11355070998163501,1.0,18/80,5.50%,NR4A3;CXCL2;HLA-DRA;GPNMB;TLR2;P2RY6;CTSS;ADGRE5;SLC15A3;MYO1F;PLEK;SLA;GPR34;NRP2;MARCHF1;SIGLEC1;PTPRC;AHR
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.7283139452578068,1.5741803837179118,0.0,0.1132490881911017,1.0,16/46,14.07%,ANXA1;IL1RAPL1;RIMS2;SYT1;SEPTIN4;SEPTIN5;RAB15;RAB3C;CPLX2;SNCA;CPLX1;SYTL4;LGI3;STX4;HAP1;RAB27B
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.9485498924187115,1.5741304215563927,0.0,0.11253491859998647,1.0,4/8,2.81%,SCN1B;ANK3;PKP2;SCN3B
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.7427631413467164,1.5728135553328568,0.0,0.11406569661730616,1.0,5/34,3.51%,ECM2;NPNT;PTPRO;DMTN;THY1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6922267049768722,-1.572557256900057,0.02631578947368421,0.514939791268351,1.0,10/24,15.37%,NIFK;NSA2;DDX18;RPL7L1;RPF1;SNU13;RRP15;ZNHIT3;RPF2;MAK16
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7771444173050565,1.571024215372846,0.0,0.11590401955807249,1.0,10/29,16.46%,NLGN1;SRCIN1;RELN;EFNA1;SHANK3;SIPA1L1;EPHA4;CAMK2B;NGEF;CUX2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.6779695286916727,1.568687071303833,0.0,0.1193496768379647,1.0,2/70,1.67%,LEF1;SP100
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.9437314777265116,1.5680626550466934,0.01639344262295082,0.11918081638032053,1.0,1/8,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.877905181433615,1.5680601707727295,0.0,0.11837006252739318,1.0,3/10,8.55%,NLGN1;SHANK1;PCLO
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6514897584092918,1.5680384329439905,0.0,0.11757026480761348,1.0,49/147,15.31%,NR4A3;FOSL2;FOSB;CXCL2;TLR2;SOCS3;KLF2;MAFF;PLK2;SERPINE1;ATF3;NR4A1;ZFP36;DUSP1;PLEK;ICAM1;IRS2;EFNA1;NFIL3;PMEPA1;BTG3;BCL6;KLF10;BIRC3;CD44;LDLR;TRIP10;SMAD3;NAMPT;CD83;NR4A2;B4GALT5;CCL2;KLF9;GADD45A;KLF6;RELB;SPSB1;PER1;KLF4;CDKN1A;CCND1;TNFAIP6;TNIP2;IFIH1;GPR183;SLC2A3;IER5;PFKFB3
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.8039459834230872,1.567757433156742,0.01694915254237288,0.11694008861766628,1.0,7/18,16.70%,NDST4;UGDH;HS6ST1;HS3ST3B1;NDST1;HS2ST1;HS6ST2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8192052142002813,1.5674981577333114,0.019230769230769232,0.11655505490197314,1.0,5/21,7.26%,GRIN2A;GRIN2D;GRIN2B;GRID2;GRIN1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.7540311126178477,-1.5673686163928502,0.023809523809523808,0.5323513632449346,1.0,13/25,16.95%,ATP5PF;ATP5MC1;APOO;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;SAMM50;ATP5F1B;ATP5F1A;LETM1;ATP5MC2;AFG3L2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.8043785702358253,1.5662299337279582,0.03076923076923077,0.11774293636830767,1.0,2/25,1.67%,LEF1;SP100
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.9015874888745433,1.5657003871962283,0.0,0.11766918715716519,1.0,4/13,5.47%,HPN;COL4A1;CTSS;LAMB1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.9230604779507114,-1.56558182282062,0.0,0.5296885916529509,1.0,1/9,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.8332547094648446,1.563825008948116,0.01818181818181818,0.12069104414557735,1.0,3/13,2.91%,SPOCK3;SP100;WAS
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.8799895645572355,1.5634234456753329,0.0,0.12106029122119757,1.0,1/14,0.01%,LEF1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.6302074757448771,1.5629135631997995,0.0,0.12150114160069841,1.0,35/111,10.81%,ECM2;COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;COL4A2;ICAM1;ASPN;THY1;PODN;ANGPTL2;MCAM;POSTN;SLIT3;FAP;SLC38A11;COLEC11;ABCC9;TNS1;ZIC1;LDB2;STEAP4;APLNR;C1R;MYO1B;ADGRF5;BGN;PDZD2;RASL12;LHFPL6;LAMA2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.7463725484746334,1.5611576536052587,0.015873015873015872,0.12390917442771351,1.0,9/37,11.51%,MTMR7;SGPP2;PLPPR5;PLPPR4;PLPPR1;MTMR11;SYNJ2;PLPP4;INPP5J
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8557470431778139,1.5610173575446236,0.0,0.12319533896163086,1.0,7/19,9.86%,TGFBR2;NRP2;SEMA3C;TBX20;ROBO2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.6400721798996131,1.5599006956015122,0.0,0.12481298998141584,1.0,24/120,11.49%,MRAP2;ANK3;TESC;FYB1;PKP2;S100A10;EPHA2;ZDHHC22;SCN3B;KCNB2;KCNIP4;RAB15;RAB3C;TNFRSF1A;RAMP3;RAB40B;MRAP;PLEKHF1;ATP1B1;PACSIN1;ATP1B3;GAS6;FGF13;TSPAN14
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.7333722728709184,1.5598783359841537,0.01694915254237288,0.12417689578345398,1.0,12/36,4.33%,CACNA1H;SCN9A;ANK3;CACNA1G;YWHAH;KCNJ2;SCN3B;KCNQ1;KCNE4;SCN1A;SCN2A;KCNMB4
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.7156653891915037,1.559435907226689,0.0,0.12428856565376283,1.0,12/59,6.82%,LEF1;EPHA7;GRID2;CAMKV;ZDHHC22;CNTNAP2;EFNB3;UNC5D;FRAS1;SEMA5B;ADAMTS19;CCKBR
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.7771842480508565,1.558569971890519,0.0,0.1254281532122564,1.0,8/29,7.39%,RIMS2;SYT4;SYT1;SYT5;RIMS3;SEPTIN5;RAB15;SYT13
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.8166342053247724,1.5585122607913218,0.017857142857142856,0.12472697329275319,1.0,7/18,7.26%,TGFBR2;GRIN3A;GRIN2A;GRIN2B;SLIT2;SLIT3;GRIN1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.5932420160101932,1.558448681060132,0.0,0.12425225581863172,1.0,54/217,11.55%,OPTC;ECM2;COL4A1;ADAMTS4;CTSS;COL11A2;NPNT;ADAMTSL2;DCN;THBS1;SERPINE1;P4HA2;ITGA8;COL4A2;TIMP2;ICAM1;APP;TLL1;ADAMTS10;COL8A1;COL21A1;POSTN;COL23A1;COL12A1;LAMB1;ITGA2;COL27A1;ADAMTS19;CD44;AGRN;SCX;CYP1B1;PDGFA;ITGA11;LAMA5;CAPN1;SH3PXD2B;SCUBE3;ITGA3;BGN;LOXL1;MMP14;ADAM19;TGFB2;ITGA9;COL9A1;P3H2;ADAM12;LAMA2;ITGB8;COL4A4;GAS6;MMP17;SPARC
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.6126818083894702,1.55841032870791,0.0,0.12349462011242056,1.0,36/168,13.10%,MRAP2;ANK3;RFTN1;TESC;FYB1;PKP2;S100A10;NLGN1;EPHA2;ZDHHC22;SCN3B;KCNB2;THY1;SHANK3;KCNIP4;RAB15;RAB3C;DVL1;TNFRSF1A;AGRN;RAMP3;RAB40B;MRAP;SH3PXD2B;PLEKHF1;ATP1B1;PACSIN1;ATP1B3;SYNE3;LRRC4;GAS6;FGF13;TSPAN14;ITGAL;DLG3;PICK1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.8797212758166932,-1.5578255937808656,0.023255813953488372,0.5408811270694152,1.0,1/8,0.74%,AKR7A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.8797212758166932,-1.5578255937808656,0.023255813953488372,0.5408811270694152,1.0,1/8,0.74%,AKR7A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.8797212758166932,-1.5578255937808656,0.023255813953488372,0.5408811270694152,1.0,1/8,0.74%,AKR7A2
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.9147948427108522,1.557600629850199,0.0,0.12403747764234109,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7813119175906409,1.5571729779092451,0.014925373134328358,0.12421725838718006,1.0,9/29,5.22%,CDH6;CDH22;CDH9;CDH19;CDH23;NLGN1;CDH8;CDH7;CDH18
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.8791306664105994,1.5566037185662212,0.0,0.12467840717705665,1.0,3/16,1.03%,NR4A3;IGF1;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.6159120302768236,1.5565477192976842,0.0,0.12407719054210678,1.0,35/195,11.49%,C3;TLR2;IGF1;KLF2;P2RY6;CCBE1;RIMS2;NLGN1;SULF1;DMTN;PRKCB;SLC39A14;RELN;DAB2IP;PTPRC;SHANK3;FAS;NTRK3;GRIN1;NPTN;MYO1C;NECAB2;SHANK1;MGAT5;YAP1;CTBP2;TGFB2;DLG5;STAT3;KLK6;HOMER1;SORBS1;GAS6;TSPAN14;ASXL1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7913649879008109,1.5558674766948621,0.03333333333333333,0.12446366929655484,1.0,6/27,7.48%,EGF;PTK6;ERBIN;PTPRR;NRG1;NRG2
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.788611680255483,1.5545428055012394,0.0,0.12721300249267492,1.0,13/29,12.58%,GRIN2A;GRIN2B;NLGN1;NEFL;RELN;APP;GRIA3;GRIN1;CAPN1;GRIA1;CCL2;CAMK2B;DLG3
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.9146692804538664,-1.5544843548972433,0.0,0.525120361121233,1.0,3/8,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.9146692804538664,-1.5544843548972433,0.0,0.525120361121233,1.0,3/8,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.9146692804538664,-1.5544843548972433,0.0,0.525120361121233,1.0,3/8,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.8700176988775109,-1.5540989383925667,0.043478260869565216,0.5168171759240169,1.0,5/11,9.03%,CHAMP1;IK;KNL1;SPDL1;MIS12
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7068432870039818,1.553745607366004,0.0,0.12799195649891812,1.0,8/47,3.57%,IL1RAPL1;S100A10;NLGN1;GRID2;EPHA2;CLSTN2;THY1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.7985172122311522,1.5536233328523676,0.0,0.12724781721694767,1.0,4/18,9.86%,EPHA7;FOXO3;CTNNB1;TGFB2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6346021513212488,1.5534291661295985,0.0,0.12678596870708644,1.0,35/115,14.24%,COL4A1;CSPG4;PRRX1;GPNMB;CALD1;PPFIBP1;COL4A2;NRP2;ANGPTL2;OSMR;POSTN;COL12A1;LAMB1;AHR;FAP;PTPN21;MLANA;RHBDF1;TYR;EMP1;SH3PXD2B;YAP1;TANC1;PPARG;MMP14;PXDC1;TEAD1;KLC2;PRICKLE2;STARD13;FN1;CCND1;HMCN1;PALLD;THBS2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6368778404680276,1.5531207692016347,0.0,0.12687365897332661,1.0,25/115,10.99%,SLITRK1;L1CAM;FLRT3;ANK3;NLGN1;CNTN2;SNCB;ARHGAP39;PPFIBP1;APP;ACHE;CBLN2;PAK3;SHANK3;UNC13C;DVL1;GRM5;AGRN;KIRREL3;SNCA;PTPRD;DNER;DOK7;MAPT;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.741104999143923,1.5528765305049792,0.0,0.12668978692217567,1.0,5/33,2.81%,SCN1B;ANK3;CHRM1;PKP2;SCN3B
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.7184034701280805,1.5528480696376565,0.0,0.1261044700220808,1.0,5/54,7.89%,NR4A3;THBS1;PRKCB;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.6962545226343122,1.5511442129250828,0.0,0.1296720628478053,1.0,9/56,9.61%,CDKN2A;THBS1;THY1;SKAP1;LIMCH1;CDK6;SLC9A1;PLEKHA2;MINK1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.7755060089335424,1.5499366812108952,0.0,0.13087206913140997,1.0,5/30,9.88%,PROX1;SULF1;ITGA8;TGFB2;GLI2
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.8040413002830082,-1.5492609074222004,0.022727272727272728,0.5347128061291455,1.0,1/10,0.12%,DAO
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.8441580102770216,1.5490614618536351,0.019230769230769232,0.1321247960501294,1.0,3/14,3.70%,KIF14;STMN2;STMN4
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.9529968049177457,-1.5484879511228395,0.038461538461538464,0.5296459710710669,1.0,1/5,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.7010713187601504,1.548088678561657,0.0,0.13448154326028838,1.0,17/71,7.42%,SLITRK1;CCK;L1CAM;ANK3;CNTN4;SHTN1;GAP43;PLP1;SLITRK5;RTN4RL1;APP;PLPPR4;PAK3;BAIAP2;PARD3;MAP1B;DCC
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.6598938438897926,1.5477982459784132,0.015625,0.13419633608077944,1.0,15/74,13.18%,CDKN2A;SH3GL2;SLIT2;IRS2;DAB2IP;NTRK3;PID1;HDAC4;NIBAN1;TERF2IP;MAPT;CDKN1C;FBP1;CDKN1B;CDKN1A
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.6887413292981893,1.5475412652592553,0.0,0.13410937853378282,1.0,31/70,19.88%,NPNT;SH3GL2;CEP170B;APP;ABCC8;PCP4;PRR36;ARHGEF17;CYS1;CDK5R2;GLIS2;SCG5;EPB41L1;GLIS3;CRMP1;INPP5J;CD276;STARD13;CAMSAP3;SPP1;BCAR1;PDZRN3;SCAMP5;SEZ6L2;SLC8A2;LRP2;SLC7A8;CAMK1G;TMEM151A;ARNT2;FGFR1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.9137775404934508,1.5475198170260895,0.03636363636363636,0.13337654039971844,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7648394084160791,1.5474391041829696,0.0,0.1329089941204317,1.0,12/29,12.58%,EGF;SRCIN1;RELN;EFNA1;TGFA;FYN;NEDD9;GRM5;EPHA4;DOK7;GAS6;DLG3
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.8261674480462865,-1.547299981145891,0.05405405405405406,0.5261534958423552,1.0,2/11,6.59%,APOE;ZNF502
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.9261247371458403,1.5472152009425653,0.0,0.1327664214834275,1.0,3/10,2.13%,SIX3;KIF14;NUMBL
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.6849495404388264,1.546712650572334,0.014492753623188406,0.133261780071162,1.0,36/93,17.27%,COL4A1;CSPG4;BOK;TEAD2;AMH;COL4A2;EPHA2;DAB2IP;ARHGEF17;MCAM;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;GLIS2;LARP6;SCARA3;YAP1;GLI2;TEAD1;ENAH;CD276;MEIS3;CAP2;COL4A5;RBFOX2;BCAR1;MTCL1;SMARCA1;SEZ6L2;FZD7;FSTL1;FHL1;ADAMTS1;MAGI1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8027375146668232,1.5466848933541837,0.0196078431372549,0.132612449729887,1.0,8/27,6.38%,SHISA7;SHISA9;SLC4A10;GRIK2;SHISA8;APP;NETO1;SYP
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.7956305359015343,1.546542174114462,0.0,0.13209595275663347,1.0,7/24,8.28%,SOCS3;PTK6;SRCIN1;DMTN;THY1;PTPRC;MVP
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.9291024142641084,1.546283988045492,0.0,0.13171018068524226,1.0,2/12,0.42%,NR4A3;MET
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.6694899943237138,-1.5460858714187395,0.0,0.5225188626560391,1.0,14/52,13.26%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;UQCRHL;NDUFV3;COX7B;NDUFA8;COX5B;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.7727205343821765,1.5458951713834794,0.0,0.13220066983322545,1.0,8/29,12.81%,CLIC1;PDGFRA;PLEK;MYH9;RAP2B;P2RY12;ACTN1;FN1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.8287769596148222,1.5454424833780325,0.017241379310344827,0.13225220598610316,1.0,7/20,7.39%,RIMS2;DOC2B;SYT4;SYT1;SYT5;RIMS3;SYT13
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7795963672294322,1.545337642817766,0.0,0.13180999671019095,1.0,3/25,7.04%,TGFBR2;TBX20;APLNR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.6334906785672694,1.545033063330796,0.0,0.13216968121581985,1.0,34/120,17.81%,TGFBR2;KIF14;SRCIN1;RELN;DAB2IP;EFNA1;AGAP2;PAK3;PTPRC;INCENP;NEDD9;GRM5;SNCA;PAK4;MMD;MINK1;TGFB2;EPHA4;DOK7;GAS6;PRKCD;DLG3;PAK1;CDKN1A;IQGAP1;NOX4;CD4;STK3;SYAP1;SLC8A2;CALM3;MAP2K3;RAP1A;STK11
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.6921978185330222,1.5445696592211233,0.027777777777777776,0.13313581259524324,1.0,10/53,5.57%,CDH6;CDH22;CDH9;CDH19;PKP2;CNTNAP1;CDH8;CDH7;CDH18;GJC1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.6310771025270291,1.5444510922590684,0.0,0.13275657781918404,1.0,24/123,11.49%,MRAP2;ANK3;TESC;FYB1;PKP2;S100A10;EPHA2;ZDHHC22;SCN3B;KCNB2;KCNIP4;RAB15;RAB3C;TNFRSF1A;RAMP3;RAB40B;MRAP;PLEKHF1;ATP1B1;PACSIN1;ATP1B3;GAS6;FGF13;TSPAN14
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7527648524915227,1.5443667364440183,0.017241379310344827,0.13250199856382686,1.0,3/22,3.84%,EGF;PTK6;TGFA
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.9507954129551116,-1.5426752769791698,0.018867924528301886,0.5354105985007803,1.0,1/5,0.04%,ACP3
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.6653081689075306,1.5421274942532914,0.0,0.13597535609111208,1.0,20/72,16.77%,CACNA1G;SLC24A2;GRIN2A;GRIN2D;GRIN2B;TRPC3;ATP2B3;TRPM4;CACNA1C;GRIN1;ORAI1;MCOLN2;GAS6;MCUB;STOML2;SLC24A1;P2RX7;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8304797508369128,1.5421124334700456,0.016129032258064516,0.1352886118684297,1.0,6/19,9.86%,PROX1;PKP2;NRG1;RYR2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.7442300260657166,1.5417878991177698,0.016666666666666666,0.13526307647602617,1.0,7/43,6.55%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINE3;BIRC3;SERPINF1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.7736213612274688,1.5407861990701646,0.0,0.13665823718787543,1.0,4/29,7.18%,TGFBR2;TBX20;APLNR;RYR2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.78814276977124,1.5406174846792782,0.012658227848101266,0.13627279835243175,1.0,6/28,11.16%,CHST8;IGF1;PXYLP1;UGDH;HS3ST3B1;B4GALT7
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.6362647954041177,-1.5405707185733786,0.0,0.53776214759267,1.0,6/43,6.53%,H1-2;H2BC21;PADI4;H1-4;M1AP;NOC2L
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7412885870842667,1.5405577773342727,0.0,0.135656779579661,1.0,12/42,10.04%,IL1RAPL2;SLITRK1;TLR2;IL1RAPL1;NLGN1;GRID2;CLSTN2;APP;ROBO2;SNCA;PTPRD;DLG5
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.9354853135166165,1.5405264561113758,0.0,0.13522176108424866,1.0,6/11,5.13%,RIMS2;DOC2B;SYT1;SYT5;RIMS3;UNC13C
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.5719317420030173,1.5405058778471648,0.0,0.13461693385468243,1.0,83/337,18.66%,TGFBR2;VRK2;MAP3K6;EPHA7;PLK2;FAM20C;PTK6;PIM3;PRKCB;PRKCG;TEC;APP;PIM1;MAP3K11;NUAK2;NEK10;PAK3;PRKG2;MYLK3;PRKAR1B;FYN;NUAK1;CDK9;STK25;PAK4;AATK;DAPK2;CDK6;GRK2;DGKG;SIK2;LIMK2;PRKCE;PRKCH;IKBKE;MINK1;MAK;HIPK3;HUNK;TGFB2;STAT3;SYK;CDKL5;MAP3K21;PGK1;GAS6;TYK2;PDK4;CCL2;PXK;CAMK2B;PRKCD;HIPK1;ALK;PAK1;PICK1;HK1;GRK5;HIPK2;PDK1;BMX;PIK3CD;NEK6;RARA;MAP3K5;STK3;PINK1;CDK2;CDK19;CILK1;LIPE;CDC25B;MAPK9;CDK18;CDK20;FAM20A;STK11;STK24;PDK3;CAMK2A;PRKCA;NEK4;RPS6KA4
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.8077027219582403,-1.54003478600734,0.02564102564102564,0.5310285229290198,1.0,2/15,3.73%,DAO;THNSL2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6910322022544435,1.5396749181934708,0.0,0.13592347667779686,1.0,29/86,12.06%,HPN;SLC24A2;KCNH8;KCNJ2;KCNV1;KCNH7;KCNK10;KCNQ1;KCNC2;KCNB2;ABCC8;KCNF1;KCNK1;KCNMB4;KCNQ5;SLC9A9;KCND3;ABCC9;KCNH2;SLC9A1;KCNC1;LRRC55;HCN1;KCNQ2;KCNK12;ATP1B3;KCNAB3;SLC9C2;KCNH3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.6302593574624553,1.5385568310850444,0.014705882352941176,0.13733225700993673,1.0,21/123,8.08%,CDKN2A;ARHGAP4;RASGRP2;IGF1;PLD1;PLK2;RASGRP1;ELMO1;RIT2;SHTN1;CDC42EP3;SHC2;WAS;EPS8L2;ARHGDIG;WASF1;ARHGEF3;RHOD;CDC42EP1;RAP2B;MRAS
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.6323065131578427,1.5379783565844027,0.0,0.1382127734921301,1.0,34/141,11.41%,CA10;SOCS3;GRIN2A;TMEM235;RGS7BP;STMN2;VSTM2B;RCAN2;CNTN2;GAP43;ADCY5;OPALIN;PLP1;PLPPR4;C11ORF87;OPCML;IGSF21;TCEAL7;SYNPR;FAM107A;TMEM132C;GRM5;PHYHIP;TCEAL5;GRIA3;LUZP2;GFAP;ALDH1L1;LY6H;TEAD1;NACAD;SORBS1;LGI3;TCEAL6
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.7073258724945349,1.5377527854608444,0.015873015873015872,0.13811737584326117,1.0,9/51,9.38%,ECM2;NPNT;S100A10;DMTN;NEDD9;SKAP1;CDK6;PLEKHA2;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.7518981124303374,1.536796079712051,0.07575757575757576,0.13938216453584432,1.0,6/31,6.55%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINE3;SERPINF1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.6964946981245774,1.5365804898701714,0.0,0.1391693735143494,1.0,18/64,12.92%,L1CAM;SNCB;PPFIBP1;FBLIM1;APP;TJP3;CBLN2;PAK3;DVL1;GRM5;AGRN;SNCA;SMAD3;TGFB2;MAPT;OPHN1;SDK2;MYO9A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.7830813303221618,1.5362791125976563,0.0,0.13923909724786251,1.0,8/30,13.49%,NR4A3;IGF1;P2RY6;PPARG;CDKN1B;MEF2D;CDKN1A;FGF2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8812786037920818,1.5355660467513585,0.018518518518518517,0.139866512561849,1.0,1/9,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.8899162119499093,1.5337403468130921,0.0,0.14382240461074816,1.0,6/15,4.83%,CACNA1H;CACNA1G;DOC2B;NLGN1;SYT4;RAB15
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.8175412798043311,1.5327634073780552,0.018518518518518517,0.14525223560604417,1.0,4/19,4.42%,SCN1B;YWHAH;SCN3B;FGF12
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.6413994646330672,1.5325018980182386,0.0,0.14518225808592367,1.0,20/107,11.24%,ARHGAP4;TMEFF2;SERPINE1;SULF1;SLIT2;DAB2IP;THY1;DUSP10;PODN;PTPRR;CLIC4;FOXO3;LIMCH1;CYP1B1;RAP2B;DUSP22;LDLRAD4;DLG5;EPHA4;PHLDB2
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.7932175699819013,1.5321096985870484,0.0,0.14566093805454217,1.0,7/24,8.06%,PLEK;WAS;SHANK3;FHOD1;SYNPO2L;SLC9A1;SHANK1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.5731867605074623,1.5318117724176885,0.0,0.1455897220671025,1.0,78/376,15.54%,CXCL2;HLA-DRA;ST18;IL13RA1;ANXA1;SOCS3;IL15;SP100;STAT4;NUMBL;SLA;ICAM1;CSF2RA;TRAF3IP2;TEC;IRS2;IRAK2;LMNB1;PIM1;IRF7;FOXO1;NOD1;IL27RA;IL1R1;MAP3K14;OSMR;FYN;TNFRSF14;TRIM5;BCL6;CIITA;SAMHD1;BIRC3;CD44;TNFRSF1A;GHR;FOXO3;TCP1;PML;MYD88;LAMA5;BCL2L1;YAP1;GAB2;FSCN1;STAT3;SYK;INPPL1;TYK2;CCL2;HLA-DRB1;EIF5A;STX4;MX1;CAMK2B;PRKCD;CDKN1B;TRIM22;BCL2;IL17RE;ADIPOR2;FN1;B2M;IL4R;CDKN1A;CCND1;FGF2;TNIP2;CD70;IL12A;IKBKG;PIK3CD;HLA-E;INPP5D;CD4;STAT6;TP53;TNFRSF11B
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.7696502330962002,1.5318079324957858,0.016129032258064516,0.1449218793053268,1.0,4/29,1.71%,GGT5;CSPG4;DCN;OGN
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6206232024379119,1.5317063631930108,0.0,0.14453038684851569,1.0,51/144,12.84%,SLITRK1;CA10;PCDH8;TAGLN3;STMN2;SH3GL2;VSTM2B;CNTN2;SNCB;SYT16;NELL1;CAMKV;NEFL;SYT4;PLPPR5;GAP43;ZDHHC22;C11ORF87;STMN4;OPCML;OLFM3;RTN2;ATP2B3;FGF12;GRIP1;GALNTL6;CDK5R2;HPCA;ST8SIA3;MTUS2;TCEAL5;SULT4A1;NYAP1;KIF5A;CELF3;KCNC1;SRRM3;KCNQ2;RBPMS;LY6H;DNER;BBC3;NACAD;CRMP1;NEFM;PIANP;SLC29A4;FXYD7;ERC2;TMEM196;CCDC184
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.6679170906208526,1.531361246269012,0.0,0.1447343037266762,1.0,35/92,17.57%,COL4A1;COL4A2;EPHA2;SLIT2;DAB2IP;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;LARP6;SCARA3;MYO1B;ADGRL2;KITLG;PKDCC;YAP1;TANC1;GLI2;TEAD1;ENAH;CD276;FN1;CAP2;CCND1;PLOD2;RBFOX2;BCAR1;SMARCA1;FZD7;FSTL1;MESP1;MAGI1;WWTR1;WNT5A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.7357973062745428,1.5308613780392466,0.029411764705882353,0.14525774188881915,1.0,13/26,9.40%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNQ1;SCN1A;FGF12;KCND3;KCNH2;CACNA1C;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.9572634346991327,1.5306502551299892,0.0,0.144976666672064,1.0,1/7,0.08%,ENPP2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.6617548124314723,-1.530474299933673,0.0,0.5802659952719886,1.0,15/53,14.38%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;UQCRHL;NDUFV3;COX7B;NDUFA8;COX5B;NDUFS3;NDUFC1;COA6
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6002846260875252,-1.5292590407189737,0.03125,0.5778859683189331,1.0,15/49,15.37%,PAK1IP1;RPL35A;NSA2;NOC2L;RPL6;RPF1;SNU13;RPL14;RRP15;MDN1;RPL11;RPL23A;NIP7;RPF2;MAK16
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.6413539627361657,1.5280671918832585,0.0,0.1502185098441806,1.0,44/123,20.30%,PROX1;GAS2L3;ELMO1;CORO6;CORO7;MYO1F;DMTN;WAS;SHROOM4;BAIAP2L1;NEDD9;BAIAP2;FHOD1;RHOD;POF1B;TPM4;MYO1B;MYO1C;CLRN1;MYO15A;TCAP;INPPL1;TLE6;ACTN1;ENAH;NEBL;PPP1R9B;COBL;SPIRE1;ARHGAP17;RHOBTB2;BCAR1;CGNL1;NEB;SPIRE2;ERMN;MPRIP;FLNA;DSTN;CAPG;FHOD3;RHOB;SAMD14;MYO1E
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.613249447098565,1.5274826549181157,0.014285714285714285,0.15081614216659828,1.0,17/120,9.59%,MTMR7;PTPRO;DUSP1;PTPRB;DUSP10;PTPRR;PTPRC;DUSP8;DUSP16;PDP1;PTPN21;SBF1;DUSP22;PTPRD;SSH2;PTPN9;PPP1CB
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.688930414013701,1.5271814671351718,0.03125,0.15088237303491717,1.0,19/61,11.84%,SLC6A15;SCN1B;SCN9A;SLC24A2;SCN3B;SCN1A;SCN2A;KCNK1;ASIC3;TRPM4;SLC9A9;ASIC4;ATP1A1;SLC9A1;HCN1;ATP1B1;ATP1B3;SCN3A;SLC9C2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.6984831575459991,1.5271357280226485,0.0,0.15031950418301698,1.0,17/60,11.20%,SLC6A15;SCN1B;SCN9A;SLC24A2;SCN3B;SCN1A;SCN2A;KCNK1;ASIC3;SLC5A4;ASIC4;HCN1;ATP1B1;ATP1B3;SLC4A11;SCN3A;FGF13
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6717718977918297,1.5268410491721218,0.0,0.1503351939499888,1.0,16/56,18.53%,EGF;PTK6;ERBIN;TGFA;PTPRR;REPS2;NRG1;NRG2;MVP;GAB1;IQGAP1;BCAR1;SHC1;NCK2;ADAM17;PRKCA
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6918786096070557,1.5263212599174398,0.03076923076923077,0.15086991302833536,1.0,15/47,19.98%,EGF;SP100;ZSWIM4;NRG1;NRG2;CDK6;YTHDF1;ACTN1;ARHGAP18;PDPN;ETS1;INPP5F;ADAM17;TGFBR3;ACTN4
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.886714366135816,1.5258525354642647,0.0196078431372549,0.15083137225106258,1.0,1/9,0.11%,CACNA1H
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6561795987616487,1.5243564638252722,0.0,0.15357228981814836,1.0,22/73,11.55%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;ABCA8;THY1;PODN;ANGPTL2;POSTN;FAP;IGFBP7;TNS1;LDB2;C1R;ITGA11;BGN;ZCCHC24;LAMA2;SPARC
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.7926796956407823,1.5239862237998667,0.015873015873015872,0.15372735393167947,1.0,7/28,7.53%,EPHA7;SLIT2;SEMA3C;SLIT3;SEMA3D;SEMA3B;PDGFA
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.8454044007667744,-1.523878428510711,0.07894736842105263,0.6041751619253578,1.0,2/9,1.79%,OTUD3;TNFAIP3
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.6380460251852881,1.523703823573382,0.0,0.15347290865620633,1.0,33/118,14.92%,HPN;MET;SCN1B;TLR2;HRH1;IL15;KCNJ2;SERPINE1;RASGRP1;SLC7A2;CD55;ICAM1;IRAK2;IRF7;IL1R1;OSMR;AHR;APLNR;LDLR;MMP14;NAMPT;ITGB8;CCL2;KLF6;PDPN;IL4R;CDKN1A;TNFAIP6;LPAR1;SLC7A1;CD70;CHST2;GPR183
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.7104642003580688,-1.5227780181676773,0.022222222222222223,0.600760158689492,1.0,4/27,7.42%,AR;RNF6;HEYL;TRIM68
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.864992434290512,-1.5226508890037094,0.0,0.5914251919405016,1.0,2/9,5.98%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7875798990008418,1.52209134747187,0.047619047619047616,0.15743726342162723,1.0,6/25,8.17%,SOCS3;EGF;PTPRC;GHR;CYP1B1;OCIAD2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.729390132586637,1.521205626610797,0.03225806451612903,0.15909138745668872,1.0,11/37,11.19%,SLC32A1;RIMS2;SYT1;GAD2;CPLX2;DVL1;SNCA;PCLO;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6864092235223187,1.5208577728275454,0.0,0.1594218076166806,1.0,8/62,7.87%,ANLN;ANK3;SEPTIN4;SEPTIN5;INCENP;SEPTIN8;SEPTIN9;TRIM36
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.7688087998538042,1.520702093962995,0.01694915254237288,0.15899707551349002,1.0,12/31,12.05%,RIMS2;DOC2B;SYT1;SYT5;RIMS3;UNC13C;CPLX2;SNCA;PCLO;CPLX1;DNAJC5;STX4
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.7148945857871081,1.520202039822285,0.028169014084507043,0.15937505043245218,1.0,19/50,16.17%,STMN2;NLGN1;PTPRO;RTN4RL1;THY1;EFNA1;EFNB3;DCC;MAG;MCF2;PTPN9;EPHA4;CRMP1;LPAR1;BCL11A;STX1B;NGEF;PTPRS;KIAA0319
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.8417138809583079,1.5190954930280147,0.030303030303030304,0.1620874091499052,1.0,4/13,9.40%,ANK3;TESC;SLC9A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.8298656225272392,1.519014301415256,0.0,0.1615082735990917,1.0,3/18,3.34%,TMEM204;PRKCB;DAB2IP
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.5946288406253454,1.5173426402870835,0.0,0.16487963292878144,1.0,49/147,11.55%,GGT5;APOLD1;TGFBR2;COL4A1;PROX1;PDGFRA;DCN;S100A10;ABCA8;CASZ1;CD55;FLT1;ICAM1;PTPRB;NRP2;PODN;ACKR1;SHROOM4;PCDH12;ANGPTL2;EGFL7;MCAM;POSTN;CLIC4;SEMA3D;IGFBP7;MFSD2A;CFH;TNS1;PLAC8;LDB2;ECE1;APLNR;RAMP3;C1R;CYP1B1;EMP1;ADGRF5;SPNS2;BGN;PRKCH;RASL12;RNASE1;PODXL;FLI1;SLCO2A1;CDKN1C;USHBP1;SPARC
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7828850947384753,1.516994908231756,0.0,0.16503046061910417,1.0,3/21,3.84%,IGF1;EGF;TGFA
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.8809280394093714,1.516844077874263,0.0,0.16488656230572,1.0,4/13,4.01%,NR4A3;C3;PRKCB;RTN2
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.6166245926397077,1.5167437450922427,0.0,0.16440286462137943,1.0,34/127,11.98%,COL4A1;PRRX1;TLR2;EDIL3;PDGFRA;RGS7BP;PCDH18;KCNJ2;RCAN2;COL4A2;PLP1;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;SYNPR;POSTN;FAM107A;PTPN21;CD44;LDB2;APLNR;SCARA3;BOC;ADGRL2;PTPRD;BGN;RASL12;COL9A1;DBI;FAM13C;SPARC;PRICKLE2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.7899149116300632,-1.5160041952677243,0.05263157894736842,0.6214838537904254,1.0,2/10,2.63%,PYGM;PPP1R3C
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6592223111443594,1.515974544063198,0.0,0.16620321074542993,1.0,16/89,9.98%,GGT5;CSPG4;PAPSS2;DCN;OGN;B3GNT2;CHSY3;CHST15;GGCT;CHST6;CHPF2;UGDH;BGN;GSS;OMD;UST
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8137703690821643,1.5155468281697326,0.0,0.16668437376306386,1.0,8/19,7.26%,GRIN2A;GRIN2D;GRIN2B;ITPR3;CACNA1C;JPH4;RYR2;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7731185560722135,1.5140860591729617,0.0,0.16985622793564956,1.0,7/23,17.04%,P2RY6;THY1;SNCA;APLNR;CEMIP;HAP1;CALM3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.9370206602039904,1.5138095428891762,0.0,0.16979155122856437,1.0,1/8,0.01%,LEF1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.6114503427203936,1.5136924881603202,0.0,0.16953647665213734,1.0,36/156,18.66%,TGFBR2;VRK2;SBK1;PLK2;CAMKV;PRKCB;PRKCG;RPS6KA1;STK32B;GRK2;GALNT16;PRKCE;PRKCH;IKBKE;HIPK3;GAS6;STK32A;CDC7;PRKCD;HIPK1;MAPKAPK5;RPS6KA6;STK32C;RPS6KB2;HIPK2;NEK6;PINK1;CDK2;MAPK9;CAMK1D;PDK3;HPF1;CAMK2A;PRKCA;CAMK1G;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.9699850571664947,1.5121012665883364,0.0,0.17284881419662715,1.0,2/5,1.69%,THBS1;ATF3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.8875750640714732,1.5121004110778566,0.014925373134328358,0.17215741893984066,1.0,2/12,0.90%,NR4A3;IGF1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7647642681554399,1.5113320125802736,0.03125,0.17335790830705072,1.0,7/30,8.74%,ANK3;P2RY6;CTSS;RELN;SHANK3;STAC2;LRRC55
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.857343696032159,1.5110329800942568,0.0,0.17360942504017668,1.0,6/14,7.01%,SCN1B;CACNA1G;KCNJ2;SCN3B;TRPM4;CACNA1C
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.9536986901722964,1.5100190208881719,0.0,0.17535612425006705,1.0,1/6,0.25%,HPN
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.7368298427820696,1.5099102923124479,0.014925373134328358,0.17489875774224667,1.0,11/26,7.01%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNQ1;KCNE4;TRPM4;KCND3;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5622728645712394,1.5097521339520696,0.0,0.17458423731981404,1.0,90/354,14.23%,IL1RAPL2;SLITRK1;MOBP;MET;L1CAM;HAPLN2;FLRT3;CHST8;MOG;GRIK1;PROX1;TAGLN3;CHRM3;CHRM1;SH3GL2;RAPGEF5;ZIC4;NLGN1;NUMBL;WDR62;MBP;NELL1;SH3GL3;CNTN4;UGT8;IGF2BP2;RELN;NRGN;WNT8B;ACHE;APBA2;EFNB3;SCN2A;VLDLR;FGF12;SRRM4;NINJ2;SHANK3;GFRA2;DVL1;NRSN1;NRG1;ZBTB16;NEUROD2;ZIC1;LDB2;KIRREL3;DPYSL2;ROBO2;EIF2B2;GLIS2;THOC6;NPTX1;MYT1L;KALRN;YAP1;ARHGAP26;TRAK1;NEURL1;KCNQ2;GSS;HDAC4;GDA;STAT3;ST8SIA4;LY6H;KLK6;PCDHB15;DNER;TEAD1;GFRAL;DCX;FGF13;OPHN1;CRMP1;PCDHA1;NPAS2;DPYSL4;SDK2;FN1;RPS6KA6;JARID2;RAPGEFL1;PCDHB2;FGF2;DPYSL5;LPAR1;HAP1;PCDHB5;ALDH3A2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.8147155616766588,1.5096311114973044,0.0,0.17431841239385637,1.0,5/16,8.31%,MRAP2;PID1;MRAP;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6942201385782379,1.5094776376039898,0.0,0.1740085977542768,1.0,32/95,12.06%,KCNT2;HPN;SLC24A2;KCNH8;KCNJ2;KCNV1;KCNH7;KCNK10;KCNQ1;KCNC2;KCNE4;KCNB2;ABCC8;KCNF1;KCNK1;KCNQ5;SLC9A9;KCND3;ABCC9;KCNH2;ATP1A1;SLC9A1;KCNC1;LRRC55;HCN1;KCNQ2;KCNK12;ATP1B1;ATP1B3;KCNAB3;SLC9C2;KCNH3
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.7584676361600439,1.5094462791467338,0.018518518518518517,0.17342590556339002,1.0,9/17,7.50%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;SCN1A;FGF12;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.9078916537054508,1.509290599657851,0.0,0.17316763201401267,1.0,1/10,0.15%,NR4A3
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.9526767715195525,1.5091889752689758,0.03389830508474576,0.17291134518424586,1.0,2/7,0.32%,CACNA1H;SERPINA10
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.717044266677572,-1.5088718653009017,0.04878048780487805,0.6602247788178265,1.0,4/36,6.79%,RITA1;NXT2;AAAS;GEMIN4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7792953273670835,1.508804453992629,0.0,0.17333730995390678,1.0,5/16,13.23%,THY1;SNCA;APLNR;RAMP3;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7479591103676027,1.5079055927994944,0.04918032786885246,0.1756123790244188,1.0,8/29,13.18%,CDKN2A;GPNMB;FAM107A;CDK6;GFI1B;CCL2;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.6541003713654221,1.5078802478515345,0.0,0.17507967423253212,1.0,17/70,12.93%,MET;PROX1;STMN2;PSRC1;PLEK;CDC42EP3;APP;BAIAP2L1;MYLK3;BAIAP2;CDC42EP1;SYNPO2L;PRKCE;FCHSD1;MAPT;ARF6;PAK1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.9031806629144637,-1.5078434428471286,0.04,0.6577365564623822,1.0,2/6,6.81%,PGP;MST1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.8065378256882512,1.507746686115771,0.017241379310344827,0.17473035366259515,1.0,4/18,3.77%,RIMS2;NLGN1;RIMS3;SEPTIN5
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.9307590713184744,1.5073095955686457,0.0,0.17509835664429482,1.0,1/8,0.71%,BOK
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.675489670303822,1.506993633993327,0.0,0.17555259273329554,1.0,15/71,10.44%,EPHA7;GRIN2B;EPHA2;EPHA5;EFNA1;EFNB3;PAK3;FYN;DNM1;GRIN1;KALRN;ARPC3;ARHGEF7;SIPA1L1;EPHA4
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.9379998094321687,-1.5067955157641895,0.06,0.6564344529789253,1.0,1/5,0.29%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.9257468906876297,1.5067574569532243,0.0,0.17547142602375362,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6852592532443675,1.506660138260252,0.029411764705882353,0.17503752156569372,1.0,7/43,5.22%,CDH6;CDH22;CDH9;CDH19;CDH8;CDH7;CDH18
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.6974701654327037,1.5066425933805632,0.03389830508474576,0.17438682445950157,1.0,9/42,8.41%,HTR2C;KCNC2;ABCC8;GIPR;ITPR3;CACNA1C;HADH;GLP1R;CACNA1E
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6375890036351638,1.505838597368704,0.014705882352941176,0.1761083485824216,1.0,32/87,16.85%,IL13RA1;TLR2;P2RY6;FAM20C;SLC15A3;SLC39A14;DYSF;NRP2;SIGLEC1;IL1R1;EGFL7;ITGA2;ITPR3;TNS1;SERPINF1;PID1;SLC7A7;CHI3L1;ARHGEF10L;MMP14;RNASE1;RIN2;CCL2;TNFAIP6;KCNMA1;KCTD12;SPP1;SERPING1;TNFRSF11B;CTSZ;RASSF4;CTSK
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.6126754695501654,1.5051481777602713,0.0,0.1771183038924647,1.0,22/105,13.49%,LZTS1;GPNMB;SP100;SRCIN1;EPHA2;PAK3;WTIP;SHANK3;HECW2;BCL6;PID1;CTNNB1;CYRIB;SIPA1L1;EPHA4;MAPT;KIF13B;PHLDB2;SPARC;HECW1;PAK1;FGF2
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.6202890077609936,1.5044556821649162,0.0,0.17846898030324979,1.0,28/118,7.74%,COL4A1;PRRX1;SOCS3;COL11A2;PDGFRA;PCDH18;NPNT;DCN;ACTA2;CALD1;SULF1;COL4A2;FOXO1;NOD1;THY1;PODN;ANGPTL2;OSMR;POSTN;FAS;OLFML1;COL12A1;FAP;ITGA2;IGFBP7;CD44;C1R;EMP1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.8185879716814499,1.5043563115965948,0.0,0.17816211975276874,1.0,5/13,9.86%,ANXA1;RELN;GCM2;CDK6;TGFB2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.8518197666996176,1.5034647668663823,0.05660377358490566,0.17932632465372594,1.0,3/12,8.06%,WAS;FHOD1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.8043268205564215,1.5030156350882666,0.0,0.18000858235983938,1.0,6/18,8.06%,RIMS2;NLGN1;RELN;SHANK3;GRIN1;SHANK1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.877786342821059,-1.501854976724725,0.047619047619047616,0.6836188663434439,1.0,4/11,8.06%,CSKMT;SMYD2;METTL18;KMT5A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.6442381597366789,1.5017458307757756,0.015384615384615385,0.18235851661828834,1.0,22/86,16.14%,ANK3;YWHAH;EPHA2;FYN;STAC2;RAMP3;MYO1C;NECAB2;YWHAG;ITGA3;PTPN9;PRKCE;PRKCH;BBC3;SORBS1;STX4;ARF6;BCL2;CEMIP;MTCL1;TP53;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8422669479089077,1.5015241370237966,0.0,0.1824266414907731,1.0,4/15,3.17%,HPN;KLF2;EGF;APP
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.603158599840897,1.5009701441321341,0.0,0.18372907187255452,1.0,47/156,15.54%,CDH6;ECM2;COL4A1;PRRX1;EDIL3;IL15;DCN;THBS1;SERPINE1;ACTA2;CALD1;COL4A2;SLIT2;THY1;CTHRC1;POSTN;FAS;SLIT3;PMEPA1;OXTR;COL12A1;FAP;ITGA2;CD44;TPM4;MATN2;BGN;BASP1;PDLIM4;LOXL1;MMP14;ADAM12;LAMA2;SPARC;ENO2;GADD45A;FN1;CAP2;FGF2;COL5A1;PLOD2;THBS2;SPP1;LAMA3;RGS4;CD59;TNFRSF11B
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.8228701478254755,1.5009149836114253,0.018518518518518517,0.1832826774617701,1.0,1/16,0.08%,ENPP2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8756357747365439,-1.50091128266965,0.04,0.6815432178121891,1.0,1/12,0.09%,NGF
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6823500612397201,1.5006515914735505,0.016129032258064516,0.18338904687279697,1.0,8/52,5.71%,ELMO1;SULF1;FLT1;SHC2;DAB2IP;NRP2;FYN;BAIAP2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.5575174557569819,1.500310228311705,0.0,0.18387378040287233,1.0,101/408,18.73%,TGFBR2;VRK2;TLR2;SBK1;PDGFRA;MAP3K6;PLK2;FAM20C;PTK6;PIM3;CAMKV;FLT1;PRKCB;PRKCG;RELN;TEC;APP;RPS6KA1;PIM1;MAP3K11;DAB2IP;NUAK2;NEK10;PAK3;INCENP;PRKG2;MYLK3;PRKAR1B;FYN;NUAK1;STK32B;CDK9;STK25;PAK4;AATK;DAPK2;CDK6;GRK2;SIK2;PKDCC;LIMK2;PRKCE;PRKCH;IKBKE;MINK1;MAK;HIPK3;HUNK;TGFB2;SYK;EPHA4;CDKL5;MAP3K21;GAS6;TYK2;STK32A;PDK4;CCL2;CDC7;PXK;CAMK2B;PRKCD;HIPK1;MAPKAPK5;ALK;PAK1;RPS6KA6;PICK1;STK32C;RPS6KB2;GRK5;HIPK2;PDK1;BMX;PIK3CD;NEK6;RARA;MAP3K5;STK3;PINK1;CDK2;CDK19;CILK1;LIPE;CDC25B;MAPK9;CDK18;CAMK1D;IGF1R;PRDX4;CDK20;FAM20A;STK11;STK24;PDK3;CAMK2A;PRKCA;NEK4;CAMK1G;RPS6KA4;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.7613103184060042,1.4987252279694916,0.06666666666666667,0.18712543927202796,1.0,5/25,5.16%,LEF1;HLA-DRA;DUSP10;SOX4;BCL6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.6443116385002599,1.4986298938084566,0.014492753623188406,0.18658969927021235,1.0,9/65,9.24%,IGF1;KIF14;EGF;TGFA;PLSCR1;NUDT16;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8087716989945524,1.4972447202932813,0.05555555555555555,0.18964217764071795,1.0,5/13,9.86%,TGFBR2;SLIT3;TBX20;APLNR;TGFB2
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.928144154481626,1.4967915091602366,0.0,0.19018123379401172,1.0,3/8,2.53%,TGFBR2;HLA-DRA;CD55
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.6451026859110733,1.4965554052393903,0.0,0.1905095796551017,1.0,23/89,15.53%,TGFBR2;IGF1;KIF14;ADCY5;PAK3;PRKAR1B;NTRK3;NRG1;GHR;ADCY7;PAK4;ADCY2;CHI3L1;MINK1;TGFB2;GAS6;PRR5;PRKCD;PAK1;TNFRSF10B;PRKAR1A;STK3;PINK1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8126910040389974,-1.4963028425491252,0.08163265306122448,0.7027948645775253,1.0,2/9,9.03%,CHAMP1;MIS12
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.8720881587260843,-1.4959693926372533,0.022222222222222223,0.6955825091159717,1.0,2/8,3.73%,DAO;THNSL2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8363314709347003,-1.4956256513988844,0.0625,0.6887798183176739,1.0,3/12,5.10%,RPP25L;POP5;TRMT10C
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.7294151525708341,-1.495167967410297,0.027777777777777776,0.6829806178286654,1.0,5/24,9.23%,DAO;IDO1;THNSL2;ACMSD;TDO2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.692003602778432,1.4949583504614508,0.038461538461538464,0.1940114195570932,1.0,5/41,10.04%,LEF1;TBX20;CTNNB1;TGFB2;DLG5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.7904270326382894,1.4943332783654428,0.015625,0.19473519314402393,1.0,3/21,0.90%,NR4A3;MLIP;IGF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.6633017007065135,1.4941885176530503,0.015151515151515152,0.19455287093602686,1.0,27/74,21.03%,ENPP2;PROX1;EGF;THBS1;NRP2;EPB41L4B;MAPRE2;PRKCE;TGFB2;RIN2;SPARC;ARF6;FGF2;PIK3CD;BCAR1;ETS1;WNT5A;PRKCA;RAB11A;TEK;HIF1A;RTN4;GLIPR2;RHOB;SCARB1;ADAM9;PPM1F
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.8954388401371077,-1.4940549392330136,0.05128205128205128,0.6818592489117021,1.0,2/8,6.59%,APOE;ZNF502
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.8562966796159552,1.493744581116501,0.01694915254237288,0.1951881513813773,1.0,3/10,1.69%,HPN;THBS1;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.7625364921569316,1.4934304130089628,0.03278688524590164,0.19557500365350736,1.0,6/25,18.30%,LZTS1;SMCR8;PHF23;MTM1;PINK1;TSC2
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.7093535561916633,1.493253324879364,0.02857142857142857,0.19555382932607696,1.0,1/35,0.01%,LEF1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.6109697755060612,1.4928403989039176,0.014084507042253521,0.196138789614503,1.0,24/124,9.04%,LEF1;COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;ITGA8;COL4A2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP;TNS1;LDB2;PAWR;PML;C1R;BGN;YAP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.6735630324203741,1.4927461037883016,0.014492753623188406,0.19591453206064463,1.0,26/65,18.57%,TYMP;ADGRE5;TC2N;ZFP36;PIM3;CD55;RPS6KA1;IRF7;OSTF1;ANO9;DTX2;ABTB1;PRKCD;FRAT2;TFAP2C;IL4R;RHBDF2;IFIH1;HLA-E;ST6GALNAC2;TBC1D10A;VASP;MAP2K3;IFI35;LITAF;SBNO2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.8339751078338663,-1.4925651657563752,0.047619047619047616,0.6833438526976937,1.0,6/13,12.24%,CHAMP1;IK;KNL1;SPDL1;MIS12;CENPA
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.9240450395686824,1.4925469448311894,0.018518518518518517,0.19585229667668003,1.0,1/7,1.16%,PROX1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.8482633771652028,-1.4924961522423545,0.07894736842105263,0.6743303445295116,1.0,2/8,8.77%,SAMD9;VPS11
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.8846828656167207,-1.4915754098382812,0.07894736842105263,0.6710520890077241,1.0,3/6,8.94%,RFT1;NPC2;CPTP
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.796089490597544,1.4914942961008282,0.05084745762711865,0.1983898243913505,1.0,9/22,10.69%,TESC;SERPINE1;EPHA2;ADA;EFNA1;CYP1B1;TGFB2;SYK;P2RY12
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.7432547001512816,1.4912838233894663,0.046875,0.19812039758372776,1.0,3/20,6.43%,TLR2;IRF7;BIRC3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.6540045800385113,1.4908959589912596,0.0,0.19872665195454634,1.0,18/83,12.05%,RIMS2;PLD1;CD22;RIT2;SYT1;SEPTIN4;SEPTIN5;PTPRC;RAB15;RAB3C;ATP9A;CPLX2;CPLX1;PACSIN1;SYK;LGI3;OPHN1;STX4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.8978148761059419,1.4908709516240526,0.01818181818181818,0.19810160297226603,1.0,1/8,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.6893871460181601,1.4907603994098542,0.031746031746031744,0.19759909104572834,1.0,10/58,9.86%,LEF1;TGFBR2;HPN;DAB2IP;EFNA1;ZNF750;CTNNB1;LDLRAD4;SMAD3;TGFB2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.6220643654931567,1.4897261662696222,0.0,0.19997068702717422,1.0,25/106,13.18%,TGFBR2;FLRT3;PKP2;FGF12;SOX4;TBX19;NTRK3;ECE1;CACNA1C;APLNR;ALPK2;ZFPM2;SYNPO2L;SH3PXD2B;PDLIM4;TGFB2;GLI2;TCAP;IFT122;HDAC9;CDKN1B;FN1;SMYD4;MEF2D;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.901237583112535,1.4896127699878252,0.0,0.1997788770536831,1.0,3/6,7.95%,HRH1;GABRB2;GABRG2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7602133063928417,1.4894598430182104,0.015873015873015872,0.1994320690436773,1.0,13/38,11.71%,GRIK1;NLGN1;SYT1;RELN;CACNG3;SHANK3;GRM5;CACNG8;GRM6;CACNG4;HOMER1;OPHN1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.7920387208705879,1.48935912117549,0.03508771929824561,0.19916541770645266,1.0,7/17,16.84%,RIMS2;SYT4;SYT1;CPNE9;RASAL1;SMURF1;SYT17
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6295133345750176,1.4888708837859181,0.0,0.19987076131674586,1.0,27/92,11.60%,ENPP2;CA10;GRIN2A;RGS7BP;OPALIN;PLP1;OPCML;RTN1;TGFA;IGSF21;SYNPR;KCND3;FAM107A;TMEM132C;GRM5;TNS1;PID1;APLNR;MAOB;GRIA3;GFAP;RAMP3;CHI3L1;RNASE1;P2RY12;TCEAL6;PDK4
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.8146532629370684,1.4880128298003754,0.0,0.20184803472808416,1.0,5/16,6.12%,DUSP1;DUSP10;DUSP8;DUSP16;PDP1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.8027782154426315,1.4875759739306622,0.03278688524590164,0.20211591783993324,1.0,5/18,1.85%,SLC24A2;GRIN2A;PLK2;GRIN2D;GRIN2B
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.96394181100325,-1.4870212765945654,0.0,0.6943258108158525,1.0,1/6,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7926498951236043,1.4868728916899687,0.09259259259259259,0.20372717579795818,1.0,4/15,7.52%,IGF1;PIM1;TBX20;ZFPM2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.7115520158548225,1.48684657773185,0.0,0.20310617201302225,1.0,16/47,15.01%,LEF1;TGFBR2;IL15;EPHA2;MYH9;PML;PIR;GAB2;PPARG;PDE1B;HLA-DRB1;CDKN1A;PIK3CD;GPR183;RARA;CD4
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.9559068245397231,1.4867247138020279,0.0,0.2026800941598074,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7268551637315457,1.4866224997281352,0.03225806451612903,0.20240900081050706,1.0,8/32,13.18%,CDKN2A;GPNMB;FAM107A;CDK6;GFI1B;CCL2;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.7974069285329094,1.4865355394123856,0.014925373134328358,0.20187407138085228,1.0,7/27,6.72%,THBS1;SLIT2;SEMA3C;SEMA5B;SEMA3D;SEMA3B;ROBO2
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.8534483061400465,1.4864670478165125,0.0,0.2014181958533214,1.0,3/10,11.00%,CACNA1H;ADAM12;ERVW-1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.8507289363997173,1.4862368576028253,0.0,0.20137989618513835,1.0,2/14,0.90%,CACNA1H;IGF1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.6046553570990773,1.4861370957616893,0.0,0.2010412173084297,1.0,30/124,10.74%,SLITRK1;CCK;FLRT3;ANK3;NLGN1;CNTNAP1;CNTN4;SHTN1;SLITRK5;APP;PLPPR4;DAB2IP;CNTNAP2;PAK3;SHANK3;NYAP2;BAIAP2;DVL1;PARD3;DOCK10;FLRT1;MAP1B;DCC;SHANK1;NYAP1;CTNNB1;MINK1;PACSIN1;SLITRK4;TRIO
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7891148664705769,1.4858914641303569,0.0,0.20111672965492844,1.0,7/18,16.46%,IL1RAPL1;RELN;PTPRD;CDKL5;CAMK2B;SS18L1;CUX2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.8164893454741786,1.4851943721615688,0.0,0.20264805341834788,1.0,6/17,8.75%,MRAP2;PID1;MRAP;TMBIM1;BCL2L1;PKDCC
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.7574531065524458,-1.4851914242820168,0.02857142857142857,0.6975481141494914,1.0,3/23,9.03%,SGO2;CHAMP1;MIS12
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.9047155188357179,1.4846237436102592,0.0,0.20383473660377519,1.0,4/9,2.54%,ANXA1;MSMP;PTPRO;FLT1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.8454110958416109,-1.4838180559424563,0.0,0.6997608984007561,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.8128405565494286,-1.4837257075139927,0.09302325581395349,0.6919302296812503,1.0,2/8,7.09%,MEOX2;SFRP2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.6518355533490354,1.4834986023026926,0.03333333333333333,0.206349817465465,1.0,23/81,14.57%,RASGRP2;THBS1;NLGN1;SYT4;TRPC3;DMTN;SYT1;SYT5;KCNMB4;CLIC4;HPCA;ITPR3;NEUROD2;ITPKB;RYR2;SYT13;CPNE2;HOMER1;SYT12;ANXA11;IQGAP1;KCNMA1;CPNE9
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.8682391850563149,1.4832943032575203,0.03571428571428571,0.20614886202036317,1.0,4/8,9.38%,THBS1;DMTN;PRKCE;ARHGEF7
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.6952692058795144,1.4829305390885938,0.03333333333333333,0.2063916635407538,1.0,11/37,13.63%,ADAMTS4;CTSS;TIMP2;TLL1;CD44;CAPN1;SH3PXD2B;SCUBE3;MMP14;MMP16;WASHC1
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.9251991411665861,1.4827661697659302,0.019230769230769232,0.20593450008647723,1.0,3/6,6.64%,CCBE1;PROX1;TBX20
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.6297670046062297,1.482739422509971,0.03225806451612903,0.2053335790529362,1.0,31/108,15.29%,CDKN2A;HLA-DRA;TLR2;CTSS;IL15;FYB1;STAT4;PRKCB;ICAM1;PRKCG;WAS;IRF7;IL27RA;THY1;ACHE;PTPRC;FAS;TPD52;TGFB2;ST8SIA4;HDAC9;CCL2;ITGAL;EIF5A;B2M;IL4R;HLA-DMA;IL12A;HLA-E;CD4;ETS1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.8599030484073009,-1.4826237030989768,0.11428571428571428,0.6904471123586944,1.0,1/7,1.84%,AGER
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.7795238996851517,-1.482253383889359,0.047619047619047616,0.6850666007794052,1.0,6/16,16.23%,COX18;COX20;COX19;COA6;SMIM20;OXA1L
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.6043835409929346,1.4816383738437164,0.0,0.20762255103184427,1.0,32/127,9.94%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;OGN;ACTA2;CALD1;ABCA8;SULF1;ITGA8;COL4A2;NRP2;THY1;PODN;ANGPTL2;MYH11;POSTN;FAS;SLIT3;COL12A1;GJC1;SLC38A11;TNS1;LDB2;NEXN;C1R;OBSCN;MAP3K7CL;BGN;RASL12;ITGA9
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.9642524898381826,1.4815876868022861,0.018518518518518517,0.20742077110569362,1.0,1/5,0.15%,NR4A3
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.7707035356789433,1.4810828925961725,0.016666666666666666,0.20867262249844434,1.0,11/22,15.19%,MYRF;TLR2;PRDM8;APP;SOX4;EIF2B2;CDK6;TPPP;PICK1;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.840930993876835,-1.4803975274598835,0.11904761904761904,0.6884713127108796,1.0,2/6,14.17%,RAE1;LDB1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.888141583648996,-1.4801991776133279,0.038461538461538464,0.6734794037197578,1.0,2/5,8.80%,HEY2;HEY1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.888141583648996,-1.4801991776133279,0.038461538461538464,0.6734794037197578,1.0,2/5,8.80%,HEY2;HEY1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.6162532671996006,1.4798874699387181,0.014084507042253521,0.2119439498770297,1.0,34/94,17.27%,C1QL1;FLRT3;NPNT;SLC7A2;SHC2;DAB2IP;ABCC8;EFNB3;PRR36;EPB41L4B;PRIMA1;CKMT1B;CTNNB1;ASS1;PCLO;C2CD4C;YAP1;ATP1B1;CACNG4;EPB41L1;TEAD1;ENAH;INPP5J;CD276;COBL;CAMSAP3;BCAR1;SLC44A3;SEZ6L2;RGS16;TOX3;HS6ST2;MAPK4;MAGI1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.5592888153999849,1.4796426903381072,0.0,0.21194737110468906,1.0,34/231,14.40%,LEF1;BOK;TEAD2;CTSC;BLM;DMTN;WAS;ADD2;TGFA;WASF1;FAS;PARD3;REPS2;TNFRSF1A;TMED10;PML;SLC9A1;SHANK1;CTNNB1;SH3PXD2B;GRIA1;YAP1;TCAP;PEX14;TEAD1;TLE3;GSDMD;FN1;FADD;ANKRD28;STOML2;RSPH4A;BCL9;IKBKG
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.745570265872802,-1.479024514358812,0.02564102564102564,0.672552782127741,1.0,9/28,13.05%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.9233475948872796,1.4788256554726855,0.08888888888888889,0.213749708655089,1.0,1/5,2.35%,ZFP36
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.8779478752190458,-1.4783798928729948,0.0425531914893617,0.6689510980126796,1.0,5/9,9.03%,CHAMP1;IK;KNL1;SPDL1;MIS12
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.8688399146004351,1.478000240630407,0.01694915254237288,0.2162585172659556,1.0,3/11,7.32%,NR4A3;WNT8B;UGDH
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.9049037340669841,1.4775484297694532,0.017543859649122806,0.217285951636387,1.0,2/6,2.53%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.9542847367550604,1.477406032166965,0.018867924528301886,0.21709497311123405,1.0,4/5,4.49%,ANK3;MLLT11;DCN;TRPM4
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.7015446891932658,1.4770050376090234,0.03773584905660377,0.21754497978007392,1.0,1/37,0.01%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.7017684339080318,1.4761585864563627,0.04054054054054054,0.21923269664504616,1.0,14/42,15.68%,YWHAH;STMN2;GRIN2B;PTPRO;RTN4RL1;FYN;DCC;MAG;PTPN9;EPHA4;CRMP1;LPAR1;STX1B;PTPRS
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6248087156511003,1.4761190933616457,0.0,0.21879027676705035,1.0,21/93,11.74%,COL4A1;PCDH18;CALD1;PPFIBP1;COL4A2;SLIT2;THY1;MCAM;SLIT3;LAMB1;GJC1;PTPN21;GUCY1A2;LARP6;MAP1B;LIMCH1;ADGRL2;GLI2;ENAH;PDE10A;RUNX1T1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.8804234152517364,1.4760246126148737,0.03278688524590164,0.2183504903407092,1.0,1/9,0.25%,HPN
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.8280889331277614,-1.4758881795100058,0.06976744186046512,0.6779268500434638,1.0,3/9,6.81%,PGP;ACMSD;MST1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.8120773063260822,1.4757080428727536,0.05357142857142857,0.2186509315231521,1.0,4/15,7.82%,CCBE1;DCN;DAB2IP;MYO1C
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7543832718736792,1.4756054309311335,0.015384615384615385,0.218424284018743,1.0,12/26,18.09%,RIMS2;NLGN1;RELN;APP;SHANK3;GRIN1;SHANK1;STX1B;NLGN4X;SLC8A2;CUX2;MTMR2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.7109787234359296,1.4754367679147409,0.03773584905660377,0.21809422140002882,1.0,11/30,9.88%,SCN1B;SCN3B;KCNQ1;STAC2;PVALEF;DTNA;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,MSigDB_Hallmark_2020__Apoptosis,0.6269697727737036,1.47458140273553,0.0,0.22030757519804237,1.0,24/123,13.20%,LEF1;ANXA1;DCN;ATF3;TIMP2;APP;PLPPR4;FAS;BTG3;NEDD9;BIRC3;CD44;EMP1;CTNNB1;BCL2L1;BGN;LMNA;TGFB2;ENO2;GADD45A;CDKN1B;PAK1;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.8208511886150069,1.4736620191439453,0.018518518518518517,0.22257737270546776,1.0,3/15,7.08%,SIX3;ACTA2;POF1B
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.9108053528054749,1.4733777637818202,0.01694915254237288,0.2230341178147724,1.0,1/6,2.41%,SULF1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8992584218352606,1.4733689129335874,0.0,0.2224183827956411,1.0,6/13,6.38%,SHISA7;SHISA9;SLC4A10;GRIK2;SHISA8;SYP
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),0.9927895116688905,1.4732796907633263,0.0,0.2221847365521447,1.0,1/5,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8611300606363836,1.4732550081518614,0.017241379310344827,0.22164365331216226,1.0,6/11,11.94%,ITM2A;NECAB1;SOAT1;NECAB2;ABCA2;BACE2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.8815701251230582,1.4731494195356345,0.03076923076923077,0.22127675272461822,1.0,1/10,0.15%,NR4A3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.6448826525052337,1.4721018401730963,0.0,0.22473255675229575,1.0,15/72,8.41%,DOC2B;ADCY5;KCNC2;IRS2;ABCC8;BMP8A;EPHA5;SOX4;GIPR;ITPR3;NNAT;CACNA1C;HADH;GLP1R;CACNA1E
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.8287806742770724,1.4717066017859768,0.06896551724137931,0.22561742090350548,1.0,5/17,3.17%,HTR2C;TYMP;NPTX2;DLGAP3;APP
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.6739521586902858,1.471159079297081,0.0,0.22659896497006127,1.0,14/52,17.04%,ENPP2;LPCAT4;ACHE;PLAAT4;MFSD2A;PLAAT3;CHKB;DBI;PLB1;PNPLA8;SLC44A3;PLAAT1;ABCA3;LPIN3
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.6056942917561039,-1.4711580808165423,0.06060606060606061,0.7014447478155913,1.0,17/60,13.97%,RTRAF;TRPT1;ADAT2;TRMT61A;POP5;KARS1;TRMT10C;TRMT10A;THUMPD1;C2ORF49;QTRT2;FTSJ1;CPSF1;CLP1;URM1;TRMT10B;ADAT1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.6277603347752546,1.4699246702402047,0.014492753623188406,0.22953646124954785,1.0,16/106,5.47%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTN4;PLEK;BICDL1;PLP1;APP;CNTNAP2;STMN4;CFAP126;LAMB1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.6802000065603521,-1.4697748780229238,0.045454545454545456,0.7017147313767383,1.0,3/21,6.81%,SELENOS;PGP;MST1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7687449845398906,-1.4693374830228214,0.11627906976744186,0.6969036534827636,1.0,2/10,12.60%,POMP;PSMD10
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7839299474129475,1.4692628463555302,0.07407407407407407,0.2307035891025347,1.0,6/14,8.72%,ITGA8;TBX19;ITGA2;TBX20;SCX;ITGA3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5830907961616066,-1.469070407160863,0.0,0.6912409807494366,1.0,5/59,3.62%,H1-2;H2BC21;PADI4;H1-4;BRDT
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.792015921009789,1.4690381663949927,0.017857142857142856,0.230720738352399,1.0,7/18,16.84%,RIMS2;SYT4;SYT1;CPNE9;RASAL1;SMURF1;SYT17
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.6401551514441062,1.4687040438970274,0.015384615384615385,0.23107311639554287,1.0,14/56,11.85%,CACNA1H;NR4A3;CTSS;LMO2;SLIT2;SLIT3;ROBO2;GHR;RAMP3;ATP1A1;STAT3;TFPI;KLF9;SRA1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.7199692867605693,1.4681464618195326,0.03225806451612903,0.231958509534612,1.0,4/29,9.70%,ENPP2;CLRN1;ARHGEF7;FSCN1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.6341448075705638,1.4677569350311555,0.0136986301369863,0.23243879038829798,1.0,5/79,8.12%,LEF1;CD24;WNT8B;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.9205845288298639,1.467660813291412,0.0,0.23221812266609942,1.0,2/6,2.91%,SHTN1;WAS
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.7034579626986829,1.4675040806996738,0.08333333333333333,0.23216447557893755,1.0,5/36,3.61%,PTP4A3;TLR2;APP;NOD1;NLRP12
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.9680145559391393,1.4672165649110982,0.0,0.23264015640858618,1.0,2/5,1.86%,IL15;PTK6
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.7080094086505593,1.4671573229791854,0.05172413793103448,0.23205807801331285,1.0,7/33,9.26%,MYO1F;SYT4;BICDL1;MYO1B;MYO1C;MYO15A;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.9434840498378515,1.4668699782562884,0.0,0.2327286951580247,1.0,2/8,0.85%,CDKN2A;ANXA1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.9156992032352332,-1.4668253351775142,0.029411764705882353,0.6979968112265948,1.0,2/7,3.26%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.9354789696793574,1.4667021831335108,0.061224489795918366,0.2324447017331552,1.0,2/5,4.42%,TYMP;FGF12
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.851308888289457,1.4664859697909964,0.06153846153846154,0.23245656754343594,1.0,1/9,0.92%,KLF2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5721166406944227,1.4663685281479129,0.0,0.23227271498143845,1.0,29/189,13.12%,GGT5;HPN;CTSC;CTSS;MMEL1;FOLH1;PRSS57;PRSS48;PCSK2;FAP;ECE1;ENPEP;CAPN8;CELA2B;CAPN1;TRHDE;TBL1X;MMP14;CNDP1;ADAM19;FBXL2;TMPRSS5;TMPRSS3;MMP17;BACE2;CPA6;TPSD1;MMP16;PHEX
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.7170696518712094,1.4659157193553771,0.047619047619047616,0.23306545003676565,1.0,6/30,12.85%,C3;SERPINE1;MKLN1;TF;ARF6;B2M
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.7527238351045096,1.4657025373803452,0.04225352112676056,0.23339981918072567,1.0,3/28,4.87%,GGT5;AWAT1;ALOX12
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.8372826512716552,-1.4656168254821134,0.024390243902439025,0.6914045384515404,1.0,3/11,7.16%,BLOC1S4;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.8372826512716552,-1.4656168254821134,0.024390243902439025,0.6914045384515404,1.0,3/11,7.16%,BLOC1S4;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8677464037076364,1.4655215061748703,0.01694915254237288,0.2334736287937845,1.0,6/11,7.26%,GRIN3A;GRIN2A;GRIN2B;GLRA2;ADCY7;GRIN1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.7212051827236334,1.465460302409623,0.014492753623188406,0.23303098140610784,1.0,4/43,3.55%,GGT5;CXCL2;CD24;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.7695896820191368,1.4653495620235835,0.06349206349206349,0.2328802317115018,1.0,3/20,3.70%,SLC24A2;PLK2;ACHE
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.9447748818912216,1.4649381140099476,0.018518518518518517,0.23343602845849326,1.0,2/8,2.21%,RECQL4;BLM
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.6482419638325826,1.4647679227185801,0.0,0.2336369099020412,1.0,17/69,8.95%,ENPP2;GRIN2A;PROX1;PDGFRA;PDE1C;DCN;ABCA8;CNTN4;THY1;ANGPTL2;PIEZO2;SLC38A11;ALDOB;GRIA3;PTPRD;KALRN;BGN
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.7623954647063451,-1.4646294052706534,0.06818181818181818,0.6907695291679457,1.0,3/15,2.76%,CST3;CSTB;CTSH
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.6647619109605729,1.4643726016481884,0.05263157894736842,0.23428338790799141,1.0,11/55,7.39%,RASGRP2;NLGN1;SYT4;DMTN;SYT1;SYT5;CLIC4;HPCA;NEUROD2;ITPKB;SYT13
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.7136560249964025,1.4643318688739475,0.045454545454545456,0.23374905358231998,1.0,5/34,8.65%,EGF;DMTN;APP;PARD3;CHI3L1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5894307221123322,1.4637433724397777,0.016129032258064516,0.23474084517831834,1.0,16/83,13.35%,NR4A3;NR4A1;ADCY5;SLC39A14;IRS2;FOXO1;PRKAR1B;RAB15;ADCY7;ADCY2;PPARG;SORBS1;HDAC9;NR4A2;PRKCD;CPEB2
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.9687780998434833,1.4636489656563128,0.0,0.23433474410503186,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.6704286545956486,1.4635662970172747,0.031746031746031744,0.233804547504107,1.0,22/58,21.27%,ZFP36;IRAK2;MAP3K11;NOD1;SH2D3A;MINK1;TNFRSF19;GPS1;TNIP2;IKBKG;MAPK11;MAP3K5;TAB1;GPS2;MAPK9;SH2D3C;MAP2K3;SKP1;RPS27A;ARHGEF6;TAB2;ADORA2B
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.6323067305923317,1.4630969541229504,0.0,0.23481975967867708,1.0,33/123,15.45%,VRK2;IGF1;EPHA7;EGF;RASGRP1;CD24;RIT2;DUSP1;FLT1;EPHA2;DAB2IP;NEK10;PAK3;PTPRC;FAS;TRIM5;NTRK3;PAK4;PDGFA;WDR54;MINK1;SYK;GFRAL;HLA-DRB1;FN1;PAK1;FGF2;LPAR1;IQGAP1;GPR37;CD4;THPO;STK3
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.7579580749965971,-1.4629309564537187,0.02564102564102564,0.6959668601424686,1.0,7/22,11.72%,MT1E;MT1A;MT1G;AKR1C3;MT1F;HSF1;MT2A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.6400080701972596,1.4628590905634509,0.02702702702702703,0.23507603664259757,1.0,32/88,17.27%,C1QL1;SLIT2;DAB2IP;TRAM1L1;EFNB3;TUSC3;PTPN21;LARP6;MAP1B;SCARA3;BOC;ADGRL2;B4GALNT1;CNN3;YAP1;EPB41L1;GLI2;TEAD1;ENAH;CD276;MEIS3;CAP2;IGDCC4;KIAA1549;RBFOX2;BCAR1;SMARCA1;SEZ6L2;FZD7;PFN2;CTXN1;MAGI1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7965615409396787,1.4628286033194493,0.015151515151515152,0.23448545719712172,1.0,7/21,10.19%,MYRF;KIF14;TYMP;NKX6-2;PARD3;TENM4;TPPP
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6200997977543078,1.4626460758703188,0.03076923076923077,0.2344914061888306,1.0,32/107,13.13%,COL4A1;EDIL3;PCDH18;COL4A2;SLIT2;PLP1;DAB2IP;THY1;EFNB3;TCEAL7;TUSC3;NUAK1;GFRA2;PTPN21;SEMA3B;OLFML2A;LARP6;MAP1B;SCARA3;BOC;ADGRL2;YAP1;EPB41L1;GLI2;PCDHB15;TEAD1;ENAH;FAM13C;RUNX1T1;PRICKLE2;MEIS3;CAP2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.8576898416305058,1.462454416441928,0.016129032258064516,0.2344973238700568,1.0,3/9,5.71%,GAS2L3;BAIAP2L1;BAIAP2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8879593516681954,1.4617622764749587,0.038461538461538464,0.23599448686563743,1.0,3/8,7.95%,HRH1;GABRB2;GABRG2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.7297714117909864,1.461551350464083,0.016129032258064516,0.23624433421697527,1.0,9/38,6.43%,TLR2;TYMP;CTSS;SP100;PLEK;CSF2RA;PTPRC;CIITA;BIRC3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.6335425844658978,1.461548110919864,0.031746031746031744,0.23565841430061957,1.0,26/82,17.95%,BOK;MLLT11;CD24;EPHA2;DAB2IP;ZNF385B;SCN2A;HIC1;PRODH;PML;CYP1B1;BCL2L1;IKBKE;BBC3;PRKCD;BCL2;CDKN1A;TNFRSF10B;HIPK2;PDK1;MAP3K5;TP53;BRCA1;STK11;ITPR1;STK24
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.8958444085950924,1.4614327247189736,0.05660377358490566,0.23553792910724256,1.0,3/9,7.62%,RFTN1;IL15;MYD88
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7684963193107863,1.4613316685601283,0.037037037037037035,0.23538732434018758,1.0,4/23,6.83%,NPY;GLRA2;MCHR2;HCRTR2
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.8565466746152227,1.4610438840467386,0.0847457627118644,0.23548282646317414,1.0,1/8,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.7504672939904822,1.4610079577092632,0.016129032258064516,0.2349661034458487,1.0,7/30,8.12%,FLRT3;SH3GL2;NRP2;SEMA5B;FLRT1;MAP1B;CTNNB1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6795145378422397,1.4608750770146215,0.014285714285714285,0.2346350904376755,1.0,14/51,14.91%,ANXA1;PLEK;DMTN;THSD7B;MYH9;NEDD9;MKLN1;PDLIM4;MINK1;SIPA1L1;PAK1;PHACTR1;GAB1;BCAR1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.95935762786005,1.460822287733318,0.0,0.2341232033639494,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.939879358367835,1.4603972399503848,0.0,0.23470658808316192,1.0,1/6,1.68%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.6415689155921424,1.4603417193957446,0.03225806451612903,0.2342274101724913,1.0,8/63,7.89%,BOK;ANXA1;IL15;CHRM1;DOC2B;SFTPD;SNCA;SYNGR3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9282515114784547,1.460109435774245,0.018867924528301886,0.23432440949300282,1.0,1/5,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.7651516897669688,1.460106640428023,0.08620689655172414,0.23372816417622674,1.0,3/15,9.86%,THBS1;YAP1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7265036599631512,1.4600687848755034,0.03125,0.23328516130081423,1.0,13/23,23.00%,FOXO3;SMAD3;PPARG;TGFB2;STAT3;TEAD1;KLF4;FGF2;ETS1;TP53;HIF1A;APLN;FOS
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.7195077985394186,-1.4597111945994863,0.10256410256410256,0.7123534471449432,1.0,7/20,15.33%,COX18;TIMM8B;TIMM13;SAMM50;BAD;TIMM10;BCL2L11
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.8952818955686721,1.4595291808021322,0.05660377358490566,0.23434275669980117,1.0,3/6,2.14%,NR4A3;SGPP2;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.9073718435843341,1.459433007133874,0.01639344262295082,0.23407978779091312,1.0,3/5,6.91%,P2RY6;HRH1;SNCA
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6852445639086163,1.459404870781038,0.0,0.23351998229585477,1.0,16/46,17.57%,IGF1;PDGFRA;DYSF;MYH9;EPB41L4B;NRG1;PDGFA;SMAD3;SYTL4;TGFB2;PAK1;FGF2;FZD7;MYOF;PLEC;WNT5A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.709065622009365,1.4586215286439748,0.01639344262295082,0.2356694410721265,1.0,4/42,7.87%,ANLN;ANK3;INCENP;TRIM36
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6916534938354447,1.458480084074538,0.06349206349206349,0.2357017911729671,1.0,12/48,10.44%,PDGFRA;IL15;PTK6;FLT1;RELN;TEC;FYN;GHR;AATK;PKDCC;SYK;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.6249313537967371,1.4584015887901345,0.03225806451612903,0.2354084618513532,1.0,18/78,13.18%,PTK6;PTPRO;SRCIN1;PTPRB;DAB2IP;THY1;DUSP10;CAMK2N2;PTPRC;SMCR8;DVL1;SNCA;MVP;YWHAG;CDKN1C;GADD45A;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.9384575544589684,1.4581080350045588,0.0,0.23567745117673494,1.0,2/8,1.16%,MET;PROX1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6455440826866271,1.4577474807174495,0.046875,0.23618066456025388,1.0,7/59,12.49%,TGFBR2;SBK1;GALNTL6;GALNT16;HIPK3;PRKCD;HIPK1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7031684048931268,1.4571219884638957,0.03278688524590164,0.23750380287754372,1.0,10/36,11.19%,SLC32A1;SYT1;GAD2;CPLX2;DVL1;SNCA;PCLO;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.8874733559058012,1.4568024045047798,0.061224489795918366,0.23776560826975138,1.0,1/9,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.9058761035909974,1.456435889364376,0.0,0.23831839255515158,1.0,1/10,0.01%,GGT5
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.6679952643878655,-1.456233792194145,0.06521739130434782,0.7271501780319286,1.0,6/25,15.09%,ARRDC4;FBXO5;TRIB3;RPS2;FEM1A;DCUN1D2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9050162925160645,-1.455782034463632,0.0,0.7229575870869014,1.0,1/6,0.68%,BUD23
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.6330408293944004,1.4557044025361745,0.016666666666666666,0.24015128202909794,1.0,16/74,7.08%,CDKN2A;ANLN;ST6GAL1;BOK;CD24;PSCA;LIPH;ICAM1;PLEKHG6;NRP2;IL1R1;INCENP;BAIAP2L1;ITGA2;PGR;POF1B
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.8111415930862305,1.4550968464100622,0.03571428571428571,0.24145166071312488,1.0,2/14,5.08%,ABO;B3GALT2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.7248647717683142,1.454999377014089,0.04918032786885246,0.2410049287781998,1.0,7/22,12.33%,SYT4;SYT1;SYT5;SNCA;SYT13;GRK2;SYT12
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.6001831148081572,1.4548221552542666,0.0,0.24105238405639556,1.0,5/108,8.12%,LEF1;GNG2;DVL1;DAAM1;CTNNB1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8390076211972839,1.4544619631019422,0.01694915254237288,0.24161928129067162,1.0,7/14,11.71%,NLGN1;RELN;CACNG3;SHANK3;CACNG8;CACNG4;CCL2
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.9758788177223853,1.4542397232276656,0.0,0.24172261187163283,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.9584655880451269,-1.4540514334186252,0.0,0.727993297453534,1.0,1/7,0.09%,NGF
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.7744892697964176,1.4536873354632691,0.03278688524590164,0.24288847296276259,1.0,6/22,11.71%,IL15;PTK6;STAT4;GHR;STAT3;CCL2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6532202703804976,1.4535933203021727,0.014285714285714285,0.2425583145688447,1.0,20/65,17.21%,A4GALT;SGPP2;VAPB;ABCA8;FA2H;ST8SIA3;ST8SIA1;SPNS2;HACD1;CERS3;CYP4F22;SGMS1;ALDH3A2;ELOVL7;LARGE1;CERS5;ST6GALNAC5;ELOVL5;B4GALT6;HACD4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.8858540763976862,1.452862621220145,0.038461538461538464,0.24437413633372693,1.0,2/9,1.17%,TGFBR2;PDGFRA
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.8095520564530381,-1.452584177682651,0.08888888888888889,0.7295523783624941,1.0,1/8,0.09%,NGF
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.8165542427947002,1.4521591047170845,0.05660377358490566,0.2453825657646177,1.0,1/13,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.5960074942117676,1.4517517700576765,0.015873015873015872,0.24624387526732228,1.0,21/84,15.30%,GPNMB;ANXA1;MOG;IL15;IGF2BP2;SFTPD;IRF7;NLRP12;ACKR1;PTPRC;BCL6;NPTN;HDAC9;LURAP1;HLA-DRB1;CD276;PER1;TRIM32;PIK3CD;IFIH1;SCAMP5
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.7651252833810209,1.451598280599019,0.05357142857142857,0.24644817334839988,1.0,4/18,7.51%,C3;CCBE1;SULF1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.842272163626611,1.4513624340509748,0.03333333333333333,0.2465665393363666,1.0,4/14,5.87%,PDGFRA;RASGRP1;FLT1;NTRK3
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.8729429070690717,1.451322826968085,0.01694915254237288,0.24603457626517117,1.0,2/10,1.69%,CDKN2A;SERPINE1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8617306380549999,1.451226833013883,0.03125,0.2458715298783281,1.0,3/8,10.99%,NLGN1;SHANK3;LRRC4
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.7273872784420209,1.4508343886149428,0.0,0.24624346974225877,1.0,3/31,5.59%,GGT5;GSTT2;GGCT
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.9065004594576976,1.4506116185874431,0.0,0.24539454000372313,1.0,2/8,2.89%,EGF;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.9065004594576976,1.4506116185874431,0.0,0.24539454000372313,1.0,2/8,2.89%,EGF;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.9065004594576976,1.4506116185874431,0.0,0.24539454000372313,1.0,2/8,2.89%,EGF;MGAT3
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8812843405794282,1.4499813646934565,0.0,0.2462654336158142,1.0,4/14,6.79%,IGF1;APP;MFSD2A;GHR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.8004788523153794,1.4497282325994403,0.01639344262295082,0.24654872413276052,1.0,6/19,11.71%,NR4A3;THY1;SKAP1;CD44;CYRIB;CCL2
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.9327224144841414,1.4492328599460942,0.03333333333333333,0.2473851142844161,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.7792329098024334,1.4488728427397088,0.018867924528301886,0.24816228295754647,1.0,8/22,9.47%,SLC32A1;NLGN1;CPLX2;SNCA;PCLO;PLD2;CPLX1;DNAJC5
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.873976796187514,1.4486938703968353,0.03333333333333333,0.24830121041585346,1.0,1/8,3.94%,SUV39H1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6948378573230437,1.4485720519446725,0.014705882352941176,0.2480541007986837,1.0,8/38,9.88%,PROX1;SULF1;ITGA8;SOX4;ZBTB16;ROBO2;TGFB2;GLI2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.6127449260409565,-1.4471620670791732,0.05405405405405406,0.7595500793859544,1.0,5/31,11.81%,AR;RNF6;TRIM68;RUNX1;UFL1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.8231391915029178,1.4467680764591373,0.08333333333333333,0.25302630767166434,1.0,3/13,3.66%,ZFP36;ZC3H12D;RBM24
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.8295928303726517,1.446710797267308,0.02040816326530612,0.2526050014907495,1.0,2/8,3.17%,C3;APP
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.8765194139434569,-1.44635691676386,0.03773584905660377,0.7578857440718807,1.0,1/6,0.52%,CYP4F3
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7779528106805607,-1.4460319188773794,0.10256410256410256,0.7526924651991659,1.0,3/10,8.67%,BUD23;RIOK2;RIOK1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.875471366577025,1.4458276961691288,0.03278688524590164,0.25489202378877923,1.0,2/10,2.91%,SPOCK3;WAS
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6560049917278179,1.4457025618043433,0.015384615384615385,0.2547138280975403,1.0,13/63,9.86%,CDH6;CDH22;CDH9;CDH19;PKP2;TJP3;CDH8;CDH7;CDH18;GJC1;SMAD3;FSCN1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.6570550755894953,1.4456398110231439,0.0,0.2543731826450739,1.0,21/67,20.58%,MET;PROX1;EGF;THBS1;NRP2;RIN2;SPARC;FGF2;PIK3CD;BCAR1;ETS1;MAP2K3;WNT5A;ADAM17;PRKCA;TEK;HIF1A;RHOB;FGFR1;AKT3;SCARB1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6506242409947274,1.4456332381936619,0.03125,0.2538169070111465,1.0,15/40,18.79%,CACNA1H;IGF1;ITGA11;MRAS;FHL3;LAMA2;MEF2D;SMTN;LARGE1;FHL1;NEB;CHODL;CHD2;CAV3;SGCG
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8362293041923343,-1.4454544457784917,0.0851063829787234,0.7496719104799067,1.0,2/10,4.43%,RPP25L;POP5
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5551382964146829,-1.4454208346739346,0.047619047619047616,0.7426656309427113,1.0,45/161,18.61%,RPL35A;RPS24;RPL34;RPL39;EXOSC8;RPL13;RPL37;RPS28;NBDY;RPL18;RBM8A;RPL12;RPL23;RPL31;RPS26;RPL6;EXOSC4;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;EXOSC5;RPL15;RPS2;PYM1;RPL11;RPL23A;CNOT7;RPS21;RPS23;CNOT1;POLR2D;EIF3E;PNRC2;RPS25;RC3H1;RPL10;LSM1;CNOT9;UPF3B;RPL8;RPL32
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.7955535986204656,-1.4454069006986707,0.0,0.7358569745458716,1.0,4/15,6.14%,ADAMTS9;ADAMTS12;CTSL;FBXO27
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.9121184681370353,1.4453016879276774,0.02040816326530612,0.2546987867151208,1.0,1/5,2.12%,PCSK2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.5878362468244143,1.4452074618637563,0.0,0.2544145590486026,1.0,39/135,15.87%,IGF1;RIMS2;EGF;THBS1;SERPINE1;PLEK;SYT4;SYT1;APP;SYT5;RIMS3;MYH9;SYNGR2;RAB11FIP5;CPLX2;SNCA;TMED10;SYT13;PDGFA;SYNGR3;PCLO;CPLX1;DNAJC5;SYTL4;CYRIB;TGFB2;TF;RAB11FIP1;GAS6;ACTN1;SPARC;SYT12;FN1;RAB27B;ABCC4;ARHGAP17;SERPING1;TAGLN2;PIP5K1C
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.8653051045467799,-1.4451182283844834,0.08333333333333333,0.7310563735173483,1.0,1/5,3.70%,SF3A1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.8171531689556759,1.4447174756965553,0.05084745762711865,0.255587658928738,1.0,3/12,3.84%,IGF1;EGF;TGFA
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.6827490013883085,1.4442281898695197,0.047619047619047616,0.25670162196281493,1.0,7/42,10.56%,IL1RAPL1;S100A10;DMTN;NEDD9;PTPRD;ARHGEF7;CDKL5
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.8376577481146998,1.443924570009848,0.016666666666666666,0.2573005486139662,1.0,4/14,8.06%,PAK3;SHANK3;DOCK10;SHANK1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.9268424016171943,1.4437183033924184,0.03636363636363636,0.2572808123757164,1.0,3/5,5.57%,SCN3B;KCNQ1;GJC1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8910822476323065,1.4436703170160887,0.057692307692307696,0.2569405239872264,1.0,2/7,9.35%,IGF1;PPARG
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.7256057556985626,1.4436257625916216,0.03278688524590164,0.25638848903737393,1.0,4/18,12.47%,APP;SCN2A;FAS;BCL2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.8906434409953621,1.4434992930282282,0.0625,0.25626453536829347,1.0,2/8,1.78%,ANXA1;DOC2B
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.6353022951538928,1.4428095188710128,0.014705882352941176,0.2581316655025619,1.0,9/60,12.46%,SLC6A15;SLC32A1;SYT1;GAD2;DVL1;CPLX1;DNAJC5;SYN2;SLC29A4
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6753302476033561,1.4427539119971424,0.016129032258064516,0.25773955672910914,1.0,9/64,3.42%,PROX1;EGF;DCN;SP100;THBS1;EPHA2;SLIT2;DAB2IP;NRP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7952866418794236,1.44165214069296,0.07936507936507936,0.2611539504510612,1.0,2/14,3.31%,CHRM3;KCNB2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.8340231439649076,1.4412327775863574,0.0,0.2616004744898269,1.0,5/13,10.19%,MYRF;RIMS2;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.7766311258913196,1.4411940611109375,0.017857142857142856,0.26117696685210817,1.0,9/20,14.90%,DUSP1;COL4A2;COL8A1;COL12A1;LAMB1;TBX20;MMP14;FN1;LAMA3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8327584505619463,1.4410512072471864,0.0196078431372549,0.2608865679650306,1.0,2/9,6.17%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.7339690819509403,-1.4405674288030494,0.125,0.7520006464379891,1.0,2/14,8.07%,TNFAIP3;IFNLR1
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.9330690945622067,-1.4404173174817807,0.0,0.739750218122244,1.0,1/5,3.49%,SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.9330690945622067,-1.4404173174817807,0.0,0.739750218122244,1.0,1/5,3.49%,SMYD5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.7388072228405755,1.4403565041709192,0.05555555555555555,0.26261393518245546,1.0,8/23,14.71%,HLA-DRA;RASGRP1;CYRIB;CD160;HLA-DRB1;FADD;IL12A;HLA-E
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.6118883269552929,1.4402038600688776,0.016666666666666666,0.2626352093736929,1.0,17/72,16.40%,PDGFRA;DMTN;EPHA5;PAK3;BAIAP2;FAM107A;RHOD;PDGFA;FSCN1;ARHGAP18;PRKCD;PAK1;IQGAP1;ARHGAP17;RHOBTB2;BST1;NEB
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7547809865213295,1.4401729613177867,0.057692307692307696,0.2621349358260817,1.0,7/20,16.36%,THBS1;DMTN;PRKCE;GNA12;ARHGEF7;FGF2;RFFL
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.7641926214477468,-1.4396956109202004,0.05128205128205128,0.7375503010205421,1.0,2/18,4.67%,FAM47E;MCM9
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7610656754299736,-1.4396321321247065,0.02631578947368421,0.7317879136512769,1.0,7/21,11.72%,MT1E;MT1A;MT1G;AKR1C3;MT1F;HSF1;MT2A
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.8429372461273116,1.439535105608626,0.0,0.2634319237697546,1.0,3/15,2.84%,RFTN1;S100A10;FA2H
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.8665971591356604,1.439073331975731,0.019230769230769232,0.2643078896170872,1.0,2/9,7.51%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7988747580676143,1.4389920737604553,0.05172413793103448,0.26411805855401055,1.0,2/15,5.08%,ABO;B3GALT2
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.7312694720173738,1.4386790579358046,0.06666666666666667,0.2645493362511783,1.0,9/24,9.86%,TGFBR2;PROX1;SLIT2;SOX4;SLIT3;ROBO2;APLNR;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.8824258039590362,-1.4383144402140007,0.09302325581395349,0.7344764108537185,1.0,1/5,0.04%,ACP3
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.8259331590892162,-1.4382704457802102,0.06521739130434782,0.7284606978327394,1.0,1/11,0.29%,RAB7B
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.9250429586076235,-1.4382272952885,0.02702702702702703,0.7229864088000523,1.0,2/6,3.26%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.8292763628227722,1.4381979250107895,0.0847457627118644,0.2655460858049167,1.0,4/9,12.85%,CDKN2A;LMNA;CGAS;B2M
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6880516404828052,1.4381057824859955,0.027777777777777776,0.26535480103966924,1.0,8/35,3.65%,CXCL2;GPNMB;TLR2;TYMP;CTSS;MYO1F;PLEK;SIGLEC1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.7735507898382696,1.4375765633136197,0.015873015873015872,0.26619141826930265,1.0,6/17,11.71%,EGF;FYN;CTNNB1;GRM6;PLPP4;CCL2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5933383554707508,1.4366496311451913,0.0273972602739726,0.2687922783495415,1.0,32/145,11.38%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTNAP1;CNTN4;SHTN1;BICDL1;PLP1;APP;DAB2IP;CNTNAP2;STMN4;PAK3;SHANK3;NYAP2;LAMB1;DOCK10;SHANK1;NYAP1;MICALL1;MINK1;PACSIN1;GPRIN1;EPHA4;TRIO;FRY;MAPT;OPHN1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.7985203511230343,1.436548256674496,0.04918032786885246,0.26849295824248015,1.0,2/14,0.74%,MET;GPNMB
prerank,MSigDB_Hallmark_2020__Complement,0.5725666579726172,1.4364994297033595,0.04,0.2680928851509429,1.0,25/145,8.55%,C3;MAFF;CTSC;CTSS;SERPINE1;RASGRP1;CD55;PLEK;COL4A2;TIMP2;WAS;PIM1;IRF7;CP;PLSCR1;FYN;GNG2;PDP1;CFH;DOCK10;CASP10;C1R;ZFPM2;DGKG;PCLO
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.754174517007256,-1.4364655545392047,0.10256410256410256,0.7289116390331158,1.0,3/13,11.16%,SETDB1;SIRT6;ZNF304
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.7591195775418824,1.435533383147873,0.13114754098360656,0.2703419492561109,1.0,1/17,0.08%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.7529367386392097,-1.4352731346525425,0.04878048780487805,0.7301786740839588,1.0,3/13,8.40%,SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.8302169536503596,1.435034506969231,0.04,0.2716161112887157,1.0,2/11,3.34%,BOK;DAB2IP
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.9575987138627189,1.4348422876802953,0.019230769230769232,0.27138934892522454,1.0,1/5,0.71%,BOK
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8678793921732293,1.434200082167949,0.07547169811320754,0.27308580451031284,1.0,3/6,11.35%,GHR;STAT3;PXN
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.815605047627211,1.4340475957976526,0.05357142857142857,0.27305878603067524,1.0,3/14,9.30%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7739898355472438,1.4339654925116831,0.03278688524590164,0.27267929084767784,1.0,7/20,16.70%,SULF1;UGDH;HS6ST1;HS3ST4;HS3ST3B1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.7229088560607341,1.4339027267210782,0.057692307692307696,0.2723014071091943,1.0,4/26,4.31%,C3;IL15;SFTPD;PTPRC
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.898298082100009,1.4338848449665862,0.07407407407407407,0.27179973255760326,1.0,2/8,1.17%,TGFBR2;PDGFRA
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8764765356239262,1.433515525970332,0.047619047619047616,0.27222611842980615,1.0,4/9,7.01%,SCN3B;KCNQ1;GJC1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6848754781873135,1.4333251603307102,0.046875,0.2722011986389421,1.0,15/31,24.40%,FOXO3;SMAD3;PPARG;TGFB2;STAT3;TEAD1;KLF4;FGF2;ETS1;TP53;NFATC3;HIF1A;APLN;FOS;NFATC4
prerank,MSigDB_Hallmark_2020__Glycolysis,0.5837202623292291,1.433033152811528,0.0,0.2730984242605688,1.0,29/168,12.53%,CACNA1H;MET;IL13RA1;DCN;PKP2;P4HA2;IRS2;NSDHL;TGFA;TPST1;VLDLR;CHST6;CHPF2;CD44;AGRN;GPR87;ALDOB;HK2;LDHA;GALK1;AK3;HOMER1;PYGL;PGK1;B4GALT7;CHST4;ENO2;DPYSL4;PAM
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8708136288831027,-1.432618147470746,0.0425531914893617,0.7410156434938918,1.0,2/6,4.53%,ATF5;RGCC
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5568256508026457,1.4325417759482655,0.0,0.27419082130820105,1.0,54/164,14.35%,ENPP2;PAPSS2;CDH9;A4GALT;PDGFRA;PDE1C;DCN;GRIK2;ABCA8;DUSP1;CD55;PLEK;SLA;GPR34;ACHE;IL1R1;PODN;SHROOM4;ESYT3;POSTN;STK32B;IGFBP7;CFH;TNS1;LDB2;PID1;APLNR;MAOB;RAMP3;C1R;CSRNP1;ADGRF5;RASL12;RNASE1;ITGA9;RIN2;GNAZ;VWA5A;LAMA2;HS3ST3A1;ENAH;SPARC;PDK4;CCL2;RGL1;ENO2;STARD13;LTC4S;OPTN;COPZ2;LPAR1;RAB27B;COBL;KCTD12
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.6974690444850173,1.4325003651271804,0.037037037037037035,0.27381452199732836,1.0,17/38,21.27%,IRAK2;MAP3K11;NOD1;SH2D3A;MINK1;TNFRSF19;GPS1;IKBKG;MAP3K5;TAB1;GPS2;MAPK9;SH2D3C;RPS27A;ARHGEF6;TAB2;ADORA2B
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.9133936517753631,1.43219772913248,0.017543859649122806,0.27423223272559666,1.0,4/8,6.45%,CACNA1H;ABCC8;TRPM4;ABCC9
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.8262562154154303,1.4319035464352825,0.0,0.27504358996448564,1.0,2/11,6.17%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.8087457381463002,1.431742321820262,0.04918032786885246,0.2749884515089503,1.0,1/10,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7995632702480917,1.4317072897930434,0.031746031746031744,0.2747120598738649,1.0,3/14,3.58%,RECQL4;BLM;RPA1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.8719043214172237,-1.4316220146151615,0.04081632653061224,0.7413741025475875,1.0,1/5,3.38%,ADAMTS12
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.5848325450304649,1.4315096296699195,0.0,0.2747069542388838,1.0,31/134,15.32%,HLA-DRA;MOG;RFTN1;FYB1;PRKCB;WAS;TEC;THY1;PAK3;LAT2;PTPRC;NFATC2;FYN;SKAP1;EIF2B2;NFKBID;PAG1;SYK;HLA-DRB1;CD276;BCL2;PAK1;STOML2;IKBKG;BMX;PIK3CD;INPP5D;BCAR1;CD4;EIF2B5;SH2B2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.6210692904803343,1.431444210046314,0.06557377049180328,0.2742607390774445,1.0,16/56,17.85%,DMTN;EPHA5;PAK3;BAIAP2;FAM107A;RHOD;PDGFA;FSCN1;ARHGAP18;PRKCD;PAK1;IQGAP1;ARHGAP17;RHOBTB2;BST1;RHOQ
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.9340874776556596,-1.431409919296488,0.06,0.7366792904113995,1.0,2/5,5.74%,HEY2;HEYL
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6986965877526379,1.430891311076135,0.05172413793103448,0.2754549616210804,1.0,7/32,12.16%,ANLN;PTP4A3;FAP;FAT2;CYP1B1;PXN;STARD13
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.9451780585763152,1.4308493705040966,0.019230769230769232,0.27508226283427806,1.0,2/7,2.21%,RECQL4;BLM
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.9119399155541223,1.4306614540904095,0.0,0.2748815896469464,1.0,1/5,5.12%,NUAK1
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.8919011966161514,1.4306184261246342,0.019230769230769232,0.27385205039636656,1.0,3/5,8.84%,KIF5A;KIF5C;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.8919011966161514,1.4306184261246342,0.019230769230769232,0.27385205039636656,1.0,3/5,8.84%,KIF5A;KIF5C;KIF17
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.7717459228385095,1.4288996676403023,0.05454545454545454,0.27919842560142183,1.0,4/17,7.51%,C3;CCBE1;SULF1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6910318260184405,1.4285716715486971,0.04838709677419355,0.2796915477432976,1.0,6/35,10.32%,EPHA7;ADA;PTPRR;RNASE10;MINK1;PODXL
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.7148864497510911,-1.4281361114566753,0.05,0.7511326608049801,1.0,3/17,6.01%,MID1IP1;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7305058796857542,1.4276999359403149,0.06153846153846154,0.28228005338762663,1.0,3/21,3.17%,IGF1;EGF;APP
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.875270313856658,1.427456239788493,0.03389830508474576,0.28252431793885735,1.0,3/8,7.26%,GRIN3A;APP;GRIN1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7275314364916903,-1.4271151451654185,0.02702702702702703,0.7512826208696415,1.0,13/30,20.34%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;LSM1;PATL1;DIS3;POLR2G
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.7612881561237466,-1.4270156103695342,0.07142857142857142,0.7460934027920956,1.0,5/12,20.25%,HUS1;RAD9B;CLSPN;DNA2;RAD17
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8434498660904421,1.4268523030301277,0.07936507936507936,0.2838960688283767,1.0,1/12,0.15%,NR4A3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.874396579095266,1.4262391574435165,0.01639344262295082,0.28540603537728343,1.0,1/7,1.88%,NMNAT2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.9210056504304467,-1.4254444554316588,0.038461538461538464,0.7501790685989276,1.0,1/6,1.34%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6179683901516593,1.4253963451067533,0.015151515151515152,0.2875316427938132,1.0,15/74,7.53%,HTR2C;PDGFRA;CD24;CD55;TRPC3;ADCY5;TRPM4;ITPR3;CCKBR;CACNA1C;JPH4;RYR2;GRIN1;GLP1R;NPTN
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.795441923028182,1.4251780717399485,0.14285714285714285,0.28785880931560814,1.0,4/13,11.69%,NPY;LHX6;MAPT;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.9248957684050794,1.4251238970925544,0.04838709677419355,0.2873987011102723,1.0,2/6,4.36%,HTR2C;FABP3
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.7189607168812842,-1.4244226705586325,0.07142857142857142,0.7510833856171673,1.0,3/18,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.7094965680344966,1.4236856581771098,0.1,0.29228848572276184,1.0,8/27,8.71%,ANXA1;TYMP;TSPYL2;IGFBP7;RYR2;GRK2;YWHAG;SCG5
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7896692534515379,1.4236811849584852,0.04477611940298507,0.2911903538173872,1.0,6/16,8.52%,IL1RAPL2;SLITRK1;IL1RAPL1;APP;SNCA;PTPRD
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7896692534515379,1.4236811849584852,0.04477611940298507,0.2911903538173872,1.0,6/16,8.52%,IL1RAPL2;SLITRK1;IL1RAPL1;APP;SNCA;PTPRD
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.8261785283021641,1.4233989118269,0.03278688524590164,0.29145969886984474,1.0,5/11,14.03%,CD24;PTPRO;BASP1;PODXL;IQGAP1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.6257703116022527,1.4229358777493004,0.0,0.2926711585836661,1.0,15/63,9.88%,COL4A1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;ITGA8;COL4A2;POSTN;COL12A1;IGFBP7;GLT8D2;BGN;LOXL1;GLI2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.5860999900359468,1.4228407061448896,0.0,0.2924187667923236,1.0,24/119,15.19%,HLA-DRA;MOG;RFTN1;FYB1;WAS;TEC;THY1;PAK3;PTPRC;FYN;SKAP1;EIF2B2;NFKBID;PAG1;HLA-DRB1;CD276;PAK1;STOML2;IKBKG;PIK3CD;INPP5D;BCAR1;CD4;EIF2B5
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.7371436311050139,1.422700191094348,0.03636363636363636,0.2924257239143993,1.0,3/24,1.98%,MET;STMN2;PSRC1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5763220254342851,1.422637376581906,0.015384615384615385,0.2921044988547275,1.0,31/172,15.78%,CDKN2A;HPN;RASGRP2;KIF14;TP53TG5;PSRC1;LTBP4;SLIT2;RPS6KA1;TSPYL2;SLIT3;BCL6;FAM107A;MFSD2A;BAP1;PAK4;PML;SMAD3;MMP14;TGFB2;FBP1;CDKN1B;BCL2;TMC8;CDKN1A;PPP1R9B;TRIM32;SIPA1;BCAR1;TP53;H3-3A
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7898467957303271,-1.422213414053318,0.0425531914893617,0.7594188555798387,1.0,5/16,12.15%,RPS28;MRPS7;RPS27L;RPSA;LOC102724159
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7223793610411201,1.4220709422679871,0.047619047619047616,0.2934922538475642,1.0,9/29,9.86%,TGFBR2;PROX1;SLIT2;SOX4;SLIT3;ROBO2;APLNR;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.7555250911342467,1.4217033028838792,0.034482758620689655,0.2940573841287016,1.0,6/17,12.33%,SYT4;SYT1;SYT5;SNCA;SYT13;SYT12
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.913589163993691,1.4211924038434423,0.0,0.2951562169359231,1.0,3/8,6.72%,NPNT;SLIT2;ROBO2
prerank,MSigDB_Hallmark_2020__UV Response Up,0.5932435343066205,1.421143233678713,0.014285714285714285,0.2947623855667404,1.0,21/137,12.29%,CCK;FOSB;CXCL2;CHRNA5;ATF3;NPTX2;RASGRP1;NR4A1;ABCB1;ICAM1;BTG3;NTRK3;CLTB;STK25;KCNH2;PTPRD;MMP14;CDKN1C;DGAT1;ENO2;PRKCD
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.9415158131095787,1.4210091645034248,0.0196078431372549,0.29448614771520876,1.0,1/5,0.52%,COL4A1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.8390463604053469,1.4209265361948684,0.10526315789473684,0.2941878266336386,1.0,4/8,10.90%,IGF1;NECAB1;NECAB2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7481965808004155,1.420899232446235,0.07936507936507936,0.2937057176460943,1.0,6/18,9.58%,IGF1;PROX1;RBM24;MYLK3;NRG1;MMP14
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.9543866704025434,1.4206896064180567,0.017543859649122806,0.29396385898615773,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.7072198158453437,1.4206757489867128,0.05084745762711865,0.2933919448636165,1.0,8/36,11.14%,CLIC1;PDGFRA;PLEK;MYH9;MEGF11;RAP2B;P2RY12;ACTN1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6595329952374748,1.4202840919405748,0.08333333333333333,0.29436221180355815,1.0,11/44,9.44%,MET;ANXA1;EPHA2;FA2H;LSR;ALOX12;CLIC4;PDGFA;DHCR24;ITGA3;CERS3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.7317362331630017,1.4202339394225723,0.05172413793103448,0.29392938200842805,1.0,4/19,7.18%,HTR2C;PTPRC;ITPR3;RYR2
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.8934808029921788,-1.4202334080350174,0.0196078431372549,0.7655793055196388,1.0,1/5,1.74%,VAMP8
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8664427574325786,1.4201290248735505,0.0625,0.2938187644901425,1.0,1/7,0.49%,NDST4
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.9483752518685384,1.419732890888235,0.0,0.29423415542523446,1.0,2/6,1.52%,ANXA1;AMH
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.7908676228732874,1.419662213195008,0.07042253521126761,0.2939409182761163,1.0,2/14,6.35%,IGF1;NRG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.9812692425144616,1.4194790383113873,0.02,0.294172368854135,1.0,1/5,0.29%,ANLN
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.5639489027748721,1.4191377551078839,0.04225352112676056,0.29469828810802623,1.0,44/155,13.49%,ECM2;COL4A1;ADAMTS4;COL11A2;NPNT;ADAMTSL2;DCN;THBS1;SERPINE1;ITGA8;COL4A2;ICAM1;APP;ADAMTS10;COL8A1;POSTN;COL23A1;LAMB1;ITGA2;COL27A1;ADAMTS19;CD44;AGRN;PDGFA;ITGA11;LAMA5;ITGA3;BGN;LOXL1;MMP14;ADAM19;ITGA9;COL9A1;ADAM12;LAMA2;ITGB8;COL4A4;MMP17;SPARC;ITGAL;FN1;MMP16;COL4A5;FGF2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8732088798774803,1.4191087632682315,0.041666666666666664,0.29431514205805287,1.0,1/9,2.21%,BLM
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7953601299504007,-1.419069785944745,0.021739130434782608,0.7670773643310859,1.0,3/11,7.44%,UQCRFS1;UQCRB;UQCRHL
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.6268575716949236,1.418971576010836,0.030303030303030304,0.29418242308433207,1.0,23/69,10.81%,COL4A1;PDGFRA;DCN;ACTA2;CALD1;SULF1;COL4A2;FBLIM1;ASPN;PODN;ANGPTL2;MYH11;POSTN;SLIT3;COL12A1;TNS1;C1R;MATN2;BGN;RASL12;RBPMS;SLCO2A1;LAMA2
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.9480153189228565,1.418747953372305,0.0,0.29432128715065,1.0,1/5,0.57%,C3
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7728591594162564,-1.4186439550153307,0.11538461538461539,0.7640757641780658,1.0,3/13,3.49%,APOBEC3G;TEX15;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.8281751273827781,1.4184548738228877,0.0392156862745098,0.2945498089253076,1.0,3/12,2.44%,IGF1;SULF1;DUSP1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.6166389245513594,-1.4183988773685021,0.0,0.7602866041693306,1.0,14/51,14.54%,SLC25A5;COX18;TIMM8B;SLC25A4;AIP;TIMM13;BCAP31;BAK1;ABCB10;TIMM23;BAD;TSPO;TIMM10;SLC25A24
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.8401055179738465,1.4180292689630307,0.03508771929824561,0.2954075685926027,1.0,7/11,12.22%,APP;SHANK3;NETO1;SYP;NPTN;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.6000926763922495,-1.4173653271075757,0.0967741935483871,0.7610741284230603,1.0,5/70,5.88%,NUP62CL;RITA1;RBM8A;RAE1;U2AF1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.596124271614284,1.417308479862855,0.04918032786885246,0.29749743418886576,1.0,14/68,11.26%,HPN;NPY1R;PROX1;ABCA8;FAM124A;COL12A1;GRAMD2A;ALDOB;MAOB;MATN2;ENPEP;KALRN;SORBS1;VSTM2L
prerank,MSigDB_Hallmark_2020__Apical Junction,0.574195069007541,1.4172492157046714,0.016129032258064516,0.2970909220857982,1.0,50/157,20.13%,CDH6;YWHAH;AMH;FYB1;ZYX;ICAM1;SLIT2;THY1;MYH9;CERCAM;CDH8;PTPRC;ITGA2;BAIAP2;KCNH2;HADH;NEXN;ITGA3;FSCN1;ITGA9;COL9A1;SYK;INPPL1;ACTN1;CLDN18;CTNNA1;CD276;STX4;CDH4;CD99;IKBKG;MAPK11;LAMA3;TNFRSF11B;THBS3;VAV2;CALB2;VASP;SHC1;GNAI1;PCDH1;CRAT;SLC30A3;AMIGO2;ITGB4;LDLRAP1;ACTN4;VCAN;ARHGEF6;AKT3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.7386715417186702,1.4168071936127726,0.06060606060606061,0.2982746566143953,1.0,5/16,5.78%,ANXA1;ZFP36;SLIT2;SLIT3;FAM107A
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.9168287018609473,1.416669081710606,0.0392156862745098,0.2983595594912161,1.0,2/5,6.64%,FLRT3;TBX20
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6425339132690583,1.416263866324364,0.031746031746031744,0.2991797757401401,1.0,15/37,24.66%,EGF;ERBIN;TGFA;REPS2;GAB1;IQGAP1;BCAR1;SHC1;NCK2;ADAM17;DGKD;PTPN11;RPS6KA5;CBL;PLCE1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6899544151931628,1.4154206332148092,0.0,0.3014209092215405,1.0,11/32,17.44%,STMN2;STMN4;FAM107A;MAPRE2;TRIM36;TPPP;MAPT;PHLDB2;CAMSAP3;STMN1;SKA2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.5629383746475977,1.4153504531922658,0.041666666666666664,0.30116630730468646,1.0,44/155,13.49%,ECM2;COL4A1;ADAMTS4;COL11A2;NPNT;ADAMTSL2;DCN;THBS1;SERPINE1;ITGA8;COL4A2;ICAM1;APP;ADAMTS10;COL8A1;POSTN;COL23A1;LAMB1;ITGA2;COL27A1;ADAMTS19;CD44;AGRN;PDGFA;ITGA11;LAMA5;ITGA3;BGN;LOXL1;MMP14;ADAM19;ITGA9;COL9A1;ADAM12;LAMA2;ITGB8;COL4A4;MMP17;SPARC;ITGAL;FN1;MMP16;COL4A5;FGF2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.9640407005138537,1.41532326835427,0.018518518518518517,0.30073532552605675,1.0,4/5,3.57%,ANK3;CNTN2;CNTNAP1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6052987510626989,1.4152640421134974,0.03076923076923077,0.3002617044035986,1.0,22/86,15.01%,MET;PDGFRA;EPHA7;FLT1;EPHA2;RELN;EPHA5;AGAP2;PTPRC;NTRK3;MMD;VAC14;EPHA4;MAPT;GAS6;HLA-DRB1;EEF1A2;ALK;CDKN1A;IQGAP1;MRE11;CD4
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8880065105795104,1.4149991807701183,0.08333333333333333,0.30069529316660176,1.0,3/7,9.30%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.6824703463729319,1.4149379292360889,0.015384615384615385,0.30026759622870575,1.0,11/37,14.07%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;SLC25A45;SLC38A11;SLC7A7;SLC25A29;SLC7A14;PDPN;SLC7A1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.9064865695089148,1.4146780951652609,0.038461538461538464,0.3006995621862235,1.0,1/7,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.6383987860915477,1.4145286903930785,0.04918032786885246,0.30042717168362504,1.0,13/58,12.19%,TBC1D24;PLD1;DMTN;GAP43;EPHA2;WAS;PPP1R16B;FSCN1;PODXL;CDKL5;USP6NL;ARF6;TBC1D1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.6195049399752248,1.4144351580068317,0.04477611940298507,0.30015579003473974,1.0,9/66,7.62%,TLR2;RFTN1;CTSS;SFTPD;IRAK2;COLEC12;BIRC3;SCARA3;MYD88
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7872414502592067,1.4141852822811412,0.015384615384615385,0.3004105283735875,1.0,4/19,10.96%,SOCS3;NLRC5;PPARG;PARP9
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.8415874859908095,1.4139897008540447,0.037037037037037035,0.3006643267185649,1.0,2/12,1.68%,MET;THBS1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.8490665916821694,1.4137113113360378,0.1346153846153846,0.3011787815614115,1.0,4/8,13.10%,CNTN2;CNTNAP2;AGRN;PICK1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.7196118242190225,1.4136089130066227,0.01639344262295082,0.30082097691934023,1.0,8/29,16.24%,DAB2IP;FAS;DAPK2;NR4A2;TPD52L1;BCL2;SGMS1;MAPK8IP2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8185028385806682,1.4134200214287949,0.05555555555555555,0.30079027448474643,1.0,4/9,6.91%,ANXA1;IL1RAPL1;ATP9A;SNCA
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7433846653698375,1.4132979446610547,0.07142857142857142,0.300586248524232,1.0,2/14,2.81%,SCN1B;SCN3B
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.7993516950835404,1.4128808538552817,0.06779661016949153,0.3012052834220814,1.0,3/13,9.80%,NMNAT2;AK3;AK5
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.8664559313700876,1.4128011292672162,0.03773584905660377,0.3008932428844137,1.0,3/9,8.06%,CTSS;RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6505751068071339,1.4123694633658241,0.031746031746031744,0.30183287892913974,1.0,17/61,14.12%,SLITRK1;FLRT3;NLGN1;GABRB2;GRID2;ACHE;SHANK3;GABRA1;DVL1;KIRREL3;GABRG2;DNER;LRRC4;FGF13;SDK2;PCDHB2;PCDHB5
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.6283543170419078,1.4123035977489462,0.014705882352941176,0.30145626651294477,1.0,18/74,15.88%,GGT5;ANXA1;FOXO1;ERBIN;WNT8B;FOXO3;SNCA;CTNNB1;PPARG;STAT3;ABCA2;ASXL1;ALPL;IL12A;SPP1;RARA;RARG;RXRA
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.6105399422091519,1.4122117621981243,0.047619047619047616,0.3012958488106514,1.0,11/86,10.51%,TGFBR2;SKOR1;ADAMTSL2;VWC2;VWC2L;ASPN;PMEPA1;LDLRAD4;SMAD3;PPARG;SMAD1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.8078453453260039,1.412056046356364,0.01694915254237288,0.3013718947028956,1.0,3/13,2.82%,SERPINE1;DUSP1;SLIT2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.9158941192612883,1.4118809031975459,0.018867924528301886,0.3016403112361708,1.0,3/7,3.66%,PTPRO;PTPRB;DUSP10
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.8883302571087124,1.4117688160450208,0.03278688524590164,0.3015231628856629,1.0,2/6,3.99%,RBM24;ELAVL4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.9257762307310101,1.4117365478795603,0.041666666666666664,0.3006301534081509,1.0,1/5,2.28%,STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.9257762307310101,1.4117365478795603,0.041666666666666664,0.3006301534081509,1.0,1/5,2.28%,STPG4
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6781930736572225,-1.4116188649832226,0.07894736842105263,0.7910087378729077,1.0,11/21,15.16%,MT1E;MT1A;SLC30A8;SLC39A10;MT1G;MT1F;SLC30A5;MT2A;SLC39A8;SLC39A6;MT3
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.6025714038289834,1.411574889386613,0.04477611940298507,0.3006854604488485,1.0,18/75,12.93%,MET;PDGFRA;EPHA7;FLT1;EPHA2;IRS2;EPHA5;TSPYL2;NTRK3;LDB2;NLRC5;VAC14;EPHA4;MAPT;CDKN1C;HLA-DRB1;CDKN1B;ALK
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6605527125425562,1.4112541100183866,0.08955223880597014,0.3013981807149108,1.0,9/33,6.95%,ANK3;CTSS;KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5784627577261344,-1.411082408025319,0.13333333333333333,0.787973106365475,1.0,19/55,18.97%,BUD23;TFB2M;TRMT61A;TRMT10C;TRMT10A;METTL8;METTL2A;METTL3;FTSJ1;MTERF4;TRMT61B;TRMT5;VIRMA;TFB1M;MEPCE;TGS1;FBL;LCMT2;TRDMT1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.8262158562065262,1.4098716153188042,0.08333333333333333,0.3063645911710777,1.0,4/10,12.18%,IL27RA;STAT3;TYK2;MX1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.6221693695440467,1.4095806263958368,0.056338028169014086,0.3072337247920821,1.0,10/84,5.47%,NR4A3;HPN;IGF1;PROX1;EGF;NR4A1;NRP2;TGFA;EGFL7;LAMB1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7604387090537358,1.4094242887134922,0.04477611940298507,0.307319066080478,1.0,8/20,14.75%,IGF1;PDGFRA;PDGFA;CDK6;GAS6;FN1;CDKN1A;S100A6
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.8783006389346866,-1.4091562529848822,0.020833333333333332,0.7951696891146325,1.0,2/9,3.43%,RTRAF;SIDT1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.6912453426111564,-1.408980278584706,0.12244897959183673,0.7905962389892166,1.0,2/20,4.40%,CFAP53;FOXJ1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7452348820375803,1.4088298319503578,0.08620689655172414,0.30902589989357876,1.0,7/25,13.78%,P2RY6;PDGFRA;FLT1;NTRK3;P2RY12;FGF2;LPAR1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7653650150828094,1.4087681266544099,0.11475409836065574,0.30858213280897867,1.0,3/20,8.38%,CDKN2A;SUV39H1;CENPV
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6527258484269681,1.4081195077552713,0.06779661016949153,0.3103856125385847,1.0,11/31,17.46%,IGF1;EFNA1;RTN1;RTN2;TMED10;EPHA4;ABCA2;HAP1;BIN1;SLC2A13;ABCG1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.6295462195330319,1.408001934183646,0.04838709677419355,0.31023431608949353,1.0,10/52,10.90%,ENPP2;PLPPR5;PLPPR4;LPCAT4;PLPPR1;PLAAT4;AGPAT4;PLAAT3;PIP4K2A;ABCA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.8177287850247512,1.407815705091513,0.029411764705882353,0.3104390827131845,1.0,4/13,7.53%,IGF1;SERPINE1;SLIT2;PDGFA
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.725385238018016,1.4077753790190555,0.05,0.30997507732041163,1.0,3/23,3.70%,KIF14;STMN2;STMN4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.6060611413759754,1.4077638932412346,0.017543859649122806,0.30945018635022203,1.0,10/95,2.79%,CDKN2A;RASGRP2;IGF1;PLD1;PLK2;RAPGEF5;RASGRP1;RIT2;SHTN1;SHC2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.9469905829105856,1.4076863132836608,0.02,0.3091767784327095,1.0,2/6,0.90%,CDKN2A;IGF1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.8380621600821718,-1.4076148633494205,0.08163265306122448,0.7926761125643108,1.0,1/9,1.53%,CEP72
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.7037462642230673,1.4076010951620568,0.12727272727272726,0.3090081632294054,1.0,5/24,6.64%,TGFBR2;PROX1;PKP2;SOX4;TBX20
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.769374444096831,-1.4075628677240857,0.058823529411764705,0.7871316241304099,1.0,4/13,8.80%,SPRY1;HEY2;HEYL;HEY1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6711040184302295,1.4075317034350923,0.04411764705882353,0.30877794769623845,1.0,6/32,8.28%,GPNMB;EPHA7;NLRP12;NEK10;PDGFA;MVP
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.5190820800091951,1.407500886309994,0.0,0.3083829845774848,1.0,69/413,13.99%,LEF1;TGFBR2;HPN;MYRF;IL13RA1;TLR2;IGF1;KIF14;PROX1;PDGFRA;IL15;EGF;THBS1;PTK6;ZFP36;FLT1;TRPC3;IRS2;SFTPD;RPS6KA1;COLEC12;PRAME;TGFA;TRPM4;EPB41L4B;OSMR;SOX4;NTRK3;MFSD2A;PARD3;PRODH;NRG1;CCKBR;RHOD;SCX;RYR2;GRIN1;RAMP3;PDGFA;TENM4;CAPN1;KITLG;LMNA;GAB2;MMP14;HDAC4;NAMPT;TGFB2;TPPP;EPHA4;NOXA1;MAPT;GAS6;S1PR3;STX4;CDC7;MLXIPL;PRKCD;CDKN1B;BCL2;MEIS3;FN1;PAK1;PDPN;CCND1;FGF2;NAP1L1;TRIM32;GRK5
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8379409225860566,1.4074994677152168,0.04,0.30784479437752404,1.0,1/10,0.81%,TLR2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6813703717787644,1.4074386088656332,0.06779661016949153,0.30749407706375603,1.0,12/41,14.38%,KIF14;TMEFF2;ATRNL1;SRCIN1;ITGA8;EFNA1;LAMB1;LAMA5;RADIL;PXN;FN1;NTN4
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.7795995561340825,1.4072584147972682,0.06666666666666667,0.3073092684189435,1.0,4/14,6.11%,KIF14;PLEK;FBLIM1;SKAP1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.930345496287589,1.4072370272780084,0.038461538461538464,0.3068168460996493,1.0,1/5,1.87%,CD24
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.719553499036185,1.406934435538398,0.06153846153846154,0.3074749561803412,1.0,12/20,15.32%,RFTN1;PRKCB;TEC;LAT2;PTPRC;NFATC2;SYK;BCL2;BMX;PIK3CD;BCAR1;SH2B2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8263190366710681,1.4069316812969734,0.08620689655172414,0.30694299258833374,1.0,5/7,15.24%,DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8672242446185592,1.4067125934139137,0.07317073170731707,0.30721017782368515,1.0,4/7,11.38%,PROX1;GRID2;AGTPBP1;OPHN1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.6104463972668471,-1.4064607101144835,0.05714285714285714,0.78883999547065,1.0,6/51,6.82%,H1-2;H1-4;POLR2K;ATAD2;POLR1F;TAF1D
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.6735597756057548,1.4063084524231915,0.046875,0.3082927869894485,1.0,3/33,1.69%,C3;EGF;SERPINE1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.849317240297849,1.4060639172569096,0.12,0.30861784977021545,1.0,3/7,4.92%,DRAXIN;MDGA2;SOX4
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6758246072372064,-1.4058356896441335,0.09090909090909091,0.7819111923429387,1.0,5/17,18.31%,GSTT2B;AKR1A1;GSTM3;GSTP1;ESD
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6758246072372064,-1.4058356896441335,0.09090909090909091,0.7819111923429387,1.0,5/17,18.31%,GSTT2B;AKR1A1;GSTM3;GSTP1;ESD
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.7258876226592176,1.405109271609192,0.03571428571428571,0.3110163223657898,1.0,5/29,8.10%,YWHAH;THY1;EFNB3;MAG;MCF2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.821293072154655,1.404645289456003,0.046153846153846156,0.3120665284813093,1.0,2/12,10.96%,SOCS3;PARP9
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8399634256124909,1.4046223990658269,0.07142857142857142,0.311592974526304,1.0,1/8,0.02%,APOLD1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.920692880183362,1.40455386162177,0.019230769230769232,0.3106709149609739,1.0,3/6,2.65%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.920692880183362,1.40455386162177,0.019230769230769232,0.3106709149609739,1.0,3/6,2.65%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.6352119562396069,1.4045176578999072,0.046153846153846156,0.31032315029540947,1.0,18/58,17.98%,PROX1;PLEK;CDC42EP3;BAIAP2L1;MYLK3;BAIAP2;NTRK3;CDC42EP1;SYNPO2L;PRKCE;FCHSD1;ARF6;BIN1;P2RX7;PFN2;VASP;CRACD;NCK2
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.7288665102193361,-1.4040319734011244,0.15625,0.787875135324725,1.0,3/12,8.59%,ALG3;ALG11;ALG9
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.6036314728848947,1.40397995766625,0.014925373134328358,0.3113454739878678,1.0,29/97,11.37%,L1CAM;RGS7BP;STMN2;ZNF536;RCAN2;CNTN2;ADCY5;SHC2;PLP1;PLPPR4;THY1;ACKR1;IGSF21;PRIMA1;APOD;CCDC3;FAM107A;TMEM132C;PHYHIP;TCEAL5;APLNR;MAOB;GFAP;RAMP3;PTPRD;RASL12;SORBS1;CRTAC1;LGI3
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6607627053870342,1.4038847206205685,0.043478260869565216,0.3110178417103458,1.0,4/53,8.12%,LEF1;WNT8B;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.830072033029035,-1.4033855371088564,0.10638297872340426,0.7859673344258172,1.0,2/6,14.33%,NBDY;CNOT1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7758404382835106,1.403285013918399,0.04838709677419355,0.3127778431867898,1.0,2/14,9.33%,IMPDH1;AK3
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.7039343059747187,1.4032168727824819,0.0967741935483871,0.31256906866370526,1.0,7/25,10.56%,IL1RAPL1;SRCIN1;SHANK3;SIPA1L1;HOMER1;EPHA4;CDKL5
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.8881881036004549,1.4029373858438012,0.031746031746031744,0.31278089326283975,1.0,1/7,0.15%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.5699834899546184,1.402805279998924,0.0,0.3127923911980187,1.0,39/170,15.27%,GPNMB;HTR2C;IGF1;P2RY6;PDGFRA;NPNT;EGF;RASGRP1;CD24;RIT2;FLT1;ICAM1;APP;DAB2IP;NEK10;PTPRC;TRIM5;NTRK3;CD44;STK25;DIRAS2;RAMP3;PDGFA;NECAB2;CHI3L1;TGFB2;DIRAS1;GFRAL;GAS6;CCL2;HLA-DRB1;TPD52L1;FGF2;LPAR1;IQGAP1;GPR37;GPR183;CD4;THPO
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.8748890479186247,-1.4027307050116913,0.0851063829787234,0.7854508823825411,1.0,1/6,3.20%,PHYH
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.91378993974774,1.4021604689151308,0.034482758620689655,0.3145973362154808,1.0,1/5,0.42%,MET
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.8728251861938913,1.4019813122668139,0.016666666666666666,0.3146057426568396,1.0,5/9,12.22%,RELN;DAB2IP;NEUROD2;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.531080236157103,1.4019634710838567,0.0,0.3141771844162471,1.0,26/275,8.62%,LEF1;HPN;MET;ANXA1;IGF1;KIF14;PLK2;THBS1;PIM3;RPS6KA1;PIM1;FOXO1;NUAK2;PRAME;FAS;BIRC3;CD44;SNCA;SCX;MYD88;NAA38;CTNNB1;BAG3;THOC6;BCL2L1;DHCR24
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5935459182347277,-1.4018536719440022,0.04,0.7852929788644344,1.0,18/90,16.61%,RP9;PDCD7;SCNM1;DHX16;SF3B4;ZCRB1;RBM8A;U2AF1;PRPF18;RRAGC;YJU2;SNRNP25;LSM4;PRPF8;SRSF2;PRPF3;TARDBP;RNPC3
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.7784612387611547,-1.40135427329915,0.16666666666666666,0.7829429885663207,1.0,2/8,8.80%,CHAMP1;KIF20B
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.8919919570752493,-1.4013420369603784,0.05660377358490566,0.7777518972933596,1.0,2/6,6.97%,DIRAS3;KDM1B
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5971685011045109,1.4012519411849027,0.02857142857142857,0.31614918710205764,1.0,29/114,11.43%,SLITRK1;PCDH8;TAGLN3;STMN2;ZNF536;CNTN2;CAMKV;PLPPR5;GAP43;ZDHHC22;PLP1;OPCML;EFNB3;SEMA5B;CDK5R2;ZIC1;GFAP;SULT4A1;NYAP1;MGAT5;CELF3;SRRM3;KCNQ2;CACNG4;LY6H;DNER;DCX;NACAD;CRMP1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6755457078255962,1.4012177796593925,0.09836065573770492,0.31573927548067704,1.0,4/26,6.95%,CHRM3;KCNJ2;KCNQ1;KCNH2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.6503771604844505,-1.4011675386715396,0.07692307692307693,0.7736144770554755,1.0,4/30,7.19%,CFAP53;FOXJ1;ENKUR;PKD1L1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5748042458478724,1.4005891673418502,0.06153846153846154,0.3173463829928893,1.0,26/114,12.46%,SCN9A;KCNJ2;KCNV1;SCN3B;SCN1A;KCNB2;ABCC8;KCNF1;SCN2A;KCNK1;KCNMB4;PIEZO2;TRPM4;SLC5A4;KCND3;ABCC9;GRIN1;KCNC1;ATP1B1;SLC25A29;SLC4A11;SCN3A;KCNAB3;FGF13;KCNH3;SLC29A4
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.657156228183772,1.4003464708379876,0.07462686567164178,0.3178236178860507,1.0,11/34,20.08%,PAK3;SHANK3;DVL1;DOCK10;SHANK1;MINK1;KLF7;PHACTR1;MAPK8IP2;FARP1;CTNNA2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7026879132153419,1.3995611878050498,0.09375,0.3198158195207671,1.0,8/26,8.95%,CSPG4;DCN;PXYLP1;CHSY3;CHST15;CHPF2;UGDH;BGN
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.7181443407927756,1.399193145387464,0.017857142857142856,0.32048399487275436,1.0,4/23,8.41%,CACNA1H;CACNA1G;CACNA1C;CACNA1E
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.757138492310049,1.3987068517592616,0.05357142857142857,0.32187627118767265,1.0,7/23,3.97%,DCN;SP100;THBS1;SLIT2;DAB2IP;DUSP10;PTPRR
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7993407443972819,-1.3986198588452576,0.10416666666666667,0.783851601384899,1.0,6/9,16.79%,ATP5MC1;ATP5PB;ATP5PD;ATP5MC3;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.8430560964749356,-1.3985054793061504,0.1,0.7793402024431209,1.0,1/12,0.92%,PTCD2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7785787710837495,1.3983817153546088,0.01694915254237288,0.32224485730760366,1.0,2/19,0.46%,NR4A3;MRAP2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.8833491461342828,1.398311396799842,0.07272727272727272,0.3213571400496159,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.8833491461342828,1.398311396799842,0.07272727272727272,0.3213571400496159,1.0,1/5,0.11%,CACNA1H
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.7084464576784333,1.3974568063831727,0.10714285714285714,0.3235188364628423,1.0,5/24,4.94%,THBS1;ELMO1;XKR4;MYH9;XKR6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.6986796123559976,1.3973089231081708,0.09090909090909091,0.32331770203822674,1.0,5/22,14.92%,ANK3;FYN;MYO1C;CEMIP;MTCL1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6924240418767162,1.3968745751706744,0.078125,0.32406963095553803,1.0,8/31,10.96%,SOCS3;IGF1;IL15;PTK6;TNFRSF1A;GHR;STAT3;PARP9
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7616552646534229,1.396810452803153,0.06557377049180328,0.32375182347656195,1.0,4/17,8.84%,MYO1F;MYO1B;MYO1C;MYO15A
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7086211805684584,1.3967457086759263,0.029411764705882353,0.32335756360797374,1.0,19/37,22.03%,NPY1R;CHRM3;CHRM1;ADCY5;ADCY7;ADCY2;P2RY12;HTR1E;LPAR1;GPR37;ADCY3;GRM7;GNAI1;FLNA;HTR1F;PDE2A;ADCY9;ADCY8;HRH3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7514333860473785,1.396719073641136,0.08771929824561403,0.32288722611638915,1.0,2/16,3.51%,S100A10;THY1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5885676750879992,1.3963278980782277,0.0,0.3235190909598606,1.0,31/100,11.71%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;RELN;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;IGFBP7;COLEC11;SYP;PTPN21;LDB2;MEG3;GFAP;C1R;BGN;PPARG;RASL12;LAMA2;SPARC;CCL2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.7808370564005253,-1.3962570125052014,0.08888888888888889,0.7884403874585505,1.0,3/12,8.80%,HEY2;HEYL;HEY1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6392593457251157,1.3961609687296699,0.11320754716981132,0.3236862133281647,1.0,9/38,7.51%,TGFBR2;COL4A1;CCBE1;PROX1;FLT1;EGFL7;TBX20;APLNR;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.8078778791060354,1.3958504824988986,0.07692307692307693,0.3242377355018643,1.0,3/12,4.82%,TLR2;DYSF;PLSCR1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.8529924602724328,1.395691562553006,0.03636363636363636,0.32423020536115343,1.0,3/13,4.47%,HPN;SCN1A;PIEZO2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7760864636935629,-1.3944126959878482,0.07692307692307693,0.7953613424501628,1.0,5/14,16.23%,COX18;COX20;COX19;SMIM20;OXA1L
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8889179089071434,-1.3938206961510156,0.07317073170731707,0.7936716196169414,1.0,2/5,7.78%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.8259867112822172,-1.3937908801103909,0.06666666666666667,0.7886457477495293,1.0,1/10,0.29%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.8773620540262048,1.393739477967561,0.031746031746031744,0.3297670996407393,1.0,5/8,12.22%,RELN;DAB2IP;NEUROD2;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.8276052841323931,1.3935531449376535,0.06779661016949153,0.33007626011886193,1.0,1/7,3.36%,LPCAT4
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.6108684729859261,1.3931571377327678,0.06349206349206349,0.33101547372361484,1.0,15/62,12.85%,HLA-DRA;TLR2;SP100;ICAM1;IRF7;TRIM5;CIITA;CD44;PML;CCL2;HLA-DRB1;CAMK2B;PRKCD;TRIM22;B2M
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.7401863776429454,1.3929127683752154,0.06451612903225806,0.331397991185563,1.0,3/17,10.25%,YBX3;SCN2A;SLC4A11
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.8467725708806055,1.3927675101614039,0.09090909090909091,0.33094138060311373,1.0,4/8,8.06%,KCNQ1;SNCA;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.8467725708806055,1.3927675101614039,0.09090909090909091,0.33094138060311373,1.0,4/8,8.06%,KCNQ1;SNCA;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8793666536359314,1.3927507286193117,0.0625,0.3304671745648394,1.0,1/8,0.88%,SOCS3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.8744956713210934,1.392599783955073,0.09836065573770492,0.33039284920506523,1.0,1/5,4.64%,SHANK3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.952403709162364,1.3923113227898363,0.0,0.3306217890465124,1.0,2/6,0.85%,CDKN2A;ANXA1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.5774511435812594,1.3922694122841675,0.04225352112676056,0.3302070929578062,1.0,32/107,10.95%,CDH6;COL4A1;C3;IGF1;PDGFRA;DCN;THBS1;CALD1;CLDN16;COL4A2;NRGN;SHROOM4;ANGPTL2;KCNT1;POSTN;IGFBP7;TNS1;LDB2;ENC1;APLNR;MAOB;C1R;ADGRF5;BGN;ARHGEF10L;RASL12;RNASE1;RIN2;PXDC1;SLCO2A1;LAMA2;CDKN1C
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.6844536504538229,1.3919846267650064,0.06060606060606061,0.3306810231626505,1.0,14/37,15.46%,IGF1;PDGFRA;DAB2IP;PDGFA;CDK6;CTNNB1;NLRC3;GAS6;B4GALT7;FN1;CDKN1A;TRIM32;S100A6;TP53
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7267585934704545,1.391796021988527,0.13432835820895522,0.33066337689778,1.0,7/18,8.03%,MET;MRAP2;PLEK;ADA;SNCA;MRAP;GRK2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.8103789053726,-1.3916081084294976,0.09302325581395349,0.7986277418465783,1.0,4/10,17.12%,METAP1D;NAA11;METAP2;METAP1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.8070120311683427,1.3915701435194376,0.125,0.330402785641938,1.0,4/12,4.87%,MET;FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.8070120311683427,1.3915701435194376,0.125,0.330402785641938,1.0,4/12,4.87%,MET;FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.8699593302724519,1.3915577376332837,0.10344827586206896,0.32991668615994674,1.0,1/8,0.06%,TGFBR2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5791490904582176,1.39088297672529,0.029850746268656716,0.33166092835998073,1.0,56/186,17.21%,CARNS1;SCN9A;IMPDH1;PDE1C;TESC;SRCIN1;ARHGAP39;CNTN4;CEP170B;CLSTN2;EFNB3;PRR36;DUSP8;FGF12;EPB41L4B;CFAP126;CDK5R2;ATP9A;HPCA;NRG1;FLRT1;LARP6;SYBU;NYAP1;MAPK8IP1;WDR54;CLGN;PCLO;C2CD4C;SRRM3;EML2;EPB41L1;KLHL5;DNER;VSTM2L;MORN5;MACROD1;MEIS3;STOM;CCDC184;CAP2;FAM131C;CYB561;CERS5;RARG;SCAMP5;SEZ6L2;NRSN2;MAPK8IP2;PFN2;LRRC45;TTC9;IFT140;CTXN1;CALB2;CMIP
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.5890057311418001,1.3906852839531756,0.03389830508474576,0.33164187344760154,1.0,18/77,16.77%,CACNA1H;ACTA2;CALD1;DYSF;MYH11;OXTR;GJC1;DTNA;TPM4;TCAP;SORBS1;PXN;TPCN2;SMTN;CHRNE;NEB;MYOF;SLC8A1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.7492137962908747,1.3904169218721154,0.05263157894736842,0.3320709672101285,1.0,3/24,2.21%,RECQL4;ANXA1;BLM
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.8095800208794017,-1.3902058235178592,0.07692307692307693,0.8028794633431332,1.0,4/7,13.52%,CYP4F3;HSD17B6;ADH4;CYP4F12
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.8508931381867636,1.3901548126769632,0.03636363636363636,0.3323868637678658,1.0,3/8,9.04%,BOK;ZFP36;YAP1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.5913155328406893,1.3900768873895653,0.02857142857142857,0.3321992525238115,1.0,19/83,13.44%,FOSL2;IL13RA1;TYMP;ZFP36;ICAM1;IL1R1;AHR;SYNGR2;TNFRSF1A;TMBIM1;MVP;DTX2;FBP1;RAB20;RELB;ANXA11;KLF4;IL4R;RHBDF2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.7288623797558588,1.389856880911828,0.08620689655172414,0.3324767910110077,1.0,7/23,17.57%,IGF1;NTRK3;NRG1;GAS6;PRR5;PINK1;WNT5A
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6469743274261811,1.3897120319639193,0.03225806451612903,0.33247515995154947,1.0,6/45,9.86%,ENPP2;DAB2IP;DUSP10;PTPRR;PRKCE;TGFB2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.803169940733904,1.389531358429518,0.08064516129032258,0.3323994369313839,1.0,5/18,6.62%,CHRM3;KCNMB4;TRPM4;OXTR;ECE1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.8866906560540988,1.3892251680716636,0.05084745762711865,0.3323964314341774,1.0,3/7,9.70%,CACNG3;CACNG8;CACNG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.8866906560540988,1.3892251680716636,0.05084745762711865,0.3323964314341774,1.0,3/7,9.70%,CACNG3;CACNG8;CACNG4
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.7977093786223345,1.3887884109074045,0.015873015873015872,0.33340900945215746,1.0,5/15,7.18%,P2RY6;TRPC3;ABCC9;VGF;RYR2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.6057955143646779,1.3884320664026866,0.07352941176470588,0.3340686663584143,1.0,6/87,3.55%,GGT5;CXCL2;SERPINE1;ZFP36;DAB2IP;ERBIN
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.9059578421560787,1.388086010338227,0.08,0.3344091906006447,1.0,1/5,0.81%,TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.9059578421560787,1.388086010338227,0.08,0.3344091906006447,1.0,1/5,0.81%,TLR2
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.8680184017506791,1.3877517595985243,0.10714285714285714,0.3346561335009391,1.0,2/5,9.35%,SOAT1;PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.8680184017506791,1.3877517595985243,0.10714285714285714,0.3346561335009391,1.0,2/5,9.35%,SOAT1;PPARG
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.8871460458819248,1.3875365242214401,0.023809523809523808,0.3347790333240023,1.0,1/5,3.94%,SLC28A3
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.8328974048094462,1.387458557485426,0.11864406779661017,0.3345550164776538,1.0,3/7,11.38%,SHTN1;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.9390572256938801,1.3869163008687526,0.034482758620689655,0.3355153895391834,1.0,2/5,4.38%,RELN;VLDLR
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.696846533790025,1.3866476905309515,0.017543859649122806,0.3360727904291564,1.0,2/33,2.75%,TGFBR2;EPHA2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.7529190696682202,1.3863004711576044,0.11320754716981132,0.33690080526393174,1.0,8/19,9.88%,SCN1B;SCN3B;KCNQ1;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.918969867847508,-1.3857919741667286,0.0,0.8241050972944058,1.0,3/5,7.64%,SLC25A5;FZD9;HSPA1A
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.6347205440198515,1.3857851697862165,0.045454545454545456,0.33859638559711747,1.0,11/54,7.62%,IL13RA1;TLR2;SOCS3;CSF2RA;PIM1;IL1R1;OSMR;FAS;CD44;TNFRSF1A;MYD88
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.6639652312411479,1.3857022221660693,0.06666666666666667,0.33833204569182884,1.0,13/43,12.85%,HLA-DRA;SP100;ICAM1;IRF7;TRIM5;CIITA;CD44;PML;HLA-DRB1;CAMK2B;PRKCD;TRIM22;B2M
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.8675324941347455,1.3856023172911411,0.046875,0.3382673023492741,1.0,3/6,10.76%,AGTPBP1;STAT3;DCX
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7957366873463562,1.385272416796607,0.038461538461538464,0.3388162597678143,1.0,2/10,7.04%,PDGFRA;APLNR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.7121933629384026,1.3850952845302908,0.046153846153846156,0.33873295975304707,1.0,6/32,6.65%,MET;NRP2;SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6517390589863102,1.384935969964429,0.04225352112676056,0.3389017641266808,1.0,12/45,13.58%,TLR2;ANXA1;SERPINE1;NOD1;PTPRC;MYD88;CHI3L1;STAT3;SYK;MAPKBP1;KLF4;FADD
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.8280350988011215,-1.3846986406153785,0.06666666666666667,0.8260222600343179,1.0,2/8,5.43%,RAB7B;PTPN22
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5513745092955111,-1.3845464162165664,0.038461538461538464,0.8218217805451322,1.0,20/71,15.16%,FTL;MT1E;FTH1;MT1A;SLC30A8;SLC39A10;MT1G;CCDC22;MT1F;SLC31A2;SLC30A5;ATP6V1G1;SLC46A1;MT2A;ISCU;SLC39A8;COX19;HFE;SLC39A6;MT3
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.545199474223087,1.384103505099005,0.02702702702702703,0.34147697400732496,1.0,53/165,14.24%,FOSL2;FOSB;COL4A1;PRRX1;IGF1;KLF2;PDGFRA;PCDH18;DCN;ACTA2;NR4A1;SULF1;CD55;COL4A2;ASPN;THY1;IL1R1;PODN;ADAMTS10;CTHRC1;COL8A1;ANGPTL2;POSTN;SLIT3;COL12A1;LAMB1;FAP;IGFBP7;CD44;TNS1;TBX20;C1R;CYP1B1;BGN;MMP14;PIP4K2A;STAT3;FLI1;LAMA2;COL4A4;NR4A2;SPARC;KLF9;ITGAL;PRKCD;KLF6;FN1;KLF4;COPZ2;FGF2;PALLD;COL5A1;THBS2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6553865386105763,1.3840751954316253,0.12280701754385964,0.341103063516438,1.0,15/39,17.89%,IL1RAPL1;NLGN1;NUMBL;GRID2;CLSTN2;SERPINF1;PTPRD;DLG5;NAP1L1;TRIM32;RGS14;CLSTN3;CUX2;SRPX2;LRP2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.6340918918179141,1.3840553905822262,0.03225806451612903,0.3406228380232293,1.0,21/53,19.36%,MET;PSRC1;CDC42EP3;BAIAP2L1;BAIAP2;CDC42EP1;PRKCE;FCHSD1;TPPP;MAPT;ARF6;PAK1;BIN1;PINK1;PFN2;VASP;DCTN1;CRACD;NCK2;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.6973793947931628,-1.3839977565749966,0.11363636363636363,0.8204054337517233,1.0,5/15,14.94%,TRPT1;POP5;KARS1;ADAT1;YARS2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.7479980730884573,1.3836373956185506,0.08771929824561403,0.34137782987507415,1.0,6/18,15.46%,CDKN2A;PLEK;CDKN1C;CDKN1B;CDKN1A;TP53
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.9074254247081438,1.3836153790143098,0.01639344262295082,0.34091649230174553,1.0,2/7,1.51%,LEF1;TESC
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8832784367814306,1.3834045739491934,0.04838709677419355,0.34060317991904787,1.0,3/7,5.05%,SLIT2;NRP2;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8832784367814306,1.3834045739491934,0.04838709677419355,0.34060317991904787,1.0,3/7,5.05%,SLIT2;NRP2;SLIT3
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.6915338002271283,-1.3832486254112935,0.12121212121212122,0.8198210993971994,1.0,8/15,19.57%,GDE1;PLA2G4C;ENPP6;LYPLA2;GPCPD1;GDPD1;PRDX6;PLA2G4A
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.9394402148468806,1.383145968051446,0.0784313725490196,0.3408026950394541,1.0,1/5,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.7246603744576829,1.3831183937567542,0.05172413793103448,0.34036273301542336,1.0,9/27,10.44%,IGF1;GRIN2A;ICAM1;APP;FYN;GRM5;GRIN1;RAMP3;EPHA4
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8758690573964689,1.3829163108887341,0.08163265306122448,0.3405797308048648,1.0,3/5,7.81%,OXTR;ECE1;ENPEP
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5815161027249688,1.3826068485450145,0.08620689655172414,0.341362274490433,1.0,11/56,9.61%,EGF;SH3GL2;PTK6;DAB2IP;TGFA;SH3KBP1;RHBDF1;WDR54;MVP;ARHGEF7;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.8056438534314357,1.3825484769898124,0.07936507936507936,0.341117786161031,1.0,5/9,14.19%,THBS1;APLNR;PPP1R16B;FGF2;IL12A
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.8199286255675281,-1.3814792644984712,0.12244897959183673,0.8256751975624614,1.0,2/7,7.29%,PIK3C2G;PIK3C2A
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.6018219667309798,1.3814175624680387,0.0547945205479452,0.34438455449474953,1.0,22/80,9.54%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;TNS1;LDB2;GFAP;C1R;BGN;RASL12
prerank,MSigDB_Hallmark_2020__Coagulation,0.6203350882694194,1.381384896635456,0.030303030303030304,0.3439953796275984,1.0,18/85,12.81%,HPN;C3;ANXA1;MAFF;THBS1;SERPINE1;PLEK;FYN;ITGA2;CFH;C1R;CRIP2;MMP14;TF;GDA;SPARC;KLF7;FN1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.6013579922233566,1.3811390697038253,0.014705882352941176,0.34429330965434196,1.0,20/78,17.67%,SCN1B;STMN2;PTK6;RIT2;PLPPR5;RELN;DAB2IP;VLDLR;NTRK3;NPTN;ZNF804A;PACSIN1;CAMK2B;ALK;COBL;CUX2;CAMK1D;WNT5A;ALKAL2;RAP1A
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.7767118944667966,-1.380582174214215,0.05,0.8266750433782017,1.0,1/6,8.86%,GPLD1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8353578065983026,1.3804691714247532,0.13333333333333333,0.34583728060673985,1.0,4/7,12.47%,CHRM3;PIM1;SNCA;BCL2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.7054303825646987,1.3803448066722512,0.1,0.3457282641077862,1.0,5/17,12.47%,BOK;FAS;DCC;BCL2L1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8671350475649737,-1.3802709757531404,0.16326530612244897,0.8232198970725217,1.0,4/7,12.85%,NUDT16L1;TFIP11;HSF1;ERCC6
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.551801462767129,1.3801281051604346,0.029411764705882353,0.3457246323285283,1.0,23/128,12.29%,SH3GL2;DMTN;SLIT2;DAB2IP;THY1;NLRP12;CAMK2N2;PTPRC;PMEPA1;SMCR8;NTRK3;DVL1;PARD3;PID1;SNCA;MVP;YWHAG;LDLRAD4;NIBAN1;TERF2IP;INPP5J;MLXIPL;PRKCD
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6520987866088035,-1.379638399828868,0.13636363636363635,0.8228093328049461,1.0,15/33,19.37%,TFB2M;MRPS21;MRPS7;MRPS16;MRPL47;FASTKD2;GATC;NOA1;MRPS18B;MRPS34;SLC25A33;MRPS12;TEFM;PTCD3;QRSL1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.8072129473342227,1.3795710953687892,0.10344827586206896,0.3471722247479939,1.0,3/10,8.22%,EGF;PTPRC;MGAT5
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.8120572004101475,-1.3790986276191077,0.11627906976744186,0.8205161296446872,1.0,3/6,14.47%,SLC25A19;ABCC11;SLC25A33
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.9125570619227372,1.3786771721450506,0.0,0.349549060933249,1.0,2/6,6.20%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.9125570619227372,1.3786771721450506,0.0,0.349549060933249,1.0,2/6,6.20%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6150395167877993,1.378675772699082,0.03225806451612903,0.34903501819658245,1.0,13/62,7.44%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.6895090506177227,1.3783723639440282,0.05970149253731343,0.3494437205654497,1.0,4/32,1.68%,NR4A3;IGF1;P2RY6;THBS1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5440344297880059,1.3783500212740465,0.028985507246376812,0.3489313397435062,1.0,33/215,12.63%,NR4A3;CXCL2;TLR2;P2RY6;PDGFRA;TESC;SERPINE1;PTK6;ZFP36;DMTN;KCNQ1;SLIT2;KCNC2;GLRA2;DAB2IP;FOXO1;WNT8B;GNG2;AHR;PID1;RAMP3;MYD88;HCN1;NEURL1;SHMT1;P2RY12;MAPT;GUCY1B1;PXN;PDK4;CCL2;PRKCD;AGAP3
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.9006837637229634,-1.3782175312528335,0.046511627906976744,0.8165750419043702,1.0,1/5,1.61%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.9006837637229634,-1.3782175312528335,0.046511627906976744,0.8165750419043702,1.0,1/5,1.61%,SELENOS
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7417188630923038,1.3775748330320976,0.018867924528301886,0.3513667126911229,1.0,2/22,1.51%,LEF1;TESC
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.9002757163524923,1.377430593247433,0.05555555555555555,0.35135488004293325,1.0,1/6,0.25%,HPN
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7694514078359046,1.3772977835594957,0.08196721311475409,0.35130852134042384,1.0,4/15,8.84%,MYO1F;MYO1B;MYO1C;MYO15A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.7939054830695721,-1.3771941098388438,0.07692307692307693,0.8183262033800641,1.0,5/9,14.54%,SLC25A5;SLC25A4;CR1;CD47;SLC25A24
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.6335852002459017,1.377185993430875,0.04477611940298507,0.3512105324610147,1.0,10/47,12.17%,EPHA2;STAC2;RAMP3;ITGA3;PTPN9;PRKCE;PRKCH;SORBS1;STX4;ARF6
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7160881655410187,1.3771803377958192,0.08955223880597014,0.35071653897308414,1.0,4/20,8.55%,NLGN1;TJP3;SHANK1;PCLO
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.8096548855061622,1.377079999197347,0.07547169811320754,0.35058528548265855,1.0,5/13,12.66%,SP100;APOD;BARD1;CABP1;RANGAP1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.646369253833666,1.3764556436988122,0.09375,0.35198343121353143,1.0,6/37,9.14%,PLD1;LIPH;LPCAT4;DGKG;AGPAT4;PLD2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7050154813262628,1.3761187051239736,0.15789473684210525,0.35255408043484887,1.0,8/16,23.72%,RELN;EPHA5;CD200;CAMK1D;RPS6KA4;CRTC3;ADCY8;RPS6KA5
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.7855354682309917,1.3760824436798857,0.12727272727272726,0.35218091396536555,1.0,4/11,10.69%,NLGN1;EPS8L2;PLEKHM1;P2RY12
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.658214492963278,1.3755545421310977,0.015384615384615385,0.35329700454346513,1.0,10/42,3.65%,HLA-DRA;TLR2;TYMP;CTSS;SLC15A3;P2RY13;MYO1F;PLEK;IRF7;SIGLEC1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.5865369446416533,-1.375487555269188,0.05128205128205128,0.8237436883895304,1.0,4/34,7.38%,TPX2;AAAS;KIF4A;ABRAXAS1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7900608957247353,1.3750568419079863,0.1206896551724138,0.35478565205721263,1.0,3/12,5.78%,ANXA1;ZFP36;FAM107A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.807270914186558,1.3746545625031181,0.09433962264150944,0.3553315992099286,1.0,4/11,17.35%,IL15;STAT3;CD4;SHC1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.807270914186558,1.3746545625031181,0.09433962264150944,0.3553315992099286,1.0,4/11,17.35%,IL15;STAT3;CD4;SHC1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8762741102613542,1.3746477724614612,0.12244897959183673,0.3548550796888016,1.0,1/7,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.7073483929828625,1.3746365741974884,0.08196721311475409,0.3543629447197397,1.0,7/17,18.06%,THY1;SH3KBP1;CYRIB;CCL2;TNIP2;IL12A;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.7407071503006246,-1.3742325624927851,0.11627906976744186,0.8268819091292966,1.0,2/13,6.13%,FBXO5;IK
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8717534527881774,1.3742269809361385,0.08620689655172414,0.35522889681394054,1.0,2/6,5.73%,SHANK3;LHX6
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.6022897639455119,1.3741187245755544,0.08196721311475409,0.3551440559834749,1.0,12/57,16.25%,SKOR1;VWC2;SULF1;VWC2L;TBX20;ITGA3;PPARG;SMAD1;ELAPOR2;HIPK2;SMURF1;FSTL1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.762832240352256,1.3734986944565806,0.12727272727272726,0.3566659084039681,1.0,6/13,11.38%,SHTN1;PTPRC;ITGA2;ITGA11;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.8659138507270383,-1.3733566797780432,0.10416666666666667,0.827060028670927,1.0,2/6,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.6529785458611912,1.3733349161885082,0.10294117647058823,0.3567312326610141,1.0,6/33,6.55%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINE3;SERPINF1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.6220395704770856,-1.3732659067618094,0.07692307692307693,0.8226438556364518,1.0,9/31,15.70%,SLC25A5;SLC25A4;BAK1;APOO;MICOS10;SAMM50;BAD;TIMM50;TMEM11
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.8762773665955984,1.373263200976193,0.07017543859649122,0.35649285782822604,1.0,3/7,3.68%,GRIN3A;NLGN1;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.6944376716853381,1.3732350064853391,0.07692307692307693,0.356053106999183,1.0,9/25,16.31%,STMN2;SLIT2;SNCA;SSH2;CYRIB;EML2;PRKCD;STMN1;PFN2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.712005629815743,1.3731166956157328,0.03278688524590164,0.3559340701196571,1.0,5/19,11.14%,THY1;RHOD;ARHGEF7;SORBS1;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.7436414503704064,1.3725951696467336,0.0425531914893617,0.35720894755606947,1.0,2/16,4.31%,HLA-DRA;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.8963867738564522,1.3725803546162492,0.022727272727272728,0.3567868173630208,1.0,3/7,3.05%,THBS1;PRKCB;IRS2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.705576381603029,1.372455211894921,0.06451612903225806,0.3565500497289059,1.0,7/21,21.03%,S100A10;THY1;MAPRE2;ARF6;TEK;PTPRJ;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7361675379005427,1.3722647482251145,0.08620689655172414,0.3567152053791611,1.0,3/19,5.87%,PDGFRA;FLT1;NTRK3
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.642512737277447,-1.3721428207681878,0.10810810810810811,0.8242265251048394,1.0,11/23,15.16%,MT1E;MT1A;SLC30A8;SLC39A10;MT1G;MT1F;SLC30A5;MT2A;SLC39A8;SLC39A6;MT3
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7522386066102226,1.3719055372370843,0.10909090909090909,0.3574809279036027,1.0,4/15,9.88%,SIX3;WNT8B;TBX20;GLI2
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.9302528823115892,1.371691194196298,0.037037037037037035,0.3572744784582078,1.0,2/5,4.64%,CNTNAP2;SHANK3
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.9302528823115892,1.371691194196298,0.037037037037037035,0.3572744784582078,1.0,2/5,4.64%,CNTNAP2;SHANK3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6217679497608417,-1.3715112847485131,0.11764705882352941,0.8233337456874631,1.0,8/30,13.26%,NDUFS5;NDUFA12;NDUFB4;NDUFB1;NDUFV3;NDUFA8;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.7621601167488363,-1.371234798486639,0.18604651162790697,0.8202145571983196,1.0,3/8,17.12%,METAP1D;METAP2;METAP1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6076983360893293,-1.3711189556120842,0.07317073170731707,0.816430288908894,1.0,13/41,17.77%,RPS28;MRPS7;RPL6;RPS27L;RPSA;MDN1;RPL11;MTERF3;RPL23A;LOC102724159;RPF2;RPL10;DHX29
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.8859271624997609,-1.3710295344420662,0.058823529411764705,0.8077253782585521,1.0,2/5,0.96%,EYS;REEP6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.8859271624997609,-1.3710295344420662,0.058823529411764705,0.8077253782585521,1.0,2/5,0.96%,EYS;REEP6
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.8491492833701425,-1.370571283701193,0.0,0.805611884040956,1.0,1/7,1.13%,ERCC8
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5767686534095293,1.37053901983287,0.041666666666666664,0.3606961905329104,1.0,10/77,5.46%,HLA-DRA;C3;CTSS;C1ORF87;KCNJ2;PLD1;IL1R1;CP;CLMN;ERICH3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5800915809725329,1.3704346550061883,0.07692307692307693,0.360638550951271,1.0,24/92,9.78%,COL4A1;PRRX1;PDGFRA;DCN;ACTA2;CALD1;ABCA8;COL4A2;ASPN;PODN;ANGPTL2;MYH11;POSTN;COL12A1;PTPN21;TNS1;TPM4;C1R;CYP1B1;MATN2;ADGRF5;BGN;RASL12;RNASE1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.6463639034392488,1.3703780100353191,0.06349206349206349,0.3602660824625744,1.0,6/38,9.14%,PLD1;LIPH;LPCAT4;DGKG;AGPAT4;PLD2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.6685743743809867,1.3702379599908425,0.03636363636363636,0.3601429846462813,1.0,13/41,18.09%,TLR2;EGF;DYSF;PLSCR1;NRG1;SNCA;PXK;SCAMP5;MCTP1;LRSAM1;NDFIP2;MTMR2;CTTNBP2NL
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6559403462914063,-1.3700597951545495,0.08108108108108109,0.8035216150345422,1.0,4/20,10.70%,BUD23;TFB2M;THUMPD1;MTERF4
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7864609197763917,-1.3698242794895317,0.08888888888888889,0.800612958029485,1.0,3/11,10.43%,COX7C;COX7B;COX5B
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.7295390939608964,1.3697673135544295,0.05357142857142857,0.36124360841984193,1.0,8/21,15.19%,MYRF;RELN;SOX4;TPPP;STAT3;PICK1;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6493285811708788,1.36965401922375,0.043478260869565216,0.3611525087655862,1.0,9/31,13.18%,TGFBR2;THBS1;PID1;GRIN1;SYK;MAPT;GADD45A;PRKCD;CDKN1A
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5778530198596309,1.3695390765640052,0.03278688524590164,0.36101220462741723,1.0,32/128,8.99%,GRIN3A;CA10;GRIN2A;RGS7BP;GRIN2B;CNTN2;GAP43;OPALIN;PLP1;SEPTIN4;PLPPR4;SCN1A;C11ORF87;STMN4;OPCML;SCN2A;SYNPR;KCND3;LRRTM2;FAM107A;NTRK3;ST8SIA3;RFX4;GRM5;TCEAL5;ADCY2;GRIA3;VSTM2A;GFAP;NRXN3;GRIA1;ALDH1L1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6246573982566326,1.3695376077336285,0.06451612903225806,0.3605430277259959,1.0,12/60,13.20%,CDKN2A;GPNMB;ANXA1;KIF14;FAM107A;LSM11;CDK6;GFI1B;CCL2;KLF4;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.6312433131567632,1.3693587422950189,0.058823529411764705,0.36053548211468506,1.0,10/53,12.05%,ECM2;NPNT;EPB41L4B;RNASE10;RHOD;TGFB2;SYK;EPHA4;P2RY12;STX4
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.6531368550566858,1.3690459986864125,0.09259259259259259,0.36118465681035367,1.0,14/33,18.06%,GPNMB;ANXA1;IL15;SFTPD;PTPRC;DLG5;HLA-DRB1;CD276;SLC7A1;CD70;PDCD1LG2;TFRC;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.8334352108259142,1.3686407741450397,0.058823529411764705,0.36214353340271305,1.0,1/9,6.12%,PDP1
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.9252738094258623,1.3685785689084764,0.037037037037037035,0.36185548021859526,1.0,1/6,1.16%,PROX1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.7988903849286079,1.368420943408403,0.09090909090909091,0.3618788624283592,1.0,4/12,7.62%,ZFP36;YBX3;ELAVL4;MYD88
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.8617489838113809,1.3679988235127538,0.05357142857142857,0.3630940442133375,1.0,4/9,11.07%,ANXA1;NLRP12;TMED10;GAS6
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.9226690352699594,1.3679794653499808,0.01694915254237288,0.362675436757484,1.0,1/6,0.15%,NR4A3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.8458875434782556,1.3673152576860408,0.06451612903225806,0.3643583575292991,1.0,4/10,12.96%,ENPP2;CD44;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.7506857967930923,1.367282010868857,0.11320754716981132,0.3639066441518663,1.0,3/15,3.17%,TLR2;DMTN;APP
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8329117849105081,1.3671469010211168,0.109375,0.3640244762416499,1.0,3/8,7.18%,SIX3;DAB2IP;RYR2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7199749630496713,1.3671345677978477,0.1076923076923077,0.36354202765262394,1.0,4/26,9.88%,NPY;PKDCC;TGFB2;GLI2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.822571338917383,1.366759207802898,0.09090909090909091,0.36438871642324605,1.0,2/9,2.53%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.9079199323339715,1.3667395891739111,0.02,0.3634752206502818,1.0,3/5,9.00%,CD24;PTPRO;BASP1
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.9079199323339715,1.3667395891739111,0.02,0.3634752206502818,1.0,3/5,9.00%,CD24;PTPRO;BASP1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.8207459857731597,-1.3667330722905955,0.14893617021276595,0.8144292869440913,1.0,4/6,17.12%,METAP1D;METAP2;FKBP7;METAP1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.4854760372713974,-1.3665328383357005,0.029411764705882353,0.811017607026019,1.0,52/254,15.40%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;SCNM1;DHX16;LSM3;SF3B4;SF3A1;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;U2AF1;SF3B6;IK;BUD31;GEMIN4;TFIP11;LSM5;FRG1;DDX46;SNU13;METTL3;PPIH;PQBP1;SYF2;CPSF1;CLP1;PPIL3;POLR2C;SNRNP25;GPATCH1;LSM4;WDR77;GTF2F1;PRPF8;PPIL1;SRSF2;PNN;RBM22;PRPF3;POLR2D;ESS2;PPIE;RBMX;CWF19L1;CPSF3;SUGP1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.6303023927530141,1.3663278740539249,0.014285714285714285,0.36470558093419575,1.0,13/62,14.40%,VRK2;SOCS3;CD24;IRAK2;PTPRC;BIRC3;TNFRSF1A;SYK;GAS6;HIPK1;FADD;ELF1;IKBKG
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.887668500125293,1.3662931563979892,0.07936507936507936,0.36441874488025217,1.0,1/5,2.80%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.7103638620084378,1.3662594044533436,0.06896551724137931,0.3640040251606643,1.0,10/24,18.06%,HLA-DRA;CD55;CYRIB;HLA-DRB1;B2M;FADD;IL12A;HLA-E;ZBTB1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7888246001274222,1.3659907931274642,0.1111111111111111,0.36448985061013034,1.0,3/14,7.62%,RFTN1;IL15;MYD88
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.6392843983274537,1.3659663573921323,0.06349206349206349,0.3640761584429943,1.0,6/38,7.62%,TLR2;CTSS;SFTPD;IRAK2;NOD1;MYD88
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.5624049820499805,1.3656463669067076,0.046153846153846156,0.3647047298628167,1.0,41/118,22.72%,ARHGAP4;ARHGAP39;SLIT2;RELN;ARHGEF17;ARHGDIG;ARHGEF3;RHOD;OBSCN;MCF2;TRIP10;KALRN;ARHGAP26;ARHGEF7;CYRIB;TRIO;PLEKHG2;OPHN1;STARD13;ARHGAP18;MYO9A;ARHGAP17;CGNL1;ARHGAP22;NGEF;VAV2;RHOT1;RHOT2;MCF2L;RHOQ;VAV1;BCR;RHOB;ARHGEF6;ARHGAP35;ARHGAP9;PREX1;ARHGEF18;TAGAP;ITGAV;OCRL
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.561650517174539,1.365574550504787,0.043478260869565216,0.36446782090360186,1.0,31/120,17.54%,BOK;SLC7A2;ZDHHC9;SLC39A14;CEP170B;DAB2IP;ARHGEF17;EPB41L4B;PTPN21;RHBDF1;GPT2;SCARA3;MYO1B;ADGRL2;ASS1;FKBP5;DHCR24;PKDCC;YAP1;EPB41L1;KCTD3;TEAD1;CD276;CAP2;RBFOX2;BCAR1;SMARCA1;RORA;ADAMTS1;MAGI1;NR2F6
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.6535586023733929,-1.365418613811793,0.16129032258064516,0.8122144712454922,1.0,2/26,6.19%,CDC26;ANAPC13
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.7213184878911657,-1.365317381321019,0.14634146341463414,0.808263096537443,1.0,3/13,15.80%,EIF4EBP1;EIF2AK1;EIF3E
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.8967671164455209,1.365257306257684,0.07547169811320754,0.3651420903172946,1.0,1/5,0.57%,C3
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8995896042252449,1.364843026659408,0.037037037037037035,0.3662452689358346,1.0,3/6,8.20%,IGF1;ALOX12;BAG3
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.6426850066824217,1.36478789898963,0.047619047619047616,0.36594351766544025,1.0,12/57,10.66%,ALS2CL;CHRM3;CD24;KCNQ1;FA2H;EFNA1;TJP3;LGR5;FAAH;AATK;ARHGEF10L;SLCO2A1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.680943084285638,-1.364785249605184,0.11428571428571428,0.8066933556297013,1.0,4/30,5.37%,H1-2;KPNA2;H1-4;SIRT6
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.8025274650289186,1.3647108722804335,0.13793103448275862,0.36569030741829733,1.0,1/6,5.85%,ATP9A
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8801318865608555,1.3646161781151283,0.0392156862745098,0.3655331085241889,1.0,1/8,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.8144476989359892,1.3643198252235738,0.038461538461538464,0.3661696961051813,1.0,3/9,6.35%,EGF;KCNQ1;NRG1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6670795317480053,1.3642655813538158,0.08064516129032258,0.3659171999842789,1.0,13/33,16.36%,SP100;THBS1;SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1;STX4;TMC8;TNFRSF10B;FADD;BRCA1;RFFL
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.824582928862738,1.3641393280455905,0.07142857142857142,0.3658236277333888,1.0,2/10,0.52%,TGFBR2;COL4A1
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.9250116140839016,1.363904928704031,0.06451612903225806,0.36551097040958647,1.0,1/5,0.15%,NR4A3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.9250116140839016,1.363904928704031,0.06451612903225806,0.36551097040958647,1.0,1/5,0.15%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.8656393170235065,1.3639020174950978,0.08163265306122448,0.36502427138107835,1.0,2/7,3.34%,DCN;DAB2IP
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.7056787814110261,-1.3633703051878487,0.125,0.8057255009198392,1.0,2/18,2.54%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.7056787814110261,-1.3633703051878487,0.125,0.8057255009198392,1.0,2/18,2.54%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6027530153988252,1.363307054912156,0.014925373134328358,0.3663333065425561,1.0,23/69,16.77%,HTR2C;SLC24A2;KCNJ2;VAPB;CLDN16;ATP2B3;GCM2;RYR2;ATP1A1;NPTN;SLC9A1;ATP1B1;ATP1B3;LETM2;TMPRSS3;TPCN2;STOML2;KCNMA1;SLC24A1;ATP13A1;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6589980432657745,1.363113779507362,0.06896551724137931,0.36661707812269106,1.0,8/42,16.25%,SKOR1;VWC2;VWC2L;PPARG;SMAD1;HIPK2;SMURF1;FSTL1
prerank,PanglaoDB_Augmented_2021__B Cells,0.5913010604397946,1.3627859843908379,0.012987012987012988,0.36718267804419086,1.0,26/71,16.87%,HLA-DRA;EBF1;CTSS;CD22;CD24;CD55;PLEK;NAPSB;WAS;PTPRC;CD37;BIRC3;ACAP1;FLI1;CD5;ITGAL;PXK;TMC8;CD70;BCL11A;CRELD2;TXNDC11;IRAG2;BST1;HMGA1;BACH2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.659396893411238,1.3625562111368328,0.06896551724137931,0.3676213544559358,1.0,6/34,10.05%,S100A10;THY1;SKAP1;CDK6;PLEKHA2;RIN2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.8054865185253329,1.3624061306717923,0.08771929824561403,0.36760480529340434,1.0,2/9,11.94%,ITM2A;BACE2
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.8484528601067414,1.3620328167835103,0.125,0.36866723437362603,1.0,2/7,1.60%,SLC24A2;PLK2
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5398183832902516,1.3617752199667466,0.0,0.3692115288041104,1.0,38/209,11.38%,TLCD2;SYCE1;TEAD2;ANK3;PKP2;NLGN1;CALD1;DMTN;FBLIM1;WAS;ADD2;BAIAP2L1;WASF1;FAS;NEDD9;BAIAP2;FAM107A;DVL1;PARD3;REPS2;STK25;RHOD;PAWR;PML;PDGFA;MYO1B;SHANK1;PCLO;YAP1;YTHDF1;STAG3;FSCN1;TCAP;PEX14;TEAD1;DCX;GAS6;OPHN1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.6199492743113554,1.3616570542107558,0.045454545454545456,0.36919294996192076,1.0,21/59,19.70%,CACNA1H;KCNQ1;ATP2B3;ITPR3;ABCC9;RYR2;ATP1A1;TMEM65;ATP1B1;TGFB2;ATP1B3;FXYD7;ATP2B4;SLC8A2;SLC8A1;PDE4D;CALM3;ITPR1;CAV3;AHCYL1;CELF2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.8343907866202525,-1.3616106149591534,0.09090909090909091,0.8107184439525461,1.0,5/7,16.47%,MGME1;POLG2;PRIMPOL;TEFM;DNA2
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.8962909541217629,1.3614011448136218,0.05263157894736842,0.36956379521710336,1.0,2/5,3.99%,RBM24;ELAVL4
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7505206767161893,1.3609619684944694,0.06382978723404255,0.37035363847269803,1.0,1/15,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6139234204882541,-1.3609029074759993,0.05405405405405406,0.8105431314783507,1.0,3/31,4.10%,H1-2;H1-4;TTN
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.48399560553358384,-1.3608767569631892,0.0,0.8065333416801217,1.0,53/231,17.03%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;U2AF1;SF3B6;IK;BUD31;TFIP11;LSM5;FRG1;DDX46;SNU13;METTL3;PPIH;PQBP1;SYF2;CPSF1;CLP1;PPIL3;POLR2C;SNRNP25;GPATCH1;LSM4;GTF2F1;PRPF8;PPIL1;SRSF2;PNN;RBM22;PRPF3;POLR2D;ESS2;PPIE;RBMX;CWF19L1;CPSF3;SUGP1;DNAJC8;RNPC3;GTF2F2;SRSF9
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.7375672271755261,1.3608729645664253,0.10606060606060606,0.3701782926545642,1.0,2/16,4.36%,NR4A3;FABP3
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.772471451891675,-1.360082620605453,0.13333333333333333,0.8070237936835,1.0,1/9,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.5636945202114801,-1.3600081745109927,0.030303030303030304,0.8032611455150732,1.0,7/40,15.32%,BUD23;RIOK2;HSPA1A;RIOK1;ZPR1;RBM22;NMD3
prerank,PanglaoDB_Augmented_2021__Basophils,0.5837478268091203,1.3598645096770199,0.043478260869565216,0.3733698944753305,1.0,18/69,13.02%,L1CAM;TLR2;CTSS;P2RY13;MYO1F;PLEK;TEC;SIGLEC1;NFIL3;IGFBP7;CD44;SLC26A8;LAMA5;GRM6;JAZF1;ITGAL;IL4R;LTC4S
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8808493805936451,1.3597624315576538,0.11538461538461539,0.37326852701701,1.0,4/5,9.09%,MLIP;TRPC3;FOXO1;LMNA
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7585646791646605,1.3596404290265915,0.08823529411764706,0.37335310310110714,1.0,6/12,18.53%,CCNB2;PRKCB;NEK6;CCNB1;DCTN1;PRKCA
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7855620876863463,1.3593114495767424,0.018518518518518517,0.37417920287706247,1.0,10/15,16.35%,MYRF;PRDM8;CNTNAP1;PLP1;EIF2B2;TPPP;B4GALT5;SOX10;EIF2B5;B4GALT6
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.6455519469902511,1.3588021357967384,0.08620689655172414,0.3754044029959373,1.0,3/31,10.80%,ABO;ALDOB;TFPI
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.7210436239564424,1.3579146355253073,0.09615384615384616,0.3782447531881193,1.0,8/23,9.88%,SCN1B;SCN3B;KCNQ1;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5662642946054329,1.357706008793408,0.04225352112676056,0.3784763455687313,1.0,21/112,11.71%,NR4A3;P2RY6;HRH1;BLM;GABRB2;DMTN;ADCY5;KCNQ1;GNG2;AHR;ADCY2;RAMP3;ATP1A1;CYP1B1;GABRG2;CTNNB1;HCN1;P2RY12;TFPI;CTNNA1;CCL2
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.729799761056441,1.3571534827417777,0.1320754716981132,0.3798602915651799,1.0,5/15,13.10%,C3;APP;SRRM4;B4GALT5;PICK1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.7604226061551126,1.3569618068888611,0.11538461538461539,0.38016595179031254,1.0,4/18,8.47%,GGT5;ECE1;ENPEP;TRHDE
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6569774144593776,-1.3569127877209834,0.08108108108108109,0.8167042881369831,1.0,6/18,20.54%,EIF2S3B;EIF3D;EIF3M;DHX29;EIF2B3;EIF5
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5653475746248302,1.3568880574073268,0.06451612903225806,0.37984217085377087,1.0,37/113,17.68%,MET;COL4A1;CSPG4;COL4A2;EPHA2;DAB2IP;ARHGEF17;NFATC2;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;LIMCH1;SCARA3;BOC;SH3PXD2B;KITLG;YAP1;EPB41L1;TEAD1;ENAH;CD276;PARD3B;CAP2;TRIM32;PALLD;NTN4;RBFOX2;NOTCH3;BCAR1;FZD7;FSTL1;MESP1;WWTR1;SCRIB;SRPX2
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.8661982673936793,1.3565413950036296,0.11320754716981132,0.380575829753338,1.0,1/6,0.85%,ANXA1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6774462329410773,1.356403705744911,0.11666666666666667,0.38005190527343535,1.0,8/19,22.88%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE;PPP3CC;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6774462329410773,1.356403705744911,0.11666666666666667,0.38005190527343535,1.0,8/19,22.88%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE;PPP3CC;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.9030778170442195,1.3563797961556732,0.1509433962264151,0.37962316315969513,1.0,2/5,7.82%,CCBE1;MYO1C
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.66834187937583,1.3559129713591243,0.07936507936507936,0.38100839946075976,1.0,4/36,1.67%,LEF1;IGF1;EGF;SP100
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.585200493233371,1.355839628609062,0.0,0.38073167669479263,1.0,13/77,13.18%,TGFBR2;HPN;EGF;THBS1;PID1;ECE1;SNCA;RAMP3;PPARG;GADD45A;KLF4;PICK1;CDKN1A
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6154925793249221,1.3558371317099773,0.06666666666666667,0.38024293256553104,1.0,16/50,13.97%,ANXA1;RIMS2;SYT1;SEPTIN4;SEPTIN5;KCNMB4;RAB15;RAB3C;CPLX2;RHBDF1;SCG5;CPLX1;LGI3;STX4;RHBDF2;HAP1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.8395035475225784,1.3555783508129566,0.03571428571428571,0.3804990484294012,1.0,2/8,8.28%,NLRP12;MVP
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.8383335403727433,1.355396576905204,0.09615384615384616,0.38046438895473494,1.0,1/9,2.35%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.8383335403727433,1.355396576905204,0.09615384615384616,0.38046438895473494,1.0,1/9,2.35%,ZFP36
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.9001960172830261,1.355269952472528,0.12962962962962962,0.38058318315799783,1.0,1/5,4.96%,FAS
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.6894005209190546,1.3552326377691724,0.03225806451612903,0.3802185312024671,1.0,13/33,11.43%,L1CAM;NRP2;THY1;MYH9;ACHE;RTN1;VLDLR;DPYSL2;PML;CDK6;TLE3;OPHN1;CRMP1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.5365309225840836,1.3552140548662799,0.02857142857142857,0.3798397293076477,1.0,33/158,15.27%,GPNMB;HTR2C;P2RY6;PDGFRA;NPNT;EPHA7;RASGRP1;PSCA;EPHA2;ICAM1;APP;DAB2IP;DUSP10;NEK10;PTPRR;PTPRC;NTRK3;CD44;RAMP3;PDGFA;NECAB2;CHI3L1;SYK;GAS6;CCL2;HLA-DRB1;FN1;RPS6KA6;FGF2;RGS14;GPR183;CD4;THPO
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.9247388019971089,1.3551988419890533,0.09836065573770492,0.37893460677447827,1.0,1/5,0.73%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.9247388019971089,1.3551988419890533,0.09836065573770492,0.37893460677447827,1.0,1/5,0.73%,PAPSS2
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.5226601548399772,1.3551377936594022,0.0,0.37858891952765106,1.0,41/238,14.78%,MET;IGF1;PDGFRA;EGF;RASGRP1;GRIN2B;MBP;RASGEF1A;RIT2;ZFP36;ZDHHC9;NEFL;SHC2;CSF2RA;IRS2;DAB2IP;TGFA;SHANK3;PRKG2;FYN;GFRA2;NRG1;GRIN1;NRG2;PDGFA;MRAS;BCL2L1;KITLG;PPP1CB;MINK1;FGF13;CCL2;RGL1;CAMK2B;DLG3;PAK1;FGF2;TNIP2;IKBKG;MAPK11;RASAL1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.5474105850328583,1.3549187906103128,0.039473684210526314,0.3791142560287992,1.0,23/103,14.12%,TLR2;IGF1;EGF;PLD1;THBS1;IRS2;NLRP12;SAMD4A;SOX4;CIITA;EIF4A3;LARP6;NLRC5;YTHDF1;NAMPT;TGFB2;GLI2;NIBAN1;SORBS1;CCL2;KLF4;FGF2;HSPH1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.7015849786498327,1.3549165827203105,0.08196721311475409,0.3786343645654716,1.0,8/24,19.01%,MTMR7;MTMR11;SYNJ2;INPP5J;MTM1;INPP5F;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.6564612607852833,1.354649084299558,0.05084745762711865,0.37915831532952726,1.0,7/29,9.19%,RIMS2;RIMS3;SEPTIN5;BAIAP3;KCNMB4;CPLX2;CPLX1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9307574730311413,1.3546070313255445,0.03636363636363636,0.378754308657727,1.0,1/5,0.04%,NPY
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6524297928896752,1.3545767384937022,0.031746031746031744,0.3783662477861743,1.0,9/43,10.69%,HTR2C;P2RY6;HRH1;CHRM1;GRM5;CCKBR;GNA14;HOMER1;P2RY12
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6605327239091338,1.3543210215437562,0.12280701754385964,0.3788885565659569,1.0,4/22,13.97%,BICDL1;KIF5A;TRAK1;HAP1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.5486090586074798,-1.3542440742037147,0.11428571428571428,0.8286713245240258,1.0,5/58,9.03%,TPX2;SGO2;AAAS;ABRAXAS1;MIS12
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.8065882687991972,1.3542147707840388,0.11320754716981132,0.3782785993180688,1.0,2/10,9.29%,SYCE1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.8065882687991972,1.3542147707840388,0.11320754716981132,0.3782785993180688,1.0,2/10,9.29%,SYCE1;STAG3
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.7120593867421917,1.3539058820984118,0.11940298507462686,0.37882875594557314,1.0,1/18,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7352615414335911,-1.3537062436006049,0.1111111111111111,0.8280774379766861,1.0,7/12,23.30%,GUCA1B;PPEF1;NMT2;METAP2;METAP1;FNTB;CALM1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.738685689801508,-1.3536032626192347,0.13513513513513514,0.8245424889488058,1.0,4/15,9.85%,HSD17B8;SLC25A1;PPCS;GCDH
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7056246995393134,1.353366850686687,0.0967741935483871,0.38004503408701007,1.0,5/23,7.35%,SLIT2;NRP2;SLIT3;SEMA5B;MAP1B
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.8591799224160247,1.3533260732711458,0.10714285714285714,0.37968790144112136,1.0,4/7,11.23%,ANK3;THBS1;SNCA;FBP1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.9033271710216217,1.3532687403344836,0.07272727272727272,0.3795092167206385,1.0,2/6,1.66%,RFTN1;S100A10
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.808841722491736,1.353202848099212,0.07142857142857142,0.3792275336551765,1.0,2/11,7.08%,MET;POF1B
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8683974858370007,1.352796837529446,0.0196078431372549,0.38017157987289196,1.0,2/8,8.12%,MET;CTNNB1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5465395578996216,1.3526299808244064,0.06349206349206349,0.3803320028977922,1.0,45/155,18.96%,TMEM204;SP100;PTK6;CD24;SULF1;CD55;IRAK2;APP;NLRP12;RGS6;TSPYL2;PLSCR1;FYN;TRIM5;IGFBP7;ZIC1;GRK2;SIK2;YWHAG;ITGA3;LRIT3;ZDHHC7;HOMER1;PXN;USP20;NCLN;ELF1;GRK5;RGS14;RGS4;RGS16;MAPK8IP2;BST1;SLC8A2;RORA;UBASH3B;FRRS1L;WWTR1;CBFB;NCK2;TSC2;TSPAN15;CAV3;CDC42SE2;LFNG
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.7455739819648249,1.3524063590491326,0.11864406779661017,0.38077175710770766,1.0,6/19,3.49%,ANK3;RIMS2;GRIK2;SYT1;CLSTN2;RIMS3
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.781566275764967,1.3522130394720766,0.12280701754385964,0.38085751422633674,1.0,5/12,13.58%,IRF7;AHR;SKAP1;ADCY7;FADD
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7939169255106429,-1.3520093839406568,0.11764705882352941,0.8300963534149794,1.0,4/8,17.18%,CES2;AKR1C3;PTGR1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.8623125618202603,1.35198103037928,0.10909090909090909,0.3811339780038347,1.0,1/5,2.72%,TIMP2
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6918583552031249,1.3518196223010297,0.06521739130434782,0.38117506999992157,1.0,8/18,17.50%,GPNMB;SFTPD;TNFRSF14;DLG5;HLA-DRB1;PRKAR1A;PDCD1LG2;SCRIB
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.7134510754436875,1.3516355293309874,0.08620689655172414,0.3811721110025053,1.0,7/21,17.86%,SP100;BAG3;GAS6;BARD1;RANGAP1;TP53;YWHAE
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.4765639562900056,-1.3515830244812617,0.07407407407407407,0.8289206996507573,1.0,66/320,15.25%,MRPL10;RPL35A;RPS24;FIP1L1;RPL34;RPL39;MRPS21;RPL13;RPL37;MRPL52;POLR2K;RPS28;AAAS;MRPS7;RPL18;RBM8A;RAE1;NUP50;M1AP;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;U2AF1;RPS26;RPL6;FASTKD2;RPL41;RPS13;RPL22;RPL29;TFIP11;RPL30;RNASEL;ASMT;RPSA;RPL14;RRAGC;RPL15;EEF1A1;CPSF1;RPS2;DDX25;CLP1;POLR2C;IGF2BP3;TSPAN33;RPL11;RPL23A;NUP54;MRPS18B;RPS21;MRPS33;MCM3AP;SRSF2;RBM39;RPS23;NFKBIB;POLR2D;YARS2;MLF1;MRPS12;THAP1;CPSF3
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.8307138401818778,1.3515492465823393,0.07142857142857142,0.38100821115121364,1.0,3/8,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.8378028039473,1.3513975933979605,0.13559322033898305,0.3810200790465089,1.0,2/6,5.06%,APP;TNFRSF14
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.7194629443534951,1.351327181314014,0.08196721311475409,0.3807546018683238,1.0,7/23,14.90%,COL4A2;COL8A1;COL12A1;LAMB1;MMP14;FN1;LAMA3
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.6903074035753318,1.3509017074757503,0.14,0.3821953570619698,1.0,3/22,7.51%,ENPP2;FAAH;CYP1B1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.7841054357123631,-1.3507464073875366,0.1794871794871795,0.8299704243650211,1.0,2/8,15.09%,UBE2M;DCUN1D2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8916444563291057,1.3505658962377782,0.05454545454545454,0.3828026671550088,1.0,2/6,1.52%,CHRM3;CHRM1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7038496686423815,-1.3502005204865972,0.15555555555555556,0.828698637676298,1.0,9/15,16.79%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7955671545263945,1.3501910668746488,0.09523809523809523,0.38385928016407833,1.0,5/15,12.89%,KLF2;NOS1AP;ASS1;SMAD3;KLF4
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.647807905002587,-1.350075513154769,0.13636363636363635,0.8254988294622804,1.0,5/19,15.34%,SGO2;BRDT;ZSCAN21;BCL2L11;FOXJ2
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5721748926505534,1.3500407673102635,0.07142857142857142,0.38379495733575025,1.0,26/82,19.15%,COL4A1;PRRX1;PLD1;SULF1;ANGPTL2;FABP3;LAMB1;ITGA3;ARHGAP26;RASL12;TCAP;ADAM12;TRIO;LAMA2;PXN;MEF2D;IL4R;WASHC1;NOTCH3;NEB;CHODL;ENO3;LDB3;CAV3;SGCG;WIPF1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.5570974029018858,1.3500277550685358,0.046875,0.38338264491868557,1.0,13/127,8.65%,ST18;NPNT;ZFP36;YBX3;DAB2IP;ERBIN;MAP3K14;TNFRSF14;BIRC3;TNFRSF1A;PID1;FOXO3;CHI3L1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8131516694866077,1.349697546848691,0.1346153846153846,0.38413041221404837,1.0,5/11,7.99%,GABRB2;GABRG3;GABRA1;GABRG2;GABRA5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.7284333338187409,1.349560617384192,0.06666666666666667,0.3842830538480994,1.0,4/23,3.41%,MET;ANXA1;PROX1;LSR
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.8380632998145288,-1.3495497151896172,0.09302325581395349,0.8206158560082509,1.0,3/7,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.8380632998145288,-1.3495497151896172,0.09302325581395349,0.8206158560082509,1.0,3/7,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6629224043488331,1.3494084896077905,0.09375,0.38423298074368106,1.0,8/37,10.96%,SOCS3;IGF1;IL15;PTK6;TNFRSF1A;GHR;STAT3;PARP9
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.6724101857911736,1.3492021787841875,0.05454545454545454,0.38438512499749095,1.0,15/31,18.06%,ANXA1;IGF1;IL15;CD24;IL27RA;PTPRC;SYK;CD276;FADD;SLC7A1;CD70;PDCD1LG2;TFRC;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5998298932361846,1.3491300010080443,0.03125,0.3841764538495637,1.0,13/61,7.44%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.9115131061678925,1.3485515026257664,0.0847457627118644,0.3856675200253825,1.0,1/6,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7765435356264215,1.348459572894741,0.125,0.3855009460415212,1.0,4/13,6.44%,DMTN;EPHA2;WAS;CD44
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.8134389186818787,1.348442024776671,0.08196721311475409,0.38510493158183934,1.0,2/10,2.82%,SH3GL2;SLIT2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5938861027315877,1.348346045169423,0.09836065573770492,0.3849681391118165,1.0,16/59,15.81%,MRAP2;C3;PLEK;SLC39A14;RGS6;SYP;RAMP3;MRAP;ZDHHC7;KLK6;USP20;PPP1R9B;GRK5;RGS14;RGS4;RGS16
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8478460762077784,1.3481888325505027,0.14285714285714285,0.38498931353491744,1.0,5/6,15.24%,DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.7795307533109599,1.3481029770028177,0.1346153846153846,0.3846669202447028,1.0,8/11,16.35%,MYRF;CNTNAP1;PLP1;TENM4;ABCA2;B4GALT5;SOX10;B4GALT6
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7558930388222145,1.3478278634774543,0.1694915254237288,0.38526024336361336,1.0,5/10,20.02%,TLR2;PGK1;B2M;RPS27A;MRC1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5292508287049793,1.347826223750497,0.027777777777777776,0.38479551448138943,1.0,22/138,10.90%,IGF1;KLF2;EGF;PLD1;THBS1;IRS2;SAMD4A;NOS1AP;FABP3;SOX4;MFSD2A;SNCA;EIF4A3;LARP6;LDLR;ASS1;SMAD3;YTHDF1;GLI2;NIBAN1;SORBS1;DUOXA1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.731114262580707,1.3474841154670973,0.18,0.3855298675063879,1.0,3/11,10.41%,LDLR;PPARG;SYK
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6418843965748401,1.3471792046370035,0.10344827586206896,0.3864333846336522,1.0,9/41,10.44%,PDGFRA;FLT1;RELN;TEC;TPST1;FYN;PKDCC;SYK;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.6351243314248748,1.3469950613762147,0.056338028169014086,0.38652378109906466,1.0,16/53,14.24%,DCN;THBS1;SULF1;COL4A2;ISM1;DAB2IP;SERPINF1;PML;CTNNB1;PPARG;CD160;TGFB2;PGK1;SPARC;KLF4;THBS2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.7992446035888442,1.3468858931381917,0.05357142857142857,0.3864718596107458,1.0,5/11,13.90%,RFTN1;COLEC12;SCARA3;FADD;TNIP2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7552904626313216,1.346768836697263,0.16363636363636364,0.38637748347520673,1.0,9/14,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.9096179582960529,1.346495049754923,0.1016949152542373,0.3867511432182444,1.0,1/5,0.42%,MET
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.6863237307736259,1.346494652474134,0.13846153846153847,0.38630268133192197,1.0,4/21,9.24%,KIF14;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7790779645462633,1.3464462927106686,0.125,0.38603913940385326,1.0,5/10,15.24%,DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5906291645622983,1.346366812428378,0.05,0.38591747951204164,1.0,26/98,9.54%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;CALD1;SULF1;COL4A2;SLIT2;THY1;TCEAL7;ANGPTL2;POSTN;SLIT3;LAMB1;PTPN21;NNAT;GUCY1A2;ZIC1;MAP1B;SCARA3;BOC;ADGRL2;PKDCC;BGN;RASL12
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.8054404914318584,1.346225544471537,0.06666666666666667,0.38600773668050986,1.0,4/13,11.77%,ANXA1;ZFP36;FAM107A;KLF9
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.7191749789287631,-1.3460279173065137,0.21568627450980393,0.8370855235081364,1.0,2/11,4.15%,APOBEC3G;SETDB1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.7915989813571067,1.345779598427285,0.07547169811320754,0.386731904285926,1.0,1/11,1.84%,RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.779371081829447,1.3457555165386839,0.12727272727272726,0.3863424311907747,1.0,4/12,15.53%,SMCR8;PHF23;MTM1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.584449619711813,1.3457081368192703,0.07575757575757576,0.3860522906252665,1.0,7/64,3.34%,SKOR1;THBS1;VWC2;SULF1;SLIT2;VWC2L;DAB2IP
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.707791979582506,-1.345617356673472,0.1794871794871795,0.8352814422667212,1.0,4/14,9.23%,PMVK;NUDT7;PPCS;TDO2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.628602220280664,1.345574804603123,0.08620689655172414,0.3860155858766982,1.0,12/34,22.21%,SLC39A14;FOXO1;SOX4;HK2;GAS6;HK1;IGF1R;PDK3;HIF1A;KCNB1;ADCY8;FOXK1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.6627604081480315,1.3452029957395264,0.08064516129032258,0.38649788899643384,1.0,12/41,11.97%,TGFBR2;TEAD2;MFSD2A;PDGFA;KITLG;PKDCC;PBX3;TGFB2;GLI2;TEAD1;IFT122;RNF112
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.9222509336406558,1.3451889951663216,0.0,0.3860825199192288,1.0,2/5,1.51%,LEF1;TESC
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5612265039256276,1.34481479061639,0.05714285714285714,0.38675948798844,1.0,24/103,15.22%,NPNT;CEP170B;DAB2IP;ARHGEF17;EPB41L4B;RAP1GAP;PTPN21;AGRN;RHBDF1;ATP1A1;LAMA5;CTNNB1;ASS1;ARHGEF10L;ATP1B1;EPB41L1;CMTM4;CTNNA1;INPP5J;GPRC5C;COBL;CAMSAP3;BCAR1;SLC44A3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.8037774060318021,-1.3446035300047268,0.14285714285714285,0.8368267795442801,1.0,2/8,11.76%,ZC3H8;SNAPC5
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8739377219320686,1.3444065951245614,0.12962962962962962,0.3877423122576769,1.0,3/6,6.91%,ANXA1;DOC2B;SNCA
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.757610618022557,-1.3440813823446378,0.20454545454545456,0.8361930855848632,1.0,3/10,12.77%,ADCY10;SPAG17;SPEF2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.7467489942051504,1.344028679828236,0.13793103448275862,0.3883180152652772,1.0,2/15,8.12%,SIX3;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.8363820941539638,1.3437622506514977,0.12280701754385964,0.3888226506200166,1.0,1/8,1.69%,SERPINE1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.6294631293817968,1.343681168647621,0.06944444444444445,0.38858802644286816,1.0,8/43,13.11%,NR4A3;ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.7239139077399053,1.3433806037058433,0.14754098360655737,0.38920243473313615,1.0,2/12,5.50%,ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.9048543084036389,1.3432340346449567,0.12280701754385964,0.38927356595716306,1.0,1/5,0.15%,IPCEF1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.5634311387195783,1.34317863244738,0.012987012987012988,0.3890531152424379,1.0,29/141,14.19%,ENPP2;DCN;NLGN1;RELN;RPS6KA1;DAB2IP;VLDLR;TRPM4;SHANK3;GRIP1;DVL1;ZBTB16;NEUROD2;SCX;SHANK1;BASP1;LMNA;NEURL1;ARHGEF7;DLG5;PACSIN1;TLE6;PHLDB2;B4GALT5;CAMK2B;ELAPOR2;ALK;COBL;SPIRE1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7635264923730982,1.3429260878072566,0.07272727272727272,0.38949849263258496,1.0,4/16,13.44%,EGF;RHBDF1;WDR54;RHBDF2
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7773879343136667,1.3421331995949761,0.1111111111111111,0.391244206669489,1.0,4/12,7.18%,SCN3B;KCNQ1;TRPM4;RYR2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5747984683058174,1.342009790694978,0.10144927536231885,0.3911466809170378,1.0,17/81,11.07%,CACNA1H;GRIN3A;CACNA1G;SLC24A2;CDH23;TRPC3;CACNG3;TRPM4;FYN;CACNA1C;CACNG8;RYR2;RAMP3;CACNA1E;ORAI1;MCOLN2;GAS6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.609547219327526,1.3419648048204302,0.08064516129032258,0.3908974491934369,1.0,12/52,12.85%,HPN;THBS1;SULF1;DAB2IP;DUSP10;CDK6;NLRC3;TGFB2;CDKN1C;SPARC;KLF9;B2M
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.45991970209057653,-1.3418762032917433,0.0,0.843799452231293,1.0,54/274,15.40%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;GTF2H5;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;GTF2H2;U2AF1;SF3B6;IK;BUD31;PRPF18;TFIP11;LSM5;FRG1;DDX46;SNU13;METTL3;KIN;ERCC2;PPIH;PQBP1;SYF2;CPSF1;CLP1;PPIL3;POLR2C;SNRNP25;GPATCH1;LSM4;GTF2F1;PRPF8;PPIL1;SRSF2;PNN;RBM22;PRPF3;POLR2D;ESS2;PPIE;RBMX;CWF19L1;CPSF3;SUGP1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7968585740970637,1.3417860098247036,0.07407407407407407,0.3909661074549878,1.0,3/7,19.77%,CTNNB1;STARD13;RHOB
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.726236913568512,-1.3416122091644065,0.18867924528301888,0.8415136353062274,1.0,2/10,4.15%,APOBEC3G;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7639775581122974,1.3413333288056057,0.09259259259259259,0.3920543246760027,1.0,7/12,14.71%,HLA-DRA;CD55;SYK;HLA-DRB1;HSPH1;IL12A;HLA-E
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5562702682487454,1.3409493392728031,0.0273972602739726,0.3926032166896934,1.0,13/126,8.94%,TGFBR2;ANXA1;STMN2;NR4A1;ZFP36;FLT1;DAB2IP;NTRK3;CD44;VSTM2A;DUSP22;CTNNB1;SMAD3
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.6509482347120652,1.3409391020819077,0.07692307692307693,0.3922022234357111,1.0,10/44,9.28%,ARHGAP4;SHTN1;CDC42EP3;WAS;EPS8L2;ARHGDIG;ARHGEF3;RHOD;CDC42EP1;GNA12
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5796746642190347,1.340893457116743,0.1095890410958904,0.39185708866376934,1.0,26/82,19.88%,PROX1;EGF;RASGRP1;CD24;PSRC1;FLT1;DAB2IP;NEK10;INCENP;SNCA;DIRAS2;PDGFA;DIRAS1;TPD52L1;CCND1;CEMIP;FGF2;ATP2B4;SYAP1;SLC8A2;CALM3;WNT5A;ADAM17;TELO2;CCND2;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6253076269221319,1.3407393865991692,0.07042253521126761,0.39188308881461764,1.0,16/61,11.55%,KLF2;DCN;THBS1;SERPINE1;SULF1;COL4A2;ISM1;DAB2IP;SERPINF1;PML;CTNNB1;PPARG;CD160;TGFB2;PGK1;SPARC
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.9327311837141989,1.3407267946866344,0.03333333333333333,0.3914432206635044,1.0,3/5,6.72%,GAP43;APP;ROBO2
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.8238196569465001,1.340069719240599,0.15517241379310345,0.3928928167889001,1.0,3/7,7.95%,COL4A2;ITGA2;ITGA11
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.895918776562344,1.3395702711603643,0.17777777777777778,0.39413403614057535,1.0,2/5,8.02%,IL15;TMBIM1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),-0.8589111311949352,-1.3395484233280224,0.1,0.8483696857807755,1.0,1/5,0.12%,DAO
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5418463655403328,1.339378116639607,0.029411764705882353,0.39417094293291444,1.0,25/120,15.17%,LEF1;GPNMB;ANXA1;THBS1;ZFP36;SFTPD;NLRP12;PTPRC;APOD;ADCY7;NPTN;NLRC5;NLRC3;IKBKE;GAS6;HDAC9;MAPKBP1;HLA-DRB1;FN1;KLF4;IL12A;IFIH1;RARA;PDCD1LG2;OTUD7B
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.811401189809692,-1.3393537770361987,0.1111111111111111,0.8458440848356747,1.0,2/6,12.24%,MIS12;CENPA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.8243572081574854,1.3391948092834298,0.11904761904761904,0.3943714099342953,1.0,1/7,2.35%,ZFP36
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8685439090174106,-1.3390210937448166,0.08163265306122448,0.8439216177664748,1.0,1/6,0.76%,DCXR
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6272705327214931,1.3388150953710827,0.1111111111111111,0.3955112929281229,1.0,9/38,11.54%,PAPSS2;IMPDH1;ADCY5;ADCY7;ADCY2;GUCY1A1;AK5;GUCY1B1;ACOT7
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.6055579134209198,1.3386221683556943,0.09523809523809523,0.39570975845364403,1.0,12/71,10.69%,ANLN;NLGN1;PLPPR5;CDC42EP3;EPS8L2;PLEKHM1;AGRN;CDC42EP1;CLRN1;NEURL1;FSCN1;P2RY12
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.5914523757626223,1.3380038573381632,0.06944444444444445,0.3974570434760208,1.0,17/73,14.30%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;SLC25A45;SLCO1A2;MFSD2A;SLC7A7;SLC26A8;SLC25A29;SLC51A;SLC27A3;SLC7A14;SLC27A5;PDPN;SLC7A1;ABCC4
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.7957801543141785,1.3378736482797509,0.14035087719298245,0.39751707695552546,1.0,4/10,14.19%,STAT4;IL27RA;STAT3;IL12A
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.5410010578195438,-1.3378587755336702,0.12121212121212122,0.8469719885973053,1.0,12/91,13.73%,NUP62CL;FIP1L1;AAAS;RBM8A;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.7294341293790825,1.3374161548882066,0.13043478260869565,0.39860745683623194,1.0,2/18,2.44%,CXCL2;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.7033231928539645,-1.3371913472903278,0.1951219512195122,0.8474605794836021,1.0,2/11,11.16%,SETDB1;ZNF304
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.702731875969294,-1.336923949242965,0.1,0.8448173538121592,1.0,1/13,0.12%,DAO
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.72112899785691,1.3369189403736434,0.10144927536231885,0.3995057327726595,1.0,3/22,2.41%,CHST8;IGF1;SULF1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.7015842873322349,1.3368608877885948,0.04838709677419355,0.3991573788495158,1.0,5/23,10.81%,MBP;LSR;TJP3;MFSD2A;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.6672433407941782,1.336582025881492,0.13636363636363635,0.39953949872259836,1.0,4/25,9.24%,KIF14;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8694409345985985,1.336528230715715,0.1076923076923077,0.3992728836585342,1.0,2/7,1.91%,NR4A3;NLGN1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8411585932999917,1.3362392642558463,0.08771929824561403,0.39966748332853885,1.0,2/7,9.86%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.6600949597587448,1.3361973704107293,0.12727272727272726,0.39934746350965244,1.0,6/29,12.96%,WTIP;MFSD2A;CD44;SPARC;MYO9A;PDPN
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.7863609662633828,-1.3359890190419812,0.1388888888888889,0.8469850061469218,1.0,2/7,8.80%,CHAMP1;KIF20B
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.870668003820221,1.3359128788967753,0.11475409836065574,0.3999832021948368,1.0,2/7,2.75%,PROX1;EPHA2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.7001620697355166,1.3353552792047285,0.14035087719298245,0.40131616318169205,1.0,5/20,9.40%,P2RY6;STAC2;RYR2;SLC9A1;ATP1B1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.5600425596606771,1.3353207169851211,0.05970149253731343,0.40096852133003696,1.0,15/95,18.97%,NR4A3;TEC;LAT2;NFATC2;GAB2;SYK;PAK1;IKBKG;VAV2;TAB1;MAPK9;SHC1;SKP1;NFATC3;VAV1
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.7935143140349996,1.3350606799044245,0.1875,0.401224911828412,1.0,4/5,17.79%,TPST1;UST;CHST4;TPST2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.8726939619511037,-1.3349989721870308,0.08333333333333333,0.8484665216346384,1.0,1/7,0.79%,ID2
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6875112638167401,1.3349819738027882,0.0847457627118644,0.4009317208365618,1.0,8/16,20.67%,PLEK;FHOD1;ARF6;FMNL3;FMNL1;RHOQ;FHOD3;STRIP1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8903883120569887,1.3348762977318664,0.06779661016949153,0.40081306935123073,1.0,2/6,6.72%,SLIT2;ROBO2
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8802746060219568,1.3348067148563811,0.08163265306122448,0.4006145253889855,1.0,5/7,9.34%,GRIN2A;GRIN2D;GRIN2B;GRIN1;PDLIM4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5840499328391722,1.3347564387094675,0.0625,0.40029632419071987,1.0,9/82,8.94%,TGFBR2;ADAMTSL2;THBS1;LTBP4;ASPN;PMEPA1;LDLRAD4;ITGA3;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.8447226218156532,1.3345716762434885,0.14285714285714285,0.40059201791365084,1.0,2/7,4.92%,CCBE1;SOX4
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.7262890257476432,1.3345079063733036,0.1076923076923077,0.4003145027993336,1.0,8/19,20.36%,STAT4;GHR;STAT3;CCL2;THPO;STAT6;PIAS1;NMI
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6712249590355884,1.3338393351549096,0.1,0.4016070121435016,1.0,7/41,6.35%,SIX3;MET;ANXA1;PROX1;LSR;GCM2;NRG1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.57451701336781,1.3337777312454442,0.07462686567164178,0.4015282569952785,1.0,16/83,5.54%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.6741388940022072,-1.333720786556489,0.17073170731707318,0.8518585343798131,1.0,4/12,22.07%,SETDB1;ZNF304;TET1;TRIM28
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.7140635298269112,1.3334963533766793,0.06060606060606061,0.40239186166122687,1.0,4/16,6.62%,TYMS;GMPR;ADA;POLD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.663977993215794,1.333463444203286,0.09523809523809523,0.40204729748245943,1.0,7/32,10.41%,TLR2;SERPINE1;NOD1;MYD88;CHI3L1;STAT3;SYK
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8284309165993563,1.3333307611868481,0.08928571428571429,0.4020874786165409,1.0,4/8,14.15%,RASGRP1;PTPRC;BCL2;CD70
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.8507058430199311,1.3329569443823073,0.07407407407407407,0.4027095009940329,1.0,2/7,3.34%,TLR2;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.8518027176251043,1.3328002229214329,0.1016949152542373,0.40232625042755443,1.0,3/6,13.63%,CDC42EP3;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.8518027176251043,1.3328002229214329,0.1016949152542373,0.40232625042755443,1.0,3/6,13.63%,CDC42EP3;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.6917300584612303,-1.3327813326102078,0.10416666666666667,0.8526113016649488,1.0,4/13,16.29%,ENY2;DDX25;MCM3AP;DDX19A
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.8394031936049163,1.3326585148991923,0.0847457627118644,0.40231321585730145,1.0,3/9,7.18%,SYT1;KCNMB4;RYR2
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6910041531721288,-1.3325509271444547,0.11428571428571428,0.850004243734205,1.0,2/20,2.25%,HEY2;ADAMTS9
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7701647551929002,-1.3322655416479312,0.21428571428571427,0.8476822752522722,1.0,7/9,19.24%,ALDH1A1;ADH6;ADH4;ADH5;SULT1C4;ALDH2;ACSS1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.7474703534414083,1.332256614808766,0.12307692307692308,0.40322189041589424,1.0,2/11,3.20%,GMPR;ADA
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.7524192048708988,1.3322352395887953,0.125,0.40280017055154926,1.0,9/16,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.7424421602601023,1.3316988972216195,0.11475409836065574,0.40399531551385875,1.0,7/16,18.23%,EGF;APP;TGFA;ZFYVE28;SHC1;NCK2;ADAM17
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.7301573089190512,1.3315389563319464,0.12,0.4040592267426204,1.0,4/17,9.64%,NDST4;B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7031787715951099,1.3314236916266395,0.11538461538461539,0.40395258547554247,1.0,7/17,21.03%,DMTN;INPP5J;GADD45A;MLXIPL;PDE4D;NCK2;PPM1F
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6457429360624543,1.3311993985078152,0.1076923076923077,0.40436994147908806,1.0,3/23,7.62%,TLR2;IRAK2;MYD88
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5447285550366218,1.3311870424311647,0.043478260869565216,0.40396236255895457,1.0,31/105,15.22%,FLRT3;HTR2C;SLC4A10;ADCY5;SHC2;CEP170B;DAB2IP;EFNB3;ARHGEF17;EPB41L4B;ATP9A;PTPN21;ADGRL2;ARHGEF10L;ATP1B1;CHMP1A;EPB41L1;CMTM4;TEAD1;PRICKLE2;PARD3B;SLC29A4;SLC13A4;COBL;DIP2C;NOTCH3;BCAR1;PDZRN3;CGNL1;SMARCA1;SLC44A3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5872059460498943,1.3310782371035326,0.07142857142857142,0.4039084418360221,1.0,12/59,12.99%,ZYX;MYH9;EPB41L4B;MYLK3;OBSCN;EPB41L4A;SYNPO2L;EPB41L1;TCAP;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5887977704600209,1.3310676279692504,0.08955223880597014,0.4035283719235939,1.0,16/62,16.31%,MET;TMEFF2;S100A10;WAS;FHOD1;LIMCH1;SYNPO2L;SLC9A1;ARHGEF10L;PHLDB2;PXN;PAK1;LPAR1;CGNL1;STMN1;PFN2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5686091901051075,1.33090923355988,0.06153846153846154,0.4034880842825271,1.0,23/89,9.58%,COL4A1;PRRX1;TLR2;PDGFRA;PCDH18;DCN;ACTA2;SULF1;COL4A2;ICAM1;THY1;PODN;ANGPTL2;POSTN;FAP;IGFBP7;CFH;TNS1;LDB2;C1R;B4GALNT1;BGN;MMP14
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5504057439441934,1.3308482603749403,0.030303030303030304,0.4033567312195823,1.0,15/103,8.65%,GPNMB;HTR2C;P2RY6;PDGFRA;NPNT;RASGRP1;ICAM1;APP;PTPRC;NTRK3;CD44;RAMP3;PDGFA;NECAB2;CHI3L1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6459466326888279,-1.3305461867505692,0.10810810810810811,0.8547968748647758,1.0,7/22,8.54%,MT1E;MT1A;SLC30A8;ZNF658;MT1G;MT1F;SLC30A5
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.845777757059178,1.3301535945775496,0.15254237288135594,0.4052128177803824,1.0,3/6,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.845777757059178,1.3301535945775496,0.15254237288135594,0.4052128177803824,1.0,3/6,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6711883222101931,1.3299025547409866,0.1111111111111111,0.40559917258564004,1.0,6/36,1.91%,TLCD2;ANK3;RFTN1;IL1RAPL1;S100A10;NLGN1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8758602667647459,1.3297482844575195,0.07936507936507936,0.4058939263466701,1.0,1/7,0.85%,ANXA1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.912373694337097,1.329337134443968,0.0847457627118644,0.4071852446306093,1.0,2/5,5.05%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6977991508653494,1.3293227516132609,0.16071428571428573,0.4067661066720026,1.0,2/18,3.05%,IGF1;IRS2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.704069544594109,-1.3290936544382006,0.1111111111111111,0.8585075124070142,1.0,9/14,16.79%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.8185858226236068,1.3288161002017902,0.1,0.40788566087496053,1.0,1/8,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.8070853573181058,1.3285289301806424,0.12280701754385964,0.4086155211891637,1.0,2/7,16.96%,IRF7;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6771291781556843,1.3284567925098318,0.109375,0.40844118743112273,1.0,5/23,10.24%,ANK3;CTSS;ABCB1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.5591234838755311,1.3283273756403162,0.058823529411764705,0.4084217968096964,1.0,7/101,9.35%,GGT5;IGF1;FA2H;ALOX12;ACOT4;LDHA;PPARG
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7707152840414822,1.328266321174494,0.14516129032258066,0.40818372105234224,1.0,2/8,10.04%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.6541876695789587,1.327739854259438,0.11290322580645161,0.40955270494005547,1.0,10/34,15.38%,EPHA7;GRIN2B;FYN;FOXO3;SNCA;CTNNB1;TGFB2;MAPT;ZNF746;MAP3K5
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.6197383273698127,-1.326711473564781,0.1282051282051282,0.8688703170078841,1.0,12/39,18.67%,PARS2;AIMP1;KARS1;VARS1;EPRS1;NARS1;WARS2;YARS2;RARS1;AIMP2;LARS1;TARS3
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.7224247732863156,-1.3266729294234227,0.21052631578947367,0.865252396496903,1.0,3/11,12.77%,ADCY10;SPAG17;SPEF2
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7790935255722412,-1.3261976614659918,0.1702127659574468,0.8643550786412945,1.0,3/7,13.16%,TRMT10C;TRMT10A;TRMT10B
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.9027950640966803,1.326162024531165,0.08928571428571429,0.414192511633271,1.0,1/5,0.20%,SLC6A15
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.6297642124964322,1.3260208099793818,0.12962962962962962,0.41432086783017247,1.0,5/26,12.47%,BOK;YWHAH;YWHAG;BBC3;BCL2
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6733712961460023,1.3259876354991185,0.13114754098360656,0.4139877641380128,1.0,10/27,20.87%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;TINF2;CDK2;TELO2;WRAP53;ACD
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.6572811728456808,1.32598339225335,0.15873015873015872,0.41354020979840417,1.0,4/28,5.87%,PDGFRA;BAIAP2L1;BAIAP2;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5650095618292102,1.325918961198645,0.05084745762711865,0.41332371509295146,1.0,13/72,12.29%,PLD1;THBS1;EFNA1;SAMD4A;SOX4;TNFRSF1A;EIF4A3;LARP6;YTHDF1;EPHA4;NIBAN1;ABCA2;PRKCD
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6288921318928213,1.3258822096429503,0.1206896551724138,0.41297999592890505,1.0,12/38,19.36%,MET;STMN2;PSRC1;SNCA;EML2;MAPT;PAK1;CAMSAP3;STMN1;DCTN1;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),0.8680239391065826,1.3258615829696836,0.07407407407407407,0.41262426214425024,1.0,2/6,3.26%,PLEK;RPS6KA1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.5280759097904631,1.3257272350946276,0.0375,0.41247316083280644,1.0,39/151,17.49%,NPY1R;PAPSS2;RASGRP1;SLC7A2;TJP3;KLF10;CD44;PGR;SEMA3B;RHOD;HR;SYBU;TTC39A;ANXA9;FKBP5;ITPK1;PLAAT3;AFF1;GAB2;PODXL;MAPT;TMPRSS3;TPD52L1;SYT12;BCL2;TFAP2C;KLF4;LRIG1;RAPGEFL1;CCND1;ELF1;RARA;ELOVL5;ABCA3;MED13L;MYOF;CALB2;INPP5F;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.8860598154703163,1.325637336830223,0.09230769230769231,0.4122969285429943,1.0,2/5,2.65%,ANK3;DMTN
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.8579776390616902,1.325603765325978,0.12280701754385964,0.41193036045381437,1.0,2/6,5.98%,ST6GAL1;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.8347764412029669,1.3255255643186816,0.12962962962962962,0.4117042861467786,1.0,1/5,10.92%,MAPT
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.7517334268804001,1.3250114214289208,0.08620689655172414,0.41312801136972177,1.0,2/17,2.82%,THBS1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.6740172663497466,1.324763380955853,0.07936507936507936,0.41356015850041694,1.0,4/29,9.38%,S100A10;DMTN;NEDD9;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.8240899425307255,-1.3246364870843728,0.10638297872340426,0.868628954391442,1.0,2/6,11.69%,IDO1;PRELID1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7806949350635557,1.3245781946959863,0.12727272727272726,0.4131696915419298,1.0,1/7,0.81%,TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7806949350635557,1.3245781946959863,0.12727272727272726,0.4131696915419298,1.0,1/7,0.81%,TLR2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.6283434382481271,1.3243090734522482,0.08928571428571429,0.4134993475610068,1.0,6/28,10.69%,PTPRO;DMTN;WASF1;RHOD;ARHGEF7;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7398516547553462,1.3240465868995386,0.1,0.4138283006887852,1.0,2/22,5.48%,CACNA1H;RNASE10
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.7019473317394774,1.3239302773768757,0.16129032258064516,0.41367752629381627,1.0,10/23,23.59%,TRPC3;GRIN1;GRM6;ORAI1;CCL2;P2RX7;CAMK2A;CACNB2;CACNA1D;CXCL12
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.68226395672634,1.3236910953219119,0.12698412698412698,0.4137159610930825,1.0,3/28,3.59%,TESC;PTK6;WNT8B
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5705875497260637,1.3236504459108227,0.07462686567164178,0.4134020972263815,1.0,25/78,16.70%,CSPG4;DCN;OGN;B3GNT2;PXYLP1;CHSY3;CHST15;CHST6;CHPF2;AGRN;UGDH;BGN;OMD;UST;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;B4GALT5;CEMIP;CHST2;NDST1;HS2ST1;B4GALT6;HS6ST2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.5918471855892433,1.32333363734442,0.10526315789473684,0.4139056783004038,1.0,15/64,17.50%,SIX3;ANXA1;PROX1;BASP1;CNN3;PPARG;ZDHHC7;OVOL3;PGK1;DEUP1;TAGLN2;FZD7;FSTL1;MESP1;SCRIB
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5583684226777582,1.3231744947365311,0.12162162162162163,0.41415714136042525,1.0,18/76,18.91%,CTSS;TESC;MMEL1;PCSK2;NNAT;ECE1;MMP14;ADAM19;TSPAN14;MMP16;PHEX;SRGN;PCSK5;ADAM17;F3;TSPAN15;MMS19;PCSK7
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.5826662661742975,1.3230268796458653,0.08695652173913043,0.41432029724895403,1.0,17/72,17.38%,SH3GL2;SLIT2;DAB2IP;NTRK3;PID1;PPP1R16B;TPPP;NIBAN1;TERF2IP;MAPT;DBI;XRCC1;ATP2B4;TINF2;CDYL;MFHAS1;WWTR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.8345573351233405,-1.3228173406747874,0.17777777777777778,0.8733735837772785,1.0,3/6,6.31%,TNFAIP3;GREM1;IL33
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7345860082610272,1.3227522563437069,0.1,0.4147712042824942,1.0,4/13,8.22%,GHR;CYP1B1;OCIAD2;MGAT5
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.6745576121845077,1.3225894892286447,0.12307692307692308,0.4148457772762361,1.0,5/33,7.62%,ZFP36;YBX3;RBM24;ELAVL4;MYD88
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.7231023646513391,1.3222518087890862,0.05263157894736842,0.4157076599298883,1.0,8/24,10.44%,IGF1;GRIN2A;ICAM1;APP;FYN;GRM5;GRIN1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.847812896644176,-1.3221223160248252,0.125,0.8735271966507365,1.0,1/6,1.84%,AGER
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7536195793258239,1.3220079745417108,0.11666666666666667,0.41604329993805284,1.0,7/12,22.15%,LSR;TJP3;CGNL1;SCRIB;TJP2;ARHGEF18;TJP1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.6212861127925176,-1.3215667453377986,0.10810810810810811,0.8731760924980513,1.0,7/31,11.41%,TRIM21;CTSH;PYHIN1;NR1D1;MUL1;ISOC2;RAD23A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8770255986292428,1.3213454974756431,0.1,0.4179747940245464,1.0,2/5,11.86%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.7108194548914393,1.3213382452384015,0.04918032786885246,0.4171206661848581,1.0,9/20,22.21%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP;FOXK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.7108194548914393,1.3213382452384015,0.04918032786885246,0.4171206661848581,1.0,9/20,22.21%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP;FOXK1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6822325825817338,1.320731224524356,0.09230769230769231,0.41867192704016626,1.0,7/33,11.11%,SGPP2;PLPPR5;PLPPR4;PLPPR1;ALOX12;DGKG;PLPP4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.7976455161435138,1.320616870546728,0.12698412698412698,0.418592809783387,1.0,2/11,2.82%,SERPINE1;SLIT2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5638998201437501,1.3205051673207158,0.08571428571428572,0.41853867391761285,1.0,21/101,14.52%,ARHGAP4;CNTNAP1;DMTN;THY1;SH3KBP1;WTIP;NEDD9;DPYSL2;RHOD;PAK4;PCLO;PLD2;PACSIN1;SYNE3;CCL2;FGD5;FMNL3;PALLD;SIPA1;RHOBTB2;BIN1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6439410486693976,-1.3204610633700566,0.15789473684210525,0.8715782040330182,1.0,13/30,23.09%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6439410486693976,-1.3204610633700566,0.15789473684210525,0.8715782040330182,1.0,13/30,23.09%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.8522915685905728,1.3204162433386784,0.10909090909090909,0.4183854932578174,1.0,3/6,12.25%,TRPM4;PLAAT3;KLF7
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.5495663019853999,1.3202572948751268,0.04411764705882353,0.41840597833950527,1.0,18/82,11.10%,PDGFRA;CDH23;CD24;CD55;TRPC3;ADCY5;ATP2B3;TRPM4;ITPR3;CCKBR;HCRTR2;CACNA1C;RYR2;GLP1R;NPTN;SMAD3;CCR10;S1PR3
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.8266394056860451,1.3200327525435598,0.24528301886792453,0.4185995847559631,1.0,1/5,6.91%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.725437690286949,1.3198739362162748,0.12727272727272726,0.4187310072015478,1.0,4/13,13.49%,PIM1;TBX20;ZFPM2;FGF2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7447041214243798,1.3198737857265173,0.15517241379310345,0.4182943742430477,1.0,1/10,0.25%,HPN
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.7993001655740082,1.3196811884754505,0.12244897959183673,0.41851215232341454,1.0,1/9,1.60%,PLK2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7532502181401164,1.3194031382266225,0.11627906976744186,0.4190374117775147,1.0,6/9,23.72%,INCENP;PRKCD;CDK2;RPS6KA4;CCNA2;RPS6KA5
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.8117134269809191,-1.3190815365072879,0.13157894736842105,0.871491991002135,1.0,4/5,18.58%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.8117134269809191,-1.3190815365072879,0.13157894736842105,0.871491991002135,1.0,4/5,18.58%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.7760048887316833,1.3189494360206482,0.08333333333333333,0.419979934946464,1.0,9/14,16.38%,A4GALT;ST8SIA3;ST8SIA1;B4GALNT1;ST8SIA4;LARGE1;ST6GALNAC5;B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.5027991505261507,1.3188540258887758,0.012345679012345678,0.419900280996706,1.0,75/385,16.69%,LEF1;MYRF;TEAD2;IGF1;KLF2;MLLT11;YWHAH;EGF;CREB5;TESC;SP100;ACTA2;PSRC1;BLM;CASZ1;RPS6KA1;IRF7;FOXO1;NFATC2;NFIL3;SOX4;AHR;SKAP1;CIITA;ZBTB16;ZIC1;FOXO3;KCNH2;GLIS2;SCX;PML;CTNNB1;TBL1X;SMAD3;YAP1;RAI1;PPARG;HDAC4;GLI2;RGMB;STAT3;FLI1;TEAD1;CDKN1C;PARP9;NPAS2;HLA-DRB1;MLXIPL;KLF6;BRD4;KLF4;DEAF1;FGF2;SS18L1;ELF1;HIPK2;SPP1;SOX10;PRDM16;RARA;CD4;SMARCA1;ETS1;MAP3K5;TP53;RXRA;BRCA1;FZD7;ZMIZ1;CXXC1;HMGA1;NPAS3;RORA;TFEB;MESP1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.6218171631971577,1.3187930727047719,0.11594202898550725,0.41966116462642283,1.0,10/52,9.86%,TLR2;IGF1;DOC2B;IRS2;ACHE;SOX4;NNAT;TMED10;SYTL4;TGFB2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.727551487718914,-1.3187533245953775,0.21951219512195122,0.8698323528275962,1.0,1/11,4.32%,AAAS
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8531604253332675,1.3178895505649377,0.09836065573770492,0.4218880757064416,1.0,3/6,4.64%,SHISA7;NLGN1;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.827394359085246,1.3173756546925353,0.09836065573770492,0.4231178322019551,1.0,2/8,2.58%,STMN2;PLEK
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.867474003363558,1.3172993553798535,0.07142857142857142,0.4228394074336859,1.0,2/5,6.22%,ABCB1;GRM5
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.6824497705802984,1.3171878747075234,0.18333333333333332,0.42273275429462626,1.0,2/17,4.69%,SGPP2;PRKG2
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6763165648046242,1.3171304393082799,0.13333333333333333,0.422516380051339,1.0,10/26,20.87%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;TINF2;CDK2;TELO2;WRAP53;ACD
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7974232746914227,-1.316644080762882,0.14545454545454545,0.8765602097128432,1.0,2/7,2.01%,VAMP8;NMB
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.6082402541248825,1.3166182221612837,0.0958904109589041,0.42365499595500095,1.0,8/56,13.91%,HPN;RFTN1;RPS6KA1;MFSD2A;MMP14;TGFB2;BCL2;TRIM32
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.5629037162316359,-1.3166179313992947,0.09090909090909091,0.8731522335085076,1.0,13/40,14.78%,HSPG2;APOE;ALDH1A1;AKR1C3;SDC3;APOM;ADH4;CYP4V2;GPC6;LRAT;RDH10;RDH11;NAPEPLD
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.7281751564278092,-1.3163467208616364,0.1590909090909091,0.8705025714719117,1.0,1/12,4.60%,NAA11
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7190614398724897,-1.3153923078872125,0.16216216216216217,0.8721763161130235,1.0,1/10,2.26%,EIF2S3B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5855519394854827,1.3153155937913639,0.09836065573770492,0.42798518591263846,1.0,12/58,12.36%,CDKN2A;NR4A1;DUSP1;TSPYL2;BTG3;CDK6;HECA;SMAD3;GMNC;CHMP1A;CDKN1C;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8344634433908339,1.3153125422742078,0.0625,0.4275570499253341,1.0,5/9,14.09%,DAB2IP;VLDLR;PACSIN1;ALK;COBL
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6846139797259282,1.3152808610663949,0.0847457627118644,0.4272027868152044,1.0,4/27,3.34%,ANXA1;NR4A1;FLT1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.5541979998791032,1.315210313338127,0.08571428571428572,0.4269586279992174,1.0,21/97,15.21%,KIF14;EPHA7;TESC;DUSP1;EPHA2;EFNA1;EPB41L4B;ARHGDIG;NUAK1;RHOD;PPP1CB;MINK1;PODXL;EPHA4;STX4;PLXNA4;FUT2;IL12A;SIPA1;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.53070536598567,-1.315181315508496,0.05555555555555555,0.8695524781153933,1.0,9/50,20.20%,ATF5;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;PSMD2;CUL1;PSMB4
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.6829838802666875,1.314800403356973,0.0967741935483871,0.4278318977913165,1.0,7/24,16.60%,CDKN2A;NUAK1;CDK6;CGAS;B2M;NEK6;HMGA1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7197209071615869,1.3146309774397211,0.16981132075471697,0.42814548640799527,1.0,5/11,17.50%,ZDHHC7;OPHN1;MYO9A;CAMSAP3;SCRIB
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6999039083117174,1.3145252395169225,0.10204081632653061,0.4279859220859943,1.0,3/23,10.44%,IL1RAPL1;ZNF804A;HOMER1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.8613228301222369,1.3141770275582096,0.09523809523809523,0.4287586365064318,1.0,3/5,13.76%,HLA-DRA;HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.7746762956349663,-1.3140632960203684,0.09523809523809523,0.8712163973633672,1.0,2/10,8.58%,TAX1BP3;GOPC
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.6953837205467375,1.3138589632845827,0.12280701754385964,0.4294693177704807,1.0,8/23,14.92%,PDGFRA;THBS1;ZSWIM4;YTHDF1;CYRIB;P2RY12;STX4;GPR183
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.8746673937503243,1.3137066720526982,0.1509433962264151,0.429719562707864,1.0,1/5,0.81%,TLR2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6748672201289645,1.3136329973870784,0.10526315789473684,0.42955904444191617,1.0,7/26,10.04%,IL1RAPL1;NLGN1;GRID2;CLSTN2;AGRN;PTPRD;DLG5
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6836823107954171,1.3134597953980727,0.11290322580645161,0.4296881485655789,1.0,2/22,9.80%,NMNAT2;AK5
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.9036918348859287,1.3133088293633073,0.09259259259259259,0.42974473972305266,1.0,1/5,1.45%,EGF
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6489432226513598,1.3129828618446722,0.15,0.4303666013191076,1.0,4/23,4.64%,EGF;RELN;TGFA;SHANK3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6822763807991282,1.3129366971469214,0.1864406779661017,0.43003783629875786,1.0,2/21,3.73%,ZFP36;SAMD4A
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.637732445312417,1.3125333970798054,0.0392156862745098,0.4310062864968022,1.0,3/33,3.58%,RECQL4;BLM;RPA1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.4721029858948797,1.3124180253914257,0.0,0.430881419096675,1.0,165/835,19.07%,TGFBR2;MTMR7;SERPINA10;VRK2;C3;ANXA1;SOCS3;CHGB;MAP3K6;CHRM3;PLK2;THBS1;FAM20C;PTK6;PTPRO;B3GNT2;PIM3;DUSP1;PRKCB;PRKCG;PTPRB;TEC;APP;PIM1;MAP3K11;ASB16;NUAK2;DUSP10;NEK10;PTPRR;PAK3;CP;PTPRC;DUSP8;PRKG2;MYLK3;PRKAR1B;FYN;B3GALT2;NUAK1;FBXW12;DUSP16;LAMB1;IGFBP7;NOTUM;ST8SIA3;PDP1;ZBTB16;PTPN21;BAP1;SBF1;VGF;CDK9;STK25;PAK4;ST8SIA1;AATK;SHISA5;DAPK2;CDK6;GRK2;SIK2;PTPRD;ITIH2;SSH2;LIMK2;PTPN9;PRKCE;PRKCH;IKBKE;LOXL1;PPP1CB;MINK1;B3GALNT1;MAK;HIPK3;HUNK;FBXO32;ART3;TGFB2;UST;TF;KLHL5;ST8SIA4;FBXL2;SYK;CDKL5;PARP9;MAP3K21;GAS6;B4GALT7;FBXL16;TYK2;WSB2;PDK4;CHST4;B4GALT5;CCL2;PXK;CAMK2B;MACROD1;PRKCD;SPSB1;HIPK1;FN1;PAK1;PICK1;PHEX;FUT2;MSRA;MTM1;GPS1;ATG4B;GRK5;PLOD2;HIPK2;PDK1;SERPIND1;BMX;PIK3CD;NEK6;SPP1;PPM1D;LCMT1;RARA;ST6GALNAC2;LARGE1;MAP3K5;STK3;PINK1;PTPRS;HIF3A;FSTL1;CDK2;CDK19;TAB1;CILK1;LIPE;CDC25B;MAPK9;CDK18;ANO8;CDK20;FAM20A;PIGK;STK11;STK24;FN3KRP;DDB2;MTMR2;CTTNBP2NL;PDK3;SKP1;CAMK2A;LOXL2;PRKCA;NEK4;B3GALT5;RPS6KA4;DCAF5;FBXO41;FBXO31;MTMR3;RAB11A;GAN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5911108453944595,1.3123727717160032,0.13559322033898305,0.4306130351578507,1.0,3/47,1.48%,BOK;MLLT11;DCN
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5978759505559658,1.3120422892260217,0.06153846153846154,0.43123087491020995,1.0,13/58,12.93%,NR4A3;ELMO1;WAS;FYN;BAIAP2;MYO1C;PLD2;ARPC3;PRKCE;SYK;PLPP4;PRKCD;PAK1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7998994000213557,-1.311669063705993,0.14893617021276595,0.8807659800549636,1.0,4/7,16.31%,TRMT10C;TRMT10A;TRMT10B;TRNT1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7140559437755134,1.3111695519101332,0.14754098360655737,0.4334974734336532,1.0,2/15,1.17%,NR4A3;PDGFRA
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.7124994671229429,1.3110372756901574,0.08620689655172414,0.4335975418574067,1.0,2/22,2.04%,SLC6A15;SLC43A1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5538538944989756,1.3106781315991278,0.06756756756756757,0.4342582344313931,1.0,26/109,11.74%,RGS7BP;STMN2;ZNF536;NLGN1;RCAN2;CNTN2;GAP43;SLIT2;PLP1;PLPPR4;C11ORF87;OPCML;EFNB3;TCEAL7;SEMA5B;GUCY1A2;MAP1B;GFAP;BOC;PTPRD;LY6H;NACAD;ASXL3;CRMP1;FAM13C;RUNX1T1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7357289372543139,1.3097416327867708,0.05357142857142857,0.4366460614681181,1.0,7/18,15.19%,MYRF;PRDM8;EIF2B2;TPPP;SOX13;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.8035596857800695,1.3097334894667794,0.1509433962264151,0.4362305966301275,1.0,2/7,10.20%,SLC25A45;SLC25A29
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.8380703232394764,-1.3094181976093577,0.15384615384615385,0.8892843316568364,1.0,1/6,1.13%,ERCC8
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.6089569385366327,1.3093711384311382,0.125,0.4369937192782647,1.0,5/53,3.61%,PTP4A3;TLR2;APP;NOD1;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.7237463554240327,1.3092419443803582,0.109375,0.43706600597463974,1.0,5/21,17.04%,EGF;APP;CHI3L1;CEMIP;CALM3
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.7083135144391484,1.3092199015860297,0.14516129032258066,0.4366632426975921,1.0,8/20,16.95%,CXCL2;ANXA1;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C;ADGRE2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.638308953566121,1.3089151500976932,0.12307692307692308,0.4371152589563676,1.0,7/32,17.81%,BOK;ZNF385B;PML;HIPK1;HIPK2;TP53;STK11
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.7017848833862171,1.3084367977998983,0.11538461538461539,0.438182510743296,1.0,5/15,15.13%,GPNMB;SFTPD;DLG5;HLA-DRB1;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.47427070951088574,1.30822814052948,0.0,0.43844271160146436,1.0,149/669,20.29%,LEF1;NR4A3;MLIP;FOSL2;MET;ST18;TLR2;IGF1;KLF2;MAFF;PROX1;DCN;SERPINE1;ATF3;NR4A1;CASZ1;LMO2;WAS;APP;RPS6KA1;IRF7;DAB2IP;FOXO1;PPARGC1B;PLSCR1;SOX4;AHR;SSBP4;KLF10;DVL1;SKAP1;RFX4;CIITA;ZNF750;TNFRSF1A;PLAC8;AGRN;PGR;LDB2;PID1;CDK9;FHOD1;FOXO3;GLIS2;SCX;GRIN1;ZFPM2;NLRC5;SLC9A1;CTNNB1;CSRNP1;TBL1X;SMAD3;NR1I3;YAP1;BEX1;PPARG;CTBP2;HDAC4;NAMPT;TGFB2;GLI2;STAT3;GLIS3;SMAD1;TEAD1;ASXL3;NR4A2;ASXL1;NPAS2;EIF5A;MLXIPL;KLF7;KLF6;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;FGF2;SS18L1;FADD;TNIP2;ELF1;MAML2;ZNF746;HIPK2;BCL9;IKBKG;AKIRIN1;PTPRN;NOTCH3;MRTFA;RARA;IER5;SMARCA1;RARG;ETS1;STAT6;TP53;ZNF513;RXRA;BRCA1;ZMIZ1;TOX3;HMGA1;ZBTB38;RORA;TFEB;MESP1;GPS2;RGMA;LPIN3;DOT1L;UBP1;WWTR1;WNT5A;MLXIP;LAGE3;RHOQ;NCK2;TBL1XR1;RLF;BCLAF1;NFIA;LITAF;SBNO2;RPS6KA4;SMAD2;NFATC3;CRTC3;ZFPM1;MED24;HIF1A;METTL23;POU2F3;TLR3;ARNT;SMAD9;MAP2K5;NOTCH4;ARNT2;RPS27A;MRTFB;BMP6;SMARCD2;HJV;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6548761418213461,1.308204870632445,0.15789473684210525,0.4380756579809998,1.0,6/24,11.24%,MET;TMEFF2;WAS;SHANK3;SHANK1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7601571350276819,-1.3075539944785546,0.26666666666666666,0.8954187381989599,1.0,3/9,6.01%,MID1IP1;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7815423343352088,1.3075531951649388,0.1,0.4397057981369362,1.0,3/10,6.20%,CHRM1;GAP43;PARD3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.6968399104148499,1.3075401297459832,0.1206896551724138,0.4393382171193685,1.0,3/15,14.96%,BIRC3;SEC14L1;PUM1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.8706969070355977,1.307177548060097,0.1016949152542373,0.4402093022557576,1.0,3/5,11.71%,TGFB2;P2RY12;CCL2
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7703285857010728,1.3069266008035703,0.09090909090909091,0.44057219491538996,1.0,3/13,7.88%,C3;MFSD2A;LDLR
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4924434462617683,1.3064798932988602,0.013333333333333334,0.4415697521399613,1.0,49/309,11.60%,NR4A3;HPN;MET;FLRT3;IGF1;PDGFRA;EPHA7;GRIN2B;PTK6;ELMO1;SULF1;FLT1;COL4A2;SLA;EPHA2;SHC2;SLC39A14;IRS2;FOXO1;NRP2;EPHA5;EFNA1;EFNB3;PAK3;FYN;GFRA2;NEDD9;ANOS1;BAIAP2;DNM1;NTRK3;NRG1;GHR;FLRT1;GRIN1;PDGFA;MVP;KALRN;ARPC3;ARHGEF7;NAMPT;SIPA1L1;STAT3;SYK;EPHA4;GFRAL;SORBS1;PXN;PDK4
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.524739645407792,1.306466954952012,0.06756756756756757,0.44119002550552616,1.0,17/107,8.52%,SLITRK1;SCN1B;IL1RAPL1;STMN2;PTK6;RIT2;PLPPR5;SLIT2;RELN;DAB2IP;GRIP1;NTRK3;DVL1;ROBO2;NPTN;ZNF804A;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.672262389693477,1.3062916010199577,0.1,0.4413512331378517,1.0,12/29,18.39%,CDKN2A;IL15;TGFB2;HOMER1;PRKCD;CGAS;B2M;IFIH1;IER5;HMGA1;WNT5A;BCLAF1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7697918337060713,1.3058177475644595,0.1568627450980392,0.4425562179170842,1.0,4/12,11.60%,FOXO1;PID1;FOXO3;PDK4
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6694398040641676,-1.3056590464292663,0.11627906976744186,0.9023017784877954,1.0,6/16,11.72%,MT1E;MT1A;MT1G;MT1F;HSF1;MT2A
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5949312137868128,1.3056251405618828,0.125,0.44278607250964774,1.0,6/56,8.94%,TGFBR2;ADAMTSL2;ASPN;PMEPA1;LDLRAD4;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.752551692072015,-1.3054947525174303,0.1702127659574468,0.8996496204327156,1.0,1/8,1.84%,AGER
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8783009197793837,-1.305198905892595,0.125,0.8974292010867823,1.0,1/5,0.60%,SPRY1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7469663812266942,1.305095376672487,0.14516129032258066,0.44405750360795654,1.0,4/10,17.49%,TEC;AATK;BMX;IGF1R
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7483629295843588,1.3048939462683615,0.2037037037037037,0.4442620271655581,1.0,9/15,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.755342483564886,1.3044371697287778,0.1694915254237288,0.4454710655214028,1.0,2/10,11.10%,TNFRSF1A;S1PR3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.7261484884595215,1.3042125187885256,0.15,0.4457905273960641,1.0,9/24,18.09%,PAK3;SHANK3;FYN;DOCK10;SHANK1;ITGA3;PICK1;IGF1R;MTMR2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.7335069077785389,-1.304203880579992,0.1111111111111111,0.8984975615340881,1.0,3/6,19.42%,MOCS2;NFS1;MOCOS
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.7044537971071151,-1.304012211640448,0.15,0.8960084338419252,1.0,6/13,11.72%,MT1E;MT1A;MT1G;MT1F;HSF1;MT2A
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.8109488830267186,-1.3038370398790722,0.17391304347826086,0.8896459176778813,1.0,2/5,16.51%,FLAD1;SLC52A1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.8109488830267186,-1.3038370398790722,0.17391304347826086,0.8896459176778813,1.0,2/5,16.51%,FLAD1;SLC52A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.7473434954917326,1.3037887504477235,0.16363636363636364,0.4467857601464985,1.0,2/9,1.48%,MLLT11;DCN
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7950886240402456,-1.3036644874053778,0.18421052631578946,0.8871057941684503,1.0,3/7,20.25%,HUS1;CLSPN;RAD17
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7702506394618256,1.3034073380092974,0.11363636363636363,0.4474994194564145,1.0,3/13,9.86%,TGFBR2;TBX20;TGFB2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6608687574588861,1.3033050074965098,0.1016949152542373,0.44729218317873354,1.0,10/27,19.62%,THY1;RHOD;ARHGEF7;SORBS1;ACTN1;FN1;LAMA3;PLEC;ITGB4;BCR
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.677752411150065,1.3032757279702112,0.08333333333333333,0.4470155877999119,1.0,7/23,13.11%,ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.5532512552278869,1.3032456727227506,0.06451612903225806,0.4467163027039679,1.0,32/136,19.09%,RASGRP2;S100A10;RASGRP1;DAB2IP;THY1;EPHA5;RGS6;RAP1GAP;DOCK10;AGRN;MAPRE2;ARHGEF7;SIPA1L1;EPHA4;CDKL5;USP6NL;CCL2;FGD5;PLXNA4;CPEB2;PLXNA1;PLXNA2;NGEF;RGS16;TBC1D10B;VAV2;PKP4;RAP1A;DOCK9;SEMA4D;VAV1;SNX13
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.7131116109754694,1.3030509120183602,0.18032786885245902,0.44691661548945477,1.0,4/17,10.69%,NLGN1;EPS8L2;PLEKHM1;P2RY12
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.8110445961432876,1.3029398929349836,0.078125,0.446803510258884,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.7989399420479512,1.3027156693201982,0.125,0.44711916769153487,1.0,3/8,13.63%,DAB2IP;PIP4K2A;WASHC1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.8575879125514023,1.3026712772759275,0.14035087719298245,0.44686723507408843,1.0,1/6,0.40%,SIX3
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8375420113445401,1.3026680558051438,0.11764705882352941,0.4464424008662551,1.0,3/6,10.58%,VAPB;GRAMD2A;TLE6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6845999039028144,1.3024442016425377,0.13333333333333333,0.44679213162168924,1.0,5/18,16.92%,ANXA1;PTPRC;STOML2;CD4;PDE4D
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8420883945720011,1.3023617495409203,0.1346153846153846,0.44661047665671716,1.0,2/6,4.92%,EFNA1;SOX4
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.6399778597587147,1.3017512318420388,0.11594202898550725,0.44816957266944074,1.0,11/33,16.38%,FA2H;ST8SIA3;B4GALNT1;CERS3;CYP4F22;ST8SIA4;SGMS1;CERS5;ST6GALNAC5;B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.7569232270555373,1.3017153446262193,0.21666666666666667,0.44784875602533364,1.0,2/7,5.50%,PTPRC;AHR
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7619396502913438,-1.3016472980765115,0.1282051282051282,0.8939493904031448,1.0,4/10,23.22%,HUS1;CLSPN;RAD17;CHEK2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7807243412398959,1.3016399657540612,0.15873015873015872,0.4476896106356742,1.0,2/10,2.74%,CCNB2;PRKCB
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.6624482918426706,1.3016119751253914,0.13559322033898305,0.4473583906799839,1.0,11/33,13.02%,IL13RA1;CTSS;CD24;P2RY13;IRF7;PTPRC;KLF3;GFI1B;CAMK2B;KLF6;IL4R
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.8439034329368051,1.3015348306996963,0.12962962962962962,0.44677816623711425,1.0,2/8,8.06%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.8439034329368051,1.3015348306996963,0.12962962962962962,0.44677816623711425,1.0,2/8,8.06%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.787572824366101,1.301322544267843,0.22388059701492538,0.4469415216668387,1.0,3/6,20.30%,PODXL;IQGAP1;MYO1E
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.8169072412435056,1.3009055679974453,0.18518518518518517,0.4478028758108355,1.0,3/7,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5532167591202323,1.3008061353680316,0.06666666666666667,0.44765613405287186,1.0,22/99,16.45%,ENPP2;SGPP2;VAPB;UGT8;FA2H;ESYT3;B4GALNT1;SPNS2;HACD1;CERS3;B3GALNT1;ABCA2;SERINC1;TEX2;SGMS1;ALDH3A2;ELOVL7;STS;CERS5;ELOVL5;ST6GALNAC3;NEU4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5299812516341748,1.3007324616346123,0.0547945205479452,0.4474296958081773,1.0,35/143,14.53%,GPNMB;DCN;SP100;THBS1;SERPINE1;SULF1;FLT1;COL4A2;PRKCB;EPHA2;ISM1;DAB2IP;SERPINF1;APLNR;PAK4;PML;CYP1B1;HK2;CTNNB1;PPP1R16B;CHI3L1;PPARG;CD160;TGFB2;ADAM12;ITGB8;PGK1;SPARC;HIPK1;KLF4;FGF2;GAB1;THBS2;HIPK2;PIK3CD
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7465273514079999,1.3003319774203888,0.11864406779661017,0.44839081930579155,1.0,4/13,15.37%,GHR;STAT3;PXN;STAT6
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.8648566690003405,1.3003063443711511,0.09259259259259259,0.44807288023375075,1.0,1/5,5.60%,PLEKHM1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.777128065558273,-1.2998129010380561,0.13333333333333333,0.9000836706284933,1.0,4/7,21.35%,MGME1;PRIMPOL;DNA2;PARP1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7581933071685422,-1.2996641439315513,0.11428571428571428,0.8973905584258741,1.0,3/9,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5627738556386914,1.2995924126683285,0.08196721311475409,0.4499315572083098,1.0,22/103,12.85%,CACNA1H;RASGRP2;ANK3;NLGN1;SYT4;DMTN;SYT1;GLRA2;SYT5;CLIC4;HPCA;NEUROD2;ITPKB;ADCY7;SNCA;SYT13;TF;CPNE2;FBP1;SYT12;CDKN1B;B2M
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6727335902211201,-1.2995707550298334,0.13157894736842105,0.8944068982830271,1.0,4/13,16.10%,SLC25A5;SLC25A4;SLC25A24;SLC19A1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7614049960655641,1.2994256296745093,0.12903225806451613,0.45006801755006803,1.0,1/16,0.01%,LEF1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.7763149262320463,-1.299425599934996,0.21052631578947367,0.8918691166845881,1.0,6/7,19.24%,ALDH1A1;ADH6;ADH4;ADH5;ALDH2;ACSS1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7747124487666881,1.2989934588374328,0.16666666666666666,0.4509660595424028,1.0,1/7,6.64%,TBX20
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.8076313667018196,1.2989893306551996,0.17391304347826086,0.45054463050853555,1.0,2/7,3.80%,SH3GL2;TJP3
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6081120745078853,1.298726105384101,0.03571428571428571,0.450884392536031,1.0,15/52,21.09%,TLR2;IRAK2;DAB2IP;MAP3K14;BIRC3;TNFRSF1A;NLRC3;RELB;IKBKG;TAB1;PRDX4;TLR3;RPS27A;TAB2;TBK1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.8133894374956294,1.2982225757445511,0.08823529411764706,0.45228928776630656,1.0,1/8,2.21%,BLM
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.7055535431600587,1.298143718503347,0.08928571428571429,0.452173638854642,1.0,4/20,4.94%,ANXA1;THBS1;XKR4;XKR6
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.7759934865741345,1.2980461719724454,0.1864406779661017,0.4519676794724241,1.0,3/6,15.82%,RNF112;PRKCD;XRCC1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.48168058070742015,1.2975317620588767,0.012195121951219513,0.45325445814572296,1.0,42/345,12.96%,LEF1;HPN;ANXA1;IGF1;KIF14;PLK2;THBS1;PIM3;PRKCG;RPS6KA1;PIM1;FOXO1;NUAK2;PRAME;AGAP2;ALOX12;FAS;BIRC3;CD44;SNCA;SCX;MYD88;MAG;NAA38;CTNNB1;BAG3;THOC6;BCL2L1;DHCR24;YAP1;PRKCH;HIPK3;GAS6;VSTM2L;NR4A2;PDK4;BARD1;CCL2;PRKCD;BCL2;KLF4;PDPN
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.6250568574991386,1.2974868998304905,0.13333333333333333,0.4525031341669203,1.0,7/38,14.71%,SP100;IRF7;SAMHD1;MYD88;TYK2;MX1;HLA-E
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.6250568574991386,1.2974868998304905,0.13333333333333333,0.4525031341669203,1.0,7/38,14.71%,SP100;IRF7;SAMHD1;MYD88;TYK2;MX1;HLA-E
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.6720153795164263,-1.2974174421169422,0.14,0.8983948365047474,1.0,6/15,15.01%,TRMT61A;TRMT10C;METTL8;METTL3;TRMT61B;VIRMA
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.8535587638587001,1.297337915589184,0.13725490196078433,0.4525005656940034,1.0,1/5,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.48555295861534853,1.2969677985600527,0.012658227848101266,0.45338774853498953,1.0,79/391,15.53%,MET;PTP4A3;BOK;TLR2;IGF1;PDGFRA;EGF;DCN;PLK2;THBS1;NLGN1;RIT2;FLT1;PRKCB;TRAF3IP2;RELN;IRS2;SEPTIN4;APP;DAB2IP;NOD1;NLRP12;NOS1AP;TGFA;PTPRC;MAP3K14;FYN;TRIM5;SMCR8;NTRK3;NRG1;BIRC3;TNFRSF1A;NEUROD2;CASP10;RAMP3;NRG2;PDGFA;SHISA5;MYD88;UNC5CL;BCL2L1;CHI3L1;KITLG;GAB2;IKBKE;TGFB2;DLG5;BBC3;P2RY12;GFRAL;TERF2IP;GAS6;APOL3;TNFRSF19;LURAP1;HLA-DRB1;TRIM22;BCL2;CGAS;BRD4;FN1;FGF2;TNFRSF10B;FADD;GAB1;LPAR1;TNIP2;TRIM32;IQGAP1;GPR37;IKBKG;PIK3CD;NEK6;PUM1;CD4;THPO;TP53;PINK1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.5315462957351847,1.2965118714239352,0.028169014084507043,0.45449828285826926,1.0,26/138,11.97%,CCK;SIX3;MET;IL1RAPL1;HES7;RELN;WNT8B;ANOS1;LHX6;NEUROD2;MAP1B;CDK6;CTNNB1;PTPRD;MYT1L;YAP1;TGFB2;CDKL5;DNER;DCX;MAPT;ASTN2;FGF13;NR4A2;OPHN1;RNF112
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6577956653980741,1.2964903176354161,0.10606060606060606,0.4541341078864347,1.0,10/32,22.15%,PRKCB;PID1;SIK2;PIP4K2A;SORBS1;PRKCD;TSC2;PTPRE;GRB10;PTPN11
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.6967665242025626,1.2964145372184865,0.1016949152542373,0.45395031284817455,1.0,6/20,11.20%,KIF14;STMN2;STMN4;TPPP;MAPT;FGF13
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7467048138323861,1.2962857139313015,0.171875,0.453991264459328,1.0,5/9,17.50%,ECE1;SNCA;RAMP3;INPP5F;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7658922422418565,1.2962726301731637,0.12280701754385964,0.45361739492031694,1.0,4/11,9.67%,STMN2;SNCA;ARHGEF7;EML2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.8184971508264658,1.2962484769903113,0.125,0.45325543147906444,1.0,2/6,6.49%,CPLX2;NEUROD2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7911629052181173,1.2959979049635322,0.18518518518518517,0.45353187378761217,1.0,2/11,6.79%,IGF1;GHR
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.7541408394386392,-1.295958330309251,0.1702127659574468,0.9026603276749882,1.0,1/7,0.12%,DAO
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.8401425355334797,1.2957207122423486,0.14545454545454545,0.4540872323111755,1.0,2/5,12.93%,YAP1;PAK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6460583215277568,1.295509085874169,0.12121212121212122,0.45438470228675737,1.0,8/28,9.00%,PTPRO;DUSP1;PTPRB;DUSP10;DUSP8;DUSP16;DUSP22;PTPN9
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5592594851472059,1.2954861623397635,0.06557377049180328,0.4540456931894295,1.0,19/86,13.18%,TGFBR2;FLRT3;PKP2;FGF12;SOX4;NTRK3;ECE1;CACNA1C;APLNR;ZFPM2;SH3PXD2B;PDLIM4;TGFB2;GLI2;HDAC9;CDKN1B;FN1;SMYD4;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.654790948590299,1.295450788437585,0.07017543859649122,0.45367388465654285,1.0,9/37,13.58%,HLA-DRA;IL15;PTPRC;PLSCR1;SKAP1;TGFB2;HLA-DRB1;STX4;FADD
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6502094160041814,1.2954417773417322,0.1044776119402985,0.4532916401977981,1.0,5/24,9.70%,NLGN1;PLPPR5;AGRN;NEURL1;FSCN1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8537554508059402,-1.295298505068575,0.13157894736842105,0.9028517188660481,1.0,2/5,5.98%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6679352599632672,1.2949956697343799,0.109375,0.4543897400252676,1.0,9/28,19.55%,IGF1;APP;PID1;MLXIPL;PFKFB3;PINK1;P2RX7;HIF1A;ARNT
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6840602867702261,1.294070987952747,0.15384615384615385,0.4569640141550463,1.0,6/14,26.40%,PPARG;CDKN1B;CDKN1A;APLN;TAFA5;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7927390409525862,1.2937331424258616,0.13725490196078433,0.45767906821684473,1.0,3/12,10.89%,IGF1;IRS2;SORBS1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7894259344870982,1.293584931601552,0.21428571428571427,0.4577715332830696,1.0,5/9,16.81%,TYMS;MTHFD2;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.6814811910071444,-1.2935826315912844,0.11904761904761904,0.9077344444958151,1.0,5/14,7.01%,MT1E;MT1A;ZNF658;MT1G;MT1F
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.626147854784916,1.293537835230086,0.1267605633802817,0.45755349169647674,1.0,11/41,16.11%,BOK;EPHA2;HIC1;PML;BCL2L1;IKBKE;BCL2;HIPK1;HIPK2;TP53;BRCA1
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.6340743149236748,1.293509380488049,0.10144927536231885,0.45726942021807565,1.0,7/41,2.58%,CXCL2;TLR2;CTSS;CD24;P2RY13;MYO1F;PLEK
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.6047509767936753,1.2934878159210585,0.1206896551724138,0.4569084413557376,1.0,10/54,13.78%,MET;RIT2;EPS8L2;ARHGEF3;SYNPO2L;ITGA3;OPHN1;KCTD13;STARD13;LPAR1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.551751290936001,1.293280383739825,0.09230769230769231,0.45721127419544366,1.0,23/100,18.27%,RASGRP2;S100A10;RASGRP1;THY1;RGS6;RAP1GAP;DOCK10;AGRN;MAPRE2;ARHGEF7;CDKL5;USP6NL;CCL2;MTCL1;PINK1;RGS16;PKP4;CD200;CALM3;RCN3;RAP1A;DOCK9;SEMA4D
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5559145443593018,1.2932610060991414,0.04918032786885246,0.4568399810583804,1.0,34/109,14.24%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;CALD1;SULF1;COL4A2;NRP2;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;IGFBP7;C1R;BOC;EMP1;CTNNB1;BGN;MMP14;PBX3;COL9A1;LAMA2;CRTAC1;SPARC;FN1;CHAD;HMCN1;COL5A1;THBS2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.7264740370437799,1.2929376860847448,0.11290322580645161,0.4575394541774121,1.0,4/18,6.65%,SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7775994252461322,1.2924902098783324,0.20689655172413793,0.45870052442528647,1.0,4/8,11.20%,GABRB2;GABRA1;GABRG2;FGF13
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7918677129605672,1.2923286539274077,0.11538461538461539,0.4587473065131399,1.0,3/10,8.31%,BOK;FAP;BCL2L1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6199291773617157,1.2922480544418151,0.12307692307692308,0.45854098013631994,1.0,9/48,11.36%,CCK;RELN;MAP1B;CDKL5;DNER;DCX;ASTN2;FGF13;NR4A2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.6746780591894412,1.2920695372704523,0.1694915254237288,0.45878565646062885,1.0,6/17,21.09%,IRF7;NLRC3;IFIH1;PTPRS;TLR3;TBK1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6715565974691717,1.2920215034354214,0.140625,0.45807788052769505,1.0,7/19,19.55%,IGF1;APP;MLXIPL;PFKFB3;P2RX7;HIF1A;ARNT
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6715565974691717,1.2920215034354214,0.140625,0.45807788052769505,1.0,7/19,19.55%,IGF1;APP;MLXIPL;PFKFB3;P2RX7;HIF1A;ARNT
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.7038921708321002,-1.2920055242722477,0.18604651162790697,0.9130782564284237,1.0,1/9,1.20%,GALNT3
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.5940904547694225,1.2917449327307158,0.12244897959183673,0.4586182311477999,1.0,11/47,11.71%,ANXA1;IRAK2;APP;DAB2IP;IL1R1;MYLK3;SNCA;MYD88;CHI3L1;HDAC4;CCL2
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.6215491331889644,-1.2915824980358634,0.20930232558139536,0.9120157203036042,1.0,3/19,10.46%,ATF5;VPS4B;CEP131
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5452997775102022,1.2914304204500369,0.04838709677419355,0.4592780326166931,1.0,23/92,16.32%,DMTN;EPHA5;PAK3;CLIC4;BAIAP2;FAM107A;RHOD;NEXN;PDGFA;TRIM36;FSCN1;TPPP;MAPT;PHLDB2;ARHGAP18;PRKCD;PAK1;IQGAP1;ARHGAP17;RHOBTB2;CAMSAP3;P2RX7;BST1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7880169971967665,1.29124769248489,0.16363636363636364,0.45935679810191415,1.0,1/7,0.15%,NR4A3
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5591755588243245,1.291052327273022,0.12857142857142856,0.45947913745051544,1.0,19/80,12.96%,COL4A1;PCDH18;CALD1;COL4A2;FBLIM1;EPHA2;SLIT2;NRP2;PTPN21;ADGRL2;CNN3;YAP1;PDLIM4;LOXL1;GLI2;P3H2;ENAH;CD276;PDPN
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.8177306531812012,1.2907770905845746,0.1724137931034483,0.46010355946418,1.0,2/8,11.60%,SLC9A1;PDK4
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.8047485550963973,1.2905190795933303,0.22413793103448276,0.4604540883899684,1.0,2/7,3.51%,ICAM1;THY1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.7756412493049285,-1.290495815052577,0.2,0.9137891066540829,1.0,5/7,21.42%,NT5E;AMPD3;PRTFDC1;PNP;NT5C1A
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.6354658692529367,1.290185451945366,0.11666666666666667,0.46097836597339226,1.0,6/29,9.70%,DMTN;EPHA2;SLIT2;WAS;CLRN1;FSCN1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7961363371075055,1.2901033683728413,0.16666666666666666,0.46078296465355245,1.0,6/6,20.41%,PLSCR1;PLSCR2;ANO7;P2RX7;PLSCR4;ANO6
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.6168815698828195,1.2898417015407666,0.07272727272727272,0.461305976215441,1.0,15/37,18.06%,ANXA1;IL15;THY1;PTPRC;CYRIB;CCL2;CD276;SLC7A1;CD70;PDCD1LG2;ZMIZ1;ZBTB1;TFRC;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.6965133768890099,1.2897428968997642,0.125,0.461208459421471,1.0,7/20,8.95%,CSPG4;DCN;CHSY3;CHST15;CHPF2;UGDH;BGN
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.6394549934015078,1.289587982710522,0.08620689655172414,0.46120885830627417,1.0,14/32,17.98%,CDC42EP3;BAIAP2L1;BAIAP2;CDC42EP1;PRKCE;FCHSD1;ARF6;SPIRE1;BIN1;PFN2;SPIRE2;VASP;CRACD;NCK2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6771860698381608,-1.2895384889784454,0.21621621621621623,0.9154124912391843,1.0,4/14,14.69%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.7058572107161353,-1.2892855398795753,0.23255813953488372,0.9136445801380785,1.0,1/8,1.61%,SELENOS
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.736563678057949,1.2889561587948422,0.10909090909090909,0.46297775510255923,1.0,5/14,9.24%,TMEM204;SULF1;SLIT2;ITGA3;LRIT3
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.6258065750274956,1.2885471821738643,0.125,0.46372447572544695,1.0,8/42,7.26%,IGF1;GRIN2A;ICAM1;APP;NOD1;FYN;GRM5;GRIN1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.6017664529416077,1.288326770915429,0.1206896551724138,0.46396082788070003,1.0,12/43,16.32%,TGFBR2;THBS1;PID1;SNCA;CYP1B1;NOXA1;GADD45A;CDKN1A;TP53;PINK1;BRCA1;BST1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6726165399353088,1.2882413225371823,0.11538461538461539,0.4639262496331844,1.0,3/21,2.91%,MET;TMEFF2;WAS
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5423548047338008,-1.28819492432227,0.15151515151515152,0.9167226229523775,1.0,16/63,20.34%,KPNA2;POLR2K;NT5E;METTL3;DNASE1L1;POLR2C;DNASE2;GTF2F1;POLR2D;RBMX;DNA2;GTF2F2;LSM1;DDX24;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.822319027700239,1.288130322376192,0.18181818181818182,0.4638701144395405,1.0,3/7,8.72%,ITGA8;ITGA2;ITGA3
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.9081620743743133,1.2877816680322955,0.01818181818181818,0.46457009485545775,1.0,3/5,5.57%,SLIT2;SLIT3;PADI2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.6817880593889347,1.2876198940869594,0.13846153846153847,0.46466453989217255,1.0,7/21,16.31%,SLIT2;TMSB10;SSH2;CYRIB;PRKCD;PFN4;PFN2
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.6610060132645401,1.2875950512424497,0.09803921568627451,0.46432759226933984,1.0,10/24,20.11%,APP;POSTN;PDGFA;SLCO2A1;SPP1;VAV2;FSTL1;CCND2;FGFR1;VCAN
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7582811991315963,1.287483928743401,0.13793103448275862,0.464357461851092,1.0,3/8,12.03%,HECW2;PRKCE;HECW1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.5278339331880986,1.2873954662837213,0.06060606060606061,0.4642581461472113,1.0,35/141,14.56%,CACNA1H;PTP4A3;IGF1;COL4A2;APP;MYH9;ACHE;MYH11;FABP3;APOD;SYNGR2;IGFBP7;AGRN;DTNA;KCNH2;APLNR;DAPK2;MYO1C;MRAS;PKIA;CNN3;TCAP;ADAM12;LAMA2;SORBS1;SPARC;TPD52L1;CAMK2B;MEF2D;PICK1;CDKN1A;FGF2;SMTN;BIN1;RIT1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.6794394258842016,1.2872748292085618,0.15384615384615385,0.4642127665583816,1.0,4/20,7.18%,HTR2C;PTPRC;ITPR3;RYR2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6552196673646085,1.287236518690257,0.15384615384615385,0.4639311588584972,1.0,9/23,19.15%,STMN2;STMN4;MAPRE2;MAP1B;MAPT;CAMSAP3;STMN1;SKA2;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.7710008020255813,1.2868811908998086,0.1746031746031746,0.46468029985821624,1.0,3/8,5.16%,HLA-DRA;DUSP10;BCL6
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.7378023179594501,1.286821683336991,0.14545454545454545,0.46437733497499334,1.0,3/10,13.49%,ITPKC;ITPKB;FGF2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.643646314051748,1.2867018198752636,0.14285714285714285,0.46448198291292014,1.0,8/19,23.66%,ABCA5;PRKCH;PPARG;MAPK9;ABCG1;CSF1;ITGAV;MSR1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.6171980188023324,1.28655042118187,0.0784313725490196,0.46461854922596674,1.0,11/33,14.07%,CACNA1H;SLC7A2;ABCC8;TRPM4;ABCC9;ATP1B1;SFXN3;SLC25A29;SLC29A4;MFSD12;SLC7A1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.7640178950655245,-1.286425851434746,0.2,0.9194958067897206,1.0,1/8,6.51%,SCPEP1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.7640178950655245,-1.286425851434746,0.2,0.9194958067897206,1.0,1/8,6.51%,SCPEP1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5184510475167382,-1.2862811049019673,0.075,0.9170406762258645,1.0,8/59,6.23%,DAO;SOD3;OSGIN1;C6;APOE;SERPINF2;PPIC;ADH6
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.8070929655401483,1.2861722244902145,0.14814814814814814,0.46547129104606616,1.0,1/6,2.37%,P4HA2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.7348664743860086,1.2860334325893235,0.16071428571428573,0.4655533018789476,1.0,3/14,9.30%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.7295434181889427,1.2856972085829144,0.16129032258064516,0.4661048025706703,1.0,7/13,16.38%,ST8SIA3;B4GALNT1;ST8SIA4;B4GALT5;ST6GALNAC5;B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8155962086866736,1.285617162922394,0.19672131147540983,0.4658128559692848,1.0,1/5,1.65%,SH3GL2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.6232412413457857,1.2855206667134549,0.13559322033898305,0.46561732426391866,1.0,9/40,19.96%,ANXA1;STAT4;EIF2B2;STAT3;EIF2B5;STAT6;GNAI1;TGFBR3;SORT1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.7608635824442465,1.2851980318432246,0.19672131147540983,0.4662524378383407,1.0,2/10,10.41%,ANK3;SYK
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.8837051220022086,1.2851229888217215,0.10526315789473684,0.4660781329919568,1.0,4/5,10.32%,PLD1;RAP1GAP;FSCN1;PODXL
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.7779904209066211,1.2850259178711703,0.16923076923076924,0.4659997721904269,1.0,4/14,5.44%,FLRT3;GAP43;RTN4RL1;APOD
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.8312171896211504,1.2849169726965386,0.15789473684210525,0.4660489457356556,1.0,3/6,11.45%,STAT4;STAT3;TYK2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7750052609571795,1.284861797605844,0.1111111111111111,0.46585407851842614,1.0,1/11,0.42%,MET
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.7254064219079489,1.2848100240556166,0.1016949152542373,0.4655641859459234,1.0,2/14,3.17%,C3;APP
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.565387991162328,1.284466270991197,0.07272727272727272,0.4661641755830586,1.0,17/61,14.91%,FYB1;PLEK;ZYX;TEC;THY1;MYH9;ERBIN;NEDD9;ITGA2;ITGA11;LAMA5;SYK;ITGB8;ADAM11;FN1;LAMA3;BCAR1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.5367108647464205,-1.2844349883644925,0.05555555555555555,0.9226030695534397,1.0,6/39,11.81%,SLC25A5;CEBPA;SNRK;SLC25A38;RUNX1;UFL1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6676097975007791,-1.2844134154990041,0.2,0.9192748065371874,1.0,3/12,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6320958629918378,1.2843550315960672,0.14705882352941177,0.466043775225144,1.0,8/31,16.86%,CLDN16;LSR;PARD3;POF1B;CLDN18;CLDN20;PATJ;MICALL2
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.7723203349202522,-1.2836846072567496,0.16666666666666666,0.9192376216237178,1.0,1/6,2.46%,TRIM21
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.6031258641726427,1.2832772782106043,0.16393442622950818,0.46922104160970307,1.0,4/37,3.84%,IGF1;EGF;DUSP1;TGFA
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.7626042543392203,1.2827610633521223,0.10344827586206896,0.4706925876200784,1.0,3/11,13.90%,IRAK2;MYD88;TNIP2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.5334927823405514,1.2825485914858137,0.1111111111111111,0.4710432194104793,1.0,23/79,12.01%,HLA-DRA;C3;IL15;CD22;NPDC1;ICAM1;SFTPD;COLEC12;IRF7;PLSCR1;BCL6;AHR;SAMHD1;BIRC3;ADCY7;CD160;TGFB2;SYK;PIANP;HLA-DRB1;CD276;PILRA;ITGAL
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.8129819839144226,-1.2823392906635331,0.22916666666666666,0.9192959021921057,1.0,6/7,18.10%,CEL;APOE;SCARF1;CYP46A1;MT3;SNX17
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.8129819839144226,-1.2823392906635331,0.22916666666666666,0.9192959021921057,1.0,6/7,18.10%,CEL;APOE;SCARF1;CYP46A1;MT3;SNX17
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.814581707404962,1.2823186515994134,0.14285714285714285,0.47132998361308226,1.0,1/10,1.03%,TTLL7
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.8077901540610816,1.2821540668481233,0.1724137931034483,0.47146880153815524,1.0,2/6,10.74%,PTPRD;TRIO
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.8859543820775059,1.2818147362733152,0.08620689655172414,0.472101896492587,1.0,1/5,2.72%,TIMP2
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6896195921232009,1.2817462717679668,0.15384615384615385,0.4719138967066791,1.0,8/21,12.22%,GRIN3A;NLGN1;SHANK3;SHANK1;NEURL1;DLG5;ARF6;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8273663445984242,1.2816519898018564,0.1320754716981132,0.47182075854973876,1.0,2/7,7.51%,SERPINE1;CYP1B1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8171305190323127,-1.2814543613033622,0.17777777777777778,0.9211245703433365,1.0,5/8,8.98%,CEL;APOE;SCARF1;CYP46A1;ADH4
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7928838467461022,1.281448015490097,0.18,0.4721160561265442,1.0,3/11,10.89%,IGF1;IRS2;SORBS1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.5456460749304894,1.2813951225185132,0.07352941176470588,0.47187612082997205,1.0,5/83,7.62%,ST18;IRAK2;NOD1;IL1R1;MYD88
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5988037376652667,1.281326915315353,0.16901408450704225,0.4717413624653651,1.0,13/48,13.49%,EGF;RASGRP1;CD24;FLT1;MAP3K11;DAB2IP;NEK10;DIRAS2;PDGFA;DIRAS1;TPD52L1;PAK1;FGF2
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.7679693855473667,1.2812267159759472,0.1864406779661017,0.4716696381893924,1.0,5/8,20.20%,HK2;PFKL;FBP1;HK1;PFKP
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.746730103600133,1.2810820985542783,0.15873015873015872,0.47162941079266907,1.0,3/13,2.54%,ANXA1;RIMS2;LTBP4
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.8794863523366863,1.2810629127233306,0.1590909090909091,0.47127582970416404,1.0,2/5,9.25%,CHRM1;PRKCH
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.6506219029538216,-1.2809137859330364,0.11428571428571428,0.9208980418415081,1.0,5/19,6.61%,MID1IP1;ABCD2;NPC2;ABCD1;ARV1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6102410085319601,1.2807800285923958,0.09523809523809523,0.47178924921632426,1.0,9/37,6.22%,HLA-DRA;MGAT3;APP;SHROOM4;TUSC3;PTCHD1;FAM107A;MFSD2A;GRM5
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8647105129792113,1.2806698380741517,0.11538461538461539,0.4718741717281438,1.0,2/6,8.74%,NOS1AP;LRRC55
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.8064813411585011,1.280615366629734,0.19230769230769232,0.471542148733684,1.0,4/7,18.53%,PLEKHM1;SYK;SPP1;PRKCA
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.689444280637435,1.2806070477299714,0.18032786885245902,0.47115865609518326,1.0,1/12,1.34%,SGPP2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4854430342104636,1.2805342670639808,0.013888888888888888,0.4710774834624877,1.0,38/311,9.86%,LEF1;TGFBR2;NR4A3;IL13RA1;IGF1;KIF14;PROX1;PDGFRA;IL15;EGF;THBS1;FLT1;IRS2;PIM1;PRAME;TGFA;PTPRC;TRPM4;OSMR;SOX4;LAMB1;NTRK3;NRG1;PID1;TBX20;CCKBR;SCX;ZFPM2;PDGFA;CDK6;CAPN1;KITLG;YAP1;PRKCH;GAB2;HDAC4;NAMPT;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6861042670000762,-1.2804103030830558,0.1951219512195122,0.9206209495561763,1.0,2/13,7.32%,TRMT10C;FASTKD2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.58789391304815,1.2801362822913944,0.08450704225352113,0.4719213818585534,1.0,5/47,5.17%,ANXA1;RIMS2;STEAP3;RAB15;RAB3C
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7572242252666219,1.2797421173857433,0.25,0.47281571642520837,1.0,2/6,9.88%,ACHE;GLI2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7550707765571104,1.2795376718105247,0.1509433962264151,0.47313790023547947,1.0,3/9,17.58%,CLMN;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7368413690912045,1.2795082071094097,0.21311475409836064,0.472827245386348,1.0,8/13,21.60%,TRPM4;SLC9A9;SLC9A1;SLC9C2;SLC8A1;SLC9A5;SLC9A2;SLC9A6
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.7276658397400475,1.2794748329212717,0.14285714285714285,0.47243428542757215,1.0,4/16,15.78%,MET;ITGA3;KCTD13;STMN1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.650926725634152,-1.2793960218030944,0.19444444444444445,0.9230493578144958,1.0,9/28,23.13%,ZC3H8;POLR2K;SNAPC5;POLR3H;GTF3A;POLR3K;POLR2L;RO60;GTF3C6
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.669733464807648,1.2793087121660427,0.171875,0.4724869348995527,1.0,6/23,10.75%,ANK3;PPFIBP1;UNC13C;DVL1;AGRN;DOK7
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.6879768800688776,1.2792265739060555,0.0967741935483871,0.4724154364466625,1.0,10/29,11.38%,TBC1D24;NLGN1;SNCB;SYT1;SYT5;SYNJ2;SNCA;PLD2;PACSIN1;OPHN1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.7262955549609844,-1.279041553165493,0.2,0.921600956570918,1.0,5/8,24.33%,CTH;TXN2;MPST;TST;BLMH
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6679026117720372,1.2787679170529422,0.18032786885245902,0.4734182762548463,1.0,7/21,12.22%,NLGN1;RELN;SHANK3;SHANK1;NEURL1;DLG5;CAMK2B
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.7401638533103098,1.278504806005631,0.13725490196078433,0.4739549687561517,1.0,1/11,0.99%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6682897256342285,1.278464855800442,0.0967741935483871,0.4736658477685877,1.0,10/28,11.89%,RIMS2;GRIK2;SYT1;CLSTN2;RIMS3;ECE1;SNCA;RAMP3;HOMER1;KCTD13
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.6462410188198542,-1.2782642776875648,0.2564102564102564,0.9226665644493051,1.0,1/9,6.17%,MUL1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.6829932264162644,-1.2780487723286684,0.1590909090909091,0.920586623183803,1.0,1/21,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6810106977617965,1.2778983383814524,0.17543859649122806,0.47501524917977134,1.0,2/17,4.49%,KREMEN2;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7469381220736386,1.2778594691541612,0.15625,0.4747051229305083,1.0,5/16,12.89%,KLF2;NOS1AP;ASS1;SMAD3;KLF4
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7694323038378559,1.2778247842027346,0.125,0.47448809251858093,1.0,3/9,12.17%,EPB41L4B;MAPRE2;ARF6
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.8009741056087529,1.277794956215663,0.1,0.4741892374632524,1.0,1/8,1.16%,PROX1
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.5688600061339454,-1.2777650793441848,0.14285714285714285,0.9156017737006602,1.0,5/33,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.5688600061339454,-1.2777650793441848,0.14285714285714285,0.9156017737006602,1.0,5/33,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.7249510539311756,-1.277724057357796,0.11904761904761904,0.9126516865029366,1.0,5/13,18.19%,UQCRFS1;ETFB;ETFDH;SLC25A22;ETFRF1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6922858690156952,1.2774676941870424,0.15789473684210525,0.4748353973995654,1.0,4/18,5.05%,TGFBR2;EFNA1;SOX4;SLIT3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4926346104466258,-1.2774460115043118,0.09090909090909091,0.9107620163219625,1.0,23/120,17.79%,EIF2S3B;RPS28;MRPS7;CRNKL1;RPL6;PRPF18;GEMIN4;RPS27L;RPSA;CLP1;MDN1;RPL11;RPL23A;LOC102724159;LSM4;WDR77;KHDC4;POLR2D;RPF2;SRSF9;RPL10;DHX29;TGS1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.49569833186945716,1.276675664931853,0.0410958904109589,0.4769062120579392,1.0,48/238,15.01%,CDKN2A;PROX1;THBS1;CCNB2;PTK6;NR4A1;PIM3;DUSP1;DAB2IP;UHRF2;TSPYL2;PTPRC;FAP;BAP1;BIRC3;CDK9;PML;CDK6;CDC14A;DHCR24;SMAD3;GMNC;CHMP1A;TGFB2;STAT3;RASSF1;PES1;TTLL12;BARD1;SRA1;GADD45A;RNF112;MLXIPL;CDKN1B;CDKN1A;CCND1;CKS1B;PPP1R9B;TRIM32;GRK5;IQGAP1;IL12A;HIPK2;SIPA1;BIN1;NEK6;PUM1;RARA
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6708429746120392,1.2765300484858157,0.18333333333333332,0.47691349434738023,1.0,3/18,10.92%,CENPV;TERF2IP;MAPT
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6359771613156395,1.2764856053141784,0.12121212121212122,0.47667501304283805,1.0,6/33,6.91%,NELL1;TIMP2;PRKCG;DAB2IP;AGAP2;SNCA
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.5630224370291506,-1.276214208769015,0.14285714285714285,0.9138146690952904,1.0,5/35,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6184583198300182,1.276077371262713,0.12857142857142856,0.4776032522874931,1.0,8/26,22.72%,ACHE;MFSD2A;CHKB;SLC44A3;LPIN3;SLC44A5;SLC44A1;SLC27A1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8437082546643659,1.2759925231949996,0.14814814814814814,0.4774361408002549,1.0,2/5,10.92%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.8236548912357506,1.2759767333067287,0.2553191489361702,0.4770446290415883,1.0,1/6,0.20%,SLC6A15
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.812752186290489,1.275656974085834,0.21311475409836064,0.4774701375620047,1.0,2/8,3.14%,GAP43;RTN4RL1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.7951332926429828,1.2755115221083764,0.17307692307692307,0.47745650543995033,1.0,1/5,6.65%,CDK9
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.7689212574993685,1.2750826421873227,0.11864406779661017,0.47879773484617333,1.0,3/9,16.46%,RELN;CAMK2B;CUX2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.536924012673695,1.2750471449632053,0.07462686567164178,0.4784878228321418,1.0,22/100,13.21%,HAPLN2;PAPSS2;IGF1;ADAMTS4;COL11A2;SULF1;TLL1;SOX4;NOTUM;ZBTB16;CD44;SH3PXD2B;CHI3L1;PKDCC;MMP14;TGFB2;GLI2;ITGB8;MMP16;ALPL;PHEX;DEAF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7816074036231138,-1.275035882004255,0.20512820512820512,0.9167203837037836,1.0,2/5,5.43%,TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.6501994342491045,-1.275023734637715,0.2,0.9137315619804974,1.0,4/12,11.69%,CBFA2T3;IFNLR1;NOA1;PRELID1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.8182539065144584,1.2749798685331655,0.22580645161290322,0.47834115130270793,1.0,1/8,0.88%,SOCS3
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7402363562064435,1.2748763324612058,0.1896551724137931,0.4782353736514456,1.0,4/10,18.59%,NUAK1;LMNA;NEK6;NEK4
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6859054469796575,1.274031128782386,0.1509433962264151,0.48079970251799903,1.0,3/16,7.89%,ZFP36;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.8111242914659134,1.2740233462278978,0.19298245614035087,0.48039784930783164,1.0,3/6,8.02%,SHANK3;FYN;NECAB2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7717908634269455,1.2739144050263662,0.14583333333333334,0.4803919267057784,1.0,2/9,4.96%,ST18;FAS
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.552480116608136,-1.2738840706975765,0.07894736842105263,0.9160172558240798,1.0,10/48,14.43%,GRPEL2;TIMM8B;AIP;TIMM13;BCAP31;TIMM23;SAMM50;TSPO;TIMM50;TIMM10
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.518076397459067,1.273559197136957,0.06756756756756757,0.48112519426767214,1.0,31/129,10.81%,ECM2;C3;TLR2;PDGFRA;DCN;ACTA2;ABCA8;ASPN;IL1R1;PODN;ANGPTL2;POSTN;OLFML1;FAP;IGFBP7;CFH;ZBTB16;TNS1;SERPINF1;STEAP4;MAOB;C1R;CYP1B1;MYO1C;TRIP10;ADGRF5;BGN;PPARG;PXDC1;ADAM12;LAMA2
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7367799737698794,1.2730327945020958,0.17307692307692307,0.482332712050724,1.0,3/10,15.01%,IL15;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.6907441413058425,1.2729584815216572,0.16326530612244897,0.48215330849116994,1.0,4/22,7.04%,TGFBR2;EGFL7;TBX20;APLNR
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.6432848060082704,1.2727698195067239,0.16666666666666666,0.4822570064522608,1.0,7/22,20.08%,NRG1;BOC;CTNNB1;CTNNA1;MAPK11;MESP1;CTNNA2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6872545562017421,1.272665889359471,0.18518518518518517,0.48213852066784246,1.0,5/15,16.81%,FOLH1;ASS1;NAT8L;MSRA;MTHFR
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6804252377013605,1.2723616219657754,0.1694915254237288,0.4829579212148325,1.0,4/20,6.62%,CACNA1H;KCNQ1;KCNMB4;ECE1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.8546746820566199,1.272325457566921,0.06896551724137931,0.48263755962764937,1.0,2/5,10.99%,NLGN1;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7366183558542838,1.2723149891965166,0.19298245614035087,0.48227748094706774,1.0,3/11,10.90%,IGF1;SOAT1;ABCA2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6895692946055428,1.2717977768299131,0.14814814814814814,0.48349695208725185,1.0,2/14,6.52%,HPN;ZIC1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.590412333101158,-1.271463688281037,0.17073170731707318,0.9241470058991575,1.0,12/35,19.37%,AIMP1;KARS1;VARS1;GATC;EPRS1;NARS1;WARS2;YARS2;RARS1;AIMP2;LARS1;QRSL1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6528185526459954,1.2714402071942463,0.17543859649122806,0.48406120731172425,1.0,7/27,8.95%,CSPG4;DCN;CHSY3;CHST15;CHPF2;UGDH;BGN
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.7873579642274221,1.2713861334591425,0.15517241379310345,0.4837811563142466,1.0,5/11,17.11%,APOD;CCDC3;ASXL3;ALK;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5563265027425488,1.271366244887909,0.10144927536231885,0.48342132908962754,1.0,8/80,13.18%,CDKN2A;GPNMB;FAM107A;CDK6;GFI1B;CCL2;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.7673454484337336,1.2712977988979663,0.14545454545454545,0.48332270577442454,1.0,2/9,12.18%,SP100;MX1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.9158735405992106,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.9158735405992106,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.9158735405992106,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.7019538825452769,-1.2707977624746956,0.15789473684210525,0.9149403219640135,1.0,3/10,15.47%,MAL;GOPC;VANGL2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7186843115475553,1.2706376068006717,0.1568627450980392,0.4848966520792198,1.0,6/15,14.71%,HLA-DRA;CYRIB;HLA-DRB1;FADD;IL12A;HLA-E
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.700426557790064,1.2706169154044151,0.22580645161290322,0.484576818101363,1.0,1/14,1.60%,PLK2
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.7983837401931466,1.270521244812956,0.20634920634920634,0.4844774687565433,1.0,1/7,10.77%,TERF2IP
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.7884912375161057,1.2704515635133653,0.21818181818181817,0.4843083638462558,1.0,2/11,4.36%,LIPH;FABP3
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7466186617818442,-1.2704305780190364,0.20408163265306123,0.9133758899344541,1.0,4/11,8.80%,TMEM100;HEY2;ASB4;HEY1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.6448123870325995,1.269843167976752,0.16393442622950818,0.48591609310359735,1.0,4/25,6.43%,CD55;TRIM5;SAMHD1;BIRC3
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6866118585779483,1.2697861473308596,0.21818181818181817,0.4857161445258416,1.0,2/19,8.06%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7860214956017619,-1.2697826680939168,0.18181818181818182,0.9130681132660432,1.0,2/9,7.50%,FICD;BAK1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.6989568010276906,1.269731090970865,0.17543859649122806,0.4855165325618531,1.0,5/15,22.17%,NEFL;KIF5A;HAP1;MAP1A;DST
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6871983536593216,1.2691899212771192,0.16666666666666666,0.48709927832971356,1.0,5/15,17.57%,GRIP1;MFSD2A;DVL1;MYO9A;WNT5A
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.7275237359435742,1.268907285190707,0.13793103448275862,0.4875652928439247,1.0,5/12,12.73%,RIMBP2;TBC1D24;DTNA;FCHSD1;ERC2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.7033966178409841,1.2687620517749982,0.2459016393442623,0.48770254729485396,1.0,2/12,9.04%,PTPRC;YAP1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7440739963885464,-1.2682814101924922,0.14634146341463414,0.917073149050157,1.0,1/7,1.63%,CFAP53
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.8204911370011978,1.2681647279465966,0.10204081632653061,0.48915038087032997,1.0,4/8,10.99%,NLGN1;GRID2;SHANK3;LRRC4
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.8024128787659406,-1.2680592438540985,0.22727272727272727,0.9150559898928028,1.0,2/6,16.65%,BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7678654366667783,1.2678700669844518,0.19298245614035087,0.4895242057765295,1.0,4/6,18.73%,TBX19;SCX;MESP1;SMAD2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.6348464743986024,1.2677808363849437,0.1724137931034483,0.48944137244366853,1.0,9/30,13.13%,HTR2C;RIMS2;EPHA5;AHR;ADCY2;GLP1R;NUDT4;GUCY1B1;CAP2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6607209199647847,1.2676172756701036,0.12903225806451613,0.4895865029689485,1.0,2/23,1.69%,KLF2;ATF3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.8323529531787593,1.2672210134594002,0.1896551724137931,0.49068151839323576,1.0,2/5,11.93%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5333513231417658,1.2668172925672585,0.07575757575757576,0.49155714854734,1.0,26/100,15.21%,ENPP2;SPOCK3;KIF14;EGF;SRCIN1;MGAT3;WAS;TMSB10;NRG1;DOCK10;LDB2;NEXN;NRG2;CDK6;LMNA;CYRIB;MINK1;PLXNA4;ARHGAP18;CFAP20;ROBO4;FGF2;TRIM32;PLXNA1;CAMSAP3;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6689334767481987,1.2665128314168324,0.09615384615384616,0.49185823978410953,1.0,3/31,5.58%,ANXA1;DOC2B;SMCR8
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.6460248638048043,1.2663210975873018,0.18333333333333332,0.4919515084072168,1.0,2/18,2.35%,MAFF;ZFP36
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6956972179137422,1.266275874782085,0.1694915254237288,0.49169937556691395,1.0,3/13,8.42%,NLGN1;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4611250969286696,1.266071569302033,0.012345679012345678,0.49179262114836514,1.0,116/545,20.29%,LEF1;HPN;BOK;ANXA1;IGF1;KIF14;MLLT11;PLK2;THBS1;GRID2;PIM3;STEAP3;SLIT2;SEPTIN4;RPS6KA1;PIM1;MAP3K11;DAB2IP;FOXO1;NUAK2;PRAME;KLF11;ARHGEF17;SOX4;FAS;BCL6;ARHGEF3;TFPT;BIRC3;CD44;FOXO3;SNCA;CASP10;ALPK2;SCX;PAWR;CYP1B1;MYD88;OBSCN;DAPK2;NAA38;MCF2;CTNNB1;BAG3;THOC6;BCL2L1;DHCR24;KALRN;NEURL1;ARHGEF7;HIPK3;PNMA2;NDRG1;TP53I3;TRIO;PXT1;GAS6;ACTN1;PLEKHG2;BARD1;SRA1;GADD45A;BCL2;ALK;PDPN;TNFRSF10B;FADD;GRK5;KCNMA1;FMN2;BIN1;MRE11;BCAR1;LCMT1;RARG;MAP3K5;STK3;TP53;PINK1;NGEF;VAV2;FSTL1;TOX3;MCF2L;SHC1;IGF1R;SCRIB;WNT5A;TFRC;LRP2;RNF122;SEMA4D;FLNA;BCLAF1;BFAR;CAPN13;PLK3;RBM5;VAV1;DNM2;TEK;RTN4;VIP;EGLN3;CCND2;RHOB;DNAJA3;RTKN;ING5;DDX42;RPS27A;ACTN4;ARHGEF6;TFAP4;ANGPTL4;DDRGK1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6617974878567376,-1.265735894089626,0.1111111111111111,0.9240361585125567,1.0,4/16,8.67%,BUD23;RIOK2;METTL18;RIOK1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.7314379735486178,-1.2656679265259514,0.16666666666666666,0.9214788514177146,1.0,4/8,14.69%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7502703555017267,1.2655767781487592,0.1568627450980392,0.49290003075050604,1.0,5/12,10.80%,THBS1;SERPINE1;DMTN;FAP;TFPI
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.7031947992235823,1.2654275246252915,0.14545454545454545,0.4929429253946255,1.0,4/13,7.18%,DMTN;PTPRC;GRM5;RYR2
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.7574957246080837,-1.26492393212833,0.15625,0.9220869265038476,1.0,3/10,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6673629751304565,1.2646984961862549,0.2,0.49534528491529717,1.0,2/18,7.04%,ROBO2;APLNR
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.8374691192417736,1.2643568099775726,0.14754098360655737,0.4960344130608502,1.0,1/5,0.85%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7570647339210902,1.2643011315928825,0.12698412698412698,0.49584885479447566,1.0,1/10,3.34%,DAB2IP
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.8138337468823857,1.2642142871405255,0.14545454545454545,0.49575186667955695,1.0,3/7,2.95%,MYRF;CNTNAP1;PLP1
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.7066541492381849,-1.2640948670661176,0.16279069767441862,0.9229545505793665,1.0,3/7,15.19%,ALDH1A1;NAGK;GNPDA2
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.8340701067917823,1.2635927614385596,0.1694915254237288,0.4974972222333013,1.0,3/6,12.29%,IL15;SYK;PRKCD
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5954107652423326,1.2635864353461264,0.16216216216216217,0.4971053089084643,1.0,7/39,9.00%,YWHAH;MBP;PLP1;PADI2;MAOB;SYNGR3;BASP1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.6056903585996659,1.2633674085435305,0.13636363636363635,0.4973694809105557,1.0,11/34,18.66%,ABO;B3GALT2;ST8SIA3;ST8SIA1;ST8SIA4;FUT2;ST6GALNAC5;ST6GALNAC3;NEU4;B3GALT5;MAN2C1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.7876125368059764,1.2632484242872226,0.1935483870967742,0.4972813320463359,1.0,1/12,0.88%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.7522729793077505,1.2630002415010233,0.18181818181818182,0.4976816539827476,1.0,4/12,19.74%,RBM24;BOC;AKIRIN1;BTG1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.706025094029951,1.2629642248731983,0.1935483870967742,0.49742749936284747,1.0,4/11,18.09%,NECAB2;WDR54;ANKRD13A;MTMR2
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.7164131478718043,-1.262913524970177,0.1388888888888889,0.9258939633817893,1.0,4/8,21.42%,ADSS2;AMPD3;PNP;NT5C1A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5834716082743927,1.2628832259133447,0.18032786885245902,0.4972225155341363,1.0,12/35,20.67%,NLGN1;PLEK;FHOD1;RHOD;ARF6;FMNL3;RHOBTB2;FMNL1;RHOQ;FHOD3;RHOB;STRIP1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.7513743185277771,1.262705815613188,0.18181818181818182,0.4974270495904231,1.0,3/8,14.66%,IRF7;CLPB;IFIH1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6764192520084381,1.262630111901614,0.18333333333333332,0.4973002783171822,1.0,7/15,25.70%,SYNGR2;SYP;STX4;STX1B;SYNGR1;SNAP25;STX3
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.6857786133964382,1.2623713718936482,0.2222222222222222,0.49765030807017846,1.0,9/19,24.44%,APP;WDR54;ABCA2;ARF6;ANKRD13A;MTMR2;ITGAV;RIN3;PSEN1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.6020585776064051,1.2621954554076893,0.13846153846153847,0.49771792957946753,1.0,6/35,12.85%,KCNJ2;TRPM4;SAMHD1;HCN1;SHMT1;B2M
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.7460148831137399,-1.2620440999591813,0.21818181818181817,0.9268625985462404,1.0,2/7,12.75%,IGSF1;FSTL3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7706114122863076,1.262019751699183,0.15789473684210525,0.4978048609898943,1.0,3/8,12.17%,EPB41L4B;MAPRE2;ARF6
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.7229682992237092,1.2618667351971897,0.14285714285714285,0.49777522032011307,1.0,2/13,2.41%,PDGFRA;SULF1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6268148399329657,1.2618047307585056,0.09375,0.4975129597742252,1.0,13/39,20.13%,ANXA1;THBS1;HDAC9;FGF2;ETS1;MAP2K3;HDAC7;SRPX2;ADAM17;PRKCA;HIF1A;FGFR1;AKT3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7060342711492609,-1.2617191737201985,0.16666666666666666,0.9255711768229519,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6795819722075014,1.2616711821498867,0.18032786885245902,0.49743517356540284,1.0,5/20,13.70%,C3;NOS1AP;PDK4;ADIPOR2;MFSD12
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.8058812914103877,1.2615162170509544,0.16666666666666666,0.4975026945243715,1.0,1/7,8.75%,PKDCC
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.640905032457985,1.261458906032264,0.1875,0.49731866547967263,1.0,7/25,10.27%,ANXA1;STAT4;ERBIN;FYN;EIF2B2;RAMP3;STAT3
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.7311789354646603,-1.2607416306596873,0.25,0.927362268178277,1.0,2/11,6.61%,NPC2;ARV1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6670899333287661,1.2607047933966586,0.21052631578947367,0.49916413796245523,1.0,6/15,15.24%,TYMP;DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),0.8823923315106491,1.2604930037674327,0.125,0.49904509653969437,1.0,1/5,0.85%,ANXA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),0.8823923315106491,1.2604930037674327,0.125,0.49904509653969437,1.0,1/5,0.85%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.5352829078676835,1.2604828824816985,0.047619047619047616,0.498648347280503,1.0,14/90,8.51%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R;NLRC3
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.8246699250266698,-1.2604254815407232,0.11538461538461539,0.9256532575556381,1.0,1/5,1.81%,COX18
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.79795492882073,1.260377066728805,0.2459016393442623,0.49861823735094757,1.0,3/6,14.71%,ANXA1;STOML2;HLA-E
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.8797299997930005,1.2603324057485465,0.03333333333333333,0.49789467649113656,1.0,2/5,10.27%,STAT4;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.8797299997930005,1.2603324057485465,0.03333333333333333,0.49789467649113656,1.0,2/5,10.27%,STAT4;STAT3
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.7343082982030348,1.2603272493837465,0.17543859649122806,0.49749054120177694,1.0,3/13,2.69%,HPN;CTSS;LMO2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.6490182921166533,-1.260239433978785,0.15,0.9236967465494124,1.0,8/20,24.13%,TRMT10C;FASTKD2;MTG2;TSFM;MALSU1;ALKBH1;RPUSD4;COA3
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8719009047659781,1.2602328103058773,0.13793103448275862,0.49736546629514883,1.0,3/5,10.92%,SH3GL2;WASF1;MAPT
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.8110718553858115,1.2602115310628113,0.12698412698412698,0.49662710849043545,1.0,1/6,10.27%,STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.8110718553858115,1.2602115310628113,0.12698412698412698,0.49662710849043545,1.0,1/6,10.27%,STAT3
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.8128945326353868,1.2599098353691311,0.04,0.49711595515145024,1.0,3/10,6.95%,KCNJ2;KCNQ1;KCNH2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.7158344390323481,1.2598949929242833,0.1935483870967742,0.4967619285355346,1.0,3/13,5.78%,ANXA1;RIMS2;RAB11FIP5
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7762422055179559,-1.2597998074404286,0.17073170731707318,0.9233921998495589,1.0,2/5,17.95%,IDH3G;IDH1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5989101012274624,1.2597401687055885,0.1724137931034483,0.4969247891497317,1.0,17/40,18.06%,ANXA1;IL15;IRS2;PTPRC;NFATC2;CD276;BCL2;SLC7A1;CD70;IL12A;HLA-E;GPR183;PDCD1LG2;BST1;TFRC;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6422304157491954,1.2596497661383552,0.19047619047619047,0.49686765229416174,1.0,5/24,10.27%,ST18;SOCS3;PID1;YAP1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.580660862117584,1.2595136002688467,0.11666666666666667,0.4967628777308882,1.0,7/49,13.63%,MET;LZTS1;SMCR8;SNCA;STAT3;BCL2;WASHC1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.6895195214410498,-1.2592930899855819,0.24390243902439024,0.9229028224896016,1.0,4/14,5.85%,RAB7B;TNFAIP3;PTPN22;NR1D1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6994343743510579,1.2592279747527477,0.21052631578947367,0.49720195401816475,1.0,4/11,8.52%,IL1RAPL1;NLGN1;CNTN2;PTPRD
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6935256134085888,1.2591417937603357,0.203125,0.49703989540487997,1.0,4/14,8.03%,CHRM3;CHRM1;AGRN;GRK2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8271447231371456,1.259135489886813,0.09615384615384616,0.4966590700767227,1.0,4/7,10.19%,MYRF;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.7280938354975597,-1.2590955297384454,0.2,0.9210202208429087,1.0,3/8,12.64%,TRMT10C;TRMT61B;TRMT5
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.7041515513246335,1.2586664068126951,0.27450980392156865,0.49767760292365315,1.0,6/11,25.48%,DUSP1;LRCH1;SH2B3;CXCL12;OXSR1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8614722701325508,1.258551334989588,0.22807017543859648,0.4976771825699916,1.0,1/5,2.18%,MBP
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.730300272465935,1.258444789158898,0.19047619047619047,0.49763876287098213,1.0,2/13,2.98%,TRPC3;SLC39A14
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.8088683234533084,1.2582396563056042,0.24074074074074073,0.4979611154871306,1.0,1/6,0.82%,HTR2C
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8283569048744862,1.2576830008888302,0.13114754098360656,0.49918400567441534,1.0,2/7,10.25%,PDGFRA;SLC4A11
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.721221431097131,1.2572714540465364,0.234375,0.5000068958272808,1.0,2/10,7.32%,CARNS1;UGDH
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5473579728841731,1.2568122777887818,0.1746031746031746,0.5011220271109695,1.0,27/85,18.47%,RASGRP1;APP;MAP3K11;DAB2IP;DUSP10;DUSP22;UNC5CL;MAPK8IP1;SH3RF3;MINK1;TNFRSF19;GADD45A;TPD52L1;PER1;HIPK2;MAP3K5;PINK1;FZD7;MAPK8IP2;ANKRD6;GPS2;TRAF5;NCOR1;MFHAS1;IGF1R;MECOM;MAPK8IP3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5877336362590168,-1.2566792636207167,0.21875,0.9292640998289049,1.0,6/23,18.33%,SELENOS;TMED9;DERL2;AUP1;RANGRF;PREB
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6154441962636696,1.2563538505393832,0.17142857142857143,0.502102907115597,1.0,9/29,13.35%,IL1RAPL1;NLGN1;GRID2;ICAM1;IGSF21;TENM4;PTPRD;ITGAL;HMCN1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7276987726041434,1.256329554599915,0.18333333333333332,0.5017491388441498,1.0,5/13,10.41%,PDGFRA;PLEK;TEC;PDGFA;SYK
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6486346265855929,1.2563081691821403,0.15555555555555556,0.5013959352467193,1.0,5/15,17.46%,EFNA1;EPHA4;ABCA2;SLC2A13;ABCG1
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.8428712015016533,1.2560905898584211,0.10416666666666667,0.5015719013122459,1.0,1/5,6.35%,NRG1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.46321386408454207,1.25602377248006,0.011627906976744186,0.5013891756090593,1.0,79/523,13.18%,LEF1;TGFBR2;CDKN2A;NR4A3;SIX3;ST18;BOK;GPNMB;IL13RA1;IGF1;KIF14;PROX1;PDGFRA;IL15;EGF;TESC;CHRM1;THBS1;STAT4;FLT1;IRS2;APP;DAB2IP;PRAME;TGFA;PODN;FABP3;KLF11;TRPM4;OSMR;SOX4;NUAK1;BTG3;BCL6;CLMN;NTRK3;IGFBP7;KLF10;NRG1;BAP1;CCKBR;SCX;PML;CYP1B1;PDGFA;CDK6;DUSP22;CTNNB1;CAPN1;ZBTB7C;KITLG;YAP1;LMNA;GAB2;NEURL1;CTBP2;HDAC4;NAMPT;TGFB2;DLG5;STAT3;P3H2;S1PR3;STX4;CDC7;MLXIPL;CDKN1B;BCL2;MEIS3;DLG3;ATP8A2;FN1;TFAP2C;KLF4;ALK;PAK1;PDPN;TRAPPC14;CDKN1A
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.788020903036025,1.2559636988925373,0.24528301886792453,0.50115961903019,1.0,4/9,12.79%,NPTX2;DLGAP3;NPTX1;DLGAP1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7491530175628318,-1.2558143139352573,0.14634146341463414,0.9305183580477702,1.0,3/9,10.84%,PGP;COQ3;GK
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7139377838665517,1.2556715351181031,0.16363636363636364,0.5016272761154899,1.0,1/15,0.71%,BOK
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.7233119187488241,1.2555870660782615,0.14285714285714285,0.5014073046072915,1.0,2/12,8.12%,MET;CTNNB1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.8694036305724332,1.2554214015724652,0.09259259259259259,0.5014321322298221,1.0,1/5,6.91%,SNCA
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.8625895691095368,1.2549808070884445,0.12727272727272726,0.5025372821252256,1.0,3/6,5.57%,SLIT2;SLIT3;PADI2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5823756025755117,1.2548319029688357,0.15,0.5025705612731247,1.0,9/37,13.58%,PIEZO2;MAP3K14;FAS;TNFRSF1A;MYD88;SLC9A1;GADD45A;TNFRSF10B;FADD
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.530653516258654,1.2547899637789366,0.12307692307692308,0.5023880577727602,1.0,26/101,12.00%,COL4A1;IGF1;PDGFRA;DCN;CALD1;ABCA8;COL4A2;ANGPTL2;COL21A1;POSTN;COL12A1;PTPN21;MLANA;MAOB;C1R;MATN2;ASS1;ADGRF5;BGN;YAP1;RASL12;SLCO2A1;LAMA2;GAS6;PRICKLE2;PARD3B
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.671072280442053,1.2543240597123588,0.16981132075471697,0.5035366864140344,1.0,6/18,17.67%,ACSL5;CTNNB1;FBP1;IL4R;CDH17;RAP1A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5650314685874367,1.2542452214435982,0.14035087719298245,0.5033256131851108,1.0,18/62,23.80%,DAB2IP;EPHA5;RAP1GAP;SIPA1L1;EPHA4;FGD5;PLXNA4;PLXNA1;PLXNA2;NGEF;TBC1D10B;VAV2;CAMK2A;VAV1;ARHGAP9;EPHA3;OCRL;TDG
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6877665296038447,1.2542430808079872,0.1896551724137931,0.5029277273248856,1.0,4/17,12.41%,WNT8B;DVL1;CTNNB1;FRAT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.718284807046347,-1.2541006859160044,0.275,0.9361216771453891,1.0,5/8,26.66%,MTRES1;MTG2;TSFM;ALKBH1;METTL4
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.8403743175266596,1.2539807953108473,0.1276595744680851,0.5034187130015721,1.0,2/6,10.06%,DENND3;DENND4A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7654441478836438,1.2539296807296287,0.14,0.5031428348392076,1.0,7/11,17.95%,PRODH;STK25;CYP1B1;PRKCD;PDK1;MAP3K5;STK24
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7854782873187948,-1.2539236092916808,0.2926829268292683,0.9340833611144541,1.0,1/5,4.36%,APOE
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.7632089620233162,1.2537322427546944,0.23333333333333334,0.5034181673434331,1.0,2/14,6.91%,NOS1AP;SNCA
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.6652034797090006,-1.2536305496195412,0.17073170731707318,0.9327908585671152,1.0,4/13,18.19%,UQCRFS1;ETFB;ETFDH;ETFRF1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.5921600366631733,1.2535091846347919,0.18840579710144928,0.5038143275988621,1.0,16/54,11.23%,CXCL2;C3;TYMP;SFTPD;SIGLEC1;IL1R1;SOAT1;NRN1;STEAP4;GRK2;CAPN8;ADGRF5;RNASE1;DUOXA1;CLDN18;FBP1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.704339902965618,-1.2534145876884584,0.28888888888888886,0.9305015723481174,1.0,2/9,17.60%,PDZD11;SLC5A6
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7959061259365365,1.2532413233606763,0.23214285714285715,0.5044708373460752,1.0,2/7,12.01%,ICAM1;ITGAL
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.652370334584503,1.2531758742606063,0.16393442622950818,0.5043719493545266,1.0,4/17,16.11%,BLM;BARD1;MRE11;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.8119807485894367,1.252990135076471,0.13953488372093023,0.5046454497482709,1.0,3/6,18.09%,SNCA;NDFIP2;CTTNBP2NL
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.8274363448030048,1.2528374012772707,0.18518518518518517,0.5047511472250183,1.0,1/5,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.8412174301208755,-1.2525261613524614,0.15217391304347827,0.9318463427930899,1.0,1/5,3.91%,SRI
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.8246199423960299,1.2521285839292615,0.15789473684210525,0.5067427951525921,1.0,2/6,17.14%,HOOK1;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.8117886362682932,-1.2519455381909006,0.23404255319148937,0.9310266864613671,1.0,1/5,3.74%,ORMDL1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.6110183164635282,1.2519118958383542,0.2153846153846154,0.507041644308516,1.0,3/28,9.35%,KLF2;GLRA2;NEURL1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6214810824508009,-1.2516275006962319,0.13793103448275862,0.9297595749166283,1.0,4/24,5.88%,PYGM;PPP1R3C;NR1D1;AGL
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.548581020058851,1.2515418627843695,0.14705882352941177,0.5078409641849225,1.0,15/53,15.77%,PTK6;PSCA;TJP3;SYNGR2;CAPN1;ANO9;SH2D3A;DTX2;PRKCD;ANXA11;IL4R;RHBDF2;RPS6KB2;PRRG4;ABHD11
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6484702526370252,1.2515143339380912,0.2153846153846154,0.5074803589075741,1.0,10/33,12.18%,NLGN1;SNCB;SYT1;SYT5;DNM1;SYNJ2;SNCA;PACSIN1;OPHN1;MX1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.8401906138560871,-1.2515135276868616,0.06666666666666667,0.9273498986912867,1.0,1/6,6.62%,BCAP31
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8730276735340005,1.2511736180095405,0.13043478260869565,0.5081298904785068,1.0,2/5,7.04%,CNTNAP2;APLNR
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.6671255718178817,1.2509411901621388,0.09836065573770492,0.508361936244502,1.0,9/21,22.21%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP;FOXK1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6539195119627318,1.2505033076162122,0.16129032258064516,0.5087972195849589,1.0,4/21,10.01%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6539195119627318,1.2505033076162122,0.16129032258064516,0.5087972195849589,1.0,4/21,10.01%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.7300191887376264,1.250499644271364,0.24074074074074073,0.5084095751127808,1.0,3/11,4.94%,THBS1;XKR4;XKR6
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5298960682800552,1.2503391694679544,0.09375,0.5084930628368881,1.0,26/118,18.30%,RASGRP2;KIF14;CD22;RIT2;LTBP4;DAB2IP;FAM107A;BAP1;PAK4;GFAP;PACSIN1;SLITRK4;OPHN1;ANGPTL7;TMC8;NCLN;CAMSAP3;BCAR1;PINK1;WNT5A;RAP1A;TFRC;STK11;ERMN;SEMA4D;TSC2
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.5782281853297809,-1.249258670402124,0.11764705882352941,0.9344669783186897,1.0,9/49,11.55%,HEY2;NRARP;HEYL;ASCL1;POFUT1;MAML3;HEY1;NCSTN;HES5
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.7075432362675765,1.2487960321328637,0.171875,0.5129000622098168,1.0,3/17,9.24%,ANXA1;DMTN;PRKCE
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.8212403059216907,1.2486725653655562,0.2037037037037037,0.5128970203472937,1.0,2/8,9.80%,AK3;AK5
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6824572222849047,1.2484881585932077,0.14925373134328357,0.5130504599700131,1.0,7/22,21.17%,PRKCB;PID1;PIP4K2A;PRKCD;TSC2;PTPRE;GRB10
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.7148806192178105,1.2483375738816551,0.2153846153846154,0.5130932927906514,1.0,2/9,1.68%,KLF2;THBS1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.5902477547407017,1.2483327018811978,0.14285714285714285,0.5126949284328948,1.0,19/61,16.31%,C1QL1;ARHGAP39;EFNB3;CDK5R2;VGF;C2CD4C;SRRM3;B4GALNT1;GLI2;TEAD1;ENAH;MEIS3;IGDCC4;FAM131C;RBFOX2;BCAR1;SEZ6L2;FZD7;PFN2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5022961113029779,-1.248266643515122,0.08571428571428572,0.935801478066074,1.0,20/97,14.87%,ERCC8;RFC3;COPS8;HUS1;GTF2H5;POLR2K;POLD3;GTF2H2;CETN2;BRIP1;GTF2H2C;COPS7A;ERCC2;POLR2C;RAD23A;HMGN1;ERCC6;PNKP;POLR2D;PPIE
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.49981312480185397,1.2477440016609114,0.0547945205479452,0.5141521668616149,1.0,24/182,10.05%,LEF1;TGFBR2;IGF1;NPNT;VWC2;ZFP36;NELL1;RPS6KA1;RBM24;PCP4;TRPM4;ZBTB16;NEUROD2;BOC;CTNNB1;KITLG;PKDCC;SMAD3;YAP1;PRKCH;PPARG;MMD;TGFB2;RIN2
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.7712996782776333,1.2477206894986397,0.21568627450980393,0.513854535002637,1.0,2/10,3.61%,PTK6;NLRP12
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.6119236847961826,-1.2473192094304442,0.1794871794871795,0.9369713918985713,1.0,6/21,13.90%,ISCU;CIAO3;ISCA2;CIAO2B;NFS1;NFU1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6732865676567172,1.247199490839353,0.1864406779661017,0.5151069026172694,1.0,3/17,7.56%,PAPSS2;TPST1;SULT4A1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7388674158707212,1.2471299751663667,0.24074074074074073,0.5149647426114331,1.0,4/10,14.96%,ZFP36;WTIP;STAT3;PUM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5380341656606568,1.2471279036476308,0.1323529411764706,0.5145756260326562,1.0,11/76,13.76%,HLA-DRA;CTSS;SH3GL2;MARCHF1;AP1S1;KIF5A;ACTR1A;HLA-DRB1;KLC2;KLC1;HLA-DMA
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7331581607313935,1.2469654842917386,0.23076923076923078,0.5147908530750833,1.0,2/13,3.34%,SHTN1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.8353725564812267,1.2468583085237992,0.23636363636363636,0.5146127042696707,1.0,2/5,10.41%,MMP14;SYK
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.8304613235021259,1.246757049324794,0.19047619047619047,0.5146357672197914,1.0,3/7,5.44%,GAP43;RTN4RL1;APOD
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7192120234325876,1.2464680916421205,0.22033898305084745,0.5151333700305458,1.0,3/12,10.65%,HRH1;NFATC2;INPP5A
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.552789909846548,1.2462846940508105,0.15384615384615385,0.5154386983136202,1.0,4/40,2.82%,CCBE1;THBS1;NR4A1;SLIT2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.8155278959473762,1.2460521906453919,0.16363636363636364,0.5157162193023723,1.0,1/6,6.40%,BAP1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.42827870670847046,-1.2460222064526294,0.041666666666666664,0.9410085569261282,1.0,66/271,15.31%,MRPL10;RPL35A;RPS24;RFC3;RPL34;RPL39;MRPS21;ATRIP;RPL13;RPL37;HUS1;GAL3ST2;MRPL52;POLR2K;RPS28;APOE;MRPS7;RPL18;MCM9;POLD3;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;ALAS1;RPS26;RPL6;BRIP1;RPL41;MCM6;RPS13;RPL22;RPL29;RPL30;ASMT;RPSA;KIN;EEFSEC;RPL14;RRAGC;RPL15;EEF1A1;RPS2;ATR;POLR2C;GAL3ST4;IGF2BP3;EEF1B2;RPL11;RPL23A;MCM4;MRPS18B;RPS21;MRPS33;RAD9B;RPS23;NFKBIB;RMI2;POLR2D;YARS2;MLF1;MRPS12;THAP1;CLSPN
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.6552897682001647,1.2459869322620212,0.24074074074074073,0.5154743061385217,1.0,1/13,0.99%,TYMP
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7005383443312347,1.2459190422931372,0.2028985507246377,0.5149097719941603,1.0,4/14,12.99%,ZYX;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7005383443312347,1.2459190422931372,0.2028985507246377,0.5149097719941603,1.0,4/14,12.99%,ZYX;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.754795417518904,1.2458363040984937,0.20754716981132076,0.5147235412741441,1.0,4/10,10.90%,CNTNAP1;TENM4;TPPP;ABCA2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.7973519339974947,1.2456604348932958,0.19607843137254902,0.5147736101124187,1.0,4/6,18.06%,TNFRSF14;MAPK8IP1;SYK;TNFSF4
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7666848149435528,-1.2456587585450227,0.2653061224489796,0.9397786644085766,1.0,2/7,7.09%,SMYD5;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.707276191975826,1.2454935080427134,0.21666666666666667,0.5148870957369711,1.0,4/10,18.06%,SYK;HLA-E;RARA;TNFSF4
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6864228979370067,1.2454370363700429,0.1935483870967742,0.5147013101688823,1.0,5/14,16.87%,CD55;STAT3;HLA-DRB1;CD70;BACH2
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.7490334230146687,1.2453575388583429,0.2692307692307692,0.5146335449928531,1.0,4/8,18.30%,DAPK2;IKBKG;STK11;TSC2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.7955615081776923,-1.2451787794699172,0.21818181818181817,0.9367449317012942,1.0,2/6,13.38%,ASIP;CDH3
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.7955615081776923,-1.2451787794699172,0.21818181818181817,0.9367449317012942,1.0,2/6,13.38%,ASIP;CDH3
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.7716213589585735,1.2451679977847103,0.22807017543859648,0.5146835295199107,1.0,1/7,6.47%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5487384472334568,1.2448305269216589,0.1076923076923077,0.5153935610197689,1.0,21/75,17.13%,RASGRP1;APP;MAP3K11;DAB2IP;RELL1;STK25;DUSP22;UNC5CL;MAPK8IP1;SH3RF3;MINK1;TGFB2;TNFRSF19;GADD45A;TPD52L1;HIPK2;MAP3K5;FZD7;ANKRD6;TRAF5;MFHAS1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6375499663319845,1.2448264271558438,0.1694915254237288,0.5150182025857885,1.0,1/20,1.17%,PDGFRA
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7354509126692728,-1.2445773843345407,0.2,0.9365075492932764,1.0,2/7,13.49%,VAMP8;ATG14
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6727085332884045,1.24450542432551,0.23809523809523808,0.5155734027794969,1.0,4/17,10.27%,ST18;SOCS3;YAP1;STAT3
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.7643162803829626,1.2443884107060332,0.20689655172413793,0.5155683859091374,1.0,2/9,6.20%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.8078957732682546,1.2438681433759704,0.1896551724137931,0.5169697536611451,1.0,2/6,7.88%,MGAT3;LDLR
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5817680442327959,1.2438331196032357,0.1791044776119403,0.5166934304706006,1.0,4/35,9.10%,ZFP36;ZC3H12D;RBM24;YTHDF1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.798049677431856,-1.2437279603051277,0.18604651162790697,0.9375226427822814,1.0,2/5,14.46%,TMEM126A;ERBB3
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6554918210029482,1.2436919342144956,0.20967741935483872,0.516741582467493,1.0,3/19,11.65%,CD24;SCX;GFI1B
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.7118084449200601,1.2436673223938906,0.21311475409836064,0.5163938951185538,1.0,5/22,15.46%,ZFP36;WTIP;STAT3;PUM1;TP53
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.7175379546869186,-1.2436479139031904,0.3333333333333333,0.9351617238536196,1.0,3/8,12.80%,GINS3;MCM6;MCM4
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.7223305404124118,-1.2434225261723784,0.18604651162790697,0.9334693883784644,1.0,1/8,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5834698186254785,1.2432542628884118,0.1791044776119403,0.5173499748776977,1.0,14/39,19.68%,ATP2B3;ITPR3;ABCC9;RYR2;ATP1A1;TMEM65;ATP1B1;ATP1B3;FXYD7;ATP2B4;SLC8A2;SLC8A1;ITPR1;AHCYL1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.7094713335385396,1.2430681264868795,0.17543859649122806,0.5175322346844485,1.0,4/12,15.01%,IRF7;CDK6;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.7004837462520772,-1.2430297003173487,0.2553191489361702,0.9327442257064175,1.0,2/12,10.22%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.572494454411269,1.2427849413381138,0.1388888888888889,0.5178847284557093,1.0,6/36,11.92%,SLC39A14;CHST15;ALDOB;PGK1;FBP1;ENO2
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7446505062599669,1.2423632628485826,0.21666666666666667,0.5182655319045698,1.0,5/10,16.77%,SLC24A2;SLC24A1;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7446505062599669,1.2423632628485826,0.21666666666666667,0.5182655319045698,1.0,5/10,16.77%,SLC24A2;SLC24A1;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.8477861371893971,1.242271412588718,0.22580645161290322,0.5181421163642351,1.0,2/7,4.85%,SULF1;MCAM
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.775319053806625,-1.2416175814766337,0.18,0.936773152986283,1.0,2/9,7.46%,FBXO5;FBXO43
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.59136806871672,1.2416024976315596,0.16901408450704225,0.520040930789282,1.0,10/38,12.29%,NLGN1;PLPPR5;DMTN;GAP43;AGRN;PPP1R16B;NEURL1;FSCN1;ARF6;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.6049728224326609,1.2415647628568316,0.15,0.5197911960228581,1.0,10/47,12.17%,EPHA2;STAC2;RAMP3;ITGA3;PTPN9;PRKCE;PRKCH;SORBS1;STX4;ARF6
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7751752898552549,1.2411974134661752,0.24,0.5204619979459169,1.0,4/6,16.70%,HS6ST1;HS3ST3B1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8068403630118435,1.2406629321061098,0.1509433962264151,0.5219352048153564,1.0,2/7,5.54%,BOK;FAP
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6540814000090485,-1.2403602455067089,0.25,0.9400430743150666,1.0,5/12,19.42%,MOCS2;NFS1;LIAS;NOXRED1;MOCOS
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6114788953193254,1.239993296564834,0.14516129032258066,0.5236113542093428,1.0,13/37,16.80%,SLIT2;PTPRC;SLIT3;CCDC3;PADI2;SAMHD1;NLRC5;PPARG;GAS6;TTLL12;TRAIP;RFFL;GPS2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.7747771376548938,-1.2399817914270914,0.2564102564102564,0.9394343417682661,1.0,3/7,14.36%,CCDC22;PSMD10;NFKBIB
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.7563636387832375,1.239910863994079,0.22033898305084745,0.5234933842090609,1.0,2/6,19.36%,BRCA1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6202683616455912,1.2398701711660354,0.1724137931034483,0.523179644308433,1.0,7/25,10.44%,SHISA7;RELN;APP;SHANK3;FAM107A;YTHDF1;EPHA4
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.7407611392078739,1.239781564401241,0.2692307692307692,0.5229820762582464,1.0,3/9,17.13%,PLSCR1;CD200;MFHAS1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7788841978947717,1.239473543819233,0.21666666666666667,0.523638563607281,1.0,1/8,0.15%,NR4A3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.7100325640940489,1.239410151959448,0.22413793103448276,0.5234320610304793,1.0,4/13,18.50%,APP;BAG3;CAMSAP3;APBA1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.6358378709048446,1.239319753985049,0.21311475409836064,0.5233057880571499,1.0,5/25,7.49%,HLA-DRA;C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.8258962756979807,1.2389301980736411,0.2222222222222222,0.5242090092901655,1.0,3/5,11.20%,RELN;LHX6;FGF13
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.7691802915157724,1.2386542292306886,0.21428571428571427,0.5246852771579394,1.0,2/10,9.47%,GGCT;GSS
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.7691184849445214,-1.2385383466058335,0.24489795918367346,0.9428922583152338,1.0,1/7,10.58%,KMT2A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.7659542687494929,1.2382576842801252,0.19642857142857142,0.5254709332615745,1.0,4/9,10.44%,NELL1;DAB2IP;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.5626541555045106,1.2379003227208023,0.19696969696969696,0.5260783459566365,1.0,12/52,12.85%,KCNJ2;GRIN2B;TRPM4;SAMHD1;SNCA;GRIN1;KCNC1;HCN1;SHMT1;HOMER1;HLA-DRB1;B2M
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7412937716131063,1.237523852072353,0.2641509433962264,0.526914867274405,1.0,1/5,6.43%,BIRC3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6331603494600062,1.2374651979472375,0.109375,0.5267246777871297,1.0,3/27,2.65%,ANXA1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.6818537287931656,-1.237373111043464,0.22,0.9455797311895849,1.0,1/9,1.61%,SELENOS
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.613419566725582,1.237298153107066,0.19047619047619047,0.5267997797674343,1.0,6/31,15.53%,IGF1;MLLT11;BCL2L1;BBC3;TP53;PINK1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5939373289373916,1.2369376330530704,0.22807017543859648,0.5273955627059423,1.0,5/25,10.69%,PTPRO;DMTN;RHOD;ARHGEF7;P2RY12
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6701177132580454,1.2368963753971416,0.1896551724137931,0.52714369723451,1.0,6/24,16.14%,KLF2;NOS1AP;ASS1;SMAD3;KLF4;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6675139101159653,1.236474515083693,0.23214285714285715,0.5281085187279483,1.0,3/15,14.58%,THBS1;P2RY12;AKIRIN1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8116268325511019,1.236157200625283,0.2641509433962264,0.5286403469554851,1.0,1/5,9.35%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4840839845648227,1.2357999468297647,0.11594202898550725,0.5294706097972512,1.0,39/210,15.37%,C3;TLR2;ANXA1;RFTN1;CCBE1;IL15;SERPINE1;RASGRP1;MBP;SULF1;APP;IRF7;NOD1;IL1R1;PTPRC;TNFRSF14;TMED10;CYP1B1;MYD88;CTNNB1;CHI3L1;CYRIB;STAT3;SYK;LURAP1;CD276;CGAS;FADD;STOML2;IL12A;MRE11;PIK3CD;MAPK11;IFIH1;HLA-E;RARA;CD4;SCAMP5;STAT6
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.5649891103930096,1.2353884143923315,0.11320754716981132,0.5303611984325429,1.0,16/67,16.20%,GPNMB;KIF14;GRIN2B;SNCB;GRID2;FYN;SNCA;DCC;DHCR24;INPP5A;MAPT;ZNF746;IKBKG;MAP3K5;CTSZ;CD200
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.8158820530369122,-1.2353255866764214,0.1951219512195122,0.9488193938990981,1.0,2/5,7.89%,AR;NCOA4
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.8158820530369122,-1.2353255866764214,0.1951219512195122,0.9488193938990981,1.0,2/5,7.89%,AR;NCOA4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7216501544321272,1.235264204993858,0.18032786885245902,0.5303013951951053,1.0,3/11,10.24%,ANK3;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6576761991760154,1.235248858374222,0.1791044776119403,0.5299870269911584,1.0,7/23,21.17%,PRKCB;PID1;PIP4K2A;PRKCD;TSC2;PTPRE;GRB10
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.8144916892452696,1.2351450232638397,0.16666666666666666,0.5298924911761858,1.0,2/7,10.92%,TPPP;MAPT
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.6521239163764392,-1.2350919494523653,0.1951219512195122,0.9474290981642538,1.0,3/17,9.85%,HSD17B8;SLC25A1;GCDH
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7020975980475138,1.2347992107078167,0.21875,0.5306135336227945,1.0,8/13,17.57%,CD55;ICAM1;CFH;TGFB2;NOXA1;CD59;FZD7;WNT5A
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.7861879541560006,1.2345723847994858,0.2631578947368421,0.530869140528109,1.0,3/6,19.47%,GNG2;TNFSF4;TGFBR3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.704270758845687,1.2344863557417927,0.1568627450980392,0.5307741620311157,1.0,2/12,10.78%,TYMP;PUDP
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.5677481566523697,1.2341874715242593,0.18181818181818182,0.5312217440253743,1.0,9/41,13.78%,S100A10;PLEK;FHOD1;LIMCH1;SYNPO2L;ARHGEF10L;PXN;PAK1;LPAR1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6440872271056056,1.2341198168372807,0.2222222222222222,0.5310741919065052,1.0,5/29,11.94%,NR4A3;MYH9;PLEKHM1;SYTL4;KLC2
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.47211992532131375,1.2339462096229603,0.0547945205479452,0.5313112326875316,1.0,29/185,14.91%,ANLN;ARHGAP4;RAPGEF5;CCNB2;LMNB1;MAP3K11;MYH9;INCENP;WASF1;NEDD9;ARHGEF3;SEPTIN9;CDC42EP1;CLIP2;SSH2;ARHGEF7;FSCN1;TRIO;PLEKHG2;PXN;OPHN1;DOCK4;ARF6;STAU1;KLC1;ATG4B;PALLD;BIN1;BCAR1
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.5027891439737412,1.2336135338361391,0.078125,0.5319407448548493,1.0,32/147,15.04%,SOCS3;IL15;STAT4;ICAM1;PIM1;IRF7;NOD1;MARCHF1;PLSCR1;FAS;MTHFD2;CIITA;CFH;SAMHD1;PML;C1R;NLRC5;MYD88;MVP;NAMPT;STAT3;ST8SIA4;CCL2;HLA-DRB1;MX1;B2M;IL4R;CDKN1A;TNFAIP6;HLA-DMA;IFIH1;SERPING1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6116611090784284,-1.2335877560689001,0.2,0.9513436163383022,1.0,6/22,13.90%,ISCU;CIAO3;ISCA2;CIAO2B;NFS1;NFU1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.627333699314603,1.2335298770327334,0.22033898305084745,0.5318191578607301,1.0,4/29,9.86%,KREMEN2;NOTUM;ZBTB16;TGFB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6182287815056157,-1.233472147629697,0.1388888888888889,0.9491723954908395,1.0,3/15,14.30%,SELENOS;DERL2;AUP1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.6754729338390906,1.2334282674282748,0.14285714285714285,0.5317500489310472,1.0,2/15,3.76%,CD55;IL1R1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.7957317839866651,1.233272147841574,0.23728813559322035,0.5318900837599553,1.0,2/5,13.41%,SLC4A11;SLC12A5
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.6124224070089613,-1.2325906268086453,0.1282051282051282,0.9504473041703643,1.0,9/20,26.48%,PPP1R35;ZCCHC9;PTPA;PPP6R1;BMP2;PPP1R26;SH3RF2;GPATCH2;PPP1R2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.8265651810516947,1.2325177272029257,0.2807017543859649,0.5340404629820434,1.0,3/6,14.76%,ANXA1;ABCC4;PNPLA8
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.5220827047639687,1.2324200248075157,0.10606060606060606,0.5339524797020021,1.0,24/134,14.66%,VRK2;PDGFRA;PTK6;PIM3;FLT1;TEC;PIM1;MAP3K11;STK25;AATK;DAPK2;SIK2;MINK1;MAK;EPHA4;CDKL5;MAP3K21;CAMK2B;MAPKAPK5;ALK;PAK1;GRK5;BMX;NEK6
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.8234450022326933,1.2323674218764336,0.22033898305084745,0.5337168803134906,1.0,5/7,17.39%,RTN4RL1;THY1;EPHA4;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.7933447437101437,1.2320903535936558,0.22916666666666666,0.5340374361699918,1.0,2/7,8.26%,SYT4;KIF5A
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.6513162765362671,-1.2320790013993135,0.24324324324324326,0.9505176225858526,1.0,6/13,26.48%,SNF8;TMEM50B;TMEM50A;VPS25;VPS28;VTA1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.7684884247011023,1.2320619674777957,0.22413793103448276,0.5337934417932518,1.0,2/6,13.58%,SKAP1;FADD
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7985188221611503,-1.2319802078945719,0.24074074074074073,0.9483673721849467,1.0,1/6,2.37%,DNMT3B
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.7257835995795616,-1.2317997861599317,0.25,0.9467097358089254,1.0,4/7,9.60%,APOBEC3G;CDADC1;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7741128593636092,1.2317616598416972,0.2545454545454545,0.5343736258654228,1.0,1/6,3.46%,UHRF2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.7446883930342858,-1.23134337626623,0.23404255319148937,0.9459986862980554,1.0,1/6,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5527308134427321,1.2313319885516152,0.16666666666666666,0.5353255748722379,1.0,8/78,7.16%,IGF1;TYMS;IGF2BP2;SAMD4A;RTN1;RTN2;ENC1;EIF4A3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4621927259501073,1.2312656509340092,0.04878048780487805,0.5351850829969321,1.0,59/429,13.21%,LEF1;CDKN2A;SIX3;PROX1;MAEL;ZNF93;TYMS;IGF2BP2;DAB2IP;FOXO1;PRAME;SAMD4A;SUV39H1;CIC;ZNF282;TSPYL2;TCEAL7;NFIL3;BCL6;NKX6-2;AHR;GZF1;KLF10;CIITA;NRG1;ZBTB16;BAP1;ENC1;TBX20;MSX2;GLIS2;EIF4A3;PML;HMBOX1;ZFPM2;CTNNB1;GMNC;BASP1;PPARG;CTBP2;CHMP1A;HDAC4;PEX14;SHMT1;CDKN1C;GAS6;DBI;HDAC9;L3MBTL3;RUNX1T1;PRICKLE1;MLXIPL;CDKN1B;PER1;KLF4;JARID2;CDKN1A;SOX13;DEAF1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6134480573981436,1.2311211097643429,0.16666666666666666,0.5351659354719839,1.0,3/35,2.45%,IGF1;NPNT;NELL1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7307009294648696,1.2310630110913265,0.26666666666666666,0.5349306543741588,1.0,1/9,5.92%,AIPL1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5247416089493,-1.2310304619485846,0.1282051282051282,0.9449178599529341,1.0,13/48,18.79%,ABCD2;MCAT;ACOXL;ABCD1;GCDH;ETFB;ETFDH;CPT2;ECHS1;MTLN;EHHADH;ACADS;DECR1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6178286456743854,1.231000761351847,0.2857142857142857,0.534756197806235,1.0,4/24,6.91%,KCNJ2;PRKCB;PIM1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7045145446412131,1.2306861730068686,0.23076923076923078,0.5354626482776366,1.0,1/14,0.82%,HTR2C
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6880749116623722,-1.2306285495763183,0.2916666666666667,0.944133056245854,1.0,4/8,6.16%,CD247;CD96;PYHIN1;P2RY10
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7566262946090616,1.2304697800657174,0.26229508196721313,0.5358143391591657,1.0,1/11,0.62%,SCN9A
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5295517493548301,1.2303426219653142,0.12121212121212122,0.5358465306866421,1.0,11/85,8.06%,SLC32A1;SLC24A2;SLC15A3;PIEZO2;SLC9A9;LASP1;GRIN1;SLC20A2;SLC17A5;SLC26A8;SLC9A1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8867966112627036,1.2303376466894567,0.15789473684210525,0.5354910004787268,1.0,2/5,3.81%,THBS1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.6584709170488949,1.2302042467389684,0.21818181818181817,0.5355750327284882,1.0,2/15,9.88%,EGF;GLI2
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.8373685423151993,1.2294398744989674,0.16666666666666666,0.5376031022955603,1.0,2/6,9.58%,RBM24;MMP14
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.8476906565226159,1.2293003495932326,0.22033898305084745,0.537694074879335,1.0,1/5,2.74%,PRKCB
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.7457409352364889,1.2290281658451578,0.22807017543859648,0.5381285150283798,1.0,3/10,2.65%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.49105728269725446,1.2286840625965614,0.075,0.5386138276627169,1.0,28/222,13.02%,LEF1;TGFBR2;IL15;EGF;SERPINE1;NLGN1;ACHE;TRPM4;PPARGC1B;OXTR;PLAAT4;ZBTB16;PLAC8;GHR;HADH;SCX;CTNNB1;SMAD3;PRKCH;TGFB2;SYK;TLE6;GAS6;B4GALT5;LURAP1;ADIPOR2;PDPN;IL4R
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4932455255086345,1.2283566028283177,0.13636363636363635,0.5390898594046474,1.0,14/96,10.71%,TEAD2;DMTN;WAS;ADD2;WASF1;FAS;PARD3;REPS2;PML;SHANK1;YAP1;TCAP;PEX14;TEAD1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5849274506898111,-1.2279040161124952,0.15789473684210525,0.9532440105885313,1.0,2/33,1.73%,PTCD2;RBM23
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.6267701509601071,-1.2278873457400066,0.21951219512195122,0.9506487267395076,1.0,2/20,2.54%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.7958808837495285,-1.2278738801509324,0.22727272727272727,0.9480269137239015,1.0,1/7,0.79%,ID2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6208686632005483,1.2278624777088953,0.24528301886792453,0.5403023360953481,1.0,2/27,1.98%,MET;PSRC1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.735919006489646,1.2276182042867725,0.3064516129032258,0.540759326893413,1.0,7/10,23.95%,FYN;ITGA3;PICK1;IGF1R;MTMR2;SUPV3L1;PRNP
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7638516584910476,1.2275672884078048,0.30612244897959184,0.5404710295312579,1.0,3/5,17.98%,PXN;MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.5081858911258195,1.2272787771041649,0.140625,0.5410640820525974,1.0,14/95,13.02%,GGT5;ACSL5;LIPH;FA2H;ALOX12;FAAH;ACOT4;PPARG;ACOT7;SLC27A3;ACSM5;ADIPOR2;SLC27A5;LTC4S
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.8497305076870599,1.2272062298741158,0.16666666666666666,0.5409127261630841,1.0,4/5,14.12%,NLRP12;CIITA;NLRC5;HSPH1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7501550937143446,-1.2272032609092292,0.3333333333333333,0.9482046098632088,1.0,1/5,5.04%,OAT
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7616270888579983,1.227004217885699,0.15789473684210525,0.5411629878822705,1.0,5/10,13.97%,NEFL;SYBU;TRAK1;MAPT;HAP1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.4837860315768148,-1.2269742870069822,0.1388888888888889,0.9466456255027361,1.0,17/50,14.88%,HSPG2;APOE;RETSAT;ALDH1A1;AKR1C3;ADH6;SDC3;SCPEP1;APOM;ADH4;CYP4V2;GPC6;LRAT;RDH10;RDH11;NAPEPLD;CYP2C8
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.6351120967514994,-1.2268157936289197,0.175,0.9445658598270861,1.0,12/23,26.23%,SUPT16H;HMGN1;ERCC6;CCNT1;LDB1;HTATSF1;TSFM;WDR43;THOC1;EAF1;CCAR2;CCNK
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.5920411381057873,1.2267697251720224,0.15625,0.5413872859805509,1.0,3/45,1.68%,NR4A3;TESC;THBS1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.680164202510305,1.2266386833898097,0.2222222222222222,0.5414321707304854,1.0,5/15,10.34%,CHRM3;CHRM1;AGRN;GRK2;LY6H
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6622249488157639,1.2264828685067235,0.22641509433962265,0.5415281226280201,1.0,2/19,1.98%,PROX1;PSRC1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8235202636610883,1.2262452601124458,0.2549019607843137,0.5418112847656738,1.0,3/5,12.49%,THBS1;PDE10A;CGAS
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6849381083703954,-1.2259403321403237,0.2391304347826087,0.945949765468988,1.0,3/10,14.43%,TIMM8B;TIMM13;TIMM10
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6211422501353209,1.225841171316207,0.22413793103448276,0.5427237582896876,1.0,10/25,16.17%,THY1;EFNB3;TRIM46;DCC;MAG;MCF2;DIP2B;FGF13;PTPRS;KIAA0319
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.7964430861774897,-1.225489694067449,0.2553191489361702,0.945057950943224,1.0,1/6,0.60%,SPRY1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7475282794535464,1.2254773265780967,0.14754098360655737,0.5430747089824622,1.0,2/11,10.27%,IRS2;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7475282794535464,1.2254773265780967,0.14754098360655737,0.5430747089824622,1.0,2/11,10.27%,IRS2;STAT3
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.7307124919711917,1.2252715679042736,0.288135593220339,0.5432455609937235,1.0,2/8,15.78%,SUV39H1;H3-3A
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.7659621763052386,-1.2250123603669079,0.2765957446808511,0.944716311655257,1.0,1/6,1.34%,HEY2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.7289929122459767,1.2249063397977011,0.26785714285714285,0.543984683768362,1.0,1/10,2.80%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.560875038629641,1.224833763100685,0.21311475409836064,0.5437900322354426,1.0,18/56,17.13%,RASGRP1;APP;MAP3K11;DAB2IP;DUSP22;UNC5CL;MAPK8IP1;SH3RF3;MINK1;TNFRSF19;GADD45A;TPD52L1;HIPK2;MAP3K5;FZD7;ANKRD6;TRAF5;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.7075225429850729,-1.2247277553034095,0.20833333333333334,0.9434702766936489,1.0,2/8,5.85%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.6306488162266728,-1.2245551120652405,0.24444444444444444,0.9414678689833562,1.0,3/13,18.58%,HMGB3;MTERF1;ERCC3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.6800331597976752,-1.2237472365287054,0.21428571428571427,0.9425809517879407,1.0,3/10,9.17%,M1AP;NOC2L;SUPT16H
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.7494735202419814,1.2237066971008381,0.19607843137254902,0.5466205779360909,1.0,3/8,16.10%,SLCO1A2;SLCO2A1;SLCO3A1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.7263276320991555,1.2232533353993145,0.2,0.5473980359367645,1.0,5/9,19.98%,PPARG;RARA;RARG;RXRA;ACTN4
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.8049101634273019,1.2232265190887632,0.25862068965517243,0.5470998293841152,1.0,1/5,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.7145403389756262,1.2231613286784506,0.2727272727272727,0.5469711489301513,1.0,2/13,3.66%,YBX3;RBM24
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.6664621580532829,1.223132865530313,0.2222222222222222,0.5466821217539221,1.0,12/20,26.96%,CD55;TNFRSF14;CD160;B2M;HLA-E;WNT5A;TNFSF4;HLA-F;SCIMP;FZD5;HLA-A;MAP3K7
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.573626530886547,1.2229816818636106,0.18309859154929578,0.5468409828699521,1.0,12/43,11.69%,MYRF;MBP;CNTNAP1;PLP1;BCAS1;SCN2A;PLLP;PARD3;EIF2B2;TPPP;KLK6;B4GALT5
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.644933621375299,1.2226989882472923,0.2542372881355932,0.5472358514363347,1.0,5/21,7.44%,RIMS2;EPHA5;AHR;ADCY2;GLP1R
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6986092221119097,1.2224442707459648,0.2727272727272727,0.5475458483505378,1.0,1/11,5.85%,ATP9A
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5835662313927505,1.2221606865033816,0.21666666666666667,0.5478806787344417,1.0,8/33,9.61%,EGF;SH3GL2;DAB2IP;TGFA;SH3KBP1;MVP;ARHGEF7;ZFYVE28
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5694407092708085,-1.2221107303864114,0.14285714285714285,0.9470437298745623,1.0,1/21,1.39%,CSKMT
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5200411886431703,1.2220914187269065,0.15492957746478872,0.5477435731219579,1.0,25/95,15.68%,TGFBR2;TLR2;MAFF;P2RY13;LMO2;ABCB1;DYSF;THY1;SIGLEC1;PTPRC;CD44;TNS1;KITLG;RNASE1;TGFB2;FLI1;GFI1B;FGD5;ROBO4;ELF1;HLA-E;SERPING1;CD59;BAALC;PTPRS
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.7673353027226932,-1.2220285946682004,0.21739130434782608,0.9447292078398281,1.0,2/7,10.04%,MTIF2;MTIF3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.7708282651933135,1.2219902578354005,0.20408163265306123,0.5477749211955293,1.0,2/6,16.39%,PADI2;SPTY2D1
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7851645205266639,1.2216723989726619,0.26,0.5484535610200338,1.0,3/6,16.14%,CHRM3;LY6H;ATP2B4
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7964829940571276,1.2215259803429437,0.11538461538461539,0.5485515686862076,1.0,3/5,12.22%,SHANK3;FRMPD4;CAMK2B
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.537907597869999,1.2214471792774644,0.2,0.5484059811774439,1.0,17/70,12.17%,MRAP2;EPHA2;STAC2;PID1;RAMP3;MRAP;TMBIM1;BCL2L1;ITGA3;PTPN9;PRKCE;PRKCH;MMP14;ZDHHC7;SORBS1;STX4;ARF6
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6132045017682154,-1.2214047375958148,0.16666666666666666,0.9451886747366641,1.0,3/18,2.89%,SLC2A5;SELENOS;SLC30A8
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7922767870779531,-1.2213587971789754,0.2545454545454545,0.9428124260502306,1.0,2/5,15.22%,NOL8;RPF2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.6613158533668038,1.2213354306878814,0.26,0.548470327284085,1.0,4/16,9.88%,PROX1;PKP2;TBX20;TCAP
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5668462716794751,1.2213106388232784,0.15873015873015872,0.5481992562927636,1.0,18/60,17.72%,HTR2C;SLC24A2;VAPB;ATP2B3;GCM2;SNCA;RYR2;GRIN1;NPTN;ATP1B1;TPCN2;STOML2;SLC24A1;ATP13A1;ATP2B4;SLC8A2;SLC8A1;FAM20A
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.6059504744643516,1.2212909336189792,0.1791044776119403,0.547844796822642,1.0,5/38,10.02%,C3;SERPINE1;NLGN1;SNCA;TF
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.5448379565411627,1.221127520526773,0.1746031746031746,0.548026601368868,1.0,15/72,14.84%,BOK;BLM;KCNC2;SNCA;UGDH;SLC9A1;KCNC1;HOMER1;GSDMD;POLQ;HLA-DRB1;RNF112;GLRA3;STOML2;ATL3
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.5747943900173285,-1.2210828424594025,0.24390243902439024,0.9415752735421327,1.0,9/31,16.83%,ATRIP;HUS1;BRIP1;ATR;ERCC6;RAD9B;CLSPN;DNA2;HINFP
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.7061780917047716,-1.2209845456513853,0.2127659574468085,0.9395171081885696,1.0,2/9,5.85%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6701032424409448,-1.2209555339901688,0.225,0.9371555232354427,1.0,2/10,9.24%,ID2;HSF1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5466464622003665,-1.2208038308405331,0.20512820512820512,0.9353749934490085,1.0,5/24,7.89%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.5764422296365292,-1.2205900391080629,0.20930232558139536,0.9336039598214353,1.0,6/21,6.16%,CD247;CD96;PYHIN1;IL5;CD6;P2RY10
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6834969863754835,1.2205455585137477,0.1746031746031746,0.5494964167658569,1.0,3/16,3.41%,MET;PROX1;LSR
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5373756244557838,1.2203642885497032,0.19047619047619047,0.5495764845154245,1.0,7/66,9.35%,IGF1;NPNT;NELL1;TRPM4;CDK6;YAP1;PPARG
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7438216208787706,-1.2202502231403223,0.2619047619047619,0.9328171790434808,1.0,1/8,6.62%,BCAP31
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.48642338893426557,-1.2201519502996738,0.12121212121212122,0.9307317615968947,1.0,16/54,26.89%,MCM6;PSMD10;MCM4;PSMD12;PSMB5;PSMB6;ORC6;PSME3;PSMD2;UBB;PSMB4;ORC2;PSMA1;PSMD11;ORC3;MCM3
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6227643494318335,-1.2200410949772762,0.25,0.9286379846127669,1.0,3/14,17.03%,SCNM1;PQBP1;SRSF9
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.7796971597772995,-1.220027505911629,0.3,0.9262264371076356,1.0,2/6,4.40%,ZC3H8;FOXJ1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.49342451755935673,1.2199150309284619,0.1323529411764706,0.5506588674483578,1.0,36/153,17.43%,MTMR7;PLD1;LIPH;LPCAT4;ACHE;PLSCR1;MFSD2A;SBF1;SYNJ2;DGKG;AGPAT4;PLEKHA2;PLD2;CHKB;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;INPP5J;PLEKHA4;PLEKHA8;INPP4A;FGF2;MTM1;CDS2;BMX;PIK3CD;INPP5D;SLC44A3;CPNE7;IMPA1;PIP5K1C;LPIN3;INPP5F;PITPNM1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.6839924272918815,1.219886175149913,0.25,0.5503790523664378,1.0,1/16,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6185851245942218,1.2198529510577802,0.21568627450980393,0.5500746062848034,1.0,4/24,10.44%,CTSC;EFNA1;RHBDF1;EPHA4
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6967914479085824,1.2197508989985792,0.21568627450980393,0.5499706510779783,1.0,1/13,2.44%,DUSP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.7069687809903734,1.2196551196600998,0.2692307692307692,0.5498335219692551,1.0,5/12,14.71%,HLA-DRA;ABCB9;HLA-DRB1;B2M;HLA-E
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7466267587921801,-1.2195267662788707,0.275,0.9237117321628489,1.0,3/8,14.47%,UQCRFS1;LYRM7;SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7466267587921801,-1.2195267662788707,0.275,0.9237117321628489,1.0,3/8,14.47%,UQCRFS1;LYRM7;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6501385714509413,1.2194264022924401,0.16981132075471697,0.5498842574401495,1.0,5/19,18.23%,THBS1;CDKN1C;HIPK2;STK11;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6501385714509413,1.2194264022924401,0.16981132075471697,0.5498842574401495,1.0,5/19,18.23%,THBS1;CDKN1C;HIPK2;STK11;ADAM17
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.6637483488177239,1.219416783527138,0.22413793103448276,0.5495562902957175,1.0,3/20,6.08%,LIPH;FABP3;FAAH
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.6626559230995365,1.2193584440394283,0.25396825396825395,0.5493866102060864,1.0,3/17,4.01%,IGF1;RTN1;RTN2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.6875480579813276,1.2193092075364207,0.29508196721311475,0.5490843545625529,1.0,2/12,3.61%,PTK6;NLRP12
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5882094523713778,1.2192934953808963,0.1,0.5487493424272718,1.0,12/39,19.17%,EGF;GRAMD2A;CTNNB1;ORAI1;HOMER1;PLPP4;CAMK2B;BCL2;CD4;CAMK2A;CAV3;CACNB2
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.8141958903041399,1.219083216263554,0.21428571428571427,0.549135961642312,1.0,4/6,18.50%,APP;MAPT;DCTN1;APBA1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7056561654973028,1.2190777333838057,0.296875,0.5487848154305336,1.0,2/10,14.15%,CD55;CD70
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.7994976518826522,1.2189426409673605,0.2711864406779661,0.5489390955640984,1.0,5/7,18.53%,PRKCH;GAS6;CCL2;PRKCD;PRKCA
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5368066042038994,-1.218892252675323,0.20588235294117646,0.9240186781308312,1.0,5/37,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5263814317264414,1.2188876854864477,0.208955223880597,0.5487540145399904,1.0,14/87,11.20%,P2RY6;HRH1;GABRB2;DMTN;KCNQ1;SLIT2;GLRA2;AHR;GABRG2;CTNNB1;HCN1;NEURL1;P2RY12;CTNNA1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.8468782149733041,1.218681335372565,0.2,0.5490320916947944,1.0,2/6,4.29%,NLGN1;BAIAP3
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.7497943408877948,1.2178522130893688,0.2542372881355932,0.5511022652923999,1.0,2/13,2.21%,ANXA1;BLM
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.690658584247984,1.2177748707824094,0.30357142857142855,0.5509903538147486,1.0,5/12,25.76%,DMTN;BST1;FLNA;LIMS1;EMP2
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5886478290388442,1.2176163290712505,0.18309859154929578,0.5510023300839588,1.0,8/28,12.68%,RASGRP1;DUSP1;DAB2IP;DUSP10;RELL1;MINK1;GADD45A;PER1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6445576427103374,1.217392783371709,0.25396825396825395,0.5512945530523715,1.0,1/13,0.15%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.7750796731048382,-1.2173238242220494,0.2765957446808511,0.9288602755556771,1.0,2/5,8.23%,GREM1;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5677980647756831,1.217225722004508,0.18055555555555555,0.5513392501797829,1.0,8/56,6.91%,TLR2;IL15;SERPINE1;APP;NLRP12;PLSCR1;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.7104800021178104,-1.217045937117575,0.3137254901960784,0.9274340729744631,1.0,2/8,8.80%,HEY2;HEY1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.7890931291150342,-1.2169511806057687,0.2,0.9252917256710915,1.0,1/7,4.95%,FBXO5
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.7391080016223094,-1.2167914233060841,0.2708333333333333,0.9234453519321426,1.0,2/5,11.58%,FASTKD2;MTERF3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.542296787783898,1.2166632644766715,0.12280701754385964,0.5527503267534389,1.0,19/73,12.81%,ECM2;L1CAM;NPNT;ITGA8;ZYX;THY1;SIGLEC1;ITGA2;CD44;RHOD;ITGA11;ITGA3;MKLN1;ARHGEF7;ITGB8;SORBS1;ACTN1;ITGAL;FN1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5772265402426354,1.2164655668756423,0.23076923076923078,0.5530078223482687,1.0,6/31,12.47%,BOK;SEPTIN4;BCL2L1;BBC3;EIF5A;BCL2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.6880663233433679,1.2163724984538995,0.25862068965517243,0.5529114941513922,1.0,4/16,16.34%,HELB;POLQ;CGAS;RADX
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.771561601858391,-1.2160617917743255,0.19148936170212766,0.9242794099743977,1.0,1/8,0.60%,SPRY1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5839967677436567,1.2160417524226128,0.22058823529411764,0.553579242455486,1.0,11/59,14.32%,SIX3;SLC4A10;CDH23;TYR;CLRN1;EML2;RP2;CABP1;MYO9A;PCDH15;SLC24A1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6144874517069839,1.2160213355991485,0.26229508196721313,0.5532445980692593,1.0,3/27,8.22%,ST6GAL1;TUSC3;MGAT5
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.7834544646784551,1.2160072986843045,0.2641509433962264,0.5528776052864708,1.0,2/5,3.31%,CDKN2A;IRF7
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.6100382963367307,1.2152571157389351,0.17857142857142858,0.5548227799197751,1.0,5/24,3.34%,DCN;SP100;THBS1;SLIT2;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5765165254453639,1.2151685698593468,0.2153846153846154,0.5547746792114309,1.0,10/44,17.86%,YWHAH;BAP1;YWHAG;ARIH2;BBC3;BCL2;TP53;PINK1;MICALL2;YWHAE
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.742970918194858,-1.2149695642283165,0.3090909090909091,0.9238240113091271,1.0,2/6,9.32%,GBA2;FUCA2
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.742970918194858,-1.2149695642283165,0.3090909090909091,0.9238240113091271,1.0,2/6,9.32%,GBA2;FUCA2
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5972077288724933,-1.2147556822528012,0.2222222222222222,0.9225830379597235,1.0,7/22,15.01%,TRMT61A;TRMT10C;METTL8;METTL3;TRMT61B;RPUSD2;VIRMA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.8376256586722505,1.214600275185985,0.14814814814814814,0.5560282245581365,1.0,2/6,11.94%,ITM2A;BACE2
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.7431561764640608,1.2145702723644307,0.21052631578947367,0.5553419770535861,1.0,2/7,17.35%,SYK;SHC1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.7431561764640608,1.2145702723644307,0.21052631578947367,0.5553419770535861,1.0,2/7,17.35%,SYK;SHC1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.4387806465667965,1.2145661016617426,0.011235955056179775,0.554975056443132,1.0,181/886,19.55%,LEF1;NR4A3;MLIP;FOSL2;MET;ST18;MYRF;TEAD2;TLR2;IGF1;KLF2;MAFF;MLLT11;PROX1;YWHAH;EGF;DCN;CREB5;TESC;SP100;SERPINE1;ATF3;ACTA2;PSRC1;NR4A1;BLM;CASZ1;LMO2;WAS;APP;RPS6KA1;IRF7;DAB2IP;FOXO1;PPARGC1B;NFATC2;NFIL3;PLSCR1;SOX4;AHR;PADI2;SSBP4;KLF10;DVL1;SKAP1;RFX4;CIITA;ZNF750;ZBTB16;TNFRSF1A;PLAC8;ZIC1;AGRN;PGR;LDB2;PID1;CDK9;FHOD1;FOXO3;KCNH2;GLIS2;SCX;GRIN1;PML;ZFPM2;NLRC5;SLC9A1;CTNNB1;CSRNP1;TBL1X;SMAD3;NR1I3;YAP1;RAI1;BEX1;PPARG;CTBP2;HDAC4;NAMPT;GLI2;RGMB;STAT3;FLI1;GLIS3;SMAD1;TEAD1;CDKN1C;PARP9;ASXL3;NR4A2;ASXL1;NPAS2;HLA-DRB1;EIF5A;MLXIPL;KLF7;KLF6;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;DEAF1;FGF2;SS18L1;FADD;TNIP2;ELF1;MAML2;ZNF746;HIPK2;BCL9;IKBKG;AKIRIN1;SPP1;PTPRN;SOX10;MRTFA;PRDM16;RARA;CD4;IER5;SMARCA1;RARG;ETS1;STAT6;MAP3K5;TP53;ZNF513;RXRA;BRCA1;FZD7;ZMIZ1;TOX3;CXXC1;HMGA1;NPAS3;ZBTB38;RORA;TFEB;MESP1;GPS2;UTP15;RGMA;LPIN3;DOT1L;SHC1;UBP1;WWTR1;MAP2K3;WNT5A;MLXIP;LAGE3;RHOQ;RNF187;MECOM;NCK2;TBL1XR1;RLF;BCLAF1;NFIA;LITAF;MMS19;SBNO2;NEK4;RPS6KA4;SMAD2;NFATC3;ARID1A;CRTC3;ZFPM1;DNM2;MED24;HIF1A;CDK5RAP2;METTL23;WAC;POU2F3;TLR3;ARNT
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6633557730480488,1.2144907781300645,0.23728813559322035,0.5547800744344216,1.0,4/16,14.26%,PTP4A3;TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.635194223780156,1.2138963116605082,0.19298245614035087,0.5560292964717155,1.0,12/25,19.13%,FOXO1;ZFPM2;SMAD3;YAP1;TRIO;ASXL1;RUNX1T1;RORA;GPS2;WWTR1;WNT5A;ZFPM1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7156843685699988,-1.2138682188853391,0.225,0.9238982349380095,1.0,4/7,22.83%,SLC30A5;DNAJC30;SPHK2;ANTKMT
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.8095754171185156,1.2138236241962213,0.1836734693877551,0.5558583135971283,1.0,2/6,10.55%,SCX;INPPL1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.6510970846048671,1.2137765914631378,0.22033898305084745,0.5555979535009095,1.0,4/18,15.53%,MLLT11;BBC3;TP53;PINK1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6065275262625044,1.2137577535373578,0.21666666666666667,0.5552646825820756,1.0,5/20,20.85%,PTK6;HAP1;RTN4;DOK1;DGKD
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.7186245828012519,1.2134417979464702,0.208955223880597,0.5560220132987777,1.0,2/11,8.61%,LPCAT4;PLAAT3
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.4928191429209357,-1.2133133346664084,0.13513513513513514,0.9215281230821001,1.0,13/50,22.92%,POLR2K;AAAS;RAE1;NUP50;POLR2C;NUP54;POLR2D;POLR2L;POLR2G;NUP85;NUP42;POM121C;POLR2E
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.4928191429209357,-1.2133133346664084,0.13513513513513514,0.9215281230821001,1.0,13/50,22.92%,POLR2K;AAAS;RAE1;NUP50;POLR2C;NUP54;POLR2D;POLR2L;POLR2G;NUP85;NUP42;POM121C;POLR2E
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6397925548457917,1.2132493155616269,0.21212121212121213,0.5561035293311316,1.0,3/22,9.78%,ZC3H12D;NUDT16;RNASE1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6492650815600981,1.2130058842166913,0.2833333333333333,0.5563230454144339,1.0,6/16,22.65%,THBS1;AKIRIN1;BST1;CAMK1D;CSF1;RARRES2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),0.8061809296109042,1.2128858152185322,0.2857142857142857,0.5563068192388227,1.0,4/5,17.70%,FLT1;PPARG;CCL2;COL4A3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5287759897899661,1.2126315328543336,0.1323529411764706,0.5567449486509459,1.0,25/78,23.91%,HLA-DRA;CTSS;SH3GL2;AP1S1;KIF5A;MFSD6;ACTR1A;HLA-DRB1;KLC2;KLC1;HLA-DMA;HLA-E;KIF3C;DYNC1LI2;DCTN1;DNM2;DYNC1LI1;ACTR1B;CAPZB;RAB7A;HLA-F;DCTN3;DYNC1I1;DCTN6;CLTC
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.49885557490568994,1.212460035009192,0.125,0.556785208497858,1.0,18/103,13.10%,SLC6A15;SLC15A3;SLC7A2;SLC43A1;MYH9;AMN;SLC16A10;SLC25A45;SLC35F3;RAMP3;SLC7A7;SEC14L1;CHMP1A;SLC25A29;SLC7A14;SLC29A4;PDPN;PICK1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6300388020315646,1.2124250783997759,0.27419354838709675,0.5565013336631798,1.0,4/17,14.64%,PARD3;OPHN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.7526427950256636,-1.2123106894294484,0.3157894736842105,0.9238593099806003,1.0,3/6,22.96%,NUP54;INTS13;PLK1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4574374003646224,1.212140775330374,0.10126582278481013,0.5571084563917509,1.0,49/362,13.21%,LEF1;CDKN2A;SIX3;PROX1;MAEL;ZNF93;DAB2IP;FOXO1;PRAME;SUV39H1;CIC;ZNF282;TCEAL7;NFIL3;BCL6;NKX6-2;AHR;GZF1;KLF10;CIITA;NRG1;ZBTB16;BAP1;TBX20;MSX2;GLIS2;PML;HMBOX1;ZFPM2;CTNNB1;BASP1;PPARG;CTBP2;CHMP1A;HDAC4;PEX14;CDKN1C;GAS6;HDAC9;L3MBTL3;RUNX1T1;PRICKLE1;MLXIPL;CDKN1B;PER1;KLF4;JARID2;SOX13;DEAF1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7657466400703359,1.2116678682593511,0.25862068965517243,0.5582163857793875,1.0,1/5,12.76%,ATP8A2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.7103388384070222,1.211599978888702,0.22950819672131148,0.5580372251035262,1.0,2/11,1.69%,THBS1;SERPINE1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7354508001449671,1.211466193375641,0.24528301886792453,0.5580926251803482,1.0,6/12,9.40%,PKP2;GJC1;CACNA1C;RYR2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.8280178905160744,1.2114591031642443,0.22033898305084745,0.5573640381146702,1.0,1/5,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.8280178905160744,1.2114591031642443,0.22033898305084745,0.5573640381146702,1.0,1/5,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5116823544729401,1.2112872684192317,0.15,0.5575326705309315,1.0,24/100,16.27%,CDKN2A;TP53TG5;PSRC1;SLIT2;TSPYL2;SLIT3;BCL6;TRIM46;DCC;PML;MAG;SMAD3;TGFB2;DIP2B;FGF13;FBP1;CDKN1B;CDKN1A;PPP1R9B;SIPA1;TP53;PTPRS;KIAA0319;FHL1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.5321406916285092,-1.211163992301433,0.14634146341463414,0.9259931050445757,1.0,26/66,24.68%,FIP1L1;GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;CPSF1;CLP1;CPSF3;POLR1B;LSM10;MTERF1;MTERF2;ERCC3;POLR3K;TTF1;POLR2L;CSTF2;SSU72;CSTF2T;POLR2E;GTF2H3;CPSF7;UBTF;SLBP
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.8093617110446489,1.2111534290492219,0.23529411764705882,0.5574512794899651,1.0,2/6,14.72%,RAB11FIP5;PTPRN
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6924878527317518,-1.2109032135068531,0.21739130434782608,0.9249505765113369,1.0,2/13,10.22%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7792271314472561,1.2106891910107351,0.24528301886792453,0.5585134378843531,1.0,4/6,16.69%,RBM24;NRG1;HDAC9;MESP1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7181491134275193,-1.2106341844721755,0.3469387755102041,0.9234701318447223,1.0,2/7,11.11%,PTPN22;SPSB4
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.6714027785518102,1.210588088253693,0.21739130434782608,0.5585039129691537,1.0,8/22,20.78%,MET;ICAM1;PPP1R16B;ROBO4;PDE4D;RAP1A;RAP1B;PDE2A
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.647078694689343,1.2105253029290697,0.20967741935483872,0.5582933648837857,1.0,6/19,15.87%,CXCL2;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.6672761386798763,1.210484557673167,0.21666666666666667,0.5580348867635598,1.0,3/15,13.78%,P2RY6;P2RY12;LPAR1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5250342767842547,1.2104322218073154,0.18309859154929578,0.5577687288265007,1.0,26/84,15.22%,RIMBP2;ANK3;NPNT;ADCY5;SHC2;KCNQ1;LGR5;PRIMA1;ZNF704;TMEM132C;RAI2;APLNR;MAOB;SYT13;ZBTB7C;KALRN;RASL12;ITGA9;ASXL3;TNFRSF19;DLG3;LRIG1;NEBL;COBL;PDZRN3;SLC44A3
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6723507167370607,1.2102873799640173,0.22950819672131148,0.5578640607858805,1.0,6/17,15.87%,CXCL2;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.4861368638992758,-1.2102315997167392,0.16129032258064516,0.9226417896712589,1.0,25/70,26.02%,SELENOS;SEL1L2;TMUB2;FBXO27;UBXN8;FOXRED2;DERL2;ERLIN2;USP19;AUP1;RNF5;RNF103-CHMP3;UBE4A;YOD1;DNAJB9;TMUB1;DNAJC10;RHBDD2;ERLIN1;VCP;FAM8A1;DERL1;DNAJB12;UBXN4;DNAJC18
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6765035038757701,-1.20969830428966,0.28888888888888886,0.9224790197468481,1.0,3/13,14.53%,LSM2;PRPF8;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5896077333102452,1.2096529370545872,0.24074074074074073,0.5593627026573947,1.0,7/26,6.91%,ANXA1;IL1RAPL1;SYT4;SERGEF;TNFRSF1A;RHBDF1;SNCA
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8050641747364179,-1.2095350076231823,0.2653061224489796,0.9209242230560939,1.0,2/5,6.00%,PDCD7;AKR1C3
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7545634334876544,1.2092001102786494,0.3050847457627119,0.5598711746348088,1.0,4/7,16.30%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7545634334876544,1.2092001102786494,0.3050847457627119,0.5598711746348088,1.0,4/7,16.30%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.704960333524961,1.2091871065041728,0.2545454545454545,0.5595326444499737,1.0,4/11,11.49%,KLF2;PRAME;CTBP2;ASXL1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.7019438095304703,1.208972262355961,0.2807017543859649,0.5598584038457786,1.0,2/13,12.15%,SMCR8;PHF23
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.7833688853508161,-1.2089461532171017,0.22727272727272727,0.9207848293076134,1.0,1/7,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.7366305942842001,1.2088569762177368,0.3191489361702128,0.5597840944830225,1.0,4/7,21.91%,TFPI;SERPING1;F3;F10
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5255971397338615,1.2088481006545175,0.2,0.5594303339730868,1.0,13/89,18.23%,ST18;MAP3K14;TNFRSF14;BIRC3;TNFRSF1A;FOXO3;EIF5A;CD70;TP53;TNFRSF11B;TRAF5;TNFSF4;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.4992765655402878,1.208768676445712,0.09333333333333334,0.5593005408914021,1.0,23/124,18.55%,ANK3;YWHAH;FYN;BAP1;ZIC1;MYO1C;BAG3;YWHAG;ARIH2;SMAD3;BBC3;GAS6;PRKCD;BCL2;OAZ2;CEMIP;MTCL1;TP53;PINK1;MICALL2;YWHAE;FLNA;PLK3
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5277737860919722,-1.2087485519684256,0.20454545454545456,0.9196066957648724,1.0,14/42,18.00%,PMVK;TM7SF2;DHRS11;AKR1C3;ABCB11;OSBPL3;HSD11B1;CYP46A1;SRD5A1;CYP7B1;SC5D;DHCR7;OSBPL6;PRLR
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7659574347162953,1.208619286554566,0.2653061224489796,0.5593144982805484,1.0,1/6,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.7609970013611496,-1.2083025825741485,0.2857142857142857,0.9193257397189126,1.0,3/6,14.38%,NDUFA12;NDUFV3;COA6
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.5735920404466222,-1.208110738027111,0.25,0.9177578514108884,1.0,2/28,0.52%,DAO;CYP4F3
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.7199785816255377,1.2081089744246234,0.22641509433962265,0.560532065117092,1.0,3/10,3.50%,IGF1;CD24;IL27RA
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.7574444434550521,1.2080880382737536,0.3090909090909091,0.5601867191950824,1.0,2/6,5.16%,IRS2;BCL6
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.712418969121634,1.207930193994385,0.26,0.5601920921479651,1.0,4/10,24.19%,HR;KDM3A;PHF8;KDM4C
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.8132013189521815,1.2075076591041756,0.17307692307692307,0.5610327304977777,1.0,2/5,13.97%,SEPTIN9;HAP1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.802867194506913,-1.2074359145001676,0.2631578947368421,0.9177000549635814,1.0,2/5,11.01%,WDR11;C17ORF75
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6152148773757999,1.207263299452868,0.2698412698412698,0.5613555134526086,1.0,3/26,8.22%,ST6GAL1;TUSC3;MGAT5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5877398694656052,1.2072020721986776,0.2,0.5611694279738254,1.0,7/34,9.35%,NR4A3;IGF1;THBS1;OGN;APOD;CTNNB1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5642189100871094,1.2070853522882297,0.18333333333333332,0.5611264935906204,1.0,11/43,16.08%,GRIN2A;GRIN2B;NOD1;FYN;GRIN1;SYK;USP50;NLRP2;FADD;MAP3K5;TBC1D10A
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),0.7799114345410477,1.2068773145946974,0.3076923076923077,0.5614644319747731,1.0,3/5,19.53%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.7645006033014509,1.2064113621959764,0.23333333333333334,0.5626106079751423,1.0,3/7,10.32%,PLD1;FSCN1;PODXL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6523451629585038,1.2064087370836902,0.22580645161290322,0.5622419509458769,1.0,3/12,18.06%,STAT3;SYK;TNFSF4
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.9132775800527964,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.9132775800527964,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.9132775800527964,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.9132775800527964,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7011247480695968,1.2061969825039436,0.29310344827586204,0.5626101359872225,1.0,5/12,13.28%,PROX1;PDGFRA;MYLK3;TCAP;NEBL
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7467350642312525,-1.2061963874214265,0.24074074074074073,0.9115507096681622,1.0,3/5,24.01%,RPAP2;SSU72;CTDP1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5818514521862133,1.2060481487102146,0.16666666666666666,0.5625901193731758,1.0,11/42,15.49%,GABRB2;GLRA2;GABRG3;GABRD;GABRA1;GABRG2;GABRA5;ANO9;SLC12A5;GLRA3;ANO7
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7960989783638922,1.206046029518442,0.27450980392156865,0.5622301219737985,1.0,2/5,9.43%,PPARG;CTBP2
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.7657951916602896,-1.205988554768074,0.22916666666666666,0.9102603149594062,1.0,3/6,11.69%,IDO1;ZC3H8;PRELID1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5913928555100263,-1.205825785167723,0.22916666666666666,0.9086737023088761,1.0,9/20,23.09%,GTF2H5;GTF2H2;CETN2;ERCC2;XPA;ERCC3;UBB;PARP1;GTF2H3
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6063498986728784,1.2056159255333898,0.23943661971830985,0.5631902180584041,1.0,3/23,10.99%,RFX4;GLIS2;IFT122
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7184095122326464,-1.2053154897816813,0.2978723404255319,0.9086035209717687,1.0,1/5,5.24%,SLC6A13
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6675793420038136,1.2052512679600036,0.3018867924528302,0.5640542739380717,1.0,2/16,1.98%,PROX1;PSRC1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5500695600360989,1.2049716603605898,0.22580645161290322,0.5644042408056142,1.0,13/56,15.49%,GABRB2;GLRA2;GABRG3;GABRD;GABRA1;SLC20A2;GABRG2;GABRA5;ANO9;SLC12A5;GLRA3;SLC37A2;ANO7
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5213109093080618,1.2045564322512623,0.15942028985507245,0.5652426783286765,1.0,22/74,23.91%,HLA-DRA;CTSS;SH3GL2;AP1S1;KIF5A;ACTR1A;HLA-DRB1;KLC2;KLC1;HLA-DMA;KIF3C;DYNC1LI2;DCTN1;DNM2;DYNC1LI1;ACTR1B;CAPZB;RAB7A;DCTN3;DYNC1I1;DCTN6;CLTC
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6548628436012944,1.2045242280343647,0.23636363636363636,0.564937279112928,1.0,4/17,11.17%,RBM24;MMP14;HDAC4;HDAC9
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5506785820638498,1.2044182452104821,0.19047619047619047,0.564829175941591,1.0,14/51,20.27%,FSD1;CLIP2;HOOK1;LIMK2;TPPP;MAPT;KATNAL1;CAMSAP3;HOOK2;DCTN1;PLK3;RAB11A;TUBGCP6;FIGN
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7594310432437028,-1.2044043985744712,0.30612244897959184,0.9099679539087686,1.0,1/6,2.70%,RNF6
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6504481127774239,1.2041949917181791,0.2692307692307692,0.5651304747193795,1.0,1/15,2.35%,ZFP36
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5782599961450658,1.2041503447086845,0.23728813559322035,0.5648965449106286,1.0,4/32,4.31%,ANXA1;ZFP36;SFTPD;PTPRC
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5349801929303691,1.2037098063694702,0.17142857142857143,0.5659283693291742,1.0,14/59,10.69%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;NAPSB;WAS;IRF7;PTPRC;CD37;SERPINF1;ETV6;PACSIN1;CD83
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.53317271800518,1.2036618998930018,0.23880597014925373,0.5656470924251953,1.0,10/60,10.79%,RFTN1;ZDHHC9;ZDHHC22;PARD3;MYO1C;MICALL1;ZDHHC7;ZDHHC1;SYNE3;NACAD
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.765469357354842,1.2035407403373433,0.25862068965517243,0.565523178040356,1.0,1/5,0.25%,HPN
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6773197785540972,1.2032124860399087,0.23214285714285715,0.5661524779888718,1.0,8/17,17.94%,CD22;RIT2;PLEK;NEUROD2;MAPT;BST1;SLC8A2;ITPR1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7610928917956958,1.202919314148088,0.21818181818181817,0.5666241628877506,1.0,2/7,10.90%,GRIN1;DUOXA1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6051527623808652,-1.202909193457069,0.24324324324324326,0.9138518253184,1.0,1/21,0.12%,DAO
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.7941395192019722,1.20281061800482,0.15384615384615385,0.5666643595578416,1.0,1/5,2.75%,EPHA2
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.6494064185149366,1.2028094773421811,0.2631578947368421,0.5663052389579392,1.0,6/15,21.30%,EPHA2;GAB2;GPR183;SNX10;SBNO2;CSF1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.6226182090458461,1.2024561957613336,0.21153846153846154,0.5669949465662767,1.0,2/27,3.31%,TLR2;IRF7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.7906174921671729,1.2022194805721922,0.2037037037037037,0.5672615512995384,1.0,2/7,8.51%,DAB2IP;NLRC3
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6047264251180265,1.2019544972470406,0.2463768115942029,0.5676137493392779,1.0,7/28,16.86%,CLDN16;PARD3;POF1B;CLDN18;CLDN20;PATJ;MICALL2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5810178493434481,1.2015324158657334,0.1791044776119403,0.568512046351057,1.0,14/42,16.45%,A4GALT;UGT8;ESYT3;ST8SIA3;ST8SIA1;B4GALNT1;B3GALNT1;ABCA2;STS;LARGE1;ST6GALNAC5;B4GALT6;ST6GALNAC3;NEU4
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7476677013035964,-1.2013435706814788,0.3111111111111111,0.9176994022979755,1.0,3/7,18.26%,PPP1R3C;PPP1R3G;PPP1R3E
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.7853376370715541,1.2012019016349322,0.19298245614035087,0.5689409847806425,1.0,3/5,19.54%,IFIH1;SERINC5;TLR3
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.7504267801936063,1.2011213154050402,0.3050847457627119,0.5687533346918975,1.0,4/8,16.30%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7606523146267232,1.2010136271979355,0.2692307692307692,0.5686984063980662,1.0,2/5,6.21%,NUDT16;SAMHD1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.804278855879232,1.2009851974197778,0.3137254901960784,0.5684255002631239,1.0,4/5,15.22%,CD55;CFH;TGFB2;CD59
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.8072287257725239,1.200933625343598,0.2222222222222222,0.5682307768203558,1.0,2/5,12.00%,PARD3;PARD3B
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5886286355786565,1.2008452142601216,0.1746031746031746,0.5681218592354497,1.0,8/33,19.01%,SMCR8;PIP4K2A;PHF23;MTM1;PINK1;LRSAM1;ELAPOR1;MTMR3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.687007300551692,1.20024786801264,0.21875,0.5695675175439892,1.0,4/14,14.76%,LPCAT4;PLAAT4;PLAAT3;PNPLA8
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.825720289175393,1.2000918188747063,0.25,0.5697996166057802,1.0,3/8,8.72%,SULF1;MCAM;ITGA3
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.5712484429749137,-1.200055045576043,0.3333333333333333,0.9208956560233924,1.0,4/23,8.06%,CSKMT;SMYD2;METTL18;KMT5A
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6772821838869637,1.2000546101954304,0.1864406779661017,0.5695656929965629,1.0,7/19,19.47%,LTBP4;ITGA3;SMAD3;BCL9;DKK3;SMAD2;TGFBR3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.7096709363246072,1.200001122933561,0.25,0.569332075971368,1.0,10/19,19.02%,PKP2;NOS1AP;TRPM4;CACNA1C;RYR2;FGF13;CALM3;CTNNA3;CAV3;CXADR
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.8035676315561561,1.1999087766222771,0.3125,0.5692770564431369,1.0,1/5,2.35%,ZFP36
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.508793233359703,1.1998611194676783,0.15873015873015872,0.5689974537066118,1.0,22/98,17.18%,HTR2C;SLC24A2;CDH23;VAPB;TRPC3;ATP2B3;GCM2;HCRTR2;RYR2;PML;NPTN;ATP1B1;TPCN2;MCUB;BCL2;STOML2;SLC24A1;ATP13A1;ATP2B4;SLC8A2;SLC8A1;CALB2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7601466295918895,1.1996455251594211,0.2923076923076923,0.5692678749396208,1.0,5/7,18.09%,FYN;ITGA3;PICK1;IGF1R;MTMR2
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.7711755776560735,1.1995682531336498,0.2962962962962963,0.5690582731463972,1.0,2/9,9.47%,GGCT;GSS
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.8217942087573114,1.199447463848205,0.25,0.5689726499969556,1.0,4/6,17.39%,RTN4RL1;EPHA4;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6021856266432438,1.1992903249541964,0.2698412698412698,0.5690262157240469,1.0,8/21,12.25%,PIM3;ADCY5;EPHA5;BAIAP3;TRPM4;HLA-DRB1;STX4;KLF7
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),-0.768857242388287,-1.1991284867103027,0.2894736842105263,0.922550840622586,1.0,1/5,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6644822691808199,-1.198813882905263,0.2608695652173913,0.9214862756222022,1.0,2/9,8.43%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.6627021933843773,-1.198786572391922,0.1794871794871795,0.9194493479677596,1.0,4/12,16.63%,CCDC22;PSMD10;NFKBIB;NFKBIE
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6715606129631148,1.198772487393778,0.3148148148148148,0.5702147669617046,1.0,6/10,30.58%,PPARG;NFATC3;NFATC4;NFIB;PPARD;SRF
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.7924681588120396,1.1987108649016234,0.1568627450980392,0.5695951986008709,1.0,1/5,3.51%,THY1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.7924681588120396,1.1987108649016234,0.1568627450980392,0.5695951986008709,1.0,1/5,3.51%,THY1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.5946066181522516,-1.198588706285224,0.2894736842105263,0.9179967155106609,1.0,4/20,11.21%,ABCD2;PXMP2;ABCD1;PEX11B
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.5454638080648322,1.1985381238500334,0.22535211267605634,0.5696867514501962,1.0,8/53,6.91%,TLR2;IL15;SERPINE1;APP;NLRP12;OSMR;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6429968994795406,1.198495542524088,0.19642857142857142,0.5694701303529968,1.0,5/18,13.91%,THBS1;P2RY12;STX4;CFAP20;TRIM32
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5983932543030867,1.1983642135570294,0.15254237288135594,0.5694923781998997,1.0,9/35,16.57%,A4GALT;ST8SIA3;PGAP4;ST8SIA1;PIGA;LARGE1;ST6GALNAC5;B4GALT6;PIGB
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5859664092409591,-1.1979097550148503,0.24324324324324326,0.9183575954555839,1.0,4/17,17.30%,SELENOS;DERL2;AUP1;HM13
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.6671908111111254,-1.1978490702456808,0.3076923076923077,0.9165678051160875,1.0,6/8,30.95%,GLUD1;GLYATL1;SIRT4;GLUL;CPS1;NIT2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.6164697529717528,-1.1970164676886343,0.30434782608695654,0.9176738005660057,1.0,6/17,14.23%,ALAS1;HMBS;ABCB10;SLC25A38;FECH;TSPO
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7919462304803814,1.1969117911963056,0.25925925925925924,0.5733987349889337,1.0,3/6,18.63%,SNCA;ATP2B4;CAV3
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7165812854554274,1.1968578064966393,0.23404255319148937,0.5731493800311771,1.0,4/6,27.01%,COLGALT1;AEBP1;CHADL;EMILIN1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.8279415538846626,1.196548019463866,0.22413793103448276,0.573591672881767,1.0,2/5,10.92%,TPPP;MAPT
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.5221677362562094,1.1964902247734706,0.17647058823529413,0.5734039274065297,1.0,34/96,15.22%,MET;A4GALT;NPNT;FBLIM1;EPHA2;ICAM1;CEP170B;DAB2IP;OSMR;COL12A1;PTPN21;SEMA3B;RHBDF1;OLFML2A;GRAMD2A;RHOD;SCARA3;LAMA5;ITGA3;YAP1;EPB41L1;RADIL;PXDC1;SLCO2A1;TEAD1;COL4A4;CLDN18;PDPN;PALLD;NTN4;NOTCH3;LAMA3;SMARCA1;SLC44A3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.7643431981216853,1.196454387233636,0.2641509433962264,0.5731780681656973,1.0,4/9,7.18%,PKP2;TRPM4;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6445854151412085,1.1962536055948059,0.3387096774193548,0.573297491955859,1.0,3/19,4.01%,IGF1;RTN1;RTN2
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.5132012028014369,1.1959258857927766,0.1864406779661017,0.5738841122080508,1.0,19/86,14.19%,IGF1;KCNC2;ABCC8;ACHE;GIPR;ITPR3;SERGEF;RHBDF1;CACNA1C;HADH;TMED10;GLP1R;CACNA1E;SYTL4;TGFB2;ARF6;PICK1;RHBDF2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5730067263457442,-1.1955813341636634,0.1956521739130435,0.9215688969634834,1.0,4/25,15.09%,ARRDC4;TRIB3;RPS2;DCUN1D2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6146734909085168,1.195378389601236,0.19117647058823528,0.5751054661461891,1.0,2/20,5.04%,TEKT2;DNAH3
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5451574236941349,-1.1951934060886804,0.1794871794871795,0.9211608373193696,1.0,5/24,7.89%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.7421511529576847,1.1950797092753738,0.32075471698113206,0.5755906886634229,1.0,1/8,0.79%,ANK3
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7402790401689715,1.194740769726893,0.3090909090909091,0.5755610646775511,1.0,6/8,21.96%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7402790401689715,1.194740769726893,0.3090909090909091,0.5755610646775511,1.0,6/8,21.96%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7402790401689715,1.194740769726893,0.3090909090909091,0.5755610646775511,1.0,6/8,21.96%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.44898174569262655,-1.1946243095801377,0.13793103448275862,0.9213727373059658,1.0,27/162,14.53%,RP9;PDCD7;SCNM1;DHX16;LSM3;SF3B4;SF3A1;ZCRB1;RBM8A;M1AP;U2AF1;PRPF18;FASTKD2;TFIP11;LSM5;RNASEL;METTL3;KIN;RRAGC;CLP1;YJU2;SNRNP25;LSM4;PRPF8;SRSF2;RBM39;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.6117484755587007,1.1945933620260458,0.22950819672131148,0.5756020945118324,1.0,6/21,8.31%,MRAP2;DMTN;PID1;MRAP;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.708637494010611,1.194370189012574,0.23809523809523808,0.5758489987721159,1.0,6/15,17.39%,SERPINE1;RTN4RL1;EPHA4;FGF2;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.519522009135277,-1.193740865210197,0.1891891891891892,0.9226284488466566,1.0,14/52,18.97%,APOBEC3G;ADAT2;TRMT61A;THUMPD1;QTRT2;METTL3;FTSJ1;URM1;TFB1M;MEPCE;DTWD2;DTWD1;LCMT2;TRDMT1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.6574927793126784,-1.1936384183951225,0.23076923076923078,0.9209391750317898,1.0,4/12,19.85%,LSM3;LSM4;RC3H1;PATL1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.5043900774423206,1.193428083014252,0.11428571428571428,0.577909627230488,1.0,14/86,14.84%,KCNJ2;BLM;KCNC2;TRPM4;SAMHD1;STEAP4;HCN1;SHMT1;GSDMD;POLQ;RNF112;B2M;GLRA3;ATL3
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5217324980916905,1.193295356553752,0.14285714285714285,0.5779871521607847,1.0,8/86,3.26%,HPN;L1CAM;IGF1;RIMS2;SYT4;SHTN1;SYT1;RPS6KA1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6862662206028336,-1.1932387623219878,0.25,0.918128421660938,1.0,3/8,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6862662206028336,-1.1932387623219878,0.25,0.918128421660938,1.0,3/8,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.7102328886658208,1.1930128897273256,0.2777777777777778,0.5784299640687477,1.0,2/10,10.78%,TYMP;PUDP
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.6166865469243845,1.192528189583151,0.2545454545454545,0.5791536780381086,1.0,5/17,12.47%,BOK;GGCT;BCL2L1;BBC3;BCL2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.6334007564867787,1.192494487785603,0.22413793103448276,0.5788729396932112,1.0,4/18,13.24%,SERPINE1;TNFRSF14;GSDMD;OPTN
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.768417991410433,1.1923289329441549,0.25925925925925924,0.5789040618958441,1.0,3/7,7.36%,PKP2;NEFL;GFAP
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.6827728261990855,-1.1921997490089589,0.25,0.9180355220703262,1.0,2/8,3.47%,EXOSC8;ERI2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.6827728261990855,-1.1921997490089589,0.25,0.9180355220703262,1.0,2/8,3.47%,EXOSC8;ERI2
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.7099506391120768,-1.1919725654628017,0.32,0.9147078397262179,1.0,3/8,23.20%,ABHD17A;LYPLA2;ABHD17C
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.7099506391120768,-1.1919725654628017,0.32,0.9147078397262179,1.0,3/8,23.20%,ABHD17A;LYPLA2;ABHD17C
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.6032661345388393,1.1918793090714683,0.22857142857142856,0.5796868206440933,1.0,5/25,16.26%,ZFP36;DAB2IP;DUSP22;IQGAP1;SYAP1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7743121034867809,1.1916862557155148,0.2631578947368421,0.5799298403144958,1.0,1/6,1.91%,NLGN1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7028456789153621,1.1913267731185573,0.3448275862068966,0.5805213649485658,1.0,3/10,12.89%,KLF2;ASS1;KLF4
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5739329397641746,-1.1913181740873164,0.24390243902439024,0.9148124707153956,1.0,9/24,23.09%,GTF2H5;GTF2H2;CETN2;ERCC2;XPA;ERCC3;UBB;PARP1;GTF2H3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7112277447232623,1.191226190658879,0.30357142857142855,0.5804301023790414,1.0,3/8,14.64%,OPHN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7479648644575801,1.1911857818531892,0.36363636363636365,0.5801723448559524,1.0,3/7,18.39%,RPS6KA1;RGS14;BCLAF1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.6133981046500945,-1.1910386524872985,0.23684210526315788,0.9135410606316475,1.0,13/29,24.17%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;POLR1B;ERCC3;TTF1;POLR2L;POLR2E;GTF2H3;UBTF
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.6683469872529483,-1.1910225400073051,0.3111111111111111,0.9115892452436123,1.0,3/12,8.80%,HEY2;HEYL;HEY1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7573977024773542,1.1909776767246096,0.2711864406779661,0.5804144325551953,1.0,1/8,0.56%,HLA-DRA
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.47422555079302153,-1.190784168651417,0.13333333333333333,0.9102474760373565,1.0,12/94,8.15%,G0S2;RPP25L;AR;GOLT1A;CEBPA;C6;FGL1;TM7SF2;LEPR;ADH6;APOM;HSD11B1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.488774992922939,1.1907087013440327,0.18181818181818182,0.5807999189403191,1.0,33/132,16.17%,TGFBR2;MET;SERPINE1;DUSP1;ICA1;VLDLR;FYN;PTPN21;SYNJ2;MAP1B;LDLR;ADGRL2;KALRN;SMAD3;PRKCE;PPARG;RBPMS;PEX14;SIPA1L1;TFPI;CDKN1B;MMP16;CAP2;LPAR1;GRK5;KCNMA1;SLC7A1;PIK3CD;RGS4;RXRA;VAV2;ATP2B4;ZMIZ1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.4987133520721786,1.1905915678205126,0.13636363636363635,0.580806975385847,1.0,18/109,9.35%,GGT5;IGF1;PLK2;ADCY5;MYH9;NLRP12;PRKAR1B;FYN;GIPR;RXFP1;GNG2;TNFRSF1A;ADCY7;ADCY2;RAMP3;GLP1R;NLRC3;PPARG
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.7393668218497091,1.190503958122306,0.19642857142857142,0.5806251746078844,1.0,4/12,11.69%,SCX;TENM4;TLE6;B4GALT5
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5678022110923254,1.190418529813334,0.26229508196721313,0.5804964494965833,1.0,5/36,9.60%,KLF2;LTBP4;APP;LDLR;CNDP1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4759846811463544,1.1902861570129653,0.11475409836065574,0.5805112301654126,1.0,22/135,11.85%,HPN;SIX3;PKP2;CNTN4;DAB2IP;FOXO1;ABCA5;PRAME;EFNA1;TRPM4;ZNF750;ZBTB16;ZFPM2;CDK6;LDLRAD4;SMAD3;YAP1;PPARG;TRIO;ASXL1;RUNX1T1;SRA1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),0.8153706754490714,1.1902785065231112,0.21666666666666667,0.5801791752616535,1.0,2/5,8.63%,APLNR;PPP1R16B
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.5734395817801997,-1.1902724984371222,0.28125,0.9099780952488057,1.0,5/27,11.21%,ABCD2;PXMP2;ABCD1;PEX10;PEX11B
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.5090444127413917,1.1902146576495343,0.2,0.5799982369937075,1.0,11/81,10.69%,ANXA1;PDGFRA;CD55;IL1R1;TRIM5;BCL6;SAMHD1;BIRC3;MYD88;CYRIB;P2RY12
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5534105483221211,1.190103714287099,0.3,0.5799756568732446,1.0,4/32,15.51%,ABCA8;AGPAT4;SGMS1;CPNE7
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.5668385492858182,-1.1899205389035254,0.2571428571428571,0.9091613773600378,1.0,5/25,11.21%,ABCD2;PXMP2;ABCD1;PEX10;PEX11B
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8491983593984258,1.1899056384453672,0.2978723404255319,0.580269160301959,1.0,2/5,9.80%,AK3;AK5
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6404399802676528,1.1897270926045356,0.2631578947368421,0.5803893231012768,1.0,10/21,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;RAB11A;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.798361343335195,1.1895880513189228,0.18,0.5805093333129128,1.0,3/6,16.21%,SEPTIN9;HAP1;MAP4
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),0.7774140313243901,1.189537784075194,0.3333333333333333,0.5803062272242373,1.0,1/5,5.57%,GJC1
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.7776809515169972,1.189441995450753,0.3191489361702128,0.5793910951625816,1.0,2/5,17.19%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.7776809515169972,1.189441995450753,0.3191489361702128,0.5793910951625816,1.0,2/5,17.19%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.7776809515169972,1.189441995450753,0.3191489361702128,0.5793910951625816,1.0,2/5,17.19%,SLC28A3;SLC29A1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.7902817926996167,1.1893844934464541,0.27586206896551724,0.5791068014749978,1.0,4/6,19.03%,GRIP1;GRIP2;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.5646829498388093,1.189331980654005,0.2413793103448276,0.5788752766875686,1.0,4/45,3.58%,RECQL4;ANXA1;BLM;RPA1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.5828465759675511,1.1891662367253975,0.23076923076923078,0.5789433367924809,1.0,11/30,19.54%,RASGRP1;IL1R1;CYRIB;CD276;FADD;IL12A;PDE4D;SCRIB;TNFSF4;ZFPM1;TLR3
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.4858559419141839,1.1891599077476822,0.14492753623188406,0.5785850889525948,1.0,32/136,18.09%,IGF1;PROX1;NELL1;IGF2BP2;APP;YBX3;TRIM61;PTPRC;TRIM5;AHR;APLNR;ALPK2;LDLR;CDK6;MKLN1;TRIM17;AFF1;ATP1B1;NFKBID;TRIM22;PRDM1;KDM6A;STX1B;ZNF513;NOVA2;CDK2;SLC8A2;TFEB;SLC8A1;RNF187;FUBP1;MTMR2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.6745268869184083,-1.1891461561093295,0.2972972972972973,0.9101229912015156,1.0,3/13,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.690706852251453,-1.1891248958485319,0.39473684210526316,0.9081181813348127,1.0,3/7,20.68%,GTF2H2;CHTOP;MSH3
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6323391052023463,1.1890309182670147,0.28125,0.5785710448900481,1.0,6/17,17.72%,ANK3;SNCA;GRIN1;TMC8;SLC8A1;FAM20A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6620503437678341,1.1889877917483787,0.3392857142857143,0.5782732291243601,1.0,3/15,8.17%,GHR;CYP1B1;OCIAD2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.558374885490582,1.1888258708265245,0.23076923076923078,0.5784161315178419,1.0,8/37,12.36%,PLK2;BTG3;BCL6;HECA;CTNNB1;SMAD3;CDKN1C;CDKN1B
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.515022229308877,-1.1887664840112706,0.25,0.9073607028330545,1.0,23/62,26.67%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3;EAF1;CTDP1;CTR9;LEO1;CCNK;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.7485826193300229,1.1885609603013843,0.3508771929824561,0.5789467078371934,1.0,2/6,12.81%,CD24;FN1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5325577266541861,1.1884567580023475,0.14285714285714285,0.5789026552937618,1.0,15/60,12.19%,CHRM3;RCAN2;DMTN;LAT2;PTPRC;TRPM4;GRM5;CACNA1C;RYR2;SLC9A1;NUDT4;ATP1B1;CCR10;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.7623646857448829,1.1884553759287504,0.24,0.5785606844715241,1.0,2/8,2.82%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6642683894211449,1.188397162146266,0.26153846153846155,0.5783233690135524,1.0,8/23,11.38%,NLGN1;SNCB;SYT1;SYT5;SYNJ2;SNCA;PACSIN1;OPHN1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.7281753660330561,-1.1883866814703845,0.34210526315789475,0.9064748401432768,1.0,3/6,20.78%,TTN;MYOM1;RDX
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6726609584496736,1.1883534349034583,0.2692307692307692,0.5780937918567554,1.0,1/13,2.35%,ZFP36
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5741031392732362,1.188325303484779,0.24561403508771928,0.5778347618917312,1.0,7/25,16.80%,ABCA8;ABCA5;PPARG;ABCA2;RXRA;ABCA3;GPS2
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6279802470883217,1.1881402696177346,0.23728813559322035,0.5779921728621016,1.0,6/18,20.82%,ABCA8;ABCB1;SLC29A4;ABCA3;ABCC3;ABCC1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.6588416210312424,1.1881012076305246,0.2786885245901639,0.5777335316542448,1.0,6/21,18.97%,PLEK;RAP1GAP2;RARG;VAV2;CAV3;VAV1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6545542495347082,1.188056966316602,0.2,0.5775865345694017,1.0,7/22,10.76%,PCSK2;LMO2;FOXO1;ABCC8;PAK3;SYT13;DCX
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5647657463071046,1.188041267555006,0.16417910447761194,0.5772839716091588,1.0,16/52,13.95%,L1CAM;CNTN2;CNTN4;IGSF21;EMB;FAT2;KIRREL3;ROBO2;NEXN;NPTN;VSTM2L;SDK2;ROBO4;CDH4;HMCN1;PALLD
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7209782551846804,1.1879813746340349,0.30357142857142855,0.5771522641716045,1.0,4/11,15.18%,NLGN1;BAIAP3;HAP1;USP46
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7889989199038367,1.187778619817133,0.24561403508771928,0.577457757474843,1.0,4/5,20.41%,SHANK3;KCNMA1;P2RX7;ANO6
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7123107378220445,1.1875464438989873,0.2459016393442623,0.5777258548944852,1.0,1/8,0.15%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.7989707322587152,1.187507109493589,0.3220338983050847,0.5775127388133354,1.0,2/5,14.04%,DOCK4;KCNMA1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.7725225827935192,-1.1872997795498483,0.2708333333333333,0.9080584454758844,1.0,1/6,10.58%,KMT2A
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.553905576473837,1.1870799850883775,0.2,0.578505030759268,1.0,5/35,10.01%,ZDHHC9;ZDHHC22;FOXO1;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.7296578455699883,-1.1869121305718355,0.2549019607843137,0.9075685822150855,1.0,3/8,13.37%,KDM1B;RIOX1;RIOX2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7169329804088816,1.1868595985601917,0.33962264150943394,0.5786906945744635,1.0,1/8,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6423424466968707,-1.1868511415146152,0.2926829268292683,0.9057882083736687,1.0,5/16,7.50%,SLC25A5;THEM4;SLC25A4;MUL1;BAK1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.7452387190088792,-1.1865791265814547,0.2653061224489796,0.9047831252485821,1.0,2/6,17.35%,AKR1C3;BMP2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.4991575863639843,1.1865391709813768,0.1780821917808219,0.5790459652618879,1.0,14/75,13.94%,MYRF;CTSS;MMEL1;PCSK2;C1RL;ECE1;C1R;ATP23;MMP14;ADAM19;KLK6;MMP16;PHEX;STOML2
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.5585090751944786,1.186449849371143,0.27692307692307694,0.5789211137873403,1.0,12/39,14.39%,CD24;PLEK;NAPSB;CD37;CCR10;ABCB9;ITGAL;KLF4;TMEM156;PRDM1;MAN1A1;PDK1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.7974361951946773,1.1863957841201993,0.2857142857142857,0.5786857916642932,1.0,2/5,18.06%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.718198222631041,-1.1863087769832963,0.3111111111111111,0.9041409008970483,1.0,5/9,24.91%,PPP1R3C;PPP1R3G;PPP1R3E;PPP1R3D;RUBCNL
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.7162515650589445,1.1861606318548916,0.32075471698113206,0.5789003624588445,1.0,3/10,15.12%,TYMP;MACROD1;NME4
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6790813167651133,1.1860551098862449,0.23636363636363636,0.5787390051510444,1.0,6/14,17.50%,ECE1;SNCA;RAMP3;OPTN;INPP5F;SCRIB
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.8060008032824088,-1.1859543718408456,0.2909090909090909,0.9034202524840579,1.0,3/5,15.20%,SELENON;RYR1;MYORG
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.7466975618555154,1.1858995967203227,0.21428571428571427,0.5788281334944934,1.0,1/7,6.90%,STK25
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6325723740682173,1.1857934574526783,0.24193548387096775,0.5788067998426173,1.0,9/17,19.69%,CD24;IRAK2;PARP9;KLF4;ELF1;IFIH1;WNT5A;CBFB;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.7136254345023338,1.185713335663929,0.2037037037037037,0.5786972665586115,1.0,4/14,12.85%,TLR2;ROBO2;ELAPOR2;B2M
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.4903052525465478,-1.1855336694359864,0.16666666666666666,0.903124472520206,1.0,2/45,2.56%,FTL;FTH1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.53296711261328,1.1855124089912414,0.2318840579710145,0.5789405547312781,1.0,22/84,14.11%,CNR1;NPY1R;ADGRE5;ADCY5;GPR12;LGR5;GIPR;RXFP1;ADCY7;ADCY2;RAMP3;GLP1R;ADGRL2;GNA14;GNA12;GNAZ;P2RY12;S1PR3;HTR1E;LPAR1;GRK5;GPR37
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7844085133622581,1.1854992184260487,0.2711864406779661,0.5786107826905087,1.0,1/6,1.48%,KCNJ2
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.7686424196722115,1.1853583495581048,0.3064516129032258,0.578655683224427,1.0,1/7,1.37%,NPNT
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.4772790021012258,1.1851948614580914,0.1038961038961039,0.5788912109959558,1.0,17/163,10.52%,PLD1;THBS1;TYMS;IGF2BP2;APP;RPS6KA1;SAMD4A;SOX4;GRM5;ENC1;EIF2B2;FOXO3;EIF4A3;LARP6;YTHDF1;SHMT1;NIBAN1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.5678106644342131,1.1851243517748284,0.21311475409836064,0.5787306586478617,1.0,8/43,12.89%,PTK6;PIM3;SLIT2;THY1;NLRP12;CDK6;KLF7;KLF4
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6871400776850434,1.1850667530737204,0.2537313432835821,0.5785043810822066,1.0,4/14,6.48%,TYMS;TRPC3;ABCC9;VGF
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.6768140189458605,1.1850394982268422,0.31343283582089554,0.578219820588357,1.0,5/16,17.13%,APOD;CTNNA1;CABP1;OTUD7B;MFHAS1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.4965461457903535,1.1849591125897183,0.1694915254237288,0.5781111916588173,1.0,26/108,14.88%,SERPINA10;EGF;SNCB;GRID2;CLDN16;EPHA5;ARHGDIG;PRODH;ZBTB16;RYR2;DCC;MYO15A;STAG3;KCNQ2;TGFB2;MFSD6;NR6A1;NR4A2;BARD1;GPRC5C;MX1;ARPP21;COPZ2;PNMT;SOX10;CHST2
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5497920262074079,1.1849141313034834,0.15492957746478872,0.5778345368577804,1.0,14/62,6.44%,HLA-DRA;TLR2;TYMP;CTSS;P2RY13;MYO1F;PLEK;ICAM1;IRF7;DYSF;PTPRC;PLSCR1;TNFRSF14;CD44
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7277265516721361,1.1849082433455984,0.25,0.577492462460032,1.0,1/9,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7427509326903943,1.1842359981309385,0.25,0.5792246594531373,1.0,2/8,4.96%,FOXO1;FAS
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.4899257519287189,1.1839375600183357,0.18571428571428572,0.5797943728530415,1.0,28/110,17.43%,MTMR7;SOCS3;ITPKC;SBF1;ITPKB;PGAP4;SYNJ2;PLEKHA2;PIGA;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;INPP5J;PLEKHA4;PLEKHA8;INPP4A;FGF2;MTM1;BMX;PIK3CD;INPP5D;IMPA1;PIP5K1C;PIGB;INPP5F;PITPNM1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.6998097022066785,1.1839205347258601,0.2777777777777778,0.5794954829437184,1.0,2/11,3.05%,NR4A3;IRS2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6618014749041501,-1.1837614057660553,0.29545454545454547,0.9076524278874096,1.0,2/13,5.17%,AR;ESR2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.7429538730924216,-1.1836083886567963,0.33962264150943394,0.9021954682361525,1.0,2/5,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.7429538730924216,-1.1836083886567963,0.33962264150943394,0.9021954682361525,1.0,2/5,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.7429538730924216,-1.1836083886567963,0.33962264150943394,0.9021954682361525,1.0,2/5,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5854610602660896,1.1834868574107724,0.3076923076923077,0.5803558798410485,1.0,11/29,19.36%,ANK3;CLDN16;SNCA;KCNH2;GRIN1;LETM2;SLC12A5;SLC8A1;FAM20A;SLC7A8;SLC12A7
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.7554016064462815,1.1833207335377958,0.2978723404255319,0.5804576493881756,1.0,1/6,2.58%,PLEK
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6200634863390082,1.1833072139426513,0.23333333333333334,0.5801516231854579,1.0,8/29,17.47%,SCN9A;CDH23;ASIC3;CLRN1;CCL2;PCDH15;P2RX7;WHRN
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.6884948495401523,1.1831961623079905,0.2978723404255319,0.5801297121002953,1.0,4/16,18.55%,PLK2;ZFYVE19;WEE2;PLK3
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7354939325473324,1.182808725363794,0.35185185185185186,0.5807258534436668,1.0,1/7,2.35%,ZFP36
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.6274252410892288,-1.1828062242319306,0.2564102564102564,0.9032370079901155,1.0,3/13,21.05%,NIFK;GTF3A;RPAP2
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.7550586518588024,-1.1827094688152469,0.4,0.8996367280898637,1.0,2/5,12.80%,GINS3;MCM4
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.7550586518588024,-1.1827094688152469,0.4,0.8996367280898637,1.0,2/5,12.80%,GINS3;MCM4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.629538083769503,-1.1826257687231687,0.13793103448275862,0.8979997239020174,1.0,4/22,8.20%,RAB7B;TNFAIP3;NR1D1;LY96
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5223697727005566,1.1823487406401496,0.22058823529411764,0.5817499819486247,1.0,16/64,11.98%,SLC24A2;XKR4;SCN3B;GABRG3;SV2B;SRRM4;CDH7;PMEPA1;UNC13C;AIPL1;MYT1L;GRM6;MYO15A;HCN1;PDE10A;SLC7A14
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.7581249312312854,1.1823464622311386,0.24528301886792453,0.5814003420862347,1.0,2/6,5.16%,IRS2;BCL6
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5743214916106119,1.1822284155894958,0.24193548387096775,0.5812761139182405,1.0,8/35,9.61%,EGF;SH3GL2;DAB2IP;TGFA;SH3KBP1;MVP;ARHGEF7;ZFYVE28
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.4271268144765672,1.181731525954198,0.07954545454545454,0.5825011085562177,1.0,90/735,13.21%,LEF1;CDKN2A;NR4A3;SKOR1;MLIP;FOSB;SIX3;KLF2;PROX1;ZNF536;SP100;ATF3;MAEL;ZNF93;ZFP36;IRF7;DAB2IP;FOXO1;ZNF140;PRAME;EFNA1;SUV39H1;HIC1;CIC;ZNF282;TCEAL7;KLF11;NFIL3;BCL6;NKX6-2;AHR;GZF1;CHD3;KLF10;CIITA;ZNF608;ZNF750;NRG1;ZBTB16;BAP1;LDB2;TBX20;FOXO3;SNCA;MSX2;GLIS2;PML;HMBOX1;ZFPM2;DUSP22;CTNNB1;MYT1L;TBL1X;SMAD3;BASP1;NR1I3;YAP1;PPARG;ETV6;CTBP2;CHMP1A;HDAC4;GLI2;PEX14;STAT3;GLIS3;TLE6;NR6A1;CDKN1C;PARP9;JAZF1;GAS6;HDAC9;FBP1;NR4A2;GFI1B;L3MBTL3;RUNX1T1;GADD45A;PRICKLE1;MLXIPL;KLF7;CDKN1B;PER1;TFAP2C;KLF4;JARID2;SOX13;CCND1;DEAF1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7885720316618783,1.181499177284964,0.3448275862068966,0.582782281514996,1.0,1/5,5.87%,NTRK3
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.7403274182202179,-1.1814935148861643,0.22857142857142856,0.9003452772616394,1.0,2/5,15.06%,SDSL;SDS
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.7790394295369616,1.1810490427903073,0.29508196721311475,0.5837295757891564,1.0,1/6,1.37%,NPNT
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6767994060719987,1.1810065273189647,0.3333333333333333,0.5834594317519965,1.0,4/9,22.60%,ABCA5;PPARG;ABCG1;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4424669842230962,1.1808619503467135,0.07894736842105263,0.583421148648921,1.0,40/332,11.07%,LEF1;HPN;ANK3;TLR2;IGF1;IL15;RIMS2;EGF;TESC;AMH;PLD1;THBS1;ACTA2;APP;RBM24;SAMD4A;NOS1AP;ELAVL4;EPB41L4B;PLSCR1;SOX4;NTRK3;PID1;SCX;EIF4A3;VSTM2A;LARP6;RAMP3;MYD88;MYO1C;ZNF804A;SMAD3;YAP1;YTHDF1;ADAM19;STAT3;SMAD1;NIBAN1;ITGB8;GAS6
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.6480760747480621,-1.1808600298274172,0.1875,0.9007131187659826,1.0,2/17,2.08%,CYP4F3;CEL
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6870921084482686,1.1806624665978414,0.3103448275862069,0.5836287633948372,1.0,1/11,3.51%,THY1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.46555047619718576,1.180530336223087,0.1506849315068493,0.5835904236584061,1.0,43/142,19.77%,SCN9A;MAFF;ABCB1;PIM1;NFIL3;PLSCR1;AHR;SYNGR2;CD44;EMP1;MYO1C;HK2;BCL2L1;PRKCH;ADAM19;NDRG1;CD83;CDKN1C;GUCY1B1;KLF6;BCL2;IL4R;LRIG1;HIPK2;IKZF2;SPP1;SLC2A3;RGS16;CTSZ;RORA;PLEC;GABARAPL1;IGF1R;ENO3;AHCY;SMPDL3A;APLP1;CDC42SE2;CAPG;RRAGD;GLIPR2;CCND2;RHOB
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.716455891785758,-1.180214787316619,0.3023255813953488,0.9013960339607617,1.0,1/6,3.35%,RHOH
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.4607300386592999,1.1802010711424622,0.12987012987012986,0.5841371200329845,1.0,17/170,9.38%,TLCD2;GOLGA8O;ALS2CL;ANK3;A4GALT;VAPB;DYSF;ATP8B4;SUN3;SYNGR2;DNM1;SYP;TMED10;HOOK1;PLEKHF1;GOLGA8A;ARHGEF7
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.6829320049793296,-1.1795302685976594,0.29545454545454547,0.9021392015907707,1.0,2/8,19.87%,ABCD1;PEX1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.6985476768597773,-1.179491841031107,0.30952380952380953,0.9003567676106621,1.0,3/6,24.24%,CTH;MPST;TST
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.6383790928378549,1.1792117786205583,0.3137254901960784,0.5866896666182412,1.0,4/20,8.12%,GPNMB;SP100;EPHA2;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.49217600807834966,1.179085473640036,0.15151515151515152,0.586663958282475,1.0,31/145,18.27%,RASGRP2;S100A10;RASGRP1;TBC1D9;EPHA2;THY1;RGS6;NTRK3;RAP1GAP;DOCK10;AGRN;MAPRE2;ARHGEF7;SIPA1L1;CDKL5;USP6NL;CCL2;TBC1D1;RANGAP1;RAP1GAP2;SIPA1;ARHGAP22;NGEF;RGS16;TBC1D10B;TBC1D10A;PKP4;SCRIB;RAP1A;DOCK9;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6811227885302682,1.1790638429552178,0.24074074074074073,0.5863715521302169,1.0,3/9,9.24%,IRS2;SNCA;PRKCE
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5316768771313894,-1.1788368846587165,0.10810810810810811,0.9008315454330776,1.0,6/35,11.81%,ID2;SLC25A5;ALAS1;ABCB10;SLC25A38;UFL1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.8289789225344514,-1.1787701312349341,0.2631578947368421,0.899090940155937,1.0,1/5,0.62%,DSCAM
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.7110845324873607,1.1786533714430663,0.32075471698113206,0.5868462254437459,1.0,2/9,10.78%,TYMP;PUDP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.7110845324873607,1.1786533714430663,0.32075471698113206,0.5868462254437459,1.0,2/9,10.78%,TYMP;PUDP
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7699735188904604,1.1785679455831992,0.26229508196721313,0.5863273352359308,1.0,2/6,12.17%,MAPRE2;ARF6
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7699735188904604,1.1785679455831992,0.26229508196721313,0.5863273352359308,1.0,2/6,12.17%,MAPRE2;ARF6
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.7275644084140892,-1.1785346466316164,0.32558139534883723,0.8979216764462735,1.0,2/5,15.71%,ENTR1;CCDC66
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7578311022562445,1.1783297365865577,0.27419354838709675,0.5866972261262106,1.0,3/10,6.72%,NPNT;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.8132919131862386,-1.178144849352392,0.2830188679245283,0.8979140615503356,1.0,2/6,5.85%,LEPR;GREM1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.7542008658390129,1.1776374958527556,0.3191489361702128,0.5883523623668907,1.0,3/7,5.57%,DUSP1;SLIT2;PADI2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6756171448334836,1.1773021102198844,0.3,0.5889143905281906,1.0,2/15,6.20%,DMTN;PARD3
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5719866535517688,1.1769207378115598,0.23529411764705882,0.5893753022386659,1.0,4/33,7.47%,ABCB1;SLC25A21;SLC38A11;SLC7A7
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6796355404706582,1.1768070439075,0.2641509433962264,0.5893409533465608,1.0,1/12,1.68%,THBS1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4800723816499064,1.1764213283352676,0.13043478260869565,0.5901091549375618,1.0,22/107,12.93%,MET;IL1RAPL1;WNT8B;EPHA5;SOX4;ANOS1;LHX6;NEUROD2;UGDH;TENM4;CTNNB1;PTPRD;MYT1L;PBX3;TGFB2;GLI2;HS6ST1;NR4A2;OPHN1;RNF112;ATP8A2;ALK
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.5710311924633988,1.1763607957087685,0.23728813559322035,0.5899168633397852,1.0,7/34,11.09%,L1CAM;SHTN1;TRIM46;MAG;CDKL5;MAPT;DIP2B
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7185129491944606,1.1762719182305295,0.3076923076923077,0.5897677438222457,1.0,1/6,8.97%,JADE2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.6012701013921729,1.176198988962458,0.2037037037037037,0.589604499970283,1.0,6/28,20.33%,ZFP36;WTIP;ZC3H7B;PUM1;NOTCH4;XPO5
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.7796524792088879,-1.176160572548958,0.21153846153846154,0.9031783729909799,1.0,4/5,21.35%,MGME1;PRIMPOL;DNA2;PARP1
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),0.7660184851279882,1.1760391086343365,0.34,0.5897059274462523,1.0,2/5,6.64%,TGFBR2;TBX20
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6295952508805052,1.1759848665771917,0.2545454545454545,0.5895143433885376,1.0,2/17,2.55%,SIX3;CNTN4
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7762087788725228,1.1758563658921262,0.27586206896551724,0.5895300309529247,1.0,1/6,4.64%,NFATC2
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.83685276039107,1.1758405354568573,0.32075471698113206,0.588862538167148,1.0,2/5,9.22%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.83685276039107,1.1758405354568573,0.32075471698113206,0.588862538167148,1.0,2/5,9.22%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.8363361471497245,1.1757593975662393,0.2857142857142857,0.5887004289742864,1.0,2/5,10.44%,OPALIN;EPHA4
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.5432163281405331,1.1757328120397648,0.21212121212121213,0.5884459269637954,1.0,5/44,6.62%,RECQL4;SP100;BLM;RPA1;POLD1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.565869538018511,1.1756420116934136,0.22950819672131148,0.588398149057544,1.0,6/35,4.58%,MET;PROX1;PKP2;EFNA1;BAIAP2L1;EPB41L4B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.636333130609257,1.1754207794024292,0.35,0.5886918806801051,1.0,4/10,19.47%,KCNH2;BIN1;CAV3;VIP
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4918758076879077,-1.1753226925055433,0.2962962962962963,0.9045137154635298,1.0,12/69,20.20%,CDC26;FBXO5;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;PSMD2;UBB;SKP2;PSMB4
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.7448398252641568,-1.1752069357988044,0.3541666666666667,0.9030011847998036,1.0,1/5,8.40%,VPS4B
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.6318767653259778,1.1749243191011716,0.3018867924528302,0.5894758020733533,1.0,6/14,7.18%,PKP2;SCN3B;KCNQ1;KCNE4;KCNH2;RYR2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7445043843943737,1.17491951073623,0.3220338983050847,0.5891290801070745,1.0,3/8,11.59%,SOAT1;MFSD2A;DGAT1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.5528859640157141,1.174709428888851,0.25396825396825395,0.5893295344607677,1.0,6/37,15.68%,TLR2;IRF7;NLRC3;RELB;IFIH1;PTPRS
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5083838097484014,1.1745950834645966,0.17142857142857143,0.5893452387717278,1.0,14/81,14.48%,PLK2;PRKCG;DAB2IP;FOXO1;AGAP2;HECW2;GFAP;BARD1;HECW1;EEF1A2;CDKN1B;OAZ2;TRIM32;FMN2
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.813674216539255,1.1744929722830615,0.3191489361702128,0.5893538319892941,1.0,1/5,0.90%,IGF1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7158724292820028,1.1741416432471294,0.30612244897959184,0.5898869289651043,1.0,6/9,26.23%,P4HA2;P3H2;EGLN3;CRTAP;P4HA1;OGFOD1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6948292011594519,1.1740178988207153,0.2545454545454545,0.5899022715121884,1.0,8/14,24.38%,ARPC5L;ARPC3;WASHC1;SPIRE1;SPIRE2;ARPC2;JMY;ACTR3
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.7126785433931292,1.173971718838281,0.3333333333333333,0.5897264478786993,1.0,3/13,12.25%,PIM3;BMP8A;KLF7
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.7998465675714063,1.1737696762299505,0.3076923076923077,0.5899753534875481,1.0,1/5,2.61%,COL4A2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.8040690267237939,-1.1737075301714885,0.23404255319148937,0.9066095194406373,1.0,2/5,13.47%,RPL23;MCM3AP
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6143088305453246,1.1734070274148498,0.22580645161290322,0.5905280186290434,1.0,6/20,15.61%,ACSL5;HACD1;ACOT7;DGAT1;ELOVL7;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.7949509704433533,1.1733053325547222,0.2222222222222222,0.5904934737112787,1.0,1/5,4.88%,OSMR
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5272434904793744,1.1732904877632018,0.22388059701492538,0.5901976518594354,1.0,18/78,14.53%,IGF1;PDGFRA;EGF;DCN;FLT1;IRS2;DAB2IP;NTRK3;PDGFA;NLRC3;PPP1R16B;TGFB2;PIP4K2A;FBXL2;FN1;FGF2;GAB1;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7132505461928673,1.173290406328962,0.3111111111111111,0.5898457152751424,1.0,1/7,2.60%,SYT4
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6706573444639892,-1.1729852557800644,0.32608695652173914,0.9071868182467302,1.0,4/13,19.75%,SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6639316638198571,1.17295159738529,0.27419354838709675,0.5903830317665428,1.0,6/16,17.04%,CACNA1C;RYR2;SLC9A1;ATP1B1;SLC8A1;CALM3
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5708386448258208,1.1726197808260295,0.2463768115942029,0.5908351078124308,1.0,7/41,9.99%,SEMA3C;SEMA5B;SEMA3D;FAT2;SEMA3B;CENPV;RADIL
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6075463551156223,-1.172587703799563,0.225,0.9066350673186203,1.0,3/13,5.53%,SGO2;TERB1;RNF212
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.568357284646441,1.172471046081813,0.16417910447761194,0.5909625371680105,1.0,12/53,17.21%,SGPP2;VAPB;FA2H;SPNS2;HACD1;CERS3;SGMS1;ALDH3A2;ELOVL7;CERS5;ELOVL5;HACD4
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.7703460812901607,1.1724137690564143,0.23214285714285715,0.5907729408602442,1.0,2/5,21.30%,P2RY12;CSF1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6425366324434562,1.1723586762425116,0.1935483870967742,0.5906117198304961,1.0,9/21,10.24%,KCNT2;KCNQ1;KCNE4;KCND3;KCNH2;ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.4875433821701817,-1.1721661192450827,0.1951219512195122,0.9064090496754281,1.0,23/69,26.23%,ZC3H8;POLR2K;TAF13;GTF2A2;TAF11;POLR2C;SNAPC5;CCNT1;GTF2F1;POLR2D;GTF2F2;NABP2;INTS3;POLR2L;POU2F2;POLR2G;RPAP2;INTS13;POLR2E;PHAX;TAF6;NABP1;CCNK
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.6257238955732298,1.171796761248075,0.31343283582089554,0.5917377801948721,1.0,5/13,22.08%,SLC43A1;KCNH2;BIN1;CAV3;SLC43A2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.5673543772894125,1.1716481965952015,0.21568627450980393,0.5917659634237635,1.0,16/40,18.06%,BLM;ADCY5;GLRA2;GNG2;AHR;ADCY7;ADCY2;CTNNB1;CTNNA1;KLF9;BRCA1;GRAMD1A;ADCY3;GNAI1;OSBPL7;TNFSF4
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7786738371718535,1.1716182944139122,0.3,0.5914569165834624,1.0,4/5,19.98%,PPARG;RXRA;PDK3;ACTN4
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7015946273809854,1.171505870750793,0.22033898305084745,0.591408004574141,1.0,6/10,19.50%,FHOD1;ACTN1;COBL;SPIRE1;SPIRE2;FHOD3
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.75812925286416,1.1713416095493838,0.25,0.591499482576126,1.0,4/8,18.06%,ANXA1;NFKBID;RARA;TNFSF4
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5076976477141769,-1.1712996311159307,0.2,0.9074288223510886,1.0,21/69,21.07%,ERCC8;RFC3;COPS8;GTF2H5;POLR2K;POLD3;GTF2H2;COPS7A;ERCC2;POLR2C;HMGN1;ERCC6;POLR2D;PPIE;XPA;ERCC3;UBB;COPS3;POLR2L;POLR2G;COPS6
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.7735107457403225,1.1712280093177247,0.28846153846153844,0.591450603302602,1.0,2/5,11.23%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6554256746871865,1.1708368166352374,0.32142857142857145,0.5921516692200729,1.0,5/14,22.28%,ITPKC;ITPKB;FGF2;ACER3;ISYNA1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5842388081650138,-1.170828493422068,0.2564102564102564,0.9072634349183355,1.0,7/12,18.61%,TFB2M;SLC25A33;TFB1M;TEFM;MTERF1;MTERF2;FASTKD1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7531166786280422,1.1708172355435784,0.28846153846153844,0.5918433084912542,1.0,3/7,5.54%,THBS1;SERPINE1;FAP
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.6667537345984276,1.1707292380437118,0.2698412698412698,0.5917803125999892,1.0,3/12,9.48%,DYSF;MYH9;SYTL4
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.7003069038851948,-1.1707240079257986,0.3090909090909091,0.9057519632423071,1.0,5/8,27.90%,GBA2;FUCA2;FUCA1;GBA3;GUSB
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6182574985219579,-1.1705385595093598,0.3111111111111111,0.9008901621106858,1.0,7/12,34.49%,IK;PLK1;MAD2L2;ZNF207;ATM;TEX14;TPR
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6182574985219579,-1.1705385595093598,0.3111111111111111,0.9008901621106858,1.0,7/12,34.49%,IK;PLK1;MAD2L2;ZNF207;ATM;TEX14;TPR
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6182574985219579,-1.1705385595093598,0.3111111111111111,0.9008901621106858,1.0,7/12,34.49%,IK;PLK1;MAD2L2;ZNF207;ATM;TEX14;TPR
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.6827064400819206,1.1705374228069565,0.352112676056338,0.5920042217017177,1.0,1/13,0.86%,IMPDH1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6944991063473657,1.1704610119756633,0.24242424242424243,0.5918852713087106,1.0,1/10,3.21%,PXYLP1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.6002251806202724,-1.1700523317104168,0.2857142857142857,0.9008159119405091,1.0,6/31,9.66%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6633473491510777,1.1699082377409682,0.3050847457627119,0.5930102553984504,1.0,2/14,1.45%,IGF1;EGF
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.7399780185614319,1.1698149564902511,0.2923076923076923,0.5929467197058037,1.0,4/5,23.81%,NTRK3;ANGPT2;F3;CDH13
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.8218819366642406,1.1697499804536242,0.22641509433962265,0.5927995065345911,1.0,1/6,2.80%,ABCB1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6397904222094233,1.1696970407305614,0.2653061224489796,0.5925757390661262,1.0,2/13,1.31%,GPNMB;IL15
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.686083890657084,1.169659758255539,0.3333333333333333,0.5923173794325687,1.0,3/11,13.62%,WASF1;PID1;MTM1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.690191368410549,-1.1695207971496715,0.2830188679245283,0.9007722609036145,1.0,5/9,24.36%,PIH1D2;ZNHIT3;RUVBL1;NUFIP1;ZNHIT6
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.571335611556685,-1.169216053004422,0.22857142857142856,0.9001846524626966,1.0,7/16,19.53%,NSA2;RPF1;EXOSC4;RRP15;MAK16;LAS1L;NOL9
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.5191692172064724,1.1689234444242431,0.20634920634920634,0.5939334585284133,1.0,5/58,3.34%,CXCL2;TLR2;SERPINE1;ZFP36;DAB2IP
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5809955428628787,1.1684669704261788,0.25,0.5944946761737331,1.0,8/26,21.09%,IRF7;BIRC3;IKBKE;FADD;IKBKG;TLR3;RPS27A;TBK1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5809955428628787,1.1684669704261788,0.25,0.5944946761737331,1.0,8/26,21.09%,IRF7;BIRC3;IKBKE;FADD;IKBKG;TLR3;RPS27A;TBK1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7807713496234262,1.1681483061529605,0.2127659574468085,0.5950773225672075,1.0,2/7,4.96%,ST18;FAS
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.7452453730681458,-1.1681198512748097,0.2826086956521739,0.9022542157741876,1.0,2/8,7.60%,APOE;APOM
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5710989089494446,1.167606461183571,0.2857142857142857,0.5962778951284485,1.0,6/28,12.75%,APP;GRM5;FOXO3;TMED10;PRKCD;MAPKAPK5
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5208051535512976,1.167591193076964,0.23809523809523808,0.5959696463857185,1.0,12/58,7.97%,CNR1;ADGRE5;ADCY5;GPR12;LGR5;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R;ADGRL2
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.7361369528878853,1.167501364649126,0.38461538461538464,0.5954860636782527,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.7361369528878853,1.167501364649126,0.38461538461538464,0.5954860636782527,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5026656079659084,1.1673372273214586,0.19117647058823528,0.595511671337286,1.0,15/78,15.14%,ST6GAL1;B3GNT2;GALNT12;GALNTL6;GALNT8;GALNT16;TRAK1;POMGNT1;CHST4;B4GALT5;TMTC1;PLOD2;POMGNT2;ST6GALNAC2;LARGE1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5837639924544789,-1.167245937154397,0.3488372093023256,0.9037131656770873,1.0,6/20,8.69%,GDF9;FSHR;MCM9;M1AP;DMC1;METTL3
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.695084806308059,-1.1671098966706968,0.27450980392156865,0.9024621747707021,1.0,5/9,15.50%,ID2;ASCL1;POU3F2;PAX6;EPOP
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.550950977103656,1.1670323554710635,0.27941176470588236,0.5959184172449038,1.0,12/41,9.71%,FOSL2;MAFF;S100A10;SERPINE1;CD55;PLEKHG6;IL1R1;SMAGP;MLANA;GPR87;SH2D3A;ADAM19
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.71448130030856,1.166838081940554,0.3333333333333333,0.5961099725816322,1.0,2/7,26.37%,MAPT;BAG6
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5278114571993436,1.1668377639671297,0.2459016393442623,0.5957613702584851,1.0,16/61,9.58%,COL4A1;ACTA2;COL4A2;FBLIM1;EPHA2;MYH11;OSMR;POSTN;COL12A1;RHBDF1;RHOD;EMP1;MYO1C;ITGA3;YAP1;MMP14
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5323447209281901,1.1665771397661824,0.21621621621621623,0.5960842388945209,1.0,10/63,9.86%,TGFBR2;FLT1;PLEK;PTPRC;ZBTB16;KIRREL3;ARIH2;KITLG;ETV6;TGFB2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5755185114718853,1.1664801438681016,0.2909090909090909,0.5959019981884291,1.0,5/26,10.89%,IGF1;IRS2;RTN2;PID1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.5958928009648803,1.1664286681097495,0.22580645161290322,0.5956785096387276,1.0,5/20,18.06%,PTPRC;STX4;HLA-E;TFRC;TNFSF4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.6736339818583946,1.166131585385418,0.3333333333333333,0.5961458890017289,1.0,1/13,1.69%,ATF3
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.7121960978004143,-1.1661090798206963,0.3333333333333333,0.9039746974783746,1.0,1/5,6.98%,RHCE
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7312831369566543,-1.1660098629571882,0.2926829268292683,0.9007254959864803,1.0,3/8,9.78%,RFC3;DSCC1;POLG2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7312831369566543,-1.1660098629571882,0.2926829268292683,0.9007254959864803,1.0,3/8,9.78%,RFC3;DSCC1;POLG2
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.7162320912776481,1.1659357780769017,0.2542372881355932,0.5963573476708077,1.0,3/9,12.09%,MFSD2A;DCX;CDHR1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.41677230444982916,1.165848084806664,0.08333333333333333,0.596223658769971,1.0,80/776,11.07%,LEF1;SKOR1;MYT1;HPN;ELAVL2;PTP4A3;TEAD2;ANK3;TLR2;IGF1;MOG;PROX1;RIMS2;EGF;ZNF536;TESC;AMH;SH3GL2;ACTA2;PRDM8;NELL1;CASZ1;IGF2BP2;SFTPD;APP;YBX3;NOS1AP;TRIM61;HIC1;ZNF282;WTIP;PTPRC;SRRM4;PPARGC1B;EPB41L4B;NFATC2;NFIL3;PLSCR1;SOX4;TRIM5;BCL6;NKX6-2;AHR;CCDC3;SMCR8;GZF1;CHD3;NTRK3;DVL1;ZNF114;PGR;MBNL2;PID1;APLNR;ALPK2;SCX;VSTM2A;PML;RAMP3;MYD88;FAM50A;CDK6;ZNF804A;TRIM17;SMAD3;YAP1;AFF1;ATP1B1;HDAC4;ADAM19;TGFB2;NFKBID;DENND4A;STAT3;SMAD1;TERF2IP;ITGB8;MAPT;PARP9;GAS6
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6324532350027896,-1.1657576540489878,0.23255813953488372,0.8997738459234139,1.0,5/14,15.22%,NIFK;DDX18;RPL7L1;ZNHIT3;RPF2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.794559063199822,1.1647954608814572,0.28888888888888886,0.5985512853088719,1.0,1/5,6.65%,CDK9
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.639823747156163,1.1646736183917954,0.31666666666666665,0.598540494867123,1.0,3/13,10.43%,CTU2;GTPBP3;TRMT9B
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.43568876216124663,1.1645699659360165,0.1780821917808219,0.5983644533670947,1.0,38/273,11.07%,ENPP2;C3;CSPG4;GPNMB;IGF1;IL15;EGF;RASGRP1;RELN;TEC;APP;BMP8A;EFNA1;NEK10;AGAP2;PTPRC;FAS;TNFRSF14;NTRK3;CD44;CDK9;GHR;SNCA;APLNR;RAMP3;LIMCH1;PDGFA;NPTN;CHI3L1;SH2D3A;LIMK2;MMD;TGFB2;RBPMS;NIBAN1;WDFY2;TERF2IP;GAS6
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5085309955918008,-1.1642564053888085,0.2619047619047619,0.902930081384319,1.0,7/31,12.64%,TRMT61A;TRMT10C;TRMT10A;METTL2A;FTSJ1;TRMT61B;TRMT5
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.6932729770036266,-1.1640560818330539,0.32558139534883723,0.9019036236579082,1.0,3/6,17.92%,ACMSD;ASMT;PNPO
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5210394408454472,1.1638312930560428,0.2037037037037037,0.600074279190468,1.0,4/37,6.91%,TLR2;SP100;CIITA;SNCA
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.5574582026341793,-1.163642898074564,0.2777777777777778,0.9014885058484635,1.0,4/29,5.27%,ID2;GOLT1A;CFTR;KRT8
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.6712268387295461,1.1633871539314153,0.34615384615384615,0.6010736858995595,1.0,2/9,11.36%,CTNNB1;NR4A2
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7585729553563147,1.1633417836090008,0.30357142857142855,0.6008414881181408,1.0,3/5,23.45%,NLGN4X;MTMR2;TMEM25
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7285947161312725,1.1631906575139674,0.3,0.6009599297531193,1.0,3/10,15.37%,GHR;STAT3;STAT6
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.788121783299633,1.16233268054244,0.3508771929824561,0.6029595215214973,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.6989977934241947,-1.162103592926936,0.32653061224489793,0.9053907395312673,1.0,5/7,28.16%,BCAP31;SLC25A23;FIS1;MCU;MICU1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6328956009598629,-1.1619750972044958,0.4,0.9039230273028676,1.0,2/10,7.49%,COPS8;COPS7A
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.7950749303212159,1.1619720735214443,0.32727272727272727,0.603632422628823,1.0,4/6,18.53%,PRKCH;CCL2;PRKCD;PRKCA
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.534180049313464,1.1619080944119384,0.208955223880597,0.6034952932958021,1.0,3/46,8.47%,ENPP2;ENPEP;TRHDE
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6770978041524539,1.1617239995410085,0.27419354838709675,0.6036256321171084,1.0,1/15,0.33%,CXCL2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6027737212931535,1.1613168427052378,0.22950819672131148,0.6044956329740936,1.0,3/18,10.96%,NMNAT2;NAMPT;PARP9
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.8047875302925809,-1.161262901630857,0.30952380952380953,0.9051844763997734,1.0,2/5,16.65%,BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.8251210381146538,1.161245263719997,0.2037037037037037,0.6043445500061095,1.0,1/5,3.33%,YBX3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4884070889452693,-1.1612079890548628,0.23076923076923078,0.9035761515195663,1.0,23/68,26.23%,ZC3H8;POLR2K;TAF13;GTF2A2;TAF11;POLR2C;SNAPC5;CCNT1;GTF2F1;POLR2D;GTF2F2;NABP2;INTS3;POLR2L;POU2F2;POLR2G;RPAP2;INTS13;POLR2E;PHAX;TAF6;NABP1;CCNK
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.5934146255562781,-1.1610263364333233,0.2631578947368421,0.90250207322493,1.0,5/19,7.88%,CEL;CFTR;PRSS3;AKR1C3;CPA1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.5290697501888356,1.161001654841456,0.2923076923076923,0.6047068067114729,1.0,13/47,12.19%,HRH1;CHRM3;RCAN2;LAT2;TRPM4;RYR2;NUDT4;GUCY1A1;CCR10;INPP5A;P2RY12;GUCY1B1;TPCN2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7757286476442394,1.1609006973145426,0.2545454545454545,0.6046173205363675,1.0,1/6,5.58%,SMCR8
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7611308107507837,1.1608630421533421,0.3333333333333333,0.6043912517095853,1.0,3/7,12.21%,CLDN16;CLDN18;CLDN20
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),0.7538335238493146,1.1608108529724572,0.32653061224489793,0.6038170208036625,1.0,3/5,16.49%,CHI3L1;CHI3L2;CTBS
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),0.7538335238493146,1.1608108529724572,0.32653061224489793,0.6038170208036625,1.0,3/5,16.49%,CHI3L1;CHI3L2;CTBS
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.7010162281487639,-1.1604965055140268,0.40476190476190477,0.9027052854370797,1.0,5/9,21.52%,GCDH;ETFB;ETFDH;ACADS;ACADM
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.46394790933415925,1.1603915918438292,0.12903225806451613,0.6047789160081135,1.0,32/140,14.71%,C3;TLR2;SP100;PTK6;SLA;SFTPD;APP;COLEC12;IRF7;TRIM61;FYN;TRIM5;COLEC11;CIITA;SNCA;PML;NLRC5;MYD88;TRIM17;CLPB;PPARG;ZDHHC1;SYK;MX1;RELB;TRIM22;B2M;TRIM32;IKBKG;PIK3CD;IFIH1;HLA-E
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.7371847638942263,1.1599737309880616,0.37254901960784315,0.6056033319985875,1.0,3/7,12.89%,KLF2;ASS1;KLF4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.48337137099578753,1.1598376959558234,0.26666666666666666,0.6056431166988798,1.0,20/84,14.66%,TLR2;IRF7;PTPRC;MAP3K14;PLSCR1;TRIM5;SAMHD1;ABCC9;NLRC5;MYD88;APOBEC3H;BCL2L1;CLPB;RNASE1;ZDHHC1;MX1;BCL2;CGAS;FADD;IFIH1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.5179657767694225,1.159715451428808,0.27631578947368424,0.6055534522114835,1.0,13/64,15.14%,CHST8;IGF1;B3GNT2;B3GALT2;ST8SIA3;ST8SIA1;B3GALNT1;ST8SIA4;B4GALT7;B4GALT5;FUT2;ST6GALNAC2;LARGE1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.7487476010967706,-1.1596710831358363,0.358974358974359,0.9039299027915754,1.0,2/6,8.80%,DCHS1;HEY1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6134570482828827,-1.159458919165108,0.25,0.9028469532117062,1.0,4/12,25.55%,USP19;CLU;NR1H2;EIF2AK3
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.6701163291110432,-1.1591926057944872,0.2972972972972973,0.8999681049297459,1.0,2/7,9.65%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.6701163291110432,-1.1591926057944872,0.2972972972972973,0.8999681049297459,1.0,2/7,9.65%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.8086967704877939,1.1591571523670627,0.3404255319148936,0.6066210449937481,1.0,4/5,16.70%,FSCN1;SPIRE1;FMN2;SPIRE2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7060219188976454,1.1585836938098029,0.296875,0.6077486365522831,1.0,4/11,15.80%,PRKG2;FTCD;MTHFD1L;GCHFR
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7502660257286062,-1.1584155562587246,0.3409090909090909,0.9010435746760382,1.0,3/5,23.94%,ZFAND2B;SEC61A1;SRP54
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.7400402776669506,-1.158336143136664,0.3137254901960784,0.8995700085361733,1.0,5/7,24.36%,PIH1D2;ZNHIT3;RUVBL1;NUFIP1;ZNHIT6
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.49805663367008113,1.1582538981253916,0.22727272727272727,0.6082018347724272,1.0,11/71,11.38%,EGF;CLDN16;ZNF750;EPB41L4A;ZBTB7C;ADGRF5;ALDH1L1;PDZD2;ITGB8;CFAP61;OPHN1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.4734108451438773,-1.158210641370224,0.1875,0.89824654974497,1.0,5/39,14.09%,AAAS;RAE1;NUP50;NUP54;JMJD8
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6765991629601236,1.1581542993800304,0.3225806451612903,0.6081788580016804,1.0,3/9,19.57%,HDAC4;HDAC9;RCOR1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.71178911364316,1.1581351428686013,0.38,0.6078910520339655,1.0,3/7,12.11%,SAMHD1;POLQ;PMS2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.6209736449511933,-1.1577443596802461,0.24242424242424243,0.8981524815720866,1.0,6/15,16.85%,PYGM;MGAM;AGL;PHKG1;GAA;PGM2
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.7910620043295744,1.1577403196287777,0.3148148148148148,0.6086827527211365,1.0,1/5,3.97%,PTPRR
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.47009931759602935,-1.1575687399696635,0.17142857142857143,0.8969951062818065,1.0,24/93,23.20%,FIP1L1;AAAS;RBM8A;ENY2;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2;POLR2D;CPSF3;DDX19A;SRSF9;UPF3B;CHTOP;NUP85;NUP42;POM121C;THOC3;THOC1;NXT1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.4455615096086514,-1.157509549159739,0.17647058823529413,0.8953114636088874,1.0,7/79,6.01%,NUP62CL;ABCD2;PXMP2;NXT2;APOE;NUP50;ABCD1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4941313427117232,-1.1574788476671594,0.21052631578947367,0.8936773512203391,1.0,23/64,26.67%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3;EAF1;CTDP1;CTR9;LEO1;CCNK;NELFCD
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.7484558162897155,1.1574611494551537,0.3064516129032258,0.6091004598580066,1.0,3/7,11.71%,RAMP3;GRM6;CCL2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.587121497637018,1.157456716044375,0.22950819672131148,0.608778723068289,1.0,9/26,16.36%,SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1;TNFRSF10B;FADD;BRCA1;RFFL
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.7734744286382673,1.157242421829408,0.36666666666666664,0.6089926285038408,1.0,4/5,22.08%,SLC43A1;GRM7;HRH3;SLC43A2
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7517601700526624,-1.1572199971018264,0.3953488372093023,0.8928212664912737,1.0,2/7,5.85%,TNFAIP3;GREM1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.5126270127101427,1.1569351171929292,0.2608695652173913,0.6094839306473395,1.0,8/64,16.91%,TBC1D24;PLK2;CDKL5;USP6NL;TBC1D1;TBC1D10B;TBC1D10A;IFT140
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6951635068558917,-1.1568915622685172,0.35555555555555557,0.8925675227213276,1.0,1/7,2.52%,DISP3
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.7375969959579347,-1.1565082408869867,0.34782608695652173,0.8923574677043755,1.0,1/5,5.39%,PDCL3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7247575834750258,-1.1564646327180241,0.3617021276595745,0.8907843682338716,1.0,2/6,15.32%,MCRS1;NMD3
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.7040066431140573,1.1561270652967275,0.3333333333333333,0.6111996556195741,1.0,3/10,9.88%,RELN;SOX4;GLI2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6867104237464869,1.1558812320106426,0.34615384615384615,0.6114591589950752,1.0,1/7,6.43%,BIRC3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5959299885563751,1.1558774436728592,0.27586206896551724,0.6111167134481065,1.0,7/24,22.35%,RBM24;BOC;SRA1;AKIRIN1;BTG1;ANKRD2;FLOT2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6576122613488824,1.1558072618736246,0.2978723404255319,0.6108962718986509,1.0,4/15,9.98%,CSPG4;DCN;BGN;UST
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.6490945600247906,1.1557404872945782,0.2982456140350877,0.6107165964191413,1.0,5/14,24.45%,IRF7;IFIH1;TLR3;TBK1;DHX9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6314420950659853,1.1556146958992664,0.34545454545454546,0.6108138175230533,1.0,4/17,13.49%,PIM1;TBX20;ZFPM2;FGF2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.599000046088144,1.1554401810472077,0.23809523809523808,0.6109041831007771,1.0,5/28,9.88%,PDGFRA;MYLK3;OBSCN;SYNPO2L;TCAP
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.7543155447633112,1.1554222185469518,0.31666666666666665,0.6105967331317655,1.0,2/5,15.08%,ST8SIA3;ST6GALNAC2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.4626882689163222,1.1549396263794607,0.140625,0.6115561995403596,1.0,23/202,10.02%,TLCD2;ANK3;A4GALT;EGF;SH3GL2;VAPB;CNTN2;SYT1;DYSF;TGFA;SH3KBP1;SUN3;SYNGR2;DNM1;CLTB;REPS2;SYP;SYNJ2;LDLR;TRIP10;ARPC3;CHMP1A;TF
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.65856782462859,1.1549369294384386,0.3114754098360656,0.6112083291196881,1.0,2/9,12.46%,RAB40B;SLC29A4
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.5511669343026325,1.1546757999611594,0.2537313432835821,0.6115876289185375,1.0,5/38,6.62%,RECQL4;SP100;BLM;RPA1;POLD1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6870665104545812,1.1545072239072915,0.35185185185185186,0.6114106125776084,1.0,4/12,14.71%,RASGRP1;CD160;IL12A;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6870665104545812,1.1545072239072915,0.35185185185185186,0.6114106125776084,1.0,4/12,14.71%,RASGRP1;CD160;IL12A;HLA-E
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.4696488247054259,-1.1544889720443197,0.2727272727272727,0.8956406139413289,1.0,12/52,22.33%,AAAS;RAE1;NUP50;ABCD1;NUP54;JMJD8;SLC25A33;FIS1;NUP85;NUP42;SPHK2;POM121C
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.7238068565769746,1.1542899960637152,0.2909090909090909,0.6115607418909597,1.0,3/7,18.96%,DOCK10;GPR183;LFNG
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7179316611430243,1.1542306735953762,0.3559322033898305,0.6113548521515476,1.0,1/7,8.31%,BCL2L1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.7222152380076844,1.153859142191405,0.3559322033898305,0.612075220145898,1.0,5/8,6.95%,KCNT2;KCNQ1;KCNE4;KCND3;KCNH2
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.6647715687357636,1.15354849862948,0.328125,0.6124728589413134,1.0,1/8,3.70%,ACHE
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6459595643360535,1.153491912434823,0.32142857142857145,0.6122399915842099,1.0,5/17,8.55%,IL1RAPL1;NLGN1;DVL1;PTPRD;PCLO
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.6045390572207543,-1.1534219994570591,0.28888888888888886,0.8975486440333251,1.0,2/17,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7622589650072996,1.1532207493345987,0.40384615384615385,0.6127509688387466,1.0,2/6,6.72%,LHX6;ROBO2
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.44338906195532557,-1.1530293671802976,0.1875,0.8971611135207034,1.0,28/83,26.02%,SELENOS;SEL1L2;TMUB2;FBXO27;UBXN8;FOXRED2;DERL2;ERLIN2;USP19;AUP1;RNF5;RNF103-CHMP3;UBE4A;YOD1;POMT2;DNAJB9;TMUB1;DNAJC10;RHBDD2;ATXN3;ERLIN1;VCP;ERLEC1;FAM8A1;DERL1;DNAJB12;UBXN4;DNAJC18
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.5595046957257088,1.1529814848590667,0.23880597014925373,0.6129801722148195,1.0,5/36,14.19%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.7426011164311362,1.152678043925422,0.2459016393442623,0.6134901533500009,1.0,2/10,15.19%,EIF2B2;EIF2B5
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5979902486483312,1.1526646297580823,0.234375,0.6131569238918967,1.0,7/29,14.85%,SEMA3C;SEMA5B;SEMA3D;SEMA3B;RADIL;FN1;SOX10
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.739069043333265,-1.15260204114273,0.32558139534883723,0.8968737565496462,1.0,3/6,5.85%,RAB7B;TNFAIP3;NR1D1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.7440903792207056,1.1522551965130907,0.32075471698113206,0.6139603164111396,1.0,3/5,19.53%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6308498136828425,-1.1520869714566142,0.3125,0.8970377592650208,1.0,3/9,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.5521995775150461,-1.1518699180369352,0.24324324324324326,0.8960916921105315,1.0,7/28,16.83%,ATRIP;HUS1;BRIP1;ATR;ERCC6;CLSPN;HINFP
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5677893433724249,1.1516546965563519,0.26153846153846155,0.6151836438112427,1.0,6/34,9.99%,SEMA3C;SEMA5B;SEMA3D;NRG1;SEMA3B;RADIL
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.619510608839072,-1.151326426581346,0.34210526315789475,0.8961163958931491,1.0,2/11,14.39%,APOE;CLU
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6170081362093249,1.1512248236567728,0.3125,0.6160250445270782,1.0,2/14,5.09%,CD55;TRIM5
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.753593104431584,1.1511042716349997,0.35185185185185186,0.6159913997972876,1.0,3/5,14.07%,SLC7A2;SLC25A29;SLC7A1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.6717766858139949,-1.1508407226434512,0.3157894736842105,0.8961410053865201,1.0,5/13,20.68%,DMC1;TPRKB;RAD54B;RAD51;MSH3
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.7660615622306511,-1.150768028805948,0.3181818181818182,0.8946854097981886,1.0,1/5,9.13%,MTRES1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7703666003083434,1.1506731030703365,0.3695652173913043,0.6165107423301728,1.0,1/5,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7703666003083434,1.1506731030703365,0.3695652173913043,0.6165107423301728,1.0,1/5,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6873873611940454,1.1504811120937724,0.3448275862068966,0.6166900404458938,1.0,3/11,12.89%,KLF2;ASS1;KLF4
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4670132576929797,1.1504154060670373,0.2631578947368421,0.6164963177818708,1.0,34/138,18.44%,PLK2;PRKCB;TRAF3IP2;NOD1;MAP3K14;TRIM5;BIRC3;TNFRSF1A;CASP10;SHISA5;MYD88;UNC5CL;IKBKE;TERF2IP;APOL3;TNFRSF19;LURAP1;HLA-DRB1;TRIM22;BRD4;TNFRSF10B;FADD;LPAR1;TNIP2;TRIM32;IKBKG;NEK6;CD4;PINK1;TRAF5;TFRC;NDFIP2;FLNA;LITAF
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.78732448964615,-1.1504042215945294,0.3333333333333333,0.892500217327058,1.0,1/6,0.86%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.78732448964615,-1.1504042215945294,0.3333333333333333,0.892500217327058,1.0,1/6,0.86%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.567412232551562,1.1502730229399016,0.26229508196721313,0.6165356938610597,1.0,6/27,15.46%,ZFP36;IRS2;MAPT;CDKN1C;CDKN1B;TP53
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.7163517379634339,1.1502416571623801,0.32075471698113206,0.6162890755464137,1.0,1/6,4.48%,ASIC3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5555264346317381,1.1499488748971407,0.2033898305084746,0.6167937626462475,1.0,6/51,5.54%,CTSC;CTSS;DAB2IP;VLDLR;DENND3;FAP
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.6126023638326915,1.1498711335190501,0.2833333333333333,0.6166801270997827,1.0,10/26,27.47%,SIGLEC1;CLTB;PIP5K1C;INPP5F;FCHO2;CLTC;AP2A2;FCHSD2;GAK;PICALM
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5534599995598833,1.149840883759394,0.2542372881355932,0.6164471203578852,1.0,9/38,15.53%,BOK;SEPTIN4;DAPK2;BCL2L1;BBC3;BCL2;SGMS1;TP53;PINK1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.7104121113036844,1.1496096396516975,0.39344262295081966,0.6167385471963971,1.0,3/11,9.88%,SIX3;GCM2;GLI2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7391232254238577,-1.1493670007958772,0.425,0.8940031908156932,1.0,1/5,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.5466166125337851,1.1491356160724322,0.3230769230769231,0.6177060478635376,1.0,7/30,6.95%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.600347244431519,-1.1490591363746083,0.3404255319148936,0.8935188263478197,1.0,2/24,4.46%,NGF;BLOC1S2
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.7584692699887512,1.1489687103409083,0.4074074074074074,0.6178771455342263,1.0,1/5,3.33%,YBX3
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.7936348539159472,1.1487390427150295,0.3442622950819672,0.6178480327457507,1.0,3/5,20.13%,TCP1;CCT4;WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.7936348539159472,1.1487390427150295,0.3442622950819672,0.6178480327457507,1.0,3/5,20.13%,TCP1;CCT4;WRAP53
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6377932270690939,1.1484300759595985,0.2711864406779661,0.618230493704418,1.0,9/17,17.50%,ERBIN;CLIC4;PARD3;FSCN1;PARD3B;DLG3;PATJ;MTCL1;SCRIB
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5855578373717306,1.1483954631715272,0.23728813559322035,0.6179975320354749,1.0,3/28,9.84%,BOK;ZNF385B;NDRG1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.726477598204362,1.148198734105144,0.42857142857142855,0.6181679892971602,1.0,4/8,22.72%,ZDHHC7;SLC2A3;SORT1;SLC27A1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.7722860467033823,1.148157956707122,0.36363636363636365,0.6179287170375323,1.0,2/6,13.58%,TNFRSF1A;FADD
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.590134356288577,1.1480804260091966,0.23214285714285715,0.6178019420733954,1.0,5/24,13.18%,CDKN2A;PML;PRKCD;MAPKAPK5;CDKN1A
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.5903750969865236,-1.1477562527215819,0.35,0.8962175542351578,1.0,13/33,24.17%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;POLR1B;ERCC3;TTF1;POLR2L;POLR2E;GTF2H3;UBTF
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.6451312629225935,1.1475945013039544,0.24074074074074073,0.618546258734281,1.0,5/13,18.06%,CD22;PTPRC;STX4;HLA-E;TNFSF4
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7290189769849369,1.147581569843186,0.40350877192982454,0.6182280424480842,1.0,3/5,15.29%,PML;HIPK2;ETS1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.5151713039742111,1.1473738730761378,0.24242424242424243,0.6183188076876346,1.0,8/55,13.20%,CDKN2A;PLK2;MAP3K11;CDK6;CDC7;CDKN1B;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.5008561706223659,1.1471273309805108,0.23333333333333334,0.6185609750492407,1.0,10/69,16.79%,RECQL4;BLM;RPA1;SAMHD1;POLQ;MRE11;ZSWIM7;XRCC1;BRCA1;MEIOB
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),-0.688653887082668,-1.147116408247724,0.325,0.8968076758163813,1.0,1/7,1.02%,RGS2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.7295259853173718,1.1470108883256982,0.31746031746031744,0.6185197855679153,1.0,1/8,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.46414253275405054,-1.1466418496199529,0.1891891891891892,0.896513685351476,1.0,7/63,6.01%,ABCD2;CEL;MCAT;PHYH;NUDT7;ABHD1;ABCD1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.5095919418715213,1.1465806819454278,0.26785714285714285,0.6191826772694724,1.0,11/66,9.67%,HPN;OTOS;COL11A2;CDH23;KCNQ1;EPS8L2;LHFPL3;CLRN1;CDC14A;TBL1X;EML2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7412518638649946,1.1462807628077738,0.36363636363636365,0.6197067340184124,1.0,2/5,6.22%,ABCB1;GRM5
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6968790870105694,1.1462731054954074,0.3275862068965517,0.6193889335136887,1.0,3/11,13.63%,ARPC5L;ARPC3;WASHC1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6564696123635113,-1.1462102227892867,0.3333333333333333,0.8944189301399176,1.0,2/11,5.85%,PPP1R3C;NR1D1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6564696123635113,-1.1462102227892867,0.3333333333333333,0.8944189301399176,1.0,2/11,5.85%,PPP1R3C;NR1D1
prerank,MSigDB_Hallmark_2020__Androgen Response,0.47384106684429345,1.1457543479781442,0.20967741935483872,0.6203786800929297,1.0,27/92,23.18%,PMEPA1;PTPN21;STEAP4;TPD52;CDK6;FKBP5;DHCR24;GUCY1A1;MAK;NDRG1;DBI;ACTN1;B2M;CCND1;ABCC4;ELOVL5;ZMIZ1;ADAMTS1;PIAS1;HMGCS1;MAP7;UBE2I;MAF;PLPP1;ITGAV;ELL2;INPP4B
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6673838508301823,1.1456605200791923,0.3392857142857143,0.620270944954275,1.0,2/11,3.03%,HTR2C;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6663843408797105,1.1456076436495908,0.3076923076923077,0.6200714677883139,1.0,5/10,22.39%,GAS6;IL12A;HLA-E;ZBTB1;HLA-F
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5778181855497057,1.1452837820396993,0.30303030303030304,0.6205804646553875,1.0,6/23,6.72%,SLIT2;EFNA1;SLIT3;TNFRSF1A;TBX20;ROBO2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5457169040078281,1.145225425832016,0.2835820895522388,0.6203613742091785,1.0,13/38,16.70%,B3GNT2;PXYLP1;B3GALT2;AGRN;UGDH;B3GALNT1;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;NDST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6472356469982078,1.145160138299415,0.32142857142857145,0.6202538871316409,1.0,4/16,11.71%,IGF1;EPHA2;GAS6;CCL2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7574869221329639,1.144631539035359,0.36666666666666664,0.6212595118002983,1.0,4/7,21.96%,MYO1C;GAB1;PIK3CD;HSPB1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6299786217821071,-1.1445180308055478,0.2972972972972973,0.8985980088048525,1.0,2/13,7.89%,AR;NCOA4
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.6524768211313708,-1.1445172377644053,0.28205128205128205,0.8969215199824553,1.0,4/15,5.09%,DCLRE1B;GINS3;RFC3;POLD3
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.7882508707325259,-1.1441620110648634,0.32653061224489793,0.8965208445780461,1.0,2/5,8.25%,CTSH;MICA
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.7461589090883484,1.14406603485977,0.40384615384615385,0.6225519341614837,1.0,1/5,5.94%,MFSD2A
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.7422184484704732,1.1439814572490017,0.37254901960784315,0.6220539602868326,1.0,3/5,15.01%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.7422184484704732,1.1439814572490017,0.37254901960784315,0.6220539602868326,1.0,3/5,15.01%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6609166047526955,-1.1436548283025387,0.2608695652173913,0.8967620764873139,1.0,4/9,26.04%,VPS35;DNM1L;FIS1;CCAR2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5867831512616135,1.1436371833555679,0.2727272727272727,0.6225794944321567,1.0,4/19,10.80%,PDGFRA;SERPINE1;PDGFA;TFPI
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7321862461296351,-1.1434663342450664,0.4117647058823529,0.8957511552397183,1.0,1/5,5.77%,MRPL18
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.618026567540071,1.1432297546662944,0.30158730158730157,0.6234831285743747,1.0,4/15,16.03%,TRPC3;ABCC9;P2RY12;P2RX7
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.647987276132034,1.1427608502919369,0.40425531914893614,0.6243922917893423,1.0,3/12,20.62%,CDK9;HPF1;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.6872455473767077,1.1422822165013138,0.3050847457627119,0.6254374102687056,1.0,2/9,9.25%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7152963334058637,1.1420435258552633,0.39344262295081966,0.6257252694076081,1.0,3/7,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.7279616443041841,1.1420185950608168,0.4307692307692308,0.6254134696067585,1.0,2/6,14.58%,FGF2;AKIRIN1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.7076284042182694,-1.1415753408556004,0.23255813953488372,0.9002420332079132,1.0,2/7,8.43%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5900213226151896,1.1414689534607938,0.34375,0.6266060548686064,1.0,3/19,4.64%,SHISA7;NLGN1;SHANK3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.6620871404379455,1.1414130419405422,0.37735849056603776,0.6263852176305269,1.0,4/11,18.31%,CDK9;AKAP8;MTHFR;HPF1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6813595993126438,1.1412600886691333,0.3275862068965517,0.6263857539567712,1.0,3/8,12.03%,HECW2;PRKCE;HECW1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.43589489249943225,1.141075110423689,0.17567567567567569,0.6265682974781964,1.0,45/246,15.99%,BOK;MLLT11;EPHA7;SLIT2;SEPTIN4;MAP3K11;DAB2IP;FOXO1;KLF11;ARHGEF17;SOX4;FAS;BCL6;ARHGEF3;FAP;TFPT;FOXO3;SNCA;PAWR;CYP1B1;OBSCN;DAPK2;MCF2;CTNNB1;KALRN;NEURL1;ARHGEF7;PNMA2;TGFB2;TRIO;PXT1;PLEKHG2;BARD1;GADD45A;TPD52L1;TNFRSF10B;FADD;KCNMA1;BIN1;RARG;MAP3K5;STK3;TP53;NGEF;VAV2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.7263239959967268,-1.1408574541148662,0.32608695652173914,0.901057714173106,1.0,3/7,18.76%,SLC8B1;JAM2;MIA3
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.7385355719679603,1.1408374293401322,0.28846153846153844,0.626919555091569,1.0,1/5,12.17%,ARF6
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.7643104339195128,1.140803404068804,0.29310344827586204,0.6266665647089287,1.0,1/6,2.72%,TIMP2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5498988334694842,1.1403844781142645,0.2676056338028169,0.6273872897422293,1.0,18/55,17.10%,SLC24A2;KCNJ2;SLC39A14;TRPM4;SLC9A9;ABCC9;KCNH2;ATP1A1;SLC9A1;ATP1B1;ATP1B3;SLC9C2;SLC12A5;SLC24A1;ATP2B4;SLC8A2;SLC8A1;SLC9A5
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.7775616254589669,1.1401798823227878,0.3275862068965517,0.6275429402582396,1.0,2/5,16.14%,NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.611959840535213,-1.1398770094652526,0.34146341463414637,0.9027495330414935,1.0,3/13,8.80%,HEY2;ZNF593;HEY1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5693383600006805,-1.139817283229454,0.28205128205128205,0.901316518397639,1.0,3/24,6.17%,TNFAIP3;TRIM21;MUL1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.6956498894023454,-1.1392548658547115,0.38181818181818183,0.9018562134625268,1.0,2/8,5.26%,TMEM100;ASB4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.7140502242362567,1.1392080356091143,0.3333333333333333,0.6297987434165584,1.0,2/8,6.02%,GRIP1;DVL1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6231799067713025,1.1392043798560079,0.25,0.6294669838484626,1.0,4/26,6.79%,IGF1;APP;MFSD2A;GHR
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.6598751888979255,1.1390459095007226,0.3584905660377358,0.6296082904595715,1.0,3/10,11.24%,SCX;TENM4;PHLDB2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.688681582034715,1.138855394050261,0.37735849056603776,0.6298206328583008,1.0,6/8,27.56%,OGG1;NEIL2;NEIL1;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.5031119007571929,1.1387939582831645,0.2602739726027397,0.6296252396948882,1.0,9/78,6.91%,TLR2;IL15;THBS1;SERPINE1;APP;NLRP12;PLSCR1;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.6599713274517697,1.1387740760165348,0.3492063492063492,0.6293330883078466,1.0,7/12,27.52%,APLNR;AKAP8;DYRK1A;AKAP8L;CTBP1;NNMT;BRMS1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5789145357371696,1.1383324561171584,0.24615384615384617,0.6301590517595049,1.0,2/26,1.68%,TLR2;THBS1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.7719808581777214,-1.1381181118958643,0.2972972972972973,0.904088741298897,1.0,3/6,19.57%,PLA2G4C;CHPT1;PLA2G4A
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6587001934989762,1.1378974693345658,0.3181818181818182,0.6309970294422609,1.0,4/12,9.98%,CSPG4;DCN;BGN;UST
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5895006103564749,1.1378103930261179,0.375,0.6308466004118028,1.0,9/18,31.24%,SNCA;PXK;CAV3;VIP;HRH3;WNK1;NEDD4;NOS1;PLN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5681985678183954,1.1377526410510599,0.22388059701492538,0.6306189271214145,1.0,12/31,23.59%,THBS1;SERPINE1;GAS6;IL12A;AKIRIN1;ADAM17;IL6R;VEGFD;ANO6;CSF1;RARRES2;CXCL12
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.47020613950883144,-1.1376242458403938,0.28125,0.9041380366274185,1.0,5/40,14.09%,AAAS;RAE1;NUP50;NUP54;JMJD8
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.765260773928639,-1.13752044520768,0.41304347826086957,0.9028603815739,1.0,1/5,7.44%,FAM3A
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.6859491628869983,-1.1373895766254063,0.36585365853658536,0.9015873894950293,1.0,1/10,4.81%,GALT
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5187423480202066,1.1372555143994894,0.30158730158730157,0.6314810737674608,1.0,16/54,23.89%,FOXO1;MAP1LC3A;FAM107A;MFSD2A;KLF10;PDK4;TFEB;STK24;ELAPOR1;RRAGD;KCNB1;WDR45;ULK1;CDKN2B;ATG7;EIF4G1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.5698858995826372,1.1370770099269005,0.28846153846153844,0.6316399226591026,1.0,4/25,8.57%,SULF1;PTPRC;NOTUM;SH3PXD2B
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.48439423210129867,1.1369466603532576,0.2318840579710145,0.6315860735615587,1.0,29/122,10.66%,C3;BOK;AMH;FAM20C;CD55;SHC2;DAB2IP;ARHGEF17;FAS;SEMA5B;PADI2;PTPN21;TNS1;SEMA3B;RHBDF1;CDC42EP1;MAOB;SCX;C1R;MATN2;LAMA5;KITLG;BGN;ARHGEF10L;YAP1;RASL12;TF;PXDC1;SLCO2A1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6224322045662573,-1.1369072149058201,0.25,0.9014807368906,1.0,6/14,16.85%,PYGM;MGAM;AGL;PHKG1;GAA;PGM2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.7707848621437305,-1.1368862017825694,0.3333333333333333,0.8999083240970173,1.0,2/5,7.44%,BCL10;FAM3A
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5726691976696442,-1.1366502767378188,0.3,0.8990201446425865,1.0,6/18,14.87%,PPWD1;PPIC;PPIH;PPIL3;PPIL1;PPIE
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.765607495278767,1.1361450508122304,0.34,0.6334568424997755,1.0,3/6,10.40%,CLDN16;SLC4A11;LETM2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.649731924247512,-1.1361248230765326,0.391304347826087,0.8988921618252906,1.0,3/6,19.74%,STXBP4;CDH3;MDK
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6556720235090601,1.136100737792614,0.32786885245901637,0.6332862676771257,1.0,7/10,31.31%,CACNA1C;ORAI1;CACNA1D;AKAP5;MAPK3;NOS1;NF1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5863141379861906,1.1360150440661163,0.25,0.6331480264671367,1.0,2/26,3.62%,ANK3;AMN
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7242855123750537,1.135878805012612,0.34615384615384615,0.6333055392039698,1.0,4/7,22.78%,SNCA;ABCG1;BMP6;PTH1R
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4394329379216911,1.1358745974351772,0.13157894736842105,0.6329683343570077,1.0,32/207,13.49%,C3;GPNMB;EPHA7;SH3GL2;ATF3;RASGRP1;SLIT2;APP;DAB2IP;EFNA1;TSPYL2;FYN;FAS;NTRK3;GRM5;PID1;PML;LIMCH1;PDGFA;NPTN;LIMK2;NIBAN1;WDFY2;TERF2IP;GAS6;HLA-DRB1;BRD4;FN1;PAK1;AKAP8;CCND1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6918577536763206,1.1357957316918068,0.32608695652173914,0.6328240712656182,1.0,1/5,9.35%,PPARG
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.7381793551924863,1.135467378094704,0.37735849056603776,0.6332509637745956,1.0,3/6,9.37%,KCNK10;KCNK1;KCNK12
prerank,PanglaoDB_Augmented_2021__Microglia,0.5375761100157925,1.1352990996841972,0.2698412698412698,0.6333054835058498,1.0,11/59,4.31%,HLA-DRA;P2RY6;CTSS;P2RY13;MYO1F;PLEK;SLA;GPR34;COLEC12;SIGLEC1;PTPRC
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.6254700604865046,-1.1351691168867513,0.26666666666666666,0.9004349370843457,1.0,2/9,3.47%,EXOSC8;ERI2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5836811297778863,1.1348335403947436,0.328125,0.6341161795762272,1.0,8/27,18.63%,SLIT2;SHANK3;SHANK1;SSH2;CYRIB;PRKCD;PFN2;CAV3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.5372314128323901,-1.1346940661870442,0.34285714285714286,0.9004901158814347,1.0,2/27,3.49%,DNMT3B;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.7586642449126896,1.1346781218894315,0.33962264150943394,0.6341445508874193,1.0,2/6,3.66%,DUSP1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7465012038262022,1.134471324885701,0.42,0.6344417688833015,1.0,1/5,10.90%,ABCA2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.752841464817153,1.1336367591497367,0.36363636363636365,0.6363126674749582,1.0,3/6,23.85%,PLSCR1;IL6R;APOL2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.43164670542771,1.133625510542581,0.1794871794871795,0.6360072700519659,1.0,31/254,11.07%,LEF1;HPN;ANK3;TLR2;IGF1;KLF2;RIMS2;EGF;TESC;AMH;ACTA2;APP;NOS1AP;EPB41L4B;PLSCR1;NTRK3;PID1;ECE1;SNCA;SCX;VSTM2A;RAMP3;MYD88;ZNF804A;SMAD3;YAP1;ADAM19;STAT3;SMAD1;ITGB8;GAS6
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4608531732203568,-1.1335470342476826,0.34285714285714286,0.9026980879687986,1.0,1/38,0.09%,NGF
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5540951709188178,1.1333440968871555,0.3333333333333333,0.6363860899420887,1.0,8/35,16.86%,CLDN16;PARD3;POF1B;CLDN18;CTNNA1;CLDN20;PATJ;MICALL2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7398046742549008,1.1333426541661988,0.37037037037037035,0.6360490424063687,1.0,2/5,12.46%,SNCA;SLC29A4
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6091502220104352,-1.133233311161703,0.3157894736842105,0.9020633890809089,1.0,6/16,19.57%,CES2;AKR1C3;PTGIS;PTGR1;GSTP1;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6110903066061246,1.1331413908495496,0.3275862068965517,0.636229509218838,1.0,2/16,4.92%,NOS1AP;FYN
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.6912526940434435,1.1327856961581837,0.3064516129032258,0.6369457968354073,1.0,4/9,10.46%,MYH9;PIR;PPARG;PDE1B
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6458930448462052,1.1324486419194824,0.36363636363636365,0.6374572262756183,1.0,5/13,15.68%,SLITRK1;PTPRD;LRRC4;LRFN5;PTPRS
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.7396355075928521,1.1324174940776222,0.38181818181818183,0.6372095676151528,1.0,3/5,9.88%,PROX1;MYH11;TCAP
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6543090005068705,-1.1322968808232192,0.3469387755102041,0.9035630695312389,1.0,4/10,21.95%,NCL;DDX11;NOL11;PWP1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.7077783925609903,1.1319703027652652,0.42,0.6379878795273524,1.0,1/6,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6319638389719036,1.1317082853466978,0.3,0.6382559616794425,1.0,7/11,28.20%,MFSD2A;MYO9A;ERMN;SEMA4D;FAM110C;MOV10;MACF1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5670891917702512,-1.1316349244250057,0.3191489361702128,0.9043742233771421,1.0,7/19,15.37%,ALAS1;HMBS;ABCB10;SLC25A38;FECH;TSPO;SUCLA2
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7059151002951223,1.131633276541959,0.3469387755102041,0.6381228247142066,1.0,2/8,11.17%,HDAC4;HDAC9
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.7136272978892633,1.1314836400107589,0.3584905660377358,0.6381933688204472,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5067683676195058,1.131374178335211,0.25,0.6381176227913358,1.0,25/93,12.79%,GRIK1;RIMS2;NPTX2;NLGN1;GRIK2;GRID2;SYT1;RELN;CLSTN2;DLGAP3;APP;RIMS3;BAIAP3;KCNMB4;CPLX2;GRM5;NPTX1;GRM6;CPLX1;HOMER1;LRRC4;OPHN1;KCTD13;PXK;DLGAP1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6457685155227382,1.1312948663617601,0.3389830508474576,0.6379085296665458,1.0,3/10,8.52%,IL1RAPL1;NLGN1;PTPRD
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.7036156025932966,1.131167725992568,0.24528301886792453,0.6378711196721599,1.0,2/8,18.14%,ACOT4;CRAT
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.7489431306228845,1.1310926453930117,0.34545454545454546,0.6377385459920893,1.0,1/7,2.21%,BLM
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6492304273492369,1.1308410932186903,0.36507936507936506,0.6380057560962002,1.0,5/12,6.95%,SCN1B;KCNQ1;KCNE4;NOS1AP;KCNH2
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5653472006759338,1.1306162403701199,0.2542372881355932,0.6384058224997751,1.0,9/28,17.50%,ERBIN;PARD3;OPHN1;PARD3B;DLG3;MYO9A;CAMSAP3;MTCL1;SCRIB
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.7051352809894147,1.1304915672519438,0.3898305084745763,0.6384189202126518,1.0,1/7,1.10%,RFTN1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.7448360075766463,1.130243531330097,0.4230769230769231,0.6389576708541276,1.0,1/5,0.74%,FLRT3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.44646191747752134,1.130151199044568,0.2222222222222222,0.6388565203550634,1.0,44/178,18.44%,PLK2;PRKCB;TRAF3IP2;DAB2IP;NOD1;NLRP12;CARD19;MAP3K14;TRIM5;BIRC3;TNFRSF1A;CASP10;SHISA5;MYD88;UNC5CL;NLRC3;IKBKE;TERF2IP;APOL3;TNFRSF19;MAPKBP1;LURAP1;HLA-DRB1;TRIM22;BRD4;PER1;OPTN;TNFRSF10B;FADD;LPAR1;TNIP2;TRIM32;IKBKG;NEK6;CD4;OTUD7B;PINK1;RORA;TRAF5;WNT5A;TFRC;NDFIP2;FLNA;LITAF
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.7171560130542898,1.1294684783757154,0.36666666666666664,0.6403054868164049,1.0,1/6,9.20%,SEC14L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.630751446713596,1.1294039014398325,0.29508196721311475,0.6401721084614499,1.0,5/14,6.95%,SCN1B;KCNQ1;KCNE4;NOS1AP;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6105859996020258,1.129172714467348,0.3548387096774194,0.6404054215743904,1.0,1/18,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6530282607522699,1.1291107564354614,0.34285714285714286,0.6402216007284695,1.0,6/13,20.13%,ANXA1;HDAC9;FGF2;HDAC7;SRPX2;AKT3
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5178527628217311,1.1290333549070823,0.29850746268656714,0.6401326720081393,1.0,9/61,8.51%,CDKN2A;IRAK2;DAB2IP;ERBIN;NLRP12;TCEAL7;CYP1B1;NLRC5;NLRC3
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.5171204136900525,1.128666674421852,0.2459016393442623,0.6407000473964051,1.0,19/55,17.98%,CDC42EP3;SLIT2;PAK3;BAIAP2L1;BAIAP2;CDC42EP1;SSH2;PRKCE;CYRIB;FCHSD1;PLEKHG2;ARF6;ARHGAP18;PRKCD;BIN1;PFN2;VASP;CRACD;NCK2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.6721107327847725,1.128307468309972,0.36363636363636365,0.6414497021829407,1.0,1/9,0.99%,TYMP
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.6090252226200888,1.1281532046325102,0.3148148148148148,0.6415997750186866,1.0,7/16,14.71%,HLA-DRA;PTPRC;CYRIB;HLA-DRB1;FADD;IL12A;HLA-E
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7154238421334441,1.1281504615084978,0.38,0.6412646165467515,1.0,1/6,12.29%,PRKCD
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.47786657169908164,1.127911546652394,0.2112676056338028,0.6414838872594893,1.0,19/91,15.86%,IGF1;EGF;THBS1;SERPINE1;PLEK;APP;PDGFA;SYTL4;CYRIB;TGFB2;TF;GAS6;ACTN1;SPARC;FN1;RAB27B;ABCC4;SERPING1;TAGLN2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.7128140970540593,1.1279011310408205,0.3076923076923077,0.6411806114223053,1.0,2/5,17.89%,LDLR;LRP2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6881575539179736,1.1278836033824808,0.3148148148148148,0.6408524995206493,1.0,1/8,5.94%,MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5906270640802731,-1.127705478140923,0.34210526315789475,0.9158572915713594,1.0,2/9,1.61%,AR;SELENOS
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6414782620584716,1.1275746899012702,0.40384615384615385,0.6412350822182299,1.0,4/11,7.19%,EPHA2;ADCY5;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.5404831014087162,1.1272918657570368,0.3181818181818182,0.6416361075131369,1.0,9/35,16.31%,S100A10;FHOD1;LIMCH1;SYNPO2L;ARHGEF10L;PXN;PAK1;LPAR1;PFN2
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.7965517805848975,1.127141874497456,0.32075471698113206,0.6417164487924052,1.0,2/5,1.69%,THBS1;SERPINE1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5939565206409019,1.1269553847222586,0.3382352941176471,0.6418845723648756,1.0,12/25,23.19%,ICAM1;TJP3;RAP2B;PPP1R16B;ROBO4;PDE4D;RAP1A;TJP2;RAP1B;PDE2A;TJP1;PECAM1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6886243935787995,1.1266594674152157,0.3888888888888889,0.6423598909872875,1.0,3/8,16.95%,GAB2;SYK;ADGRE2
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.6970278903338738,-1.126474309116446,0.36363636363636365,0.9166691923255025,1.0,1/5,2.55%,XG
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.6970278903338738,-1.126474309116446,0.36363636363636365,0.9166691923255025,1.0,1/5,2.55%,XG
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.7174189817624502,1.1264155991442548,0.3333333333333333,0.6426905052765122,1.0,3/7,15.68%,NLRC3;RELB;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5246356313963646,1.1263800964030448,0.3389830508474576,0.64248186929241,1.0,16/56,18.63%,IRS2;THY1;CAMK2N2;PTPRC;SMCR8;DVL1;SNCA;YWHAG;MAPT;CDKN1C;CDKN1B;TAB1;UBASH3B;WWTR1;TSC2;CAV3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.6267036722423222,1.1262789808117883,0.37254901960784315,0.6423736615474674,1.0,5/11,16.77%,ACTA2;MYH11;TPCN2;SMTN;SLC8A1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6429466148847635,1.1262143476630737,0.38461538461538464,0.6421716734332491,1.0,12/18,27.16%,PRKAR1B;APLNR;CGAS;PRKAR1A;PDE4D;GNAI1;UBE2B;PDE2A;PRKAR2B;PEX5L;RNF157;RAPGEF2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6175317686355083,1.126128994228783,0.3235294117647059,0.6420574876783153,1.0,4/13,17.24%,GRM5;GRM6;HOMER1;GRM7
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.5064636374142449,-1.126119839460789,0.2702702702702703,0.9161598942025504,1.0,5/27,7.89%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5483404725394988,1.1260273084353123,0.24193548387096775,0.6419809408082342,1.0,10/33,18.66%,ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1;NEU4;ENO3;MAN2C1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6473233687272187,-1.1257842299717749,0.34146341463414637,0.914028908136631,1.0,1/8,3.91%,SRI
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6473233687272187,-1.1257842299717749,0.34146341463414637,0.914028908136631,1.0,1/8,3.91%,SRI
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.5204352832970722,-1.1257716372362971,0.2564102564102564,0.9124760316627962,1.0,4/35,5.85%,ID1;LAMA4;ALDH1A1;NR1D1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5675029435740343,1.1255877918993262,0.2923076923076923,0.6428606848834592,1.0,4/22,10.12%,GMPR;ADA;PRPS2;SHMT1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6393355484804295,-1.1254046412826864,0.2926829268292683,0.9120943077693686,1.0,6/18,19.75%,RPS26;RPS13;SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6351410677153643,-1.1253015255726666,0.2702702702702703,0.9107959717098402,1.0,5/15,5.43%,SELENOS;CD200R1;TNFAIP3;FOXJ1;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.6572091032072346,1.1252648788633979,0.39622641509433965,0.6433209889021754,1.0,2/12,11.09%,TERF2IP;DIP2B
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.6700101155907263,-1.1252362511776348,0.4,0.9093860511632743,1.0,1/6,2.65%,TPP1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.7485635056170461,-1.1249055449433318,0.3611111111111111,0.9072112377673298,1.0,1/5,4.31%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7485635056170461,-1.1249055449433318,0.3611111111111111,0.9072112377673298,1.0,1/5,4.31%,SNF8
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5245325727783632,1.1247280869174647,0.3076923076923077,0.6443302042828133,1.0,13/53,14.53%,IGF1;PDGFRA;EGF;DCN;FLT1;IRS2;NTRK3;PDGFA;TGFB2;FN1;FGF2;GAB1;PIK3CD
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5477941428182104,-1.1247146652460573,0.3023255813953488,0.9062515092670673,1.0,3/21,10.96%,TPP1;USE1;BECN1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6989539854164872,1.1245897601864492,0.36363636363636365,0.6444148570086453,1.0,2/6,16.81%,PLOD2;MTHFR
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.5233730796605534,1.1242087416752213,0.25806451612903225,0.6450108191166024,1.0,7/42,10.92%,EGF;RAB11FIP5;TRIM46;DVL1;CTNNB1;ABCA2;MAPT
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5910188856266188,1.1239938809274315,0.36764705882352944,0.6452072233918098,1.0,4/22,9.44%,ANXA1;EPHA2;CLIC4;CERS3
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.6314867260982608,-1.1239687421012523,0.36585365853658536,0.9054551460855857,1.0,1/8,4.88%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.6314867260982608,-1.1239687421012523,0.36585365853658536,0.9054551460855857,1.0,1/8,4.88%,PDZD11
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.5485945281370899,-1.123952376165366,0.32653061224489793,0.9039415547168307,1.0,6/17,15.68%,HSD17B8;HSD17B6;SRD5A1;TSPO;STARD3NL;DHCR7
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6926814485547992,-1.1239063819588602,0.3148148148148148,0.9025224718060335,1.0,2/7,6.97%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7144191058450906,1.1237162840210282,0.39215686274509803,0.6455031009783295,1.0,3/8,8.12%,NRP2;SOX4;CTNNB1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.6790856837475809,-1.1236682467896317,0.3783783783783784,0.9019737508597075,1.0,4/9,20.92%,PPCS;PDHA1;ACSS1;MLYCD
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.7269335237343123,-1.1235582437334704,0.39622641509433965,0.9007789808624408,1.0,2/5,18.76%,BCAP31;MIA3
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6949069002221434,1.123244706115711,0.3673469387755102,0.6462843519117935,1.0,2/11,1.48%,CSPG4;DCN
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.5305411612360105,1.122568298270802,0.2571428571428571,0.6476435624034265,1.0,5/33,11.92%,SLC39A14;ALDOB;PGK1;FBP1;ENO2
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.633210039589926,-1.1224707704886452,0.3448275862068966,0.9029873732916691,1.0,3/16,10.99%,ALG3;ALG9;DOLK
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.4856991251525644,1.1221446017680496,0.27419354838709675,0.6485161702105104,1.0,34/90,17.68%,COL4A1;CSPG4;PRRX1;CALD1;COL4A2;RBM24;ACHE;ANGPTL2;POSTN;COL12A1;LAMB1;ZBTB16;PTPN21;RHBDF1;MYD88;CAPN1;PKDCC;BGN;YAP1;ADAM12;TEAD1;CCL2;FN1;CAP2;PALLD;COL5A1;BCAR1;PDZRN3;ANGPT2;FSTL1;FAM114A1;WWTR1;ENO3;SRPX2
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.6332560835526291,1.1221037652964254,0.41379310344827586,0.6482688167039875,1.0,4/15,15.38%,MAP3K11;DAB2IP;PAK1;MAP3K5
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7362652664100111,1.121450804137989,0.39622641509433965,0.6496062040381271,1.0,5/6,24.68%,PCLO;ERC2;CAST;RAB3A;ERC1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.4480242585285242,-1.1211893826301258,0.2,0.9057958671702498,1.0,32/134,16.56%,ERCC8;RFC3;BRF2;GTF2H5;POLR2K;AAAS;BCAM;POLD3;RAE1;CETN2;MPC2;BCAP31;ZNF707;MRPL40;ELOA;TAF13;ERCC2;GTF2A2;APRT;CLP1;POLR2C;NT5C;SNAPC5;TMED2;PRIM1;GTF2F1;EIF1B;POLR2D;NUDT9;DAD1;RALA;DGCR8
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6832489224782236,1.1208710556019166,0.3880597014925373,0.6507124035411964,1.0,1/11,0.86%,IMPDH1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7290035912391357,1.1208308015867765,0.4,0.6504456660852402,1.0,2/8,15.53%,FYN;PINK1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.6451803091298068,-1.1207066907231618,0.40476190476190477,0.9056497413465274,1.0,2/6,9.60%,EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5712649157431868,1.1204895893987818,0.2982456140350877,0.6508492274501477,1.0,10/28,24.22%,EGF;WDR54;MKLN1;PICK1;ANKRD13A;MTMR2;AHI1;FLOT1;ARRB1;RIN3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6589605155578756,-1.1200435116187677,0.30434782608695654,0.9063873402345596,1.0,5/11,26.00%,UTP20;RPS21;NOL9;RPP40;NOP14
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4833400230512475,1.1199853450875816,0.26865671641791045,0.6518166235171345,1.0,17/84,10.89%,ABO;COBLL1;EGF;PLD1;CLDN16;CLMN;LPP;EPB41L4A;TRHDE;ZBTB7C;ADGRF5;ALDH1L1;PDZD2;ATP1B1;GDA;CDKL5;ITGB8
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5878918470982828,-1.1197048267544412,0.2857142857142857,0.9058628270844836,1.0,6/9,17.25%,TFB2M;SLC25A33;TFB1M;TEFM;MTERF1;MTERF2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.5719737881563344,1.1193289025919817,0.32786885245901637,0.6532044288160859,1.0,4/26,12.99%,SHTN1;DAB2IP;CAMK2B;PHACTR1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.7250569802670241,1.1191969784131583,0.3488372093023256,0.6532776234733949,1.0,1/5,14.84%,ATL3
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6780164433418661,1.1189855481703803,0.3793103448275862,0.6531391505530051,1.0,2/7,23.89%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6780164433418661,1.1189855481703803,0.3793103448275862,0.6531391505530051,1.0,2/7,23.89%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.6593880826551457,1.1183728306502911,0.31666666666666665,0.6538586799432,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.6593880826551457,1.1183728306502911,0.31666666666666665,0.6538586799432,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.6593880826551457,1.1183728306502911,0.31666666666666665,0.6538586799432,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7042894660052523,1.118355231664022,0.46875,0.6535731684024234,1.0,5/5,29.59%,CDK9;RPS6KA4;RPS6KA5;MAPK3;FMR1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.5226351091663909,-1.1181796861627302,0.24444444444444444,0.9095021629809147,1.0,4/33,6.17%,OTUD3;THEM4;TRIB3;MUL1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6836862508720662,1.1181719728848991,0.3076923076923077,0.6533237906540582,1.0,1/9,4.38%,VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6836862508720662,1.1181719728848991,0.3076923076923077,0.6533237906540582,1.0,1/9,4.38%,VLDLR
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4133698311278006,-1.1181179501147296,0.18181818181818182,0.9081205331833043,1.0,46/185,22.20%,KPNA2;RPL34;LSM7;SNRPB2;CCT7;SF3A1;DDX18;RPL18;KARS1;LSM2;U2AF1;NOP56;RPL6;EIF2S1;MCM6;RPL22;RPL14;RPS2;EIF3D;EPRS1;EEF1B2;VBP1;EIF1AX;MCM4;MRPS18B;SRSF2;EIF3J;SRM;TARDBP;DDX21;AIMP2;HDGF;FBL;APEX1;PRDX3;CUL1;NOP16;CYC1;ORC2;CSTF2;RPLP0;MRPL9;CDK4;PWP1;TRIM28;RRM1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.6965359989643956,-1.1179887976891953,0.3728813559322034,0.9070067816786166,1.0,1/6,5.85%,GREM1
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.7762348643700812,1.1179402044394684,0.391304347826087,0.6535876983739095,1.0,2/5,11.59%,DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5392059264341543,1.1179343218350253,0.3484848484848485,0.6532721129114611,1.0,6/31,9.97%,ANXA1;EPHA2;CLIC4;CTNNB1;CERS3;OVOL3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.7309402807335504,1.1176896212810912,0.35,0.653523455516743,1.0,2/7,15.53%,PID1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.4276119682260072,1.117511389843144,0.1927710843373494,0.6536391159468968,1.0,53/270,15.46%,CDKN2A;HPN;ST18;GPNMB;PROX1;TESC;OGN;NELL1;APP;DAB2IP;DUSP10;PODN;FABP3;KLF11;SOX4;BTG3;CLMN;APOD;FAP;IGFBP7;KLF10;BAP1;PML;CYP1B1;CDK6;CTNNB1;NLRC3;ZBTB7C;LMNA;PPARG;NEURL1;CTBP2;TGFB2;DLG5;P3H2;CDKN1C;B4GALT7;CDKN1B;DLG3;ATP8A2;B2M;KLF4;PAK1;PDPN;CDKN1A;CGREF1;TRIM32;IL12A;NOX4;PPM1D;RARG;ETS1;TP53
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.591169589489112,1.1172404354881806,0.3064516129032258,0.653982290883543,1.0,1/20,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.6702696404851787,-1.117178536484603,0.3409090909090909,0.9079984769949632,1.0,1/9,8.29%,GAS1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6259613452574293,1.1170820908947516,0.3275862068965517,0.6540545491318807,1.0,4/18,14.22%,PLSCR1;GGCT;GSS;PLOD2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.7427206691924636,1.1170229078283649,0.43636363636363634,0.6539116257938514,1.0,2/5,21.41%,GPS2;TRIM44
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.7676297623361288,-1.1166316816900204,0.4318181818181818,0.9082874383499159,1.0,1/5,7.58%,S1PR1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.6056085138992178,1.1164145779340737,0.3709677419354839,0.6550833911868874,1.0,4/15,12.01%,ICAM1;CERCAM;SYK;ITGAL
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6134482117197873,1.1156659392065567,0.3508771929824561,0.6564626849418562,1.0,6/16,21.14%,OXTR;NRG1;GLI2;NOTCH4;ARHGAP35;APLN
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.7934475651789418,-1.1155583912796627,0.35555555555555557,0.9102460276785931,1.0,2/5,8.86%,ABCB11;GPLD1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.4960023059193709,1.1153632520479386,0.3333333333333333,0.656907824452177,1.0,8/46,6.95%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;KCNIP4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.7280773357521297,-1.1152088302577308,0.43859649122807015,0.9098083194269801,1.0,4/5,26.88%,DMC1;FANCM;RAD51;RAD54L
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6719481232510504,1.1150061505316933,0.375,0.6573218368587236,1.0,1/10,0.99%,TYMP
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6299926164394911,1.1150011089998346,0.30303030303030304,0.6569936919470957,1.0,4/18,12.66%,SP100;PML;BARD1;RANGAP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6658062942880713,-1.1149951024887153,0.40476190476190477,0.9090117704195473,1.0,2/9,9.24%,ID2;HSF1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6839187658239643,1.114621385171663,0.39344262295081966,0.6574468004690112,1.0,3/8,9.64%,B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6839187658239643,1.114621385171663,0.39344262295081966,0.6574468004690112,1.0,3/8,9.64%,B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.6812134657331652,1.1144392898402282,0.3888888888888889,0.6576944249776948,1.0,2/6,13.58%,TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.7846277381861634,1.1142293184471959,0.44642857142857145,0.6579112069642692,1.0,3/5,19.03%,LIMK2;IKBKG;RAB11A
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.46112204339939983,-1.114024475381728,0.19444444444444445,0.9109839999853013,1.0,7/75,6.97%,DIRAS3;DNMT3B;SMYD5;POLR2K;POLR1F;TAF1D;KDM1B
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.799106784110482,1.1139234300781915,0.3559322033898305,0.6582806189055674,1.0,3/5,11.23%,ALDOB;PFKL;FBP1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.7372821339860995,-1.1138337903603162,0.3695652173913043,0.9100767090128354,1.0,2/6,16.31%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.7138891677840298,1.113762226155926,0.3559322033898305,0.6583196554408098,1.0,4/6,14.73%,ALOX12;NOXA1;TAFA4;NOX4
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.638384888670291,1.1135073006195868,0.3684210526315789,0.6587006910870339,1.0,3/14,5.87%,BAIAP2L1;BAIAP2;NTRK3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.5086497510062401,1.1130929703596928,0.288135593220339,0.6594415107959807,1.0,7/36,11.07%,THBS1;SLC39A14;IRS2;SOX4;EIF2B2;PFKL;GAS6
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6509792485945717,1.1129642041077452,0.3448275862068966,0.6594798885675651,1.0,2/14,8.31%,IGF1;BCL2L1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.43190974976585245,1.1127078635500274,0.14754098360655737,0.6597499662268679,1.0,24/202,13.89%,MET;BOK;DCN;PLK2;DEPP1;FOXO1;TRIM5;SMCR8;FOXO3;GFAP;DAPK2;CAPN1;PLEKHF1;PIP4K2A;STAT3;FBXL2;MAPT;EEF1A2;TPCN2;TRIM22;BCL2;OPTN;WASHC1;RNF152
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.780089458250476,1.1126884121263492,0.45454545454545453,0.6594590012854645,1.0,2/6,7.91%,FYN;DUSP22
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.614222616340778,1.112467267510991,0.35,0.6596008769893662,1.0,9/15,27.56%,TERF2IP;OGG1;TINF2;NEIL2;NEIL1;ACD;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7192533333254447,-1.1124406164971037,0.4146341463414634,0.9130541852719544,1.0,5/7,26.89%,MCM6;MCM4;MCMDC2;ORC3;MCM3
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.7400783991677833,1.1121991446525745,0.25862068965517243,0.6600166115049786,1.0,1/5,7.49%,C1R
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.7159979674625543,1.1121702370294098,0.4444444444444444,0.6594112727855659,1.0,3/6,22.33%,HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.7159979674625543,1.1121702370294098,0.4444444444444444,0.6594112727855659,1.0,3/6,22.33%,HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.7044127947700213,1.1118422763922489,0.40540540540540543,0.6598386233325919,1.0,8/8,29.59%,CDK9;AKAP8;RPS6KA4;RPS6KA5;MACROH2A1;MAPK3;AKAP8L;FMR1
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.7830206939227807,1.1117382708846317,0.3953488372093023,0.6597429568165637,1.0,1/5,1.04%,SQOR
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7177847387612846,1.1111063644747117,0.4107142857142857,0.6610685580256114,1.0,3/6,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.5736292262223647,-1.111043558880065,0.21052631578947367,0.9152811575621173,1.0,5/30,6.17%,REEP6;DISP3;SLC30A8;LEPR;MUL1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6913506503357167,-1.110998343503756,0.3389830508474576,0.9138907167611865,1.0,3/6,23.08%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5114669022787309,-1.1108976102042096,0.275,0.9126894403610315,1.0,7/36,17.79%,LSM2;GEMIN4;LSM4;WDR77;PRPF8;PRPF3;TGS1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.44782315607547063,1.110819355593084,0.29850746268656714,0.6614883309607738,1.0,7/111,7.62%,ST18;IRAK2;DAB2IP;NOD1;IL1R1;MYLK3;MYD88
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.47086155941064334,1.1102957859015001,0.26666666666666666,0.6623263068101181,1.0,18/77,14.66%,TLR2;IRF7;PTPRC;MAP3K14;PLSCR1;TRIM5;SAMHD1;ABCC9;NLRC5;MYD88;APOBEC3H;BCL2L1;RNASE1;MX1;BCL2;CGAS;FADD;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.6487508392486889,1.1102836857787346,0.38461538461538464,0.6620476407013666,1.0,2/11,9.25%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.6125311506299478,-1.110153538214622,0.375,0.9139357683654361,1.0,4/7,24.24%,PM20D1;MPST;CYP2D6;TST
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.5242623398665099,1.1099854435258825,0.31746031746031744,0.6624117190857068,1.0,6/38,14.93%,KIF14;PMEPA1;NLRC3;LDLRAD4;TMC8;LCMT1
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.637944744897532,1.1097543210633383,0.38596491228070173,0.6626300368217184,1.0,5/16,20.36%,NLRP12;NLRC3;HDAC7;IFI35;NMI
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.7151952923676643,-1.1095249475848592,0.39655172413793105,0.9143443321863575,1.0,2/5,12.63%,MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.6921589014528968,1.109501943435076,0.38181818181818183,0.66259397475073,1.0,3/7,16.00%,ENPEP;AOPEP;CTSZ
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.6921589014528968,1.109501943435076,0.38181818181818183,0.66259397475073,1.0,3/7,16.00%,ENPEP;AOPEP;CTSZ
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7183311042297045,1.1093996115554718,0.2909090909090909,0.6624791946059169,1.0,4/8,21.64%,NOS1AP;BIN1;CACNB2;SESTD1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.6721375366601154,1.1093402311906249,0.41379310344827586,0.6622919862104688,1.0,3/10,12.18%,CLPB;ZDHHC1;MX1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6688665108668758,1.1092867727415494,0.29508196721311475,0.6620868418262674,1.0,5/12,17.11%,FABP3;PPARG;PDK4;ADIPOR2;NCOR1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.641871674953493,-1.1089269986238808,0.3870967741935484,0.9147637701515899,1.0,3/11,19.53%,PYHIN1;HTRA2;AIM2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4654210273294076,1.1087155537411384,0.25757575757575757,0.6632649039321916,1.0,26/119,16.20%,MET;PDGFRA;EPHA7;FLT1;EPHA2;EPHA5;PLAAT4;NTRK3;TCP1;HMBOX1;CTNNB1;VAC14;CCT4;EPHA4;DBI;SERINC1;HLA-DRB1;MAPKAPK5;KLF4;ALK;MRE11;CHTF18;CD4;PINK1;SERINC5;CD200
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.558270108710031,1.1086612194970378,0.3582089552238806,0.6630413640111666,1.0,6/28,13.49%,KLF2;THBS1;PPP1R16B;SMAD1;KLF4;FGF2
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.725404937537723,-1.1082997309450637,0.3170731707317073,0.9153528605922322,1.0,3/7,16.94%,SDSL;SDS;ALDH18A1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.488411542968732,1.1081412481535065,0.296875,0.6641212086112597,1.0,13/59,16.13%,SERPINE1;PTPRO;DUSP1;DMTN;PTPRC;ARHGDIG;CYP1B1;PODXL;PLXNA4;SIPA1;PLXNA1;PLXNA2;FZD7
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.48100710711979067,1.108015436089285,0.3333333333333333,0.6641205724123509,1.0,6/90,7.50%,CTSC;SH3GL2;ICA1;TPD52;TMED10;ATP1A1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6230391541586469,1.1078888312111856,0.3188405797101449,0.6640777479388131,1.0,5/19,14.76%,LPCAT4;PLAAT3;DBI;PLB1;PNPLA8
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7712488532576514,1.10773654719482,0.3469387755102041,0.6641313498006397,1.0,3/6,16.26%,PRR5;PINK1;SYAP1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.415680185714921,1.1076483915579616,0.19480519480519481,0.6640283548332216,1.0,21/339,6.16%,SKOR1;MYT1;ELAVL2;PTP4A3;TEAD2;ZNF536;PRDM8;CASZ1;HIC1;ZNF282;WTIP;PPARGC1B;NFATC2;NFIL3;SOX4;NKX6-2;AHR;GZF1;CHD3;DVL1;ZNF114
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7631785213519429,1.1076162632811173,0.42857142857142855,0.6637810374661439,1.0,3/6,17.89%,NLGN1;PHACTR1;LRP2
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.44169451888307815,1.107288133062325,0.2191780821917808,0.6643399464570952,1.0,30/129,23.76%,KREMEN2;DRAXIN;PTPRO;DAB2IP;NOTUM;DVL1;TLE6;TLE3;HECW1;PRICKLE1;SOX13;STK3;ANKRD6;MESP1;WWTR1;WNT5A;STK11;DKK3;FRMD8;TLE2;MLLT3;AMFR;GLI1;RBMS3;AXIN2;CUL3;PSMB3;TMEM131L;PRKN;TLE4
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7244881762841324,1.1070814091985457,0.3559322033898305,0.6645676451068159,1.0,4/6,25.08%,FSTL1;MESP1;PECAM1;KDM6B
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5518246504772801,-1.106884085681126,0.21052631578947367,0.9187698271037785,1.0,2/24,3.59%,H1-2;H1-4
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7380362738424012,1.106852558048847,0.4262295081967213,0.664795112590395,1.0,1/5,6.79%,GHR
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5309061426456094,1.1066816705840912,0.3181818181818182,0.6648361761527147,1.0,11/46,15.00%,NR4A3;NR4A1;FOXO1;PID1;STEAP4;PPARG;CTBP2;NR4A2;KLF4;TRIM32;PRDM16
prerank,MSigDB_Hallmark_2020__Hypoxia,0.43960802554645473,1.1066036385496192,0.273972602739726,0.6646731117537171,1.0,47/162,15.31%,FOSL2;MAFF;DCN;SERPINE1;ATF3;ZFP36;P4HA2;DUSP1;IRS2;PIM1;MYH9;EFNA1;CP;VLDLR;NFIL3;PLAC8;FOXO3;DTNA;TPD52;ALDOB;HK2;LDHA;KIF5A;GALK1;BGN;NDRG1;PFKL;CDKN1C;PGK1;FBP1;ENO2;DPYSL4;KLF7;CDKN1B;KLF6;BCL2;PAM;HK1;CDKN1A;COL5A1;PDK1;CHST2;NDST1;SLC2A3;LARGE1;ETS1;PFKFB3
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.6919522567718304,-1.1065156015315807,0.45652173913043476,0.9183639438157833,1.0,2/7,10.82%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.6998292007154443,1.106256134311825,0.4745762711864407,0.6652121537208465,1.0,2/6,11.71%,MSMP;CCL2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.5369473885094425,1.1060336559018402,0.32786885245901637,0.665324901094319,1.0,12/35,18.06%,IRS2;SH3KBP1;PTPRC;NFATC2;MMP14;SYK;BCL2;TNIP2;GPR183;BST1;TFRC;TNFSF4
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.6583374115678738,-1.1058580841495946,0.3695652173913043,0.9189441330209592,1.0,1/6,1.93%,SFXN2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6351716447254759,1.1057714332909492,0.4067796610169492,0.6656592908660721,1.0,8/15,16.77%,KCNJ2;ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3;KCNMA1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5316927648174755,1.1057370103449917,0.3387096774193548,0.6654302457353449,1.0,10/43,14.71%,TLR2;THBS1;RASGRP1;APP;PTPRC;STAT3;SYK;FADD;IFIH1;HLA-E
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.7522246964351929,1.1056279700104166,0.41509433962264153,0.6653810530466227,1.0,1/5,16.26%,SYAP1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4745045653359678,1.105557083004564,0.28125,0.6651942704901372,1.0,10/70,13.20%,CDKN2A;PLK2;TYMS;KLF11;CDK6;CDC7;CDKN1B;BRD4;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.43376324069752653,1.1055455780546086,0.2537313432835821,0.6648820692544228,1.0,38/194,16.13%,MET;C3;GPNMB;IGF1;PDGFRA;EPHA7;EGF;THBS1;RASGRP1;FLT1;EPHA2;APP;EPHA5;EFNA1;FAS;NTRK3;LIMCH1;NPTN;LIMK2;VAC14;EPHA4;NIBAN1;WDFY2;GAS6;HLA-DRB1;MLXIPL;ALK;PAK1;CCND1;FGF2;MRE11;CD4;THPO;PFKFB3;PINK1;P2RX7;SLCO3A1;FZD7
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.7102799025089113,1.105480200337107,0.3090909090909091,0.6647196405231475,1.0,3/9,20.23%,OR51M1;ADCY3;OR51I2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5775044094107344,1.105263049954778,0.3584905660377358,0.6648860155280475,1.0,7/23,7.44%,ADCY5;LGR5;GIPR;RXFP1;ADCY7;ADCY2;GLP1R
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7136104721672675,1.1049823536072771,0.42857142857142855,0.6651716677151095,1.0,2/7,13.35%,RBM24;CPEB2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.714660835144977,1.1047463471761143,0.4098360655737705,0.6654391240760834,1.0,5/6,28.51%,ATP10A;DNM2;ASAP1;SH3GLB1;PLEKHM2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.6483814743105956,1.1043260920006868,0.3508771929824561,0.6662134406279653,1.0,1/9,10.90%,ABCA2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.588820524689466,-1.1041704154203669,0.3142857142857143,0.922180401199632,1.0,4/21,8.80%,HEY2;FBXO5;S1PR1;HEY1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6848826085213735,1.1037747443498984,0.3898305084745763,0.6672672486966102,1.0,4/7,21.17%,PRKCB;HIF1A;ARNT;GRB10
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5732386488781356,-1.1034289400535011,0.2682926829268293,0.9227281303784242,1.0,3/18,7.42%,KPNA2;TRIM21;TRIM68
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7183651923669649,1.102946613827076,0.4,0.6690829042900355,1.0,2/6,12.92%,BLM;ZFYVE19
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6584200295324714,1.1028453986498303,0.36363636363636365,0.6689844630951786,1.0,4/13,9.98%,CSPG4;DCN;BGN;UST
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4868678383213594,1.1027835896540386,0.25,0.6687968075082689,1.0,14/64,18.55%,PLK2;SP100;SOX4;PML;NDRG1;GADD45A;CDKN1B;RPS6KA6;CDKN1A;HIPK2;TP53;CCNB1;PRMT1;PLK3
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.7015587767606605,1.1027750871961608,0.44680851063829785,0.6685022183862281,1.0,3/6,22.97%,KLF4;RBMS3;DLEC1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.714187756673949,1.10250631901832,0.38596491228070173,0.6688800769449931,1.0,3/7,18.47%,ZBTB16;PKDCC;LOXL2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6505407876432935,1.1024198543927115,0.37254901960784315,0.6687343733403435,1.0,1/15,1.15%,CCBE1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.4544685784231338,1.1023286078888423,0.2835820895522388,0.6687076614687583,1.0,14/129,7.62%,CXCL2;TESC;SERPINE1;PTK6;ZFP36;ADCY5;DAB2IP;WNT8B;AHR;PID1;ADCY2;RAMP3;ATP1A1;MYD88
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.47067596556466335,1.1021764329040267,0.2878787878787879,0.668829458668955,1.0,14/83,13.91%,KLF2;PLK2;RASGRP1;APP;DAB2IP;FOXO1;HECW2;ABCA2;BARD1;HECW1;CDKN1B;OAZ2;KLF4;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6537386832719155,1.1021528806354455,0.3492063492063492,0.6685534007972691,1.0,1/11,1.69%,ATF3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.6440375369522521,1.1020812472605124,0.2777777777777778,0.6684734197787582,1.0,6/14,28.85%,OR51M1;ADCY3;OR51I2;C5AR1;CD36;UBR3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.7118856761479755,1.1020576053774371,0.41509433962264153,0.6681740954389475,1.0,3/7,22.68%,LAMB1;NTN4;LAMB4
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.7148694500801175,1.1016902252776108,0.3548387096774194,0.6687167608520502,1.0,3/7,12.71%,MAFF;KLF7;ELAPOR2
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7325029905725848,1.1014967304724161,0.34615384615384615,0.6688204754175411,1.0,1/5,25.65%,ZDHHC3
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5186926156397599,1.1012340646995158,0.31746031746031744,0.6687730977703924,1.0,7/47,21.55%,CCNB2;LMNA;RANGAP1;IST1;CCNB1;UBE2I;RCC1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5186926156397599,1.1012340646995158,0.31746031746031744,0.6687730977703924,1.0,7/47,21.55%,CCNB2;LMNA;RANGAP1;IST1;CCNB1;UBE2I;RCC1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6790666536512366,1.1007103113691785,0.3220338983050847,0.6695510008577209,1.0,3/12,17.50%,WTIP;DLG5;MAP2K3
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5729128199082434,1.1006424146130311,0.3620689655172414,0.6693939375144266,1.0,10/28,16.17%,DUSP10;TRIM46;DCC;MAG;DIP2B;FGF13;CDKN1B;CDKN1A;PTPRS;KIAA0319
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.7553728236203266,1.1005238533264823,0.4074074074074074,0.6693670430499372,1.0,3/5,23.69%,PINK1;HIF1A;PRKN
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5108040559510292,1.1004380104695224,0.3142857142857143,0.6692515750800277,1.0,10/53,18.30%,CD22;RIT2;SNCA;PACSIN1;OPHN1;SCAMP5;MCTP1;LRSAM1;MTMR2;TSC2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6232636299740744,1.100339265574058,0.4126984126984127,0.6691303185463713,1.0,7/11,9.40%,KCNJ2;KCNQ1;KCNE4;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7139751248413014,1.1003226994739481,0.35714285714285715,0.6688321588848409,1.0,2/6,16.95%,SYK;ADGRE2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6726749620661442,1.1002376479423859,0.3870967741935484,0.6687348236039364,1.0,6/11,22.87%,DUSP1;LCMT1;CCNB1;CDK5RAP2;DYNC1LI1;USP44
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6605979968295792,1.1001785628654366,0.3333333333333333,0.6686081106533596,1.0,4/7,29.59%,RAP1A;RAP1B;PRKN;FMR1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.6488023016400049,-1.10010216112796,0.40540540540540543,0.9308588275016525,1.0,3/8,14.88%,ADH6;SCPEP1;CYP2C8
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5853390868110926,1.1000450101874473,0.31746031746031744,0.6686877434692076,1.0,6/21,16.31%,SLIT2;RAP1GAP;LIMK2;YAP1;PRKCD;PFN2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.48164358955902575,1.099701801676551,0.3466666666666667,0.6692501997910719,1.0,8/81,10.12%,TYMS;IGF2BP2;RBM24;SAMD4A;ENC1;EIF4A3;YTHDF1;SHMT1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.4985059500684992,-1.0996390263305047,0.3157894736842105,0.9306054496126992,1.0,6/25,9.75%,APOBEC3G;TNFAIP3;PTPN22;MUL1;IFNLR1;PQBP1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5147190280774157,-1.0993580509705807,0.375,0.9298223911186154,1.0,4/31,11.27%,REEP6;AAAS;GAS1;DNAJC30
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.6123884266423923,1.0989195906057692,0.41509433962264153,0.6707891942160246,1.0,5/13,15.14%,MGAT3;CHST6;CHST4;CHST2;LARGE1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6481350338783363,-1.0988412017105003,0.4594594594594595,0.9296678459272537,1.0,2/10,8.86%,APOE;GPLD1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.49149213022348104,1.0988276787609226,0.3387096774193548,0.6706322961013954,1.0,13/40,21.58%,TBL1X;HDAC4;MORF4L2;HDAC9;HDAC7;TBL1XR1;FLNA;MTA1;MORF4L1;MTA3;RCOR1;TRERF1;MIDEAS
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.6186695552530002,1.0983828826307434,0.35714285714285715,0.6713928777541069,1.0,2/14,9.59%,SHTN1;CYRIB
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.7023364362241185,1.09838132112123,0.4642857142857143,0.6710712695787104,1.0,4/7,25.76%,EMP1;P2RX7;ANO6;EMP2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.5479156328473647,1.098337729339694,0.265625,0.6708263483996594,1.0,12/30,18.30%,DVL1;TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;MTHFR;VASP;SCRIB;LRP2;TSC2
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.6736487911202034,-1.0981545325880027,0.4318181818181818,0.9305473216172183,1.0,1/7,6.00%,AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.4479855144510398,1.097744716379106,0.2894736842105263,0.6718440493370256,1.0,36/158,18.63%,THBS1;CD22;DUSP1;PLEK;EPHA2;SLIT2;DAB2IP;NLRP12;CARD19;WTIP;TNFAIP8L1;APLNR;DGKG;BCL2L1;NLRC3;CYRIB;DLG5;PDE10A;MAPKBP1;BCL2;PER1;MAPKAPK5;OTUD7B;CGNL1;PINK1;P2RX7;ATP2B4;RFFL;RORA;PDE4D;MAP2K3;HDAC7;ITPR1;IFI35;TSC2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.6863813268305685,1.0976156273768234,0.3877551020408163,0.6718982874943602,1.0,3/8,12.05%,GAB2;SYK;STX4
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.6210745573829226,-1.097498978779154,0.38095238095238093,0.9312679453064101,1.0,4/8,20.96%,PRDX1;PRDX3;GPX1;CAT
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7060282519387155,1.0962430679313562,0.4716981132075472,0.6746624539544215,1.0,2/6,18.37%,SLC16A10;SLC7A8
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.7060282519387155,1.0962430679313562,0.4716981132075472,0.6746624539544215,1.0,2/6,18.37%,SLC16A10;SLC7A8
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.6867331989760975,1.0961172759664415,0.34615384615384615,0.674674196981628,1.0,2/6,22.49%,MAPT;KIF13A
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.49396214873159405,1.0961050394491167,0.2833333333333333,0.6743696501405998,1.0,23/77,23.69%,DCN;PLK2;FOXO1;TRIM5;FOXO3;PLEKHF1;TRIM22;OPTN;RNF152;IKBKG;PINK1;TRIM65;TFEB;STK11;TSC2;PLK3;WAC;DHRSX;TBK1;SUPT5H;SESN1;ULK1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5149825535704263,1.0958593739873088,0.328125,0.6745630037076651,1.0,9/37,10.24%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2;ATP1B1;ATP1B3
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.4250023515112624,-1.0955411995558928,0.2,0.9359749990619467,1.0,9/79,15.08%,RAB7B;VPS29;STX16;WASHC2C;ARL1;TMED9;VPS35;VTI1B;RNF126
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.4448537517698312,-1.0954044696642264,0.2682926829268293,0.9349623511411495,1.0,9/47,11.63%,HSD17B8;MCAT;ACMSD;ABCB11;ELOVL4;OSBPL3;CYP46A1;ACSM6;CYP7B1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.595974275292353,1.0951272302902364,0.39344262295081966,0.6760200283787628,1.0,4/16,17.47%,SLIT2;DAPK2;BST1;CAMK1D
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5951165607779,1.09478872104696,0.35384615384615387,0.6764638533803614,1.0,8/17,21.03%,KCNQ1;KCNH2;GAS6;FBP1;TP53;TFRC;KCNE2;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5881708723677325,1.0947800948814541,0.4,0.6761590243324025,1.0,8/23,12.75%,GRIN2B;MBP;EFNA1;FYN;GRIN1;STAT3;EPHA4;USP50
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.710460631248713,1.0944690800264611,0.375,0.6767016659481866,1.0,2/8,9.71%,PPARG;ADAM19
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.46286294066626754,1.0944265167689116,0.30434782608695654,0.6765196533663529,1.0,13/100,5.87%,MET;PDGFRA;EPHA7;PTK6;FLT1;SLA;EPHA2;SHC2;EPHA5;FYN;GFRA2;NEDD9;NTRK3
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5686530102772371,-1.0944072714739377,0.38095238095238093,0.9366154692375835,1.0,1/10,4.36%,APOE
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.542589621400389,1.0944030587020264,0.36666666666666664,0.6762269213103383,1.0,7/25,14.19%,THBS1;SULF1;FLT1;PPARG;SPARC;CCL2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.7061683509436887,-1.0939583366914223,0.3617021276595745,0.936558665271889,1.0,1/5,4.36%,APOE
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.6783633862272345,-1.093872221493063,0.4864864864864865,0.935323891078293,1.0,2/6,7.46%,FBXO5;FBXO43
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.7569920246121624,1.0937788826944255,0.38461538461538464,0.6775388034404332,1.0,1/6,2.65%,DMTN
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5762007275220234,1.093491077080179,0.41935483870967744,0.677939751216002,1.0,4/16,15.61%,ACSL5;HACD1;ELOVL7;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5768003933196033,1.093167963189536,0.39285714285714285,0.6783461323301734,1.0,6/23,19.61%,ANXA1;LSM11;CCND1;ADAMTS1;ADAM17;CCND2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.6045707416626553,-1.0929668237505448,0.34146341463414637,0.9367307600727707,1.0,2/13,4.40%,TMEM100;FOXJ1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.4785719655719006,-1.0925775823350896,0.2972972972972973,0.93624701189678,1.0,17/42,23.59%,GRPEL2;TIMM8B;AIP;TIMM13;BCAP31;TIMM23;TSPO;TIMM50;TIMM10;RALA;DNAJC19;FIS1;TIMM17A;TOMM34;SLC25A6;GDAP1;TOMM70
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4670232644496989,1.0924889915540097,0.3230769230769231,0.6796958117960745,1.0,29/90,22.32%,RELN;THY1;CAMK2N2;AGAP2;TSPYL2;PTPRC;SMCR8;DVL1;SNCA;RAP2B;YWHAG;MMD;GAS6;CDKN1A;IQGAP1;CD4;TAB1;UBASH3B;WWTR1;MAP2K3;RAP1A;TSC2;CAV3;TAB2;PPM1F;CSF1;C5AR1;HSPB1;MAPRE3
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6187175971670967,1.092404509181323,0.3709677419354839,0.6795827328122123,1.0,3/16,3.40%,BLM;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.6257028758635464,1.092309038809309,0.3333333333333333,0.6794872237284121,1.0,2/15,3.96%,NMNAT2;PRPS2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5535333601276524,1.0919540123541374,0.34285714285714286,0.680113080636507,1.0,11/28,19.35%,SEMA3C;SEMA5B;SEMA3D;TRIM46;SEMA3B;MAG;DIP2B;PTPRS;KIAA0319;SEMA4D;RTN4
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7016598533399786,1.0918799904344034,0.4528301886792453,0.6799650802040175,1.0,2/6,18.96%,DOCK10;LFNG
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.5176791366181788,1.0918642234678424,0.3333333333333333,0.6796719500928566,1.0,6/30,12.47%,BOK;GGCT;HK2;BCL2L1;BBC3;BCL2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.4877445353414176,1.0917620838165225,0.39655172413793105,0.6795765846886709,1.0,22/65,18.38%,ADGRE5;PRSS57;LMO2;LMNB1;PIM1;IL27RA;GAB3;TUBB1;CD44;ADCY7;GFI1B;TMC8;MFSD2B;ELF1;BCL11A;SIPA1;ETS1;GRSF1;ADGRE2;VASP;TFRC;RELT
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.4215858477047301,1.091475024808274,0.25,0.6797831884144265,1.0,42/226,15.99%,BOK;MLLT11;SLIT2;SEPTIN4;MAP3K11;DAB2IP;FOXO1;KLF11;ARHGEF17;SOX4;FAS;BCL6;ARHGEF3;TFPT;FOXO3;SNCA;PAWR;CYP1B1;OBSCN;DAPK2;MCF2;CTNNB1;KALRN;NEURL1;ARHGEF7;PNMA2;SYK;TRIO;PXT1;PLEKHG2;BARD1;GADD45A;TNFRSF10B;FADD;KCNMA1;BIN1;RARG;MAP3K5;STK3;TP53;NGEF;VAV2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.6542205009417629,1.0913191491349334,0.4262295081967213,0.6797342816095099,1.0,2/12,13.12%,APLNR;AKAP8
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.6792691206164181,1.0910770587908598,0.4166666666666667,0.6799580044505944,1.0,4/7,25.83%,B2M;HLA-E;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4059382570000956,1.0908343662717148,0.225,0.6801931017122583,1.0,26/375,7.53%,SKOR1;MYT1;ELAVL2;PTP4A3;TEAD2;ZNF536;PRDM8;CASZ1;APP;HIC1;ZNF282;WTIP;PPARGC1B;NFATC2;NFIL3;SOX4;NKX6-2;AHR;GZF1;CHD3;DVL1;ZNF114;GRM5;FOXO3;PML;PDGFA
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.442407399288848,-1.0907893184159192,0.22857142857142856,0.940099319241155,1.0,21/88,23.20%,FIP1L1;AAAS;RBM8A;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;NUP85;NUP42;POM121C;THOC3;THOC1;NXT1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.6327114802558962,-1.0905972449787487,0.45652173913043476,0.9390914523127228,1.0,2/6,10.54%,CFTR;NOX1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.4517572762332664,-1.0905584046226031,0.3103448275862069,0.9376854703617462,1.0,6/44,14.09%,AAAS;RAE1;NUP50;NOA1;NUP54;JMJD8
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6939353819918974,1.0903728687524732,0.4032258064516129,0.6811116529843481,1.0,2/8,15.53%,PID1;PINK1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.6017324971591019,-1.0899043250384715,0.3617021276595745,0.9383465165114241,1.0,2/18,1.74%,AR;VAMP8
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5330226239208715,1.0897300067685098,0.3387096774193548,0.6823709803163045,1.0,2/32,3.62%,ANK3;AMN
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5086015861725249,1.089404454938547,0.39655172413793105,0.6828708130400593,1.0,11/47,19.70%,RBM24;SRRM4;KHDRBS2;MBNL2;CELF3;WTAP;RBFOX2;NOVA2;RBM5;KHDRBS3;CELF2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.46110411245716965,-1.0892885501966265,0.30303030303030304,0.9388054042763057,1.0,15/49,18.79%,ABCD2;MCAT;PHYH;ABCD1;ADH4;CYP4V2;ADH5;ADIPOR1;CPT2;ECHS1;MTLN;PEX13;EHHADH;ACADS;DECR1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.4815389223409654,1.0891323585774664,0.3,0.6832718047219056,1.0,15/68,15.01%,TLR2;IGF1;THBS1;RASGRP1;ZFP36;APP;PTPRC;NLRC3;STAT3;SYK;GAS6;FADD;IFIH1;HLA-E;RARA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5524066285044195,1.0891069520754517,0.3389830508474576,0.6829784912089829,1.0,3/19,4.06%,PDGFRA;FLT1;AGAP2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6836015673721652,1.0888490635265418,0.4426229508196721,0.6832345440149256,1.0,2/10,9.86%,RBM24;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.6679419626532586,1.0886406166028733,0.43859649122807015,0.6834845699239112,1.0,3/7,18.63%,KCNH2;BIN1;CAV3
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.45109669640445665,-1.088478011534445,0.34285714285714286,0.9398384723113601,1.0,7/75,5.85%,ID2;MID1IP1;DISP3;PMVK;TM7SF2;NPC2;NR1D1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.5375908328744795,1.088257857917789,0.29310344827586204,0.6841269940638084,1.0,7/37,11.69%,ST6GAL1;B3GNT2;GALNT12;GALNT8;POMGNT1;CHST4;B4GALT5
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7171857131446492,-1.088150053949315,0.4186046511627907,0.9393903573277619,1.0,4/6,26.00%,UTP20;RPS21;RPP40;NOP14
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.5448671782568698,-1.0879242694515734,0.30434782608695654,0.9385572292566149,1.0,2/23,1.79%,OTUD3;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.4435796438262028,1.0878098524987976,0.34782608695652173,0.6849188464408051,1.0,13/89,16.08%,PLD1;THBS1;SAMD4A;SOX4;EIF4A3;LARP6;YTHDF1;NIBAN1;KLF4;FADD;TRIM32;IST1;TBC1D10A
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.5881303053628668,1.0874240172433782,0.40625,0.6854734176476673,1.0,8/13,10.24%,KCNJ2;KCNQ1;KCNE4;KCND3;KCNH2;ATP1A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6234605236608819,1.087389377951022,0.4444444444444444,0.685243311800079,1.0,6/17,16.62%,AGTPBP1;STAT3;IFT122;COL5A1;RARG;C12ORF57
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.688487481896819,1.0873616429211805,0.45,0.6850076671041183,1.0,2/6,3.55%,SLC15A3;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.543955611452454,1.0873579891049439,0.373134328358209,0.6846743300398341,1.0,3/27,3.17%,TLR2;MBP;APP
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5272494351958472,1.0872105230072737,0.3333333333333333,0.6848019011342792,1.0,5/43,12.96%,S100A10;DMTN;NEDD9;ARHGEF7;PDPN
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.45676010000522455,-1.0870278263792077,0.3404255319148936,0.9399248115394384,1.0,21/50,22.03%,IMP4;TFB2M;DDX18;NOP56;NDUFAF4;EXOSC5;UTP20;NIP7;RABEPK;MCM4;SRM;SLC19A1;DCTPP1;TMEM97;AIMP2;LAS1L;NOP16;WDR43;CDK4;SORD;MPHOSPH10
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5258685293567564,1.0869707806925615,0.3448275862068966,0.6850847196894123,1.0,4/41,10.20%,SLC6A15;SLC16A14;SLC17A5;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7564586244746715,1.0863755209639003,0.38461538461538464,0.6862645291766724,1.0,3/5,11.71%,TLR2;NAMPT;CCL2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.4834609711838836,1.0862026062542447,0.3188405797101449,0.686442882273961,1.0,7/64,4.53%,PROX1;EGF;THBS1;NR4A1;SULF1;NRP2;EGFL7
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6299195399291944,1.0861646202080641,0.35714285714285715,0.686253310562332,1.0,8/13,26.96%,CD55;TRPM4;B2M;TNFSF4;HLA-F;FZD5;HLA-A;MAP3K7
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.6254843142147594,-1.085894717105758,0.41025641025641024,0.9418133303496754,1.0,3/11,25.71%,HES5;ZFP36L2;HES1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6300734757662266,-1.0856047311985864,0.37209302325581395,0.9412716886271646,1.0,2/9,6.01%,FBLN5;ABCD1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6220823965846293,1.0854659265593987,0.37254901960784315,0.6877639489400938,1.0,1/10,4.64%,SHANK3
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6837700549338621,1.0852129879831578,0.45454545454545453,0.6879987208460498,1.0,3/7,19.68%,PRKCD;CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.6234796610728341,-1.0851287807047225,0.3888888888888889,0.9412321185031589,1.0,4/9,24.45%,MICA;CEBPG;TUBB;VAMP7
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.7021822398876308,-1.0848820475610736,0.4,0.9403678203193782,1.0,1/5,9.26%,ACVR1C
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6558225334232994,1.0846163382838085,0.4153846153846154,0.689134094030662,1.0,4/11,17.57%,NLGN1;DVL1;NLGN4X;WNT5A
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.5603172577145552,1.0843318990917017,0.3508771929824561,0.6894884092711165,1.0,8/27,16.77%,ATP2B3;ITPR3;CACNA1C;JPH4;RYR2;MCUB;SLC8A2;SLC8A1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.5263572124918179,1.0839330403498513,0.30303030303030304,0.6902608324176093,1.0,5/35,12.57%,RTN4RL1;APP;THY1;CD160;ADIPOR2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.7063831280884943,1.0838660663571287,0.3684210526315789,0.6900814221254536,1.0,1/5,10.25%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.5992051332473357,1.0837156703790873,0.40384615384615385,0.6901255251687798,1.0,7/24,15.38%,MAP3K11;DAB2IP;DUSP10;MAPK8IP1;HIPK3;PAK1;MAP3K5
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.46808177100605486,-1.0836040040806478,0.38461538461538464,0.942649660045628,1.0,4/39,1.74%,TRIM29;GALNT3;CEBPA;VAMP8
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.44691238407006123,1.082903538353881,0.3055555555555556,0.6918753050289483,1.0,36/142,16.53%,NPY1R;PAPSS2;CHST8;ZFP36;LSR;TJP3;PCP4;GINS2;BTG3;CD44;PGR;SEMA3B;HR;UGDH;ASS1;ANXA9;FKBP5;ITPK1;PLAAT3;AFF1;DLG5;MAPT;TMPRSS3;TPD52L1;BCL2;TFAP2C;KLF4;RAPGEFL1;CCND1;ALDH3A2;ST6GALNAC2;LARGE1;ELOVL5;ABCA3;ATP2B4;MYOF
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7245933227328456,-1.0817750470146004,0.3958333333333333,0.9464529753036935,1.0,1/5,8.81%,ATP6V1G1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5342711078116859,1.0815720879552253,0.30434782608695654,0.6946589169683944,1.0,5/38,7.51%,GGT5;AWAT1;ALOX12;FAAH;CYP1B1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4230676406700733,1.0806012639953708,0.32,0.696639268956506,1.0,23/179,15.61%,CTSC;MLLT11;ARPC5L;SLA;RPA1;VLDLR;NFIL3;MTHFD2;LDLR;HK2;LDHA;DHCR24;NAMPT;PFKL;NIBAN1;PGK1;ADIPOR2;CDKN1A;PLOD2;PDK1;RIT1;SLC2A3;ELOVL5
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6530814854694523,1.0805603092464648,0.3728813559322034,0.6963428999438612,1.0,1/9,6.52%,ZIC1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.6517038055820341,1.080286904568984,0.4067796610169492,0.6967894863129159,1.0,1/8,0.79%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6188544408467574,1.0801855708089672,0.4107142857142857,0.6966703434047111,1.0,5/11,26.57%,PIP4K2A;LRSAM1;ELAPOR1;ANXA2;SH3GLB1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6093987067270357,1.07996889773741,0.44642857142857145,0.6969850726088612,1.0,1/12,1.14%,GRIN2A
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6389756438063534,1.079880886412408,0.36363636363636365,0.6968659502787385,1.0,3/13,9.25%,EPHA2;MYO1C;PRKCH
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5037747792602505,1.0798222156989798,0.4074074074074074,0.6966215023740011,1.0,12/41,15.60%,ITPKC;PLCH2;ITPKB;ITPK1;NUDT4;INPPL1;INPP5A;INPP5J;INPP4A;FGF2;INPP5D;IMPA1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5432915141260953,-1.079796413720261,0.30434782608695654,0.9509380536130612,1.0,5/17,13.68%,SRPRA;SRPRB;SPCS1;ZFAND2B;SPCS2
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6604209117485127,1.0793874626932578,0.40384615384615385,0.6971808612951883,1.0,1/7,2.91%,WAS
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.48777172628446924,1.0793340643931932,0.34285714285714286,0.6969592825000774,1.0,14/57,9.85%,RASGRP2;CTSS;CD22;MYO1F;PLEK;NAPSB;WAS;PTPRC;LINC00926;CD37;BIRC3;ACAP1;STAG3;ADAM28
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5354086371600486,-1.079246534359605,0.3333333333333333,0.9511721842571419,1.0,2/22,2.37%,FAM47E;DNMT3B
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.7117466856705159,1.0792388705360574,0.43859649122807015,0.6968745634008089,1.0,3/5,25.08%,KDM6A;PHF8;KDM6B
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6713562305919649,1.0789865016353517,0.38181818181818183,0.6971825956811735,1.0,4/5,31.48%,PLEKHA4;MLLT3;RSPO3;SPEF1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.5697436389023721,1.0788439281139228,0.423728813559322,0.6971717964311615,1.0,3/22,3.88%,TLR2;APP;ACKR1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.7038880535111374,1.078430291996785,0.4603174603174603,0.6979512783855831,1.0,3/7,12.29%,SYK;MAPT;PRKCD
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.49326643450724206,1.0782547716049253,0.2714285714285714,0.6980480912501164,1.0,6/54,7.62%,ANXA1;IL1R1;BCL6;SAMHD1;BIRC3;MYD88
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.48028429286508784,1.078252887369238,0.29411764705882354,0.6977188152976224,1.0,7/73,5.44%,CDKN2A;PROX1;CCNB2;PSRC1;BLM;CCNI2;CDK5R2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4970847791997349,1.0779462565821147,0.35294117647058826,0.6981846661687681,1.0,20/61,22.94%,KIF14;PLK2;FSD1;BCL2L1;CDC14A;CENPV;PRKCE;ZFYVE19;PKP4;CALM3;CDC25B;PLK3;RAB11A;RAB11FIP4;PRPF40A;DCDC1;KIF13A;KLHL21;CUL3;PIN1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5729996387633857,1.0776961062688641,0.2857142857142857,0.6984344394083958,1.0,2/17,4.89%,ELMO1;WASF1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.6145168029269301,-1.0775710329690487,0.27906976744186046,0.9550133170789157,1.0,5/13,23.56%,BRDT;ZSCAN21;FOXJ2;SYCP3;MOV10L1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6019075129353216,1.0774161784156686,0.3620689655172414,0.6988087524616702,1.0,4/14,15.90%,LPCAT4;CDS2;PNPLA8;ABCA3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.6045924501732961,1.07709004844476,0.3787878787878788,0.6992393976205104,1.0,1/12,0.99%,TYMP
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.4036255826420502,1.0769500188590209,0.2702702702702703,0.6992503205423852,1.0,78/373,17.85%,VRK2;ARHGAP4;CD24;NLGN1;BLM;RIT2;ARHGAP39;MOB3B;DAB2IP;RPA1;NLRP12;PAK3;ARHGEF17;ARHGDIG;PRKAR1B;NUAK1;ARHGEF3;CHD3;NTRK3;BIRC3;RHOD;PAK4;PML;OBSCN;DAPK2;MCF2;WDR54;TRIP10;PPP1R16B;KALRN;ARHGAP26;GNA12;ARHGEF7;TAF4B;MINK1;PIP4K2A;FBXL2;TRIO;MAPT;PLEKHG2;OPHN1;BARD1;PRR5;STARD13;ARHGAP18;HIPK1;MAPKAPK5;MYO9A;PAK1;OPTN;SGMS1;PRDM1;HIPK2;IKBKG;ARHGAP17;MRE11;MAPK11;PRKAR1A;TTI1;STK3;TP53;ARHGAP22;NGEF;PIP5K1C;VAV2;BRCA1;CDK2;BST1;RFFL;RHOT1;TRAF5;RHOT2;MCF2L;RCN3;GNAI1;WNT5A;STK11;RHOQ
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.49419627170204505,1.0769188094593714,0.3787878787878788,0.6989780510439345,1.0,7/50,21.55%,CCNB2;LMNA;RANGAP1;IST1;CCNB1;UBE2I;RCC1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.44552331888316576,1.0767164143490648,0.3188405797101449,0.6992268475972525,1.0,24/88,17.46%,ABCA6;ABCA8;ABCA5;FABP3;SLCO1A2;ABCA10;MFSD2A;LDLR;SPNS2;ABCA9;SLCO2A1;ABCA2;SLC51A;SLC27A3;PLEKHA8;SLC27A5;MFSD2B;ABCC4;NME4;RXRA;ABCA3;SLCO3A1;PITPNM1;ABCG1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5634017827062577,1.07668562562831,0.33962264150943394,0.6990227483124608,1.0,3/18,3.50%,IGF1;CD24;IL27RA
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7241532738786733,1.076576157145409,0.5094339622641509,0.6989376100070658,1.0,2/6,14.94%,UNC13C;STX1B
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.7555310026747457,1.076339858836673,0.45454545454545453,0.699140846866666,1.0,1/5,1.62%,PKP2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5471595760613371,1.0763371890029887,0.34375,0.6988071280853455,1.0,5/24,16.90%,TYMS;NUDT13;AK5;NME4;DUT
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.5644530394461851,1.0759959710423732,0.3793103448275862,0.6993660211482499,1.0,5/25,5.50%,CD22;IRS2;PTPRC;NFATC2;AHR
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5930361103535327,-1.0759881275309098,0.38095238095238093,0.958589208852821,1.0,2/8,13.49%,BECN1;ATG14
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6647587338883365,1.0758580126346151,0.4444444444444444,0.6994389340853262,1.0,3/6,15.46%,MAPKAPK5;CDKN1A;TP53
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.7114072441121007,1.0753612543963216,0.4262295081967213,0.7002057488065838,1.0,2/8,8.19%,SKAP1;ASS1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6643718837158016,1.0753176183671627,0.36538461538461536,0.6999736670360945,1.0,2/9,9.35%,PRKCB;PPARG
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.6042841826389431,1.0752795062469864,0.4,0.6997474429655068,1.0,2/10,1.68%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5819109812943283,1.0752644853142583,0.3333333333333333,0.6994425584287615,1.0,2/20,3.52%,ELMO1;MYH9
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.49079185863261743,1.0752509406133401,0.34375,0.6988167733250582,1.0,14/57,16.00%,ELMO1;WAS;FYN;BAIAP2;MYO1C;PLD2;ARPC3;PRKCE;SYK;PLPP4;PRKCD;PAK1;VAV2;WIPF3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.49079185863261743,1.0752509406133401,0.34375,0.6988167733250582,1.0,14/57,16.00%,ELMO1;WAS;FYN;BAIAP2;MYO1C;PLD2;ARPC3;PRKCE;SYK;PLPP4;PRKCD;PAK1;VAV2;WIPF3
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.594938510569642,-1.0752465838843792,0.36363636363636365,0.9594536967030671,1.0,6/11,12.90%,RETSAT;ADH6;ADH4;LRAT;RDH10;RDH11
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.5131524609192805,1.0750997780287386,0.35384615384615387,0.6988728268697891,1.0,4/26,7.82%,ANK3;DMTN;FYN;MYO1C
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.5108850073433312,1.0749239098689103,0.3225806451612903,0.6988950874717144,1.0,15/46,19.54%,RASGRP1;IL1R1;CYRIB;GAS6;HLA-DRB1;CD276;FADD;IL12A;RARA;PDCD1LG2;PDE4D;SCRIB;TNFSF4;ZFPM1;TLR3
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6414675386813304,1.074629480186799,0.4,0.6992264605250628,1.0,4/6,31.90%,POLE3;BAHD1;SIRT1;EZH1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.5025913477539407,1.0745176927221374,0.373134328358209,0.6991698809549912,1.0,11/54,10.10%,TLCD2;ANK3;A4GALT;FA2H;DYSF;MYH9;PLSCR1;PLSCR2;MICALL1;SYTL4;PACSIN1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.6444497831778179,1.0744260759443578,0.4482758620689655,0.6990572022846409,1.0,2/10,3.96%,ADA;PRPS2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.45736650203219287,-1.0742992301773742,0.2857142857142857,0.9603269510077477,1.0,2/42,2.56%,FTL;FTH1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.610635293414483,1.073962523773747,0.3888888888888889,0.6999212255798277,1.0,4/9,29.79%,SLC27A5;SLC27A1;CD36;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6429018890786903,1.073783702385201,0.37037037037037035,0.6999373266045149,1.0,3/13,8.75%,ZBTB16;SCX;PKDCC
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5442600970861287,-1.0737429122539066,0.37142857142857144,0.9605331280726109,1.0,9/18,23.10%,RPL6;FASTKD2;MDN1;RPL11;RPL23A;RPF2;RPL10;RPLP0;RSL24D1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.5930260389703806,1.073430941782256,0.39705882352941174,0.7005029275869089,1.0,1/16,0.01%,GGT5
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.4684745180240582,1.073102208111078,0.35,0.7011240393934329,1.0,12/84,16.79%,RECQL4;BLM;RPA1;GINS2;SAMHD1;POLQ;CDC7;MRE11;ZSWIM7;XRCC1;BRCA1;MEIOB
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.46044630079041043,1.073083675223501,0.32142857142857145,0.7008314388275909,1.0,8/60,12.19%,BOK;DEPP1;SMCR8;DAPK2;PIP4K2A;FBXL2;MAPT;TPCN2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7091431114143992,1.0728583484967649,0.35714285714285715,0.7010094597027904,1.0,2/7,16.95%,SYK;ADGRE2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.717714521632871,1.0726865403041648,0.5,0.7011201519175723,1.0,2/5,14.94%,BAIAP3;STX1B
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5552469443614532,-1.0721586781180987,0.45,0.964409750087308,1.0,1/19,1.54%,TPX2
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.7131615507446271,1.0719653028379572,0.3888888888888889,0.7023644498997872,1.0,2/7,12.25%,APOD;CABP1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.7131615507446271,1.0719653028379572,0.3888888888888889,0.7023644498997872,1.0,2/7,12.25%,APOD;CABP1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.46474957714687626,1.071919491706984,0.31666666666666665,0.7021613746844488,1.0,19/64,15.21%,SLITRK1;IL1RAPL1;NUMBL;SLIT2;SHANK3;SERPINF1;ROBO2;NPTN;CTNNB1;PTPRD;NEURL1;CDKL5;PLXNA4;SS18L1;NAP1L1;TRIM32;RGS14;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6902965215821693,1.0718358716102134,0.38461538461538464,0.7020366969386568,1.0,2/8,9.35%,PRKCB;PPARG
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.7367794447372793,1.071781940588289,0.4807692307692308,0.7018395513976791,1.0,2/5,10.92%,BAG3;MAPT
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.6045611013786977,1.071629912967669,0.48148148148148145,0.7017988558643197,1.0,3/14,17.68%,CD24;BARD1;SRPX2
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5844030071851811,-1.0712966946404088,0.2826086956521739,0.9656480177977124,1.0,3/13,14.47%,CBFA2T3;ABCD1;SLC25A33
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.6031096205386984,-1.0712721336644135,0.41304347826086957,0.9642602407884474,1.0,3/7,27.30%,RNF168;RNF8;MSH2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6905714553778467,1.0712226504905664,0.4528301886792453,0.7023773823314884,1.0,4/7,22.17%,LAMA3;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.55041892427008,1.0711728606006787,0.41509433962264153,0.702185930505764,1.0,3/22,6.62%,KLF2;KCNMB4;ECE1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6175743845930226,1.071145380242156,0.3620689655172414,0.7015807531888304,1.0,1/13,2.35%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6175743845930226,1.071145380242156,0.3620689655172414,0.7015807531888304,1.0,1/13,2.35%,ZFP36
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.6943230744911952,1.0710331239822315,0.4074074074074074,0.7014957332085535,1.0,1/6,1.69%,SERPINE1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6328582823405804,1.070933663935179,0.42857142857142855,0.70139966293559,1.0,5/15,11.17%,NLGN1;CNTN4;NINJ2;NRXN3;ASTN2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5229314964697036,1.0709155601508638,0.3492063492063492,0.7011089953513954,1.0,5/38,14.19%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.7285892580690563,-1.0709104202779303,0.48936170212765956,0.9637646583142331,1.0,4/5,25.32%,MUL1;OAS3;MAVS;SIRPA
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.5796795246817148,1.0709025625812982,0.38461538461538464,0.7008519601639523,1.0,5/27,18.90%,ODAD1;ZMYND10;SPAG1;ODAD4;DNAH17
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.6416348443062068,-1.0707623894223746,0.4473684210526316,0.9627705310357572,1.0,2/9,6.86%,WASHC5;ARFIP2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.3637320944624451,-1.070742502273517,0.2916666666666667,0.9613482615457702,1.0,33/335,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;NEU1;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4522664998719916,1.070736665504491,0.3287671232876712,0.7008730303206465,1.0,14/104,13.18%,CDKN2A;EGF;THBS1;CD24;APP;GRM5;LDB2;PML;NLRC5;CDKN1C;BARD1;CDKN1B;FN1;CDKN1A
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6853132886807243,1.0705804417896907,0.4666666666666667,0.7008940807024402,1.0,4/7,26.81%,YAP1;UBR5;TRERF1;NEDD4
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.5821454723879833,1.0705263705847823,0.42,0.7006597162679158,1.0,7/16,19.33%,TMCC2;ACHE;ADAM19;KLK6;ABCG1;ADAM17;LDLRAP1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5609185790920513,1.070260986646651,0.40625,0.7009971663542077,1.0,8/24,18.21%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2;B4GALT6;B4GALT3
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.4357532703357883,1.0702371466570018,0.35384615384615387,0.70072969208168,1.0,24/103,26.96%,LZTS1;DCN;SMCR8;CAPN1;IKBKG;PINK1;CAPNS1;TSC2;RRAGD;WAC;ATP6V1B2;RHEB;TBK1;SUPT5H;SESN1;ULK1;ATP6V1C1;ATP6V1C2;UCHL1;GNAI3;EXOC4;SH3GLB1;NEDD4;MAP3K7
prerank,PanglaoDB_Augmented_2021__Platelets,0.4817488980115412,1.070174197497873,0.3472222222222222,0.7005678094097834,1.0,12/91,5.77%,RASGRP2;CTSS;ADGRE5;THBS1;SERPINE1;P2RY13;MYO1F;PLEK;NRGN;ALOX12;ITGA2;TUBB1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.5988401353484588,1.069910497731855,0.39705882352941174,0.7008771202289102,1.0,3/13,4.78%,RASGRP1;PTPRC;NFIL3
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.6655249194333037,1.0696356542755083,0.42105263157894735,0.701114133573576,1.0,2/8,8.06%,RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.6010523381078087,1.0694414412507802,0.45454545454545453,0.7012512684620964,1.0,2/15,7.37%,ODAD1;ZMYND10
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.3622897696012159,-1.0694353042590437,0.3333333333333333,0.9638393612489361,1.0,33/338,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;NEU1;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6587255459047705,1.0694212279424171,0.38461538461538464,0.7009787667295415,1.0,3/9,12.70%,OXCT1;HMGCLL1;SLC27A5
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4879881863418011,1.0693421688300795,0.31746031746031744,0.7007839580301659,1.0,5/63,8.77%,CTSC;VAPB;TGFA;TMED10;GRIA1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4076352057127819,-1.0691722167598625,0.2903225806451613,0.963256984467259,1.0,11/61,11.37%,DHFR2;CD320;FLAD1;PRSS3;PDZD11;ALDH1L2;SLC25A19;MMAB;AOX1;SLC46A1;MMACHC
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.45468331549865837,-1.0688484951006194,0.3783783783783784,0.9628910157212677,1.0,1/42,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5909122647783506,1.0687757026956763,0.38596491228070173,0.7018222376127892,1.0,9/16,21.14%,FLT1;PPARG;CCL2;FGF2;COL4A3;ADAM17;FGFR1;AKT3;APLN
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7284780802646837,1.0687632062550536,0.375,0.7015166940961683,1.0,3/5,15.68%,DCC;FGF13;PTPRS
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.6258655104603629,1.0687407008830458,0.40350877192982454,0.7012666714146202,1.0,4/9,13.67%,CDH23;CLRN1;SHANK1;PCDH15
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.3886149187512029,1.0683110054190754,0.27848101265822783,0.7019444085725417,1.0,61/418,13.51%,CDKN2A;ST18;GPNMB;TLR2;PROX1;TESC;SP100;TP53TG5;PSRC1;NR4A1;BLM;DUSP1;SLIT2;APP;DAB2IP;DYSF;MYH9;PRAME;PODN;TSPYL2;FABP3;KLF11;ARHGDIG;PLSCR1;SOX4;SLIT3;BTG3;BCL6;CLMN;IGFBP7;KLF10;BAP1;PML;CYP1B1;APOBEC3H;CDK6;CTNNB1;ZBTB7C;SMAD3;GMNC;LMNA;NEURL1;CTBP2;CHMP1A;TGFB2;DLG5;PODXL;P3H2;ACTN1;FBP1;NPAS2;PLXNA4;CDKN1B;BCL2;DLG3;ATP8A2;KLF4;PDPN;CDKN1A;FGF2;CGREF1
prerank,PanglaoDB_Augmented_2021__T Cells,0.4950000144695131,1.0680740957779131,0.40298507462686567,0.7021745219631964,1.0,5/55,6.11%,LEF1;MAFF;THY1;PTPRC;SKAP1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3616758929484214,-1.0676570705009805,0.28,0.9650750149698647,1.0,33/337,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;NEU1;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.6764767361980432,1.0670208776183152,0.4166666666666667,0.704384609733139,1.0,1/7,1.54%,TEKT2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.5165367783241716,1.0669729333843894,0.3728813559322034,0.7041778232998959,1.0,12/27,19.02%,IGF1;DYSF;MYH11;ALPK2;TCAP;NEBL;BIN1;NEB;MYOF;SLC8A1;CAV3;CXADR
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.6768573608992826,1.0668443412838198,0.36538461538461536,0.7040979757477887,1.0,3/8,11.59%,FAAH;DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.6927632355233013,1.0664205295409672,0.41379310344827586,0.7047397696634398,1.0,3/5,17.57%,DVL1;MAPT;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.7142406859468039,1.0662325046818113,0.4406779661016949,0.7049350142329033,1.0,2/6,9.98%,CACNA1C;ORAI1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5114468466246601,1.066060298877337,0.36065573770491804,0.704959483496475,1.0,9/32,19.36%,SMCR8;LIMK2;YAP1;PHF23;MTM1;PINK1;BRCA1;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.6776983749667438,1.0660390494535719,0.5,0.7046539019637215,1.0,2/6,15.09%,TMSB10;PFN4
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.5871898789609968,1.065573323098771,0.38571428571428573,0.7053822119026727,1.0,7/18,14.04%,KCNJ2;KCNH2;ATP1A1;ATP1B1;ATP1B3;SLC12A5;KCNMA1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5622237653774752,1.0654949321113125,0.3442622950819672,0.705285541545529,1.0,4/23,7.49%,C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.715468775222775,1.0653641529263191,0.4807692307692308,0.7053098027328283,1.0,1/5,6.79%,GHR
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.6259465201064639,1.0651907226888166,0.45161290322580644,0.7054109050913537,1.0,3/10,16.69%,HES7;BMX;MESP1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5058208773020528,1.0651258140124846,0.4057971014492754,0.7051991138193167,1.0,20/49,26.36%,PDGFRA;FYN;APOD;STK25;MAPT;PXN;AGAP3;PTPRN;MAPK9;STK24;PLK3;HIF1A;ADAM9;FOS;ROMO1;HMOX1;GLRX2;PTPRK;MAPK3;PDCD10
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.615774746130309,-1.064978277173642,0.4897959183673469,0.9715201240392753,1.0,3/6,27.30%,RNF168;RNF8;MSH2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.7041377437951626,1.064880448131598,0.4423076923076923,0.7054373031289611,1.0,3/6,18.73%,SMAD3;SMAD1;SMAD2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5736074282117801,-1.0646461108099017,0.42105263157894735,0.9710194875413539,1.0,3/12,22.08%,PJVK;PIK3R4;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5522232990650122,1.0646146415044002,0.38461538461538464,0.7056972023257718,1.0,8/29,12.05%,DOC2B;IRS2;BAIAP3;TRPM4;SOX4;NNAT;HLA-DRB1;STX4
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.6287773560760509,-1.064342710874096,0.4782608695652174,0.9703968956560993,1.0,1/5,12.96%,AMPD3
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5494803912422885,1.0639341457323408,0.4,0.7070802804500906,1.0,5/20,16.09%,LPCAT4;PLSCR1;PLAAT3;SERINC1;SERINC5
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.6180654557531999,1.0638434217997712,0.4067796610169492,0.70695574965458,1.0,2/9,13.94%,CDC7;STOML2
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.625604808150592,-1.063809319069281,0.4318181818181818,0.97041512543531,1.0,3/9,2.82%,WFDC10B;RPL39;H2BC21
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.651261872616109,1.0637264393739552,0.4727272727272727,0.7068860843188834,1.0,1/8,9.80%,AK5
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.7273066208328111,1.0633978596247424,0.5,0.7072488104878739,1.0,1/5,1.91%,NLGN1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6606649841793722,1.0633646756293045,0.41379310344827586,0.7069930952710521,1.0,3/8,17.57%,ARHGAP39;PICK1;WNT5A
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5411834315565558,-1.0633507674503457,0.4411764705882353,0.9702430360679757,1.0,7/25,6.16%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5011477744428214,1.062918934472447,0.36065573770491804,0.7076834832931023,1.0,27/72,20.24%,THBS1;SERPINE1;FLT1;PRKCB;APLNR;PAK4;CYP1B1;HK2;CHI3L1;ADAM12;ITGB8;HIPK1;FGF2;GAB1;HIPK2;PIK3CD;ETS1;BRCA1;WNT5A;F3;PRKCA;TEK;HIF1A;BTG1;RHOB;ANGPTL4;VEGFD
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.528281360497737,1.0626445902313155,0.3968253968253968,0.7080016196063664,1.0,7/31,9.04%,KIF14;TYMP;HES7;NKX6-2;TENM4;CTNNB1;YAP1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.5679126651519942,-1.0625435644680055,0.41935483870967744,0.9711889622298145,1.0,2/16,3.26%,SOD3;PRDX1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.47055264070722014,1.0624293186382443,0.323943661971831,0.7080791169958893,1.0,19/78,12.96%,NR4A3;HLA-DRA;ANXA1;CTSS;CD22;MYO1F;PLEK;SLA;PTPRC;PLAC8;ASS1;ETV6;ADAM19;CD83;HLA-DRB1;ITGAL;RAB30;RELB;PDPN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6566554614294388,1.0621472839228578,0.4576271186440678,0.7084131569587978,1.0,5/10,16.80%,CCDC3;GAS6;TRAIP;RFFL;GPS2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6608458118022688,1.0619509890445487,0.47058823529411764,0.7086541138482982,1.0,2/9,3.34%,DCN;DAB2IP
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.5827362823622914,1.0615251431037074,0.484375,0.7092439585195479,1.0,1/17,4.46%,SUN3
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.7127773598301226,1.0612702394279667,0.4666666666666667,0.7095824526716965,1.0,1/5,12.30%,IFFO1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4468812392866606,1.0611296705208162,0.3389830508474576,0.7095227983686175,1.0,12/98,11.35%,TGFBR2;AMH;ZYX;BMP8A;PARD3;SCX;DUSP22;SMAD3;TGFB2;RGMB;SMAD1;PXN
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.49375032168902816,1.0609435775575917,0.3333333333333333,0.709670196778935,1.0,12/41,21.58%,TBL1X;HDAC4;MORF4L2;HDAC9;PER1;TBL1XR1;MTA1;MORF4L1;MTA3;RCOR1;TRERF1;MIDEAS
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.5458560095996728,-1.0608172563029108,0.4222222222222222,0.9750107469751474,1.0,2/15,8.43%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5088922222347722,1.0607751400193832,0.3709677419354839,0.7097739011474664,1.0,3/34,5.17%,STEAP3;RAB15;RAB3C
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.511987653975218,1.060686601710119,0.3548387096774194,0.7096326065780161,1.0,5/45,4.31%,TLR2;THBS1;RASGRP1;APP;PTPRC
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.6365245787787609,-1.0601843579668089,0.4444444444444444,0.9755009145251442,1.0,3/8,19.18%,SOX8;RORB;RPGRIP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.4885181137618232,1.0596351567244455,0.4,0.7117870377566334,1.0,3/41,9.10%,ZFP36;RBM24;YTHDF1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6737005505449085,1.0595603185193831,0.5483870967741935,0.7112964666418808,1.0,6/9,25.85%,NFATC2;NFATC3;PPP3CC;PPP3CB;NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6737005505449085,1.0595603185193831,0.5483870967741935,0.7112964666418808,1.0,6/9,25.85%,NFATC2;NFATC3;PPP3CC;PPP3CB;NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6626785883021559,1.0593963139395155,0.41818181818181815,0.711344863596813,1.0,2/8,5.32%,DMTN;NEDD9
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.6465345967824432,1.059134036604774,0.3728813559322034,0.7117461544106984,1.0,4/8,20.87%,TERF2IP;OGG1;TINF2;ACD
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.4424394363444921,-1.0587080127710262,0.3235294117647059,0.9783033940666099,1.0,13/52,14.88%,CYP3A43;DHRS11;AKR1C3;ABCB11;ARV1;HSD11B1;GBA2;CYP46A1;CYP4V2;SRD5A1;CYP7B1;TSPO;CYP2C8
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.48038763654025024,1.0585734773195676,0.32786885245901637,0.7127006648743553,1.0,13/60,17.85%,SLC39A14;IRS2;FOXO1;BAIAP2;NAMPT;SORBS1;PDK4;GAB1;BCAR1;SH2B2;SHC1;IGF1R;RHOQ
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.46543988843465833,1.0581445630480466,0.35384615384615387,0.7133722086349555,1.0,15/52,20.60%,SUV39H1;SCN2A;LMNA;NDRG1;PGK1;PICK1;CPEB2;HIPK2;FMN2;TP53;PINK1;RORA;HIF1A;EGLN3;HYOU1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.7400706537980609,1.0581252940363257,0.5087719298245614,0.7130725351684548,1.0,1/5,4.92%,FYN
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.585708924184409,1.0580187396542367,0.4264705882352941,0.7130007708638351,1.0,2/18,9.33%,IMPDH1;AK3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6706808543986076,1.0579663428971324,0.5102040816326531,0.7127936373932153,1.0,3/11,16.62%,GLI2;EPHA4;C12ORF57
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6206019721375796,1.0578857668424744,0.4262295081967213,0.7127383110781395,1.0,5/10,31.48%,FGD5;PPP1R9B;SRGAP2;DNM3;SPEF1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.6926227531928184,1.0576793836538232,0.5,0.7126656799295502,1.0,1/5,10.12%,SHMT1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.6926227531928184,1.0576793836538232,0.5,0.7126656799295502,1.0,1/5,10.12%,SHMT1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.49360737419474454,1.057318030603709,0.4074074074074074,0.7131566448743808,1.0,11/40,15.60%,ITPKC;PLCH2;ITPKB;ITPK1;NUDT4;INPPL1;INPP5A;INPP5J;INPP4A;INPP5D;IMPA1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.44201018117920127,-1.0571891714142811,0.34375,0.9817304906167221,1.0,13/36,28.89%,CSKMT;ICMT;EZH2;VCPKMT;TRMT112;EEF1AKMT1;PRMT2;FAM98A;EEF1AKMT2;SNRPB;ETFBKMT;ETF1;PRMT3
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5774327088176013,1.057062789111574,0.4142857142857143,0.7134309604219514,1.0,5/18,20.77%,RBM24;YTHDF1;PUM1;FTO;ZC3H18
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6758590503392831,1.0569862569518516,0.4489795918367347,0.7133214438951085,1.0,1/5,7.62%,MYD88
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.6503159081997989,1.0567261417612395,0.4339622641509434,0.7135900338786425,1.0,2/6,8.12%,NRP2;CTNNB1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5991237059683686,1.056424869638347,0.3898305084745763,0.7140257054918471,1.0,3/14,5.16%,DUSP10;NFATC2;BCL6
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5897454330794846,1.056102969581221,0.41379310344827586,0.7145419075291924,1.0,8/20,18.21%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2;B4GALT6;B4GALT3
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.6836043013558704,1.0559116485051747,0.49122807017543857,0.714680149274161,1.0,4/7,28.33%,CRACD;CXADR;MUC4;PIWIL4
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6656708931885033,1.0559004594218302,0.46774193548387094,0.7143762639716733,1.0,3/8,12.29%,SYK;MAPT;PRKCD
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.4686484644087687,1.055863382931278,0.35714285714285715,0.7141103699365383,1.0,13/50,14.04%,THBS1;SNCB;TRPC3;PLSCR1;ITPR3;SNCA;NDRG1;HOMER1;MAPT;BCL2;PAM;ANXA11;KCNMA1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.585182050518567,-1.055582910845181,0.45652173913043476,0.9849365005485335,1.0,2/14,6.41%,NEU1;ASAH2B
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.6328023691830595,1.0554190923963942,0.4406779661016949,0.7149002470631899,1.0,2/10,9.04%,RPUSD1;GAR1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5791652914700471,-1.0553859926619669,0.4,0.9842459820976295,1.0,3/14,9.07%,SELENOS;HSPA1A;CREB3L1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.6229036885279178,-1.0552796600315324,0.4117647058823529,0.9830378712680716,1.0,1/8,4.02%,NEU1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.6025363730035602,1.0552510116816554,0.48333333333333334,0.714989628252093,1.0,3/12,6.02%,PROX1;SOX4;DVL1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5990054577452003,1.0550977616679453,0.35714285714285715,0.7150574063558194,1.0,1/16,0.81%,TLR2
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.728179536588147,-1.0547406636671002,0.45454545454545453,0.9831692721430718,1.0,2/5,22.01%,METTL3;AKNA
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.4457954547638854,-1.054657733615012,0.3023255813953488,0.9819553901729569,1.0,4/41,5.85%,ID1;LAMA4;ALDH1A1;NR1D1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.5080344356073354,1.054431415260763,0.391304347826087,0.716259883579546,1.0,5/42,9.88%,EGF;BLM;TSPYL2;GMNC;GLI2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6296241782489885,-1.054177261242286,0.41935483870967744,0.9817798225149124,1.0,1/9,0.62%,DSCAM
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3738636557886884,1.0535968655743282,0.2553191489361702,0.7178160562883921,1.0,266/1616,18.57%,LEF1;CDKN2A;NR4A3;SKOR1;MYT1;MLIP;FOSL2;FOSB;SIX3;MET;ST18;PRRX1;ZFP92;TEAD2;TLR2;IGF1;KLF2;MAFF;EBF1;PROX1;ZNF536;DCN;CREB5;SP100;SERPINE1;ATF3;ZIC4;ZNF93;STAT4;NR4A1;ZFP36;CASZ1;LMO2;PRKCB;HES7;WAS;ZSCAN1;APP;RPS6KA1;IRF7;DAB2IP;FOXO1;ZNF140;EFNA1;TGFA;SUV39H1;HIC1;CIC;ZNF282;KLF11;PPARGC1B;NFATC2;NFIL3;PLSCR1;SOX4;GCM2;ERFL;BCL6;TBX19;NKX6-2;AHR;ZSCAN31;SSBP4;LHX6;GZF1;CHD3;KLF10;ZNF704;DVL1;SKAP1;RFX4;CIITA;CCNQ;ZNF608;ZNF750;ZBTB16;TNFRSF1A;NEUROD2;PLAC8;ZIC1;AGRN;PGR;LDB2;PID1;TBX20;CDK9;FHOD1;FOXO3;SNCA;MSX2;GLIS2;SCX;GRIN1;HR;MAMLD1;HMBOX1;DBX2;ZFPM2;NLRC5;ZNF787;HIVEP2;PCGF3;DUSP22;SLC9A1;CTNNB1;CSRNP1;ZBTB7C;MYT1L;TBL1X;ZNF654;SMAD3;NR1I3;YAP1;RAI1;BEX1;TRAK1;PPARG;ETV6;CTBP2;HDAC4;PBX3;ZNF597;NAMPT;GLI2;OVOL3;STAT3;FLI1;KLF3;GLIS3;SMAD1;TLE6;TEAD1;ABCA2;NR6A1;PARP9;ASXL3;JAZF1;HDAC9;FBP1;NR4A2;ASXL1;NPAS2;GFI1B;MED12L;KLF9;ZNF850;SRA1;GADD45A;EIF5A;ZNF467;MLXIPL;KLF7;ZNF552;KLF6;RELB;ZNF667;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;ZBTB26;CDKN1A;SOX13;CCND1;DEAF1;FGF2;SS18L1;FADD;TNIP2;ELF1;MAML2;SRCAP;PRDM1;ZNF746;DUXB;HIPK2;BCL9;BCL11A;IKBKG;IKZF2;AKIRIN1;PTPRN;ZNF182;PPM1D;SOX10;MRTFA;PRDM16;RARA;PRKAR1A;IER5;OTUD7B;SMARCA1;PHF6;RARG;ETS1;ZNF215;STAT6;TP53;ZNF513;OLIG2;PROX2;HIF3A;BACH1;ZNF571;RXRA;PKNOX2;MED13L;ZIK1;CBX7;BRCA1;ATP2B4;ETV3;ZMIZ1;ZNF20;ZEB1;TOX3;ZBTB46;ZKSCAN2;CUX2;SP140L;HMGA1;NPAS3;ZBTB38;RORA;TFEB;MESP1;GPS2;BACH2;RGMA;ZBTB1;LPIN3;NCOR1;DOT1L;HDX;ZNF668;MNT;UBP1;WWTR1;CHD2;CCNB1;NR2F6;WNT5A;CBFB;MLXIP;LAGE3;RHOQ;MECOM;NCK2;TBL1XR1;CPHXL;ZNF432;RLF;SEMA4D;ZNF524;PHF2;ZNF473;KLF8;BCLAF1;NFIA;LITAF;LOXL2;DMRTA1;PLK3;SBNO2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.626806890984773,1.0530566135563124,0.4528301886792453,0.7187152943135107,1.0,3/9,18.75%,PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5451061486134879,1.0529138565963931,0.39285714285714285,0.7187168106869697,1.0,5/25,11.84%,SLC4A10;SLC9A9;SLC9A1;SLC4A9;SLC9C2
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.6815952389107294,1.0529018347996641,0.49019607843137253,0.718439176331227,1.0,3/8,17.81%,CDKN1A;IL12A;STK11
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.654508627297428,-1.0528595195518635,0.35555555555555557,0.9843524350012807,1.0,1/6,3.87%,THEM4
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.41556374000094,1.0525937177421454,0.38666666666666666,0.7188164241294036,1.0,49/206,24.49%,KREMEN2;EGF;DRAXIN;PTPRO;DAB2IP;LGR5;TRPM4;SOX4;NOTUM;DVL1;CTNNB1;TBL1X;TLE6;TLE3;HECW1;PRICKLE1;PLEKHA4;SOX13;STK3;FZD7;ANKRD6;WWTR1;WNT5A;STK11;DKK3;TBL1XR1;FRMD8;LGR6;UBE2B;LRRK1;UBR5;TLE2;MLLT3;AMFR;LYPD6;GLI1;RBMS3;AXIN2;CUL3;PIN1;RNF220;PSMB3;TMEM131L;PRKN;TLE4;CSNK1G2;DAPK3;PSEN1;UBAC2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6148621437317495,1.052496604987651,0.39285714285714285,0.7187052613863045,1.0,6/10,31.56%,PRKCH;MAPK9;CSF1;MSR1;CD36;IL18
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5364853331992891,1.0522761744786477,0.417910447761194,0.7188836913348422,1.0,6/34,15.46%,NUAK2;NUAK1;FOXO3;SIK2;PICK1;TP53
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5703453757079162,1.0522260686179081,0.41379310344827586,0.7187136548884839,1.0,3/10,9.73%,DUSP10;MAPK8IP1;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.5554972123771604,-1.0519027703423793,0.3958333333333333,0.9859186963310332,1.0,2/13,4.54%,CCNE1;PDCD2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4573367773700638,1.0518140857998983,0.36363636363636365,0.7192400668067179,1.0,26/95,18.09%,MTMR7;PLEK;MTMR11;SBF1;SYNJ2;PLAAT3;PLEKHA2;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;INPP5J;PLEKHA4;PLEKHA8;INPP4A;FGF2;MTM1;BMX;PIK3CD;INPP5D;IMPA1;PIP5K1C;INPP5F;PITPNM1;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.625442069478627,1.0517354648581334,0.46153846153846156,0.7187824050035918,1.0,2/10,12.47%,CD44;BCL2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.625442069478627,1.0517354648581334,0.46153846153846156,0.7187824050035918,1.0,2/10,12.47%,CD44;BCL2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.6751412348024864,1.0515684665064404,0.48214285714285715,0.7184913095243355,1.0,5/6,22.87%,DUSP1;LCMT1;CCNB1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.6751412348024864,1.0515684665064404,0.48214285714285715,0.7184913095243355,1.0,5/6,22.87%,DUSP1;LCMT1;CCNB1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.5334526474984984,-1.0514286830724549,0.3902439024390244,0.9860995977605657,1.0,5/16,12.77%,CFAP53;ADCY10;SPAG17;AQP4;SPEF2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4967013412690995,-1.051362672866587,0.45714285714285713,0.9849013423939093,1.0,5/27,20.68%,MID1IP1;NCSTN;MT3;CHTOP;MSH3
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.49820479801645234,1.0513620605304774,0.390625,0.718647896094639,1.0,4/38,6.02%,PROX1;SULF1;PTPRR;DVL1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.722322224642002,1.0512766328500038,0.46153846153846156,0.718462478344854,1.0,2/5,23.66%,SCARB1;MSR1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.6670649282566674,1.0511491572782645,0.4074074074074074,0.7183840118627977,1.0,2/5,19.33%,ABCG1;LDLRAP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.6817868551296333,1.0507021760969049,0.4426229508196721,0.719127482213873,1.0,2/6,16.20%,LRFN5;CD200
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.4490153927629302,-1.0506617608948807,0.325,0.9855092995825404,1.0,11/38,17.92%,PMVK;TM7SF2;AKR1C3;ABCB11;OSBPL3;CYP46A1;CYP7B1;SC5D;DHCR7;OSBPL6;PNPO
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.674946614903134,1.0503326627051222,0.46551724137931033,0.7196729101259878,1.0,2/8,12.13%,BLM;DONSON
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.583988882260984,-1.0502802786624115,0.4186046511627907,0.9851445606672196,1.0,4/9,19.57%,PLA2G4C;GNPAT;CHPT1;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.6834889884239368,-1.0501668370999024,0.5106382978723404,0.9840837773424673,1.0,2/5,11.28%,ADAMTS12;TSPAN12
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.48021091896469964,-1.0499282705564672,0.39473684210526316,0.9834612005014106,1.0,15/46,20.63%,DCLRE1B;FANCF;ATRIP;MCM9;ATR;RNF168;XPA;RNF8;RFWD3;FANCM;MUS81;RAD51;UBB;SLX4;FANCE
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.552788645049119,1.0499032471940895,0.43859649122807015,0.7203084904031801,1.0,9/23,26.78%,RBM24;VIP;NOCT;TAF15;AXIN2;FUS;DHX34;MEIOC;TENT5D
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.6755678376581519,1.0498546977892058,0.44642857142857145,0.7197826731948124,1.0,3/7,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.6755678376581519,1.0498546977892058,0.44642857142857145,0.7197826731948124,1.0,3/7,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5542371172512751,1.049573963705073,0.45,0.7200765598579355,1.0,5/13,18.63%,HECW2;PRKCE;HECW1;YWHAE;CAV3
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5742909277511941,-1.0488750210961537,0.4186046511627907,0.9850559808912043,1.0,3/15,8.80%,FBXO5;FBXO43;KIF20B
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.4839701841843419,-1.0487296203843637,0.4523809523809524,0.9840217248000591,1.0,5/27,16.16%,CSKMT;SMYD5;KMT2A;PRDM7;WDR82
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.6840017672613657,1.0486992210501822,0.42105263157894735,0.721780616882412,1.0,3/5,31.32%,MTHFR;SUPV3L1;SIRT1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5837556681783124,1.0486014053158381,0.5087719298245614,0.7217381812484852,1.0,7/17,20.78%,KIF5A;KIF5C;LIMK2;IKBKG;RAB11A;DNM2;SYNJ1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.5632118078063517,-1.0484835586731338,0.425,0.9832395743723039,1.0,2/9,15.09%,RPL11;DCUN1D2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.6387460701031054,1.048354971961779,0.43137254901960786,0.7220573814170983,1.0,2/6,10.80%,SERPINE1;TFPI
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5682907584504719,1.048253993721034,0.3870967741935484,0.7219138703399435,1.0,3/16,7.58%,LDB2;HMBOX1;NLRC5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.6653580992891803,-1.0481008615421439,0.5217391304347826,0.9828381617082602,1.0,1/5,11.16%,ZNF304
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.438572975123176,1.0473975847003767,0.373134328358209,0.723656546085893,1.0,19/95,23.35%,TEC;LAT2;NFATC2;GAB2;SYK;PAK1;IKBKG;VAV2;TAB1;MAPK9;SHC1;SKP1;NFATC3;VAV1;TAB2;CARD11;FOS;PPP3CB;PSMB3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.596437797097095,1.046889525410832,0.47692307692307695,0.7244311552147541,1.0,2/16,3.34%,NELL1;DAB2IP
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.6427682772601864,1.0467092309815302,0.43636363636363634,0.7244725553386214,1.0,3/8,28.03%,PHLDB2;RREB1;CLASP1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.6792067490625442,-1.0466794699597208,0.52,0.9855580844044706,1.0,2/6,5.92%,FOXJ1;ASCL1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5256387534307282,1.0465743265705778,0.45161290322580644,0.7244184158332656,1.0,12/32,22.47%,ZFP36;FOXO3;CDK6;STAT3;MAPK11;ETS1;PRMT1;ZFPM1;HIF1A;ARNT;ACVR1B;MAFB
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.5453253415183537,1.0463910900540023,0.4482758620689655,0.7245605476139143,1.0,1/16,1.68%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.48217518996740694,1.0462965145250116,0.423728813559322,0.7244905143638101,1.0,11/32,29.53%,PRKCG;OPHN1;UBXN1;MAP1A;WAC;DDRGK1;GABARAPL2;OGT;BAG6;USP25;NOP53
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5947600337482373,1.0462528266911406,0.3898305084745763,0.7242721838403952,1.0,8/19,18.63%,PKP2;TRPM4;CACNA1C;RYR2;FGF13;PDE4D;CTNNA3;CAV3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6497161943738619,1.0462131050961951,0.4339622641509434,0.7240540486910504,1.0,1/7,3.40%,FOXO1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6399188552052916,1.0461479725523786,0.46551724137931033,0.7239208099506245,1.0,4/12,20.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6935055344844105,-1.0461116259679406,0.45454545454545453,0.9857042482986349,1.0,1/5,10.96%,PDHA1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.47283042090086175,1.0460313252498477,0.3275862068965517,0.7238141476557705,1.0,7/54,12.63%,ANXA1;PDGFRA;CYP1B1;MAPT;PXN;PRKCD;AGAP3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5250682045191868,-1.045778248549499,0.4166666666666667,0.9852471614255542,1.0,1/20,0.21%,G0S2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6768263800165014,-1.0456073993665904,0.5348837209302325,0.9843292128957768,1.0,4/7,20.06%,PEX11B;PEX11A;DNM1L;FIS1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.5096554368260828,1.0455900319045555,0.3898305084745763,0.724511523910964,1.0,5/40,12.49%,HELB;WAS;TERF2IP;POLQ;CGAS
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.51275891304952,1.0455272305298176,0.4107142857142857,0.7243201052563893,1.0,6/32,11.89%,MET;DAB2IP;ITGA3;TGFB2;FBP1;KCTD13
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.4245714911556288,1.045458367061031,0.36065573770491804,0.7241552794002848,1.0,24/98,15.90%,ABCA6;ABCA8;MYH9;ABCA5;AMN;SLCO1A2;SLC35F3;ABCA10;MFSD2A;RAMP3;SPNS2;ABCA9;CHMP1A;SLCO2A1;ABCA2;ABCB9;SLC29A4;PLEKHA8;PICK1;MFSD2B;MFSD12;NME4;SCAMP5;ABCA3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4869085547391275,1.045397561514777,0.4,0.723964190545719,1.0,12/50,19.70%,ANXA1;LSM11;CDC7;BRD4;CCND1;ADAMTS1;CDC25B;CCNB1;ADAM17;RAB11A;CCND2;CDC27
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.6183281520840214,-1.0453325327199279,0.4418604651162791,0.9838003456838393,1.0,1/10,7.04%,SLC5A10
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.7288739157751648,-1.0453053057843666,0.4528301886792453,0.9824263458224655,1.0,2/5,17.22%,PRIMPOL;DDX21
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.5527420363738627,-1.0451033999494503,0.46153846153846156,0.9817091680703596,1.0,3/18,10.58%,CSKMT;SMYD2;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5344336448288903,1.0449695372449748,0.423728813559322,0.7244860267677943,1.0,2/26,3.34%,CTSC;DAB2IP
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5932880117640958,1.0449489082047072,0.509090909090909,0.7242052465730793,1.0,5/12,22.53%,LAMA5;ZDHHC7;LAMA3;SCRIB;AHI1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6083470631843105,-1.0449240604990309,0.5,0.9808231018549297,1.0,2/9,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5775802930139211,1.044859468142063,0.41818181818181815,0.7240935152912327,1.0,5/22,8.63%,HPN;DAB2IP;EFNA1;ZNF750;LDLRAD4
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.5061076160077366,1.0447375498995704,0.4461538461538462,0.7239818835472766,1.0,6/44,7.24%,LEF1;SP100;SLA;PTPRC;SKAP1;ACAP1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4861261792927517,1.0446417449802192,0.36231884057971014,0.7239388646015277,1.0,14/42,20.13%,THBS1;EPHA2;PPARG;GADD45A;FGF2;ETS1;ANGPT2;ATP2B4;MAP2K3;ADAM17;PRKCA;HIF1A;FGFR1;AKT3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.6769899499881357,1.0446072983773609,0.5,0.7237009710703491,1.0,4/7,19.03%,GRIP1;GRIP2;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4387924543684591,1.0445031542461751,0.30985915492957744,0.7236212563535145,1.0,17/105,11.07%,MET;PDGFRA;EGF;THBS1;IRS2;TGFA;FYN;NRG1;RAMP3;NRG2;PDGFA;CHI3L1;KITLG;GAB2;P2RY12;GFRAL;GAS6
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6856519686169976,-1.044316989907428,0.5625,0.9811240578836891,1.0,1/6,4.88%,PDZD11
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6731169091137534,1.0441476079460106,0.5434782608695652,0.7241100414609261,1.0,3/6,26.28%,PHF19;MACROH2A1;OGT
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4486569115470376,1.0441473868260749,0.3559322033898305,0.7237882147758322,1.0,8/69,11.35%,TGFBR2;ZYX;PARD3;DUSP22;SMAD3;TGFB2;SMAD1;PXN
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5334091741607504,-1.044021663866162,0.45,0.9804864862388264,1.0,6/18,26.71%,ACVR1C;DNASE2;DEDD2;KPNB1;EXOG;CASP3
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.5771351081899222,1.043709820182754,0.4576271186440678,0.7243238184206215,1.0,7/17,31.53%,RBPMS;KIAA0319;WWTR1;BMP6;TGFB3;TGFB1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.6803391036874201,1.0435938080048803,0.5357142857142857,0.7242702498151461,1.0,1/7,0.27%,MLIP
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.7184681813059,-1.0434924937228787,0.5084745762711864,0.9805423445631242,1.0,1/5,8.96%,GBA2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.4627028626181357,1.0434359975992082,0.35714285714285715,0.7243060448330649,1.0,29/84,20.24%,THBS1;SERPINE1;FLT1;PRKCB;APLNR;PAK4;CYP1B1;HK2;CHI3L1;SMAD1;ADAM12;ITGB8;HIPK1;KLF4;FGF2;GAB1;HIPK2;PIK3CD;ETS1;BRCA1;WNT5A;F3;PRKCA;TEK;HIF1A;BTG1;RHOB;ANGPTL4;VEGFD
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.7086663897054004,1.0430796966809952,0.5,0.7248459574242876,1.0,3/5,17.57%,NLRC5;FADD;WNT5A
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.45306071410896437,-1.042847341839807,0.3333333333333333,0.9811611268117767,1.0,6/50,6.14%,ADAMTS9;TPP1;APOE;NR1D1;USE1;FBXO27
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6239820493844821,1.0427185768574097,0.4117647058823529,0.7253591450237383,1.0,3/13,13.62%,WASF1;PID1;MTM1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.431330865648278,1.042589326010346,0.3442622950819672,0.7252789779770195,1.0,21/128,9.59%,MTMR7;SGPP2;PTPRO;DUSP1;PLPPR5;PTPRB;PXYLP1;PLPPR4;DUSP10;PLPPR1;PTPRR;PTPRC;DUSP8;DUSP16;PDP1;PTPN21;SBF1;PTPRD;SSH2;PTPN9;PPP1CB
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6597571387505325,1.0425428502382834,0.5081967213114754,0.7250363001373269,1.0,2/9,12.89%,MBP;KLF4
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6328562014546276,1.0425121806873556,0.3684210526315789,0.7248095640046485,1.0,5/9,19.03%,GRIP1;GRIP2;STX1B;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5598934231246349,1.0425081607818465,0.47058823529411764,0.724493949769256,1.0,5/15,15.14%,MGAT3;CHST6;CHST4;CHST2;LARGE1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5571032239817134,1.0422750023334104,0.4117647058823529,0.7246709504967962,1.0,9/21,18.07%,PROX1;HECA;CHI3L1;ITGA3;GLI2;PDPN;FGF2;ABCA3;PCSK5
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.5634931378531469,1.0419978189868364,0.37037037037037035,0.7249525005934649,1.0,3/15,4.73%,ABCA8;ABCA5;SOAT1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5172495432376643,1.0419715240751068,0.4153846153846154,0.7246843385960883,1.0,15/35,22.64%,WAS;ZNF750;EMP1;CERS3;OVOL3;HLA-DRB1;ALDH3A2;STS;LAMA3;RBP2;SVEP1;POU2F3;UGCG;FLOT2;GLI1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.712856147718482,1.041618393212068,0.5454545454545454,0.7251591687382979,1.0,3/5,24.87%,ADAM9;PRKN;D2HGDH
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5728321532231941,1.0415538559602884,0.3829787234042553,0.7249904911820217,1.0,5/14,11.18%,ADCY5;ADCY7;ADCY2;GUCY1A1;GUCY1B1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5575891704239171,1.0414268242651947,0.421875,0.7250466827754061,1.0,5/20,6.72%,SLIT2;EFNA1;SLIT3;TBX20;ROBO2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.4144901978692172,1.0411398678437582,0.37142857142857144,0.7253692357702478,1.0,32/134,14.43%,TAMALIN;COL4A1;SQOR;DCN;CALD1;SULF1;COL4A2;ANGPTL2;POSTN;FAS;COL12A1;IGFBP7;PTPN21;C1R;CYP1B1;SCARA3;ADGRF5;BGN;ITGA9;PXDC1;SLCO2A1;COL4A4;BACE2;FGD5;FN1;ROBO4;PALLD;TMTC1;COL5A1;NTN4;TRIM47;BMX
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.6403356011417882,1.0408368046192307,0.5,0.7256862827605717,1.0,1/11,3.83%,PGD
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.4901205724805188,-1.0407671549633815,0.40476190476190477,0.985947410201567,1.0,3/17,8.40%,SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.603087684379406,-1.0406921898556887,0.40476190476190477,0.9847450953627852,1.0,4/12,15.48%,AKR1C3;CYP46A1;TSPO;STARD3NL
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.520210340787076,1.0404138513995185,0.39285714285714285,0.7263997046985264,1.0,10/27,21.85%,SLC39A14;SOX4;RAB11FIP5;GAS6;MLXIPL;PTPRN;IGF1R;PDK3;KCNB1;ADCY8
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5653623134449799,-1.0401801977700913,0.36363636363636365,0.9848473774359993,1.0,5/14,16.85%,PYGM;AGL;PHKG1;GAA;PGM2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.7009517227169606,1.0401267511767707,0.47058823529411764,0.7266847170478519,1.0,2/6,16.85%,DIO1;CTSK
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5375906329892703,1.0395898798148038,0.4,0.7276056521893075,1.0,3/13,9.35%,IRS2;PRKCE;PPARG
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.5514894752652633,-1.0395578738122846,0.35294117647058826,0.9854247009207908,1.0,4/18,14.69%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.39691889559832755,-1.0390377101853288,0.32142857142857145,0.9856733803918063,1.0,25/139,14.39%,PAK1IP1;SETD9;TPX2;RFC3;ATRIP;RPL37;HUS1;SMYD2;RPL23;CHD4;NOC2L;BRIP1;KMT5A;BRPF1;TAF13;SUPT16H;TTC5;TAF11;ATR;MAP2K6;RPL11;PIP4P1;RAD9B;BRD7;RMI2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7017827308676384,1.0388757715617318,0.5208333333333334,0.7289844537684371,1.0,4/7,18.42%,TRPM4;OXTR;SMTNL1;ADRA1D
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.7132734264928606,1.0388052616915626,0.47058823529411764,0.7288355262827735,1.0,3/6,23.69%,HK2;PINK1;PRKN
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.6080204762108269,-1.0387013152454825,0.47619047619047616,0.9852577868969656,1.0,3/10,6.23%,FBLN5;GUCA1B;ABCB11
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.6261249833683169,1.0385307999150815,0.47540983606557374,0.7290148122810051,1.0,5/10,14.04%,KCNJ2;ATP1A1;ATP1B1;ATP1B3;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3787117446614797,1.0382844347527984,0.27710843373493976,0.7292564050088041,1.0,65/531,13.21%,NR4A3;SKOR1;MLIP;FOSB;KLF2;PROX1;ZNF536;SP100;ATF3;ZFP36;IRF7;DAB2IP;ZNF140;EFNA1;SUV39H1;HIC1;ZNF282;KLF11;NFIL3;BCL6;GZF1;CHD3;KLF10;CIITA;ZNF608;ZNF750;ZBTB16;LDB2;TBX20;FOXO3;SNCA;MSX2;GLIS2;HMBOX1;ZFPM2;DUSP22;BAG3;MYT1L;TBL1X;SMAD3;NR1I3;YAP1;PPARG;ETV6;CTBP2;HDAC4;GLI2;STAT3;GLIS3;TLE6;NR6A1;PARP9;JAZF1;HDAC9;FBP1;NR4A2;GFI1B;GADD45A;KLF7;PER1;TFAP2C;KLF4;SOX13;CCND1;DEAF1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.6366855448225015,-1.0380213251997095,0.5348837209302325,0.9860949756933576,1.0,3/7,16.24%,TWSG1;RUNX1;TARM1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5377080514411677,1.037903802035051,0.5,0.7298255793666982,1.0,11/21,30.64%,LIMCH1;SLC9A1;CAMSAP3;EPHA3;VCL;DAPK3;CLASP1;MACF1;CORO1C;EFNA5;PEAK1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.5562292898503192,-1.0375885909837217,0.35714285714285715,0.985858511386363,1.0,2/15,4.32%,NXT2;AAAS
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.37095572221685047,1.0372380321556565,0.32967032967032966,0.7309611400746949,1.0,227/1648,16.69%,LEF1;CDKN2A;NR4A3;SKOR1;MYT1;FOSL2;FOSB;ELAVL2;SIX3;PTP4A3;ST18;MYRF;PRRX1;ZFP92;TEAD2;IGF1;KLF2;MAFF;EBF1;MLLT11;PROX1;YWHAH;EGF;ZNF536;CREB5;TESC;SP100;ATF3;ZIC4;ACTA2;PSRC1;MAEL;ZNF93;STAT4;TYMS;NR4A1;BLM;PRDM8;CASZ1;PRKCB;HES7;ZSCAN1;RPS6KA1;IRF7;DAB2IP;FOXO1;ZNF140;PRAME;TGFA;SUV39H1;HIC1;CIC;ZNF282;WTIP;TCEAL7;KLF11;PPARGC1B;NFATC2;NFIL3;SOX4;GCM2;ERFL;BCL6;TBX19;NKX6-2;AHR;ZSCAN31;LHX6;GZF1;CHD3;KLF10;ZNF704;DVL1;SKAP1;RFX4;ZNF114;CIITA;CCNQ;ZNF608;NRG1;ZBTB16;BAP1;NEUROD2;ZIC1;PGR;TBX20;FOXO3;KCNH2;MSX2;GLIS2;SCX;HR;MAMLD1;PML;HMBOX1;DBX2;ZFPM2;ZNF787;HIVEP2;PCGF3;CTNNB1;CSRNP1;ZBTB7C;MYT1L;TBL1X;ZNF654;SMAD3;BASP1;YAP1;RAI1;TRAK1;PPARG;ETV6;CTBP2;CHMP1A;HDAC4;PBX3;ZNF597;GLI2;OVOL3;DENND4A;RGMB;PEX14;STAT3;FLI1;KLF3;GLIS3;SMAD1;TEAD1;TERF2IP;ABCA2;NR6A1;CDKN1C;PARP9;GAS6;HDAC9;NR4A2;NPAS2;GFI1B;MED12L;L3MBTL3;RUNX1T1;KLF9;ZNF850;SRA1;HLA-DRB1;ZNF467;PRICKLE1;MLXIPL;KLF7;ZNF552;CDKN1B;KLF6;RELB;TRIM22;ZNF667;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;JARID2;ZBTB26;CDKN1A;SOX13;DEAF1;FGF2;SS18L1;SPINDOC;ELF1;SRCAP;PRDM1;ZNF746;DUXB;HIPK2;BCL11A;RGS14;IKZF2;RBFOX2;SPP1;SNAI3;ZNF182;SOX10;PRDM16;RARA;CD4;PRKAR1A;ATXN1L;SMARCA1;PHF6;ETS1;ZNF215;STAT6;MAP3K5;TP53;OLIG2;PROX2;SAMD13;HIF3A;BACH1;ZNF571;RXRA;OGG1;PKNOX2;MED13L;ZIK1;BRCA1;FZD7;ATP2B4;ETV3;ZMIZ1;ZNF20;ZEB1;TOX3;ZBTB46;ZKSCAN2;SPTY2D1;CUX2;CXXC1;SP140L;HMGA1;NPAS3;ZBTB38;RORA;TFEB;MESP1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6082011330442979,1.037191306129719,0.45901639344262296,0.7307077013136984,1.0,6/12,14.92%,MSMP;HSD3B7;GAS6;CCL2;PIK3CD;GPR183
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.5964897241979497,1.037123686956509,0.5087719298245614,0.7305636058401599,1.0,4/17,16.62%,CACNA1C;CYP1B1;IFT122;C12ORF57
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.5640822428917232,1.0370609794801786,0.41935483870967744,0.7303728912945163,1.0,1/17,1.45%,EGF
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.47895551638299505,1.0370227759843353,0.45,0.730182344042334,1.0,21/62,19.17%,CTAGE14P;MYLK3;GCM2;PTCHD1;DTNA;RYR2;ADCY2;SYNPO2L;GALNT16;ART3;COL9A1;SORBS1;MAPT;FGF13;HIF3A;WIPF3;SPTB;RGMA;CTNNA3;LDB3;CACNB2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5954158092830838,1.0364476172338726,0.3617021276595745,0.731050600108899,1.0,1/15,2.30%,CORO7
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.6116224163015826,1.0363826833073655,0.41509433962264153,0.7308391743995206,1.0,5/8,25.55%,CHI3L1;CHI3L2;CTBS;AMDHD2;CHIT1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6745778450705096,1.0362550874106693,0.4807692307692308,0.730845697491734,1.0,5/8,23.31%,PRKAR1B;PKIA;PRKAR1A;PRKAR2B;PKIG
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5919999923335039,1.036096818511158,0.5084745762711864,0.730924770952316,1.0,3/15,11.77%,ZFP36;EPB41L4B;KLF9
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.6611019608066163,-1.034570654904268,0.4642857142857143,0.9935197870105381,1.0,3/6,23.08%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6134417401311075,1.0345324154136433,0.4918032786885246,0.7337390463804316,1.0,5/12,23.17%,DMTN;ACTN4;SPRY4;AP1AR;GBP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6134417401311075,1.0345324154136433,0.4918032786885246,0.7337390463804316,1.0,5/12,23.17%,DMTN;ACTN4;SPRY4;AP1AR;GBP1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5424619830223626,1.0344326657025664,0.4,0.73356831360166,1.0,6/21,17.89%,NUMBL;SERPINF1;NAP1L1;TRIM32;RGS14;LRP2
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.6912448280777881,1.03423988178647,0.5094339622641509,0.7336770999676459,1.0,1/5,10.20%,SLC25A29
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3955645343876228,1.034182828387995,0.32926829268292684,0.7334600021192784,1.0,52/302,18.98%,RECQL4;BOK;HELB;BLM;EPHA2;IRF7;FOXO1;RPA1;RBM24;SUV39H1;HIC1;NFATC2;BCL6;SAMHD1;POLD1;HROB;PML;BCL2L1;YAP1;IKBKE;BARD1;POLQ;GADD45A;MACROD1;BCL2;CGAS;PAK1;CDKN1A;CCND1;TRAIP;IKBKG;FMN2;POLE3;MRE11;TP53;SPATA18;BACH1;OGG1;BRCA1;ZBTB38;ZBTB1;DOT1L;STK11;DDB2;HPF1;RFC4;FANCL;PLK3;MMS19;NEK4;RAD18;FBXO31
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7055388728338183,1.034136181181508,0.43478260869565216,0.7332224178825644,1.0,1/5,12.15%,PHF23
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7226267613686702,-1.0340682624080857,0.5102040816326531,0.993817960705924,1.0,3/5,25.16%,MUS81;SLX4;FBH1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6183060145176077,-1.033886600302534,0.4418604651162791,0.9928290054744537,1.0,1/7,14.72%,PJVK
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.46376528469774414,1.0338437566777599,0.45454545454545453,0.7335533826883097,1.0,15/63,14.11%,OTOS;COL11A2;CDH23;KCNQ1;EPS8L2;PIEZO2;LHFPL3;CLRN1;CDC14A;TBL1X;EML2;CEMIP;USP53;PCDH15;NDUFB9
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5489520253132624,1.0334526134641246,0.4576271186440678,0.7340958026976984,1.0,3/16,5.94%,SLC15A3;VLDLR;MFSD2A
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.3867254360634715,-1.0327616665921422,0.3333333333333333,0.9950383185851139,1.0,36/142,11.83%,MRPL10;RPL35A;RPS24;RPL34;RPL39;MRPS21;RPL13;RPL37;MRPL52;RPS28;MRPS7;RPL18;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;RPS26;RPL6;RHCE;RPL41;RPS13;RPL22;RPL29;RPL30;ASMT;RPSA;PCSK1;RPL14;RPL15;EEF1A1;RPS2;IGF2BP3;RPL11;RPL23A
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6391918798260241,1.0324185833801085,0.48148148148148145,0.7362277181653625,1.0,2/9,7.85%,PLK2;RAP2B
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.5746554628896985,-1.0320055250515716,0.4,0.9957918827656157,1.0,2/15,12.29%,MAPK7;HTRA2
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.531205532687316,1.0315598436130575,0.4153846153846154,0.7378882162834473,1.0,4/27,6.39%,DOC2B;IRS2;SOX4;NNAT
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.5330047634140669,-1.0312704879583612,0.4,0.996522480172639,1.0,1/13,1.04%,FAM47E
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.39710497680349377,-1.0311628077202744,0.35135135135135137,0.9954105212822335,1.0,5/67,5.35%,NUP62CL;KPNA2;NXT2;NUP50;RPL23
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4755686795665456,1.0310152721559107,0.40625,0.7388509728588933,1.0,7/62,8.31%,IGF1;THBS1;SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6278550637901239,1.0308121065833777,0.5370370370370371,0.7389983232927523,1.0,6/10,32.34%,SORBS1;PTPN11;IRS1;ECHDC3;SIRT1;PRKCZ
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.6033010400181915,1.030687858278257,0.38461538461538464,0.7389548753233814,1.0,2/13,8.06%,RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.66300494619072,-1.0305453527400954,0.5,0.9958592350977561,1.0,3/6,17.61%,ATP1A2;NLGN3;MTG2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.42020924569904244,1.03049106463582,0.4406779661016949,0.7390556932682907,1.0,25/119,18.14%,NR4A3;TEAD2;NR4A1;PGR;CDK9;TBL1X;NR1I3;YAP1;PPARG;TAF4B;TEAD1;NR6A1;HDAC9;NR4A2;MAML2;NOTCH3;RARA;RARG;RXRA;RORA;NCOR1;WWTR1;NR2F6;HDAC7;TBL1XR1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.5243443587147382,1.0304502291316922,0.390625,0.7388372001981672,1.0,2/26,9.62%,PLK2;CHMP1A
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.5983497339248056,1.0303893573295517,0.4915254237288136,0.7386652158421374,1.0,2/10,18.55%,STK25;PLK3
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.5722854122515287,1.0299369107583076,0.47540983606557374,0.7393833427640024,1.0,4/18,16.01%,PGD;HK2;HK1;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6828678510706903,1.0297936119951814,0.49019607843137253,0.7394580891318117,1.0,4/6,31.32%,DDB1;ARPP19;NNMT;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.48893217760241786,1.0296511576209386,0.39344262295081966,0.7394351140009072,1.0,5/53,5.94%,MET;NELL1;TIMP2;DAB2IP;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.6556535921902323,1.0290454055792495,0.5294117647058824,0.7406657306564308,1.0,1/6,1.68%,THBS1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.6072093686592507,-1.0286118000330304,0.4523809523809524,0.9999876028060637,1.0,1/7,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.501508162339274,1.0285385907114086,0.4666666666666667,0.741392014190011,1.0,5/41,4.31%,PSCA;DAB2IP;DUSP10;PTPRR;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.5285989118644867,1.028333804627632,0.47368421052631576,0.7414965586413498,1.0,7/31,10.32%,ANK3;THY1;RNASE10;SKAP1;CD44;ADAM19;PODXL
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.6455305666808818,1.02794031804737,0.5625,0.7420781869646444,1.0,2/8,7.88%,PTPRC;LDLR
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.672181498251241,-1.027756818077208,0.5384615384615384,1.0,1.0,3/6,26.30%,DHX58;TKFC;RIOK3
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.672585625915848,-1.0273968063170404,0.5217391304347826,1.0,1.0,2/5,10.84%,COQ3;GK
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6134479342737593,-1.0271701003432134,0.4772727272727273,0.9997477476849608,1.0,2/9,6.81%,CD200R1;MST1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.6008507313691318,1.0268932502377321,0.4827586206896552,0.7440286703194967,1.0,3/9,7.88%,PDGFRA;PDGFA;LDLR
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.6742323015174922,1.026726400319805,0.4166666666666667,0.743814926243562,1.0,4/9,20.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.6742323015174922,1.026726400319805,0.4166666666666667,0.743814926243562,1.0,4/9,20.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.5697370021057689,-1.0266738514206686,0.47619047619047616,0.9997850977047623,1.0,2/14,6.00%,AR;AKR1C3
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5811250073804144,-1.026608797138474,0.47368421052631576,0.9985662328505598,1.0,3/17,6.14%,ADAMTS9;BPGM;FBXO27
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4587299573548743,1.0263641961547418,0.3870967741935484,0.7443740565547813,1.0,10/47,18.55%,PLK2;SOX4;PML;GADD45A;CDKN1B;CDKN1A;TP53;CCNB1;PRMT1;PLK3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.6627498133686882,1.0262100081238057,0.5098039215686274,0.7444053625127762,1.0,2/7,5.06%,TRPM4;TNFRSF14
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.6275104167214487,1.0261675158699632,0.44642857142857145,0.7441551734617712,1.0,2/11,1.31%,ANXA1;IL15
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.6131070814734565,1.026115846597442,0.46938775510204084,0.743966585298033,1.0,3/11,20.98%,B4GALT5;B4GALT6;ARHGAP35
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.6468764674127796,-1.0260362579343267,0.5094339622641509,0.9988416106918587,1.0,3/6,17.56%,EDNRB;ARX;SOX8
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.5381923323075233,-1.0259460556454714,0.38461538461538464,0.9976890842931541,1.0,2/14,9.16%,NUDT7;PPCS
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5887924655662131,1.0256263131382217,0.39655172413793105,0.7447036452155358,1.0,3/18,12.39%,TTLL7;AGTPBP1;CFAP20
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.6988443295412587,1.0252953583590703,0.5370370370370371,0.7452100749943475,1.0,1/5,3.33%,YBX3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4752762152843433,1.0251414101691372,0.4426229508196721,0.7452205175197829,1.0,14/57,18.53%,PROX1;PTK6;PSRC1;APP;NUDT16;TGFB2;CDKN1B;CCND1;TRIM32;RARA;CDC25B;CCNB1;ADAM17;PRKCA
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5226053183071739,-1.02503891108444,0.5121951219512195,0.9992567693281066,1.0,6/19,21.81%,NCOA4;ZFYVE16;CLU;AP4M1;GCC2;GNPTAB
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6042213794464811,-1.0244937948455823,0.45652173913043476,0.9994685981323865,1.0,2/6,28.91%,GSTM3;GSTM4
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4980702126163898,1.0241891227976108,0.47368421052631576,0.7470897389023996,1.0,11/48,17.57%,PLK2;DAB2IP;FOXO1;HECW2;BARD1;HECW1;CDKN1B;OAZ2;TRIM32;SMURF1;WNT5A
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.499743559290671,-1.024007066280779,0.4186046511627907,0.9994549040085531,1.0,1/19,0.09%,NGF
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.47103864158033865,1.0237924732361388,0.4153846153846154,0.7476200063906726,1.0,8/44,9.87%,CSPG4;DCN;OGN;CD44;AGRN;SLC9A1;BGN;OMD
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.557452190928105,-1.0235203182904695,0.4523809523809524,0.9993697784190644,1.0,3/17,5.09%,GINS3;RFC3;POLD3
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.6737656581024217,1.0235155024208649,0.5263157894736842,0.7479253218056278,1.0,1/7,4.88%,OSMR
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.5519839929038816,-1.0234976598788361,0.43902439024390244,0.9980614003137142,1.0,5/18,14.01%,SFXN2;SLC6A13;SLC36A1;SLC25A38;SLC47A1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5377003291092544,1.0233269762117128,0.4852941176470588,0.7479906760294118,1.0,10/25,22.15%,TEAD2;YAP1;TEAD1;STK3;WWTR1;YWHAE;TJP2;AMOTL1;AMOTL2;TJP1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.5743965557123999,1.022943376072355,0.42857142857142855,0.7485096748905973,1.0,6/15,20.98%,TMEFF2;CD44;PDPN;MRTFA;FLNA;ARHGAP35
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.6674892535545479,1.022881067300465,0.48936170212765956,0.7482638916012733,1.0,1/6,6.64%,TBX20
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5272646739360803,-1.022738953555538,0.45,0.9988846075330482,1.0,5/17,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.67909897318926,-1.022720629698792,0.574468085106383,0.9975500292984948,1.0,3/6,24.36%,ZNHIT3;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5679998749955953,1.0223034573255776,0.4423076923076923,0.7493324108850068,1.0,4/11,31.32%,TERF2IP;TAOK1;GSK3B;SIRT1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5569646755437427,-1.0221451858353026,0.4146341463414634,0.9975898542049568,1.0,3/10,17.37%,SFRP2;BMP2;MEOX1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.5842622281794154,1.022013246151833,0.5076923076923077,0.7497839775686762,1.0,1/16,2.21%,BLM
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4253963460312193,1.0218618658464187,0.3939393939393939,0.7497364343012984,1.0,16/108,11.07%,CDKN2A;PROX1;SP100;IRAK2;PIM1;DAB2IP;ERBIN;NLRP12;TCEAL7;GLIS2;CYP1B1;NLRC5;NLRC3;HDAC4;PEX14;GAS6
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.43904320451166845,-1.0217860388623903,0.4117647058823529,0.9970820447900488,1.0,12/61,12.64%,ADAT2;TRMT61A;TRMT10A;THUMPD1;METTL2A;QTRT2;TPRKB;FTSJ1;URM1;TRMT61B;OSGEP;TRMT5
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6219486298300894,1.0217616402224634,0.5094339622641509,0.7496634978475308,1.0,5/8,23.07%,SNCA;GFAP;EEF1A2;PLK3;SNRNP70
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5247098354345917,1.021166783047646,0.45901639344262296,0.750907541845811,1.0,6/23,16.80%,ABCA8;ABCA5;PPARG;RXRA;ABCA3;GPS2
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.6330761728633534,1.0209445621448245,0.5689655172413793,0.7510984521462322,1.0,1/8,5.25%,OXTR
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.6679731609816095,-1.0209041027996102,0.5689655172413793,0.998175440557608,1.0,3/6,21.53%,PON3;EPHX2;PON1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.44130624417970576,-1.0205486858311457,0.37142857142857144,0.9978401175067078,1.0,8/56,16.42%,ERCC8;DCLRE1B;ABRAXAS1;SMARCAL1;ERCC6;PAXX;RNF168;RNF8
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.6450425454987061,-1.020388573029202,0.5510204081632653,0.9971321129998748,1.0,2/7,25.28%,CTH;MYOCD
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6808533606706488,1.0203301714591482,0.5454545454545454,0.7520969599460459,1.0,4/5,31.24%,PDE4D;CHGA;CAMK2D;PLN
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.4268056107787892,1.02005783783101,0.4393939393939394,0.7522821181036297,1.0,32/98,17.68%,COL4A1;COBLL1;DCN;SULF1;COL4A2;OSMR;POSTN;COL12A1;FRAS1;PTPN21;RHOD;C1R;SCARA3;MATN2;ADGRF5;BGN;YAP1;PXDC1;SLCO2A1;PRICKLE2;PARD3B;IL17RE;FN1;PALLD;NTN4;LAMA3;FSTL1;CALB2;FAM114A1;WWTR1;SVEP1;SRPX2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.5764939705048565,1.0200561383708129,0.4520547945205479,0.751959527143894,1.0,9/15,35.05%,ATG9A;WDR45;ULK1;ATG7;ATG5;ULK2;ATG13;RB1CC1;WDR45B
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4361135747572774,1.0198782953267316,0.4626865671641791,0.7520380372025407,1.0,20/119,16.67%,IGF1;DCN;PLK2;IRS2;APP;FOXO1;TRIM5;FOXO3;SNCA;PLEKHF1;MLXIPL;PRKCD;TRIM22;OPTN;RNF152;PFKFB3;GRSF1;TRIM65;P2RX7;TFEB
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.6426892348558297,-1.019857366901598,0.43243243243243246,0.9971722388578723,1.0,3/6,26.16%,BHLHE41;MAD2L2;DACH1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6700139241240577,1.019337067788826,0.49019607843137253,0.7529837156626872,1.0,1/5,6.08%,FAAH
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.622508746953913,1.0192206350205582,0.5606060606060606,0.7529451240714626,1.0,4/12,15.17%,ANXA1;MAPKBP1;KLF4;OTUD7B
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.4346899776954524,-1.0192154262546584,0.4230769230769231,0.9975344848133599,1.0,9/46,20.20%,PPM1K;PSMD10;PSMD12;PSMB5;PSMB6;NQO1;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6337311083349253,-1.019131460478097,0.509090909090909,0.9964376336438886,1.0,1/5,0.58%,KCNE1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.47664451098154403,1.0190033550260753,0.4745762711864407,0.7531143211957967,1.0,4/37,10.77%,HELB;CDK9;PDGFA;TERF2IP
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.47395179958888717,-1.018850370051809,0.3902439024390244,0.995845893031322,1.0,10/38,14.39%,PYHIN1;RPL23;PDCL3;CCDC22;RAD23A;RPL11;UFL1;ARAF;HFE;CLU
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.6456376350508732,1.0188126556071209,0.4897959183673469,0.7531972677850236,1.0,3/8,16.69%,NRG1;TGFB2;MESP1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.5501694917543669,-1.018646565414783,0.48,0.9936557802422383,1.0,3/13,14.73%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.5501694917543669,-1.018646565414783,0.48,0.9936557802422383,1.0,3/13,14.73%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6775799752465157,1.018362685869427,0.5263157894736842,0.7539028772809694,1.0,1/6,3.40%,FOXO1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.5967639192807265,1.0183287716013536,0.509090909090909,0.7536463480821685,1.0,2/12,20.64%,ABCA2;H6PD
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6552117434230252,1.0180384192444518,0.49122807017543857,0.7539414200542847,1.0,2/8,6.91%,APOD;SNCA
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5946558768537051,1.0175811670694426,0.4852941176470588,0.7546407510423235,1.0,1/14,0.86%,IMPDH1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.6659246656346388,1.0174891017453196,0.46808510638297873,0.754535862279653,1.0,1/7,9.80%,AK5
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.6225062413799058,1.017399983900603,0.48148148148148145,0.7544260109780463,1.0,4/10,19.01%,MFSD2A;ABCA3;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.5890024379445808,-1.0168697533632207,0.5,0.9972006736405081,1.0,1/6,1.61%,SELENOS
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.5492334271521304,-1.0168084181446844,0.5,0.9960817868399308,1.0,2/14,6.01%,ACOXL;ABCD1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.5490618549538229,1.0162661241264417,0.41818181818181815,0.7566341654668023,1.0,3/20,9.29%,SYCE1;IHO1;STAG3
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.639887095745338,1.015965132748599,0.5178571428571429,0.7571141014278764,1.0,2/7,9.45%,FOLH1;AGTPBP1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.5243318752066812,1.0159364902698442,0.4807692307692308,0.7568519232410074,1.0,9/31,10.89%,COL11A2;SULF1;ZBTB16;CD44;SCX;SH3PXD2B;CHI3L1;NAMPT;ITGB8
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5183887269471608,-1.0159295983697445,0.4,0.9971701535525119,1.0,1/13,2.14%,FSHR
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5541976514755604,1.015878325792916,0.42857142857142855,0.756665620405721,1.0,4/17,9.25%,PRKCB;PTPRC;TESPA1;PRKCH
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5840950669370478,1.0157084838861439,0.5344827586206896,0.7567315419819796,1.0,3/10,23.55%,BRCA1;CDK5RAP2;CCNF
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5656562150842804,1.015508091994346,0.49230769230769234,0.7569133083009629,1.0,4/15,13.49%,SERPINE1;TFPI;PHLDB2;FGF2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6689129281647239,-1.0154074500083945,0.5294117647058824,0.9974687034171806,1.0,2/5,18.41%,BDP1;POLR3H
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6089633315961223,-1.0153419125042473,0.42857142857142855,0.9963241672412613,1.0,1/11,0.79%,ID2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.6612609949076017,1.0152727678618951,0.5227272727272727,0.7571201050448935,1.0,2/6,16.36%,BCL2L1;RFFL
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5499025602889663,1.015260130079967,0.49122807017543857,0.7568433772487343,1.0,5/13,19.18%,PIM1;VSTM2A;SOX13;FTO;FNDC5
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.5708913266977083,-1.0150070888304608,0.425531914893617,0.9961959245083267,1.0,1/8,1.74%,VAMP8
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4481576049158877,1.0150045550915006,0.47692307692307695,0.7570399623961762,1.0,18/61,17.63%,ZFP36;FOXO1;TRPM4;ZBTB16;ZFPM2;SMAD3;YAP1;PPARG;WDFY2;TRIO;ASXL1;RUNX1T1;SYAP1;RORA;GPS2;WWTR1;WNT5A;FTO
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),-0.6459821325674979,-1.014944135704863,0.46,0.9949669298621833,1.0,3/5,16.10%,ABCB11;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5960935660469844,1.0149261884783112,0.5,0.7569043607255239,1.0,2/14,7.14%,ZBTB16;SCX
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5986797662566228,-1.0147863285899692,0.5384615384615384,0.9940384489887603,1.0,1/9,2.37%,DNMT3B
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.42904902941554146,1.0147624799622688,0.5068493150684932,0.756975041323225,1.0,7/86,8.31%,SIX3;PLK2;NUDT16;FSD1;IHO1;CTNNB1;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5694050099647806,1.0144136923607954,0.5423728813559322,0.7574377156052223,1.0,3/10,21.03%,MAPT;NDFIP2;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.6084142067981289,1.0143827378709183,0.5,0.7571664644791283,1.0,4/9,16.20%,PTPRC;LDLR;LRFN5;CD200
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.6607594562684282,-1.014268894660132,0.5106382978723404,0.994151242974406,1.0,2/6,15.20%,PLIN3;PLIN2
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),-0.6147227502394476,-1.0141623679749172,0.5476190476190477,0.9930682887954442,1.0,2/5,4.40%,TNFAIP3;FOXJ1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6341398400608277,1.0138969421833441,0.5081967213114754,0.7579802094721872,1.0,2/7,2.53%,HLA-DRA;CD55
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5367752989175257,1.013859181882042,0.4482758620689655,0.7577440978932323,1.0,3/16,7.26%,GRIN2B;KCNC2;GRIN1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5916148606783117,1.0136833083556425,0.46551724137931033,0.7577942014815365,1.0,4/12,15.21%,NRP2;PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5289576429307841,1.0135091175751716,0.4745762711864407,0.7579345448602528,1.0,7/21,17.57%,IL1RAPL1;EPHA4;SLITRK4;CDKL5;CAMK2B;ARHGAP22;WNT5A
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.4913227068525675,-1.0131563122916276,0.4418604651162791,0.9943759200925159,1.0,5/23,11.86%,ABCD2;ABCD1;PEX10;PEX11B;PEX11A
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.6207270110746361,-1.0131238760400032,0.4878048780487805,0.9931477779162143,1.0,3/6,26.01%,DNAAF1;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6006792707603065,1.0125692466915637,0.4909090909090909,0.7596540395658878,1.0,2/10,6.35%,PTPRC;NRG1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5520790747057616,1.0125128608768152,0.5254237288135594,0.7594226306213424,1.0,8/18,23.67%,APLNR;MYO1C;PRKCH;RAP1A;CBFB;RAP1B;TJP1;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4695513821937134,1.0124800981956872,0.44776119402985076,0.759166370972872,1.0,7/55,12.78%,IGF1;ACHE;TMED10;SYTL4;TGFB2;ARF6;OAZ2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5037336703732869,-1.0123131654687247,0.3225806451612903,0.9938909166810652,1.0,9/37,7.12%,GMFG;CD247;CD96;CD38;PYHIN1;IL5;CD6;P2RY10;CXCR4
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.48785065142097256,1.0120525329071361,0.4576271186440678,0.7597315079169338,1.0,5/27,16.11%,BLM;DONSON;CDKN1A;MRE11;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6687002247184647,1.0120150254390126,0.5084745762711864,0.7594803394516573,1.0,1/6,12.05%,STX4
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5362886907112541,1.0116451299682059,0.4,0.7600298570968496,1.0,3/19,5.85%,NOS1AP;STAC2;HPCA
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.512809740994171,1.0114624561742867,0.4827586206896552,0.7601738417712932,1.0,6/23,14.31%,PRKCG;EFNA1;PML;EPHA4;OPHN1;HIPK2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.5071728238438012,1.0113450106663218,0.4307692307692308,0.7600877629926223,1.0,8/41,12.68%,RASGRP1;DAB2IP;FOXO1;FAS;STK25;MAPK8IP1;TGFB2;PER1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.7000494948213046,1.0112794118591129,0.509090909090909,0.7599268074996274,1.0,1/5,8.20%,BAG3
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6313876233704765,1.0112571806059554,0.42857142857142855,0.7596660974859284,1.0,2/8,13.11%,ITPK1;HK1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7222579779423154,1.0112506932483125,0.5531914893617021,0.7593556832788511,1.0,1/5,1.62%,PKP2
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.49154585168920945,1.0108502946850988,0.4393939393939394,0.759838989486023,1.0,15/40,19.02%,RASGRP1;ADA;PTPRC;SOX4;CD44;NLRC3;KIF13B;CD276;PIK3CD;CD4;SCRIB;NCK2;TNFSF4;LFNG;CXADR
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5732314893094888,-1.0107945707877903,0.5151515151515151,0.9967841168411875,1.0,2/14,7.12%,ID2;CXCR4
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5496925204052329,1.0107686787856918,0.453125,0.759693374749133,1.0,7/16,16.45%,ST8SIA3;B4GALNT1;ST8SIA4;ABCA2;ST6GALNAC5;ST6GALNAC3;NEU4
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5978640981850669,1.0107495953356653,0.5333333333333333,0.7594132579316405,1.0,1/8,4.89%,WASF1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.4442920719385871,-1.0104456629854568,0.3888888888888889,0.9964899727074069,1.0,3/54,4.07%,FGF6;GALNT3;POLR2K
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5215916413612441,1.010433681913413,0.5,0.7598161853626786,1.0,6/20,12.66%,SP100;DMTN;APOD;BARD1;CABP1;RANGAP1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.610029475668606,1.010399135983897,0.52,0.759561162170727,1.0,1/7,12.08%,CDC7
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.61191376646165,1.0101740455600874,0.5084745762711864,0.7597246575196311,1.0,1/7,4.87%,ALOX12
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6573085995067725,1.0101319076567217,0.509090909090909,0.7594997535925001,1.0,1/5,17.76%,PIGK
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.473438619550457,1.0095641782064653,0.46774193548387094,0.7603447976066019,1.0,20/57,20.24%,PROX1;EGF;NR4A1;NRP2;EGFL7;APLNR;PPP1R16B;FGF2;PIK3CD;WNT5A;ADAM17;F3;PRKCA;TEK;HIF1A;VIP;ARNT;FGFR1;AKT3;VEGFD
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.4331592747734001,1.009422911592379,0.4603174603174603,0.7603336839889815,1.0,27/118,24.74%,APP;TRAM1L1;RPA1;DVL1;OBSCN;LMNA;MICALL1;IFT122;ARF6;OPTN;ALDH3A2;IFT140;YWHAE;SNX10;RAB11A;DDRGK1;MTCH2;SIX4;BICD1;GBP1;TUB;ARFRP1;PRNP;DHX9;UBAC2;GABARAPL2;HMOX1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.62361386490357,1.0090245182344193,0.4909090909090909,0.7609837816518522,1.0,5/8,20.36%,DYSF;SYK;IFI35;SBNO2;NMI
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6015736394198725,1.0089550527835256,0.45454545454545453,0.7608233284270141,1.0,6/10,20.15%,SNCA;TF;BCL2;B2M;HIF1A;BMP6
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6094508801066654,1.0089466093912742,0.4745762711864407,0.7605189590146479,1.0,1/7,4.35%,PDIA2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6579984184637896,1.0088803388972438,0.5192307692307693,0.7603141486894794,1.0,4/9,15.46%,SP100;RPS6KA6;HIPK2;TP53
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.6521781655008829,1.0088272593478718,0.4915254237288136,0.760084694586276,1.0,2/6,25.13%,CRACD;MUC4
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.6546613528974998,1.0086616987562256,0.45652173913043476,0.7601034840794025,1.0,4/6,19.34%,FAP;YAP1;PAK1;PTPRJ
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.6546692520995736,1.0086208940747579,0.5185185185185185,0.7598842283780936,1.0,2/8,5.50%,CD22;AHR
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.4998728117106605,1.0081741636871027,0.4852941176470588,0.76046321242473,1.0,8/35,17.83%,FOLH1;GPT2;ASS1;KYAT1;NAT8L;NOX4;MTHFR;GPT
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6384641516148228,1.0081392912074647,0.46296296296296297,0.760194441746665,1.0,2/6,5.16%,IRS2;BCL6
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5967286626482645,1.0079861005780775,0.4716981132075472,0.7602478229295975,1.0,1/14,2.80%,ABCB1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5774328744298562,1.0079289877872428,0.5283018867924528,0.7600536269167949,1.0,4/15,14.71%,RASGRP1;CD160;IL12A;HLA-E
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.44534826807506483,-1.0077317414830276,0.35135135135135137,1.0,1.0,9/39,7.58%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10;CXCR4;S1PR1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.6253346051431663,-1.0076780438882555,0.475,1.0,1.0,1/9,3.42%,CEP19
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.6359376422785867,1.007649735442419,0.49122807017543857,0.7603445542337557,1.0,2/10,6.88%,STEAP3;STEAP4
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.4599048069075809,-1.0073923856572535,0.42857142857142855,1.0,1.0,3/28,4.01%,SLC25A5;FLT3;RABL3
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5419371049761956,1.0070591060570437,0.5,0.7613079642066873,1.0,3/17,9.85%,CD22;THY1;CD160
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.6657933046630664,-1.0070551147706,0.43478260869565216,1.0,1.0,1/5,4.54%,PDCD2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.5030492972648186,1.0067364938235004,0.46774193548387094,0.7616871245731993,1.0,12/27,28.99%,TNIP2;IKBKG;MAPK11;MAP3K5;SKP1;RPS27A;MAP3K8;MAPK3;MAP3K7;MAP2K7;MAP3K20;FBXW11
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.6256029361857693,1.0064709628338262,0.5263157894736842,0.7620264292525485,1.0,1/6,2.31%,RIT2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5562330454316693,1.0064367616194052,0.48148148148148145,0.7617874332887719,1.0,6/12,18.63%,RYR2;SLC9A1;CTNNB1;TCAP;SLC8A1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6385126627903754,1.006334299119596,0.5471698113207547,0.7617856731581446,1.0,4/7,28.74%,OPTN;PINK1;PRKN;HDAC6
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.6506716161926889,1.00606595657515,0.5178571428571429,0.7617377500225714,1.0,1/8,6.88%,STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.6506716161926889,1.00606595657515,0.5178571428571429,0.7617377500225714,1.0,1/8,6.88%,STEAP4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6014768086059916,1.0059269175760976,0.5614035087719298,0.7617458769653456,1.0,1/10,0.65%,MYRF
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.5961413911818869,1.00574139475467,0.5614035087719298,0.7618476677419043,1.0,2/10,3.55%,NOD1;ERBIN
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5794590114074758,1.00560949160532,0.5172413793103449,0.7617916784261897,1.0,5/13,25.91%,CHKB;LPIN3;ETNK2;SLC27A1;ETNK1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.593018378255271,1.0055869699842823,0.47540983606557374,0.7615584022829812,1.0,6/10,9.40%,KCNJ2;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.419095453310144,1.0055022154098032,0.47435897435897434,0.761438569440979,1.0,29/119,18.57%,TLR2;ANXA1;IL15;SERPINE1;APP;NLRP12;IL1R1;BCL6;BIRC3;TNFRSF1A;SNCA;MYD88;NLRC3;PPARG;PRKCD;BRD4;KLF4;TNFAIP6;ETS1;LRFN5;CD200;BST1;RORA;GPS2;MFHAS1;WNT5A;TNFSF4;IFI35;SBNO2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.5040563094825076,1.0054022440834043,0.46551724137931033,0.7613877419017719,1.0,6/23,10.90%,THBS1;ATP1A1;YAP1;TGFB2;TFPI;ABCA2
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6182285413517408,1.0052897855188432,0.5283018867924528,0.7613123576808587,1.0,2/9,17.39%,ATP9A;INPP5F
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.6930379132875191,1.0052406091240351,0.5,0.761094421564271,1.0,1/5,8.19%,ASS1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6795242033289974,1.0052171818025069,0.4807692307692308,0.7608225937547655,1.0,2/6,12.57%,ALOX12;ADIPOR2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.5141254337109459,-1.0050913549235867,0.4864864864864865,1.0,1.0,7/16,24.95%,GRPEL2;TIMM23;TIMM50;DNAJC19;TIMM17A;TOMM70;GRPEL1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5743897414310122,1.0050486763052404,0.46153846153846156,0.7608556385244581,1.0,2/14,2.82%,NR4A1;SLIT2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.467467001428646,1.0049082889718424,0.5084745762711864,0.7608444512834396,1.0,6/63,8.42%,TGFBR2;RFTN1;ZFP36;EIF4A3;THOC6;KIF5C
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.580046656168222,1.0048897278297793,0.5245901639344263,0.760563246220182,1.0,2/14,3.61%,IGF1;NLRP12
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6664745239379866,1.0046717008315775,0.5087719298245614,0.7603400158126135,1.0,1/6,19.70%,CDC27
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6664745239379866,1.0046717008315775,0.5087719298245614,0.7603400158126135,1.0,1/6,19.70%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5127958199564797,1.0044735570998544,0.43478260869565216,0.7604761651744357,1.0,3/15,11.71%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6585853380128494,1.0041681610033024,0.45161290322580644,0.7608229642133366,1.0,6/7,32.23%,ITPK1;IMPA1;ISYNA1;PPIP5K1;IMPA2;IPPK
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.517390124126261,1.0039854229892804,0.4666666666666667,0.7608853096261047,1.0,11/23,26.70%,PLSCR1;NLRC5;FADD;HLA-E;WNT5A;IFI35;NMI;SLC15A4;DHX9;POLR3C;UBE2K
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5353932328485849,1.0038406644032265,0.5079365079365079,0.760913321677435,1.0,3/17,9.61%,RAMP3;PPARG;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.49845606818699056,1.0037904486479543,0.4827586206896552,0.7607357049914959,1.0,8/25,13.90%,THBS1;SERPINE1;ICAM1;PAK4;CD160;GAS6;CCL2;TNIP2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5418994654633315,1.0037405070345224,0.5076923076923077,0.7605386617691208,1.0,1/16,1.02%,CTSC
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.6413346698222395,1.0034867493978445,0.5192307692307693,0.7608064572576771,1.0,1/5,13.49%,FGF2
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.71419462099877,1.0034451020780293,0.54,0.7605606545440384,1.0,3/5,27.63%,CDKN1A;STK11;MME
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.4846663685783731,1.0032412181699382,0.4264705882352941,0.7606767139559697,1.0,3/30,4.73%,NSDHL;ABCA5;SOAT1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.42896930244173453,1.0030776719474406,0.47761194029850745,0.7607340543444353,1.0,10/84,12.04%,PLD1;THBS1;YBX3;SAMD4A;SOX4;EIF4A3;LARP6;YTHDF1;NIBAN1;EIF5A
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.5516939217492876,1.002980306659314,0.47368421052631576,0.7605520680055241,1.0,7/21,18.29%,TMEFF2;CD44;PDPN;COL5A1;MRTFA;ADAM17;FLNA
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.4737664631736106,1.0029218520010814,0.5074626865671642,0.7603214193615204,1.0,10/35,13.49%,COL11A2;SULF1;SLC39A14;ZBTB16;CD44;SCX;CHI3L1;ITGB8;SNX19;FGF2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.5902227935405435,-1.0028863729099518,0.4864864864864865,1.0,1.0,1/8,4.54%,RGN
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5666645252525692,1.002794519452429,0.45901639344262296,0.7602324584663286,1.0,4/13,17.86%,BAG3;GAS6;TP53;YWHAE
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.5931505254695498,-1.0025746537430933,0.4888888888888889,1.0,1.0,2/11,12.75%,IGSF1;FSTL3
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4634594913237673,-1.002148067751716,0.4090909090909091,1.0,1.0,6/15,28.72%,EMC6;EMC4;UBL4A;EMC7;EMC8;GET3
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.6452768948119856,1.0020169378990682,0.5714285714285714,0.7615091917089848,1.0,3/5,29.94%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5896135718678888,1.0020102231942234,0.5409836065573771,0.7612150561378571,1.0,4/13,17.04%,CACNA1C;RYR2;SLC8A1;CALM3
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5770774705890609,1.0018824683051204,0.4918032786885246,0.7612476672485227,1.0,4/10,25.70%,STX4;STX1B;SNAP25;STX3
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6015063853903366,1.001699843958142,0.47368421052631576,0.7613338346746445,1.0,6/11,31.53%,RBPMS;KIAA0319;BMP6;TGFB3;TGFB1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.3850057662682473,1.0015601590408156,0.4675324675324675,0.7613420241349514,1.0,26/257,11.17%,GPNMB;IGF1;SH3GL2;TYMS;ZFP36;IGF2BP2;ZC3H12D;APP;NLRP12;SAMD4A;NUDT16;CCDC3;SMCR8;PGR;ENC1;APLNR;EIF4A3;NPTN;CENPV;YAP1;TGFB2;SHMT1;ITGB8;MAPT;PARP9;HDAC9
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5156621723604924,-1.0014325387615937,0.46153846153846156,1.0,1.0,3/13,10.55%,RPL23;SUPT16H;SMARCD1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.6452106320812638,1.0007415276973606,0.559322033898305,0.7628687701626654,1.0,2/7,0.79%,TLCD2;ANK3
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5147705696418544,-1.000546069830155,0.4090909090909091,1.0,1.0,2/14,6.01%,ABCD2;ABCD1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5106085654460543,-1.0003413368292717,0.4523809523809524,1.0,1.0,8/23,21.35%,COPS8;CETN2;COPS7A;XPA;UBB;COPS3;COPS6;PARP1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.5880343340281786,-1.000164716363327,0.5454545454545454,1.0,1.0,1/8,4.02%,NEU1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6722536107228759,1.0000568199917241,0.46774193548387094,0.76406342826714,1.0,1/5,2.14%,TYMS
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),0.6834601576379926,0.999974252322091,0.5084745762711864,0.7639002745142919,1.0,3/5,20.22%,HDAC9;SORT1;ANGPTL4
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.3646373537563054,-0.9992860209304885,0.42857142857142855,1.0,1.0,38/197,19.08%,TTC29;TMEM17;CATIP;CNGA4;UBXN10;CEP19;FOXJ1;CFAP221;INTU;TEKT5;WDR11;CFAP52;TMEM237;TEKT1;CEP131;RAB8A;SCLT1;EXOC7;IQCB1;CEP83;DYNC2I1;FAM149B1;TMEM250;ARF4;BBS9;CCDC66;AVIL;CFAP70;DYNLL1;MKS1;UNC119B;CEP78;CEP20;DNAAF1;FAM161B;ARL6;EXOC1;FBF1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6714151873506068,0.9990611395085651,0.5178571428571429,0.7656088142788198,1.0,4/5,32.81%,MTMR2;MTMR3;MTMR1;MTMR9
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6516675128502545,0.9989487625174057,0.4915254237288136,0.7655763584284011,1.0,3/6,10.44%,GRIN2B;FYN;HOMER1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.5019531469729943,0.9989056107221378,0.5079365079365079,0.7653642126642973,1.0,1/28,0.99%,HELB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.6115109503510643,-0.9987926673466138,0.5081967213114754,1.0,1.0,2/8,6.27%,BLOC1S2;VDAC2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.525811916272351,0.9985107661274341,0.42105263157894735,0.765943640448481,1.0,3/20,12.71%,SULF1;TBX20;ELAPOR2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.48869239939192444,0.9982715984829464,0.49056603773584906,0.7661052160828885,1.0,8/34,17.04%,THY1;SNCA;APLNR;JPH4;CEMIP;PDE4D;UBASH3B;CALM3
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5295577935777249,-0.9977532429461894,0.4857142857142857,1.0,1.0,3/17,15.20%,SELENON;RYR1;MYORG
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6262617298456655,0.9976146946522573,0.5581395348837209,0.7673969963507467,1.0,3/7,29.15%,PHF23;HDAC6;RUBCN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5305098389779137,0.9975823215158391,0.4339622641509434,0.767140809164627,1.0,6/26,13.63%,PDGFRA;FLT1;DAB2IP;P2RY12;FGF2;WASHC1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.6232098603615694,-0.9972858115248044,0.575,1.0,1.0,3/6,14.81%,CFTR;AQP4;AQP6
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.4760171582692177,0.9972197207348555,0.49206349206349204,0.7676167678910938,1.0,8/40,14.96%,APP;GRM5;FOXO3;PARP9;ZC3H7B;PER1;MAPKAPK5;PUM1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.6617284972903966,-0.9970662033760788,0.6,1.0,1.0,1/5,4.02%,NEU1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.4984814539089832,-0.9969376205283604,0.47368421052631576,1.0,1.0,5/27,8.78%,MID1IP1;ABCD2;APOE;ABCD1;LCN12
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5977370288222373,-0.9966984461010945,0.5116279069767442,1.0,1.0,1/8,4.36%,APOE
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5351630805015625,-0.9965513480507018,0.42857142857142855,1.0,1.0,5/10,20.44%,SLC6A13;SLC46A1;SLC19A1;SLC5A6;SLC1A4
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.5442273877550413,0.996098906056532,0.48333333333333334,0.7698221000579106,1.0,5/16,9.88%,PDGFRA;MYH11;MYLK3;ALPK2;TCAP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5008890883826007,0.9956077019398016,0.4915254237288136,0.7706646624123897,1.0,7/29,20.29%,ANXA1;LSM11;CCND1;ADAMTS1;ADAM17;CCND2;DDRGK1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.570174701914555,0.9950221652874595,0.5076923076923077,0.7716033617813249,1.0,3/11,17.73%,PRKCB;GFI1B;CBFB
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.5429070122367365,-0.9946320944780108,0.5217391304347826,1.0,1.0,3/12,16.16%,KMT2A;PRDM7;WDR82
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6408881486834006,0.9943622856268999,0.49122807017543857,0.772700991570376,1.0,1/5,17.55%,GNAI1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.6319998991621467,-0.9942730832762096,0.5333333333333333,1.0,1.0,1/8,0.79%,ID2
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4486618607017485,0.9942356443652919,0.48484848484848486,0.7727189942021164,1.0,9/56,16.91%,TBC1D24;LIMK2;YAP1;CDKL5;USP6NL;TBC1D1;TBC1D10B;TBC1D10A;IFT140
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.4699998272621497,0.9942174336882041,0.4852941176470588,0.7724468594235511,1.0,13/45,14.92%,CD22;RASGRP1;PRKCB;LAT2;PTPRC;TPD52;HDAC4;HDAC9;KLF6;BCL2;CD70;PIK3CD;GPR183
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.5138667882314174,0.9937139234051168,0.4528301886792453,0.7732237955418425,1.0,5/24,11.71%,GPNMB;THY1;CYRIB;PAG1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.54741268263585,0.9934544958755864,0.4528301886792453,0.7735556057631998,1.0,6/16,18.06%,PTPRC;TNFRSF14;STX4;HLA-E;WNT5A;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6764342814608995,0.9934223953286861,0.5645161290322581,0.7733124394996452,1.0,2/7,20.36%,GPS2;UBR5
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.45390990769093,0.9932983817537682,0.45588235294117646,0.7732287787576517,1.0,11/46,15.38%,GRIN2B;FYN;PRODH;SNCA;RAMP3;MAPT;CDKN1B;ZNF746;HEBP2;RARG;MAP3K5
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.40253145171338445,0.9928836675536732,0.4861111111111111,0.7738014572622364,1.0,20/178,13.02%,ENPP2;COL4A1;C3;SQOR;PIM3;BCL6;HADH;MRAP;YWHAG;PPARG;OMD;PFKL;PEX14;ATP1B3;SORBS1;DGAT1;GADD45A;ADIPOR2;STOM;LTC4S
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5026138025361878,0.9926484624312515,0.5,0.7739154312228036,1.0,1/27,0.99%,HELB
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.47476776196602477,0.9922808985950557,0.5081967213114754,0.7743957532596586,1.0,3/33,9.35%,GLRA2;FYN;NEURL1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.6521028514709375,0.9921330587190453,0.5714285714285714,0.7743792624756236,1.0,2/5,16.76%,PLAAT3;LIPE
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5749631421013596,0.9916059465056704,0.515625,0.7750998880685677,1.0,6/13,9.40%,KCNJ2;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.41027529254314005,0.9914466010759159,0.4461538461538462,0.7750831242360213,1.0,19/140,11.07%,MET;PDGFRA;EGF;THBS1;EPHA2;IRS2;TGFA;FYN;NTRK3;NRG1;RAMP3;NRG2;PDGFA;CHI3L1;KITLG;GAB2;P2RY12;GFRAL;GAS6
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5237091516486742,-0.9913248274835833,0.425,1.0,1.0,4/10,25.66%,EMC6;EMC4;EMC7;EMC8
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.41540129990127844,-0.9910344434729044,0.4482758620689655,1.0,1.0,2/93,0.15%,NGF;FGF6
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4572237572592055,-0.9910192977333728,0.46511627906976744,1.0,1.0,1/28,0.17%,FTL
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5458839669280726,0.9910165304478576,0.5,0.7756921612739595,1.0,2/18,1.16%,SIX3;PROX1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5584532685323845,0.9909364792331641,0.5185185185185185,0.7755163812008113,1.0,3/12,10.22%,GPNMB;ASS1;PAG1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.5256120541078848,0.990292178129499,0.4461538461538462,0.7766490193563877,1.0,5/23,4.31%,CTSS;MYO1F;PLEK;ICAM1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.6063783103446856,0.9902510035989726,0.5961538461538461,0.7764008751923674,1.0,2/7,12.96%,FSCN1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.4540257339266309,0.9901105179667717,0.5283018867924528,0.7764028408998332,1.0,2/40,1.15%,CTSC;CCBE1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.5139757442471313,-0.9896162520556884,0.5,1.0,1.0,4/20,6.16%,CD247;CD96;S100B;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5916136583481612,0.9895592677124485,0.5079365079365079,0.7771446179025536,1.0,4/11,27.34%,SMCR8;IGF1R;CALCOCO2;UVRAG
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4330654692925592,0.9892779618176865,0.423728813559322,0.7773911838715873,1.0,15/70,12.17%,IGF1;KIF14;RASGRP1;RASGEF1A;IRS2;DAB2IP;ERBIN;EPS8L2;DENND3;TGFB2;DENND4A;FBP1;OPHN1;STARD13;ARF6
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.6027019157143707,0.9891663280024283,0.5084745762711864,0.7772727435116891,1.0,3/8,15.24%,GDA;SHMT1;DPYD
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.5205000669102828,-0.9889370219140136,0.4444444444444444,1.0,1.0,7/19,20.06%,BCAP31;SLC8B1;SLC25A23;LETM1;MICU2;AFG3L2;FIS1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.6346961189634893,0.9889104072695972,0.5660377358490566,0.7775382502052722,1.0,3/5,32.70%,BRCA1;SIRT1;AUTS2
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.45447850442454407,0.9888164172212155,0.515625,0.7767999411033499,1.0,7/56,16.00%,CTSC;TGFA;TMED10;GRIA1;ANKRD28;CD59;CTSZ
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.45447850442454407,0.9888164172212155,0.515625,0.7767999411033499,1.0,7/56,16.00%,CTSC;TGFA;TMED10;GRIA1;ANKRD28;CD59;CTSZ
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.45447850442454407,0.9888164172212155,0.515625,0.7767999411033499,1.0,7/56,16.00%,CTSC;TGFA;TMED10;GRIA1;ANKRD28;CD59;CTSZ
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.6240237489388726,0.9887295192126304,0.5283018867924528,0.7767250930141285,1.0,3/8,19.15%,SHANK1;ADCY3;MAP1A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5229803360351579,0.9886559240345126,0.5660377358490566,0.7765545368226108,1.0,7/23,17.04%,PLAAT4;PLAAT3;CHKB;PLAAT5;PNPLA8;PLAAT1;LPIN3
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.524538876796981,-0.9885753846467589,0.4,1.0,1.0,2/16,14.01%,SLC6A13;SLC25A22
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.6545003706942096,0.9882669012855022,0.5531914893617021,0.7771068795621672,1.0,2/6,7.88%,PTPRC;LDLR
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.6292984328849262,0.9880958550860017,0.484375,0.7771516122175404,1.0,2/6,17.02%,FADD;ZBTB1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.4024930453566351,0.9879559134808382,0.4927536231884058,0.7771102214071115,1.0,6/112,6.62%,RECQL4;HELB;BLM;RPA1;GINS2;POLD1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.5948387308321579,0.987947407325379,0.4406779661016949,0.7765114331934264,1.0,3/9,7.19%,ADCY5;AHR;ADCY2
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.5948387308321579,0.987947407325379,0.4406779661016949,0.7765114331934264,1.0,3/9,7.19%,ADCY5;AHR;ADCY2
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.6171721412605146,-0.9876426491780839,0.4358974358974359,1.0,1.0,4/10,15.33%,BLOC1S2;VDAC2;BAD;BCL2L11
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.6003232666249478,0.9874320833840233,0.6274509803921569,0.7774878174771417,1.0,5/10,25.99%,SH3PXD2B;NAMPT;ZNF516;PGRMC2;ARID5B
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.45759800727320765,-0.9871415345762772,0.5263157894736842,1.0,1.0,5/32,12.24%,FAM47E;TPP1;MCM9;ATR;CENPA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.430436210859279,-0.9871146726066902,0.4722222222222222,1.0,1.0,14/51,17.99%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;CNOT1;POLR2D;RC3H1;LSM1;CNOT9
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6027285529698868,0.9869891972283393,0.52,0.7781960189779923,1.0,4/9,27.90%,CTNNB1;PIP5K1C;VCL;TBCD
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.631268566994629,0.9867768314599313,0.56,0.7782736151448256,1.0,4/7,15.55%,PLAAT4;PLAAT3;PLAAT5;PLAAT1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4263604072614689,0.9860621356488564,0.5,0.7795916250292643,1.0,20/60,19.74%,GRIN3A;THY1;PRAME;NEUROD2;ALPK2;DCC;CDK6;MAPT;GAS6;KLF7;ELAPOR2;RPS6KA6;BCL11A;PINK1;PTPRS;KIAA0319;TFRC;LOXL2;ADCK1;NOTCH4
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4603364421900724,0.9859409094991146,0.47368421052631576,0.7795302913090248,1.0,4/35,13.49%,ITPKC;ITPKB;AGPAT4;FGF2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5660055556932234,-0.9855761002333306,0.5434782608695652,1.0,1.0,1/7,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6386462087884369,0.9854631786457008,0.5714285714285714,0.7802698998835501,1.0,3/10,9.09%,MLIP;FOXO1;LMNA
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.6252580014106486,0.9853849568707173,0.49056603773584906,0.7800939752786572,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5143712945868416,0.9852150390610435,0.484375,0.7801706515512714,1.0,8/25,19.47%,LTBP4;ITGA3;SMAD3;BCL9;FSTL1;DKK3;SMAD2;TGFBR3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5071835515345777,0.9851149199289149,0.5,0.7800330001352617,1.0,5/24,15.53%,DCN;CYRIB;MAPT;SPIRE1;PINK1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.4444770845449297,-0.9847353396505986,0.47368421052631576,1.0,1.0,3/44,2.90%,NGF;PIK3C2G;PLCB4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.6676923981173352,0.984717630966011,0.54,0.7805855944810047,1.0,4/8,31.04%,PDPN;EMP2;GSN;CAMK2D
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.5995130033029534,0.9846313214616019,0.48333333333333334,0.7804336140220467,1.0,2/8,4.78%,PTPRC;NFIL3
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.6361619471707156,0.9845469785492026,0.5087719298245614,0.780338824417227,1.0,1/5,5.33%,CTU2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4077657489162729,0.9844376737504026,0.5211267605633803,0.7802536185841805,1.0,22/129,19.49%,FOXO1;NUAK2;MAP1LC3A;FAS;NUAK1;MFSD2A;KLF10;FOXO3;SIK2;PDK4;PICK1;CDKN1A;RNF152;MAP3K5;TP53;TFEB;GABARAPL1;STK24;ELAPOR1;MTMR3;RRAGD;ATP6V1B2
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.5385137842700125,0.9842893780003906,0.5510204081632653,0.780230255983953,1.0,5/22,11.93%,GPNMB;SFTPD;DLG5;PAG1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.6426984032150276,0.9842860582812568,0.6071428571428571,0.7799219119832582,1.0,2/6,20.41%,P2RX7;ANO6
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.5915655619004581,0.9841734209579642,0.5185185185185185,0.7798037392373213,1.0,4/9,23.56%,THPO;ZFPM1;SH2B3;CDKN2B
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.4532286372279243,-0.9834382998104775,0.5357142857142857,1.0,1.0,3/46,4.07%,H1-2;H1-4;POLR2K
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.6359309760405534,0.9833140560860708,0.6166666666666667,0.7813942908684804,1.0,2/8,13.02%,ALOX12;LTC4S
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.6156159688211675,0.9832834945153398,0.55,0.7811285496947967,1.0,3/9,3.81%,ANK3;KCNE4;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.5587647778850247,0.9830677030664005,0.4807692307692308,0.7812661246324231,1.0,3/15,4.31%,ZFP36;SFTPD;PTPRC
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5530909375866504,0.9830545065560794,0.5178571428571429,0.7809769451797323,1.0,2/9,9.10%,ZSWIM4;YTHDF1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4067636630946725,0.9829876383382817,0.4864864864864865,0.7807638147498395,1.0,15/90,16.90%,RECQL4;HELB;BLM;RPA1;RBMS1;POLD1;BARD1;CDC7;DONSON;NAP1L1;POLE3;MRE11;BRCA1;CDK2;DUT
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5822973532904361,-0.9829653388008004,0.6274509803921569,1.0,1.0,2/7,7.12%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5822973532904361,-0.9829653388008004,0.6274509803921569,1.0,1.0,2/7,7.12%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6380407171114628,-0.9826944054393688,0.5416666666666666,1.0,1.0,3/7,30.48%,LSM1;PATL1;PATL2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5046574583874348,0.9826134880802887,0.5517241379310345,0.7813181998356745,1.0,6/24,12.57%,C3;SORBS1;ASXL3;PDK4;MLXIPL;ADIPOR2
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5491696424632069,0.9825893952471615,0.5,0.7810719597907554,1.0,6/13,22.69%,RAI2;TGFB2;CAMSAP3;BRCA1;FGFR1;CELF4
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6234757270901795,0.9824839203145632,0.6226415094339622,0.7809300406645292,1.0,5/9,32.34%,SORBS1;PTPN11;IRS1;SIRT1;PRKCZ
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.46705159074740743,0.9822504514324362,0.463768115942029,0.7811194062209345,1.0,2/39,1.98%,KIF14;PSRC1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4891197056590234,-0.9820713401515345,0.5675675675675675,1.0,1.0,7/20,26.71%,DNASE1L1;DNASE2;MUS81;KPNB1;FBH1;EXOG;CASP3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5746812512724937,0.9820081282477469,0.543859649122807,0.7812944330838234,1.0,3/11,16.21%,LIMK2;YAP1;MAP4
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.509632970236016,0.9819743102015228,0.4426229508196721,0.7810722320797173,1.0,4/25,7.49%,C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.6440621476932488,-0.9819260609187355,0.5,1.0,1.0,1/5,15.12%,TRIB1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4304557693276182,0.9818674195807297,0.5396825396825397,0.7809730676283374,1.0,14/56,19.44%,PLK2;SOX4;PML;GADD45A;CDKN1B;CDKN1A;CCND1;TP53;CDK2;CCNB1;PRMT1;PLK3;FBXO31;WAC
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.5377607765679167,0.9818257299288671,0.5737704918032787,0.7807322783331111,1.0,8/24,15.90%,PROX1;CHI3L1;ITGA3;BASP1;GLI2;PDPN;FGF2;ABCA3
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.6542039914889197,-0.9818148199701173,0.5555555555555556,1.0,1.0,2/5,16.31%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.48176616486912704,0.9816747698350899,0.4461538461538462,0.7807749760557366,1.0,9/41,17.57%,TESC;PTK6;WNT8B;ASXL1;RARA;RARG;RXRA;FZD7;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.41217108132621616,-0.9813500546320184,0.42857142857142855,1.0,1.0,2/59,4.10%,NGF;HAX1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.4766748129320573,0.9813354722306045,0.5,0.7811668974893899,1.0,7/36,20.13%,WAS;PARP9;SPIRE1;FMN2;SPIRE2;MMS19;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.626769232367967,0.9813010086337276,0.543859649122807,0.7809216010326538,1.0,3/6,32.70%,BRCA1;ARRB1;AUTS2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5416699368923674,0.9809044401785181,0.5081967213114754,0.7813886067819246,1.0,1/11,4.35%,PDIA2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.6120122584932874,-0.9802383249280765,0.574468085106383,1.0,1.0,3/9,19.36%,MICA;CEBPG;TUBB
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6281749421325127,0.9800695107744994,0.5306122448979592,0.7827933386294812,1.0,4/6,18.63%,DYSF;BIN1;MYOF;CAV3
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.5226917917617621,-0.979753492541483,0.46511627906976744,1.0,1.0,2/13,15.21%,DSCC1;RAD21L1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.49901555529457403,0.9794232425867506,0.4745762711864407,0.7837869920504125,1.0,3/21,9.25%,ZFP36;PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.5022044374081728,0.978888594877085,0.47540983606557374,0.7843876474368928,1.0,11/27,18.30%,TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;MTHFR;VASP;SCRIB;LRP2;TSC2
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.5022044374081728,0.978888594877085,0.47540983606557374,0.7843876474368928,1.0,11/27,18.30%,TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;MTHFR;VASP;SCRIB;LRP2;TSC2
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5038476434002446,-0.9784737078125021,0.575,1.0,1.0,5/17,17.85%,CTSH;NCSTN;PRELID1;MAPK12;PSME3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.46904985852668535,0.9783349332120362,0.49122807017543857,0.7851629797617222,1.0,7/44,6.79%,L1CAM;RIMS2;SYT4;SHTN1;SYT1;AGRN;GHR
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.6313781135648032,0.9781427848043313,0.5818181818181818,0.7853025622817943,1.0,4/6,23.59%,WAS;NEB;ARHGAP35;CXCL12
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.43645654589138805,0.9779956966137323,0.603448275862069,0.785319760484182,1.0,9/60,6.91%,FOSB;THBS1;TMCC2;MYO1F;CD55;GAB3;TUBB1;CD44;SNCA
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.5949901578080079,0.9779612390713931,0.5454545454545454,0.7851442058459155,1.0,5/10,17.95%,RTN4RL1;EPHA4;PTPRS;INPP5F;STK24
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5000321510616181,0.9779018716951896,0.5166666666666667,0.7849969851285674,1.0,4/29,10.01%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.4117796634408473,0.9777059612105318,0.5362318840579711,0.7850800452635284,1.0,6/133,4.92%,TLR2;EGF;SULF1;LGR5;TRPM4;SOX4
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.5259780214405655,0.9776043878998447,0.5,0.7850127879370226,1.0,7/19,33.25%,BIRC3;FLOT2;FLOT1;OGT;BIRC2;HSP90AA1;NUPR1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.5372494158782685,0.9770174128412302,0.5818181818181818,0.7859030578865722,1.0,3/17,10.90%,ABCA8;ABCA5;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.637988118960139,0.9768214774575126,0.5161290322580645,0.7859950434116807,1.0,1/5,3.80%,TJP3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6414448779204265,0.9767270669838879,0.6037735849056604,0.7859040546044174,1.0,4/10,15.46%,SP100;RPS6KA6;HIPK2;TP53
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4925466704693773,0.9764899902256532,0.45614035087719296,0.7860615978007222,1.0,1/22,1.37%,KREMEN2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5526391032650717,0.976426077062665,0.47619047619047616,0.7859284800809294,1.0,5/12,20.13%,PML;USP50;HIPK2;ETS1;WRAP53
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.4302685945394908,0.9764020441012563,0.5,0.7856736781794462,1.0,5/74,10.25%,PDGFRA;LMO2;RBM24;YAP1;SLC4A11
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.6402664394159394,0.9762012041442362,0.576271186440678,0.7853987043187675,1.0,1/6,2.53%,CD55
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.6402664394159394,0.9762012041442362,0.576271186440678,0.7853987043187675,1.0,1/6,2.53%,CD55
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.6422395493318696,0.975912027782996,0.5576923076923077,0.7856543877386342,1.0,3/6,20.78%,GUCY1A1;GUCY1B1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.536668589336097,-0.9757487483797489,0.5217391304347826,1.0,1.0,3/18,3.49%,APOBEC3G;TEX15;SMYD5
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.5117980992821263,0.9754630492974566,0.532258064516129,0.7861811241003497,1.0,4/25,12.07%,SULF1;SLC39A14;SCX;SNX19
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4046720900848063,-0.9753455871920901,0.5135135135135135,1.0,1.0,16/46,24.18%,ATRIP;HUS1;BRIP1;ATR;ERCC6;TRIAP1;CLSPN;HINFP;SESN2;USP10;RAD17;PAXIP1;CASP9;CHEK2;E2F7;MAD2L2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5177017147717285,0.9753202042117624,0.5689655172413793,0.7861791735824113,1.0,5/18,16.80%,ABCA8;PPARG;RXRA;ABCA3;GPS2
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.5783922061479012,-0.9752511497316259,0.5,1.0,1.0,3/7,20.44%,SLC36A1;SLC36A4;SLC1A4
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5548867400002787,0.9752026235119803,0.5333333333333333,0.7861538590177982,1.0,4/12,30.04%,AK3;RHOQ;GNAI3;ENTPD7
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5305525872724725,-0.9750624911905933,0.5681818181818182,1.0,1.0,6/11,25.35%,PHGDH;SEPHS1;CTH;SRR;PSPH;SEPHS2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5625893426083171,0.9748935792996777,0.5,0.7865489790198289,1.0,4/10,26.53%,SNCA;PCSK5;PCSK6;FURIN
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5855682432173539,0.9744971923767339,0.5918367346938775,0.7870138287472193,1.0,4/10,16.69%,TBX20;RYR2;IFT122;MESP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.5364191030454456,0.9742809641345493,0.5,0.7872776055375741,1.0,4/16,19.81%,SHTN1;CYRIB;TEK;RAP1B
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.6372259432809383,0.9739351431622216,0.5862068965517241,0.7876111606252132,1.0,3/5,27.50%,CAMSAP3;TJP1;PLEKHA7
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.6275981089387574,-0.9738891815389031,0.46511627906976744,1.0,1.0,2/5,21.22%,ENPP3;PRPS1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6080670013480896,0.9736948553776006,0.4642857142857143,0.7877672242440662,1.0,3/8,24.74%,FADD;CD200;HMOX1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.46883321970851144,-0.9736639832462215,0.5185185185185185,1.0,1.0,9/23,23.61%,GAL3ST2;ALG11;GAL3ST4;GK;TNIP1;ST8SIA6;RRM2B;RRM1;ALG6
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.37468968808046554,-0.9734205755485414,0.4838709677419355,1.0,1.0,22/92,19.05%,UCP3;DHX16;CHD4;ABCB10;BRPF1;URB2;EIF3D;GANAB;GART;NEMP1;PRPF8;MCM3AP;NOL6;USP19;CNOT1;DDX11;RFWD3;RUVBL1;DDX21;SLC11A2;HDGF;TAF5L
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.456770402856284,0.9731779187712357,0.47619047619047616,0.7884686276046807,1.0,4/40,7.51%,ANXA1;FYN;STK25;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.3856446124879134,0.9729427049848481,0.5285714285714286,0.7886335512307339,1.0,22/147,12.98%,HPN;GPNMB;IL15;KREMEN2;PTPRO;DAB2IP;NLRP12;DUSP10;EFNA1;PTPRR;RAB11FIP5;ZNF750;ALPK2;NPTN;LDLRAD4;RAB11FIP1;GAS6;HDAC9;TLE3;KLF7;ELAPOR2;RPS6KA6
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6719582020803001,0.9728903997397577,0.5396825396825397,0.7881201696577013,1.0,1/5,19.56%,DYNC1LI1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6719582020803001,0.9728903997397577,0.5396825396825397,0.7881201696577013,1.0,1/5,19.56%,DYNC1LI1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.46924731723486157,0.9727087463570769,0.5079365079365079,0.7881826314471474,1.0,2/32,3.38%,APP;TRAM1L1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6104502233010676,0.9723498397457038,0.5555555555555556,0.7886219299437056,1.0,1/6,12.08%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5163425670328914,0.9723389542725146,0.5555555555555556,0.7883306631834176,1.0,4/20,10.92%,L1CAM;SHTN1;CDKL5;MAPT
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.578490942884672,-0.9721163879146749,0.5476190476190477,1.0,1.0,1/6,3.20%,PHYH
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5480529177671314,0.972070050077382,0.5769230769230769,0.7885603419195271,1.0,3/11,11.71%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5965949936209514,0.9716476907599509,0.5555555555555556,0.789087275874601,1.0,2/7,8.12%,NRP2;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.41840312077186825,-0.9715569553239769,0.4772727272727273,1.0,1.0,11/54,15.60%,SELENOS;TPT1;NOC2L;SFRP2;HSPA1A;MAPK7;CREB3L1;HTRA2;NDUFS3;CLU;ARMC10
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.4829445940749427,0.9715568703751669,0.543859649122807,0.7889494744442545,1.0,6/30,17.86%,THBS1;BAG3;CLPB;MAPT;IER5;YWHAE
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.394792583549084,0.9709928222484521,0.47058823529411764,0.7898937828843468,1.0,18/163,9.22%,C3;TMCC2;P4HA2;DMTN;LMO2;ADD2;ACKR1;RAP1GAP;TNS1;FOXO3;SNCA;TYR;DAAM1;AGPAT4;NUDT4;ALDH1L1;SEC14L1;FTCD
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5167881899881367,0.9709165787191227,0.5396825396825397,0.7897418473665855,1.0,10/24,20.13%,ANXA1;THBS1;HDAC9;STARD13;KLF4;FGF2;HDAC7;SRPX2;MAP2K5;AKT3
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4778456887781802,-0.9707311026423009,0.475,1.0,1.0,3/24,9.07%,SELENOS;HSPA1A;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5302173914826087,0.9706088638808678,0.5185185185185185,0.7900540453244453,1.0,3/18,7.53%,GPNMB;NEK10;PDGFA
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.5103210077498026,0.9705965186085267,0.6,0.789758377994286,1.0,8/31,17.91%,DUSP1;FOXO1;DUSP10;PER1;PINK1;GPS2;NCOR1;MECOM
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5543624078141478,0.9705125383052118,0.49056603773584906,0.7896252200857901,1.0,3/11,13.20%,PIM1;VSTM2A;SOX13
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.6400710577378375,0.9702526455496374,0.5660377358490566,0.7898536725154034,1.0,2/5,20.72%,ST6GALNAC3;GAL3ST1
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.6444991681713622,-0.9701330447454888,0.5909090909090909,1.0,1.0,2/6,16.92%,WDR76;RFWD3
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5847185154647417,-0.9700531008942026,0.6,1.0,1.0,2/6,10.75%,VEGFC;VEGFB
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4578837847906183,0.969919243321336,0.5333333333333333,0.7902811599211451,1.0,4/40,2.82%,SLITRK1;L1CAM;SHTN1;SLIT2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4465739731707737,0.9698932435117603,0.5072463768115942,0.7900507013712137,1.0,10/43,16.70%,PXYLP1;AGRN;UGDH;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;NDST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.5959240119217092,-0.9695252237538232,0.5918367346938775,1.0,1.0,1/6,4.46%,BLOC1S2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5143987993618869,0.969237887422579,0.5,0.7911258731225621,1.0,6/23,3.55%,IGF1;RASGRP1;RASGEF1A;RELN;IRS2;ERBIN
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6149939942799646,-0.9692108211522975,0.5769230769230769,1.0,1.0,1/5,4.10%,HAX1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.4667704182007204,-0.9688407213200748,0.4666666666666667,1.0,1.0,4/32,5.92%,NGF;BEND6;HEYL;ASCL1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.5815461932114454,0.9685087887241145,0.5185185185185185,0.7923390276120182,1.0,2/8,8.65%,PID1;CHI3L1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.5805672591959337,0.9683620501824373,0.6111111111111112,0.7922745580159974,1.0,3/10,21.77%,ATG9A;PACS2;WDR45
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.5504642349864982,0.9682645042156153,0.509090909090909,0.7921454051589041,1.0,3/12,12.52%,ABCB1;ABCA2;PLEKHA8
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.4706670060360961,-0.9682403145107424,0.5,1.0,1.0,6/24,11.55%,HEY2;HES6;HEYL;HEY1;BHLHE41;HES5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.627358041576162,0.9672087140857799,0.6078431372549019,0.7939298715498967,1.0,4/6,36.10%,HIF1A;PRKN;MCL1;FBXW7
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.6209633723579424,-0.9671521603665679,0.5882352941176471,1.0,1.0,2/5,10.75%,VEGFC;VEGFB
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5893073853073908,0.967138733682769,0.5789473684210527,0.7937585914234456,1.0,2/11,13.12%,APLNR;AKAP8
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5856911640647093,0.9668820521170924,0.48148148148148145,0.7939846289317929,1.0,5/10,31.31%,IFT122;C12ORF57;TENM3;TBX2;NF1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.42509366406420634,-0.9660335918369326,0.5111111111111111,1.0,1.0,9/38,12.47%,CST3;CSTB;FICD;PLXNB3;RRP1B;MAPK7;PPP1R35;TMED2;ZCCHC9
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5622896235279837,-0.9659722782828786,0.5555555555555556,1.0,1.0,5/10,30.48%,PNRC2;LSM1;PATL1;EDC3;PATL2
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5376294503686003,-0.9658733144793498,0.4594594594594595,1.0,1.0,4/11,22.40%,EXOSC4;EXOSC5;FBL;LARP7
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.535305316463335,-0.9657378922418602,0.5555555555555556,1.0,1.0,3/12,6.81%,PTPN22;CD6;BCL10
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.44124595290467683,0.9653866813780934,0.578125,0.7968511951068916,1.0,2/44,3.62%,ANK3;AMN
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5711533824932421,0.9653859707501461,0.4838709677419355,0.7965405318729318,1.0,2/7,21.89%,STAU1;DDB1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3594898420559648,-0.9652360063000788,0.5,1.0,1.0,9/114,5.85%,NGF;ID2;AR;HEY2;SMYD5;PDCD2;SERPINF2;NR1D1;GREM1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.5444335822288937,-0.9649248142066751,0.475,1.0,1.0,3/10,12.63%,PGP;DGKB;PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5169918696857678,-0.9648782709872418,0.4473684210526316,1.0,1.0,2/23,3.78%,NGF;PYHIN1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.3930024326227491,0.9645439078479925,0.5,0.7979323147160291,1.0,22/96,13.49%,CORO6;RBM24;FABP3;VLDLR;COL21A1;PDE1A;TBX20;RYR2;NEXN;ZFPM2;OBSCN;SYNPO2L;CTNNB1;RASL12;ART3;TCAP;LAMA2;SORBS1;ADIPOR2;CAP2;PNMT;FGF2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.6785548039647727,0.9640879772293546,0.6,0.7985575503820167,1.0,4/6,29.33%,ATG9A;ULK1;ATG7;ULK2
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.6062946552194921,-0.9637764136249847,0.6,1.0,1.0,2/5,18.25%,GTF2H2;ADM
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5865465204636221,0.9635903840646469,0.5522388059701493,0.7993251913137763,1.0,2/10,8.96%,TSPYL2;GMNC
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4106965308336071,0.9635855951734628,0.5507246376811594,0.7990140487714199,1.0,15/76,16.08%,RASGRP1;TBC1D9;EPHA2;NTRK3;RAP1GAP;SIPA1L1;USP6NL;TBC1D1;RANGAP1;RAP1GAP2;SIPA1;ARHGAP22;NGEF;TBC1D10B;TBC1D10A
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4058683217674545,-0.963569067578933,0.47058823529411764,1.0,1.0,12/67,15.58%,CEBPA;SIRT6;TRIB3;CBFA2T3;BCAP31;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5884999113216058,-0.9634757852436958,0.5217391304347826,1.0,1.0,1/8,0.29%,RAB7B
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.5809899317087371,0.9632200973222987,0.58,0.7995368052239391,1.0,3/9,7.88%,IGF1;PTPRC;LDLR
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.39001947181634405,0.9628247874359939,0.5882352941176471,0.8000315307350265,1.0,28/189,12.47%,EGF;DCN;THBS1;PTK6;SULF1;PLEK;PRKCB;DAB2IP;NLRP12;PRAME;HIC1;PTPRC;EGFL7;APOD;NOTUM;PID1;SNCA;GLIS2;DCC;TMBIM1;NEURL1;MMP14;PIP4K2A;IFT122;NR4A2;ASXL1;PRKCD;BCL2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6495101268101495,0.9626176833549713,0.5964912280701754,0.8000886570839706,1.0,1/5,15.53%,PINK1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5798586588349546,0.9624956925446194,0.52,0.8000583301210218,1.0,3/9,7.19%,ADCY5;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5719408528005121,0.9620990553427626,0.5,0.8004970922379899,1.0,1/12,2.91%,WAS
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.47550172749031117,-0.9616980484664085,0.5588235294117647,1.0,1.0,10/28,21.11%,SF3B4;HSPA1A;ZPR1;RBM22;NCL;RBMX;CIRBP;HABP4;PRDX6;SNW1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.5543072136357627,-0.9616287113887086,0.5555555555555556,1.0,1.0,2/8,9.23%,IDO1;TDO2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6270050906456669,-0.961515209763933,0.5909090909090909,1.0,1.0,3/8,21.19%,GTF2A2;TAF11;TAF12
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5819429947182452,0.9614706494332347,0.5714285714285714,0.8014503658796462,1.0,8/11,30.90%,CYP1B1;MTARC2;GCHFR;CYB5B;GCH1;CYB5R3;DDAH2;NOS1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.6515918418544722,0.9612809993249319,0.5925925925925926,0.8014609016218095,1.0,3/7,26.65%,FN1;CXCL12;FERMT3
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5628245209683356,0.9612389118651481,0.5507246376811594,0.8012325761312883,1.0,2/13,11.22%,GAR1;TRUB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.49364386833212026,0.9610916002625568,0.5,0.801183498078641,1.0,1/18,1.48%,DCN
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.49463138291531517,-0.9610683109844126,0.4594594594594595,1.0,1.0,4/24,4.95%,ID2;CCNE1;CDK15;FBXO5
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.47843441890743166,0.9610220889993256,0.5223880597014925,0.801065611597267,1.0,8/37,20.36%,WAS;PML;TERF2IP;SPIRE1;FMN2;SPIRE2;WRAP53;UBR5
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4129228952273816,-0.9609454775087738,0.5454545454545454,1.0,1.0,9/57,6.81%,RAB7B;SELENOS;CD200R1;TNFAIP3;AGER;FOXJ1;PTPN22;IL33;BCL10
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5647713122568789,0.9604601214591963,0.53125,0.8019204697277313,1.0,8/12,30.90%,CYP1B1;MTARC2;GCHFR;CYB5B;GCH1;CYB5R3;DDAH2;NOS1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.3815065996831797,-0.9603853890822978,0.47368421052631576,1.0,1.0,4/67,6.79%,NUP62CL;NXT2;NUP50;GEMIN4
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.35631976817678784,-0.9600724297307859,0.5357142857142857,1.0,1.0,25/106,20.40%,H2BC21;PADI4;GTF2H5;GTF2H2;CETN2;MCM6;DMC1;H2BC18;ERCC2;PSMD10;MCM4;PSMD12;PSMB5;XPA;PSMB6;ORC6;PSME3;ERCC3;H2BC5;PSMD2;RAD51;SMARCA5;UBB;PSMB4;ORC2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.4830703816982228,-0.9597651003354236,0.5277777777777778,1.0,1.0,8/20,19.42%,DHRS11;SRD5A1;MOCS2;NFS1;LIAS;PRLR;NOXRED1;MOCOS
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.43071866928071567,0.9597442962237764,0.4909090909090909,0.8031690794356756,1.0,13/62,18.73%,THBS1;SULF1;BMP8A;TBX20;TGFB2;RBPMS;CDKN1C;ELAPOR2;HIPK2;KIAA0319;STK11;ADAM17;SMAD2
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.6148270829737587,-0.9594961136281258,0.5208333333333334,1.0,1.0,1/6,2.08%,CEL
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.5743529367567497,0.959489649693793,0.5797101449275363,0.8033577179337829,1.0,1/11,1.93%,VAPB
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.4227676113539118,0.9593358792034219,0.5606060606060606,0.8034499745471423,1.0,11/70,12.04%,RECQL4;TEAD2;KREMEN2;EPHA2;BAIAP2L1;AGRN;PAK4;LAMA5;PES1;TTLL12;EIF5A
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6107813830951654,0.9592184742456118,0.6,0.8033680861330902,1.0,2/6,7.34%,CDK9;LARP6
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5234830225210947,0.9590289759637763,0.5272727272727272,0.8033686851037104,1.0,4/11,20.78%,KIF5A;KIF5C;DNM2;SYNJ1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.626982582132279,0.9590001533234874,0.6333333333333333,0.803140416514169,1.0,3/8,19.03%,LIMK2;TPPP;RAB11A
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.5906813439708617,-0.9589171795289613,0.5952380952380952,1.0,1.0,2/10,6.23%,ABCD1;ABCB11
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.5814584415491499,-0.9588174869887734,0.5294117647058824,1.0,1.0,3/8,12.21%,IFNLR1;PRELID1;ISCU
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.5679824329193297,-0.9587233869127616,0.6041666666666666,1.0,1.0,3/8,23.22%,MAP2K6;MAPK12;CHEK2
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.5741553840934609,-0.9586803932254133,0.5348837209302325,1.0,1.0,6/10,23.54%,SAT1;ASMT;MOXD1;SRM;SAT2;TPH1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.5532422055706695,0.9583484884631199,0.41509433962264153,0.8041843335741984,1.0,3/10,5.44%,APP;TNFRSF14;APOD
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.39502891563493353,-0.9580045907766177,0.5714285714285714,1.0,1.0,6/34,5.85%,DPEP2;GMFG;EPX;C1ORF162;IL5;NR1D1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.5195300050617561,-0.957941579988156,0.6052631578947368,1.0,1.0,4/14,21.45%,SEC24A;SEC31B;MIA3;SEC24C
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.6046755890904261,0.9573351001345752,0.5555555555555556,0.8060141382854458,1.0,2/9,15.80%,PRKG2;GCHFR
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5865680621694769,0.9573046961914632,0.5166666666666667,0.8057896844347375,1.0,5/9,26.19%,APLNR;PDE4D;UBE2B;PDE2A;RNF157
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.5318921250600492,0.957186646216051,0.5714285714285714,0.8057070823606843,1.0,2/15,14.96%,ZC3H7B;PUM1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3933262074829662,-0.9571663301778492,0.4418604651162791,1.0,1.0,3/59,2.90%,NGF;PIK3C2G;PLCB4
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5684122591588483,0.957097977110575,0.5081967213114754,0.8056336810649614,1.0,1/9,11.09%,DIP2B
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.5620625029346875,0.9570570225049173,0.5689655172413793,0.8054050670338982,1.0,3/11,10.69%,PLEK;SKAP1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6111647820801945,0.9569863642402561,0.5862068965517241,0.8051903242896923,1.0,3/7,10.32%,ADA;SKAP1;PODXL
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.42734385363240107,0.9568721653414299,0.5254237288135594,0.8051582761235887,1.0,7/52,12.46%,TRIM5;TRIM46;DVL1;TRIM17;MMD;ZDHHC7;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.501774128054007,-0.9567520333411671,0.5333333333333333,1.0,1.0,1/18,1.25%,KPNA2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.4170143123583472,0.9566322895521192,0.5,0.8052630966603422,1.0,7/76,7.16%,TYMS;NELL1;IGF2BP2;DAB2IP;SAMD4A;ENC1;EIF4A3
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3892281872985961,-0.9565115950546959,0.5,1.0,1.0,4/85,4.60%,SLC2A5;CFTR;LDHC;NAA11
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5657737197237991,0.9564623801245534,0.6530612244897959,0.8053404781837716,1.0,2/9,11.62%,CDK9;BARD1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4341165823000318,-0.9564548378329317,0.55,1.0,1.0,2/29,2.52%,TMEM17;DISP3
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5759609028955336,-0.9563748413408094,0.5681818181818182,1.0,1.0,3/7,25.07%,ZCCHC17;NRDE2;PHAX
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4460226866543997,0.9561851490747582,0.5172413793103449,0.8056365819009185,1.0,13/50,12.93%,SLITRK1;SLIT2;THY1;EFNB3;PAK3;ROBO2;MAG;MCF2;SIPA1L1;EPHA4;KIF13B;PLXNA4;PAK1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5259736091251063,-0.9559718229556465,0.525,1.0,1.0,5/12,25.31%,BCAP31;DERL2;YOD1;ERLEC1;SVIP
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5435863885921949,0.955847142230463,0.5531914893617021,0.8059142328727054,1.0,7/17,19.02%,MYH11;NRG1;ALPK2;TCAP;MESP1;SLC8A1;CXADR
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.6461497705632452,-0.955757432724525,0.56,1.0,1.0,1/5,7.64%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.6461497705632452,-0.955757432724525,0.56,1.0,1.0,1/5,7.64%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5388539063910358,0.9557088546170242,0.5333333333333333,0.8059138489528569,1.0,2/13,7.88%,MFSD2A;LDLR
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.5853688000923134,0.9556766443990835,0.5283018867924528,0.8056585144244262,1.0,2/8,10.96%,HMBOX1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.4730455812697039,0.9556258737841593,0.5483870967741935,0.8054534366195005,1.0,6/24,14.19%,OGN;APOD;PPARG;CDKN1B;CDKN1A;IL12A
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.3997804811058584,-0.9555742416806511,0.43333333333333335,1.0,1.0,6/78,7.12%,G0S2;KSR2;DISP3;LEPR;SIRT6;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.49729534231531985,0.9552634510317659,0.4909090909090909,0.8059036005732237,1.0,5/21,13.49%,PDGFRA;FLT1;P2RY12;EEF1A2;FGF2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.5792498820802007,-0.9552355577513335,0.6382978723404256,1.0,1.0,1/6,3.28%,LRPPRC
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.5479795386459554,0.9551712820378291,0.5964912280701754,0.8057395132122998,1.0,2/16,3.28%,RFTN1;COLEC12
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3836515227463352,0.9549473162050983,0.625,0.8058619310620684,1.0,53/188,23.94%,CDKN2A;PLK2;CCNB2;ABCB1;CCNI2;CDK6;HAUS7;YWHAG;PPP1CB;ACTR1A;CDC7;TPD52L1;CDKN1B;CDKN1A;CCND1;OPTN;LCMT1;NEDD1;CDK2;CDC25B;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;CAMK2A;PLK3;DNM2;CDK5RAP2;CDKN2D;CCND2;PPP2R2D;CDC27;PPME1;CCNA2;FBXL8;ACVR1B;CEP76;MAX;TUBA4A;RCC1;PRKAR2B;TUBB4A;CUL3;DCTN3;ARPP19;PHF8;CEP70;ACVR1;CCNF;CDKN2B;BCAT1;ODF2
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.6271348799929053,0.95457767244578,0.65,0.8063523153881413,1.0,2/5,8.71%,ANXA1;SCG5
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5518543660000405,0.9544840897410054,0.5555555555555556,0.8062518357151705,1.0,8/14,13.95%,CNTN2;CNTN4;EMB;NEXN;NPTN;VSTM2L;ROBO4;PALLD
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.37627720734303316,-0.9537693907378267,0.47058823529411764,1.0,1.0,9/72,9.85%,DAO;IDO1;SDSL;PIPOX;HYKK;ACMSD;GLUD1;TDO2;GCDH
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4748552200130522,-0.9536498235555844,0.5625,1.0,1.0,2/14,4.74%,ORMDL1;SMPD3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.5681621886880046,0.953576897224785,0.603448275862069,0.8078495690448352,1.0,1/11,0.90%,IGF1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.5521286202467116,0.9532556624098872,0.5517241379310345,0.8082478525595521,1.0,4/10,18.35%,ABCA8;ABCA2;SGMS1;SMPDL3A
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.6363672886586824,0.9532157127384896,0.5238095238095238,0.8080424111227004,1.0,1/5,9.15%,CLPB
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4957689626861466,0.9529890357325977,0.6190476190476191,0.8081863414729499,1.0,6/29,13.49%,MET;THBS1;NTRK3;P2RY12;STX4;FGF2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.39632235963473084,0.9529151369182887,0.5625,0.8080218825907648,1.0,15/99,14.44%,CDKN2A;TP53TG5;PSRC1;SLIT2;TSPYL2;SLIT3;BCL6;PML;SMAD3;TGFB2;FBP1;CDKN1B;CDKN1A;PPP1R9B;SIPA1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6428079391313455,0.9528950279329774,0.6379310344827587,0.807766914058009,1.0,1/5,12.68%,PER1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.41558778788494455,0.9527586516615063,0.5223880597014925,0.8077567630815923,1.0,4/64,3.38%,VAPB;SHTN1;APP;TRAM1L1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.5676882130476225,0.9525161339282463,0.5818181818181818,0.808013790250112,1.0,5/10,19.02%,MYH11;ALPK2;TCAP;SLC8A1;CXADR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.6262544910228184,0.9523678217577312,0.5576923076923077,0.8079311273523633,1.0,1/6,3.34%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.4729846772599628,0.9522203915135196,0.6212121212121212,0.8079616488896734,1.0,6/29,12.89%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;KLF4
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3862583753472404,0.9522171512276882,0.6190476190476191,0.8076619593075623,1.0,27/137,11.27%,SCN1B;ST6GAL1;PRRX1;GPNMB;CTSS;ABCB1;CSF2RA;RELN;PCP4;PTPRR;LAT2;CD37;PRKG2;APOD;ITGA2;CFH;BIRC3;SEMA3B;EMP1;KIF5C;SCG5;GUCY1A1;MMD;VWA5A;TFPI;HDAC9;NAP1L2
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.5753836755601246,0.952123444082665,0.5416666666666666,0.8075207474175866,1.0,3/6,28.99%,MTCL1;MAP2;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.45633702869782367,-0.9519430174674202,0.4634146341463415,1.0,1.0,1/30,0.63%,TAX1BP3
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.6396383664748657,0.951739819356689,0.625,0.8079265229962486,1.0,2/5,22.33%,THPO;SH2B3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.41870305160041665,-0.951635042923356,0.5151515151515151,1.0,1.0,6/44,5.43%,SLC25A5;FLT3;RHOH;RABL3;LEPR;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.5442575263972562,0.9512332612972858,0.6122448979591837,0.8085849935363593,1.0,1/12,3.05%,IRS2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.41019816101853795,-0.9511413441829494,0.42857142857142855,1.0,1.0,17/60,24.64%,FIP1L1;RBM8A;U2AF1;CPSF1;CLP1;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;CSTF2;THOC3;CSTF2T;THOC1;TENT4A;CPSF7;SRRM1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5370012758575883,-0.9511010301941534,0.5714285714285714,1.0,1.0,1/7,3.91%,SRI
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.5531051366472036,0.9507037124783123,0.5735294117647058,0.809401029233954,1.0,5/12,9.86%,SCN3B;KCNQ1;TRPM4;RYR2;TGFB2
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.6232234463974936,-0.9493572870286467,0.6486486486486487,1.0,1.0,1/6,6.31%,IL33
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5353177848306601,0.9493184092272321,0.5645161290322581,0.8117107403694821,1.0,3/14,14.53%,EGF;FGF2;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.41033855481672904,0.949084121564487,0.6229508196721312,0.8118390205319473,1.0,8/87,11.35%,TGFBR2;ZYX;PARD3;DUSP22;SMAD3;TGFB2;SMAD1;PXN
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.5251801499281636,-0.9490194307735552,0.5333333333333333,1.0,1.0,3/12,16.48%,CNOT7;CNOT1;RC3H1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5839932094209312,0.9487076383297581,0.576271186440678,0.8122874877689626,1.0,4/12,23.69%,BMP8A;MIDN;KCNB1;PRKN
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.38236361846185946,0.9484208004076881,0.5967741935483871,0.8125417118808953,1.0,36/165,13.11%,EPHA7;PLPPR5;ITPKC;PRKCG;PTPRB;PLCH2;PXYLP1;PLPPR4;LPCAT4;DUSP10;PLPPR1;PTPRC;DUSP8;DUSP16;PLAAT4;ITPKB;ALDOB;HK2;ITPK1;PTPRD;PLAAT3;NUDT4;LIMK2;PFKL;PIP4K2A;STAT3;INPPL1;INPP5A;PGK1;FBP1;INPP5J;INPP4A;ALK;PAK1;ALPL;HK1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.641740062561573,-0.9479651474028854,0.6578947368421053,1.0,1.0,5/6,34.21%,MEPCE;METTL4;NOP10;METTL16;NHP2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.5364628628242059,-0.9477728160457182,0.5526315789473685,1.0,1.0,3/9,10.05%,ZC3H8;FOXJ1;CLPTM1
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.6039226697138915,0.9470549614855422,0.6363636363636364,0.8147565564314107,1.0,1/6,3.31%,IRF7
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.4983358220178965,0.9464667683987003,0.6,0.8155773908482383,1.0,1/23,0.47%,TMEM204
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.410176646237394,0.9462916223386588,0.559322033898305,0.8155688299761247,1.0,13/81,15.62%,IL15;GMPR;IRF7;PLSCR1;TRIM5;PARP9;MX1;B2M;IL4R;TMEM140;ELF1;IFIH1;CNP
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.6185219125924051,-0.9460827576274932,0.5818181818181818,1.0,1.0,1/6,1.34%,HEY2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5345969592862001,-0.9455749029034415,0.5581395348837209,1.0,1.0,2/7,22.84%,ALDH18A1;ARG1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.4630577473535432,0.9455693012510348,0.5238095238095238,0.816690396791794,1.0,6/28,21.87%,DYSF;DNM1;MX1;MYOF;DNM2;GCA
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.5500544056658647,-0.9453898461800792,0.627906976744186,1.0,1.0,2/6,17.84%,PKD1L1;DNAAF1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.47580759567508096,0.9452818498021505,0.5849056603773585,0.8169739688178662,1.0,7/27,12.16%,PTP4A3;NR4A1;MYH9;FAP;CYP1B1;PXN;STARD13
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.500573991381449,0.945199731957534,0.5692307692307692,0.8168209172215258,1.0,7/30,13.41%,KCNJ2;ABCC9;KCNH2;ATP1A1;ATP1B1;ATP1B3;SLC12A5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4214338404820543,0.9450362868923844,0.5833333333333334,0.8169018437514523,1.0,2/76,1.69%,KLF2;ATF3
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.6076632582125882,-0.9449811239786834,0.6037735849056604,1.0,1.0,2/5,29.39%,RC3H1;RC3H2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.6410974424380753,0.944353890010096,0.6428571428571429,0.8179762440864665,1.0,3/5,29.53%,FLNA;MACROH2A1;NOP53
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.6086670478788925,-0.944284398851681,0.6,1.0,1.0,1/5,1.64%,ZNF358
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.6086670478788925,-0.944284398851681,0.6,1.0,1.0,1/5,1.64%,ZNF358
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.5350349024816246,0.9438010575607851,0.5522388059701493,0.8187082901026203,1.0,1/9,10.96%,PARP9
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.5846766861419525,0.94369364253819,0.4909090909090909,0.8186671182183932,1.0,3/8,25.43%,THPO;SH2B3;ANXA2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.6071523097823824,0.9433893858183563,0.58,0.8189986905916569,1.0,2/9,7.18%,P2RY6;RYR2
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5248423006305606,0.9429795439905834,0.5,0.8195454746279413,1.0,3/13,10.51%,CACNA1G;MSX2;SMAD1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5337863762522137,0.9429734088967063,0.5490196078431373,0.8192392924943647,1.0,4/12,25.29%,SLC26A8;SLC13A4;SLC26A11;SLC26A6
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.5070078542472561,0.9429165553325044,0.5081967213114754,0.8190679048101434,1.0,1/18,4.19%,WTIP
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5414304210587657,0.9426030273382278,0.6296296296296297,0.8194077904168999,1.0,9/19,29.15%,ARF6;SCAMP5;MCTP1;LRSAM1;MTMR2;EPHA3;PICALM;ABCA7;RUBCN
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.4216758542572679,0.9424785570945546,0.5303030303030303,0.8192812888894275,1.0,7/72,4.31%,PSCA;DUSP1;DAB2IP;FOXO1;DUSP10;PTPRR;PTPRC
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.518173634709412,0.9424376678896037,0.5671641791044776,0.8190652767177463,1.0,5/17,18.13%,PML;HK2;HK1;PINK1;SKP1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.6174275755290578,0.9416435504572106,0.5102040816326531,0.8204124681807791,1.0,3/7,17.57%,CTNNB1;NR4A2;WNT5A
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.6218388548127438,0.9415674885949438,0.6065573770491803,0.8199442766027949,1.0,5/7,33.37%,ULK1;ATG7;ULK2;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.6218388548127438,0.9415674885949438,0.6065573770491803,0.8199442766027949,1.0,5/7,33.37%,ULK1;ATG7;ULK2;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.5667306837515396,0.9412584382062278,0.5714285714285714,0.8201891157935495,1.0,2/9,10.44%,GRAMD2A;HOMER1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.40288909114707616,0.9411578190917773,0.5079365079365079,0.8201252118374132,1.0,23/73,22.88%,SLC7A2;ABCB1;MFSD2A;ABCC9;ABCA2;SLC29A4;SLC7A1;ABCC4;SLC2A3;SLCO3A1;ATP2B4;SLC8A2;SLC2A13;SLC29A1;TFRC;LRP2;SLC7A8;ABCC3;SLC6A9;ABCC1;SLC44A1;SLC27A1;SLC6A17
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.5601404277117057,0.9410585002808456,0.5942028985507246,0.820043475473007,1.0,4/14,6.44%,MBP;THY1;SKAP1;CD44
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5577153114569035,0.9406108556332461,0.603448275862069,0.8206856947468312,1.0,5/11,33.94%,FBXL2;PRKN;FMR1;NUCKS1;VAPA
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.5539103375678913,-0.9403830594322159,0.5116279069767442,1.0,1.0,4/9,31.53%,TPRKB;RAD51;SMC6;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.49269407954130573,0.9402686861106835,0.49206349206349204,0.8210862224069967,1.0,7/22,14.61%,SERPINE1;ICAM1;PAK4;YAP1;GAS6;TNIP2;CAST
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.4820460075582132,0.940176534035062,0.5846153846153846,0.8209684951517953,1.0,8/28,14.31%,SIX3;C3;SH3PXD2B;PBX3;TGFB2;HIPK1;MEIS3;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5380984107918598,0.9399852718091908,0.603448275862069,0.820944588630311,1.0,2/12,5.06%,APP;TNFRSF14
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5979191238275483,0.9397384971210813,0.6428571428571429,0.8211348638326013,1.0,4/9,19.34%,APOD;SNCA;F3;PTPRJ
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.5733989789550463,0.9394083867512346,0.5517241379310345,0.8212207309739451,1.0,4/8,18.12%,PDP1;PDK4;PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.5733989789550463,0.9394083867512346,0.5517241379310345,0.8212207309739451,1.0,4/8,18.12%,PDP1;PDK4;PDK1;PDK3
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3639641692184865,0.9393815699664796,0.64,0.8209605601673962,1.0,22/277,11.53%,SERPINA10;C3;SOCS3;CHGB;FAM20C;APP;ASB16;CP;FBXW12;LAMB1;IGFBP7;NOTUM;ZBTB16;VGF;SHISA5;ITIH2;FBXO32;TF;KLHL5;GAS6;FBXL16;WSB2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4170581151431067,-0.9388609903096675,0.4857142857142857,1.0,1.0,5/45,7.81%,TRIM29;KRT8;PPIC;TMEM54;TUFT1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.6230513535784812,0.938846763403559,0.6136363636363636,0.8216227757499817,1.0,1/5,13.90%,TNIP2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.5525896360499727,0.9384729709590373,0.5925925925925926,0.8219683051493055,1.0,2/14,12.17%,PLEK;ARF6
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.39380214644444056,-0.9383234488925565,0.4594594594594595,1.0,1.0,9/54,15.97%,CFTR;VIM;BECN1;UFL1;ATG14;TEX264;AUP1;PJVK;DYNLL1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4743041164815641,0.9381032719398771,0.5333333333333333,0.8223580914135142,1.0,7/23,13.10%,NLGN1;THY1;DVL1;AGRN;ITGAL;DLG3;PICK1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4464780614496686,-0.9377059183571073,0.5882352941176471,1.0,1.0,2/21,6.20%,KCNE1;ATP1B2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.5104297151590996,0.9376891015376091,0.55,0.8228632846664606,1.0,6/12,17.50%,FSCN1;OPHN1;MYO9A;PATJ;CAMSAP3;SCRIB
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.5581074703870019,0.9376837922358902,0.559322033898305,0.8225585021492063,1.0,1/8,1.24%,YWHAH
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.5654805413908528,0.9376654087074637,0.5925925925925926,0.8222761819145585,1.0,2/12,2.69%,CTSS;LMO2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.40578200999141706,0.9371753236234585,0.532258064516129,0.8228786265634119,1.0,23/71,22.88%,SLC7A2;ABCB1;MFSD2A;ABCC9;ABCA2;SLC29A4;SLC7A1;ABCC4;SLC2A3;SLCO3A1;ATP2B4;SLC8A2;SLC2A13;SLC29A1;TFRC;LRP2;SLC7A8;ABCC3;SLC6A9;ABCC1;SLC44A1;SLC27A1;SLC6A17
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.41586739388260874,0.9369684877143224,0.6438356164383562,0.8230407301806143,1.0,11/90,7.37%,SIX3;C1ORF87;TEKT2;NME9;EFNB3;ANGPTL2;CFAP126;ERICH3;TMEM212;GFAP;ZMYND10
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4631562784456397,-0.9368531498972482,0.5681818181818182,1.0,1.0,2/18,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),-0.5932568648262575,-0.9366248646018773,0.6041666666666666,1.0,1.0,1/5,19.13%,SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6096787943683675,0.9365471658736588,0.5932203389830508,0.8235935776413463,1.0,3/7,31.20%,TP53;TGFB1;MAP2K1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.5300606053951946,-0.9364718777468612,0.5576923076923077,1.0,1.0,1/8,2.70%,RNF6
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5390546696037593,0.9357236030682407,0.6190476190476191,0.82494964807163,1.0,6/15,28.13%,TGFB2;PCSK5;PTCH1;ZNF141;IQCE;FBXW4
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.614532788989248,-0.9356742590484988,0.6346153846153846,1.0,1.0,1/6,4.36%,APOE
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.5213117618368097,-0.9349960656999045,0.5531914893617021,1.0,1.0,3/14,14.73%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.4130644215469786,0.9348580172266251,0.631578947368421,0.8263934680272955,1.0,13/86,12.22%,RELN;DAB2IP;SHANK3;NRG1;NEUROD2;SNCA;NEURL1;ATP10A;TGFB2;TPPP;SYK;FRMPD4;CAMK2B
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.4657504069911412,0.9347688041486485,0.5245901639344263,0.8262212617775984,1.0,2/38,6.21%,NR4A3;MTFR2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.516349417137881,-0.9344594786330493,0.4772727272727273,1.0,1.0,3/12,15.22%,NRARP;SEMA5A;THAP1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5532956467018857,-0.9342351624610333,0.6,1.0,1.0,1/11,0.04%,ACP3
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.6606141128632887,0.9342022135898741,0.7049180327868853,0.8271490637568927,1.0,3/5,27.16%,GAS6;CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5423362909104035,0.933737569793042,0.5833333333333334,0.8276949038853652,1.0,2/15,7.68%,OPALIN;TENM4
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5546953705922657,0.9337148456526737,0.5789473684210527,0.8274382019651659,1.0,1/10,4.89%,WASF1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6007398907106754,-0.933547075553508,0.5333333333333333,1.0,1.0,2/5,15.74%,PTPN22;TIRAP
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5772169579790132,0.9334986606961584,0.6,0.8274917933988334,1.0,3/5,33.65%,STX1B;NAPA;STXBP1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.45924460783146787,-0.9333736911344896,0.5,1.0,1.0,6/18,15.06%,SDSL;PIPOX;HYKK;GCDH;ALDH7A1;SDS
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4498590988122778,0.9333429985829649,0.5806451612903226,0.8274877760542918,1.0,10/33,21.43%,ROBO2;YAP1;TGFB2;STAT3;TSPAN14;MAML2;ZMIZ1;MESP1;NOTCH4;TSPAN5
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.45198761562000417,-0.9328276639895087,0.5526315789473685,1.0,1.0,4/24,9.60%,EXOSC8;EXOSC4;NUDT16L1;EXOSC5
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.4209895958099585,-0.9326918505989239,0.5263157894736842,1.0,1.0,5/28,9.35%,ABCD2;ABCD1;ELOVL4;ACOT2;ELOVL2
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.5885023228874454,0.932326570455604,0.5882352941176471,0.8290286813787459,1.0,2/5,15.01%,PAG1;CD4
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.6119384162953392,-0.9317310907200405,0.631578947368421,1.0,1.0,3/5,26.70%,JAM2;EIF2AK3;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.5112629279138028,0.9312641897935423,0.5932203389830508,0.8307852620287087,1.0,3/19,13.78%,ARHGEF3;SYNPO2L;LPAR1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.6465823258725812,0.9311817889801778,0.6538461538461539,0.8306119294172761,1.0,4/5,29.33%,ULK1;ATG7;ATG5;ULK2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.5642671803849932,-0.9308816442400384,0.6486486486486487,1.0,1.0,2/8,10.83%,SCPEP1;GPR37L1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.5542153298630357,-0.9306890077093433,0.6818181818181818,1.0,1.0,2/6,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.42484222392509896,0.9302395507028127,0.5384615384615384,0.8320349755590978,1.0,11/57,14.94%,IGF1;ACHE;BAIAP3;SNCA;TMED10;GRK2;SYTL4;TGFB2;ARF6;RAB27B;STX1B
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.4780396818289193,-0.929993903102331,0.5652173913043478,1.0,1.0,2/12,9.35%,ABCD1;ELOVL2
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.4256054061377949,-0.9298464568714154,0.5555555555555556,1.0,1.0,7/32,6.16%,DPEP2;GMFG;CD247;PYHIN1;C1ORF162;CD6;P2RY10
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.556273800359452,-0.9296391123811993,0.5555555555555556,1.0,1.0,2/8,7.58%,XG;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5671190957595682,0.9291231447832238,0.5932203389830508,0.8337619452779004,1.0,3/7,18.02%,MAPT;HEBP2;RNF122
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6125012993944082,0.9290518427253585,0.6666666666666666,0.833565603440384,1.0,2/5,30.19%,XRCC1;XRCC4
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.45974488565990196,-0.9289716044403765,0.5777777777777777,1.0,1.0,3/26,2.46%,CST3;CSTB;TRIM21
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.423029919434077,0.9287922885281558,0.53125,0.8338287546379272,1.0,4/60,3.34%,CXCL2;SERPINE1;ZFP36;DAB2IP
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4417509012614196,0.9286874645717347,0.5671641791044776,0.8337120069767868,1.0,12/35,15.01%,CTSS;PLEK;SLA;IL1R1;PTPRC;ITGB8;CD5;ITGAL;IKZF2;HLA-E;GPR183;CD4
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.4183454520307547,0.9285992824929403,0.6206896551724138,0.8335556248783039,1.0,12/67,13.65%,ATF3;NSDHL;NFIL3;PLSCR1;SEMA3B;LDLR;CTNNB1;PPARG;NIBAN1;ABCA2;CPEB2;ETHE1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.40176925202994174,-0.9284222425049374,0.5,1.0,1.0,10/43,25.39%,PSMD10;PSMD12;PSMB5;PSMB6;NQO1;PSME3;PSMD2;PSMB4;PSMA1;PSMD11
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4250658679708528,-0.9282295563018063,0.48,1.0,1.0,8/44,11.41%,TRIM29;AR;KRT8;IL20RA;ATP2C2;EHF;RUNX1;B3GNT3
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.5939133093885266,0.9279086796720714,0.5686274509803921,0.834542029728631,1.0,2/5,15.46%,PTPRC;TP53
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5251192101234685,0.9278346942537603,0.5666666666666667,0.834403095754759,1.0,3/10,11.18%,KCNC2;GUCY1A1;GUCY1B1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.36491615929018084,-0.9278208269104126,0.6060606060606061,1.0,1.0,3/61,0.74%,TRIM29;KCNE1;TMEM229A
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4801932339314545,-0.9275822563534715,0.525,1.0,1.0,8/21,14.29%,UCP3;SLC36A1;ATP12A;SLC46A1;DMAC2L;ATP1A2;ATP6V1F;ATP5F1B
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.42771122090454683,0.9272422593106375,0.5517241379310345,0.8352606017365919,1.0,3/33,4.92%,PROX1;PLEK;FYN
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.5422736300294824,-0.9272201929225091,0.5714285714285714,1.0,1.0,2/7,13.34%,INTU;COL5A2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.5530043195705038,-0.9271641022378975,0.5384615384615384,1.0,1.0,4/10,12.96%,NT5E;ADSS2;NUDT2;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.5308727914705345,-0.9268183615900681,0.55,1.0,1.0,1/8,3.77%,CXCL13
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5629699101823584,0.926745740966596,0.5925925925925926,0.8359279713517713,1.0,2/9,16.96%,RYR2;UBASH3B
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.4000955830415643,0.9266576236709042,0.5540540540540541,0.8357798661266129,1.0,9/70,7.53%,EGF;RASGRP1;CD24;DUSP1;FLT1;DAB2IP;NEK10;DIRAS2;PDGFA
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5418531928942906,0.9265361336009258,0.6346153846153846,0.8356450820432731,1.0,5/7,39.78%,SLC27A1;CD36;ACSL1;RPS6KB1;SLC27A4
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.48378543185687,0.9261607334725516,0.5161290322580645,0.8360694535427765,1.0,4/17,14.38%,MYH11;LAMB1;GAS6;NTN4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.600515758006355,0.9261605281939022,0.6166666666666667,0.8357586470544707,1.0,1/6,4.64%,NFATC2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.5107761553852728,-0.9259235823010991,0.5348837209302325,1.0,1.0,1/12,1.04%,FAM47E
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.593152707775206,-0.9257034166810382,0.65625,1.0,1.0,4/9,26.04%,WDR76;RFWD3;THOC1;CCAR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.526588437858962,-0.9255503065921271,0.5333333333333333,1.0,1.0,3/9,17.35%,GREM1;EFNB2;BMP2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.5909591545482848,0.9254437044114024,0.6140350877192983,0.8368292755629453,1.0,3/8,24.32%,TGFB2;SIX4;PTCH1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5190762338480622,0.9254106072164644,0.5263157894736842,0.8365623887824716,1.0,2/13,12.50%,FAP;ANGPTL7
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5055204952194896,0.9254026979255469,0.5862068965517241,0.8362737228494903,1.0,7/18,26.17%,SOX4;DIP2B;BRCA1;RPS6KA4;RPS6KA5;ARRB1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.39745551301731347,-0.9253224229865148,0.575,1.0,1.0,8/58,7.99%,SELENOS;TNFAIP3;TRIM21;APOE;NR1D1;MUL1;METRNL;MAPK7
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.4067063632732553,0.9249381268170731,0.5357142857142857,0.8368201009105276,1.0,4/32,7.88%,ABCA8;ABCA5;SOAT1;LDLR
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.5261298655527085,-0.9247951276537296,0.575,1.0,1.0,7/11,21.42%,NT5E;NT5C;NUDT15;PNP;GPX1;ITPA;NT5C1A
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.5821079667617324,-0.9247658989727258,0.6585365853658537,1.0,1.0,1/7,5.43%,PTPN22
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.44714912414314395,0.924510351087023,0.582089552238806,0.837260660453499,1.0,6/32,14.53%,BLM;SAMHD1;CDK9;EME2;TRAIP;MRE11
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6040840059114149,0.9243955426793928,0.6363636363636364,0.8371652422954614,1.0,1/6,8.19%,ASS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.5025253623367736,-0.9241092743721241,0.6041666666666666,1.0,1.0,6/14,7.64%,SLC25A5;CHCHD10;MUL1;FZD9;BAK1;HSPA1A
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.4661663070048251,-0.9237676348026808,0.5526315789473685,1.0,1.0,7/23,16.77%,PPWD1;PPIC;PPIH;PPIL3;PPIL1;PPIE;FKBP7
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.4531221648546881,0.9235470177515072,0.546875,0.838614806353694,1.0,8/44,8.04%,IGF1;RASGRP1;RASGEF1A;IRS2;ERBIN;ARHGEF3;MAPRE2;SYNPO2L
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.5737901458590721,0.9233941411925766,0.6111111111111112,0.8385628302834781,1.0,3/5,20.15%,TF;B2M;BMP6
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.6422115194940153,0.9233588441920205,0.6190476190476191,0.8383266932979329,1.0,1/5,14.61%,CAST
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.4869981736166411,0.9233349943657202,0.6065573770491803,0.8380556586175537,1.0,2/19,7.00%,IGF1;MSX2
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.6111244325060318,0.9226665325909135,0.625,0.8391258553265488,1.0,1/5,12.57%,KLC1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.42599223260349994,0.9226305010193906,0.5671641791044776,0.8388897721477812,1.0,8/54,4.66%,RASGRP2;CTSS;CD22;PLEK;NAPSB;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.5713510047426379,-0.9225595264544497,0.5897435897435898,1.0,1.0,3/7,32.92%,ACADS;MMAA;MMUT
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.5733536628392761,-0.92244279686806,0.5918367346938775,1.0,1.0,1/7,2.08%,CEL
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.4051343510973795,-0.9220057431182737,0.5675675675675675,1.0,1.0,2/59,0.21%,NGF;G0S2
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.6026159215535093,-0.9219348476996532,0.6888888888888889,1.0,1.0,1/5,3.36%,FBLN5
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5356782741592561,0.9219117483087411,0.6037735849056604,0.8399720060420555,1.0,2/13,7.18%,BLM;RYR2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.6001919810986049,0.9217536913679459,0.6545454545454545,0.8400203279750003,1.0,3/6,27.17%,SLC29A4;SLC29A1;SLC22A3
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.6244075065651334,-0.9213092055666712,0.6,1.0,1.0,2/5,22.16%,AQP4;AQP1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5936201164625048,-0.9212989650569161,0.6122448979591837,1.0,1.0,1/7,15.45%,GNGT1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.5728260651478866,0.9212450377590349,0.603448275862069,0.8407337620360597,1.0,3/9,15.22%,CD55;SERPING1;CD59
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.3739364431466029,-0.9211371933228799,0.575,1.0,1.0,8/63,8.80%,RITA1;NRARP;ENHO;BEND6;POFUT1;MAML3;METTL3;HEY1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.5982453423973103,0.9211084412229473,0.6078431372549019,0.8406592847912747,1.0,1/8,10.68%,LRMDA
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6178528478870304,0.9209260331708303,0.6363636363636364,0.8407247902411988,1.0,2/5,20.96%,SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.47629948726424587,0.9208885854243585,0.6551724137931034,0.8404973819430306,1.0,6/24,18.15%,SLC4A10;SLC4A9;SLC4A11;SLC12A5;FHL1;SLC30A3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5750541711258135,0.9207909674374885,0.62,0.840322575672042,1.0,3/8,10.24%,LRRC55;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.5896773205247647,-0.9206628663797113,0.6111111111111112,1.0,1.0,1/6,5.08%,MSRB1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.4855108803709776,0.9205882645079452,0.5932203389830508,0.8405148019242166,1.0,5/14,18.32%,KCNMB4;CPLX2;CPLX1;MCTP1;CAMK2A
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.4556063176392094,-0.9205088157432328,0.6046511627906976,1.0,1.0,5/18,21.31%,CNOT1;WNT9B;TAF5L;WDR43;TAF6L
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5633679962903712,0.9203012212480712,0.6333333333333333,0.840754915530237,1.0,1/10,2.71%,IGF2BP2
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.5801057300045737,0.920250888034566,0.5370370370370371,0.8405802076682547,1.0,1/7,6.17%,CIITA
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.5881420392060477,-0.9201613588559315,0.6136363636363636,1.0,1.0,1/5,5.43%,PTPN22
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.4518274232603093,-0.9199437424565635,0.5652173913043478,1.0,1.0,6/32,8.69%,TNFAIP3;TRIM21;MUL1;CR1;FAM3A;METTL3
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4899165811818507,-0.9197946109717752,0.6363636363636364,1.0,1.0,2/9,15.06%,SDSL;SDS
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.5052294796423645,0.9196286290374721,0.5254237288135594,0.8414920327855047,1.0,5/14,17.11%,PID1;HDAC4;FBP1;MLXIPL;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.5800641410440646,0.9195687925063212,0.5714285714285714,0.8409724258161646,1.0,1/6,9.35%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.5800641410440646,0.9195687925063212,0.5714285714285714,0.8409724258161646,1.0,1/6,9.35%,PPARG
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5492540757384555,-0.9194138431162131,0.5833333333333334,1.0,1.0,1/8,5.15%,ZNF593
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.3208819332931686,-0.9193027960288704,0.6521739130434783,1.0,1.0,38/231,20.23%,AR;OTUD3;TNFAIP3;COPS8;CFTR;MCRS1;IL33;KDM1B;ABRAXAS1;COPS7A;BECN1;USP27X;RAD23A;USP51;PSMD10;FOXO4;PSMD12;USP19;PSMB5;TADA2B;CLSPN;PSMB6;USP9Y;RUVBL1;PSME3;TNIP1;BRCC3;ESR1;NFRKB;PSMD2;TADA3;USP18;UBB;YOD1;SKP2;USP10;PSMB4;COPS3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.5615843446916998,-0.9186887610200565,0.5714285714285714,1.0,1.0,1/11,3.42%,CEP19
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.5154566582285486,0.9186280582688346,0.5833333333333334,0.842515045562703,1.0,8/11,35.37%,TGFB2;WNT5A;TGFB3;TGFB1;SIRT1;PLCG2;CD74;IRAK3
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.5964150458824912,0.9186240095707621,0.6595744680851063,0.8422049553729486,1.0,1/5,4.31%,PTPRC
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.4565114627661328,0.9184719569924854,0.6527777777777778,0.8421868812241482,1.0,8/41,15.23%,ABCA8;FA2H;ASS1;CERS3;CYP4F22;PAM;SGMS1;CERS5
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.5555937837782823,-0.9177975904503056,0.5609756097560976,1.0,1.0,1/7,1.34%,HEY2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.6010627294576919,0.9173531427807952,0.6875,0.8440712741149744,1.0,3/6,34.14%,MTA1;SASH1;TAF1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.4742497068636715,0.917232166694987,0.625,0.844009008704052,1.0,6/31,12.29%,APOD;ZIC1;BAG3;SMAD3;CABP1;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.5660179858328732,0.9171759585840293,0.6538461538461539,0.843794530618369,1.0,6/8,34.66%,RARA;TNFSF4;IL18;CD81;PRKCZ;CD74
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.45567038733080756,0.917000664756711,0.59375,0.8438367800584325,1.0,4/27,5.78%,CORO7;WAS;WASF1;FAM107A
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5377853055245421,0.9168462227922548,0.546875,0.8437703223170059,1.0,2/11,10.10%,MICALL1;PACSIN1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.47290616698510735,0.916786484906621,0.5686274509803921,0.8435778953149894,1.0,3/22,10.25%,SLC4A10;SLC4A9;SLC4A11
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.4386732194744326,-0.9167250227338155,0.5789473684210527,1.0,1.0,5/24,11.63%,ABCB11;OSBPL3;GBA2;CYP46A1;CYP7B1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.562906807788569,0.9166547244403309,0.5517241379310345,0.843524612919979,1.0,4/7,38.08%,RAB7A;MAPK3;MAPK1;TRIM27
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.39455782214847146,0.9166015043110305,0.5714285714285714,0.8432933368743549,1.0,8/66,15.37%,TLR2;IRF7;MYD88;CTNNB1;CGAS;MRE11;IFIH1;STAT6
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5154518423158662,0.9163809923824402,0.639344262295082,0.8434355280417224,1.0,5/16,15.46%,DAB2IP;NLRC3;B4GALT7;TRIM32;TP53
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.4325806971349315,0.9163185652044906,0.582089552238806,0.8432435059159094,1.0,4/37,9.07%,ALS2CL;DNM1;HOOK1;PLEKHF1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5503487581105906,0.9161938437293119,0.6065573770491803,0.8432337990362916,1.0,2/10,7.88%,MFSD2A;LDLR
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.527554155358375,0.9161576738126428,0.6440677966101694,0.8429986324821745,1.0,1/8,3.82%,CBLN2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5368363548060754,-0.9161213498363752,0.5686274509803921,1.0,1.0,2/6,15.16%,SLC6A13;MT3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.4528280036720573,0.9156653775275312,0.5970149253731343,0.8436911809303256,1.0,1/31,0.29%,ANLN
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.48325757720504436,-0.9156413550443546,0.5853658536585366,1.0,1.0,5/12,24.14%,SLC25A4;SLC25A24;SLC19A1;SLC25A17;ABCC6
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5238782270134172,0.9150494817308091,0.5918367346938775,0.8445348677832899,1.0,3/11,9.86%,PROX1;TBX20;TGFB2
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.5817538578082572,-0.91471887529105,0.5918367346938775,1.0,1.0,1/5,4.01%,RABL3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.39933750918806205,0.9144884238477229,0.6307692307692307,0.8453259635463386,1.0,12/90,15.53%,FBLIM1;DAB2IP;SEPTIN8;NRG1;GFAP;TPPP;SYK;TMC8;NCLN;LCMT1;STX1B;PINK1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.5499653144927241,0.9143951521012017,0.5932203389830508,0.8452375807209339,1.0,4/10,18.79%,FYN;RAMP3;NOX4;SGCG
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.5475410751839632,-0.9140636806896099,0.5128205128205128,1.0,1.0,1/11,0.81%,AR
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.42202488430378526,-0.9140338970962915,0.575,1.0,1.0,10/34,13.27%,RIOK2;RPS28;DDX52;SNU13;RIOK1;DCAF13;RRP36;LOC102724159;SRFBP1;NGDN
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.43834925497931937,-0.9138527669865215,0.5588235294117647,1.0,1.0,7/25,24.64%,SF3B4;PRPF8;PRPF3;LSM1;MPHOSPH10;SCAF11;SRRM1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.5712715543577125,-0.9133787878582299,0.5918367346938775,1.0,1.0,1/6,7.26%,RAB5IF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.49099519655335844,0.9130921477257014,0.639344262295082,0.8474474162084562,1.0,1/16,0.81%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.5518527165424653,0.9129277542328986,0.58,0.8474664823849911,1.0,4/7,29.94%,PPARG;NCOR1;NCOR2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.5559161066451893,0.9123881667249735,0.6296296296296297,0.848272650134652,1.0,4/8,22.33%,PTPRC;KLF4;MAP2K5;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.537836682587332,-0.912169955699163,0.5869565217391305,1.0,1.0,1/12,2.37%,DNMT3B
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.46104928622294256,-0.9119676757319976,0.5428571428571428,1.0,1.0,2/28,1.74%,AR;VAMP8
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.4836151865839411,0.9117860833950374,0.6153846153846154,0.8490739057799477,1.0,4/21,13.49%,HMBOX1;PDGFA;CDKN1A;FGF2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.4951054774330979,0.9112768852342448,0.5714285714285714,0.8498183948708161,1.0,4/15,11.62%,FABP3;MFSD2A;PPARG;SLC27A3
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.5669332286065505,0.9107005746326762,0.5714285714285714,0.850226118584209,1.0,1/6,8.21%,THOC6
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.5669332286065505,0.9107005746326762,0.5714285714285714,0.850226118584209,1.0,1/6,8.21%,THOC6
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5371910197365369,-0.9105998966442669,0.6744186046511628,1.0,1.0,1/9,1.00%,MADCAM1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4063355333387915,0.9104271442838835,0.5970149253731343,0.850503145109296,1.0,13/63,10.30%,GRIN3A;CDH23;TRPC3;CACNG3;TUSC3;FYN;CACNA1C;CACNG8;RYR2;RAMP3;CACNA1E;NIPAL2;NIPAL3
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.44379091422707856,0.9103781313846464,0.5084745762711864,0.850288019696409,1.0,5/31,12.70%,LIPH;FABP3;PLAAT3;DGAT1;SLC27A5
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5114662900991974,0.9102196137620763,0.639344262295082,0.8502671710809706,1.0,1/12,4.31%,PTPRC
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5732404704721363,0.9098612589708013,0.5714285714285714,0.8506732460780102,1.0,3/6,15.19%,CDK6;STAT3;EIF2B5
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.568511932190898,0.9096759817470967,0.5849056603773585,0.8506781361764706,1.0,4/7,29.33%,ULK1;ATG7;ATG5;ULK2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.47579130074721004,0.9091596759896086,0.5555555555555556,0.8513724733882331,1.0,5/26,18.73%,SMAD3;SMAD1;ZC3H7B;PUM1;SMAD2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.5041751976824228,-0.9091167258450917,0.5348837209302325,1.0,1.0,1/12,1.49%,RIOK2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5178513933018276,0.9090151258044838,0.5454545454545454,0.8513340304917755,1.0,1/11,2.53%,CD55
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3771651400188279,0.9089229695762486,0.6885245901639344,0.8511879672713726,1.0,20/107,17.85%,SLC39A14;IRS2;FOXO1;RAB15;BAIAP2;PPARG;NAMPT;ZDHHC7;SORBS1;HDAC9;PDK4;CPEB2;GAB1;BCAR1;SH2B2;SYAP1;LPIN3;SHC1;IGF1R;RHOQ
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5561300482846596,-0.9088756272280494,0.6470588235294118,1.0,1.0,4/10,17.29%,METTL3;PRELID1;IKZF3;ZFP36L2
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5265771547275606,0.908767962493668,0.5789473684210527,0.8511496194265183,1.0,3/13,18.35%,AK3;AK5;SMPDL3A
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.5663085403800141,0.908616548893048,0.5862068965517241,0.851111299460868,1.0,2/8,24.91%,PINK1;DYRK1A
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.458907516442209,0.908382200557874,0.532258064516129,0.8512837679931522,1.0,5/24,23.03%,DUSP16;XPO6;SMURF1;XPO5;CCHCR1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.5634206077037887,-0.908259017811806,0.6595744680851063,1.0,1.0,1/7,8.29%,GAS1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.6031799131775031,0.9081385998130476,0.6078431372549019,0.8515722024650512,1.0,4/5,30.53%,CAV3;FLOT1;EMP2;PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4507248957907529,0.9078278646287623,0.6515151515151515,0.8518389369005638,1.0,11/31,23.29%,NELL1;ZBTB16;PKDCC;TGFB2;P2RX7;SLC8A1;WNT5A;BMP6;ANO6;PTPN11;ACVR1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4395094166355503,-0.9076395716990071,0.5121951219512195,1.0,1.0,10/31,24.68%,FIP1L1;CPSF1;CLP1;CPSF3;LSM10;CSTF2;SSU72;CSTF2T;CPSF7;SLBP
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.58449399851378,0.9073054362561014,0.6296296296296297,0.8525823951927672,1.0,2/6,23.14%,SMURF1;FCHO2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.41701149104671376,-0.9072699758331014,0.6486486486486487,1.0,1.0,3/17,5.13%,TPX2;ANKRD53;RAE1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.43270457583958355,0.9072100901966997,0.5535714285714286,0.8524362499977062,1.0,8/41,13.20%,ZFP36;PIM1;TRPM4;ZBTB16;VSTM2A;PPARG;WDFY2;SOX13
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.5941104744427017,0.9070281304972464,0.6491228070175439,0.8521485694253585,1.0,3/6,25.83%,HLA-E;HLA-F;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.5941104744427017,0.9070281304972464,0.6491228070175439,0.8521485694253585,1.0,3/6,25.83%,HLA-E;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.5058250653875115,0.9066377929503879,0.640625,0.852607676184987,1.0,6/13,20.41%,MYLK3;PLSCR1;TNFSF4;F3;IL6R;ANO6
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.613726087408415,0.9065072969407417,0.6170212765957447,0.8525260651904978,1.0,2/5,15.19%,CDK6;EIF2B5
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.40134711698189335,-0.9062600640383247,0.5588235294117647,1.0,1.0,9/46,8.15%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10;CXCR4;HSD11B1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.4158734584558308,0.9062288910941866,0.5901639344262295,0.8527231824207162,1.0,6/50,7.78%,PROX1;ZFP36;PLSCR1;TRIM5;PML;APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5389274105835178,0.9060924357132725,0.6029411764705882,0.8526758740206426,1.0,2/14,9.86%,STK25;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6231213976330329,0.9060542237396186,0.6363636363636364,0.8520888650827727,1.0,2/6,12.89%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6231213976330329,0.9060542237396186,0.6363636363636364,0.8520888650827727,1.0,2/6,12.89%,MBP;KLF4
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.5434363783797564,-0.9056873179245863,0.5681818181818182,1.0,1.0,1/6,8.77%,VPS11
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5098248776425266,0.9056829796704411,0.6818181818181818,0.8525898073311217,1.0,1/18,1.34%,SGPP2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.46318821483424444,0.9051511579082565,0.6166666666666667,0.8533557143311603,1.0,8/27,17.91%,DUSP10;MAPK8IP1;HIPK3;PER1;PINK1;GPS2;NCOR1;MECOM
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.43384922700598855,0.9049519415956802,0.5789473684210527,0.8534152108340168,1.0,10/33,24.62%,MAP1LC3A;ATG9A;PINK1;CTSK;GABARAPL1;WDR45;ULK1;ATG7;PRKN;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4388103728414678,-0.9048622689217346,0.6388888888888888,1.0,1.0,6/25,14.39%,TPT1;FBXO5;SFRP2;YJU2;PSMD10;CLU
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.5396391819328853,-0.9048007895590843,0.6052631578947368,1.0,1.0,1/7,3.77%,CXCL13
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.5396391819328853,-0.9048007895590843,0.6052631578947368,1.0,1.0,1/7,3.77%,CXCL13
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.523225733296439,0.9043027597384726,0.6612903225806451,0.8543684267421542,1.0,2/10,7.85%,TJP3;RAP2B
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4334152633585037,0.904125206202754,0.6333333333333333,0.854371941740243,1.0,12/44,18.23%,CCDC3;BIRC3;TNFRSF1A;SYK;GAS6;HIPK1;FADD;TRAIP;IKBKG;RFFL;GPS2;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.5283059441988812,-0.9040155867597499,0.6153846153846154,1.0,1.0,4/9,14.39%,APOE;PFDN4;VBP1;CLU
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.5641065574013077,-0.9034452151610697,0.5681818181818182,1.0,1.0,2/5,13.49%,BECN1;ATG14
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.46338067310736475,-0.9031685807474628,0.5675675675675675,1.0,1.0,5/14,8.25%,TNFAIP3;FGL1;FOXJ1;PTPN22;MICA
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.34954370908557253,-0.9031409312802736,0.6666666666666666,1.0,1.0,41/155,20.06%,PTCD2;ATAD3C;TFB2M;MSTO1;TIMM8B;HAX1;MGME1;ALAS1;SLC25A4;CHCHD10;MUL1;AIP;TIMM13;BCAP31;RAB5IF;MTFR1L;POLG2;TIMM23;SAMM50;YME1L1;TSPO;ATP5F1B;TIMM50;TIMM10;SLC25A33;CHCHD2;ESRRA;TFB1M;TMEM11;OXA1L;MTFR1;AFG3L2;MTERF1;TRAK2;MIEF1;TMEM70;PRDX3;DNM1L;AFG1L;DNAJC19;FIS1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5434152713771726,0.9021669628694663,0.625,0.8576573389665295,1.0,5/10,18.24%,ARHGEF7;EML2;PAK1;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3765303552638858,0.9021223172705715,0.6865671641791045,0.8574375337670855,1.0,18/111,12.19%,SFTPD;COLEC12;AMN;VLDLR;WASF1;DNM1;COLEC11;CLTB;SNCA;RAMP3;LDLR;GRK2;AP1S1;MICALL1;SYK;SPARC;MX1;TPCN2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.5805433455194121,0.9019533891701828,0.6610169491525424,0.8574313973710457,1.0,1/5,19.28%,HIF1A
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6037820413552478,0.901896074708844,0.6379310344827587,0.857233175504908,1.0,3/5,28.45%,STOML2;TNFSF4;CDH26
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.40305002458079836,-0.9017147858435997,0.65625,1.0,1.0,12/68,15.58%,CEBPA;PYHIN1;TRIB3;CBFA2T3;CCDC22;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5739377555655671,0.9012778597048423,0.6964285714285714,0.8580464053062653,1.0,2/9,12.93%,MFSD2A;ALK
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.35986931211707224,0.9012400048411479,0.703125,0.857818245563381,1.0,32/164,18.61%,C3;GPNMB;RASGRP1;APP;EFNA1;NOS1AP;FAS;NTRK3;LIMCH1;NPTN;PPP1R16B;LIMK2;NIBAN1;WDFY2;TERF2IP;GAS6;HLA-DRB1;PRKCD;PAK1;CCND1;FGF2;CD4;THPO;PINK1;SLCO3A1;CALM3;PPP1R7;FAM20A;TFRC;ADAM17;SEMA4D;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.4710585655498963,0.9010778109236993,0.55,0.8577991887116602,1.0,1/25,1.93%,VAPB
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.5776621958956726,0.9008769409408467,0.660377358490566,0.8578526083525573,1.0,2/7,27.63%,CCND1;MME
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.5653065001713857,0.9004604606465908,0.5961538461538461,0.8582639119696774,1.0,1/6,7.77%,RPUSD1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.46070342255581426,0.9001538213784536,0.6461538461538462,0.8584832444142152,1.0,7/28,15.01%,ANXA1;PTPRC;SOX4;SOX13;FADD;PIK3CD;CD4
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.5952040019314476,0.9001198306439528,0.6122448979591837,0.8582340483146197,1.0,1/5,6.17%,CIITA
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.46926565544402465,0.9000879132868934,0.5833333333333334,0.8579594931192608,1.0,4/19,13.40%,CYP1B1;SERINC1;TEX2;FUT2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3595746615595544,0.8998009847675018,0.6753246753246753,0.8581659339041142,1.0,33/147,23.76%,KREMEN2;DRAXIN;PTPRO;DAB2IP;HIC1;NOTUM;DVL1;ALPK2;TLE6;TLE3;HECW1;PRICKLE1;SOX13;STK3;ANKRD6;WWTR1;WNT5A;STK11;DKK3;TSC2;FRMD8;TLE2;MLLT3;GRB10;AMFR;GLI1;RBMS3;AXIN2;CUL3;PSMB3;TMEM131L;PRKN;TLE4
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.33211687307444065,-0.8994595237003653,0.7575757575757576,1.0,1.0,20/176,16.54%,CDC26;PCYOX1L;RNF6;ELOC;FBXO45;RNF114;PPP1R11;SPSB4;FEM1A;ANAPC15;UBL7;PCYOX1;WDR91;KLHL8;RNF5;RNF126;RNF168;RNF8;RC3H1;RNF167
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4299748996442352,-0.8994333698759899,0.5625,1.0,1.0,8/21,25.55%,DHX33;NCL;DDX11;WDR43;NOL11;PWP1;UBTF;EIF2AK3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.4699706741632596,-0.8992414313583112,0.7105263157894737,1.0,1.0,1/17,3.55%,NIFK
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4881647665106925,-0.8985159423888359,0.6326530612244898,1.0,1.0,4/14,21.95%,NCL;DDX11;NOL11;PWP1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6071652449824047,0.898034991906029,0.6607142857142857,0.8612006881192593,1.0,3/6,19.28%,SMAD3;TGFB2;HIF1A
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5553232788428728,0.8972712954536466,0.5925925925925926,0.8622306652318649,1.0,2/9,4.92%,EFNA1;SOX4
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.6158374146021134,0.8971711592953788,0.7169811320754716,0.8617816411542072,1.0,3/5,16.11%,CTNNB1;CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.6158374146021134,0.8971711592953788,0.7169811320754716,0.8617816411542072,1.0,3/5,16.11%,CTNNB1;CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.5391485227901267,0.8969441998866118,0.673469387755102,0.861880159618186,1.0,2/8,17.46%,PPARG;ABCG1
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.4094547071014823,-0.8964896340307021,0.6,1.0,1.0,3/30,11.25%,TNFAIP3;ABRAXAS1;USP27X
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.49690383790711284,0.8964881934537212,0.6779661016949152,0.8623394917459217,1.0,3/16,10.94%,MRAP2;PID1;PYGL
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.5386954771675838,0.896476116348513,0.6031746031746031,0.8620684962509518,1.0,4/9,10.24%,ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5701862859665703,0.8960943096908607,0.6779661016949152,0.8624892477130379,1.0,3/6,18.02%,MAPT;HEBP2;RNF122
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.4934989172565059,0.8960420774517415,0.6458333333333334,0.8622608040982366,1.0,4/14,24.60%,PPARG;ABCG1;ITGAV;OSBPL8
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5792286578371821,0.895973854393957,0.639344262295082,0.862062201432933,1.0,2/6,12.57%,MCAM;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4949045322208858,-0.8959591203548043,0.525,1.0,1.0,3/17,12.12%,GMFG;ARFIP2;BRK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4417296026935406,-0.8956531737196083,0.631578947368421,1.0,1.0,3/18,7.50%,SELENOK;BCAP31;BAK1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.52055333989618,0.8954789606270807,0.578125,0.8626223604305624,1.0,5/10,27.85%,CCDC91;SORT1;GAK;AP1G1;ANKFY1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.5496745406958792,0.8953730728749041,0.6779661016949152,0.8624873192336876,1.0,2/10,6.43%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.48840030462410183,-0.8953723787848752,0.6060606060606061,1.0,1.0,2/13,8.76%,STX16;TMED5
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.5590552406627813,0.894756168767875,0.7021276595744681,0.8633137343880705,1.0,3/7,24.80%,MSRA;MTHFR;SMS
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3945367626873268,0.8947351516925656,0.65625,0.8630473024596511,1.0,7/52,10.25%,TLCD2;SLC4A10;IRS2;VGF;SLC4A9;PPARG;SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.4458742831956153,0.8947312288901962,0.5964912280701754,0.8627472047514086,1.0,9/25,24.85%,TRPM4;CDK6;PPARG;HDAC7;SEMA4D;NOCT;PTCH1;SUFU;SMAD6
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4042799001283134,-0.8945755812199844,0.575,1.0,1.0,8/48,6.23%,TLCD1;CEBPA;TLCD3A;ORMDL1;APOE;ACOXL;ABCD1;ABCB11
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.36386375565692153,-0.8944940415472413,0.6756756756756757,1.0,1.0,7/54,7.78%,SLC25A5;SFXN2;SLC3A2;SLC6A13;SLC25A4;SLC25A19;SLC25A1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.5450616317549695,-0.8943018610465331,0.5263157894736842,1.0,1.0,3/7,26.01%,DNAAF1;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.5289198277987042,0.8943000444017393,0.6530612244897959,0.8632257379745174,1.0,4/13,23.66%,PPARG;ABCG1;SCARB1;MSR1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.49683021982383146,-0.8942452623361051,0.6428571428571429,1.0,1.0,3/13,13.90%,ISCA2;CIAO2B;NFU1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3111475364141622,-0.894213774011955,0.7368421052631579,1.0,1.0,59/258,21.79%,ERCC8;DCLRE1B;KPNA2;FANCF;APEX2;RFC3;ATRIP;HUS1;GTF2H5;POLD3;GTF2H2;MGME1;CETN2;WDHD1;BRIP1;PMS1;GTF2H2C;ABRAXAS1;SMARCAL1;ERCC2;ATR;PRIMPOL;RAD23A;NSMCE4A;ERCC6;RAD9B;TEX264;PNKP;RMI2;RNF168;MEN1;XPA;RNF8;DNA2;HINFP;RFWD3;FAM111A;FANCM;NABP2;BRCC3;MUS81;ERCC3;APEX1;RAD51;SMARCA5;UBB;UBE2V2;INTS3;RAD17;SLX4;FANCE;MSH3;XRCC2;MPG;PARP1;BRCA2;CHRNA4;UBE2T;UBE2A
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.42642175465675847,0.89396626725523,0.6,0.8635093946867035,1.0,5/30,11.84%,SLC4A10;SLC9A9;SLC9A1;SLC4A9;SLC9C2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.526184589868569,0.8939465844505647,0.59375,0.8632432734966466,1.0,5/6,24.68%,CBLN2;ERC2;DCTN1;RAB3A;ERC1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.3911431180844829,-0.8934016425661334,0.6341463414634146,1.0,1.0,9/28,24.95%,GRPEL2;PEX10;TIMM23;TIMM50;PEX1;DNAJC19;TIMM17A;TOMM70;GRPEL1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5328614693468854,-0.8933876077922344,0.5365853658536586,1.0,1.0,3/9,25.16%,DNASE1L1;MUS81;FBH1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.42916999513080567,-0.8933575626645291,0.5882352941176471,1.0,1.0,6/27,19.18%,TMEM17;BBS10;VANGL2;TBC1D32;IFT57;RPGRIP1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.5614876517208127,0.8932710133817725,0.6666666666666666,0.8641944282948686,1.0,1/9,2.58%,PLEK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6072419142774201,0.8930413064237471,0.68,0.8643380275956352,1.0,3/6,18.06%,HLA-E;RARA;TNFSF4
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.48850845055517517,-0.8930183585777777,0.6888888888888889,1.0,1.0,1/9,10.54%,CLP1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.421235417819985,0.8927909831627002,0.6491228070175439,0.8645237542113952,1.0,3/42,4.11%,STEAP3;SLC39A14;CP
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.43450791539491984,-0.891626752472263,0.6060606060606061,1.0,1.0,2/21,1.54%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5740270213683863,0.8913042531739854,0.6666666666666666,0.867069150956274,1.0,2/5,33.42%,KIF13A;KIF3A
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.5665646443194319,0.8912645426252822,0.7068965517241379,0.8668148949599566,1.0,2/9,9.98%,CACNA1C;ORAI1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.45175966539528906,-0.8907863688633041,0.5945945945945946,1.0,1.0,2/16,8.10%,POLR2K;DHX33
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.424513484205421,0.8907111169611952,0.696969696969697,0.8675141927502076,1.0,15/40,27.64%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;KLF4;TP53;WRAP53;ACD;PARN;PARM1;PIF1;MAPK3;MAP2K7;NVL
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.5276470696513698,0.8905432131646919,0.5862068965517241,0.8674581564774659,1.0,4/17,13.41%,KCNH2;SLC9A1;PDK4;SLC12A5
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.5931473756355059,0.8903105296098274,0.6617647058823529,0.8675707784392881,1.0,2/5,22.23%,AKIRIN1;SIX4
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.5730340033590148,0.889840644242894,0.6833333333333333,0.8681510694826802,1.0,1/6,2.14%,NR4A1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.47545263356041767,0.8893239737395106,0.6379310344827587,0.868768859627207,1.0,7/18,17.79%,IRS2;PTPRC;NFATC2;BCL2;GPR183;BST1;TFRC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.4116208696379158,-0.8890394725346507,0.6666666666666666,1.0,1.0,5/33,9.66%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3902313313339332,0.8887363921391468,0.625,0.8696851883215934,1.0,9/66,12.36%,CDKN2A;DUSP1;DAB2IP;PRKAR1B;PKIA;CDKN1C;GADD45A;PRKCD;CDKN1B
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.3556698757637067,0.8887103446770902,0.7341772151898734,0.8694053781706145,1.0,18/150,11.60%,PAPSS2;IGF1;SERPINE1;GSTT2;EPHA2;IL1R1;PGD;TPST1;FAS;RAP1GAP;TNFRSF1A;UGDH;TYR;ENPEP;GSS;TGFB2;FBP1;PDK4
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5502578295841819,-0.8884789882277667,0.5531914893617021,1.0,1.0,2/5,36.27%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5502578295841819,-0.8884789882277667,0.5531914893617021,1.0,1.0,2/5,36.27%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.5668369682229436,0.8883176136492493,0.6274509803921569,0.8697653776786183,1.0,1/5,7.99%,ACOT4
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.5897985800571038,-0.8882042997887006,0.6666666666666666,1.0,1.0,2/6,19.18%,RORB;RPGRIP1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.44866381628874547,0.8876263994809322,0.5483870967741935,0.8708402212036619,1.0,6/21,19.17%,HPCA;JPH4;PDE4D;YWHAE;CAV3;CACNB2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.4607045303338406,0.8876259895568918,0.7049180327868853,0.8705308641090959,1.0,4/27,9.85%,IGF1;NYAP2;NYAP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.483195344480128,0.8875979530166807,0.6307692307692307,0.8702889824457203,1.0,1/15,2.58%,PLEK
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.5064816462358903,0.8875847078022115,0.6326530612244898,0.8700094546009646,1.0,3/11,10.83%,RDH13;CYP1B1;DHRS13
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.42682968289150036,-0.887535336280917,0.6,1.0,1.0,2/16,4.92%,RGCC;SERPINF2
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.5042548449006948,0.8875125335676858,0.6,0.8698477391163106,1.0,3/9,28.13%,TGFB2;PTCH1;FBXW4
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.4043320554795587,0.8873563761144797,0.6060606060606061,0.8698373026866646,1.0,10/61,9.39%,SIX3;YWHAH;NLGN1;VWC2;CASZ1;CNTN4;PCP4;NEUROD2;YWHAG;MMD
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5528166928857814,0.8873270342165738,0.6964285714285714,0.8695834175017707,1.0,1/8,7.37%,ZMYND10
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5382136263966856,0.8873146471153632,0.5932203389830508,0.8689922960285295,1.0,3/7,26.85%,PRKN;MAPK3;GABPA
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5382136263966856,0.8873146471153632,0.5932203389830508,0.8689922960285295,1.0,3/7,26.85%,PRKN;MAPK3;GABPA
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5824268455049866,0.8871024201275036,0.6491228070175439,0.8690953900124967,1.0,4/6,34.19%,SND1;PARN;DIS3L2;LIN28B
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.5702385804352944,0.8870273158316689,0.66,0.8689469165166014,1.0,4/5,42.78%,PSIP1;PRPF39;SNRPC;SFSWAP
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4045271634326505,0.886780977101306,0.671875,0.869083474302893,1.0,14/45,20.23%,AMH;BMP8A;SCX;SMAD3;TGFB2;RGMB;SMAD1;SMURF1;RGMA;SMAD2;TGFBR3;SMAD9;BMP6;HJV
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.3955900523796335,-0.8867273416981409,0.5897435897435898,1.0,1.0,10/34,14.91%,TRIM29;CFTR;IL33;IL20RA;TEKT1;EHF;CYP4F12;MAP3K19;ERBB3;MUC20
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.5259391282242311,0.886623044058032,0.6415094339622641,0.8690858999888095,1.0,2/12,1.62%,PROX1;PKP2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.46672349538429325,0.886607129915629,0.6190476190476191,0.8687952251126235,1.0,6/19,18.74%,SLCO1A2;SLC51A;SLC27A5;ABCC4;RXRA;ABCC3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.4129130834496879,0.886585863009998,0.6216216216216216,0.8685256840345338,1.0,8/42,13.31%,IGF1;APP;NLRP12;MYD88;STAT3;GSDMD;USP50;NLRP2
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3467331530917132,-0.8864536386134064,0.7,1.0,1.0,4/88,3.67%,SLC2A5;G0S2;CES2;SDSL
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4410416783476153,0.886302814664793,0.6567164179104478,0.8687458809605891,1.0,6/34,10.55%,PLSCR1;ALDOB;RYR2;ATP1B1;ATP1B3;AHSA1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.5611370544455463,0.8860757565642301,0.6612903225806451,0.8688780858282841,1.0,2/8,12.70%,HMGCLL1;SLC27A5
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),-0.5579715424407923,-0.8853160148094201,0.6410256410256411,1.0,1.0,2/9,19.57%,HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5312276197803734,-0.8852501028774544,0.631578947368421,1.0,1.0,2/6,19.43%,TMX3;PRDX3
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.5975317341298685,0.884823827132369,0.64,0.8707244935055474,1.0,2/6,22.72%,CDS2;SLC27A1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3790486687397231,-0.8841641281056002,0.7037037037037037,1.0,1.0,1/57,0.09%,NGF
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.565805621624161,0.8840317309005006,0.7142857142857143,0.8718548627348685,1.0,2/8,6.35%,EGF;NRG1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.4553429754877191,0.8838832830538379,0.6290322580645161,0.8718019868148832,1.0,9/33,18.29%,PRKCG;AGAP2;HDAC4;ZDHHC7;FBP1;ALK;FMN2;NCOR1;FLNA
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.5242906982237125,-0.883742135043557,0.5813953488372093,1.0,1.0,1/5,8.86%,GPLD1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.6207153881771961,0.8834225507959802,0.6981132075471698,0.8723673122630157,1.0,2/5,30.71%,PLAT;AAMP
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.5817472637794526,-0.8833512760127099,0.7380952380952381,1.0,1.0,2/5,12.37%,TPRKB;OSGEP
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.4779679049200003,0.8833086720129957,0.65625,0.8721890335616302,1.0,2/21,6.43%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.45947025451731205,-0.8830122326424844,0.5641025641025641,1.0,1.0,5/19,21.37%,APOE;ARV1;FMO5;EPHX2;GNB3
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.4804267994765982,0.8829247607467567,0.6190476190476191,0.8726619994063767,1.0,3/11,14.93%,FOLH1;AGTPBP1;LCMT1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5425630716642459,0.8826777484300887,0.7121212121212122,0.8728467384752581,1.0,2/7,9.87%,OGN;OMD
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.5326535617954827,0.8825455951069764,0.625,0.8727852644197388,1.0,7/15,31.55%,BASP1;LARGE1;SIX4;FXR1;MYH14;IGSF8;MEF2C
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.5257047814819364,-0.8823613867622837,0.575,1.0,1.0,3/7,21.06%,BRPF1;MEAF6;BRPF3
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.544855893601195,0.8821962983053826,0.6086956521739131,0.8731824707572848,1.0,4/8,36.98%,ARRB1;CTBP1;TAF7;IWS1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.5610043325107812,0.8821772682166652,0.6727272727272727,0.872904187860458,1.0,2/7,8.63%,PMEPA1;LDLRAD4
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5278511408262831,-0.8818692242767284,0.625,1.0,1.0,1/7,3.78%,PYHIN1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.4637306908543392,-0.8817315905419449,0.6578947368421053,1.0,1.0,2/13,2.25%,HEY2;ADAMTS9
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.5907309326922979,0.8812595911956378,0.6041666666666666,0.8743926938467551,1.0,1/5,7.09%,MAOB
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.5355444173112793,0.8812582001408764,0.65,0.8740850257630652,1.0,2/7,14.71%,MAPK8IP1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5759339592366464,0.881232788112133,0.6818181818181818,0.8738150461747823,1.0,3/5,35.63%,CTBP1;SIRT1;TAF7
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5435360658781261,0.8811702219383326,0.7142857142857143,0.873586877423948,1.0,6/12,19.28%,NEFL;SYBU;MAPT;RHOT1;RHOT2;HIF1A
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5061658349055205,0.8811431208729731,0.68,0.8733505478031651,1.0,3/15,7.23%,TYMS;POLD1;HROB
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.595160432694846,0.8810922156684159,0.6779661016949152,0.8731393392986008,1.0,3/5,39.64%,VPS13D;VPS13C;GOLPH3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.5158785101822156,-0.8810838126512309,0.7142857142857143,1.0,1.0,3/17,6.61%,APOE;ABCB11;ARV1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.3888279293848415,-0.8810596393666982,0.6,1.0,1.0,5/32,8.40%,TPX2;ANKRD53;RAE1;HSPA1A;VPS4B
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.5554672323076044,-0.8804280749951949,0.7567567567567568,1.0,1.0,1/6,6.98%,RHCE
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.4023760118077563,0.8803559220164802,0.6065573770491803,0.8741173848176726,1.0,6/55,10.01%,ZDHHC9;ZDHHC22;PGAP4;PIGA;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.37021467524284396,0.8801297224010962,0.703125,0.8742177742937789,1.0,14/70,19.38%,GPNMB;FYN;SOX4;SNCA;INPP5A;NPAS2;FGF2;IKBKG;PINK1;CD200;MECOM;AMIGO2;RAD18;PACRG
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.4954695432803198,-0.879901983282742,0.6744186046511628,1.0,1.0,5/13,11.31%,RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5511851958850338,-0.8794402549350144,0.660377358490566,1.0,1.0,5/7,30.26%,CLU;ATXN3;DNAJB12;DNAJC18;DNAJB14
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.531042036630871,0.8792954208088789,0.6909090909090909,0.8754108039473225,1.0,4/9,33.05%,CSRP2;PTCH1;NF1;SRPK3
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.47264917342532414,-0.8791630107516524,0.6764705882352942,1.0,1.0,1/12,3.78%,PYHIN1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.44430893896532564,-0.8790127189444422,0.6,1.0,1.0,2/18,2.08%,CYP4F3;CEL
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.5244504597057947,0.8789139668757354,0.6415094339622641,0.8758637026632186,1.0,4/7,23.95%,PRKAR1A;PDCD1LG2;SCRIB;PRNP
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.5153271270417388,-0.8789120516324412,0.6666666666666666,1.0,1.0,2/10,19.57%,HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.5600061905925029,-0.8788531028425871,0.6363636363636364,1.0,1.0,1/6,10.83%,GPR37L1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.34396819954291313,-0.8784966050847488,0.7073170731707317,1.0,1.0,21/85,17.29%,LSM3;SF3B4;SF3A1;LSM2;U2AF1;PRPF18;HSPA1A;NUDT16L1;LSM5;METTL3;RNH1;KIN;HSF1;PRPF8;SRSF2;PRPF3;CPSF3;LSM10;NUDT12;SRSF9;ZFP36L2
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.5347201404803449,0.8781275715852982,0.6842105263157895,0.8769805842633681,1.0,1/11,7.37%,ZMYND10
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3314673654037943,0.8774071683455255,0.75,0.878096682636589,1.0,36/278,18.35%,NR4A3;PRRX1;TEAD2;NR4A1;GCM2;PGR;CDK9;LSM11;PIR;TBL1X;NR1I3;YAP1;PPARG;TAF4B;GLIS3;TEAD1;NR6A1;HDAC9;NR4A2;DEAF1;MAML2;NOTCH3;RARA;RARG;RXRA;TAF1C;RORA;ZBTB1;NCOR1;MNT;WWTR1;NR2F6;HDAC7;CBFB;TBL1XR1;ZNF473
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.39183506720325056,0.8773173410511808,0.6944444444444444,0.8779756060851475,1.0,8/58,12.48%,EPHA2;TPST1;SULT4A1;ACOT4;AK3;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.516947636185527,0.8770861978105332,0.6825396825396826,0.878049547559978,1.0,5/12,11.42%,ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.4320740844816489,-0.8769582696495474,0.55,1.0,1.0,5/14,31.07%,CLP1;NRDE2;AGO4;PRKRA;TSN
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.43707029129332015,0.8769395856133181,0.6101694915254238,0.877986617199681,1.0,9/29,18.03%,BMP8A;RAB11FIP5;SERGEF;RHBDF1;RAB11FIP1;RHBDF2;IL12A;CD200;MIDN
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.5463259868067922,-0.8768157564602588,0.6326530612244898,1.0,1.0,2/5,15.16%,SLC6A13;MT3
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.3501410438940809,0.8767432312855665,0.7468354430379747,0.8780605030393351,1.0,27/170,13.44%,CDKN2A;PLK2;S100A10;ATF3;STEAP3;EPHA2;APP;ADA;TGFA;TSPYL2;EPS8L2;FAS;BAIAP2;ZBTB16;FOXO3;PDGFA;RAP2B;NDRG1;VWA5A;FGF13;KIF13B;GADD45A;TPD52L1;STOM;KLF4;CDKN1A;RHBDF2
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.5878942816326806,0.8767276668739539,0.7142857142857143,0.8777780254525227,1.0,1/5,12.10%,DEUP1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.30629613564863223,-0.8764653641888955,0.8928571428571429,1.0,1.0,49/273,19.36%,TMEM17;CEP72;CNGA4;SSNA1;UBXN10;DYNLRB2;CEP19;FOXJ1;CETN2;CFAP221;INTU;TEKT5;WDR11;CFAP52;RSPH1;TMEM237;HAUS1;TEKT1;DYNLRB1;CEP131;RAB8A;SCLT1;EXOC7;IQCB1;CEP83;DYNC2I1;FAM149B1;TMEM250;ARF4;BBS10;BBS9;VANGL2;CCDC66;AVIL;CFAP70;DYNLL1;MKS1;TBC1D32;CEP192;UNC119B;CEP78;CEP20;DNAAF1;ARL6;EXOC1;FBF1;IFT57;RPGRIP1;TUBB
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3103955335281619,-0.8760576353056925,1.0,1.0,1.0,36/223,20.20%,AR;OTUD3;TNFAIP3;CFTR;MCRS1;ENY2;IL33;KDM1B;ABRAXAS1;BECN1;USP27X;RAD23A;USP51;PSMD10;FOXO4;PSMD12;USP19;PSMB5;TADA2B;CLSPN;PSMB6;USP9Y;RUVBL1;PSME3;TNIP1;BRCC3;ESR1;NFRKB;PSMD2;TADA3;USP18;UBB;YOD1;SKP2;USP10;PSMB4
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.5651646964134343,0.8758604140323529,0.6530612244897959,0.8790198947013232,1.0,4/8,12.33%,SFTPD;P2RY12;CCL2;TAFA4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5566581551883929,0.8758317694054086,0.6779661016949152,0.8787496999344723,1.0,2/9,6.43%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.4694249212072173,0.8757858573486053,0.6721311475409836,0.8785210822487618,1.0,5/29,16.34%,HELB;POLQ;CGAS;OGG1;RADX
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5192454266562755,0.8756780106657132,0.6981132075471698,0.8783877838147758,1.0,3/13,17.58%,CLMN;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.4515691395769902,0.8755426023015475,0.6785714285714286,0.8782669862947053,1.0,7/27,9.52%,ABCB1;ATP8B4;PLSCR1;ATP9A;MFSD2A;PLSCR2;ATP10A
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.4337006540828404,0.8753751930354349,0.6461538461538462,0.8782413661196763,1.0,4/24,11.08%,ANK3;KCNIP4;KCNH2;KCNAB3
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3391953403881702,-0.8750837916629032,0.6666666666666666,1.0,1.0,14/89,15.58%,CEBPA;TRIB3;CBFA2T3;HSPA1A;RAD23A;RPL11;UFL1;ARAF;PSMD10;HFE;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.48003347451792183,0.8746907240528546,0.6792452830188679,0.8791498292733724,1.0,2/20,3.05%,IGF1;IRS2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.496487389854673,0.8744482587522037,0.6833333333333333,0.8792974456288795,1.0,6/13,32.70%,ARF6;ARHGAP17;KBTBD6;OGT;RASGRF1;AUTS2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.35067759368679796,0.8743946388257227,0.7076923076923077,0.8790815058842638,1.0,27/147,18.14%,NR4A3;TEAD2;NR4A1;PGR;CDK9;TBL1X;NR1I3;YAP1;PPARG;TAF4B;TEAD1;NR6A1;HDAC9;NR4A2;MAML2;NOTCH3;RARA;RARG;RXRA;TAF1C;RORA;POLR1E;NCOR1;WWTR1;NR2F6;HDAC7;TBL1XR1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4381080031913292,-0.8732824644530761,0.6097560975609756,1.0,1.0,1/17,3.91%,SRI
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.5841250722337055,0.8731567246887394,0.6346153846153846,0.8810910904681155,1.0,1/6,7.18%,RYR2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.4497078972103803,0.8726938539772616,0.6379310344827587,0.881617584252141,1.0,5/21,19.01%,ENO2;MTM1;ENO3;ELAPOR1;MTMR3
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.49106274077151707,0.8724975417574615,0.6721311475409836,0.8817187505242807,1.0,5/16,12.96%,DMTN;ALOX12;SYK;PRKCD;PDPN
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.33049122401077363,0.8720809128924891,0.7794117647058824,0.882137424513813,1.0,33/184,17.79%,TLR2;PRKCB;RELN;IRAK2;APP;NOD1;EPHA5;PPARGC1B;TRIM5;NEUROD2;MYD88;CTNNB1;SMAD3;PRKCH;BEX1;IKBKE;PPARG;HDAC4;STAT3;TERF2IP;TRIM22;ALK;TRIM32;HIPK2;IKBKG;STK3;SLCO3A1;CD200;TAB1;TRAF5;CAMK1D;WNT5A;TFRC
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5108186782589605,0.8715936376259216,0.6792452830188679,0.8827207250801935,1.0,2/12,11.94%,MGAT3;BACE2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.48543953355119523,-0.8714397436233965,0.6666666666666666,1.0,1.0,3/12,9.33%,HEY2;HEYL;PEF1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5335896293154977,0.8713358997586361,0.6666666666666666,0.882899710460675,1.0,4/11,23.89%,FAM107A;KCNB1;ULK1;EIF4G1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.49915573033942306,0.8711014001138873,0.631578947368421,0.883000289614368,1.0,3/12,15.46%,PXK;PAM16;TP53
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.4965936626014132,0.87093784568267,0.5970149253731343,0.882964883254962,1.0,3/16,10.04%,MOB3B;WTIP;DLG5
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.4078593174121314,0.8709220618491592,0.6533333333333333,0.8826701166933978,1.0,5/45,4.40%,CXCL2;C3;S100A10;EFNA1;EPS8L2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.3949937388447366,0.8707121213299319,0.65,0.8827418602464432,1.0,9/51,10.95%,THBS1;SERPINE1;PMEPA1;KLF10;CDK9;CTNNB1;SMAD3;SMAD1;CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.42945735068063007,0.8704755840161204,0.6176470588235294,0.8828999554311193,1.0,10/32,17.57%,APP;NLRP12;TMED10;MYD88;STAT3;GSDMD;USP50;NLRP2;P2RX7;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5074434242352595,0.8704342297772657,0.6851851851851852,0.8826918901756067,1.0,3/11,20.85%,DGKG;WNT5A;DGKD
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.49870088949620406,-0.8703821904643055,0.6739130434782609,1.0,1.0,5/12,11.31%,RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.3052176547566203,-0.8701623712205095,0.9523809523809523,1.0,1.0,60/291,22.42%,FBXO48;CDC26;ERCC8;SELENOS;DMAC2;SEL1L2;FBXO45;TMUB2;FBXO5;KCTD2;FBXO27;UBXN8;ZFAND2B;SPSB4;RAD23A;FBXL22;FEM1A;FOXRED2;PSMD10;ANAPC15;PSMD12;DERL2;ERLIN2;USP19;PSMB5;FBXO9;AUP1;RNF5;RNF103-CHMP3;RNF126;DCAF11;PSMB6;TRIM3;FEM1C;PSME3;RNF34;GID8;PSMD2;UBXN2A;UBB;UBE4A;CUL1;YOD1;SKP2;PSMB4;KLHL20;SHARPIN;DNAJB9;DDIT3;NHLRC3;TMUB1;UBE3D;DNAJC10;KBTBD7;RHBDD2;UBE2A;GID4;FBXL14;ATXN3;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.44493235434727063,-0.8699143863292481,0.65,1.0,1.0,5/22,8.80%,RITA1;NRARP;BEND6;METTL3;HEY1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5228943645389477,0.8698605871919005,0.6271186440677966,0.8833679417922198,1.0,5/11,10.69%,SKAP1;TGFB2;PODXL;SYK;P2RY12
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.5818887746145934,0.869759483000287,0.7222222222222222,0.8832831606796697,1.0,4/6,32.91%,TGFB2;TGFB3;TGFB1;MSN
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.48715855452040946,-0.8697365238671435,0.7058823529411765,1.0,1.0,2/11,13.28%,TRIB3;ERLIN2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4462578442083995,0.869200226388499,0.6774193548387096,0.8838886907829075,1.0,10/29,28.03%,TLE6;PHLDB2;B4GALT5;RPS6KA6;TDG;NIBAN2;BAG6;CRB2;NLRP5;CLASP1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.535076940201604,0.8691739035542485,0.7288135593220338,0.8836107485042768,1.0,5/9,20.82%,SLCO2A1;ABCC4;SLCO3A1;ABCC3;ABCC1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.42406271355713443,-0.8688285653611683,0.6,1.0,1.0,3/24,11.86%,ID2;PER3;FBXL22
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.5652389345317644,-0.8686339460534334,0.6346153846153846,1.0,1.0,1/5,3.74%,ORMDL1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.3796717958175958,-0.8686151574954858,0.6470588235294118,1.0,1.0,17/42,18.79%,CYP4F3;PIK3C2G;C6;ADH4;NCMAP;FRK;CYP4F12;SPTLC3;ACKR2;SLC3A1;TSHR;KCNIP3;FMO5;PON3;PRLR;F11;TTF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.49653891092586827,0.8683726694248082,0.6666666666666666,0.8846550649484831,1.0,2/14,12.47%,CD44;BCL2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.38346204313342136,0.8681477432547057,0.6428571428571429,0.8847218168569614,1.0,9/55,13.58%,IGF1;SP100;THBS1;FAS;PML;STX4;TMC8;TNFRSF10B;FADD
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.41948711714865544,-0.8679572590655839,0.6842105263157895,1.0,1.0,3/23,2.28%,DAO;GOLT1A;FGL1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.39121013819397715,0.8677736671206205,0.6212121212121212,0.884993669912344,1.0,10/45,10.74%,CNTNAP1;SHTN1;DAB2IP;CNTNAP2;NYAP2;WASF1;NYAP1;MINK1;PACSIN1;TRIO
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.375029054423617,0.86767619846456,0.6851851851851852,0.8848141666288799,1.0,27/99,24.36%,INCENP;PADI2;TBL1X;HDAC4;MORF4L2;HDAC9;PRKCD;CDK2;TBL1XR1;PRMT1;RPS6KA4;MTA1;TAF10;MORF4L1;MTA3;RCOR1;UBE2B;ATXN7;CCNA2;TRERF1;MIDEAS;CARM1;NSD1;RPS6KA5;UHRF1;SUPT3H;HDAC5
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.38853925670949474,-0.8675379285701228,0.6538461538461539,1.0,1.0,5/68,7.12%,G0S2;KSR2;LEPR;SIRT6;CXCR4
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.46567697921320933,0.8675240848458948,0.6666666666666666,0.8847946918353444,1.0,8/23,17.46%,PROX1;CHI3L1;ITGA3;GLI2;PDPN;FGF2;ABCA3;RCN3
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.5083254789550058,0.8674650007273564,0.6440677966101694,0.8846112830734839,1.0,3/13,5.50%,CD22;SH3KBP1;AHR
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.41241015566051187,-0.8673954371489455,0.6470588235294118,1.0,1.0,2/24,1.54%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3870997691045097,0.8671259227146398,0.6521739130434783,0.884907381597568,1.0,12/75,12.47%,KIF14;EPHA7;GRID2;PRKCG;AGAP2;FOXO3;MAG;CTNNB1;TGFB2;VSTM2L;CCL2;BCL2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.4513379967198141,-0.8666397313114568,0.6744186046511628,1.0,1.0,2/12,10.58%,DNMT3B;KMT2A
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4618203586593612,0.866217772130718,0.7192982456140351,0.8862518127872762,1.0,3/14,12.68%,HDAC4;HDAC9;PER1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.5158564037989355,0.8661476747414424,0.6724137931034483,0.8861172235274448,1.0,4/11,22.96%,RNF152;STK11;SPAAR;SESN1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.598453651133571,0.8659489605743987,0.6779661016949152,0.8855381357072636,1.0,2/5,27.80%,MAN1A1;EDEM1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.598453651133571,0.8659489605743987,0.6779661016949152,0.8855381357072636,1.0,2/5,27.80%,MAN1A1;EDEM1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.598453651133571,0.8659489605743987,0.6779661016949152,0.8855381357072636,1.0,2/5,27.80%,MAN1A1;EDEM1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.3901981351628049,-0.8650484362081134,0.7045454545454546,1.0,1.0,4/37,5.43%,SPRY1;RGS2;APOE;PTPN22
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4317026574683027,0.864992640839411,0.5964912280701754,0.886810517841236,1.0,7/30,17.07%,BICDL1;TRAK1;PEX14;MAPT;HAP1;RHOT1;RHOT2
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.542821358407527,0.8648528664699671,0.6,0.8867781521302871,1.0,2/6,30.91%,UBE2E1;UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.41051281407618506,0.8643592348577727,0.71875,0.8874404207977945,1.0,10/44,13.58%,BOK;SEPTIN4;DAB2IP;FAS;PML;BCL2L1;BBC3;TPD52L1;BCL2;FADD
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.45715382624774153,-0.8643192820360772,0.6122448979591837,1.0,1.0,2/15,4.36%,DISP3;APOE
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.41967110955705644,-0.8641905622277298,0.5909090909090909,1.0,1.0,3/25,11.86%,ID2;PER3;FBXL22
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.30251294052949806,-0.8639738952437874,0.9166666666666666,1.0,1.0,67/326,14.02%,MRPL10;RPL35A;RPS24;CST3;RPL34;CTSH;RPL39;MRPS21;PADI4;RPL13;RPL37;MRPL52;RPS28;MCRS1;APOE;MRPS7;RPL18;MSRB1;CCN1;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;RPS26;CKAP4;RPL6;RPL41;RPS13;RPL22;RPL29;PRSS23;RPL30;TNC;ASMT;RPSA;TMEM132A;UBE2M;FUCA2;RPL14;YES1;SPCS1;SPARCL1;SERP1;RPL15;ICMT;EEF1A1;RPS2;ADA2;NCSTN;IGF2BP3;CALU;RPL11;SEPHS1;RPL23A;HTRA2;ARAF;CCDC59;FSTL3;MRPS18B;RPS21;MRPS33;SCG3;SPCS2;GGCX;YME1L1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.520417168769564,-0.8638588128639783,0.6744186046511628,1.0,1.0,2/5,9.84%,AGBL1;AGBL2
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.47744270188704957,-0.8634135004691007,0.6857142857142857,1.0,1.0,4/19,13.40%,EXOSC8;ERI2;UTP20;RPS21
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.36569667758845664,0.8629870003645694,0.6545454545454545,0.8895890061453096,1.0,15/85,13.58%,ST18;BOK;NOD1;NLRP12;FAS;SNCA;CASP10;SMAD3;PPARG;SYK;BBC3;MAPT;NLRP2;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.40440544173276255,0.8629096099228972,0.6753246753246753,0.8894046395297306,1.0,11/37,24.62%,MAP1LC3A;ATG9A;PINK1;SPATA18;CTSK;GABARAPL1;WDR45;ULK1;ATG7;PRKN;GABARAPL2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5588551594319162,0.8628020809031324,0.6666666666666666,0.8893061163157169,1.0,5/7,34.82%,NCAM1;NFIB;NRP1;EPHB2;VEGFA
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.4853993290037609,0.8628015377952181,0.6440677966101694,0.8890036450609553,1.0,1/13,2.01%,MAEL
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.46528319048459854,0.8625319642979252,0.6557377049180327,0.8891255892413403,1.0,4/18,24.82%,TINF2;EXOSC10;ACD;PIF1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.41653910297015956,0.8624575220128551,0.7142857142857143,0.8889457138037217,1.0,4/31,13.71%,GLRA2;GRIN1;NEURL1;GLRA3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.4629036099747041,0.8624050667310571,0.6779661016949152,0.8887170489982804,1.0,4/22,16.16%,PML;TERF2IP;MRE11;TINF2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5056971098640661,0.8622467510008222,0.7,0.8881256521469644,1.0,2/11,22.83%,CDC27;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5056971098640661,0.8622467510008222,0.7,0.8881256521469644,1.0,2/11,22.83%,CDC27;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.5056971098640661,0.8622467510008222,0.7,0.8881256521469644,1.0,2/11,22.83%,CDC27;CUL3
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5390277342028365,0.8620419327531966,0.6938775510204082,0.888247646646411,1.0,3/8,27.19%,LMTK2;ARFGEF2;NSG1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.5405697396285047,-0.8619907415556558,0.625,1.0,1.0,1/6,1.49%,RIOK2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.4607891794348008,0.8611680320505865,0.6727272727272727,0.8894966974342763,1.0,8/18,24.47%,MYH9;ADAM19;BACE2;ADAM17;ADAM9;SPPL2B;PSEN1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.4763230183757441,0.8609780182965264,0.6,0.8896018661401498,1.0,3/9,26.17%,IL12A;CSF1;MAPK3
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3879362650522112,0.860889835229508,0.6911764705882353,0.889471117051427,1.0,7/84,8.72%,TLR2;SULF1;APP;HIC1;NOTUM;CTNNB1;ITGA3
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.5657507485994523,0.8605131776097289,0.71875,0.8898567008240623,1.0,3/5,40.16%,NUCKS1;VAPA;YTHDC2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.38362638454375647,0.8601726093138086,0.6571428571428571,0.8900876064624206,1.0,16/67,21.89%,PLK2;DAB2IP;FOXO1;HECW2;BARD1;HECW1;CDKN1B;OAZ2;TRIM32;SMURF1;WNT5A;PLK3;VIP;ADAM9;RAB7A;DDB1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.45870714737116647,-0.859979376598974,0.717391304347826,1.0,1.0,2/11,16.32%,POLD3;XPA
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.5461210352129467,0.859955825638331,0.6851851851851852,0.8901477447452909,1.0,2/6,37.89%,LIN28B;NFKB1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5238937408713187,0.8598818949011058,0.6610169491525424,0.8899560769683892,1.0,6/12,26.53%,HDAC9;PCSK5;SORT1;ANGPTL4;PCSK6;FURIN
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.35805296738093884,-0.8598740664128305,0.7105263157894737,1.0,1.0,25/81,23.21%,ERCC8;GTF2H2;NOC2L;EIF2S1;BAK1;METTL3;ERCC2;USF1;ATR;PRIMPOL;ERCC6;TRIAP1;MEN1;XPA;CIRBP;SMPD1;ERCC3;GPX1;CAT;PARP1;UBE2A;AQP1;CASP9;MAP3K4;YY1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5313268160993003,0.8597814616352072,0.6779661016949152,0.8898538459106624,1.0,1/9,9.20%,SEC14L1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5099052432141429,-0.8590915010962961,0.7254901960784313,1.0,1.0,1/11,5.74%,HEYL
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5224048996316033,-0.8583050410994836,0.6666666666666666,1.0,1.0,5/8,32.55%,MT3;OXA1L;SIRT4;ECSIT;SZT2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.5342374189026131,0.8580472161612923,0.7142857142857143,0.8923852869544587,1.0,1/8,15.51%,CPNE7
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5222277677594942,0.85760439280588,0.7222222222222222,0.8928218143215926,1.0,3/9,21.30%,HLA-DRB1;CD4;CSF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.450373727421639,0.8575283614659536,0.625,0.8926173276282036,1.0,4/19,15.46%,PML;HIPK1;HIPK2;TP53
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.5456779524715905,0.8574557252281929,0.7450980392156863,0.8924129809941933,1.0,3/10,9.88%,STAC2;PVALEF;TCAP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.5761074510508357,0.8573640556647436,0.6842105263157895,0.8922695599976562,1.0,3/5,23.95%,IL12A;TNFSF4;PRNP
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.4382525334403569,-0.8573192783959702,0.6296296296296297,1.0,1.0,2/16,7.36%,HEYL;MAML3
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.5279164668959049,0.8571588209925749,0.7021276595744681,0.8924179087794184,1.0,2/8,14.07%,SLC7A7;SLC7A1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.508304168353147,-0.8571266340497222,0.627906976744186,1.0,1.0,5/8,28.83%,DERL2;YOD1;ERLEC1;SVIP;OS9
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.4858484244667452,-0.856985718672949,0.6511627906976745,1.0,1.0,1/9,1.47%,ADAMTS18
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.367828025937766,0.8567927157791493,0.6307692307692307,0.8926876443179439,1.0,10/64,19.14%,SEPTIN4;FAM107A;BIRC3;HDAC4;PHF23;PRICKLE1;PINK1;BRCA1;NDFIP2;PIAS1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5357779393174049,0.8565120095070959,0.6981132075471698,0.8929369542400735,1.0,3/10,19.03%,PADI2;ZMIZ1;ARID1A
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.4543350244775489,-0.8564027053208256,0.6739130434782609,1.0,1.0,5/13,30.51%,DNASE2;KPNB1;EXOG;CASP3;ENDOG
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.5591350906430642,0.8563883429886942,0.75,0.8928340186361067,1.0,1/6,0.85%,ANXA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.39491583877903447,-0.8563009578946946,0.7368421052631579,1.0,1.0,5/35,9.66%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.3824042680204373,0.8553178233518087,0.6785714285714286,0.8941915632537554,1.0,7/56,12.53%,ACSL5;LIPH;AGPAT4;CYP21A2;OLAH;ACSM5;PAM
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.44578552079921835,-0.8549676746219189,0.5555555555555556,1.0,1.0,2/14,7.09%,TPT1;SFRP2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.4740983024018443,0.8548902964023181,0.6666666666666666,0.8946948805367392,1.0,1/15,7.43%,RAMP3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3179760598779231,-0.8548455710879654,0.8333333333333334,1.0,1.0,9/163,6.18%,CDC26;ID2;RIOK2;CEP72;TPX2;SSNA1;RGCC;FBXO5;CETN2
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4788714597157058,0.8547581701383675,0.6428571428571429,0.8946642184959774,1.0,5/19,11.18%,PSCA;LIPH;CAPN8;KPNA7;CLDN18
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.44969114608921706,0.8546943422573917,0.746268656716418,0.8945042553708844,1.0,7/25,25.78%,CDKN1A;TP53;TINF2;EXOSC10;ACD;PIF1;NIBAN2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.6000825257538938,0.8542867198819555,0.7307692307692307,0.8949503915168361,1.0,1/6,3.96%,PRPS2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.3711140014808868,0.8541657769404579,0.7868852459016393,0.8948873652403597,1.0,5/73,3.45%,MET;IGF1;EGF;APP;ADD2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.3777328930505839,0.8539707462727596,0.7272727272727273,0.8949131998745631,1.0,7/46,11.17%,CD24;ABCA5;FABP3;SOAT1;LDLR;ABCA2;HDAC9
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.40985567262045786,0.8538291769510197,0.7538461538461538,0.8948179428426054,1.0,6/35,14.26%,BLM;POLD1;CDK9;EME2;DONSON;TRAIP
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.34216137822481973,-0.8537796734423737,0.7045454545454546,1.0,1.0,15/74,16.71%,ARF5;DNAJC28;TMEM115;KIF4A;USE1;COPB2;KIF15;COPE;TMED2;TMED9;ARCN1;ARF4;ERGIC3;KDELR1;RAB1B
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3834515455537408,0.8534481228045653,0.7014925373134329,0.8951665376176909,1.0,11/57,20.43%,SMCR8;TNFAIP8L1;GNA12;GAS6;MAPKAPK5;TTI1;RFFL;TSC2;TELO2;RRAGD;RHEB
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.538591986173573,0.8531937878790916,0.6222222222222222,0.8953172753243152,1.0,1/7,14.96%,PUM1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.43212038991579993,0.8527024443064745,0.7719298245614035,0.8958751098143567,1.0,5/30,15.38%,ANXA1;CYP1B1;RNF112;PRKCD;MAP3K5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.5289510044106336,0.8524115478090378,0.6666666666666666,0.8960577460577229,1.0,1/6,8.06%,SLC9A1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.42147796919933794,0.8520707894304944,0.6727272727272727,0.8963409813085201,1.0,8/32,17.79%,LIMK2;YAP1;PARP9;CTNNA1;OTUD7B;MFHAS1;WWTR1;TFRC
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.5164559056503767,0.851909391984882,0.7454545454545455,0.8963179290650304,1.0,5/11,16.81%,TYMS;MTHFD2;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.38602624268307867,0.8518869828599853,0.6470588235294118,0.8960694257175724,1.0,14/65,16.31%,STMN2;SLIT2;SHANK3;SNCA;LDLR;SHANK1;SSH2;CYRIB;EML2;FGF13;PRKCD;CAMSAP3;STMN1;PFN2
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5025929420986325,0.8518314978894593,0.7241379310344828,0.8958814637167603,1.0,4/12,12.29%,PDGFRA;ALOX12;PDGFA;PRKCD
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.5306057587653368,-0.851708194456417,0.6382978723404256,1.0,1.0,2/7,8.25%,PTPN22;MICA
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.5248091465562045,0.8514579703492189,0.7254901960784313,0.8962166787169197,1.0,3/7,10.92%,GRID2;SHANK3;MAPT
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.3910608964944329,-0.8514061076165768,0.65,1.0,1.0,2/28,6.51%,MEOX2;SCPEP1
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.44076330643271755,-0.8513173122184075,0.6052631578947368,1.0,1.0,1/12,2.32%,HSD17B8
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.47270747335148716,0.8512145499812823,0.6666666666666666,0.896318384783114,1.0,3/12,9.40%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.48042388562077587,0.8511760656122953,0.6379310344827587,0.8960943432546735,1.0,3/15,15.19%,YTHDF1;RPS6KB2;EIF2B5
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3568860192832999,0.8510853101418345,0.7763157894736842,0.8959548603728764,1.0,15/108,14.29%,NLGN1;ZDHHC9;ZDHHC22;CACNG3;PARD3;MYO1C;TRAK1;MICALL1;ZDHHC7;ZDHHC1;NACAD;KIF13B;VPS37B;HAP1;MAN1A1
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.3855068023288964,-0.8507748524823945,0.627906976744186,1.0,1.0,10/36,11.41%,TRIM29;LEPR;ALDH1A1;TMC5;SCEL;TEKT1;ATP2C2;EHF;TFCP2L1;B3GNT3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.5046716971162272,-0.8504866101373003,0.723404255319149,1.0,1.0,1/12,0.79%,ID2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.43530281459776193,-0.8503817070718219,0.7027027027027027,1.0,1.0,3/22,15.08%,SNF8;VPS4B;RNF126
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5138912449253903,0.849510014163494,0.76,0.8982302857475832,1.0,3/12,11.54%,GLYATL2;OLAH;ACOT7
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.3156942297850268,-0.8492946621072535,0.8378378378378378,1.0,1.0,14/88,19.36%,CEP72;SSNA1;CETN2;HAUS1;CEP131;SCLT1;IQCB1;CEP83;DYNLL1;MKS1;CEP192;CEP78;FBF1;TUBB
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.46840123520613075,0.8491257307177247,0.7115384615384616,0.8986203677957598,1.0,5/14,26.48%,NRG1;MESP1;SORT1;KDM6B;MYEF2
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.46178266115188527,-0.8490278737252829,0.6428571428571429,1.0,1.0,1/12,6.62%,BCAP31
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.3993138087931389,-0.8490245818395507,0.7368421052631579,1.0,1.0,10/23,27.12%,PPP1R35;PPP1R11;ZCCHC9;BOD1L1;PTPA;PPP1R26;SH3RF2;GPATCH2;MASTL;STYXL1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.425772020555525,0.8489770410440223,0.7666666666666667,0.8985725211310309,1.0,6/33,16.61%,BLM;GADD45A;CDKN1A;RGR;TP53;RRH
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.45077964249598745,-0.8488069513981996,0.6511627906976745,1.0,1.0,7/11,21.42%,NT5E;NT5C;NUDT15;PNP;GPX1;ITPA;NT5C1A
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4907434953859781,-0.8487899177643154,0.6428571428571429,1.0,1.0,3/12,23.68%,TMED9;SNX2;SURF4
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.32389192306251924,-0.8485612082802022,0.7391304347826086,1.0,1.0,3/64,5.18%,NUP62CL;NXT2;NUP50
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.5437729876243318,0.8479868574496341,0.6862745098039216,0.8999376015243875,1.0,1/8,8.17%,OCIAD2
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5484331834467487,-0.8479729710566448,0.6666666666666666,1.0,1.0,1/7,5.99%,PRDM4
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.47638339516321593,0.8478571957720769,0.7285714285714285,0.8998572404222278,1.0,3/18,4.31%,FLT1;PLEK;PTPRC
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.526694959148812,-0.8478414986970156,0.6470588235294118,1.0,1.0,1/8,1.34%,HEY2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4285614835715303,-0.8476912890960071,0.7435897435897436,1.0,1.0,6/21,11.69%,RHOH;CR1;METTL3;CLPTM1;RUNX1;PRELID1
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3712668623044318,0.847658366322684,0.84,0.8999734818373804,1.0,16/83,16.11%,SPATA12;MARCHF11;CREB5;MAEL;DNAH3;HOOK1;NR6A1;MORN5;PLAAT5;TFAP2C;TSACC;SPATA20;ATL3;GSG1;SPATA18;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3468692936435866,0.8470861879569633,0.7761194029850746,0.9006550299594457,1.0,17/143,13.49%,IGF1;SH3GL2;APP;CCDC3;SMCR8;PGR;APLNR;LDLR;WDR54;YAP1;TGFB2;ITGB8;MAPT;PARP9;KLF4;OPTN;FGF2
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5351024343953155,0.846897794142896,0.6923076923076923,0.9006907531228469,1.0,2/6,12.75%,MYD88;USP50
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5057538523517799,0.8467653782948518,0.6842105263157895,0.9006142529885487,1.0,3/9,12.75%,MYD88;NLRC3;USP50
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5172764810213081,0.8467012484145569,0.6923076923076923,0.9004176319786791,1.0,1/8,6.65%,CDK9
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.4918434538169302,0.8466878602444275,0.6440677966101694,0.9001170296019112,1.0,3/12,19.87%,PLAAT3;LIPE;PEX7
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.49097700717876924,-0.8466612720896584,0.6666666666666666,1.0,1.0,3/7,14.10%,APOE;PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.4837527815822443,0.8462903372992995,0.7377049180327869,0.9005131604996547,1.0,6/15,17.73%,CD22;PRKCB;PRKCH;ELF1;GPS2;CBFB
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.42525820473332104,-0.8462208624496256,0.7391304347826086,1.0,1.0,2/18,12.29%,HAX1;HTRA2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3736576656210674,-0.8460599623155972,0.7407407407407407,1.0,1.0,9/59,20.20%,VAMP8;PSMD10;PSMD12;PSMB5;TAP1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.5505960598257424,0.8455055827065311,0.6851851851851852,0.9015773061987544,1.0,2/5,20.15%,CDK6;BMP6
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3835882592456496,0.8454434263410948,0.7903225806451613,0.901392626537174,1.0,8/49,10.51%,AMH;BMP8A;SCX;VSTM2A;SMAD3;TGFB2;RGMB;SMAD1
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.5258684328795576,-0.8448698826183733,0.6341463414634146,1.0,1.0,1/5,0.58%,KCNE1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.4486748217742018,0.8447903327108567,0.6833333333333333,0.902179825888681,1.0,10/22,21.56%,APP;DYSF;SNCA;SYK;MAPT;IFI35;SBNO2;CRTC3;NMI;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.48280131523150643,0.8445468565294613,0.6842105263157895,0.9022549139562668,1.0,5/14,13.90%,SERPINE1;ICAM1;PAK4;GAS6;TNIP2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.579859841424302,-0.84453047903895,0.7037037037037037,1.0,1.0,1/5,10.64%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.504195655488348,-0.8445230347449373,0.6428571428571429,1.0,1.0,2/9,13.38%,ASIP;CDH3
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.39891063910403524,0.8444954410973886,0.6666666666666666,0.9020382222694349,1.0,4/39,9.07%,ALS2CL;DNM1;HOOK1;PLEKHF1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.523414555841593,-0.844240355867727,0.7115384615384616,1.0,1.0,1/6,3.91%,SRI
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.5077206409896281,0.8442203930098052,0.7192982456140351,0.9022770999704485,1.0,3/7,29.59%,RIN3;PICALM;RAB5A
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5744776238693525,0.8439303091972242,0.72,0.9024758805668974,1.0,3/5,41.62%,ASH1L;SETD2;SETD5
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.49956220644024835,-0.8438125970312327,0.7804878048780488,1.0,1.0,1/10,1.00%,MADCAM1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4923667218734903,-0.8435210525622115,0.6875,1.0,1.0,2/9,13.37%,RIOX1;RIOX2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.37135328919245847,0.8432766190458937,0.671875,0.9032573948401446,1.0,2/67,2.21%,ANXA1;BLM
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.46483515578339474,0.8431857372293141,0.6610169491525424,0.9031045117797144,1.0,4/18,9.88%,MYLK3;OBSCN;SYNPO2L;TCAP
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.4966278176025242,0.8429305296965663,0.7115384615384616,0.9032070632209007,1.0,3/10,19.79%,ATP23;STOML2;PMPCB
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.5541989704639827,0.8429127657525256,0.6981132075471698,0.9029346538498768,1.0,1/5,12.46%,SLC29A4
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4197906931780242,0.8418731416290736,0.6825396825396826,0.9044206360504932,1.0,6/23,20.26%,SLC7A2;SLC25A29;SLC7A1;SLC1A6;SLC7A8;SLC6A9
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.40608367709549936,0.8417478796779768,0.6101694915254238,0.9043114079933665,1.0,5/24,21.84%,RHBDF1;RHBDF2;NDFIP2;PPM1F;DNAJC1
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.518329162643336,0.8415856874293247,0.7037037037037037,0.9042301427433362,1.0,1/9,2.65%,DMTN
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.41772005073104534,0.8414395359198189,0.7450980392156863,0.9041608807063807,1.0,6/25,13.58%,GRIN2A;C1RL;C1R;MMP14;PGK1;FADD
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3928786479573496,0.8403739464195102,0.6774193548387096,0.9055210245788794,1.0,5/49,11.38%,PRKCG;DAB2IP;RHBDF1;GNA12;OPHN1
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.5566992541991789,0.8403393946168516,0.8035714285714286,0.9052802280339786,1.0,1/5,1.69%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.39504034114770387,0.8402604913520848,0.7571428571428571,0.9050913181023132,1.0,22/56,27.85%,PLK2;BLM;FSD1;BCL2L1;TLE6;CALM3;PLK3;RAB11A;RAB11FIP4;PRPF40A;MLLT3;KIF13A;KLHL21;PIN1;TXNIP;CSPP1;RAB11FIP3;SH3GLB1;NLRP5;HTR2B;UVRAG;CDK2AP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.344478750245211,-0.8402302268148863,0.7142857142857143,1.0,1.0,1/77,0.09%,NGF
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49529492908238865,0.8400791954592041,0.6481481481481481,0.9051173195138976,1.0,5/10,16.58%,BAIAP3;TRPM4;HLA-DRB1;STX4;C2CD2L
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4900442995090034,0.8393656222233155,0.7090909090909091,0.9059703431954673,1.0,2/11,19.68%,BARD1;AHCYL1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.4025263180581339,0.8389893894382227,0.7205882352941176,0.906306067729885,1.0,10/41,15.22%,CD24;EFNA1;TJP3;EPS8L2;CCKBR;CAPN8;GPRC5C;ALPL;SPP1;SLC44A3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.33687352008610527,0.8388393980003818,0.8571428571428571,0.9062561390063016,1.0,13/89,12.48%,ST6GAL1;PLAAT4;MTHFD2;ACOT4;PLAAT3;ALDH1L1;SHMT1;ABCA2;DBI;ACOT7;ABCB9;PLAAT5;ACSM5
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4747691385311643,0.8387462175045792,0.7222222222222222,0.9061029678984486,1.0,2/12,7.56%,TPST1;SULT4A1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.5244551113285825,0.8385782940970627,0.6379310344827587,0.9060491699870176,1.0,3/7,21.12%,TRPM4;GPR183;TRPM2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5195601244005627,0.8385632954558545,0.6730769230769231,0.9057691474744521,1.0,2/7,14.71%,PTPRC;HLA-E
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3523280301126708,0.83844441375505,0.7428571428571429,0.9056321662860982,1.0,34/122,23.94%,CCNB2;ABCB1;HAUS7;YWHAG;PPP1CB;ACTR1A;TPD52L1;AKAP8;CDKN1A;OPTN;LCMT1;NEDD1;CDK2;CDC25B;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;PLK3;DNM2;CDK5RAP2;PPME1;CCNA2;FBXL8;CEP76;TUBA4A;PRKAR2B;TUBB4A;DCTN3;ARPP19;CEP70;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.4955167269706997,0.8384202353656832,0.703125,0.9050848600084496,1.0,5/9,26.94%,MAP1LC3A;GABARAPL1;ATG7;GABARAPL2;ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.4955167269706997,0.8384202353656832,0.703125,0.9050848600084496,1.0,5/9,26.94%,MAP1LC3A;GABARAPL1;ATG7;GABARAPL2;ATG5
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.5834242883379351,0.8383121588159874,0.7407407407407407,0.9049641022815967,1.0,1/6,18.61%,RAMP1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.3600432246001836,-0.8382063203878323,0.7045454545454546,1.0,1.0,8/42,12.85%,ERCC8;GTF2H2;DCT;ERCC2;USF1;PRIMPOL;FECH;ERCC6
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3952134850736476,0.8378997775303741,0.734375,0.9053467062251663,1.0,8/32,21.12%,GLRA2;SYVN1;GLRA3;RCN3;UBXN6;RNF185;MARCHF6;TRPM2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.4083233793290536,0.8376722722412143,0.676056338028169,0.9054557095531649,1.0,9/29,17.57%,APP;NLRP12;MYD88;STAT3;GSDMD;USP50;NLRP2;P2RX7;WNT5A
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.38178295639338905,0.8376317814848259,0.7428571428571429,0.9052121830841913,1.0,14/45,22.28%,CORO7;WAS;WASF1;FAM107A;ENAH;COBL;SPIRE1;SPIRE2;MICALL2;DSTN;CAPG;WDR1;PREX1;MICAL1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.31313155989461394,-0.837559049450372,0.8823529411764706,1.0,1.0,47/191,23.41%,TFB2M;BRF2;GTF2H5;POLR2K;ELOC;BTF3;GTF2H2;ELOA;TAF13;SUPT16H;HSF1;RRAGC;ERCC2;GTF2A2;TAF11;POLR2C;ERCC6;CCNT1;GTF2F1;NFKBIB;SLC25A33;POLR2D;RBMX;MLF1;THAP1;TEFM;GTF2F2;MTERF1;DDX21;POLR3H;ERCC3;GTF3A;POLR3K;TTF1;TAF5L;SMARCA5;POLR2L;POLR2G;RO60;TAF12;PARP1;PWP1;TBPL1;POLR2E;GTF2H3;GTF3C6;EAF1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.39988179173111027,0.8371791773458566,0.7571428571428571,0.9057051683931265,1.0,6/42,12.81%,GRM5;CDK9;PML;PPP1R16B;ABCA2;FN1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.35566423589052054,0.8369143596074076,0.7833333333333333,0.9058060274601231,1.0,11/70,17.85%,SLC39A14;IRS2;FOXO1;RAB15;PPARG;SORBS1;HDAC9;CPEB2;SYAP1;LPIN3;RHOQ
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.5506441230409831,0.8368999005585535,0.7254901960784313,0.9055230658972231,1.0,2/6,16.70%,SPIRE1;SPIRE2
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.536724230799727,-0.8361977897992642,0.72,1.0,1.0,2/6,4.36%,SELENOS;APOE
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.4628336303178914,0.8361150248438415,0.7169811320754716,0.906604732827581,1.0,2/14,7.88%,ABCA8;LDLR
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.46769942932242037,0.8358256686072201,0.7358490566037735,0.9067605404403033,1.0,3/13,9.40%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5712423260636382,0.8358161859289641,0.75,0.9064696390975047,1.0,1/5,10.92%,MAPT
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.3883203842498649,0.8357064471132594,0.7049180327868853,0.9063725278445156,1.0,9/34,13.97%,ANXA1;WDR62;GCM2;CDK6;TRAK1;TGFB2;MAPT;LPAR1;HAP1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.43875852537579835,0.8355398785650076,0.7543859649122807,0.9063426249094453,1.0,5/31,3.00%,GRIK1;NLGN1;GRIK2;GRID2;RELN
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.49434918991711035,0.835236034416134,0.7636363636363637,0.906541743378154,1.0,2/10,10.44%,SLIT2;EPHA4
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.43655224541579696,-0.8351877611834408,0.6222222222222222,1.0,1.0,2/12,10.82%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5505410373185977,0.8349831702307877,0.6774193548387096,0.9066381074622315,1.0,2/5,31.91%,LRP1;HIP1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.45841429931658667,-0.8349177245798685,0.7272727272727273,1.0,1.0,2/8,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.4214875925596346,-0.8345007300226092,0.6808510638297872,1.0,1.0,3/12,9.35%,ABCD1;ELOVL4;ELOVL2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.4294219132832652,-0.8341125122760693,0.6190476190476191,1.0,1.0,4/22,13.28%,MID1IP1;TRIB3;ADIPOR1;ERLIN2
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.5107624614958106,0.8340140972240092,0.6481481481481481,0.908064097672644,1.0,3/6,33.62%,PLK3;STX5;PLK5
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.3963768213772016,0.8338266354373604,0.7288135593220338,0.9080691701118447,1.0,6/25,12.68%,APOD;ADCY7;MYD88;NLRC3;STAT3;PER1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5750042485768933,0.8337988450062433,0.7413793103448276,0.9077982263676442,1.0,3/7,6.44%,THY1;SKAP1;CD44
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.3815276713003262,0.8336507581290211,0.6833333333333333,0.9077955005097822,1.0,7/35,9.88%,TBX19;TBX20;ALPK2;RYR2;SYNPO2L;TGFB2;TCAP
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5599882221962008,0.8336249210507262,0.7457627118644068,0.9075405899154158,1.0,2/6,9.25%,PRKCB;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.518308640718479,0.8334625029519196,0.660377358490566,0.9075221951933797,1.0,3/7,28.59%,CCNB1;RAD18;SMC5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5171509866799386,0.8334581043408213,0.7454545454545455,0.9072242293953289,1.0,7/11,22.60%,SMAD3;TGFB2;ITGB8;FN1;CD200;HIF1A;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.489977756685925,-0.8332518645654762,0.6341463414634146,1.0,1.0,1/11,6.62%,BCAP31
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.33261401348246444,-0.8332254135503461,0.7222222222222222,1.0,1.0,11/92,13.73%,FIP1L1;AAAS;RBM8A;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.566937350615506,0.8332075721321528,0.7333333333333333,0.9064354671844348,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.566937350615506,0.8332075721321528,0.7333333333333333,0.9064354671844348,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.566937350615506,0.8332075721321528,0.7333333333333333,0.9064354671844348,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.566937350615506,0.8332075721321528,0.7333333333333333,0.9064354671844348,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.5086699713213396,0.8329591833323468,0.7166666666666667,0.9065039637372656,1.0,4/8,17.57%,SYK;NOXA1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5058082775667553,0.8329407278517338,0.75,0.9062265792996091,1.0,6/13,23.31%,PRKAR1B;PKIA;PRKAR1A;ATP2B4;PRKAR2B;PKIG
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.5342278538631694,-0.8329230012483508,0.6363636363636364,1.0,1.0,2/6,8.94%,TTPA;CPTP
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.38338068239882794,0.832904489588079,0.7692307692307693,0.906004380011775,1.0,7/47,11.92%,SLC39A14;IRS2;APOD;ALDOB;PGK1;FBP1;ENO2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.5556282727170969,0.8327827192250321,0.7608695652173914,0.905915857768124,1.0,1/7,2.45%,NELL1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.44779262361477046,-0.8323919489576488,0.6666666666666666,1.0,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.4336500934163835,0.832319013387496,0.6885245901639344,0.9063338532196938,1.0,8/21,27.34%,VLDLR;SMURF1;CLTC;AP2A2;SH3GLB1;KIF16B;NEDD4;UVRAG
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.4963141027014769,0.8320677215086784,0.7049180327868853,0.9064729151716459,1.0,4/13,9.88%,PDGFRA;PKDCC;TGFB2;GLI2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3611122221768127,-0.8319674860181039,0.7941176470588235,1.0,1.0,3/40,5.08%,GMFG;EPOR;MSRB1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3461776300243718,-0.8318645499871311,0.8,1.0,1.0,9/81,12.07%,FTL;VAMP8;FTH1;BLOC1S4;CCDC22;GOPC;DOP1B;AP1B1;LLGL1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.5535798692853319,0.831698050012171,0.7833333333333333,0.9068080567353753,1.0,3/6,24.42%,AHCYL1;PACS2;VMP1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.35297151769396473,0.8312671441084281,0.7910447761194029,0.9072449517382846,1.0,34/121,23.94%,CCNB2;ABCB1;HAUS7;YWHAG;PPP1CB;ACTR1A;TPD52L1;CDKN1A;OPTN;LCMT1;BACH1;NEDD1;CDK2;CDC25B;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;PLK3;DNM2;CDK5RAP2;PPME1;CCNA2;FBXL8;CEP76;TUBA4A;PRKAR2B;TUBB4A;DCTN3;ARPP19;CEP70;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.4817793436536878,0.8311101869578117,0.6607142857142857,0.9071836110392711,1.0,1/9,0.90%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.4030898051733538,0.8310223394610566,0.671875,0.9070008052699146,1.0,6/29,14.26%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.48108941283194856,-0.8309712581776338,0.723404255319149,1.0,1.0,5/9,28.83%,DERL2;YOD1;ERLEC1;SVIP;OS9
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.41125127032266556,0.830577033795171,0.7692307692307693,0.9074058566834275,1.0,6/32,10.51%,CACNA1G;NRG1;TBX20;MSX2;TCAP;SMAD1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.48278606579645855,-0.8305535935824673,0.7878787878787878,1.0,1.0,2/14,17.87%,EXOSC4;LSM1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.42733911486968446,0.8304131664709993,0.6875,0.9073445236340345,1.0,9/29,26.78%,RBM24;VIP;NOCT;TAF15;AXIN2;PARN;FUS;MEIOC;TENT5D
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.5294334221890986,0.8303273648041628,0.734375,0.9071814242940449,1.0,5/7,34.75%,KYAT1;CYP2E1;KMO;KYAT3;KYNU
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4350166875477766,0.8301799756922527,0.6779661016949152,0.9071671782729325,1.0,7/29,22.96%,TNFAIP8L1;MAPKAPK5;RNF152;STK11;TSC2;SPAAR;SESN1
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.5339394798684248,0.8297426522961658,0.7333333333333333,0.9075872913216039,1.0,1/6,7.41%,TCP1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.5077226833841433,0.8296635403948942,0.6714285714285714,0.9074008028516792,1.0,1/8,4.20%,GLYATL2
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.542538916061682,-0.8295356122187895,0.6976744186046512,1.0,1.0,1/5,6.81%,MST1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.5118349227196187,-0.8295314660172597,0.6923076923076923,1.0,1.0,3/6,32.20%,PLA2G4A;HADHA;PLA2G5
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.48740522419450016,-0.8294856591753328,0.5909090909090909,1.0,1.0,2/9,8.23%,GREM1;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.5224842775222402,-0.8290679338748088,0.7142857142857143,1.0,1.0,1/5,1.69%,CD200R1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.47312989490508855,0.8289116440697336,0.6909090909090909,0.9083797589936662,1.0,7/12,28.56%,ADAM19;ABCG1;ADAM17;PSEN1;DYRK1A;APH1B;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3160391614710881,-0.8288078849488439,0.7941176470588235,1.0,1.0,10/113,8.10%,RAB7B;AR;AGER;TRIM21;RNF25;TRIM52;BCL10;TRIM68;HSPA1A;DHX33
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.40586662470049006,-0.8287716598965368,0.6744186046511628,1.0,1.0,2/27,5.01%,TPX2;TPPP3
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.44681591260984227,0.828738953053857,0.7258064516129032,0.9083885911386372,1.0,3/18,7.18%,PDGFRA;TBX20;RYR2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.5009721695262956,0.828309586864642,0.6727272727272727,0.9087686672353154,1.0,3/7,30.22%,CALM3;JPH2;AKAP6
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.46719532815893106,-0.828251003275863,0.7777777777777778,1.0,1.0,1/12,1.81%,COX18
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3649317304181733,0.8281675952721091,0.8208955223880597,0.9087422057734198,1.0,22/76,24.09%,SNCB;SOX4;PRODH;SNCA;DCC;RAMP3;DHCR24;NPAS2;CDKN1B;FGF2;CTSZ;RILPL1;RAD18;PACRG;ACER3;RRAS2;TBK1;AXIN2;PRKN;PARP16;EIF4G1;CCN4
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.4435416750312697,0.8280029085448773,0.7090909090909091,0.9086845192613433,1.0,2/23,3.38%,APP;TRAM1L1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3597848566563722,0.8278800391787116,0.7945205479452054,0.9085683104139216,1.0,10/63,19.12%,GOLGA8O;MAPRE2;HAUS7;GOLGA8A;KIFC2;NEK6;NCOR1;FLNA;RAB11A;TUBGCP6
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.3683846390656014,0.8278600387416852,0.7123287671232876,0.9083038741283499,1.0,4/61,8.22%,ST6GAL1;MGAT3;TUSC3;MGAT5
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.39051995311924126,0.8277040233382175,0.703125,0.9082815022001417,1.0,4/41,6.02%,ADCY5;EPHA5;TRIM46;DVL1
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),0.5609632382281919,0.8276986739243033,0.7547169811320755,0.9079900335050198,1.0,1/5,17.95%,STK24
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.5145835434714419,-0.8273976396867115,0.7209302325581395,1.0,1.0,3/7,11.53%,SELENOS;TMEM106A;CD47
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5484782637089844,0.8270875248626988,0.7142857142857143,0.9087163650633088,1.0,2/5,4.49%,WAS;TRPM4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.31647919062913826,-0.8261531774655883,0.8214285714285714,1.0,1.0,15/112,17.85%,ID2;PMVK;TM7SF2;APOE;NR1D1;ADIPOR1;SC5D;PSMD10;PSMD12;PSMB5;DHCR7;PSMB6;NQO1;TGS1;PSME3
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.39969467160333816,-0.8258969411818562,0.7045454545454546,1.0,1.0,2/22,3.26%,ATP10B;RFT1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5759375464412595,0.8255910976310262,0.8095238095238095,0.91065073679937,1.0,2/5,3.05%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.5759375464412595,0.8255910976310262,0.8095238095238095,0.91065073679937,1.0,2/5,3.05%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.5407301819516669,0.8252454607726114,0.7407407407407407,0.9107678506303156,1.0,3/6,18.85%,GRK2;GRK5;TAC4
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.4322097303797471,0.8249569815505295,0.7,0.9109939124702793,1.0,4/20,6.91%,EGF;THBS1;APP;SNCA
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.5113343601827476,-0.8248022568535225,0.7142857142857143,1.0,1.0,2/5,11.31%,PTPN22;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.5475995203767042,0.8244769321615049,0.7166666666666667,0.9115156534787824,1.0,3/6,38.12%,ACVR1B;VEGFA;SMURF2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.584908637997501,0.8239593314601997,0.7446808510638298,0.9120798545749786,1.0,2/5,18.35%,LSM11;ZNF473
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3076682810084125,-0.8236158547874056,0.8709677419354839,1.0,1.0,14/83,20.20%,FBXO48;DMAC2;FBXO27;FBXL22;PSMD10;PSMD12;PSMB5;FBXO9;PSMB6;PSME3;PSMD2;CUL1;SKP2;PSMB4
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.5099145331421844,-0.8234160737279047,0.6862745098039216,1.0,1.0,2/5,16.53%,SLC25A23;LETM1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.509250264089067,0.8232584324981966,0.7017543859649122,0.9129432081783286,1.0,1/8,9.80%,AK5
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.32911628314780034,-0.8229486042100941,0.71875,1.0,1.0,4/75,2.45%,ATF5;CEP72;TPX2;SSNA1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.5198703601971156,-0.822731618059907,0.6875,1.0,1.0,1/6,13.94%,MPI
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.42972702890920633,0.8225623649611078,0.6612903225806451,0.9138293263448555,1.0,7/24,11.71%,IL13RA1;CD24;ICAM1;GPR87;LAMA5;DUOXA1;CCL2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.40336568912439985,-0.8224219609738999,0.7317073170731707,1.0,1.0,11/19,30.29%,AUP1;RNF5;RNF126;POMT2;ATXN3;VCP;DERL1;DNAJB12;DNAJC18;DNAJB14;UGGT1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.42646010081945873,0.8223010902985327,0.7,0.913921841387608,1.0,4/25,10.69%,PLEK;PDGFA;KIF17;P2RY12
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.5117234568714262,-0.8222216147021213,0.673469387755102,1.0,1.0,1/6,23.33%,RPUSD4
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.47968030621875146,0.8220524285372003,0.7115384615384616,0.9139521183705678,1.0,2/12,7.26%,GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4925815925042091,0.8218469047999161,0.7333333333333333,0.9139474122192182,1.0,4/9,29.22%,ZFYVE28;CBL;ERRFI1;TSG101
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.5068845406746532,-0.8213045666741278,0.7647058823529411,1.0,1.0,2/10,9.68%,HSD17B6;SRD5A1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.3579830663810948,0.8213011822428299,0.875,0.9145213554589317,1.0,7/47,11.17%,CD24;ABCA5;FABP3;SOAT1;LDLR;ABCA2;HDAC9
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.3578518125317758,-0.8211674635428375,0.7567567567567568,1.0,1.0,4/31,13.67%,MTIF2;MTIF3;UFL1;TEX264
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.34425844084340645,0.820830075324503,0.8142857142857143,0.9150638641507604,1.0,18/112,15.14%,B3GNT2;MGAT3;TUSC3;B3GALT2;ST8SIA3;ST8SIA1;MGAT5;TRAK1;B3GALNT1;ST8SIA4;B4GALT7;POMGNT1;B4GALT5;FUT2;PLOD2;POMGNT2;ST6GALNAC2;LARGE1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.47701739537896287,0.8207726666891274,0.7288135593220338,0.9148337009535139,1.0,9/17,35.55%,USP6NL;CAMSAP3;MAPK3;PDCD10;MAP2K1;STX5;CAMSAP2;STX18;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.47686357114524625,0.8207249275065944,0.7377049180327869,0.9146192074879639,1.0,1/10,2.58%,PLEK
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5464057591237506,0.8207082798847704,0.7272727272727273,0.9143544348302923,1.0,1/5,4.20%,GLYATL2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.368432122538676,0.8200253086793519,0.7761194029850746,0.915218092688462,1.0,8/73,7.53%,HTR2C;SLC24A2;VAPB;SLC39A14;ATP2B3;GCM2;RYR2;NPTN
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4196953351997636,0.820012928710043,0.7407407407407407,0.9149377937161551,1.0,2/24,3.44%,IRAK2;NOD1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.47978049923975796,-0.8192849497987512,0.717391304347826,1.0,1.0,3/8,17.99%,VPS11;CNOT1;CNOT9
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.38098434687046656,0.8190844008977877,0.7538461538461538,0.9160951673846702,1.0,10/53,12.00%,PROX1;MYO1F;PLEK;WAS;ACHE;ALOX12;SYP;PPARG;FLI1;PILRA
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.40859063095202475,0.8188992022140178,0.76,0.9160626602721227,1.0,4/20,13.91%,TRIM5;PML;VPS37B;TRIM32
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.41599819159584484,-0.8188885953950421,0.6578947368421053,1.0,1.0,3/15,16.59%,LY96;BECN1;KLRG1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.4642224162745723,0.8185567729498691,0.6721311475409836,0.9159473890036623,1.0,7/11,27.16%,RAP2B;MINK1;RAP1A;RAP1B;MAP4K4;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.4642224162745723,0.8185567729498691,0.6721311475409836,0.9159473890036623,1.0,7/11,27.16%,RAP2B;MINK1;RAP1A;RAP1B;MAP4K4;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.4877467414352812,-0.8185196901999379,0.7021276595744681,1.0,1.0,2/8,12.24%,MIS12;CENPA
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.4686162049534327,0.8184398972798155,0.75,0.915825962033614,1.0,6/14,37.63%,RTN4;GBP1;SH3GLB1;CD81;KPTN;SH3BP4
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.5372158496518566,0.8178221566070377,0.6862745098039216,0.9164241187292356,1.0,2/5,16.77%,SMAD3;SLC8A1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.4852182430856132,0.8174312703357677,0.7962962962962963,0.9167666600292111,1.0,3/12,18.77%,IHO1;PUM1;RAD18
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3789045858207047,0.8173725942708638,0.734375,0.9165793662739207,1.0,8/41,16.10%,SLC16A14;SLCO1A2;SLCO2A1;SLC51A;SLC27A5;ABCC4;RXRA;SLCO3A1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.41539717542839105,0.81717477886642,0.6923076923076923,0.9165429108573069,1.0,7/23,20.32%,IRAK2;NOD1;IKBKG;IFIH1;TAB1;RPS27A;TAB2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.41802434959906154,0.8171564188475975,0.7241379310344828,0.9162592310642761,1.0,1/19,3.97%,PTPRR
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3102337731997792,-0.8171247530847916,0.875,1.0,1.0,22/111,20.26%,CSDC2;EXOSC8;EXOSC4;HSPA1A;VIM;EXOSC5;IGF2BP3;PSMD10;PSMD12;CNOT7;PSMB5;CNOT1;PSMB6;RC3H1;ZFP36L2;PSME3;APEX1;PSMD2;UBB;PCBP4;PSMB4;DIS3
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.45622425266810407,0.8170243980840435,0.6730769230769231,0.9162229038845444,1.0,4/14,19.14%,CTNNB1;HDAC4;ZMIZ1;PIAS1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.4751263591939331,0.8167031557440262,0.6964285714285714,0.9164182443595822,1.0,2/12,12.13%,BLM;DONSON
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.29435171644116237,-0.8164202763176263,0.9090909090909091,1.0,1.0,13/129,9.85%,G0S2;REEP6;ERP29;CEL;CBR3;RETSAT;ALDH1A1;BLVRA;KMT5A;ACOT2;TDO2;ECH1;GCDH
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.4787950665835306,0.8162934228320682,0.7115384615384616,0.916733101141397,1.0,3/10,18.73%,SMAD3;SMAD1;SMAD2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.36107696082737045,-0.8162259998717655,0.7714285714285715,1.0,1.0,4/41,4.78%,FTL;SELENOS;PRDX1;NDUFB4
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.5205573233550048,0.8159625387116056,0.6825396825396826,0.916912715116038,1.0,4/7,9.86%,SOX4;TBX20;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.3588050538064971,0.8158408088678767,0.8636363636363636,0.9168029401376306,1.0,16/62,14.71%,TLR2;SERPINE1;SFTPD;COLEC12;NOD1;TNFRSF14;MYD88;LYG1;TF;SYK;GSDMD;PRKCD;OPTN;LYG2;IL12A;HLA-E
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4530222549790931,0.8150480385018202,0.7543859649122807,0.9175279441312532,1.0,1/16,3.45%,ADD2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4530222549790931,0.8150480385018202,0.7543859649122807,0.9175279441312532,1.0,1/16,3.45%,ADD2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5103692962838696,0.8149926975332443,0.7166666666666667,0.9173217462816224,1.0,3/6,38.08%,MAPK3;MAPK1;TRIM27
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.32147658042425126,0.8149312483125731,0.8591549295774648,0.9171310903847122,1.0,20/146,19.41%,RECQL4;BLM;RPA1;SAMHD1;BAP1;ATP23;EME2;PARP9;BARD1;POLQ;IFFO1;MRE11;ZSWIM7;XRCC1;BRCA1;MEIOB;HPF1;UBXN1;MTA1;MORF4L1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.35709308956398317,-0.8149288215972774,0.8095238095238095,1.0,1.0,8/53,8.97%,CEL;PMVK;TM7SF2;APOE;SCARF1;ARV1;GBA2;CYP46A1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.35738000475763765,0.8148619498773978,0.7727272727272727,0.9169521105875262,1.0,12/61,13.31%,EPHA7;THBS1;RPS6KA1;NOD1;NLRP12;CD44;SNCA;DHCR24;SYK;GAS6;KLF4;NLRP2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.400495939883879,-0.8148016455945815,0.8,1.0,1.0,2/19,5.59%,SRI;SELENON
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.36943616782917044,0.8147728224361889,0.8285714285714286,0.9168040426633862,1.0,7/63,7.99%,ACSL5;AWAT1;GLYATL2;ALOX12;FAAH;CYP1B1;ACOT4
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.40440634679610044,0.8145822975758861,0.7586206896551724,0.9167830610013359,1.0,10/30,24.83%,STEAP3;TF;TFRC;DNM2;ATP6V1B2;LMTK2;CLTC;ATP6V1C1;ATP6V1C2;ARHGAP1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3830195616591003,0.8144167516706305,0.8333333333333334,0.9167428583227311,1.0,4/39,16.18%,SUN3;CHMP1A;BIN1;IRAG2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.38597067487256653,-0.8144135350851959,0.8372093023255814,1.0,1.0,4/26,9.66%,GTF2H5;GTF2H2;CETN2;ERCC2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.508027567087097,-0.8142723061447156,0.6923076923076923,1.0,1.0,1/5,15.29%,LYPLA2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.44231788540283223,-0.8139989567045615,0.7435897435897436,1.0,1.0,1/12,9.26%,ACVR1C
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.43965948868338134,-0.8137894009939564,0.7073170731707317,1.0,1.0,2/11,16.63%,GOPC;NFKBIE
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5183098500413654,-0.8133278371336169,0.7045454545454546,1.0,1.0,4/7,14.17%,ABCB10;SLC25A37;EIF2AK1;LDB1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.5098357792757736,0.8132995152018747,0.7037037037037037,0.918325559167197,1.0,1/9,0.65%,MYRF
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3991151234339255,0.8132926023739302,0.7096774193548387,0.9180388379783667,1.0,6/31,14.26%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.5149573381177588,0.8128580072129047,0.7142857142857143,0.918394114674791,1.0,1/8,8.12%,CTNNB1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3734109123864816,0.8128379661888967,0.782608695652174,0.9181190831664632,1.0,11/64,19.55%,IGF1;APP;HDAC4;FBP1;MLXIPL;GCKR;PFKFB3;P2RX7;NCOR1;HIF1A;ARNT
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.4419306439273081,-0.8125879957720906,0.6923076923076923,1.0,1.0,1/11,1.03%,NIPAL1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.37859282879246825,-0.8125140139237522,0.6818181818181818,1.0,1.0,7/29,11.55%,HEY2;HES6;HEYL;ASCL1;HEY1;BHLHE41;HES5
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33808681761312476,0.811468905365922,0.7323943661971831,0.9200411047533927,1.0,14/103,18.24%,PLK2;WDR62;INCENP;CENPP;ERCC6L;CENPH;RANGAP1;NEK6;STMN1;MAP4;DYNC1LI2;SKA2;CCNB1;CKAP5
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.35617272507698955,0.8111276579125064,0.8208955223880597,0.9202994001805396,1.0,3/63,5.54%,CTSC;CTSS;FAP
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.38543525311954663,0.81094105627432,0.7333333333333333,0.9202965305570897,1.0,9/36,18.02%,PID1;BCL2L1;SLC4A11;MAPT;BCL2;STOML2;HEBP2;PINK1;RNF122
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.5246988123813355,0.810693687421344,0.74,0.9204356301299439,1.0,3/6,12.33%,SFTPD;CCL2;TAFA4
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.34786038457653506,-0.8105961190098392,0.7804878048780488,1.0,1.0,5/62,7.42%,ERCC8;TRIM21;ASB4;TRIM52;TRIM68
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.36445407969473165,0.8105248857948838,0.8382352941176471,0.9203598396997847,1.0,7/69,10.41%,PLEK;DAB2IP;NRG1;SYNPO2L;SMAD3;TPPP;SYK
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.42577691002849094,-0.8097860384940865,0.74,1.0,1.0,2/17,1.69%,MADCAM1;CD200R1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.5344034731923373,0.8092138422074926,0.8032786885245902,0.9222588499826224,1.0,1/5,11.20%,FGF13
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.4569063285321583,0.809173309418041,0.7301587301587301,0.9220023565301604,1.0,6/14,23.95%,THY1;CD160;PTPRJ;DGKZ;GBP1;PRNP
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.39133983931283434,-0.8089592608644685,0.8,1.0,1.0,4/20,11.63%,ABCB11;OSBPL3;CYP46A1;CYP7B1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.5771163007873928,0.808865362240221,0.8113207547169812,0.9221675476599925,1.0,2/5,10.69%,FLI1;P2RY12
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3268635637591861,0.8083394818435352,0.8714285714285714,0.9227118757596503,1.0,10/153,11.67%,ANK3;CTSC;VAPB;CD55;TGFA;TMED10;GRIA1;ERGIC1;GAS6;ACTR1A
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3364773140494186,-0.8082764512227033,0.78125,1.0,1.0,4/50,5.53%,AAAS;RAE1;NUP50;RNF212
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.37056907274252493,-0.8079830989076789,0.7878787878787878,1.0,1.0,6/43,9.26%,TTC29;CFAP53;ADCY10;TEKT5;SPAG17;TEKT1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.5575899757937754,-0.8078446303951975,0.7884615384615384,1.0,1.0,1/5,10.15%,USF1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.46368045722112883,-0.8077266797997671,0.68,1.0,1.0,2/8,6.01%,APOE;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.36194008503474207,-0.8072384047077079,0.7222222222222222,1.0,1.0,4/32,8.40%,CFTR;SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.5450112204260587,-0.806929016740681,0.7692307692307693,1.0,1.0,1/6,1.74%,VAMP8
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5020154162200493,0.8065243706527366,0.7454545454545455,0.9250365724297787,1.0,5/10,23.29%,SMAD3;SMAD2;HJV;ACVR1B;ACVR1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.4401543436267052,-0.8062036742859654,0.6470588235294118,1.0,1.0,4/15,11.37%,CD320;PRSS3;MMAB;MMACHC
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.4401543436267052,-0.8062036742859654,0.6470588235294118,1.0,1.0,4/15,11.37%,CD320;PRSS3;MMAB;MMACHC
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.48030655317294674,-0.8057763029621904,0.7,1.0,1.0,3/6,26.93%,AQP6;AQP1;CA2
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5064833830443236,0.805728723488747,0.7254901960784313,0.9260849519991625,1.0,1/8,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3875885283259034,0.8051622437471243,0.7301587301587301,0.9267040262147003,1.0,9/39,14.31%,SIX3;CACNA1C;SH3PXD2B;PBX3;TGFB2;HIPK1;MEIS3;COL5A1;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.5221902957188933,-0.804931628931164,0.6511627906976745,1.0,1.0,1/6,11.55%,HES5
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.5221902957188933,-0.804931628931164,0.6511627906976745,1.0,1.0,1/6,11.55%,HES5
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3901231422217287,-0.8043675612915098,0.7777777777777778,1.0,1.0,3/30,7.68%,RAB7B;HSPA1A;ABCB10
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4055157113006742,0.8038742491702164,0.8305084745762712,0.9284283546831825,1.0,3/38,5.50%,ZFP36;ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.46796565789570377,0.8037368624867103,0.7192982456140351,0.9283616758549866,1.0,3/11,20.94%,SHMT1;CRAT;CPT1C
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.37699761192562453,-0.8036883825243455,0.7045454545454546,1.0,1.0,6/28,11.31%,APOE;RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.3373401432676895,0.8034872381960326,0.8382352941176471,0.9284365030309923,1.0,17/104,15.53%,VRK2;PDGFRA;MGAT3;FOXO1;FOXO3;SNCA;SLC4A11;MAPT;PXN;STX4;PRKCD;AGAP3;CPEB2;MSRA;NOX4;TP53;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.440329194950874,-0.8033531771394976,0.717948717948718,1.0,1.0,1/9,4.53%,RGCC
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4249295204569861,0.8032322124361567,0.6666666666666666,0.9285227481483626,1.0,6/18,21.14%,ST8SIA3;ST8SIA1;ST8SIA4;MAN1A1;MGAT4A;FUT8
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4618227508899262,-0.8032241334736511,0.8333333333333334,1.0,1.0,1/11,1.47%,ADAMTS18
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.3894119343448148,-0.802246881223515,0.6818181818181818,1.0,1.0,2/22,8.40%,HSPA1A;VPS4B
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4568901236956828,0.8021964696576448,0.7321428571428571,0.9298430734882634,1.0,1/12,0.33%,CXCL2
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.3943960867339948,-0.8018102188218328,0.6153846153846154,1.0,1.0,10/19,31.94%,TTPA;LRAT;CYP4F12;VKORC1L1;CUBN;RBP1;LGMN;GC;RLBP1;UBIAD1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.3610711602379201,-0.8017317364976606,0.85,1.0,1.0,1/27,0.79%,ID2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.4988129576941259,-0.8016345156443717,0.7636363636363637,1.0,1.0,3/8,30.90%,AGA;NGLY1;ENGASE
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3483938106840021,0.8016111063804243,0.8923076923076924,0.9304253598293073,1.0,8/95,6.91%,CCNB2;BLM;DAB2IP;THY1;INCENP;CCNI2;CDK5R2;SNCA
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.5391005796591292,0.8015767734767989,0.7611940298507462,0.9301672248967107,1.0,1/5,11.48%,KYAT1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.4356659914847691,0.8013890659482306,0.6842105263157895,0.9301573717042927,1.0,1/10,2.82%,KCNQ1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3418394380791036,0.8012537533807066,0.7794117647058824,0.9294528662931383,1.0,14/82,23.72%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;IKBKG;TAB1;SKP1;MUCL1;TAB2;CARD11;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3418394380791036,0.8012537533807066,0.7794117647058824,0.9294528662931383,1.0,14/82,23.72%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;IKBKG;TAB1;SKP1;MUCL1;TAB2;CARD11;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3418394380791036,0.8012537533807066,0.7794117647058824,0.9294528662931383,1.0,14/82,23.72%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;IKBKG;TAB1;SKP1;MUCL1;TAB2;CARD11;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5273057852047575,0.8012254960840409,0.7543859649122807,0.929203084719867,1.0,1/5,5.06%,TNFRSF14
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.39566413031801473,0.8012149788824628,0.78,0.9289153538551015,1.0,9/41,18.12%,PID1;CYP1B1;MKLN1;CNDP1;ABCA2;PDK4;PINK1;ABCG1;PDK3
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5144482494363042,0.8010445781462534,0.78,0.9288525856007771,1.0,1/6,3.40%,FOXO1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.4398392754030892,0.800897365451267,0.7241379310344828,0.9287555806927317,1.0,6/14,23.69%,PDK4;PDK1;RORA;PDK3;FOXK1;PRKN
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.4965596011718023,0.8006281664504492,0.7254901960784313,0.928898500327542,1.0,2/8,18.61%,ABCA2;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3549511635228229,0.8001596327516525,0.8428571428571429,0.9293572352934479,1.0,10/92,10.41%,PLEK;DAB2IP;RPA1;SKAP1;NRG1;SNCA;MYD88;FSCN1;TPPP;SYK
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.4670755973054877,-0.7998265050308522,0.725,1.0,1.0,3/9,29.23%,DUSP6;DUSP9;SOD1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3787256558380101,0.7997414151475282,0.7878787878787878,0.9296977238229133,1.0,4/42,8.75%,NELL1;TRPM4;NOTUM;PKDCC
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.42369539877035867,-0.7996927440005047,0.7058823529411765,1.0,1.0,2/13,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.3916250978076416,0.7995720361419753,0.7741935483870968,0.9296462160088403,1.0,10/31,20.87%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;TINF2;CDK2;TELO2;WRAP53;ACD
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4149338251943024,0.7993007849617546,0.7450980392156863,0.9296745925978949,1.0,2/22,3.44%,IRAK2;NOD1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.36124615782456027,-0.7991547887538625,0.775,1.0,1.0,2/42,5.15%,SF3A1;CRNKL1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.46440801186766056,0.7979068527002402,0.76,0.9315617486681347,1.0,5/12,26.45%,IFT122;CILK1;IFT140;IFT43;DYNC2I2
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.5331100785936732,0.7978429549255502,0.7307692307692307,0.9313386919671354,1.0,3/5,21.12%,TRPM4;GPR183;TRPM2
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.45823747191177305,-0.7973639892817981,0.7380952380952381,1.0,1.0,2/12,6.01%,SELENON;ABCD1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.504677639817527,-0.7973434980642672,0.7380952380952381,1.0,1.0,5/7,31.25%,MDH1B;ME2;FH;MDH1;MDH2
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.38711446106400066,0.7966623418258756,0.8392857142857143,0.9327112670824236,1.0,14/49,22.96%,DCN;SMCR8;BAG3;PIP4K2A;OPTN;IKBKG;PINK1;LRSAM1;TSC2;ELAPOR1;WAC;TBK1;SUPT5H;SESN1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4179123808642164,0.7962507825085446,0.7611940298507462,0.9330196436410877,1.0,5/29,9.05%,DMTN;KCNQ1;AHR;VGF;HCN1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.411826089144485,0.7962130459719428,0.782608695652174,0.9327583705233475,1.0,2/22,6.62%,RPA1;POLD1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.4798933543347519,-0.795908337077597,0.72,1.0,1.0,2/8,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5292944251211489,0.7958553886924093,0.7843137254901961,0.9330171975668324,1.0,2/7,17.57%,CTNNB1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.47794497893173715,0.7957794894706849,0.7592592592592593,0.9328281770488077,1.0,1/6,6.91%,SNCA
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5309547129447185,0.7957224994219388,0.7894736842105263,0.9326051433890851,1.0,1/5,20.60%,HYOU1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4075545538878824,-0.7956967815478652,0.7777777777777778,1.0,1.0,4/21,13.23%,SUPT16H;HMGN1;ERCC6;CCNT1
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.36320946889515615,0.795673338585087,0.8813559322033898,0.932370878162598,1.0,21/67,15.22%,TYMP;A4GALT;EPHA2;EPS8L2;ITGA2;RHOD;EMP1;MYO1C;CTNNB1;CAPN1;ITGA3;LMNA;FBXO32;DUOXA1;BACE2;BCL2;ANXA11;OPTN;HEBP2;LAMA3;CD59
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.4903362315062022,-0.7956125156395403,0.75,1.0,1.0,2/5,21.21%,LY96;CD14
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.3563996635066097,0.7955951758213813,0.859375,0.9321936169784562,1.0,19/79,17.39%,SERPINE1;GRID2;RTN4RL1;NLRP12;TNFRSF1A;NLRC3;PPARG;EPHA4;MAPKBP1;PRKCD;KLF4;TNFAIP6;FGF2;LRFN5;PTPRS;RORA;GPS2;MFHAS1;INPP5F
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.3654591910481232,0.7949030644782817,0.7457627118644068,0.9330281468288373,1.0,7/39,20.12%,TRAF3IP2;TRIM5;ARIH2;RNF152;TRAF5;BFAR;UBE2B
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.469308199350044,0.794879605416412,0.7580645161290323,0.9327712440838617,1.0,2/8,10.24%,ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.435917085647194,0.7948280268404868,0.7833333333333333,0.9325599452673963,1.0,4/16,9.24%,THBS1;SULF1;NPTN;LRIT3
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.4815269944462768,0.7945067485915487,0.7735849056603774,0.9327424652062613,1.0,1/10,2.58%,PLEK
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.4488987382799091,0.7943532149868485,0.6825396825396826,0.9326675422215123,1.0,3/11,24.53%,PARP9;PARP16;PARP8
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.47662892953891195,0.7939168925979592,0.72,0.9330920230946512,1.0,2/8,6.59%,PRKCB;PID1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5106687570436355,-0.7938216680466497,0.7906976744186046,1.0,1.0,1/6,10.99%,DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5106687570436355,-0.7938216680466497,0.7906976744186046,1.0,1.0,1/6,10.99%,DOLK
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.41280436722618724,-0.7936427441574008,0.7111111111111111,1.0,1.0,4/17,15.71%,PRDX1;ATP1B2;CDH3;CCDC66
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.4634454478339698,0.7936306064064541,0.7192982456140351,0.9331909986963902,1.0,3/11,10.92%,APP;SNCA;MAPT
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4600007029707494,0.7935569818332442,0.75,0.932998806162497,1.0,2/12,2.41%,THBS1;SULF1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.47158982342130606,-0.7932540482745576,0.7272727272727273,1.0,1.0,3/9,17.30%,SPCS1;SPCS2;HM13
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.47041694725669136,0.7930652788918179,0.7037037037037037,0.9335021415773814,1.0,2/12,3.70%,CHRNA5;ACHE
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.4396225840322053,-0.7925707889825551,0.6730769230769231,1.0,1.0,3/10,15.29%,APOE;ABHD17A;LYPLA2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.3954339605277563,-0.7921542774044541,0.7,1.0,1.0,1/12,1.76%,CST3
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3894076152440818,0.7919810400207822,0.7666666666666667,0.9349534763215376,1.0,8/30,16.66%,DAB2IP;NLRP12;CARD19;NLRC3;MAPKBP1;PER1;OTUD7B;RORA
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.3663594889778318,-0.7919099816273842,0.7105263157894737,1.0,1.0,5/26,22.08%,CFTR;VIM;DYNLL1;UBB;ACBD5
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.4512969623893487,-0.7914607358715091,0.8378378378378378,1.0,1.0,4/9,27.11%,CYP2C8;NUDT15;CYP2D6;CYP2U1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.4745262881426733,0.7913532931940125,0.7346938775510204,0.9356900386179412,1.0,2/9,7.04%,TMEM204;APLNR
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.38206992047837035,0.7912135317292632,0.8421052631578947,0.9356369972679602,1.0,3/49,4.82%,PROX1;VAPB;PLSCR1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.45412958449258783,0.7905539975718622,0.6666666666666666,0.9359989117064876,1.0,1/8,8.97%,ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.45412958449258783,0.7905539975718622,0.6666666666666666,0.9359989117064876,1.0,1/8,8.97%,ARHGEF10L
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.398353112122683,0.7905207922121662,0.7941176470588235,0.9357383543931738,1.0,17/40,29.94%,ZIC1;BAG3;SMAD3;GAS6;PRKCD;TP53;YWHAE;FLNA;UBR5;PSEN1;DHX9;NEDD4;TCF7L2;HDAC3;GSK3B;DMAP1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.3487801651081177,0.7904699425540966,0.8095238095238095,0.9355269854187932,1.0,10/57,22.94%,DVL1;PEX14;PRKCD;TMC8;B2M;CDKN1A;CTSZ;ZFPM1;TTBK2;PIN1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.35847080857399244,0.7901244624873477,0.8181818181818182,0.9357492720039713,1.0,9/48,13.20%,CCNB2;BLM;CCNI2;CDK5R2;CDKN1C;GADD45A;CDKN1B;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3282851876769895,0.789771905620191,0.8571428571428571,0.9359488057681731,1.0,22/152,16.31%,IGF1;TESC;EFNA1;SOX4;DVL1;TCP1;BAG3;TBL1X;ATP1B1;ATP1B3;CCT4;EPHA4;PRKCD;SYVN1;CDKN1A;NCLN;TNIP2;CCT8;STK3;PINK1;ZSWIM7;PFN2
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.32578991084108344,-0.7894207285485375,0.8648648648648649,1.0,1.0,9/56,10.79%,HSD17B8;MCAT;ABHD1;ABCD1;ASAH2B;ELOVL4;ACSBG2;ELOVL2;ACSM6
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.39488452942397234,-0.7891032248027927,0.8260869565217391,1.0,1.0,2/19,10.58%,MCRS1;KMT2A
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5026063242947425,-0.78888037630368,0.7777777777777778,1.0,1.0,4/6,35.14%,NPM1;ABCE1;RAN;TSC1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.4977415296865649,0.7882534513290176,0.7755102040816326,0.937817147521692,1.0,1/6,8.44%,CAPN1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4336908219499213,0.7882496749789033,0.8461538461538461,0.9375262970173917,1.0,4/22,6.65%,SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.5370421522661912,0.7879794265563485,0.7843137254901961,0.9376384813000034,1.0,1/5,7.04%,ALDOB
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.4717285937788373,-0.787128139014504,0.673469387755102,1.0,1.0,3/6,14.17%,ABCB10;SLC25A37;LDB1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5131169234407603,0.7859989754181312,0.7708333333333334,0.9402346718650453,1.0,4/7,29.94%,STAT3;NCOR1;NCOR2;TGFB1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.4691212422561683,0.7859971357913988,0.7758620689655172,0.9399358051543443,1.0,1/8,9.88%,GLI2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3079405344911905,-0.7858493760706865,0.926829268292683,1.0,1.0,9/74,11.55%,MEOX2;ZNF358;TPP1;FOXJ1;NDRG4;CDHR2;EHF;DAG1;HES5
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.4208620092262047,-0.7856762773282597,0.7777777777777778,1.0,1.0,4/10,27.11%,CYP2C8;NUDT15;CYP2D6;CYP2U1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.37701633661306116,-0.7853179446364243,0.7878787878787878,1.0,1.0,6/32,7.12%,DPEP2;GMFG;CD247;CD38;P2RY10;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.4188691541125584,0.7852135465316049,0.71875,0.9408181960530434,1.0,8/23,20.96%,FOXO3;STAT3;MAPK11;ETS1;PRMT1;HIF1A;ARNT;ACVR1B
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.47737181677052043,0.7849360450192601,0.782608695652174,0.9409931149195593,1.0,3/9,7.78%,ADARB2;NUDT16;APOBEC3H
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.3980308909069957,-0.7847799233919946,0.7446808510638298,1.0,1.0,5/20,16.53%,UQCRB;UQCRHL;MTFR1L;OXA1L;MTFR1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.48338991609886095,0.7847608683183601,0.7358490566037735,0.9409574201983055,1.0,2/6,5.50%,ADARB2;NUDT16
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.4718191915329703,0.7846194381633831,0.75,0.9408653814439254,1.0,2/7,10.90%,LDLR;ABCA2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44839200685590824,0.7844951477948845,0.7540983606557377,0.9407208088875681,1.0,3/19,12.78%,BOK;BCL2L1;SYVN1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.35896417316525525,-0.7842297943403728,0.7222222222222222,1.0,1.0,6/48,11.81%,TNFAIP3;TRIM21;PRR7;HSPA1A;RPL11;UFL1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.525394779353964,0.7841995783382211,0.7924528301886793,0.9402313460621506,1.0,3/5,38.28%,MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.525394779353964,0.7841995783382211,0.7924528301886793,0.9402313460621506,1.0,3/5,38.28%,MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.525394779353964,0.7841995783382211,0.7924528301886793,0.9402313460621506,1.0,3/5,38.28%,MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.37171862858997706,0.7841860068728933,0.7538461538461538,0.9399520920796471,1.0,9/57,14.32%,SIX3;SLC4A10;TYR;GRM6;EML2;RP2;CABP1;MYO9A;SLC24A1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.48051528139794214,-0.7839063632926443,0.7608695652173914,1.0,1.0,1/8,1.20%,GALNT3
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3147765950919288,-0.7836949562976234,0.90625,1.0,1.0,9/79,11.93%,TNFAIP3;TRIM21;POLR2K;PTPN22;DHX33;PQBP1;POLR3E;POLR3B;POLR3F
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.38490853730190955,0.7836269447113666,0.7192982456140351,0.9405094068241163,1.0,1/25,2.91%,WAS
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.46579400798138476,-0.7833762947936137,0.7333333333333333,1.0,1.0,3/14,7.89%,AR;ESR2;NCOA4
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.49096504722833645,0.7830999492802654,0.8166666666666667,0.9409801312064373,1.0,1/9,1.91%,NLGN1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.39972265576532323,-0.7825125796311998,0.7435897435897436,1.0,1.0,2/19,12.38%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.47978821250585807,0.782415987944571,0.8070175438596491,0.9415630052843942,1.0,1/8,17.53%,CCNB1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.3490709226279918,-0.7823632735869427,0.8285714285714286,1.0,1.0,11/57,14.87%,KPNA2;POLR2K;PPIH;POLR2C;RAD23A;CNOT7;CCNT1;GTF2F1;TMEM250;POLR2D;PPIE
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.5069945179752711,0.7819693146457067,0.7272727272727273,0.9418232619878995,1.0,2/6,12.19%,SIGLEC1;TPCN2
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.4324887997286251,-0.7818818742135781,0.6590909090909091,1.0,1.0,6/13,21.25%,ENTPD1;DCTPP1;NUDT15;ENPP3;ENTPD5;ITPA
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.32871258914133145,0.7817263573440733,0.8888888888888888,0.9419147890095126,1.0,19/106,20.60%,SUV39H1;SCN2A;LMNA;NDRG1;PGK1;CPEB2;HIPK2;FMN2;TP53;PINK1;HIF3A;BACH1;RORA;PLK3;HIF1A;ARNT;EGLN3;RPS27A;HYOU1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.4123919238011265,0.7816820891955206,0.7678571428571429,0.9416954477701257,1.0,8/31,21.03%,MBP;ASS1;PODXL;KLF4;MAP2K5;NOTCH4;BMP6;PPM1F
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.49069425753785223,0.7813646745444758,0.7636363636363637,0.9418917758465303,1.0,4/9,33.31%,PNMT;PRKN;PAH;LRTOMT
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.2940256052126261,-0.7812878910647568,0.9166666666666666,1.0,1.0,5/115,4.15%,FAM47E;PADI4;BRDT;CHRAC1;SETDB1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.47958724037702305,-0.7811421144028137,0.7755102040816326,1.0,1.0,1/7,10.01%,CDHR2
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3188196262877506,0.7808283999585981,0.927536231884058,0.9423499432468485,1.0,28/135,19.98%,STEAP3;SEPTIN4;FAS;BCL6;BIRC3;CASP10;ALPK2;DAPK2;NDRG1;TP53I3;ACTN1;SRA1;ALK;TNFRSF10B;BCAR1;LCMT1;RARG;TP53;PINK1;TOX3;MECOM;AMIGO2;RTN4;ACER3;DNAJA3;RTKN;DDX42;ACTN4
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.4491581014383904,0.7808093745879086,0.71875,0.9420708140079159,1.0,1/12,0.85%,ANXA1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.4788006644264483,0.7807082237481983,0.8333333333333334,0.9419414599691688,1.0,4/9,37.30%,CREBBP;BAG6;SIRT1;KAT5
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.41363523196378144,0.7805368561002922,0.8,0.9419280901066415,1.0,9/26,23.95%,THY1;TESPA1;CD160;IKBKG;PTPRJ;DGKZ;CARD11;GBP1;PRNP
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.4053478798984079,-0.7805051352333543,0.6862745098039216,1.0,1.0,4/17,8.86%,ID1;GREM1;EFNB2;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5233196887645211,0.7804306704348993,0.7536231884057971,0.9417726995627507,1.0,1/6,20.36%,UBR5
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.4327616547215746,0.7803842636156579,0.7413793103448276,0.9415314692578985,1.0,3/14,14.66%,COLEC12;CGAS;IFIH1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.47225007536460933,0.7803729323310524,0.7719298245614035,0.9412605091993663,1.0,1/8,3.44%,NOD1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.3423066465240806,-0.7802659954665009,0.9,1.0,1.0,3/43,5.09%,APEX2;RFC3;POLD3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.4757991777608557,-0.7800623185879683,0.72,1.0,1.0,3/6,23.80%,DPH2;DPH5;DPH3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.4757991777608557,-0.7800623185879683,0.72,1.0,1.0,3/6,23.80%,DPH2;DPH5;DPH3
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.3058019550600941,-0.7798244934380923,0.8787878787878788,1.0,1.0,9/82,10.54%,SOD3;SELENOS;PRDX1;BRF2;EIF2S1;HSPA1A;GPX7;NUDT2;NOX1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.34625060808545405,0.7797017061961755,0.8695652173913043,0.9420688667203794,1.0,18/60,19.28%,FOXO1;SOX4;HK2;PPARG;STAT3;PYGL;PDK4;BACE2;MLXIPL;KLF7;ADIPOR2;HK1;GCKR;IGF1R;STK11;HECTD4;CAV3;HIF1A
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.38585055387319306,-0.7791890535378301,0.8,1.0,1.0,2/24,1.54%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4797656108912447,0.7791528169944962,0.7090909090909091,0.9425631513179386,1.0,5/10,31.20%,TP53;NCOR1;NCOR2;TGFB1;MAP2K1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.4792674229917927,-0.7783575429824604,0.7317073170731707,1.0,1.0,1/5,10.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.5249413212602861,0.7779598405387962,0.7692307692307693,0.9440609561276012,1.0,2/6,18.63%,FGF13;CAV3
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4942845338324878,0.7776860754020498,0.6842105263157895,0.9441290196815377,1.0,2/8,20.62%,PLEKHA4;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.48267455236954854,0.7776053140229413,0.75,0.9439509022210482,1.0,2/7,10.24%,ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.30598311892905544,-0.777411456117573,0.967741935483871,1.0,1.0,6/91,9.50%,NUP62CL;NXT2;NUP50;CHCHD10;NOL8;RANBP6
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.4291078475809551,0.7771226506552986,0.7777777777777778,0.9443843202756359,1.0,2/14,6.42%,KCNB2;PVALEF
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.4392128648097296,0.7768993660957163,0.7910447761194029,0.944437309654566,1.0,5/15,11.42%,ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.4447578710465889,0.7768506928551766,0.8166666666666667,0.9441921981587786,1.0,4/14,9.86%,SLIT2;TNFRSF1A;ROBO2;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.40927410155180843,0.7768031277929611,0.7457627118644068,0.9439919369770331,1.0,2/19,8.12%,PROX1;CTNNB1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.4344724832379791,-0.7764870716597398,0.7674418604651163,1.0,1.0,4/14,12.46%,TRIM21;TRIM68;FUCA2;EXOC7
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.37712567375208694,0.7763313717971109,0.8571428571428571,0.9442795802751466,1.0,9/46,16.45%,UGT8;ESYT3;B4GALNT1;B3GALNT1;ABCA2;FUT2;STS;ST6GALNAC3;NEU4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.4293849416204892,-0.7760419986873504,0.8125,1.0,1.0,2/14,10.58%,TPP1;ATR
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4134168521940643,0.7759704446593778,0.7166666666666667,0.9445335417044327,1.0,5/18,17.04%,CACNA1C;RYR2;SLC8A1;PDE4D;CALM3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.3847646268423409,-0.7757963781800585,0.8108108108108109,1.0,1.0,3/22,5.43%,SELENOS;TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.4569399972555639,-0.7756368002029408,0.6976744186046512,1.0,1.0,2/7,12.38%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.38267658300399854,-0.7755875761964501,0.8611111111111112,1.0,1.0,3/23,5.43%,SELENOS;TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4310557025496551,0.7753389496092582,0.75,0.9448215063174091,1.0,2/12,14.60%,SLC20A2;SLC37A2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.4310557025496551,0.7753389496092582,0.75,0.9448215063174091,1.0,2/12,14.60%,SLC20A2;SLC37A2
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.48001898096079865,0.7753276616973239,0.7619047619047619,0.9445507044127442,1.0,1/7,2.53%,CD55
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.36847265854103095,0.7751081921461058,0.7857142857142857,0.9445774848271838,1.0,6/35,15.68%,NLRC5;NLRC3;IKBKE;RELB;IFIH1;PTPRS
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.3973344716779384,0.7750924707262856,0.7761194029850746,0.9443032131011835,1.0,9/29,18.96%,DTX2;CCND1;MAML2;NOTCH3;FZD7;WNT5A;SKP1;PRKCA;LFNG
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.28145987602612116,-0.7749569899220305,0.9473684210526315,1.0,1.0,23/134,20.26%,CSDC2;EXOSC8;EXOSC4;HSPA1A;METTL3;VIM;EXOSC5;IGF2BP3;PSMD10;PSMD12;PSMB5;PSMB6;RC3H1;ZFP36L2;CIRBP;PSME3;FASTKD1;APEX1;PSMD2;UBB;PCBP4;PSMB4;DIS3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.34165579513339056,0.774660533100575,0.8333333333333334,0.9446384258600865,1.0,12/60,13.58%,BOK;NOD1;NLRP12;FAS;SNCA;CASP10;SMAD3;PPARG;BBC3;MAPT;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.5206898180547108,-0.7738422502970284,0.8409090909090909,1.0,1.0,1/5,1.02%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4272275233124723,0.7737679058586227,0.7962962962962963,0.9455231229302185,1.0,5/19,11.23%,SLIT2;DAB2IP;CYRIB;TGFB2;FBP1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.4765544309194132,-0.7736760196962311,0.7678571428571429,1.0,1.0,2/6,17.35%,GREM1;BMP2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.48242214145126716,0.7733441664315691,0.7837837837837838,0.9458466037712716,1.0,1/7,11.48%,KYAT1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.4534258690077078,0.7729273489328642,0.76,0.9461884408586658,1.0,1/7,7.62%,MYD88
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.43595241766320236,0.7728036228232711,0.8064516129032258,0.9461033376973954,1.0,1/15,2.72%,TIMP2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.508590933601734,-0.7726689861876374,0.875,1.0,1.0,2/6,21.59%,NLGN3;CHRNA4
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.4187503862218079,-0.7724384737894874,0.7959183673469388,1.0,1.0,6/10,33.97%,NMD3;NPM1;SDAD1;ABCE1;RPS15;RAN
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.44803639335275436,-0.7718204664649276,0.8529411764705882,1.0,1.0,6/15,21.11%,SF3B4;NCL;RBMX;CIRBP;PRDX6;SNW1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.3220960178366282,-0.7717926256233709,0.8571428571428571,1.0,1.0,4/52,7.38%,ERCC8;RGCC;SIRT6;ABRAXAS1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.3833414039089078,-0.771510954944885,0.85,1.0,1.0,5/17,24.10%,CEP131;CEP83;CEP192;STIL;PCM1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.49924730921211724,0.7713358549778668,0.7962962962962963,0.9478099751272863,1.0,2/8,4.36%,TLCD2;FABP3
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.5403863468009809,-0.7709285022011018,0.7727272727272727,1.0,1.0,1/5,4.36%,APOE
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.42247204837820224,-0.7704872413208314,0.7441860465116279,1.0,1.0,2/17,6.17%,MSTO1;MUL1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.45017521942821004,0.7703980471223174,0.7090909090909091,0.9488665845593421,1.0,1/8,3.40%,DYSF
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.3299310627946782,-0.7701624911385838,0.9117647058823529,1.0,1.0,4/31,7.16%,BLOC1S4;BLOC1S2;KIF4A;SNAPIN
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2974348019401044,0.7700369419580804,0.9861111111111112,0.9490142745580173,1.0,9/239,6.62%,RECQL4;HELB;SP100;TYMS;BLM;UHRF2;RPA1;SAMHD1;POLD1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.37957455832988984,0.7700186018806001,0.8181818181818182,0.948724562516047,1.0,4/27,11.94%,TJP3;GALNT12;CAPN8;BACE2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.31640946067020176,-0.769919013413584,0.8709677419354839,1.0,1.0,3/79,4.36%,NGF;CD200R1;APOE
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.420138987061528,-0.7696394544447052,0.7555555555555555,1.0,1.0,5/10,21.51%,CR1;GPLD1;SPG21;SLA2;FPR3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.38426502062520895,0.7692793740892655,0.8181818181818182,0.9494798004544702,1.0,2/30,10.92%,MAEL;MAPT
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.4056272188202591,-0.7692746736213866,0.7631578947368421,1.0,1.0,8/25,21.37%,APOE;ABCB11;ARV1;ADIPOR1;FMO5;MLYCD;EPHX2;GNB3
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.4397499357813432,0.7691069819866226,0.75,0.9494160493885967,1.0,4/13,15.01%,ORAI1;CAMK2B;BCL2;CD4
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3574810504643737,-0.7687174127507327,0.8108108108108109,1.0,1.0,7/36,14.01%,SFXN2;SLC3A2;SLC6A13;SLC36A1;SLC38A9;SLC47A1;SLC25A22
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.35127229076063676,-0.768406313368392,0.84,1.0,1.0,3/28,6.61%,PMVK;TM7SF2;ARV1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.4476840850296897,-0.7679014673907261,0.7777777777777778,1.0,1.0,5/9,26.89%,MCM6;MCM4;MCMDC2;ORC3;MCM3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.37323783044767345,-0.767678613949338,0.8292682926829268,1.0,1.0,3/24,10.54%,FIP1L1;CPSF1;CLP1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.37323783044767345,-0.767678613949338,0.8292682926829268,1.0,1.0,3/24,10.54%,FIP1L1;CPSF1;CLP1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.44843628087872905,0.7676115175681579,0.7301587301587301,0.951136960354613,1.0,4/14,14.15%,RASGRP1;PTPRC;BCL2;CD70
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.4633139694489481,0.7676095562241589,0.7741935483870968,0.9508469469250167,1.0,3/9,33.56%,RTN4;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.3829624304769008,-0.7672489072005875,0.8,1.0,1.0,3/36,7.50%,CST3;CSTB;BAK1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.32350968695874566,0.7671960012314621,0.84375,0.9511491501341504,1.0,12/97,18.72%,PRKCG;SEPTIN4;SOX4;FAM107A;BIRC3;PHF23;PRICKLE1;WASHC1;PINK1;BRCA1;NDFIP2;UBXN1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.39166173435303175,0.7671473432778004,0.8333333333333334,0.9509111010559972,1.0,5/24,15.01%,TRIM5;CIITA;HLA-DRB1;TRIM22;CD4
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.46461805178499627,0.7670472629601528,0.8181818181818182,0.9507878358866196,1.0,2/9,11.93%,NOD1;HLA-DRB1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.47498650344067417,-0.7666194842116456,0.75,1.0,1.0,3/7,24.99%,VPS4B;VCP;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.35041761577865865,-0.7665950445262841,0.7857142857142857,1.0,1.0,3/36,4.15%,APOBEC3G;BTBD17;SETDB1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3368359317192207,0.7665032535205604,0.948051948051948,0.9512376445771776,1.0,22/134,17.21%,SGPP2;VAPB;FA2H;ACHE;MFSD2A;ASS1;SPNS2;HACD1;CERS3;CHKB;B4GALT5;PAM;SGMS1;ALDH3A2;ELOVL7;LARGE1;SLC44A3;CERS5;ELOVL5;GSTM5;LPIN3;HACD4
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.4391537454789327,0.7664618400815572,0.803030303030303,0.9509887040329094,1.0,5/12,22.00%,CNTN4;EPHA4;RTN4;ARHGAP35;EPHA3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.40842822386070055,-0.7662521420614237,0.8378378378378378,1.0,1.0,5/19,21.65%,ENY2;USP51;EPOP;BRCC3;ATXN7L3
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.38411064837285425,0.7661971620765317,0.828125,0.9510133079155422,1.0,4/32,10.04%,SOCS3;ITPKC;ITPKB;PIP4K2A
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.43355417179911016,0.7661963509868877,0.7746478873239436,0.9507165798943515,1.0,6/15,12.43%,MYH9;PIR;PPARG;PDE1B;GAS6;RELB
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.4045048562013703,0.7659299196001048,0.7543859649122807,0.9507966354333052,1.0,8/20,21.77%,CFAP20;PDPN;TRIM32;ETS1;STK11;ADAM17;ACTN4;CCDC25
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3407225237953834,0.7657647075152592,0.8333333333333334,0.9507326924206733,1.0,11/51,19.44%,BLM;EME2;DONSON;CDKN1A;CCND1;MRE11;TP53;BRCA1;CDK2;FBXO31;WAC
prerank,MSigDB_Hallmark_2020__E2F Targets,0.2996194173336494,0.7653180911434861,0.9384615384615385,0.9510414630980512,1.0,26/169,17.79%,CDKN2A;CCNB2;LMNB1;RPA1;SUV39H1;MTHFD2;POLD1;NAA38;SHMT1;BARD1;PMS2;DONSON;CDKN1B;CDKN1A;CKS1B;NAP1L1;MRE11;PPM1D;TP53;STMN1;BRCA1;HMGA1;DUT;CDC25B;PRDX4;TFRC
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.4420532950273044,-0.7652173377084718,0.7916666666666666,1.0,1.0,1/7,7.85%,GLUD1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.43712588277111686,0.7651876982922658,0.7450980392156863,0.9509000211533696,1.0,4/12,19.47%,NRG1;TGFB2;TEK;TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.4784192686922637,0.764995052835108,0.7592592592592593,0.9508914188065037,1.0,1/8,4.49%,TRPM4
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4165308699585855,0.764754610729384,0.7288135593220338,0.9508643898552871,1.0,5/13,39.49%,DGKD;SMAP1;SCYL2;UBQLN2;NEU3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.3519150593451374,-0.7647233311243651,0.8787878787878788,1.0,1.0,4/29,13.82%,VAMP8;ATG14;VIPAS39;VTI1B
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5127678396821808,0.7647102293847363,0.8070175438596491,0.9506273187812487,1.0,3/7,11.71%,TLR2;NAMPT;CCL2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3445173179220302,0.7646534526387855,0.8873239436619719,0.9503830270815155,1.0,2/80,3.69%,SIX3;NEK10
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4502234579872022,0.7643937671778942,0.7636363636363637,0.9504519382800033,1.0,2/8,10.27%,MYD88;STAT3
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.3667286543691634,0.7642593295130024,0.7727272727272727,0.9503698525644134,1.0,11/59,15.86%,C1ORF87;CYP4X1;DNAH3;ZBTB7C;ATP1B1;MORN5;NEBL;FUT2;KCNMA1;NWD1;AKAP14
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.3705164410751121,0.764238175989272,0.8382352941176471,0.9501074655008905,1.0,6/31,8.68%,PSCA;LIPH;TJP3;POF1B;CAPN8;KPNA7
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.4599522514974397,0.7640022959618631,0.7407407407407407,0.950124884856185,1.0,2/11,10.96%,HMBOX1;PARP9
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.3823086465072235,-0.7638624945366999,0.725,1.0,1.0,3/16,6.31%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.3638033068270544,-0.7635506143950835,0.8333333333333334,1.0,1.0,8/23,19.91%,NPC2;SLC25A19;MTTP;PRELID1;TRIAP1;PCTP;PRELID2;PRELID3A
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.3299716189499599,0.7625095599121682,0.8461538461538461,0.9519079127144636,1.0,17/86,17.19%,ABCA6;ACSL5;ABCA8;ABCA5;SLCO1A2;DIO1;DHCR24;ABCA9;HSD3B7;ABCA2;SLC27A5;OPTN;PNPLA8;RXRA;ABCA3;LIPE;SLC29A1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.376855653809821,-0.7624269954552946,0.7659574468085106,1.0,1.0,3/25,6.61%,PMVK;TM7SF2;ARV1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4615614330797276,0.7624134188911852,0.7761194029850746,0.9517409003833458,1.0,1/10,4.96%,FAS
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.49531683653210984,-0.7620778092300514,0.7105263157894737,1.0,1.0,2/6,22.49%,VANGL2;FUZ
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.45983702763943946,-0.7615820861095776,0.8333333333333334,1.0,1.0,3/7,22.28%,VPS11;RDX;PTPN23
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.41923066519355834,0.760970235335479,0.8545454545454545,0.953419388413575,1.0,2/16,9.96%,FAP;ZDHHC7
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.5094437404790293,0.7609285731999317,0.7678571428571429,0.9531785115757536,1.0,1/6,3.94%,SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.39655741645084114,0.7604008805449576,0.8064516129032258,0.9536027433305522,1.0,10/26,24.98%,PLSCR1;PUM1;IFI35;PRKCA;BMP6;NMI;SCIMP;SLC15A4;DHX9;POLR3C
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.41030734579732486,0.7600615171059917,0.7540983606557377,0.9538136971374239,1.0,11/22,33.38%,PPP1R16B;PRKCD;CALM3;PPP1R7;PIN1;SPPL3;DLC1;TGFB1;CAMTA1;MTMR9;NSMF
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.4083295768124088,-0.7599933352542754,0.8444444444444444,1.0,1.0,2/16,10.58%,DNMT3B;KMT2A
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.3626536805970375,0.7593237441552579,0.8513513513513513,0.9544871326068984,1.0,9/48,10.27%,EPHA2;LSR;EPS8L2;BAIAP2L1;NEDD9;PADI2;RHOD;MMP14;STAT3
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.46300656204271495,0.7591814366810179,0.7777777777777778,0.9543967094185407,1.0,4/9,27.17%,SLC29A4;OAZ2;SMS;SLC22A3
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.4706529025861883,-0.7589737177449606,0.7796610169491526,1.0,1.0,1/6,5.79%,CRACR2B
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.5158146523366589,0.758950381189229,0.8596491228070176,0.9543833965766443,1.0,2/5,30.48%,TSG101;STAM
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3876697766459581,0.7589116973960383,0.7971014492753623,0.9541353326425598,1.0,10/25,23.69%,NLRC5;PARP9;GAS6;FADD;WNT5A;ADAM17;HIF1A;CSF1;TRIM44;PRKN
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.47700962240059264,0.7587898046183057,0.7540983606557377,0.9539790968634277,1.0,1/8,14.09%,COBL
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.35837715903273487,0.7586016692484812,0.8548387096774194,0.9539402648228047,1.0,10/47,22.75%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8;TINF2;EXOSC10;ACD;PARN
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.35402191641787045,-0.7585260439666667,0.8809523809523809,1.0,1.0,2/37,5.40%,CALCRL;GTF2H2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.49630284842320177,0.7582711591145178,0.76,0.9540407157238799,1.0,2/5,36.52%,NBN;WDR18
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.46097565191839135,0.758258215855904,0.7272727272727273,0.9537674199398478,1.0,3/11,14.66%,COLEC12;CGAS;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.33233458818246553,-0.7581704160076671,0.875,1.0,1.0,8/27,14.39%,SLC25A5;MUL1;FZD9;HSPA1A;PRELID1;PSMD10;TRIAP1;CLU
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.512274255636548,0.7578345244472969,0.8166666666666667,0.954076621242992,1.0,1/5,9.91%,NFKBID
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.38403156928858506,0.7577501223471754,0.8545454545454545,0.9538803708710716,1.0,4/25,13.63%,SLCO1A2;SLC17A5;SLC26A8;SLC13A4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3290134669867616,0.7577082032075639,0.9041095890410958,0.9536366595898927,1.0,12/135,11.35%,ANLN;CLTB;NRG1;PSMG3;SNCA;TCP1;TESPA1;SMAD3;SMAD1;MAPT;SPAG1;PXN
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3512044110891389,-0.7576123359209732,0.8709677419354839,1.0,1.0,7/51,10.58%,RFC3;CCT7;RGCC;DSCC1;GREM1;POLG2;ATR
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.3980654338572176,0.7575420555700129,0.7704918032786885,0.9535248245521948,1.0,3/19,9.88%,LAMB1;TGFB2;GLI2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.4335766309083358,-0.757437787414348,0.75,1.0,1.0,1/7,1.84%,AGER
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.463984054173138,-0.7563401720995625,0.8333333333333334,1.0,1.0,1/6,3.36%,FBLN5
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.36950919657237424,-0.7561674505180797,0.7368421052631579,1.0,1.0,7/21,28.10%,VPS11;AFG3L2;MIEF1;FIS1;GDAP1;VPS18;MFN2
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5042313330129717,-0.7560176266031856,0.7843137254901961,1.0,1.0,1/5,5.70%,KRT10
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.49138019387625437,0.7555594719343505,0.8148148148148148,0.9558967815156355,1.0,3/7,18.12%,PID1;PDK4;PDK3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.35636238372908857,0.7555082469816099,0.921875,0.9556563299593414,1.0,12/56,20.29%,FYN;NECAB2;LIMK2;YAP1;MAPT;PARP9;STX4;WWTR1;TFRC;MAP1A;RTN4;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.438335380726829,0.7553039868871376,0.7936507936507936,0.95562439917498,1.0,3/15,14.19%,SERPINE1;GAS6;IL12A
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.38043477735836245,0.7546517132479368,0.8,0.9562101028204677,1.0,10/34,27.42%,PPP1R16B;PRKCD;CALM3;PPP1R7;MFHAS1;PIN1;ARPP19;SPPL3;ENSA;DLC1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.35330660518609314,0.7545192607455986,0.8857142857142857,0.9560903393011193,1.0,13/57,16.51%,C1ORF87;TEKT2;DNAH3;CFAP126;TMEM212;ZMYND10;MORN5;ECT2L;DNAJB13;RSPH4A;C6ORF118;AKAP14;FAM81B
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.4581045812639013,0.7542735510476946,0.7846153846153846,0.956105783667729,1.0,2/10,10.44%,CNTN4;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3460429117441477,-0.7536591258540231,0.8648648648648649,1.0,1.0,11/46,18.19%,ERCC8;ABRAXAS1;ATR;NSMCE4A;ERCC6;CEBPG;RNF168;RNF8;PLA2R1;SPRED1;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.40112415210396235,0.7534954398674601,0.8461538461538461,0.9567747731393685,1.0,4/26,16.86%,BAP1;ARIH2;PINK1;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5290335785554545,-0.7531036610633668,0.7659574468085106,1.0,1.0,1/5,14.39%,CLU
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.43366684549112866,-0.7530829166567309,0.675,1.0,1.0,1/7,1.61%,SELENOS
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.3831934060383165,-0.7528264693592894,0.7659574468085106,1.0,1.0,3/17,9.00%,TTN;TNNT1;VIM
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.3831934060383165,-0.7528264693592894,0.7659574468085106,1.0,1.0,3/17,9.00%,TTN;TNNT1;VIM
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3480041698464298,0.7525971658124548,0.8923076923076924,0.9575784006783556,1.0,8/54,15.71%,IGF2BP2;SRRM4;MBNL2;FAM50A;CLK1;HNRNPH1;GRSF1;NOVA2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3006903259637561,-0.7524012197327552,0.9487179487179487,1.0,1.0,13/58,19.54%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2;DNASE1L1;PNRC2;XPA;DNA2;MEI4;MUS81;ERCC3;UBB
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.344893866498075,0.7523524159032318,0.9047619047619048,0.9575824253738076,1.0,10/90,10.08%,YWHAH;ACSL5;ABCB1;ABCC8;SEMA3C;DIO1;MVP;DHCR24;HSD3B7;PEX14
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.44724818851174825,-0.7523458404807631,0.7368421052631579,1.0,1.0,1/7,0.58%,KCNE1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.4389089842193934,-0.7521140351150977,0.782608695652174,1.0,1.0,3/13,6.23%,ABCD2;ABCD1;ABCB11
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4040530277291813,-0.752097795785933,0.8108108108108109,1.0,1.0,6/20,21.11%,SF3B4;NCL;RBMX;CIRBP;PRDX6;SNW1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),0.4887583080881518,0.7517810414681114,0.7692307692307693,0.9581044306050064,1.0,1/5,12.29%,PRKCD
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3697006378684494,0.7517643900985566,0.828125,0.9578165592500772,1.0,6/32,14.07%,NEFL;KIF5A;KIF5C;TRAK1;HAP1;RAB27B
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.4839726813134873,-0.7515674311311731,0.7894736842105263,1.0,1.0,2/5,28.09%,PNRC2;EDC3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.32985169913878387,-0.7515439043539877,0.9069767441860465,1.0,1.0,3/40,9.78%,SAXO1;IL5;ENTR1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.41448392423721386,-0.7514952902053388,0.8301886792452831,1.0,1.0,2/11,6.53%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.41458935903688343,0.7514096799227687,0.7636363636363637,0.9579882008395755,1.0,7/13,27.56%,OGG1;NEIL2;DUT;NEIL1;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.4526883190795403,0.751342873059206,0.8,0.9578171632816179,1.0,3/9,11.63%,SULT4A1;UST;CHST4
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.5182714155139062,-0.7513361039753224,0.7777777777777778,1.0,1.0,2/5,10.71%,SLC36A1;SLC25A38
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.5117992114809955,0.7510191106439267,0.803921568627451,0.9578866872773065,1.0,1/5,4.11%,GAD2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.3932834809629693,0.7508305431272936,0.8688524590163934,0.9578104822581948,1.0,1/23,1.95%,SLC7A2
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.3919944726023521,-0.7507496748031335,0.7941176470588235,1.0,1.0,5/14,20.96%,PRDX1;NOX1;PRDX3;GPX1;CAT
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.45770058720416057,-0.7506707137274208,0.8163265306122449,1.0,1.0,1/6,4.53%,RGCC
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.3777997145811943,0.7503937715155204,0.7741935483870968,0.9581275559488137,1.0,4/22,18.32%,TMBIM1;PARP9;TP53;CAMK2A
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.28565627993657655,0.7501775410382259,0.987012987012987,0.9581532413714128,1.0,36/352,12.40%,GOLGA8O;ARHGAP4;VAPB;CNTNAP1;DMTN;THY1;ATP8B4;SH3KBP1;WTIP;NEDD9;CFAP126;MTFR2;DPYSL2;PAK4;TMED10;KIF5C;PCLO;PLAAT3;PLEKHF1;YTHDF1;PLD2;GOLGA8A;ARHGEF7;AGTPBP1;CHMP1A;PEX14;PACSIN1;SYNE3;CFAP61;USP6NL;CCL2;RNF112;STX4;FGD5;RAB30;FMNL3
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.45117068520327425,-0.7500927022756533,0.7894736842105263,1.0,1.0,3/8,6.31%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.48010235466603524,-0.7499400951409578,0.8181818181818182,1.0,1.0,2/6,29.75%,SENP2;SENP5
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.41081898477217016,-0.7498148283126088,0.7368421052631579,1.0,1.0,1/15,1.21%,STAB2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.45738525749398057,-0.7496257608571673,0.7142857142857143,1.0,1.0,3/11,14.14%,GTF2A2;TAF11;BDP1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.35905655679363996,-0.7495284788641166,0.875,1.0,1.0,3/18,13.77%,PDZD11;TSPAN33;BAD
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.3986939047352729,-0.7493805680023872,0.825,1.0,1.0,10/25,24.01%,POLR2K;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;POLR2E;CTDP1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4162817285423847,0.7492190278682621,0.7903225806451613,0.9590522222535298,1.0,6/12,19.44%,CCND1;TP53;CDK2;PLK3;FBXO31;WAC
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4396618593097881,0.7491742158630067,0.8,0.9588011441505119,1.0,5/15,18.06%,GAS6;HLA-DRB1;RARA;PDCD1LG2;TNFSF4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.4683113301980579,-0.749071160410376,0.696969696969697,1.0,1.0,1/7,0.45%,EYS
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.40015498102202846,0.7489961759848516,0.8571428571428571,0.9587756871055203,1.0,3/16,12.46%,SEC14L1;SLC25A29;SLC29A4
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.2602935635210663,-0.7488676865602696,1.0,1.0,1.0,31/276,13.83%,NUP62CL;ERP29;COX18;ARF5;SRPRA;NXT2;RABL3;SNF8;NUP50;VPS29;STX16;ARFIP2;TBC1D4;WDR11;TMED5;RABL2A;COPB2;DNAJC27;RANBP6;SEC31B;ARL1;C17ORF75;RPL11;TMED2;SNX31;TMED9;RANBP17;VPS35;FAM53A;VIPAS39;ARCN1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.37252829679500915,0.7488041294945428,0.8095238095238095,0.9587502456975342,1.0,8/25,14.71%,TLR2;TNFRSF14;MYD88;LYG1;GSDMD;LYG2;IL12A;HLA-E
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.49926723250225974,0.7487129188992586,0.8,0.9585939841046285,1.0,1/6,4.11%,GAD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.4433523156685494,-0.748659443144634,0.8780487804878049,1.0,1.0,3/10,6.31%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.5219191670216972,0.7484395228470161,0.7407407407407407,0.9586521779727719,1.0,2/5,24.96%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.43639781200052064,-0.7480650807668603,0.78,1.0,1.0,1/6,1.84%,AGER
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.45602298503205596,0.7479002201571445,0.8095238095238095,0.9590263286240549,1.0,3/11,9.88%,PROX1;TBX20;TCAP
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.40479964208299213,-0.7478496385555904,0.7674418604651163,1.0,1.0,2/17,8.40%,HSPA1A;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.41244759077807996,-0.7476444746014417,0.7446808510638298,1.0,1.0,2/11,11.30%,FBXO5;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.29985077383197456,-0.7474063541441649,0.84375,1.0,1.0,9/65,20.20%,ELOC;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.34318810642252795,-0.7474003043271414,0.8333333333333334,1.0,1.0,2/31,1.54%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.38038659967403926,-0.747310521577981,0.8823529411764706,1.0,1.0,4/12,20.55%,SAXO1;DAG1;SAXO2;GCC2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.329232600923442,-0.7472547918882394,0.9642857142857143,1.0,1.0,9/61,20.20%,VAMP8;PSMD10;PSMD12;PSMB5;TAP1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.4495767849179921,0.7471562068916102,0.86,0.9596762044820574,1.0,6/12,28.10%,PCGF3;BRCA1;CDYL;RBM15B;PCGF5;LRIF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.4443150577586436,-0.7468136990001991,0.7073170731707317,1.0,1.0,2/13,17.42%,ATL2;ZFYVE27
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.4784720443236308,0.7466283328711932,0.8679245283018868,0.960067960991498,1.0,1/7,8.19%,ASS1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.46833072098759554,0.7465610284596449,0.7894736842105263,0.9598425885689997,1.0,3/7,18.31%,XRCC1;TINF2;HPF1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4272987396799176,0.7464689355896111,0.7333333333333333,0.9596572583817528,1.0,2/12,7.88%,APP;LDLR
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.43681214623680376,0.7451515880022411,0.8448275862068966,0.96109310235362,1.0,1/9,15.29%,ETS1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.37918494216559356,0.744942430845284,0.8727272727272727,0.9610851484153697,1.0,1/25,0.93%,KIF14
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.462597297546683,0.7445330171452487,0.8148148148148148,0.961312779692767,1.0,4/7,35.72%,TJP1;NLGN2;F2R;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4076751923376089,0.7443789126187919,0.7547169811320755,0.9612214296990296,1.0,2/12,12.47%,PDK4;BCL2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.38933273407516983,-0.7436877315383578,0.7291666666666666,1.0,1.0,5/14,11.31%,RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.4897771963232369,-0.7436573895414021,0.803921568627451,1.0,1.0,1/5,19.13%,SLC25A11
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.46460453326930523,0.7432928142952925,0.7924528301886793,0.9622276303768248,1.0,2/7,35.37%,RABEP1;RAB29
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.46529937585730297,-0.743220765416781,0.78,1.0,1.0,1/6,19.13%,SLC25A11
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.3665777709595331,-0.7427562744362213,0.8478260869565217,1.0,1.0,3/16,8.80%,HEY2;GREM1;HEY1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.3937215853657728,-0.7425914972299517,0.8148148148148148,1.0,1.0,2/13,10.84%,MOGAT1;GK
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.34631772921769216,-0.7423459810746634,0.7333333333333333,1.0,1.0,4/27,20.55%,NCOA4;ZFYVE16;AP4M1;GCC2
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.35074642968504566,0.7423230047737164,0.8,0.963193384596946,1.0,3/34,16.11%,DAB2IP;CDC7;BRCA1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5194744531120111,0.7420538801194034,0.8367346938775511,0.963220999328413,1.0,1/5,19.79%,PMPCB
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3725682540685222,0.741639011706073,0.8823529411764706,0.9634838174157238,1.0,7/29,13.11%,IRS2;CHST15;APOD;ALDOB;GALK1;FBP1;HK1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.3360385729715707,0.7411805078662851,0.9516129032258065,0.9636885921851194,1.0,6/66,7.22%,FLRT3;NR4A1;ZFP36;ANOS1;CD44;FLRT1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3598648558910683,0.7410967431965053,0.84375,0.9635062697291615,1.0,5/35,10.06%,BMP8A;PMEPA1;LDLRAD4;TGFB2;RBPMS
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.34666623954303577,0.740883380697492,0.8857142857142857,0.963465061472583,1.0,4/46,8.12%,WNT8B;MAP1LC3A;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.45844014706353453,0.7405229986551302,0.8333333333333334,0.9636515826237714,1.0,2/9,12.08%,GINS2;CDC7
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.32583605499517004,0.7404108105259396,0.859375,0.9635236371735278,1.0,11/74,14.23%,ZDHHC9;ZDHHC22;PARD3;MYO1C;MICALL1;ZDHHC7;ZDHHC1;PEX14;NACAD;VPS37B;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.3024954878408908,-0.7403102064476885,0.9210526315789473,1.0,1.0,11/69,15.04%,RBM23;BRDT;RPS26;RRP1B;HSPA1A;RPS13;PQBP1;ZPR1;RBM22;RBM39;CLK4
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.41011921727465506,-0.7402325798924798,0.7755102040816326,1.0,1.0,4/14,19.75%,SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.416128207444571,0.7397747994734784,0.7966101694915254,0.9639159190016776,1.0,5/16,22.47%,CDK6;RARA;ZFPM1;TLR3;MAFB
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.41990067356824373,0.7396715870386965,0.7971014492753623,0.9637085279800378,1.0,5/14,23.35%,SMAD1;KLF4;FGF2;TJP1;BMPER
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.4458528099972276,0.7387819674033568,0.7868852459016393,0.9644506787170173,1.0,1/11,1.91%,NLGN1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.35455836275121744,-0.7387500419105838,0.88,1.0,1.0,3/26,6.61%,PMVK;TM7SF2;ARV1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.34760508499635245,-0.7385990026080291,0.8409090909090909,1.0,1.0,2/23,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.4079703848721083,-0.7384337109601262,0.7619047619047619,1.0,1.0,5/11,25.33%,AUP1;RNF5;POMT2;VCP;DERL1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.3420382905998278,-0.7378733904834219,0.85,1.0,1.0,11/36,22.92%,POLR2K;RRAGC;POLR2C;NFKBIB;POLR2D;MLF1;THAP1;POLR2L;POLR2G;PWP1;POLR2E
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.48110068359082625,0.7377128740369949,0.7818181818181819,0.9654702578625296,1.0,1/6,5.37%,GNG2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.43825360908884026,0.7374282988027443,0.7424242424242424,0.9655259480023202,1.0,4/10,21.56%,HIPK3;TP53;ZBTB1;C5AR1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2933083877717484,0.7365116781563346,0.9864864864864865,0.9663930991496023,1.0,36/186,23.80%,KIF14;PRAME;HECW2;ENC1;PML;CTNNB1;TBL1X;KCTD13;HECW1;SPSB1;AGAP3;SYVN1;UBXN11;SMURF1;RFFL;RCN3;RNF187;RNF122;TBL1XR1;UBXN6;BFAR;RNF185;UBXN1;MARCHF6;MTA1;UBE4B;UBE2B;TRIM9;DDB1;FBXW5;CUL3;USP44;PSMB3;PRKN;KCTD10;ARRB1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.4444513130435717,0.7359498493932919,0.8181818181818182,0.9668018177363019,1.0,4/13,9.86%,SLIT2;TBX20;ROBO2;TGFB2
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.3837281516521487,-0.73587227751397,0.8333333333333334,1.0,1.0,11/20,21.42%,NT5E;PRPSAP1;NT5C;GART;PPAT;NUDT15;PNP;GPX1;PRPS1;ITPA;NT5C1A
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.4943163451236142,-0.7358222809546539,0.82,1.0,1.0,2/5,10.31%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.45689271910763185,-0.7355280134485604,0.9024390243902439,1.0,1.0,2/6,23.21%,MAP3K4;YY1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.346962204901197,-0.7351623710617302,0.8372093023255814,1.0,1.0,10/23,30.29%,YME1L1;AUP1;RNF5;POMT2;ATXN3;VCP;DERL1;CLPP;NGLY1;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.43301374952883154,-0.7349561294674828,0.7755102040816326,1.0,1.0,3/6,24.68%,TNIP1;VCP;SART3
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.3463778672937434,-0.7343012658082636,0.8235294117647058,1.0,1.0,4/48,7.64%,TNFAIP3;FBXO5;PRR7;HSPA1A
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.45344488940098265,0.733955195500874,0.7647058823529411,0.968239013893805,1.0,1/6,7.26%,TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.45344488940098265,0.733955195500874,0.7647058823529411,0.968239013893805,1.0,1/6,7.26%,TMED10
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.45344488940098265,0.733955195500874,0.7647058823529411,0.968239013893805,1.0,1/6,7.26%,TMED10
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.49954731024594395,0.7338690034074766,0.7962962962962963,0.9680200720372226,1.0,1/5,1.17%,PDGFRA
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.32139212694790315,-0.7338240470201957,1.0,1.0,1.0,3/32,9.05%,H2BC21;PADI4;H2BC18
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.4130773627244391,-0.7338210544408916,0.8,1.0,1.0,1/14,1.21%,STAB2
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3132042926991274,0.733127496597899,0.9545454545454546,0.9687516799173909,1.0,4/113,4.92%,EGF;LGR5;TRPM4;SOX4
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.40253088219962696,-0.7331005167096181,0.825,1.0,1.0,2/13,11.30%,FBXO5;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.3284248924525634,0.7330598772280258,0.8793103448275862,0.9685291163555597,1.0,9/46,14.52%,NUMBL;HES7;SERPINF1;CTNNB1;YAP1;B2M;NAP1L1;TRIM32;RGS14
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.43290828839409645,0.7330238861041608,0.7647058823529411,0.9682671114740762,1.0,3/10,21.75%,SRA1;PRICKLE1;ANKRD2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.4393318677748317,-0.7329945161804532,0.84,1.0,1.0,2/7,9.66%,USH2A;ERCC2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.46285465973219875,0.7327573817719251,0.8507462686567164,0.9682426533633139,1.0,1/9,11.16%,B4GALT7
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.35287151264742633,0.7327398870299944,0.7777777777777778,0.9679593205459976,1.0,3/42,5.50%,ZFP36;ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.42340192056121073,-0.7324373854560344,0.847457627118644,1.0,1.0,2/10,15.81%,SAT1;SRM
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.41120416149513267,0.7320707756162973,0.8148148148148148,0.968513700793523,1.0,1/10,8.12%,CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.42150492769250003,0.7319953570971979,0.9,0.968313108341118,1.0,3/12,13.91%,TRIM5;PML;TRIM32
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.37028365167964994,-0.7309591066535569,0.8157894736842105,1.0,1.0,3/17,12.49%,KPNA2;RGPD8;NUP54
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4225581035662489,0.7309358986471083,0.8181818181818182,0.9692981344769703,1.0,3/11,12.89%,THBS1;STARD13;KLF4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3967569061062456,-0.7305668274684165,0.8909090909090909,1.0,1.0,2/13,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.2945038796066911,-0.730474382901329,0.8857142857142857,1.0,1.0,2/54,2.70%,TNFAIP3;RNF6
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.30976528213906823,0.7304641520772044,0.9523809523809523,0.9694996541154415,1.0,22/96,24.47%,APP;ADD2;DVL1;HDAC4;PEX14;PRKCD;TMC8;B2M;CDKN1A;HIPK2;STK3;CTSZ;ZFPM1;LDLRAP1;AMFR;BTBD1;PIN1;FLOT1;PRKN;HDAC5;PSEN1;SPPL3
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.3272172751839701,-0.729873205778342,0.9142857142857143,1.0,1.0,1/46,0.40%,CALCRL
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.484219955832638,-0.729698398885922,0.7959183673469388,1.0,1.0,2/5,21.72%,TMEM167B;TRAPPC11
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.3955101030972161,-0.7285929029589402,0.8409090909090909,1.0,1.0,2/14,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.4122716123795718,0.727954636625563,0.8870967741935484,0.972311152676104,1.0,5/14,17.02%,MMP14;SYK;GAS6;ZMIZ1;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.4730696004511311,0.7277551036216336,0.8,0.9722855202674561,1.0,1/7,5.69%,STAC2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.4154854808276576,0.7277440245283849,0.8333333333333334,0.9719907989821371,1.0,4/9,29.94%,TGFB2;HLA-F;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.36092856326779266,0.7275020576855512,0.8518518518518519,0.9720262577022188,1.0,5/30,12.05%,EGF;RAB11FIP5;CTNNB1;ABCA2;STX4
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4069881008386659,-0.7272008672738961,0.8636363636363636,1.0,1.0,2/11,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4069881008386659,-0.7272008672738961,0.8636363636363636,1.0,1.0,2/11,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.41395249706365717,-0.7271840221492677,0.8409090909090909,1.0,1.0,2/11,12.75%,LRRC17;FSTL3
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.46861833997041563,0.7265626664489966,0.8070175438596491,0.9728075590103437,1.0,2/10,6.91%,RASGRP1;SNCA
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.4839897913327113,0.7261240383701272,0.8363636363636363,0.9730399128444266,1.0,3/6,24.70%,COL5A1;ADAM17;PLET1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.3526614449371875,0.7260100675962164,0.8656716417910447,0.972906587191544,1.0,10/34,22.29%,DAB2IP;GFAP;NCLN;PINK1;SPTY2D1;RAP1A;RAP1B;PTPN11;TJP1;FAM110C
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.4643400062479871,0.7257643319248259,0.7931034482758621,0.972877238485585,1.0,2/5,19.68%,CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.36304476511897227,0.7257277723310399,0.8979591836734694,0.9726043624792402,1.0,5/18,17.46%,EFNA1;EPHA4;ABCA2;SLC2A13;ABCG1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.34944802909937905,-0.725224191538463,0.8372093023255814,1.0,1.0,5/17,24.99%,VPS11;RDX;PTPN23;SNX12;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3298044331895093,0.7251613602143975,0.9324324324324325,0.9729832955745323,1.0,13/55,18.29%,ZIC1;TCP1;BAG3;SMAD3;LIMK2;YAP1;CCT4;PARP9;PRKCD;CCT8;WWTR1;TFRC;FLNA
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.47937864662224894,0.7250575594880564,0.8490566037735849,0.9727821401064334,1.0,1/5,15.82%,XRCC1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.41920817548888006,0.7250326945211132,0.85,0.9725095403172588,1.0,5/11,20.36%,DYSF;SYK;IFI35;SBNO2;NMI
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.33630253269024457,-0.7248913006053175,0.9777777777777777,1.0,1.0,7/47,13.69%,SNF8;VPS29;CCDC22;WASHC2C;ENTR1;SNX31;VPS35
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.40924221204314093,0.7247169409462243,0.7586206896551724,0.9726198673545032,1.0,1/18,6.60%,ENC1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.46057835312605033,0.7247140447838478,0.803921568627451,0.9723260244942753,1.0,5/6,28.68%,SARDH;CHDH;SLC44A1;BHMT;DMGDH
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.2925003461908807,0.7246615440252752,0.9538461538461539,0.9720895600048611,1.0,18/97,18.87%,THBS1;ATF3;DAB2IP;PDIA2;NIBAN1;BBC3;BCL2;SYVN1;TNFRSF10B;EIF2B5;SCAMP5;MAP3K5;TP53;RCN3;ITPR1;UBXN6;RNF185;MARCHF6
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.39082197705892885,-0.723678875750755,0.9210526315789473,1.0,1.0,5/15,24.10%,CEP131;CEP83;CEP192;STIL;PCM1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.391760053673017,0.7228163801836858,0.8507462686567164,0.9739940495234087,1.0,4/24,12.29%,ZIC1;BAG3;SMAD3;PRKCD
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.30225942567400105,0.7226755915643124,0.96,0.9739144317526998,1.0,9/111,13.24%,GOLGA8O;ATP8B4;STK25;TMED10;GOLGA8A;ARHGEF7;USP6NL;RAB30;OPTN
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.3617844098132008,-0.7224466530082059,0.8461538461538461,1.0,1.0,1/21,1.84%,AGER
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.39311471347563953,0.7221690431264927,0.8367346938775511,0.9741956156920294,1.0,3/16,9.88%,PIEZO2;CTNNB1;TCAP
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2779056447759676,0.7219812479388774,1.0,0.9741195558928515,1.0,24/293,13.30%,ANK3;YWHAH;TBC1D9;STEAP3;PRKCB;MYH9;AMN;VLDLR;RAB15;RAB3C;TMED10;RAMP3;SCG5;PPARG;CHMP1A;TF;USP6NL;RAB20;STX4;ARF6;TBC1D1;PICK1;OPTN;COPZ2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3210785752264347,0.7208095097244767,0.9402985074626866,0.9752893547492236,1.0,9/67,14.93%,CHRM3;BAP1;ST8SIA4;FBXL2;B4GALT7;PHEX;MSRA;PLOD2;LCMT1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.42144999623125096,-0.7207647452474627,0.8285714285714286,1.0,1.0,1/11,3.20%,PHYH
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.42138356558862494,0.7203274962051381,0.851063829787234,0.9752151986886136,1.0,2/9,14.86%,CHMP1A;IST1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.42138356558862494,0.7203274962051381,0.851063829787234,0.9752151986886136,1.0,2/9,14.86%,CHMP1A;IST1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.4365250382182531,-0.7195733605597547,0.7954545454545454,1.0,1.0,1/5,1.69%,CD200R1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.36468055351227513,0.7195720354272281,0.896551724137931,0.9758022807451782,1.0,8/35,14.31%,SIX3;ECE1;SH3PXD2B;PBX3;TGFB2;HIPK1;MEIS3;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.4792514509788878,0.719338558666092,0.7916666666666666,0.9757650705552542,1.0,1/5,7.34%,LARP6
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.36821944049661204,-0.7191537155623625,0.8444444444444444,1.0,1.0,2/19,4.36%,ERP29;APOE
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.3848861556929316,0.7183325693239064,0.8421052631578947,0.9767009338755311,1.0,2/14,7.43%,PRKAR1B;RAMP3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.4929471550105752,0.7181580242818726,0.875,0.9766207169704405,1.0,3/7,9.88%,RYR2;HDAC4;TCAP
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3466456684688397,0.7180097149793883,0.8620689655172413,0.9765120511889694,1.0,5/45,15.46%,BLM;YAP1;GADD45A;CDKN1A;TP53
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.43222950932876586,0.7178967553999959,0.8275862068965517,0.9763322293324408,1.0,1/10,6.44%,CD44
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.4206068661496716,0.7177785409992546,0.8478260869565217,0.9761952356620012,1.0,1/13,2.35%,ZFP36
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.4715753293815657,0.7177439631975152,0.8421052631578947,0.9759479974917136,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.44958670911646115,0.717733945433561,0.8148148148148148,0.9753721606599152,1.0,2/9,12.29%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.44958670911646115,0.717733945433561,0.8148148148148148,0.9753721606599152,1.0,2/9,12.29%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.3433461717015473,-0.7174902295547899,0.9210526315789473,1.0,1.0,3/19,9.75%,APOBEC3G;PTPN22;PQBP1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.31824129055963296,-0.7169918146747317,0.9354838709677419,1.0,1.0,13/55,26.08%,PSMD10;PSMD12;PSMB5;PSMB6;NABP2;PSME3;PSMD2;CUL1;INTS3;PSMB4;PSMA1;PSMD11;NABP1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.4720907001839141,0.7168851410183567,0.78,0.9759645434764582,1.0,2/5,10.20%,SLC16A10;SLC25A29
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.30582127510426693,-0.7168095013651862,0.9,1.0,1.0,8/41,19.72%,ERCC8;ABRAXAS1;ERCC6;CEBPG;RNF168;RNF8;BRCC3;UBE2V2
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.43003957323680586,0.7160155826343589,0.8571428571428571,0.976606335698979,1.0,3/8,26.00%,LOXL1;LOXL2;SUMF1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.3833979714892002,-0.715691247993729,0.8478260869565217,1.0,1.0,6/16,15.14%,SLC30A8;SLC39A10;SLC30A6;SLC30A5;SLC39A8;SLC39A6
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.38448506980763614,-0.7154345868529752,0.8478260869565217,1.0,1.0,1/15,4.21%,MCRS1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.38448506980763614,-0.7154345868529752,0.8478260869565217,1.0,1.0,1/15,4.21%,MCRS1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.41750183598551927,0.7152560817153304,0.7894736842105263,0.9772122066825407,1.0,1/7,26.93%,MVD
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.4573362904167153,-0.7149262534018533,0.7884615384615384,1.0,1.0,6/6,54.29%,BBS4;MKKS;PPARA;NENF;BBS2;SPX
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.28550859982529586,-0.714860303606412,0.9705882352941176,1.0,1.0,14/105,12.23%,SRPRA;EIF4EBP1;SRPRB;NOP56;GEMIN4;EIF2S1;EXOSC4;SLC30A5;SPCS1;EXOSC5;SERP1;YIF1A;IMP3;LSM4
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.3841493008443333,-0.7145438535305858,0.7804878048780488,1.0,1.0,2/12,15.16%,UFL1;MT3
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.41362457592673263,-0.7142544757649982,0.813953488372093,1.0,1.0,2/8,12.38%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.3671066621868353,-0.7142180752274248,0.9375,1.0,1.0,6/27,20.68%,COPB2;COPE;VTI1B;COG6;RAB33B;COPG2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.4785970114905411,0.714135278663642,0.8727272727272727,0.978137441057693,1.0,1/8,1.17%,PDGFRA
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.3709994850953895,0.7140578007874312,0.7857142857142857,0.9779114481617266,1.0,2/20,5.66%,AMN;SLC35F3
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.3592073801221004,0.7140427107583804,0.9074074074074074,0.9776287845656249,1.0,5/23,19.28%,EIF5A;IL12A;MAPK11;IFIH1;HIF1A
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.3264626256356147,-0.7137186571718643,0.926829268292683,1.0,1.0,7/48,11.93%,TNFAIP3;TRIM21;PTPN22;MUL1;RNASEL;POLR3B;POLR3F
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.35778594699030697,-0.7133676646803242,0.7857142857142857,1.0,1.0,1/15,2.55%,XG
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4333143729961916,-0.7129307270019172,0.8095238095238095,1.0,1.0,3/8,35.17%,ATP6AP2;GRN;TMEM9
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2961837427230417,0.7126672602685205,0.9459459459459459,0.978943487728421,1.0,26/112,26.32%,ATF3;RPA1;NUAK1;BAG3;MAPT;NPAS2;CAMK2B;HSPH1;NEK6;PINK1;YWHAE;CAMK2A;NEK4;AMFR;ADCY8;DNAJB6;DNAJC2;MAPKAPK2;CHORDC1;PRKN;EIF4G1;NUP160;NUP88;CREBBP;MAPK3;NUP35
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3833614505879166,0.712422907593153,0.8615384615384616,0.9789303522386841,1.0,7/20,19.03%,CDC7;BRD4;CCND1;ATAD5;CDC25B;CCNB1;RAB11A
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.47617264783516994,0.7123945593105321,0.8688524590163934,0.9786547318248469,1.0,3/7,28.16%,KYAT1;THAP4;PAH
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.48225345750574444,0.7123851311621271,0.8103448275862069,0.9783721842774932,1.0,1/6,8.80%,ATP23
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.3760010842688734,0.7123416878965249,0.8245614035087719,0.9781217116481897,1.0,7/21,26.95%,CLRN1;FSCN1;AKIRIN1;ARPC2;ACTR3;PLCE1;CYFIP1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.37599847389850855,-0.7122665005536387,0.8085106382978723,1.0,1.0,2/17,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.3797035656768023,0.7121848388654333,0.8787878787878788,0.9779989735010289,1.0,4/24,9.05%,DMTN;KCNQ1;AHR;HCN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.4883610541891396,0.7117215954860953,0.8627450980392157,0.9782022605114696,1.0,2/6,28.49%,BICD1;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.3761927500048105,0.7114002598622703,0.8412698412698413,0.9783062528632935,1.0,3/19,13.97%,SEPTIN9;ZMYND10;HAP1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.48944933644978383,0.7113686237990947,0.9016393442622951,0.978031313820039,1.0,2/5,12.04%,GRM5;EIF5A
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.44446826230258646,0.7111998916601013,0.8245614035087719,0.9779229086200757,1.0,4/8,29.59%,CALM3;GNB5;CBARP;FMR1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3145743454463139,0.7107709150099331,0.9444444444444444,0.9781613624404915,1.0,2/77,1.98%,KIF14;PSRC1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.44058249914474873,-0.7107638056881873,0.8222222222222222,1.0,1.0,3/6,35.17%,ATP6AP2;GRN;TMEM9
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.43266199919204584,0.7103191881326075,0.7931034482758621,0.9783536841661894,1.0,3/7,31.58%,KIF11;RANBP1;NSFL1C
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4252910659573684,0.7097882360982077,0.7884615384615384,0.9786095498025826,1.0,3/8,9.86%,SOX4;TBX20;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.34199950361997455,0.7097587939680045,0.8208955223880597,0.9783526084981395,1.0,3/37,7.88%,PRKCG;AGAP2;LDLR
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.33163637252524303,0.7088706344585138,0.9852941176470589,0.9790077189989567,1.0,15/48,18.63%,SOX4;VGF;PPARG;STAT3;PYGL;PDK4;BACE2;MLXIPL;KLF7;ADIPOR2;GCKR;IGF1R;STK11;HECTD4;CAV3
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.41615231284402093,0.708826250517005,0.864406779661017,0.9787402119317237,1.0,1/12,5.50%,NUDT16
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4117490173885084,0.7081945305454903,0.875,0.9791051605891626,1.0,2/17,3.51%,ICAM1;THY1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.25656798492653354,-0.7081643436790506,1.0,1.0,1.0,21/132,20.20%,CEP72;TPX2;SSNA1;FBXO5;CETN2;VPS4B;HAUS1;CEP131;PSMD10;PSMD12;PSMB5;HMMR;DYNLL1;PSMB6;CEP192;CEP78;PSME3;PSMD2;TUBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.41053894646770717,-0.7078969440404967,0.782608695652174,1.0,1.0,3/7,27.30%,MSH3;PRKDC;MSH2
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.38508239179655357,-0.7076799949962563,0.8333333333333334,1.0,1.0,4/12,13.74%,PIPOX;HYKK;GCDH;ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.38508239179655357,-0.7076799949962563,0.8333333333333334,1.0,1.0,4/12,13.74%,PIPOX;HYKK;GCDH;ALDH7A1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.405207717260206,0.70734809222921,0.8387096774193549,0.9797382723068324,1.0,3/13,19.01%,PPP1R16B;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.34791551771064644,-0.7073403584516805,0.96875,1.0,1.0,8/32,15.16%,FTH1;SLC30A8;SLC31A2;SLC30A5;ATP2C2;SLC39A8;CUTC;MT3
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.4782127476254171,0.7067015489876259,0.8627450980392157,0.980039160698766,1.0,2/5,20.15%,DKK3;BMP6
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.4387333865270269,-0.7065397065625652,0.82,1.0,1.0,1/7,4.10%,HAX1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.4227321337309703,0.7063853357305316,0.8666666666666667,0.980022239806403,1.0,2/7,19.74%,GAS6;BTG1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.333003717174948,0.7060090808397069,0.8939393939393939,0.9801464557521606,1.0,11/47,16.86%,CORO7;WAS;WASF1;FAM107A;TPPP;MAPT;FGF13;COBL;SPIRE1;SPIRE2;MICALL2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4035803776360206,0.7058463885907064,0.7833333333333333,0.9800378079182483,1.0,1/10,8.20%,BAG3
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.47265421176589195,0.7058291379311985,0.8163265306122449,0.9797634996737875,1.0,2/5,20.64%,DKK3;H6PD
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.4233243345484953,0.7057363992686736,0.8363636363636363,0.9795351800230656,1.0,5/11,27.17%,SLC29A4;SLC1A6;SLC29A1;SNAP25;SLC22A3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.43399504380810705,0.7055519339836925,0.8163265306122449,0.9794373831084713,1.0,2/6,29.35%,UBXN1;USP25
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.28512254354731315,-0.7055263251619313,0.967741935483871,1.0,1.0,13/62,20.20%,PDCD2;METTL3;KMT2A;RUNX1;PSMD10;PSMD12;LMO1;PSMB5;LDB1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3592092469767778,0.7052878803443535,0.864406779661017,0.9794664694733198,1.0,8/23,18.63%,KCNQ1;RYR2;SLC9A1;ATP1B1;SLC8A1;PDE4D;CALM3;CAV3
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.3599408549990518,0.7052451240809787,0.8983050847457628,0.9792243545129106,1.0,5/23,12.24%,WAS;PAK3;FCHSD1;PLEKHG2;ARHGAP18
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.41207547111760723,0.7049751042636172,0.9,0.9792746118751958,1.0,2/12,7.04%,ROBO2;APLNR
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.46758377047961774,0.7047571611009573,0.8269230769230769,0.9791875680901181,1.0,1/6,30.19%,XRCC4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.35832366526515647,-0.7046876014022597,0.8478260869565217,1.0,1.0,3/18,9.66%,GTF2H5;GTF2H2;ERCC2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.35832366526515647,-0.7046876014022597,0.8478260869565217,1.0,1.0,3/18,9.66%,GTF2H5;GTF2H2;ERCC2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.39885159072883375,-0.7044873417173354,0.8297872340425532,1.0,1.0,1/10,2.65%,TPP1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.3592710045234893,0.7044856071139636,0.8823529411764706,0.9791639131873588,1.0,10/30,12.83%,EPHA2;EPS8L2;BAIAP2L1;GPR87;RHOD;HR;KPNA7;ITGA3;PSORS1C1;TFAP2C
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.42542436157983277,0.704361389390753,0.8518518518518519,0.9789749412016656,1.0,2/9,23.67%,ADAM9;FLOT1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.43853041823885636,-0.7035024494270433,0.8947368421052632,1.0,1.0,3/5,25.10%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.43853041823885636,-0.7035024494270433,0.8947368421052632,1.0,1.0,3/5,25.10%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.43853041823885636,-0.7035024494270433,0.8947368421052632,1.0,1.0,3/5,25.10%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.33690677557061055,0.7029628033722144,0.9310344827586207,0.9802314200519341,1.0,7/42,16.38%,FA2H;CERS3;CYP4F22;ABCA2;SGMS1;CERS5;ST6GALNAC3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4041135660442603,-0.7027338237205908,0.7619047619047619,1.0,1.0,2/6,19.64%,BCL2L11;STK17B
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.4777611493579369,0.7022508444356509,0.8771929824561403,0.9807031750079165,1.0,2/6,24.54%,DSEL;CHST14
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.39037150580830426,0.7020222110326279,0.8813559322033898,0.9806334090396606,1.0,2/11,10.96%,NAMPT;PARP9
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4066601764218285,0.7019033654402194,0.8428571428571429,0.9804617927747611,1.0,5/11,22.15%,TJP3;TJP2;BMP6;PDE2A;TJP1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.4673880215541488,0.7018965754949891,0.8793103448275862,0.9801778794868475,1.0,1/5,12.05%,STX4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.4219559477689674,0.7016767476867612,0.7894736842105263,0.9801013085885769,1.0,4/8,31.04%,WNK1;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.35785309593581316,0.7015926545750009,0.9354838709677419,0.9799054301366895,1.0,6/38,10.41%,TLR2;MBP;APP;MYD88;STAT3;SYK
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.3337222942247021,-0.7012700711565518,0.8913043478260869,1.0,1.0,3/26,17.03%,SF3A1;KHDC4;SRSF9
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.3816410742345631,0.7010613103539072,0.9402985074626866,0.9801378073977394,1.0,2/21,7.51%,IGF1;CYP1B1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.45960938120375616,0.7010034342434965,0.847457627118644,0.9799034429320151,1.0,1/7,17.47%,WHRN
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.38931120171777533,-0.7009379940613613,0.86,1.0,1.0,2/12,5.92%,EDNRB;ASCL1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.36002519998924265,0.7007700770568065,0.8870967741935484,0.9798866675378762,1.0,6/27,20.41%,NELL1;PKDCC;P2RX7;SLC8A1;BMP6;ANO6
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.3785244185133322,0.6997820666347627,0.8805970149253731,0.9807920385285891,1.0,4/25,12.29%,ZIC1;BAG3;SMAD3;PRKCD
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.32800290663500414,-0.6996418328905754,0.8958333333333334,1.0,1.0,5/29,15.02%,THAP7;NOC2L;KMT2A;BRD7;TADA2B
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3362216184844584,0.6995963876836506,0.875,0.9806943907066679,1.0,3/39,7.23%,RPA1;POLD1;HROB
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.4047718073109367,-0.6995586097246965,0.8979591836734694,1.0,1.0,2/10,17.35%,GREM1;BMP2
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.4824727651453762,0.6992839398217606,0.8103448275862069,0.9806949167955579,1.0,1/5,8.80%,ATP23
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.32641465407036907,0.6986972477461006,0.9014084507042254,0.9810947970308329,1.0,14/52,24.62%,MAP1LC3A;ATG9A;SMURF1;GABARAPL1;ELAPOR1;PACS2;TMEM41B;RAB7A;ATG16L2;WDR45;ULK1;ATG7;VMP1;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.32958497380937635,-0.6985955291017695,0.8837209302325582,1.0,1.0,1/30,1.04%,FAM47E
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.41474059937280205,-0.6979112783674524,0.85,1.0,1.0,3/8,14.10%,APOE;PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.46950114582053615,-0.6970305325192643,0.88,1.0,1.0,1/7,4.36%,APOE
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2669787608695003,0.6968823713523243,1.0,0.9826186060373087,1.0,25/263,14.18%,YWHAH;TBC1D9;CNTN2;GRID2;CNTNAP1;SEPTIN4;CNTNAP2;SEPTIN5;SEPTIN8;SEPTIN9;TMED10;CTNNB1;SH3PXD2B;SCG5;PACSIN1;DUOXA1;USP6NL;RAB20;STX4;ARF6;TBC1D1;PICK1;COPZ2;ATG9A;SEPTIN10
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3809482547627332,-0.6967842122949954,0.8571428571428571,1.0,1.0,5/13,23.22%,HUS1;RAD9B;MUS81;RAD17;CHEK2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.421615818306713,0.6966574165400194,0.8421052631578947,0.9825590449035151,1.0,1/12,2.82%,SLIT2
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.3783511290046248,-0.696221003707605,0.9024390243902439,1.0,1.0,4/11,23.07%,NLRP9;NLRP1;AIM2;NAIP
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.42007998942946245,-0.6961621061600356,0.8108108108108109,1.0,1.0,3/6,21.81%,PHGDH;SRR;PSPH
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.30594147974709374,-0.6956904367636062,1.0,1.0,1.0,15/40,24.95%,GRPEL2;PEX10;TIMM23;ZFAND2B;TIMM50;AKT2;PEX1;DNAJC19;TIMM17A;C2CD5;SEC62;TOMM70;SEC61A1;SRP54;GRPEL1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.42099444030618216,0.6952610092770644,0.8490566037735849,0.9836545196022676,1.0,3/14,11.39%,SAMHD1;NLRC5;TTLL12
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.39310164943287107,-0.695257344034731,0.7843137254901961,1.0,1.0,1/12,1.97%,MSTO1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.456875278334787,-0.6947412094997225,0.8157894736842105,1.0,1.0,1/6,7.64%,HSPA1A
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.44662286645391414,0.6941377981708392,0.8181818181818182,0.9843784561360223,1.0,1/6,7.51%,CYP1B1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.273365983889878,0.6940914620013553,1.0,0.9841295393567365,1.0,18/165,14.26%,EGF;CCNB2;LMNB1;SUV39H1;GINS2;INCENP;PML;SMAD3;CHMP1A;TLE3;BARD1;POLQ;CDC7;CDKN1B;CCND1;CKS1B;SLC7A1;TRAIP
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.36953954215269547,-0.6936204626474498,0.9148936170212766,1.0,1.0,3/12,20.37%,EIF2S1;EIF2AK1;DDIT3
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.33613050735032496,0.6934629174263832,0.8275862068965517,0.9845241992344853,1.0,7/31,22.96%,SMCR8;RNF152;STK11;TELO2;RRAGD;SPAAR;SESN1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.4301671461485341,0.6934535490014393,0.8181818181818182,0.9842439236348173,1.0,2/6,11.54%,OLAH;ACOT7
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.3788128654116434,-0.6934281838425157,0.9523809523809523,1.0,1.0,5/19,12.33%,TRIM29;IL20RA;SCEL;EHF;MGP
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.4146541029380424,0.6933949133336562,0.8666666666666667,0.9839882773811688,1.0,2/10,3.51%,ICAM1;THY1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.3544323385449438,0.6919054735853752,0.9076923076923077,0.9851337972431802,1.0,5/30,15.46%,PTPRC;TGFB2;JARID2;PUM1;TP53
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.2746495888388157,-0.6918971843869086,1.0,1.0,1.0,6/65,9.40%,AR;APOM;HSPA1A;TFIP11;HSF1;WASHC2C
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.35310177065231996,0.6912426927336929,0.9137931034482759,0.9855032455714554,1.0,3/24,15.53%,FYN;GPR37;PINK1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.42620486223817244,0.6912062092156469,0.8909090909090909,0.9852334871030025,1.0,3/9,15.21%,PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.36059918953791337,-0.6910443353569231,0.8857142857142857,1.0,1.0,4/12,25.10%,UFL1;TEX264;UFC1;UFM1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3177771007225444,0.6909813944798433,0.9857142857142858,0.9851593676398847,1.0,6/35,14.64%,FAM107A;TRIM36;TPPP;MAPT;PHLDB2;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.4566310984752237,0.6908092032265363,0.9322033898305084,0.9850503950448086,1.0,3/5,23.69%,GCKR;MIDN;PRKN
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.3467172350762237,0.6907979905489775,0.953125,0.9847670539358964,1.0,6/27,24.47%,PPP1R16B;PRKCD;CALM3;PPP1R7;PIN1;SPPL3
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.41890330116186836,-0.6904303440338926,0.8085106382978723,1.0,1.0,1/7,1.76%,CST3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.415806962687709,-0.690367521589364,0.8367346938775511,1.0,1.0,2/9,6.53%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.32074459357671115,0.690168456856202,0.8833333333333333,0.9850837516477527,1.0,3/36,16.11%,DAB2IP;CDC7;BRCA1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3584140398079106,-0.6899034273277035,0.8837209302325582,1.0,1.0,9/26,26.67%,SUPT16H;LDB1;RNF168;RNF8;WDR43;LARP7;EAF1;LEO1;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.4054593428170488,0.6893752184183377,0.7708333333333334,0.9855955123801482,1.0,2/9,5.57%,APOD;PADI2
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.2816645983835032,-0.6891262542938423,0.9736842105263158,1.0,1.0,13/59,19.71%,PGP;PIGW;GDE1;PLA2G4C;GPLD1;PLA2G15;ENPP6;DPM2;GPCPD1;GDPD1;PRDX6;PLA2G4A;PIGF
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.3215699677487616,-0.6890562726405971,0.8857142857142857,1.0,1.0,6/30,17.45%,OAT;GLUD1;ART4;SLC39A8;ALDH18A1;GLYATL1
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.44576425938197994,-0.6888241337523316,0.7884615384615384,1.0,1.0,3/5,21.25%,DCTPP1;ENPP3;ITPA
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.41195516089647194,0.6887912060151569,0.8679245283018868,0.9858316114472222,1.0,2/11,14.40%,TESPA1;IKBKG
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.3344162906631277,-0.6887407832897172,1.0,1.0,1.0,1/25,0.81%,AR
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.35602470666374453,-0.6885970143212821,0.8461538461538461,1.0,1.0,2/16,7.85%,OAT;GLUD1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.4289292999409011,-0.688084761116041,0.8958333333333334,1.0,1.0,1/8,4.05%,GTF2H5
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.32466907922570637,0.6880404207628729,0.9180327868852459,0.9863289125369108,1.0,6/41,12.89%,APP;GRM5;FOXO3;CNDP1;MAPKAPK5;KLF4
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3526401482466648,0.687762018987081,0.9322033898305084,0.9862546233889217,1.0,2/24,10.92%,FOXO1;MAPT
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.4104063445042071,0.6874855234095919,0.7857142857142857,0.986225650410271,1.0,3/8,14.52%,EFNA1;EPHA4;BIN1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3477800753722485,0.6874815878412511,0.9295774647887324,0.9859390655149305,1.0,5/35,9.04%,PPARGC1B;PMEPA1;PADI2;PGR;YAP1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.44541657106643584,0.6870402292332054,0.864406779661017,0.9860563812062142,1.0,1/7,10.12%,SHMT1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.28915318901854514,0.6869904830508206,0.9850746268656716,0.9858535207638603,1.0,8/77,17.57%,DVL1;DAAM1;PRICKLE2;PRICKLE1;CELSR3;SMURF1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.32256796605637833,-0.68547797832798,0.9130434782608695,1.0,1.0,5/36,15.97%,DYNLRB2;DYNLRB1;CEP131;DYNC2I1;DYNLL1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.4600838239848455,0.6854427746015151,0.8409090909090909,0.9870804032808836,1.0,2/5,25.29%,SLC2A13;SLC26A6
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4024089604607729,-0.685151687906622,0.9333333333333333,1.0,1.0,5/12,28.97%,RNF168;RNF8;LARP7;NELFCD;RECQL5
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.46986607788256185,0.6849594247219674,0.8627450980392157,0.9872320541007477,1.0,3/5,41.55%,ANGPT1;SLC10A7;GLCE
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4046640839793517,0.6849574383917717,0.9180327868852459,0.986942118108354,1.0,4/12,20.13%,TCP1;CCT4;CCT8;WRAP53
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.29817953619305215,-0.6849241024437344,1.0,1.0,1.0,4/34,13.61%,RPL23;PDCL3;RPL11;HFE
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.2876030894411515,0.6848085633234724,0.9848484848484849,0.9868052673030139,1.0,8/77,17.57%,DVL1;DAAM1;PRICKLE2;PRICKLE1;CELSR3;SMURF1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.33833871976758323,-0.6842892207962892,0.7894736842105263,1.0,1.0,1/17,1.84%,AGER
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.4458663048807718,0.6842581053756208,0.8478260869565217,0.9869846598996728,1.0,1/7,1.94%,ACTA2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.2935877880748716,-0.683961529243296,0.9459459459459459,1.0,1.0,7/48,12.99%,ADAMTS9;GAL3ST2;FBXO27;GANC;GAL3ST4;GANAB;AGA
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.3863112062637517,0.6839416244054846,0.8823529411764706,0.9869312361218814,1.0,3/13,10.43%,CTU2;GTPBP3;TRMT9B
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.4433997368417518,-0.6832754955855677,0.8958333333333334,1.0,1.0,1/5,7.28%,CAP1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.34059686674486295,0.6831937281139345,0.9016393442622951,0.9873084065426511,1.0,4/26,9.86%,ECE1;CACNA1C;CTNNB1;TGFB2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.4181003414636118,0.6829989461243959,0.8813559322033898,0.9872028502156284,1.0,2/10,12.17%,MICALL1;ARF6
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.32004267814896625,0.682982533581913,0.9393939393939394,0.9869238435221492,1.0,6/39,20.16%,CHD3;SRCAP;SMARCA1;SPTY2D1;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.3810150888103737,0.6827297634729206,0.8620689655172413,0.9869156001642799,1.0,6/12,22.72%,SYNJ2;INPP5A;INPP5J;IMPA1;SYNJ1;OCRL
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.36893666833882827,0.682677997407892,0.8333333333333334,0.9867131417863584,1.0,3/16,12.18%,DNM1;MTFR2;MX1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.35091993470100336,0.682550738342984,0.9122807017543859,0.9865524083620951,1.0,3/23,16.27%,SLC26A8;PDPN;SLC1A6
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.43512244399218913,-0.6820635785996745,0.9090909090909091,1.0,1.0,1/7,6.17%,MUL1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.36385935275439424,0.6816314285980335,0.8867924528301887,0.9871265993280014,1.0,8/23,27.80%,SYVN1;MAN1A1;RNF185;MARCHF6;RPS27A;AMFR;MAN1C1;EDEM1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.41557671136626434,0.6806754383186008,0.90625,0.9877558967687647,1.0,2/13,15.53%,PID1;PINK1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.43944932929786684,-0.6804323260007202,0.9166666666666666,1.0,1.0,2/8,14.29%,VAX2;AMER2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.3223567318244555,-0.6802928969279248,0.8888888888888888,1.0,1.0,1/16,5.04%,TUBD1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.449769011310393,-0.680255004156252,0.7959183673469388,1.0,1.0,2/7,14.94%,WARS2;YARS2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.26063065278630837,0.680132662431939,1.0,0.9879933767376403,1.0,64/241,26.95%,TEKT2;PTPRO;SHTN1;DMTN;CYS1;RHOD;EMP1;RAP2B;CDC14A;ARHGEF7;MINK1;MAK;FSCN1;RP2;P2RY12;IFT122;OPHN1;FGD5;ARF6;CFAP20;TRAPPC14;PPP1R9B;ABCC4;P2RX7;CILK1;TXNDC15;IFT140;RAP1A;SNX10;FLNA;RILPL1;RAB11A;EXOC2;RAP1B;ARHGEF6;EHD4;ANO6;TTBK2;ASAP1;MTSS1;ABLIM2;AHI1;OCRL;CFAP44;WDR90;VCL;CDH13;MAP4K4;CFAP54;ACTR3;CC2D2A;RAB11FIP3;EMP2;RFX3;IFT43;CARMIL1;SRGAP2;KIAA0586;EXOC4;DYNC2I2;RAP2A;GSN;TTC39C;CYFIP1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3698484033870619,0.6801089184786066,0.921875,0.9877354889902844,1.0,5/18,18.63%,RYR2;GRK2;C12ORF57;CALM3;CAV3
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.3980485597612997,-0.6799245609383904,0.8636363636363636,1.0,1.0,1/7,11.87%,CTH
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.41592137045902466,0.6795799857254199,0.9104477611940298,0.9879312905072172,1.0,5/11,24.45%,GAS6;IFIH1;WNT5A;TRIM44;DHX9
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.3543400042601145,0.6792362334617079,0.9180327868852459,0.9879781496639448,1.0,4/26,12.40%,CENPP;MIS18A;CENPV;CENPH
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.4371700463701536,-0.6782595168945115,0.9215686274509803,1.0,1.0,1/5,11.31%,RUNX1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.43420778397996596,0.6778868050768634,0.9038461538461539,0.9889073072352106,1.0,1/7,7.38%,TYR
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3158284253181876,-0.6778134793726672,1.0,1.0,1.0,5/26,9.58%,BAK1;HSPA1A;ABCB10;HSF1;HSPA13
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.3027837469799729,-0.6777969514684219,0.8947368421052632,1.0,1.0,2/27,8.40%,SNF8;VPS4B
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.3180838099627029,-0.6777250271822599,0.9117647058823529,1.0,1.0,3/24,8.52%,FOXJ1;RSPH1;SPAG17
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.2682773739829017,-0.6777238819384108,1.0,1.0,1.0,7/89,12.85%,PADI4;BRDT;CHRAC1;CHD4;SMARCD1;MPND;ERCC6
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3127481405600587,-0.6769327598730246,0.9,1.0,1.0,6/28,17.42%,SETDB1;SMYD2;KMT2A;MEN1;WDR82;EZH2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.34843566854618824,0.6758936440935274,0.9,0.9903893761698006,1.0,8/24,16.14%,THBS1;PPARG;GADD45A;STARD13;KLF4;FGF2;ANGPT2;ATP2B4
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.45519087394779456,0.6756622650173745,0.8913043478260869,0.990321359524754,1.0,1/5,1.94%,ACTA2
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.3605127564410632,-0.675400134377236,0.9,1.0,1.0,6/20,22.92%,POLR2K;POLR2C;POLR2D;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.3605127564410632,-0.675400134377236,0.9,1.0,1.0,6/20,22.92%,POLR2K;POLR2C;POLR2D;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.3256045764275663,-0.6752456578834555,0.9583333333333334,1.0,1.0,4/25,11.69%,HSPG2;SDC3;GPC6;HPSE2
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3964702946181347,0.675209985365547,0.828125,0.990505748688627,1.0,3/8,17.73%,PTPRC;ELF1;CBFB
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.3557522634591004,-0.6751796021723256,0.8809523809523809,1.0,1.0,3/11,15.74%,LY96;TRIL;TIRAP
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.3409089182913243,0.6749704117622599,0.9818181818181818,0.990399721121534,1.0,5/35,16.11%,BLM;DONSON;CDKN1A;MRE11;BRCA1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.302774165118684,-0.6743117306911991,0.8974358974358975,1.0,1.0,2/28,8.40%,SNF8;VPS4B
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.43976731899273924,0.674235644809251,0.8490566037735849,0.9907636424468831,1.0,3/7,16.42%,ATP2B3;ATP2B4;SLC8A2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.3067315941308359,-0.6740919692041387,1.0,1.0,1.0,4/30,7.95%,FBXO5;CCN1;FZD9;ATRAID
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.42122406967373716,-0.6740464595500205,0.9259259259259259,1.0,1.0,2/8,15.16%,LEPR;MT3
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.47018942432856586,0.673233252190025,0.8636363636363636,0.9913276858965415,1.0,3/5,39.01%,GSK3B;CSNK1A1;AMER1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.3743942626485378,0.6725286378030528,0.8793103448275862,0.9914709576769527,1.0,2/12,17.47%,DAPK2;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.3743942626485378,0.6725286378030528,0.8793103448275862,0.9914709576769527,1.0,2/12,17.47%,DAPK2;CAMK1D
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.38774621750091376,0.6721371695225326,0.9016393442622951,0.9915546094896694,1.0,4/12,28.03%,TLE6;MAP4;NLRP5;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.32291064797858415,-0.6720387555771759,1.0,1.0,1.0,4/21,14.39%,TPT1;SFRP2;TRIAP1;CLU
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.4318418473728115,-0.6718746110447132,0.8260869565217391,1.0,1.0,4/6,23.97%,BAD;MTLN;AKT2;VCP
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.37652582475630053,0.6717670010836156,0.8363636363636363,0.9916071623924766,1.0,1/12,6.62%,ECE1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.2965054566172501,0.6711346880294122,0.96875,0.9918355842384903,1.0,5/61,10.66%,SLC4A10;SLCO1A2;SLC4A9;SLC4A11;SLCO2A1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.3545332953983681,-0.6709784112328636,0.8913043478260869,1.0,1.0,2/13,19.13%,SLC25A22;SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.47207427292334314,0.6708958870105041,0.8372093023255814,0.9917432084074875,1.0,1/5,16.11%,BRCA1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.3095272688162851,-0.6706900051546255,0.9534883720930233,1.0,1.0,6/36,12.42%,SMYD2;FBXO5;KMT5A;WDR76;USP51;NSMCE4A
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.39603947875552686,0.6698058759561748,0.9433962264150944,0.9923850978890926,1.0,4/11,17.21%,HACD1;ELOVL7;ELOVL5;HACD4
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.3530257125216371,0.6697987354952203,0.8909090909090909,0.9921030859282823,1.0,6/26,15.61%,FABP3;MFSD2A;LDLR;SORBS1;MLXIPL;ELOVL5
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.4064743108156233,0.6692084129349204,0.875,0.9922932025706579,1.0,1/11,3.17%,APP
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.4104407819622894,-0.6692083673385522,0.7804878048780488,1.0,1.0,2/7,30.97%,PEX1;PEX12
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.39473684127223796,-0.6691501773587898,0.8421052631578947,1.0,1.0,2/11,13.83%,TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.35839638988737244,0.6688033289443556,0.8857142857142857,0.9923523368240638,1.0,6/25,20.58%,NOS1AP;ATP2B4;CAV3;DNM2;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3818615905392031,0.6687866289161212,0.8955223880597015,0.9920877954357405,1.0,4/16,13.13%,GABBR2;CACNA1C;ORAI1;CAP2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.32947715362393915,0.6686515193251603,0.967741935483871,0.9919128996552534,1.0,6/35,14.92%,PSRC1;TPPP;DCX;RSPH4A;CFAP74;MTCL1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3278113216895766,-0.6686174038155451,0.9302325581395349,1.0,1.0,2/26,5.53%,GDF9;TWSG1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.36609593348641284,-0.668491611933984,0.9024390243902439,1.0,1.0,2/12,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.36426788735009374,0.6680948080954191,0.9361702127659575,0.9920168257637294,1.0,3/15,14.52%,LDLR;SHANK1;RGS14
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.3547818290802715,-0.6680856448812933,0.8205128205128205,1.0,1.0,2/12,10.55%,SUPT16H;SMARCD1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.3547818290802715,-0.6680856448812933,0.8205128205128205,1.0,1.0,2/12,10.55%,SUPT16H;SMARCD1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.3436080230993608,0.6679261892375152,0.8301886792452831,0.991893652114897,1.0,4/24,26.37%,MORF4L2;MORF4L1;CREBBP;BAG6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.41299510122643057,0.6678601344406531,0.8793103448275862,0.9916742582952979,1.0,2/10,20.40%,TP53;THRA
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.35462615143902704,-0.6678248478013379,0.8392857142857143,1.0,1.0,1/11,6.59%,ZNF502
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.369407746260915,0.667735796788407,0.921875,0.9914756198707484,1.0,6/17,19.03%,CDC7;BRD4;CCND1;CDC25B;CCNB1;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.3950513600602292,-0.6673462331816568,0.8636363636363636,1.0,1.0,4/13,22.42%,TRIB3;ERLIN2;APPL2;ERLIN1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.4659048075006089,-0.6670290718403127,0.875,1.0,1.0,1/5,10.96%,BECN1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.39856555354122103,0.6669620357113164,0.847457627118644,0.9918476377513101,1.0,1/12,2.53%,CD55
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.3810925981102167,0.6669076394827437,0.9508196721311475,0.9916112683626426,1.0,3/13,15.61%,ALOX12;PNPLA8;ELOVL5
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4125595048080721,-0.6668480055194165,0.8409090909090909,1.0,1.0,2/6,11.13%,VPS4B;APEH
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.44282511260326973,0.6666591938377213,0.875,0.991522741112003,1.0,1/7,7.32%,UGDH
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.358379767647677,-0.6664363153600518,0.8484848484848485,1.0,1.0,6/19,16.95%,SLC8B1;YME1L1;SLC25A23;LETM1;MICU2;AFG3L2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.3252802567894455,-0.6663445175983769,0.9069767441860465,1.0,1.0,3/24,12.24%,SPDL1;LLGL1;CENPA
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.4306518932224408,0.6660279339938678,0.8653846153846154,0.9918566475206579,1.0,3/10,18.23%,PTPRC;FADD;ADAM17
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.44387205024067133,0.6660147717862839,0.890625,0.9915792850993231,1.0,1/7,11.22%,TRUB1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.39320625964434686,0.6653206119656125,0.8421052631578947,0.9916014533653459,1.0,6/11,22.72%,SYNJ2;INPP5A;INPP5J;IMPA1;SYNJ1;OCRL
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.39320625964434686,0.6653206119656125,0.8421052631578947,0.9916014533653459,1.0,6/11,22.72%,SYNJ2;INPP5A;INPP5J;IMPA1;SYNJ1;OCRL
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.3182424085149947,0.6651692401181653,0.9333333333333333,0.9914616068905565,1.0,9/43,24.78%,DAB2IP;BAG3;OPTN;HSPH1;PACRG;HSPA4;HSPB1;PRKN;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.37515362529408247,0.6648222316074887,0.90625,0.9914590025777197,1.0,3/15,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.36615784948704794,0.6645060270728207,0.9333333333333333,0.9914563997733176,1.0,2/17,9.30%,PLSCR1;IKBKE
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.3656185080318233,-0.6643538495028065,0.9142857142857143,1.0,1.0,1/11,3.65%,CXXC4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.30287584905913073,0.6634346586450495,0.9692307692307692,0.9921289259316829,1.0,2/64,1.68%,IGF1;THBS1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.3367991771442166,0.6633515291141204,0.9032258064516129,0.9918931592653614,1.0,4/26,15.61%,ACSL5;HACD1;ELOVL7;ELOVL5
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.35560748980484413,0.663028232002947,0.9285714285714286,0.9918801579172578,1.0,6/15,20.58%,MLXIPL;GCKR;PNPLA8;RORA;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.3663043119893402,0.6625449425361855,0.9361702127659575,0.9920383675368525,1.0,2/13,9.86%,TBX20;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.4051318059842195,0.6623741079363944,0.8214285714285714,0.9916187631848141,1.0,3/8,17.11%,HDAC4;FBP1;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.4051318059842195,0.6623741079363944,0.8214285714285714,0.9916187631848141,1.0,3/8,17.11%,HDAC4;FBP1;NCOR1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.41804270520791176,0.6622753010354852,0.86,0.9914176956683788,1.0,2/6,9.88%,CTNNB1;TCAP
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.3819549657964042,-0.6622383349841936,0.8043478260869565,1.0,1.0,1/8,18.58%,ERCC3
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.443790275951253,0.6618609412362304,0.8958333333333334,0.9914629923776671,1.0,1/6,9.91%,NFKBID
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.4096584487629808,0.6618202664796927,0.8490566037735849,0.9912107991570288,1.0,4/7,26.04%,BIN1;YWHAE;SESTD1;CBARP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3482531934674835,0.6616305554283162,0.9655172413793104,0.9911159858595978,1.0,6/23,17.94%,DAB2IP;BBC3;BCL2;TNFRSF10B;MAP3K5;ITPR1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.3979692317058226,0.6615339546750556,0.8545454545454545,0.9909733872097005,1.0,2/7,13.58%,FAS;FADD
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.36262443772061714,-0.6615078576434216,0.8775510204081632,1.0,1.0,4/20,19.33%,CARF;MT3;BMP2;SESN2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.31253123818128925,-0.6615014944341479,0.926829268292683,1.0,1.0,6/28,13.79%,NUDT16L1;TFIP11;HSF1;USP51;ERCC6;PNKP
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.3301494966383983,-0.661304045750306,0.9761904761904762,1.0,1.0,3/17,10.37%,DHFR2;ALDH1L2;SLC46A1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.41678986673912854,0.6610748646007405,0.864406779661017,0.9910460891633304,1.0,1/9,3.81%,NOS1AP
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.40081814642669933,0.6609354720249417,0.9152542372881356,0.9909035929640955,1.0,7/15,27.47%,CLTB;NSG2;FCHO2;CALY;CLTC;NSG1;PICALM
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.3869866865855273,-0.6603249663973167,0.8085106382978723,1.0,1.0,2/6,25.28%,FOXO4;MYOCD
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.34385392818747623,0.6602315539935769,0.9482758620689655,0.9911435685539304,1.0,7/27,24.96%,PGAP4;PIGA;PIGB;PIGK;PIGQ;PIGH;PIGX
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.39758147523755305,-0.6599360178839022,0.8666666666666667,1.0,1.0,4/6,33.97%,NMD3;NPM1;SDAD1;RAN
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.40954981169843196,-0.6593252521679781,0.9166666666666666,1.0,1.0,2/9,10.81%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.40954981169843196,-0.6593252521679781,0.9166666666666666,1.0,1.0,2/9,10.81%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.4333044683718104,-0.6588871145621785,0.9322033898305084,1.0,1.0,1/5,5.92%,ASCL1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.35146288897686695,0.6588671285979008,0.9076923076923077,0.9920250889028008,1.0,9/23,22.87%,DUSP1;HECW2;NEK6;LCMT1;CCNB1;CDK5RAP2;CDC27;CUL3;USP44
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.36957278168363217,-0.6588426122339787,0.875,1.0,1.0,3/15,6.81%,PGP;CBFA2T3;MST1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.4216651189527456,0.6587648587211016,0.8846153846153846,0.9918346625799914,1.0,1/6,5.06%,TNFRSF14
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.32740734464953314,-0.6587032349235873,0.8974358974358975,1.0,1.0,2/17,5.85%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.40620091699371375,0.6586759284138818,0.9152542372881356,0.9916272898080125,1.0,4/10,20.13%,TCP1;CCT4;CCT8;WRAP53
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.34787935517493185,0.6584148239413933,0.953125,0.9915155237547373,1.0,2/21,6.44%,HIC1;CD44
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.38012867601153993,0.6581934759596478,0.8771929824561403,0.9913867757028568,1.0,5/8,31.32%,ASXL1;GPS2;ASXL2;CITED2;SIRT1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.34519280353788506,0.6580228038921535,0.8947368421052632,0.991200160789418,1.0,3/22,12.11%,RPA1;POLD1;PMS2
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.3701763540782964,0.6579379398664551,0.9310344827586207,0.9909625436123164,1.0,6/12,20.58%,MLXIPL;GCKR;PNPLA8;RORA;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.3946022560810442,0.6578824127547259,0.9636363636363636,0.9906978125314253,1.0,4/10,23.69%,PID1;TFRC;ADCK1;PRKN
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3555434955912419,0.6574675368047819,0.9230769230769231,0.9907499315781716,1.0,2/24,13.24%,TMED10;OPTN
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.40989844173147955,0.656642117855262,0.8888888888888888,0.9911424579838998,1.0,4/10,20.24%,MYO1C;GAB1;PIK3CD;VEGFD
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.4319893182578782,0.6565545398037956,0.8958333333333334,0.9909255510451623,1.0,2/5,31.93%,CTPS1;CTPS2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.3937180579309431,0.6564800655639359,0.9354838709677419,0.9907223784665536,1.0,3/11,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.4588603526055103,0.6562651048279673,0.9230769230769231,0.9905499356010001,1.0,1/6,12.99%,PHACTR1
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.41567531686794984,0.6559063012379301,0.803921568627451,0.9905952213438657,1.0,1/5,18.63%,CAV3
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.40445949178973295,-0.6556725739009533,0.8064516129032258,1.0,1.0,1/7,4.40%,FOXJ1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2715191692841909,-0.6556343690994888,1.0,1.0,1.0,12/58,20.20%,METTL3;KMT2A;RUNX1;PSMD10;PSMD12;LMO1;PSMB5;LDB1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.4278276217130058,0.6549756968731961,0.9464285714285714,0.9910246228636046,1.0,1/6,17.55%,GNAI1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.39403491370934307,-0.6549648309847048,0.8367346938775511,1.0,1.0,1/8,4.99%,RNF2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.31756584278839306,-0.654822065225603,0.9761904761904762,1.0,1.0,4/30,8.96%,ARHGAP28;HAX1;TPPP3;GBA2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.40248113408455083,0.6547680394550199,0.9622641509433962,0.9908930238565732,1.0,1/12,2.45%,NELL1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.37517538172662224,-0.6546059479838431,0.8076923076923077,1.0,1.0,1/12,3.01%,COPS8
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.3739639643814329,-0.654460628450665,0.8205128205128205,1.0,1.0,3/10,22.28%,VPS11;RDX;PTPN23
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3065433814441344,-0.6534941309377862,0.926829268292683,1.0,1.0,5/27,24.10%,KIF20B;CEP131;TENM1;GCC2;PCM1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.3440266457880029,-0.6532761207325837,0.9148936170212766,1.0,1.0,5/15,23.90%,ASAH2B;SPTLC3;DHFR;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.3227371838387198,0.6531690277366528,0.9117647058823529,0.9919676247398221,1.0,4/32,7.51%,AWAT1;ALOX12;FAAH;CYP1B1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.34909811579355843,0.6524192964468127,0.9444444444444444,0.9922977626184466,1.0,5/21,17.14%,HOOK1;KIF5A;KIF5C;TUBA1B;HOOK2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.4170350383226935,-0.6523254568980213,0.875,1.0,1.0,1/7,4.92%,SERPINF2
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.3114899456582111,0.6522460345141525,0.9558823529411765,0.9921727028167426,1.0,13/50,24.62%,MAP1LC3A;ATG9A;GABARAPL1;ELAPOR1;PACS2;TMEM41B;RAB7A;ATG16L2;WDR45;ULK1;ATG7;VMP1;GABARAPL2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.3711939940805337,-0.6521779433416708,0.8723404255319149,1.0,1.0,6/10,28.70%,SLC25A23;MICU2;AFG3L2;MCU;MICU1;MICU3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3286321626021843,-0.6519845034361319,0.9333333333333333,1.0,1.0,5/32,10.47%,AR;CFTR;AKR1C3;NCOA4;MAP4K1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.2641584153823635,-0.6518880048535992,1.0,1.0,1.0,12/67,17.53%,ARRDC4;TRIB3;BCL10;PEF1;RPS2;SPSB4;TBC1D7;PSMD10;DCUN1D2;HSPBP1;TSPYL5;FANCM
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3284350276824244,-0.651608049591468,0.95,1.0,1.0,6/20,17.60%,ABCA13;CPTP;SLC46A1;TAP1;SLC19A1;SLC5A6
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.43797633727612184,0.6516015233940763,0.9137931034482759,0.992390570388463,1.0,2/5,22.15%,WNT5A;PTPN11
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.4109355305672576,-0.650737369023136,0.9069767441860465,1.0,1.0,2/5,18.78%,WASHC2C;CARMIL2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.4505904743021899,0.650606568676144,0.9074074074074074,0.9928560485454203,1.0,1/5,10.34%,HMGCLL1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.2721697686417835,-0.6502353102314976,0.96875,1.0,1.0,8/51,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;NQO1;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.22278998428128385,-0.6499307170953396,1.0,1.0,1.0,54/312,22.36%,CDC26;ERCC8;TNFAIP3;RNF6;ELOC;FBXO45;KCTD2;RNF114;VPS4B;PPP1R11;ZFAND2B;SPSB4;RAD23A;FBXL22;FEM1A;PSMD10;ANAPC15;PSMD12;UBL7;PSMB5;WDR91;KLHL8;RNF5;RNF126;DCAF11;RNF168;RNF8;PSMB6;RC3H1;RNF167;TRIM3;FEM1C;PSME3;RNF34;GID8;PSMD2;UBXN2A;UBE4A;SKP2;PSMB4;COPS3;KLHL20;SHARPIN;NUB1;DDIT3;NHLRC3;UBE3D;KBTBD7;RCHY1;UBE2A;GID4;FBXL14;PTPN23;ATXN3
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3337087228521105,-0.6497047818788871,0.9210526315789473,1.0,1.0,4/24,17.99%,HEYL;VPS11;CNOT1;CNOT9
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.46323749421939037,0.6494816580308878,0.8979591836734694,0.993470537111895,1.0,2/5,24.41%,BCAT1;BCAT2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.408553293760383,-0.6494344804755269,0.9,1.0,1.0,2/7,14.30%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.318010120756212,0.6484378390124521,0.9824561403508771,0.9940270147662124,1.0,5/46,8.93%,NSDHL;ABCA5;SOAT1;CYP1B1;CYP21A2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.3634506507908714,-0.6477836506098045,0.8043478260869565,1.0,1.0,7/7,63.68%,PRKRA;TSN;TARBP2;DROSHA;MRPL44;AGO2;DICER1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.3692994492079188,-0.647329725731285,0.8723404255319149,1.0,1.0,1/10,9.24%,HSF1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.3580564097369017,0.6469421217443051,0.896551724137931,0.994817133347522,1.0,2/16,6.05%,SLC39A14;SLC39A11
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.3090186376371047,0.6467539416823294,0.9375,0.9947288542035678,1.0,4/29,16.30%,RPA1;CDC7;POLE3;CDK2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.2698632780189687,-0.6462474722377038,1.0,1.0,1.0,8/62,11.37%,GSTT2B;TPP1;RHCE;PCSK1;SPCS1;APEH;ERAP2;MMACHC
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.41507240029003745,0.6461890521283193,0.8888888888888888,0.9948913952774748,1.0,2/5,24.81%,FZD7;SOX6
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.42385076713461106,0.645453086737032,0.9215686274509803,0.9951080482626289,1.0,1/6,25.75%,MACROH2A1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.3479976192961973,0.6450078837427871,0.94,0.9951416879019694,1.0,2/16,12.47%,PDK4;BCL2
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.4133042732648746,0.6446606143907443,0.98,0.9951109767409434,1.0,3/7,18.24%,PAK1;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.36552675118785893,0.6445417890822699,0.9433962264150944,0.9949347323095298,1.0,1/13,6.35%,NRG1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.3066277790890391,-0.6445321901405031,0.9310344827586207,1.0,1.0,10/41,17.18%,CYP4F3;ABCD1;PLA2G4C;ELOVL2;EPHX1;CYP4F12;DEGS1;PTGR1;FAAH2;GSTP1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.33059874767635417,0.6445157572833639,0.9420289855072463,0.9946773741956683,1.0,7/29,24.57%,NUDT16;RNASEH2C;SUPV3L1;SND1;ENTPD2;EXOSC7;DNASE1L2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.32154195214829223,0.6439442904255194,0.9682539682539683,0.9947719918938995,1.0,5/31,15.78%,CENPP;MIS18A;CENPH;CABIN1;H3-3A
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.3841957639351201,-0.643757006067172,0.9142857142857143,1.0,1.0,2/11,10.81%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.327127052337287,0.6433888231480915,0.9692307692307692,0.9948530275177286,1.0,5/25,11.08%,FGF12;KCNIP4;KCNH2;HOMER1;KCNAB3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.23736051642169378,0.6429697652311165,1.0,0.9948258237038728,1.0,54/351,23.33%,ANLN;GOLGA8O;TEKT2;MAP1LC3A;CYS1;MAPRE2;HAUS7;CDC14A;SH3PXD2B;YTHDF1;GOLGA8A;CHMP1A;MAK;RP2;MAPT;IFT122;CFAP20;TRAPPC14;VPS37B;ATG9A;CDS2;ABCC4;NEK6;IST1;ABCA3;CILK1;TXNDC15;IFT140;NCOR1;GABARAPL1;SNX10;FLNA;RILPL1;ELAPOR1;RAB11A;TUBGCP6;EXOC2;EHD4;PACS2;TTBK2;ASAP1;TMEM41B;RAB7A;ATG16L2;RCC1;WDR45;MAPRE3;AHI1;OCRL;CDS1;CFAP44;BICD1;WDR90;ULK1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.2874958021956703,-0.6419824801035174,0.9772727272727273,1.0,1.0,5/38,11.18%,CST3;HSPG2;CALB1;NCSTN;TSPAN33
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2843547307372635,0.6415804826680642,0.9836065573770492,0.9955557711773503,1.0,5/79,8.33%,RBM24;SRRM4;KHDRBS2;MBNL2;CELF3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.3833723203646462,0.6415584523115118,0.9047619047619048,0.9950044222871988,1.0,3/11,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.3833723203646462,0.6415584523115118,0.9047619047619048,0.9950044222871988,1.0,3/11,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.31479911217031575,-0.6415490523774618,0.9285714285714286,1.0,1.0,4/28,13.84%,ATP6V1E2;ATP6V1G1;ATP6V1F;GPR89A
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3368997210590361,0.6412295525875913,0.9322033898305084,0.9949772063251219,1.0,1/23,3.94%,SUV39H1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.34447183874089377,-0.6410077907311434,0.9512195121951219,1.0,1.0,4/12,20.69%,GLUD1;IDH3G;IDH1;ACO1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.42406891267459923,0.6405560101429565,0.9019607843137255,0.9951221928019538,1.0,1/5,14.30%,ABCC4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.36644003564026806,0.6402156257398234,0.8813559322033898,0.9950915835279742,1.0,1/13,10.77%,TERF2IP
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.32019370822727916,-0.6392812261912525,0.8837209302325582,1.0,1.0,1/17,3.35%,RHOH
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.34942777909744577,-0.6392666326970167,0.9230769230769231,1.0,1.0,5/9,24.39%,CYP2C8;PLA2G4A;FADS1;MGST2;LTA4H
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.257002070379504,-0.6384815254038747,1.0,1.0,1.0,10/75,15.58%,CEBPA;TRIB3;CBFA2T3;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.32378828734501663,-0.637923524359425,0.95,1.0,1.0,1/22,2.86%,EIF4EBP1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.3715219435201379,0.636986417270096,0.875,0.9969438450372262,1.0,1/14,3.17%,APP
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.27574869520992895,-0.635053459943285,1.0,1.0,1.0,3/49,4.36%,ATP10B;NPC2;APOE
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.33670851308845484,-0.6349212634084012,0.9629629629629629,1.0,1.0,4/17,17.35%,TRIB3;AKR1C3;ERLIN2;BMP2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.291233723649356,0.6346000892158342,0.9833333333333333,0.9981372519604701,1.0,5/65,13.54%,MAP3K14;BIRC3;CHI3L1;RELB;TNFRSF10B
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.30872448052229656,-0.6339425098891273,0.95,1.0,1.0,3/24,7.68%,SLC6A13;SLC25A19;SLC36A1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.33278571754872677,-0.6336409103497602,0.9767441860465116,1.0,1.0,4/20,22.96%,SPDL1;CENPA;DYNLT1;PLK1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.4139480595272833,-0.6333597460174856,0.9069767441860465,1.0,1.0,5/5,58.62%,ACSL3;ATP2C1;RACK1;CLN3;CNST
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.3563096403895357,-0.6333578984434869,0.9333333333333333,1.0,1.0,2/14,14.30%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.31173876432933456,-0.6331807457863398,0.9393939393939394,1.0,1.0,4/19,15.19%,HSPA1A;CLU;BBS10;TMEM35A
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.40018142390271194,-0.6330414473722443,0.9210526315789473,1.0,1.0,1/5,20.44%,SLC1A4
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.33078949815954733,0.6319539460342599,0.9491525423728814,0.9995862787302556,1.0,6/25,18.74%,SLCO1A2;SLC51A;SLC27A5;ABCC4;RXRA;ABCC3
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3170700889056633,0.6318727524626337,0.95,0.9993588913271131,1.0,3/30,13.24%,DAB2IP;BAG3;OPTN
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.4218190647361254,0.6315371842004385,0.9464285714285714,0.9993574532957643,1.0,2/6,21.56%,ZBTB1;C5AR1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.4114933637927176,0.6312252088390055,0.88,0.9992987348117442,1.0,1/7,17.47%,WHRN
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.3634917844282733,0.6309242289062951,0.9516129032258065,0.9991726791939489,1.0,10/13,42.09%,ATG7;UBA2;UBA6;UBA5;SAE1;ATG10;UBA1;UBA3;UBA7;DESI1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3616462975357581,-0.6304071142205926,0.9333333333333333,1.0,1.0,4/11,28.72%,SEC62;SEC61A1;SEC63;GET3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.2560721554017062,0.6301537719178943,1.0,0.9993363062643388,1.0,26/143,21.89%,PIM3;APP;BTG3;CDK9;HECA;SMAD3;CDKN1C;TTLL12;SRA1;CDKN1B;CKS1B;IQGAP1;NEK6;CDC25B;SCRIB;CCNB1;SKP1;PRKCA;CDC27;BTG1;TTC28;TFAP4;MEIS2;UBE2E1;RCC1;DDB1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.365216323929914,0.6299228167114799,0.9464285714285714,0.9991833787721865,1.0,7/11,28.56%,TMED10;ABCA2;RANBP9;FLOT2;PRNP;PICALM;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.43498968338121075,0.6297683756401925,0.8703703703703703,0.9989834190842554,1.0,3/7,10.44%,APP;FAM107A;EPHA4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3185621454588682,0.6294492687777098,0.9538461538461539,0.998955172653364,1.0,4/29,12.40%,CENPP;MIS18A;CENPV;CENPH
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.38365644392109655,0.6294158034905039,0.9242424242424242,0.9986948441143232,1.0,5/9,23.81%,NTRK3;F3;VEGFD;CXCL12;CDH13
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3415430585023987,0.629135095864376,0.9166666666666666,0.9985859888532517,1.0,1/18,1.95%,SLC7A2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.40689863574030855,-0.6288202390595139,0.8775510204081632,1.0,1.0,1/5,11.16%,ZNF304
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.400705191776334,0.628669588003827,0.8793103448275862,0.9986116686562618,1.0,2/6,18.42%,PDE4D;ADRA1D
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.34137184688846445,-0.6286443834730899,1.0,1.0,1.0,6/19,29.14%,NEMP1;TARDBP;UBXN2A;PLK1;CHMP2A;SPAST
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.3059593040098872,-0.6285773347317722,0.9787234042553191,1.0,1.0,7/20,21.42%,NUDT7;NT5E;AMPD3;PRTFDC1;PNP;MLYCD;NT5C1A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.341217319752588,-0.6283167697324625,0.8372093023255814,1.0,1.0,2/17,12.29%,MAPK7;HTRA2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.21368073255914974,-0.6282167097741036,1.0,1.0,1.0,24/341,11.81%,SELENOS;ARRDC4;TRIM21;RNF6;AAAS;ELOC;FBXO45;RNF25;RAE1;NUP50;RNF212;TRIM52;MUL1;ABCB11;BCL10;CCDC22;TRIM68;VPS11;UBE2M;PEX10;TRIM7;SPSB4;URM1;UFL1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.34214982191860804,-0.6279588004631493,0.9523809523809523,1.0,1.0,13/13,65.82%,AGO4;PRKRA;TUT4;TUT7;TARBP2;ADAR;AGO3;DROSHA;MRPL44;AGO2;DICER1;AGO1;LIN28B
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.40029648370254967,0.6277272196771778,0.9310344827586207,0.9989398127418219,1.0,3/8,19.69%,APOD;KLF4;MAP2K5
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.2946379657734965,0.6275039893909884,1.0,0.9987940214967524,1.0,6/46,10.12%,MTHFD2;GPT2;ACOT4;ASS1;ALDH1L1;SHMT1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.3212608275793605,-0.6272179301480633,0.9302325581395349,1.0,1.0,3/17,11.94%,MGAT4D;WDR87;SPATA33
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.33471337024176606,0.6268257200123233,0.9137931034482759,0.9989539791595972,1.0,1/13,7.99%,ACOT4
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.34174809505447146,-0.6267900315780165,0.8461538461538461,1.0,1.0,4/12,23.90%,ASAH2B;SPTLC3;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.34174809505447146,-0.6267900315780165,0.8461538461538461,1.0,1.0,4/12,23.90%,ASAH2B;SPTLC3;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.39145214235715686,0.6267105482101499,0.9272727272727272,0.9987108841513342,1.0,1/8,3.52%,ABCA5
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.36588161476567216,-0.6258226422760387,0.8636363636363636,1.0,1.0,1/7,10.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.35657825937777704,0.625444416095118,0.9032258064516129,0.9991695533225492,1.0,1/13,3.34%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3243675349991304,-0.6252791765559191,0.9019607843137255,1.0,1.0,3/15,18.34%,PIP4P1;RRAGA;LARS1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3668312488207599,0.6250939179652936,0.9538461538461539,0.9990876284067118,1.0,5/10,34.52%,SKP1;RAB1A;BTRC;FZR1;UBE2S
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.39401562383742883,0.6247493925005655,0.8666666666666667,0.9990057499335707,1.0,1/6,8.19%,ASS1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.36602251817842557,-0.6242182232651623,0.8461538461538461,1.0,1.0,2/7,11.70%,UNC80;COX11
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.3411418200905873,0.6242066368419338,0.9272727272727272,0.9990178357370015,1.0,5/18,21.47%,SYVN1;RNF185;MARCHF6;RPS27A;AMFR
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4151132690648661,-0.6240417795567089,0.8717948717948718,1.0,1.0,2/5,25.34%,CTR9;LEO1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4151132690648661,-0.6240417795567089,0.8717948717948718,1.0,1.0,2/5,25.34%,CTR9;LEO1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.300368477760119,0.6230081252366423,0.9423076923076923,0.9994758982146554,1.0,2/23,9.67%,NOTUM;HDAC4
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.4112468452708081,0.6224182116562172,0.8979591836734694,0.9993724313591766,1.0,1/6,3.08%,SFTPD
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.4112468452708081,0.6224182116562172,0.8979591836734694,0.9993724313591766,1.0,1/6,3.08%,SFTPD
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3258666673794011,0.6222980555127986,1.0,0.999200127021498,1.0,5/24,17.57%,SAMHD1;NLRC5;TTLL12;FADD;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3585335264054924,0.6220766996553052,0.9272727272727272,0.999054715909257,1.0,1/10,15.29%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.340803074698125,-0.6218612615514302,0.8787878787878788,1.0,1.0,6/18,19.54%,RPL37;RPL23;ATR;PLA2R1;SPRED1;UBB
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.33164042042542585,-0.6215588220541611,1.0,1.0,1.0,4/16,12.08%,FICD;PLXNB3;RRP1B;TMED2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.360133607964548,-0.6205986934844382,0.9210526315789473,1.0,1.0,2/9,8.34%,DGKB;DGKE
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.4071015201074887,0.6198845454645165,0.9047619047619048,1.0,1.0,1/7,7.04%,ALDOB
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.29635029059996754,0.6190163887952351,0.9682539682539683,1.0,1.0,2/40,4.86%,DAB2IP;DENND3
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.38039306177518006,0.6188267807173018,0.90625,1.0,1.0,2/7,14.71%,MAPK8IP1;HLA-E
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.35003067922580855,-0.6184125190954666,0.9056603773584906,1.0,1.0,1/13,4.34%,NPC2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.23318620811594298,0.6183506600850025,1.0,1.0,1.0,89/445,24.31%,UHRF2;MARCHF1;PRAME;TRIM61;TRIM5;HECW2;FBXW12;NEUROD2;ENC1;TRIM36;CTNNB1;SH3RF3;ARIH2;TRIM17;NEURL1;FBXO32;PEX14;FBXL2;DTX2;FBXL16;BARD1;KCTD13;RNF112;HECW1;SPSB1;TRIM22;BCL2;SYVN1;RNF19A;UBE2H;RNF152;TRIM32;TRAIP;TRIM47;PDZRN3;PINK1;HIF3A;SMURF1;FBXO24;BRCA1;BSPRY;LRSAM1;CBFB;ARIH1;RNF187;RNF122;DDB2;SKP1;BFAR;FANCL;RNF185;RAD18;RUSC1;FBXO41;MARCHF6;FBXO31;UBE4B;GAN;RNF144A;HIF1A;WAC;CDC27;UBE2QL1;RPS27A;UBE2B;TRIM54;UBR5;ZNRF2;UBE2E1;FBXL8;KLHL7;TRIM44;AMFR;FBXO2;DDB1;RNF181;FBXW5;KLHL21;CUL3;RNF220;PSMB3;CCNF;PRKN;KCTD10;ARRB1;UHRF1;CBL;FBXL4;SDE2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.39593000772959164,0.6170223152130424,0.8846153846153846,1.0,1.0,1/5,12.85%,B2M
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.26738824234554315,0.6167749289997422,1.0,1.0,1.0,16/72,19.11%,BLM;HK2;ERCC6L;NR6A1;CDC7;CENPH;ALPL;NAP1L1;TRIM32;PHF6;ATAD5;FUBP1;RFC4;SET;GINS1;HELLS
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.2741821975448386,0.6161663639928843,1.0,1.0,1.0,8/60,17.98%,ATF3;EIF2B2;YTHDF1;RPS6KB2;EIF2B5;GLE1;EIF3B;NCK2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.2721785368666059,-0.6157734881993004,1.0,1.0,1.0,2/39,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.3187214855859583,0.615706382776348,0.9552238805970149,1.0,1.0,4/23,12.48%,ACOT4;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.3187214855859583,0.615706382776348,0.9552238805970149,1.0,1.0,4/23,12.48%,ACOT4;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.368502843599974,0.615663380684756,0.9354838709677419,1.0,1.0,1/12,3.81%,NOS1AP
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.3997048146045593,0.6154334174456658,0.9038461538461539,1.0,1.0,3/7,24.41%,HMGCLL1;BCAT1;BCAT2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.3578938972975387,-0.6148533820492064,0.9047619047619048,1.0,1.0,3/8,20.39%,MTRF1;SHFL;JMJD4
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.38713207913661474,0.6146842443455297,0.9166666666666666,1.0,1.0,1/9,12.09%,EEF1A2
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.371760970219853,0.6146100879837597,0.9322033898305084,0.9997065737410756,1.0,2/13,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.371760970219853,0.6146100879837597,0.9322033898305084,0.9997065737410756,1.0,2/13,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.2919069812158827,0.6145789052320643,1.0,0.9994348928295561,1.0,6/44,16.77%,ZIC1;GLIS2;DLG5;IFT122;RORA;TXNDC15
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.3768970347886995,-0.6136652336407347,0.9607843137254902,1.0,1.0,8/8,62.33%,LRP6;LRP5;FGFR3;SFRP4;SKI;BMPR2;BMPR1B;FGFR2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.33295306285134973,-0.613407141335748,0.9230769230769231,1.0,1.0,4/18,12.63%,MOGAT1;DGKB;DGKE;PLA2G15
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.31342803074240716,-0.6133584645905463,1.0,1.0,1.0,4/21,17.30%,HSF1;ATR;MEN1;TSPYL5
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.333587992499656,0.6130550319875332,0.9508196721311475,1.0,1.0,6/18,16.81%,MTHFD2;ALDH1L1;FTCD;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.32901350524640277,-0.6128962441842619,0.9565217391304348,1.0,1.0,3/17,16.42%,RNF2;RNF168;RNF8
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.313362584530416,0.6120334778941829,0.9016393442622951,1.0,1.0,9/28,21.39%,DGKG;PLAAT3;DGAT2L6;DGAT1;CAV3;DGKI;DGKZ;DGKD;GK5
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.362662099721677,0.6106498722063092,0.9047619047619048,1.0,1.0,1/11,4.08%,HIC1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.4001887510553095,0.6104049643450205,0.9038461538461539,1.0,1.0,1/5,11.24%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.4001887510553095,0.6104049643450205,0.9038461538461539,1.0,1.0,1/5,11.24%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3593955837800174,0.6102412862833816,0.9180327868852459,1.0,1.0,2/13,18.06%,TFRC;TNFSF4
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.32712986035657327,-0.6101792260694202,0.9166666666666666,1.0,1.0,2/14,14.47%,ABCD1;SLC25A33
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.35706791414784417,-0.6100736611804491,0.9523809523809523,1.0,1.0,1/13,4.15%,SETDB1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.35756542895063775,-0.6094527895077096,0.9318181818181818,1.0,1.0,2/9,11.06%,RGCC;DAG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.3866874916536742,0.6094406584259744,0.9111111111111111,1.0,1.0,2/7,12.85%,ABCB9;B2M
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.34920941699563324,0.6091528597110778,0.9259259259259259,1.0,1.0,5/12,27.78%,HDAC4;FZD7;HDAC5;SOX6;HDAC3
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.37281222440257644,0.6089349394370085,0.9649122807017544,0.9997364527952812,1.0,2/12,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.37281222440257644,0.6089349394370085,0.9649122807017544,0.9997364527952812,1.0,2/12,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.30872579905219244,0.6088047845782866,0.9411764705882353,0.9995287779876311,1.0,3/16,12.96%,SMAD3;FSCN1;PDPN
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.4139193655830933,0.6082622636659425,0.9411764705882353,0.9995871452608105,1.0,1/6,4.26%,MYH11
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.3103964543479814,-0.6081908889481991,1.0,1.0,1.0,1/21,2.21%,RFC3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.305707593130414,-0.6074091445105269,0.9487179487179487,1.0,1.0,5/24,25.11%,SPDL1;CENPA;DYNLT1;PLK1;KPNB1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.41763555060525903,0.6067717191353116,0.9333333333333333,1.0,1.0,1/5,14.15%,CD70
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.38785158302596234,0.6067419724693055,0.896551724137931,0.9998300251998059,1.0,3/7,28.87%,LRP2;TGFBR3;NRP1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.414989564939072,0.6066950651933651,0.8983050847457628,0.9995893445179409,1.0,2/5,23.80%,FTO;TDG
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.35445671380151567,-0.60648972809121,0.8913043478260869,1.0,1.0,2/6,20.72%,ADRA1A;SPHK2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.33883134091343126,0.6064550499467527,0.8723404255319149,0.9994417683343761,1.0,2/13,9.86%,TBX20;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.40240351989318857,0.6062874559358044,0.9285714285714286,0.9992610808467844,1.0,3/5,32.65%,CAV3;NEDD4L;CAB39
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.37065344003274103,-0.6057755780580277,0.9555555555555556,1.0,1.0,1/5,14.03%,USP19
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.25355812926528876,0.6055309727490231,1.0,0.9993360173727717,1.0,18/127,19.56%,PLK2;WDR62;INCENP;CENPP;ERCC6L;CENPH;RANGAP1;KIFC2;NEK6;STMN1;MAP4;DYNC1LI2;SKA2;CCNB1;CKAP5;FLNA;RAB11A;DYNC1LI1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.3287783228217706,-0.6053962946544406,1.0,1.0,1.0,16/16,67.16%,ATP6V0D2;ATP6AP2;ATP6V0A2;GRN;TMEM9;DMXL1;ATP6V0D1;ATP6V0E2;ATP6V0E1;PPT1;SLC11A1;CLN3;CLN6;DMXL2;ATP6V0A1;ATP6V1H
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.23932496466123065,-0.6048929137617621,1.0,1.0,1.0,7/76,12.49%,AAAS;RAE1;NUP50;HSPA1A;HSF1;ATR;NUP54
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.3443063094612736,-0.6044617575793326,0.9523809523809523,1.0,1.0,7/7,65.59%,AGO4;TARBP2;ADAR;AGO3;AGO2;DICER1;AGO1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.2713794606966506,-0.6043880261267927,1.0,1.0,1.0,13/47,24.35%,NOC2L;EIF2S1;BAK1;METTL3;ATR;TRIAP1;GNGT1;SMPD1;PARP1;AQP1;CASP9;YY1;POLK
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.318390044624462,0.6043149258080094,0.9166666666666666,0.9996232348760917,1.0,8/19,32.02%,UGDH;NANS;AMDHD2;SLC35D1;PMM1;GFPT2;GNPNAT1;UAP1L1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.3880301986747295,-0.6034884614928228,0.8775510204081632,1.0,1.0,1/6,10.82%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.3880301986747295,-0.6034884614928228,0.8775510204081632,1.0,1.0,1/6,10.82%,PTGIS
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),0.38026666634308076,0.6031122613824541,0.8909090909090909,1.0,1.0,3/5,28.87%,B2M;ANXA2;NRP1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.3761644338859773,-0.60288689929358,0.8611111111111112,1.0,1.0,1/6,23.97%,VCP
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.33951521511117344,-0.6028793535590949,0.9347826086956522,1.0,1.0,1/9,6.99%,EIF2S1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.360556016304783,0.6026058136321168,0.9245283018867925,0.999731471807947,1.0,3/9,28.49%,ATP2B4;PRNP;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.360556016304783,0.6026058136321168,0.9245283018867925,0.999731471807947,1.0,3/9,28.49%,ATP2B4;PRNP;GSK3B
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.3779826261682385,-0.6020287443224515,0.8409090909090909,1.0,1.0,3/6,29.45%,VPS35;CAV2;DRD2
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.28108317368675184,-0.6019696325999363,0.9574468085106383,1.0,1.0,6/25,24.63%,KMT2A;PRDM7;MEN1;WDR82;PAXIP1;CTR9
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.31614564932802086,0.6018830336881839,0.9516129032258065,0.9998194270773326,1.0,9/21,27.56%,TERF2IP;OGG1;TINF2;NEIL2;NEIL1;ACD;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.39172217280682387,0.6017710593506882,0.9090909090909091,0.9995992330346436,1.0,1/6,7.60%,SCARA3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.34232919272644313,-0.6011571623493251,0.9565217391304348,1.0,1.0,3/11,16.74%,RIC3;TMEM35A;RANGRF
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.2572797285397,0.6010526734155622,1.0,0.9997401677187688,1.0,9/90,14.66%,TRPM4;NNAT;LOXL1;HDAC4;HDAC9;RANGAP1;PLOD2;BCL11A;IFIH1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.3340875346345421,0.6009063611678076,0.9655172413793104,0.9995532295390088,1.0,2/14,10.08%,SAMHD1;GDA
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.3621462660287688,0.5999659429567323,0.9245283018867925,0.9997437501369812,1.0,2/10,9.83%,PADI2;ART3
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.3955150129280587,0.5999100553804133,0.9183673469387755,0.9995006590882375,1.0,1/7,12.29%,PRKCD
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.2310172206382107,-0.5993998718336349,1.0,1.0,1.0,29/107,26.48%,VAMP8;SNF8;VPS4B;BECN1;MTERF3;ATG14;VIPAS39;VTI1B;FUNDC1;DYNLL1;YOD1;PRKAB2;PIK3R4;ACBD5;TOMM70;ATG16L1;VCP;CSNK2A2;VAMP7;RUBCNL;CHMP3;PIP4K2B;VPS25;SNAP29;CHMP2A;PRKAB1;PGAM5;VPS28;VTA1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.32329352067791167,0.5991410727777605,0.96875,0.9996580051380622,1.0,2/19,10.92%,YTHDF1;MAPT
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.40326639076229703,0.5987965392807458,0.9615384615384616,0.9995539825972009,1.0,1/5,12.68%,PER1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.40136926712728466,0.5987900065251317,0.9615384615384616,0.9992813904267842,1.0,3/5,38.02%,NPHP4;TCTN1;TMEM107
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.33029190772426276,0.5985543652941236,0.984375,0.9991213376020627,1.0,1/22,4.28%,TDRD5
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.29967074446854536,-0.5978765197900546,0.9655172413793104,1.0,1.0,3/17,12.63%,MOGAT1;GK;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.31001090452090146,-0.5975557094585373,0.9512195121951219,1.0,1.0,2/27,4.36%,EDNRB;APOE
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.31100674311822374,0.597388060557499,0.958904109589041,0.9994339291100577,1.0,3/20,13.02%,ALOX12;ACOT7;LTC4S
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3335540355658725,0.5971361082224754,0.9411764705882353,0.999336692552645,1.0,5/18,22.75%,TCP1;CCT4;CCT8;EXOSC10;PARN
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.374820339863436,0.5967630431146291,0.9016393442622951,0.9992130883677472,1.0,1/9,8.61%,PLAAT3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.3716009979867385,0.5962278293323869,0.9107142857142857,0.9992414366224577,1.0,4/8,24.74%,HIF1A;ARNT;ANKRD2;HMOX1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.3275916841231769,0.5948683843189172,0.8958333333333334,0.9997516996056651,1.0,1/15,9.62%,CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.36390505499204595,-0.594612601481127,0.8888888888888888,1.0,1.0,1/5,8.20%,LY96
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.4099264060587466,0.5943698609283625,0.8888888888888888,0.9994814421209319,1.0,1/5,7.04%,ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.4099264060587466,0.5943698609283625,0.8888888888888888,0.9994814421209319,1.0,1/5,7.04%,ALDOB
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.381173995127453,0.5940364792615188,0.9166666666666666,0.9993381809936658,1.0,1/5,7.38%,TYR
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.36510493375015574,0.5937367447880741,0.9272727272727272,0.9989596017610454,1.0,3/7,31.86%,BCAR1;NRP1;APPL1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.36510493375015574,0.5937367447880741,0.9272727272727272,0.9989596017610454,1.0,3/7,31.86%,BCAR1;NRP1;APPL1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.37077214150061927,0.5935641489498203,0.9206349206349206,0.9988001286606383,1.0,3/7,20.82%,ABCC4;ABCC3;ABCC1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.2530465433070457,-0.5932059695005896,1.0,1.0,1.0,19/70,24.68%,FIP1L1;RBM8A;U2AF1;CPSF1;CLP1;SRSF2;POLR2D;CPSF3;SRSF9;UPF3B;CHTOP;CSTF2;SSU72;THOC3;CSTF2T;THOC1;CPSF7;SRRM1;SLBP
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.33512087341986085,0.592762613643983,0.9180327868852459,0.9989010069212573,1.0,2/12,14.53%,PML;MRE11
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.24832247013061878,0.5927433282618549,1.0,0.9986230711931212,1.0,20/114,23.21%,ELAVL4;RBMS1;ADARB2;RNASE1;RBPMS;HNRNPH1;RNASEH2C;WTAP;RBFOX2;FTO;LAGE3;RBM5;CELF2;RBM6;SUPV3L1;SND1;PARN;EXOSC7;BICD1;POLR2I
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3388614364808747,0.5922323998530572,0.9666666666666667,0.9985955299981324,1.0,5/14,24.78%,RYR2;DDRGK1;UBAC2;GABARAPL2;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.36090561238318225,0.5919840367758784,0.9538461538461539,0.9984495023897095,1.0,2/11,15.88%,SYNGR3;RXRA
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.27264531950263166,0.5919467339239856,1.0,0.9981949595877577,1.0,4/60,10.27%,ZFP36;WTIP;PPARG;STAT3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.2794497848113997,0.5917288296909122,1.0,0.9980359649422632,1.0,8/41,20.12%,RPA1;POLD1;BRCA1;ZBTB1;RFC4;RAD18;RPS27A;UBE2B
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3242425102440829,0.5909919182521559,0.9245283018867925,0.998090841759875,1.0,2/16,19.41%,MORF4L2;MORF4L1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.3906229080274803,0.59087209148843,0.8653846153846154,0.997856339048632,1.0,2/7,12.96%,SLC4A11;PDPN
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.285865632513984,0.5896759692166946,0.9833333333333333,0.9981117510658204,1.0,6/32,19.78%,RPA1;POLD1;XRCC1;OGG1;RFC4;NEIL1
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),0.38739756074421605,0.5896701166215357,0.8958333333333334,0.9978346517457022,1.0,3/5,17.50%,FSCN1;PATJ;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.388270418048826,0.5879567109937802,0.96,0.9984020333596929,1.0,2/5,37.01%,EIF4G1;IMPACT
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.349664212084079,-0.5871236974593065,0.9318181818181818,1.0,1.0,2/7,23.13%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.2644643818876369,-0.5868889177734459,1.0,1.0,1.0,3/47,3.69%,SRPRA;TPP1;SRPRB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.3455615581984075,-0.5868773054260938,0.9318181818181818,1.0,1.0,1/8,6.34%,BLVRA
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.3455615581984075,-0.5868773054260938,0.9318181818181818,1.0,1.0,1/8,6.34%,BLVRA
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),-0.37166282890550517,-0.5865941326132494,0.8947368421052632,1.0,1.0,2/5,17.15%,GPLD1;JAM2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.26965861907916666,0.5865280096235883,1.0,0.9988311549776115,1.0,2/46,3.45%,APP;ADD2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.38760093934698286,0.5849498563588584,0.9019607843137255,0.9993060074816059,1.0,1/5,6.47%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.27936845423062295,0.5843156863143324,0.9838709677419355,0.9992619479797932,1.0,9/29,23.69%,IRS2;FBP1;PDK4;PDK1;RORA;PDK3;FOXK1;ZNF692;PRKN
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.3838373061864205,0.5841987572231185,0.8870967741935484,0.9990308573614284,1.0,1/6,7.68%,TENM4
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.2966209290106673,0.5840894262418924,0.9803921568627451,0.9988195794422746,1.0,7/24,25.08%,HR;KDM6A;PHF2;KDM3A;PHF8;KDM4C;KDM6B
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.3247446844709799,0.5840776113246459,0.9682539682539683,0.9985428214540668,1.0,1/14,9.80%,AK5
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.34209530289462575,0.5836583767620199,0.9433962264150944,0.9984301642494083,1.0,1/12,9.62%,CHMP1A
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.3747957734698699,-0.5826750589021144,0.9444444444444444,1.0,1.0,4/6,25.53%,TEX264;FAM111A;VCP;SPRTN
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.373287919399314,0.5817804494739764,0.8983050847457628,0.9989797337347145,1.0,3/7,33.19%,RARG;TBX2;FBN2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.22405059170193442,0.5817441847791557,1.0,0.9987293783405526,1.0,46/285,20.95%,TRAF3IP2;MARCHF1;PRAME;TRIM5;HECW2;FBXW12;TRIM36;CTNNB1;ARIH2;FBXO32;FBXL16;BARD1;HECW1;SPSB1;TRIM22;BCL2;SYVN1;RNF19A;UBE2H;RNF152;TRIM32;SMURF1;BRCA1;RFFL;TRAF5;LRSAM1;CBFB;ARIH1;RNF187;DDB2;SKP1;BFAR;RUSC1;FBXO41;MARCHF6;FBXO31;UBE4B;RNF144A;CDC27;UBE2QL1;RPS27A;UBE2B;UBR5;ZNRF2;UBE2E1;FBXL8
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.25600155225143173,-0.5814119955614417,1.0,1.0,1.0,1/35,2.46%,TRIM21
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.241349584130466,0.5813900698702266,1.0,0.9986626302148496,1.0,26/105,27.85%,CORO7;BAIAP3;HOOK1;WASHC1;TBC1D10B;TBC1D10A;GGA1;HOOK2;DCTN1;CCDC91;SORT1;LMTK2;TMEM87B;RAB7A;ARFRP1;CLTC;ERC1;EMP2;WDR81;DENND5A;ANKRD27;SLC66A2;KIF16B;GAK;AP1G1;ANKFY1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.28564139170091934,0.5812383606479159,0.9666666666666667,0.9984354283508696,1.0,5/29,23.30%,IFT122;IFT140;ODAD4;SNX10;TUB
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.32657065442421096,0.5799083514396228,0.9814814814814815,0.9986896910298717,1.0,6/13,29.36%,P3H2;PLOD2;EGLN3;OGFOD1;ASPH;PLOD3
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.2933734133414276,0.5794815788203325,1.0,0.9985870006649287,1.0,5/32,16.39%,CENPP;MIS18A;CENPH;SRCAP;SPTY2D1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.29291734581999374,0.5791644443015409,0.9818181818181818,0.9984581862553925,1.0,7/22,24.96%,MAP1B;MAPT;CAMSAP3;MAP1A;AEBP1;MAPRE3;MAP2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3268233120921141,0.5788026961871944,0.9824561403508771,0.9983785185353564,1.0,5/19,23.69%,WASHC1;PINK1;ZMIZ1;HIF1A;PRKN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.3781757819969492,0.5787928773213524,0.9074074074074074,0.9981026471569272,1.0,4/7,33.25%,CAMK2A;CAMK2D;BMPR1A;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.3374145842791818,0.57876885619026,1.0,0.9978367378673143,1.0,1/15,3.81%,NOS1AP
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3218551102050613,-0.5787154446870902,0.9272727272727272,1.0,1.0,2/11,20.72%,KMT2A;SPHK2
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.3798228248525049,-0.5780577191069549,0.9047619047619048,1.0,1.0,1/6,4.85%,IL5
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.3477521367207134,0.5775872971215028,0.9375,0.9980874755830899,1.0,2/8,25.63%,MESP1;FZD5
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.37626043885923155,0.5765710584095987,0.9516129032258065,0.9982563727047876,1.0,1/7,15.46%,TP53
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.29445959280410877,0.5755616321404502,0.9830508474576272,0.9983140923473697,1.0,6/25,19.66%,CYP1B1;ABCA2;MTARC2;GCHFR;CYB5B;ACER3
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.27675187392181777,0.5755475107888284,0.9672131147540983,0.9980549507742229,1.0,8/43,16.70%,PRKCG;FAM168A;NPAS2;SPIRE1;FMN2;XRCC1;BRCA1;SPIRE2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.2969190509171796,-0.5751785517521113,1.0,1.0,1.0,3/20,14.12%,SNF8;BECN1;WDR91
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.3638383834144832,0.5751209848513542,0.9444444444444444,0.9979494250843935,1.0,1/8,3.52%,ABCA5
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.3506550855264988,-0.5748881044980922,0.8666666666666667,1.0,1.0,3/7,23.97%,TFIP11;DHX8;VCP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.30136872732497183,0.5746985633813675,0.9833333333333333,0.9975982143127499,1.0,3/24,12.40%,CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.30136872732497183,0.5746985633813675,0.9833333333333333,0.9975982143127499,1.0,3/24,12.40%,CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.3977267193284185,0.574163261739779,0.9166666666666666,0.9975809941582993,1.0,2/5,23.89%,COL5A1;EIF4G1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.36045290066534375,-0.5740611916628602,0.9318181818181818,1.0,1.0,6/6,63.97%,LMOD1;TMOD1;FLII;PGM5;TMOD3;TMOD2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3412533301377536,0.572647377790621,0.9838709677419355,0.9979258412770269,1.0,2/10,15.78%,CABIN1;H3-3A
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.31887955471103663,0.5722355148473967,0.9180327868852459,0.9977813659075594,1.0,5/11,21.14%,FGF2;ADAM17;FGFR1;AKT3;APLN
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.3852396819742485,0.5714218250941282,0.9607843137254902,0.9979238488143185,1.0,2/5,31.62%,DDRGK1;PLCG2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.34497025428032957,-0.5714179526240339,0.8974358974358975,1.0,1.0,3/6,27.30%,RMI2;MSH3;MSH2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.28471132516040953,0.571078868154612,1.0,0.9977729353751087,1.0,8/31,19.36%,SLC39A14;SLC7A1;SLC1A6;SLC29A1;LRSAM1;LRP2;SLC7A8;SLC12A7
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.2964473862442444,0.5703206979260736,1.0,0.9978436619722503,1.0,10/23,25.76%,CTNNB1;ARF6;SMURF1;GGA1;PIGK;FLNA;VCL;GGA2;PTPRK;EMP2
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.3483132952025213,-0.5697547155249582,0.8974358974358975,1.0,1.0,6/6,65.19%,MAPK8;FNTA;C6ORF89;PRKD2;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.3497171812704817,0.5697298390550614,0.9,0.9978036016498026,1.0,1/8,9.67%,HDAC4
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.34823930603953734,-0.5695217859789626,0.9523809523809523,1.0,1.0,3/6,21.22%,GART;PAICS;PRPS1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.2982604949277816,-0.5688651444915154,0.975,1.0,1.0,9/22,20.06%,WASHC5;MUL1;MTFR1L;PEX11B;PEX11A;MTFR1;MIEF1;DNM1L;FIS1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.36206530862909525,0.5684563536740819,0.9661016949152542,0.9980436135855062,1.0,3/6,36.43%,PPM1F;CORO1C;ADARB1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.2923881507457586,0.5680563035312768,0.9454545454545454,0.9979286437540428,1.0,7/21,28.49%,MSRA;NOX4;MTHFR;AHCY;SMS;BHMT;BHMT2
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.34537615151734263,-0.5679751196568532,0.9591836734693877,1.0,1.0,1/6,8.15%,HSD11B1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.3640017001051076,-0.5677081754464894,0.9166666666666666,1.0,1.0,1/5,8.25%,MICA
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.31070518377915785,0.56632863403587,0.984375,0.9982954190050837,1.0,7/22,24.18%,APP;CDC25B;CCNB1;PRKCA;MEIS2;CUL3;USP2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.320845455515143,-0.5652109717838707,0.9423076923076923,1.0,1.0,2/7,16.42%,RNF168;RNF8
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.30853673876123255,0.5628940560535951,0.9824561403508771,0.9993387648306346,1.0,2/15,20.13%,PARP9;WRAP53
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.3787892026199722,-0.5626629204421632,0.9375,1.0,1.0,2/6,11.12%,CACNA1S;RYR1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.3787892026199722,-0.5626629204421632,0.9375,1.0,1.0,2/6,11.12%,CACNA1S;RYR1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.3295771850102004,0.5619973196639217,0.9454545454545454,0.9994121973407232,1.0,5/10,28.68%,SARDH;CHDH;SLC44A1;BHMT;DMGDH
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.384617160287209,-0.5618473491471668,0.9534883720930233,1.0,1.0,2/5,23.60%,FBL;TRMT112
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.3397835919345397,0.5616361209938259,0.9344262295081968,0.9992644586172387,1.0,4/9,17.91%,ARIH2;ETV6;WNT5A;MECOM
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.3128654943149318,0.5612726181841777,1.0,0.9991233031098904,1.0,1/11,7.99%,ACOT4
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.33131616638843353,0.5612543545187881,0.9433962264150944,0.9988619699747725,1.0,1/7,12.85%,B2M
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.3780258138908571,0.5600455748321159,0.9444444444444444,0.9990134346602335,1.0,1/5,22.75%,PARN
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.39423950171023286,0.5598752070876383,0.9310344827586207,0.9985042487084398,1.0,2/5,31.57%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.39423950171023286,0.5598752070876383,0.9310344827586207,0.9985042487084398,1.0,2/5,31.57%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.273137930192609,0.5598297755381679,1.0,0.9982498652166154,1.0,5/34,20.43%,SMCR8;GAS6;TELO2;RRAGD;RHEB
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.3363442655356387,0.5586793066402977,0.9107142857142857,0.9983656291006604,1.0,2/10,14.48%,IHO1;FMN2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.2736948951439995,-0.5586066165249335,1.0,1.0,1.0,2/23,9.58%,HSPA1A;HSPA13
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.31845747112337264,0.558190996396597,0.9152542372881356,0.9982509491876352,1.0,1/12,5.25%,OXTR
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.32395151894383534,-0.5568455905025048,0.9285714285714286,1.0,1.0,2/8,20.83%,ENTPD1;ENTPD5
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.2545089198250291,0.5565578947698036,1.0,0.9985807469990415,1.0,19/70,26.36%,CLIC4;NEXN;CENPV;MAPT;USP6NL;MTM1;CAMSAP3;PINK1;RHOT1;RHOT2;PDE2A;TJP1;SAR1A;TAOK1;PRKN;PLXNB1;MAPK3;DIAPH1;PDCD10
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.3724333996879063,0.5564393678005063,0.9629629629629629,0.9983590514793278,1.0,3/5,14.53%,HSD3B7;GAS6;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.348081023550109,-0.5553149404824508,0.851063829787234,1.0,1.0,1/5,10.82%,PTGIS
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3125111151447725,-0.5537959543765846,0.9534883720930233,1.0,1.0,1/8,5.40%,GTF2H2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.2844251927722869,-0.5537221008851585,0.9777777777777777,1.0,1.0,3/21,13.77%,ATP6V1E2;ATP6V1G1;ATP6V1F
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.2310526300468964,-0.5534373043018608,1.0,1.0,1.0,12/66,19.35%,EIF2S1;ATP6V1E2;ATP6V1G1;RRAGC;SLC38A9;ATP6V1F;RRAGA;MIOS;DAP;LARS1;SESN2;NPRL2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.2339983624434716,-0.5529979775331989,1.0,1.0,1.0,12/65,19.35%,EIF2S1;ATP6V1E2;ATP6V1G1;RRAGC;SLC38A9;ATP6V1F;RRAGA;MIOS;DAP;LARS1;SESN2;NPRL2
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.3020431990659661,-0.5523159448248047,0.9787234042553191,1.0,1.0,10/10,69.82%,PRKDC;HMGB1;LIG3;LIG4;LIG1;DCAF1;RAG1;TCF3;HMGB2;XRCC4
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.3358418823524744,0.5520558454285399,0.9310344827586207,0.9995510448440932,1.0,4/12,27.16%,PDE4D;ADRA1D;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.27901008356358026,0.5519810474988246,0.967741935483871,0.9993065163696766,1.0,5/30,18.97%,RAP1GAP2;RARG;VAV2;NEB;VAV1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.35336840707344364,0.5513332893760703,0.9454545454545454,0.9992824657168136,1.0,4/6,34.66%,WNT5A;SIRT1;PLCG2;CD74
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.293409929037441,0.5511265687291207,0.9310344827586207,0.9990737787051381,1.0,3/11,24.60%,PPARG;OSBPL11;OSBPL8
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.2705985401459854,-0.5499187183608751,0.9782608695652174,1.0,1.0,15/15,72.97%,MEPCE;INTS3;MTREX;INTS4;INTS2;INTS9;INTS11;INTS8;ZCCHC8;INTS7;INTS1;INTS10;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.2813105977338696,0.5497352374242781,0.9841269841269841,0.9992667896823446,1.0,4/32,16.86%,BAP1;ARIH2;PINK1;MICALL2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.29538624491029053,0.5486481730413757,1.0,0.999320474267094,1.0,6/19,23.34%,LAMA5;SOX10;LAMA3;PRKX;AHI1;VCL
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.3486889662546335,-0.5484781699977714,0.875,1.0,1.0,1/6,4.81%,GALT
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.3082126811601966,-0.5480891872670558,0.8695652173913043,1.0,1.0,3/8,21.52%,MST1;GPX1;BRCA2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.2890404027144881,0.5467229076295704,1.0,0.9996363109265777,1.0,7/18,36.34%,XPO5;SND1;PARN;DDX17;DIS3L2;LIN28B;DICER1
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.36661803326524667,0.5464271306386128,0.9245283018867925,0.9994730583026484,1.0,5/5,63.35%,CHM;RABGGTA;RABGGTB;PGGT1B;FNTA
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.23278409490413782,-0.5461899581707859,1.0,1.0,1.0,12/58,23.21%,NOC2L;EIF2S1;BAK1;METTL3;ATR;TRIAP1;XPA;SMPD1;PARP1;AQP1;CASP9;YY1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.28554503234681244,0.5449818100798439,1.0,0.9996236936567905,1.0,5/21,22.06%,TMTC1;POMGNT2;LARGE1;SDF2L1;DPY19L1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.33184340318284933,-0.544835691766671,0.9534883720930233,1.0,1.0,1/9,10.83%,GPR37L1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.3380780137627669,0.5443204440869007,0.9824561403508771,0.999573729104272,1.0,2/12,9.00%,ROBO2;BASP1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.33749645306416853,-0.5440419498819307,1.0,1.0,1.0,1/8,8.81%,ATP6V1G1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.2547270880922254,-0.5437475084606499,1.0,1.0,1.0,3/28,13.77%,ATP6V1E2;ATP6V1G1;ATP6V1F
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.35262211789430037,0.5437300987274641,0.9411764705882353,0.9994558931498955,1.0,1/7,8.19%,ASS1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.33812503280740636,-0.543690434208559,0.9347826086956522,1.0,1.0,3/7,27.64%,SEC62;SEC61A1;SEC63
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.2705985401459854,-0.5406766816622898,1.0,1.0,1.0,15/15,72.97%,INTS3;INTS6L;INTS4;INTS14;INTS2;INTS9;INTS11;INTS8;INTS7;TOE1;INTS1;INTS10;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.26182136230032066,-0.5406414346217214,0.9761904761904762,1.0,1.0,3/21,13.03%,TTN;KMT5A;SMC2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.31682953244984013,-0.5402301337249313,1.0,1.0,1.0,1/9,4.81%,GALT
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.3592407379927614,-0.5398620362340544,0.9056603773584906,1.0,1.0,1/5,11.60%,PVR
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2480681877007989,-0.5397554192986571,1.0,1.0,1.0,3/53,7.46%,FBXO5;RNF2;FBXO43
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.29003668957015966,0.5394984964579281,0.9655172413793104,1.0,1.0,6/19,28.49%,PPP1R16B;MFHAS1;YWHAE;ARPP19;ENSA;GSK3B
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.32669459302719167,-0.5383559265224488,0.9811320754716981,1.0,1.0,2/7,19.70%,SLC25A46;DNM1L
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.2748650835733239,-0.5376282017686161,0.975,1.0,1.0,3/16,17.30%,HSF1;ATR;TSPYL5
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.3560700756715338,-0.5374084313615483,1.0,1.0,1.0,1/6,4.81%,GALT
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.28364110605930204,0.5370972736791974,0.9864864864864865,1.0,1.0,1/17,8.22%,MGAT5
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.3533702947184125,0.5356858060329379,0.95,1.0,1.0,5/5,64.67%,NAA25;NAA16;NAA30;NAA20;NAA15
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.34952965898140875,0.535594805684973,0.9344262295081968,1.0,1.0,2/6,25.93%,MAPKAPK2;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.3379764126586062,-0.5352962804231387,0.9767441860465116,1.0,1.0,1/8,10.83%,GPR37L1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.34248067986331887,0.534648201792714,0.9672131147540983,1.0,1.0,2/8,25.93%,MAPKAPK2;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.324958080384165,-0.5336874932338154,0.9767441860465116,1.0,1.0,2/12,6.53%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.25742362168201527,0.5336519573233885,0.9833333333333333,1.0,1.0,6/39,17.07%,PID1;CYRIB;MAPT;PINK1;RHOT1;RHOT2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.32653035716558637,-0.5336497562194195,0.9361702127659575,1.0,1.0,1/8,14.39%,CLU
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.29761664829800943,-0.5330945926586104,0.9787234042553191,1.0,1.0,2/15,7.99%,HSPA1A;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.29761664829800943,-0.5330945926586104,0.9787234042553191,1.0,1.0,2/15,7.99%,HSPA1A;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.3111771998720506,0.5327703604505812,0.9615384615384616,1.0,1.0,5/7,39.59%,SRF;F2R;CTTN;GPER1;SPHK1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.32689389517917594,-0.532585793609387,0.9565217391304348,1.0,1.0,6/6,67.33%,CKMT2;CKB;SLC6A8;GAMT;GATM;CKM
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.37370341717752265,0.5325276626427493,0.9464285714285714,1.0,1.0,2/5,26.16%,FTO;ALKBH5
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.32538137670259915,0.531994324712251,0.9365079365079365,1.0,1.0,2/10,16.09%,SHMT1;SERINC5
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.33319715186179527,-0.5315347113605994,0.8888888888888888,1.0,1.0,6/6,66.70%,SLC4A7;USH1C;PDZD7;MYO6;JAG2;LRTOMT
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.2744151772799045,0.5312256013890932,0.9682539682539683,1.0,1.0,6/23,32.00%,TINF2;EXOSC10;ACD;PIF1;TNKS2;TNKS
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.2557258522831497,0.5310951075269137,1.0,1.0,1.0,3/30,11.94%,MYH9;ADAM19;BACE2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.291659724747813,0.528891692381289,0.9508196721311475,1.0,1.0,4/17,21.17%,TMTC1;POMGNT2;LARGE1;SDF2L1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.3324967900081709,-0.5269254744388896,0.8809523809523809,1.0,1.0,6/6,66.77%,ERCC4;ATM;ERCC1;SMG6;TERF2;NBN
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.30939173883609994,0.5261430580487185,1.0,1.0,1.0,1/7,14.22%,PLOD2
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.3487542258749299,-0.5255400449139727,0.9787234042553191,1.0,1.0,2/5,17.92%,AOX1;PNPO
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.27488232239781885,0.5254024819479116,1.0,1.0,1.0,5/24,22.24%,PGAP4;PIGA;PIGB;PIGQ;PIGH
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.27941099283815235,-0.5247337559430704,1.0,1.0,1.0,2/14,7.82%,RPS26;RPS13
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.32987370045741465,0.5244520770237315,0.9090909090909091,1.0,1.0,4/8,27.52%,DYRK1A;SPRED3;NNMT;BRMS1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.2696295348511517,0.5236604897299185,1.0,1.0,1.0,4/28,12.48%,ACOT4;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.2631413562671974,-0.5235375984511484,1.0,1.0,1.0,12/39,22.92%,TRIM21;POLR2K;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;TRIM14;LARP7;POLR2E
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.26886316793999254,-0.5222003813607402,0.9714285714285714,1.0,1.0,5/27,15.67%,BCAP31;SEC24A;ERAP2;HFE;TAP1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.3634082287715203,-0.5220020236099923,0.9347826086956522,1.0,1.0,5/5,63.68%,HES1;NOTCH1;RNF10;SKI;DICER1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.30936041248434576,-0.5213669908181733,1.0,1.0,1.0,5/13,28.97%,RNF168;RNF8;LARP7;NELFCD;RECQL5
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.30425568546928994,-0.5213268870575148,1.0,1.0,1.0,1/10,14.01%,SLC25A22
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.2693799726052758,0.5209506186168978,1.0,1.0,1.0,3/26,14.53%,PML;MAPKAPK5;MRE11
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.263553216663646,-0.5206146544579312,0.9743589743589743,1.0,1.0,5/18,28.10%,AFG3L2;MIEF1;FIS1;GDAP1;MFN2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.28227532842398184,0.5205854249892103,0.9848484848484849,1.0,1.0,2/11,16.03%,P2RY12;P2RX7
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.321781443156419,-0.5204829287395322,0.9534883720930233,1.0,1.0,1/10,8.69%,METTL3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.3326776420533425,-0.5194349793492773,1.0,1.0,1.0,3/8,31.49%,NR1H2;PROM2;NR1H3
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.2458226278308662,-0.5193166010235966,0.9722222222222222,1.0,1.0,2/28,9.58%,HSPA1A;HSPA13
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.22870189565967186,-0.5192831229327813,1.0,1.0,1.0,3/33,15.82%,KIF20B;CEP131;TENM1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.3106615721766128,-0.5187730423492647,0.9333333333333333,1.0,1.0,2/9,16.97%,GPLD1;GRAMD1B
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.3464059892445906,0.518501923179636,1.0,1.0,1.0,1/5,11.77%,KLF9
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.27519535895440933,-0.5178917580925138,1.0,1.0,1.0,4/12,21.21%,LY96;IPMK;DNM1L;CD14
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.31418724305789614,-0.5177797193363879,0.96,1.0,1.0,2/6,19.81%,YME1L1;AFG1L
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.22998457398814745,0.5175582213760908,1.0,1.0,1.0,13/84,19.96%,SUV39H1;PADI2;FAM50A;CENPV;CENPH;GPS1;POLE3;H3-3A;MTHFR;DOT1L;DDB2;PHF19;RPS27A
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.3147495640603473,0.5171927509002404,0.9830508474576272,1.0,1.0,2/12,16.79%,EME2;MEIOB
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.3601943995981522,-0.5171571033506395,0.9555555555555556,1.0,1.0,2/5,19.25%,NKAP;PNP
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.27123953630125264,0.5146849220270058,0.984375,1.0,1.0,5/19,27.93%,ACAD8;AUH;BCAT1;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.27123953630125264,0.5146849220270058,0.984375,1.0,1.0,5/19,27.93%,ACAD8;AUH;BCAT1;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.3205230286249684,-0.5142864772022369,0.9777777777777777,1.0,1.0,1/9,6.17%,MUL1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.3039467538533395,-0.5130571657817026,1.0,1.0,1.0,12/12,69.63%,WNT5B;TIAM1;DAAM2;SFRP4;SFRP1;CSNK1E;GPC3;ZNRF3;RNF213;CSNK1D;SPEF1;RSPO3
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.27166797138287735,0.5120165954913254,1.0,1.0,1.0,1/29,5.12%,NUAK1
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.36176819870479515,0.5112871857359743,1.0,1.0,1.0,1/5,10.27%,STAT3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2875028098678285,0.5111609101130927,1.0,1.0,1.0,2/11,21.35%,ACOT7;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.2875028098678285,0.5111609101130927,1.0,1.0,1.0,2/11,21.35%,ACOT7;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2875028098678285,0.5111609101130927,1.0,1.0,1.0,2/11,21.35%,ACOT7;PANK3
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.32709555659248035,0.510432307219732,0.98,1.0,1.0,1/6,18.13%,SKP1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.31051187766298954,-0.5099473830518049,1.0,1.0,1.0,7/7,68.97%,SPHK2;KDM5A;C6ORF89;PRKD2;PRKD1;VEGFA;CAMK2D
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.29247650732504527,-0.5086832904783851,0.9736842105263158,1.0,1.0,7/7,70.77%,MYOCD;UQCC2;DDX5;NR1D2;MEF2C;DDX17;GPC1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.2612170394758205,-0.5079008163065082,1.0,1.0,1.0,2/18,12.75%,LRRC17;FSTL3
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.3210530724197772,-0.5061080803436472,1.0,1.0,1.0,1/7,10.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.26947685655467163,0.5058372067406643,0.9615384615384616,1.0,1.0,1/18,6.65%,CDK9
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.2833311596050802,0.505740335013086,1.0,1.0,1.0,5/17,23.82%,PCGF3;DDB2;SKP1;DDB1;BCOR
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.31622661724114587,0.5039644429463077,0.9516129032258065,1.0,1.0,1/5,23.59%,CXCL12
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.33740159493622296,0.503489301451654,0.9814814814814815,1.0,1.0,2/8,30.98%,CARD11;LARP1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2831176379083479,-0.50306167533682,1.0,1.0,1.0,3/18,12.29%,HSPA1A;MAPK7;HTRA2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.323857905231843,0.5020287087730432,0.9696969696969697,1.0,1.0,2/6,31.62%,SCIMP;PLCG2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2473262728272526,0.5019412974587686,0.9846153846153847,1.0,1.0,7/26,24.10%,YAP1;PAK1;BRCA1;CBFB;DDRGK1;CARM1;DNAAF4
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.33675011233333196,0.5019385961106764,1.0,1.0,1.0,2/5,34.42%,MOV10;AGO1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.29456401616518807,0.5015802527025027,1.0,1.0,1.0,4/14,24.91%,CD44;RFFL;PRKN;DYRK1A
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.29740955536237135,-0.4988985383771939,0.95,1.0,1.0,2/10,16.46%,TARDBP;ZNF639
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.30586518821126346,-0.498560973519046,0.9574468085106383,1.0,1.0,5/5,69.43%,MYOCD;HMGCR;IFNGR1;LRPAP1;SRF
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2576471773905159,-0.4979066454326978,1.0,1.0,1.0,7/21,26.48%,VPS4B;TMEM50B;TMEM50A;VCP;CHMP3;CHMP2A;VTA1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.3125051655045443,0.4971615361541474,0.9636363636363636,1.0,1.0,2/8,23.69%,EIF5A;PRKN
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.267865130014975,0.49395449616281,0.9824561403508771,1.0,1.0,4/15,30.26%,SART1;PSIP1;WBP11;WBP4
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.2841461219641981,0.4939214447708228,1.0,1.0,1.0,4/13,34.34%,TFRC;SLC15A4;SHLD1;HMCES
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.287323779114356,0.4932032938793533,0.9833333333333333,1.0,1.0,7/18,32.16%,SGCG;SIX4;TBX2;MYH14;IGSF8;MEF2C;SGCZ
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.26538358090986375,0.4930568171027139,1.0,1.0,1.0,7/17,29.94%,ADAM17;ADAM9;SPPL2B;PSEN1;APH1B;RHBDD1;TGFB1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.26663447090322745,-0.49206818967222976,0.9705882352941176,1.0,1.0,4/14,21.21%,LY96;IPMK;DNM1L;CD14
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.26047616460712986,-0.4919716070662547,1.0,1.0,1.0,6/18,25.23%,PPP1R35;ZCCHC9;PTPA;PPP1R26;SH3RF2;GPATCH2
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.27058273969403246,-0.4917213313949107,0.9767441860465116,1.0,1.0,14/14,72.97%,TRNT1;INTS6L;ERI1;INTS14;INTS2;PTCD1;ELAC2;INTS8;INTS7;SSB;TOE1;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.3058830395704447,-0.4912628103911164,0.9166666666666666,1.0,1.0,6/6,69.43%,MYOCD;ENO1;SPHK1;CTTN;F2R;SRF
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.30138812401471493,-0.4906296623479434,1.0,1.0,1.0,1/9,8.25%,MICA
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.3277336751742838,-0.4902954579931993,1.0,1.0,1.0,2/6,17.37%,UFL1;MEOX1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.3014250007706649,0.48715007081791956,0.9795918367346939,1.0,1.0,1/6,12.28%,MACROD1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.3001264730351604,-0.4869167285784984,0.9782608695652174,1.0,1.0,1/5,15.32%,NMD3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.26566966444534046,0.4864836250167623,1.0,1.0,1.0,3/16,23.06%,BCLAF1;MED24;MED13
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.2674356610591368,0.4864713109570901,0.9803921568627451,1.0,1.0,4/12,24.32%,GRAMD1A;RORA;OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.30374131792447323,-0.4852071839088242,1.0,1.0,1.0,7/7,69.64%,THBS4;ITGB1BP1;MEGF10;DDR1;ROCK1;AAMP;PLAT
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.2579023695256475,-0.48507325649423755,1.0,1.0,1.0,1/15,4.94%,PIGW
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.30547063305015604,0.4849854812675121,1.0,1.0,1.0,2/10,22.72%,PNPLA8;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.2981137368548966,-0.48377309065933854,0.9565217391304348,1.0,1.0,1/5,19.74%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.2981137368548966,-0.48377309065933854,0.9565217391304348,1.0,1.0,1/5,19.74%,NRDE2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.30596997001658666,-0.4822772782841288,1.0,1.0,1.0,2/8,23.13%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.34117303764225276,0.4812312296888821,1.0,1.0,1.0,5/5,65.89%,ABCA7;PPP1R15A;PPP1R15B;PTPN1;NCK1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.30352598674804054,0.4796124944047457,0.9636363636363636,1.0,1.0,2/8,26.75%,LRP2;CYP3A4
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.3245004613541357,-0.4782894396958506,0.9545454545454546,1.0,1.0,1/6,14.01%,SLC25A22
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.2922325374655871,-0.47716183104034365,0.9743589743589743,1.0,1.0,1/5,15.74%,GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.2922325374655871,-0.47716183104034365,0.9743589743589743,1.0,1.0,1/5,15.74%,GNPAT
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.31609028890310586,0.4770064216502283,0.967741935483871,1.0,1.0,5/9,31.91%,SLC12A5;SLC12A7;SLC12A4;SLC12A6;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.31609028890310586,0.4770064216502283,0.967741935483871,1.0,1.0,5/9,31.91%,SLC12A5;SLC12A7;SLC12A4;SLC12A6;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.32663230268845367,0.47608851256446727,0.9636363636363636,1.0,1.0,2/5,33.94%,PRKN;VAPA
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.29426343992812315,-0.47554389865789254,0.9565217391304348,1.0,1.0,2/5,22.28%,RDX;PTPN23
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.3002042602859644,-0.47509585793151465,0.9787234042553191,1.0,1.0,5/5,69.99%,HS3ST5;GP1BA;PROCR;F2R;EPHB2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.2940636022986104,0.47496830533028145,1.0,1.0,1.0,2/8,22.05%,CPEB2;DPH6
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.2825391813670239,-0.473620141961834,1.0,1.0,1.0,1/7,12.39%,LRAT
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.2617598006603217,0.4702275398029454,0.9841269841269841,1.0,1.0,5/11,33.24%,RNF185;UBXN1;BAG6;USP25;RNFT1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.31398051806640825,0.4697930669898489,0.9636363636363636,1.0,1.0,2/5,28.07%,XRCC1;RAD21
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.28748314363269306,-0.46921779185548457,0.9803921568627451,1.0,1.0,1/8,10.19%,IGBP1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.3224394514152317,0.46815399398670055,0.9636363636363636,1.0,1.0,5/5,67.77%,NUCKS1;XRCC5;XRCC6;NIPBL;ATM
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.22742949642367039,-0.4671971212607752,1.0,1.0,1.0,5/26,21.35%,SIRT6;ART4;ARF4;PARP11;PARP1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.2388486688463335,-0.46710602266611534,1.0,1.0,1.0,12/12,76.14%,PARP11;PARP1;PARP6;PARP2;PARP10;PARP3;TIPARP;PARP12;TNKS;TNKS2;PARP8;PARP16
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.24555188822154028,0.4647153155560791,1.0,1.0,1.0,3/26,20.04%,LSM11;ZNF473;EXOSC10
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.2995214194000233,0.46428630904458523,1.0,1.0,1.0,6/6,70.06%,DHX9;SSB;DCP1A;DDX3X;YBX1;DDX1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.2801311712585224,-0.46410113028642097,1.0,1.0,1.0,1/8,9.59%,JUP
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.2760571301208128,0.4624826034331471,1.0,1.0,1.0,2/10,16.81%,NOX4;MTHFR
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.2982548298605031,-0.4618518279905445,1.0,1.0,1.0,7/7,70.19%,PRPS1;TPK1;CAD;UMPS;DHODH;CTPS2;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.2977326544342948,0.46179661934956784,0.9846153846153847,1.0,1.0,3/7,32.81%,WNT5A;NF1;SLC16A2
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.2844255910587431,0.46063739240169954,1.0,1.0,1.0,2/7,22.82%,SIX4;PAX8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2844255910587431,0.46063739240169954,1.0,1.0,1.0,2/7,22.82%,SIX4;PAX8
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.2446286781877627,-0.4596615139898059,1.0,1.0,1.0,12/12,75.56%,NRDE2;NSUN2;NCBP2;TPR;SUPT6H;CPSF6;KHDRBS1;NUP153;SETD2;IWS1;AKAP8L;DHX9
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.23325102972078007,-0.45932511648446017,1.0,1.0,1.0,1/24,4.99%,RNF2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.2844765224846114,0.4591200087970421,0.9836065573770492,1.0,1.0,2/9,24.82%,TP53;PIF1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.22251593416845486,0.4587142719870263,1.0,1.0,1.0,7/27,29.53%,UBXN1;MAP1A;WAC;DDRGK1;OGT;BAG6;NOP53
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.2906281754755897,0.4558772452235693,1.0,1.0,1.0,2/5,22.72%,ADIPOR2;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.27852681958792974,-0.45525175310723837,0.9722222222222222,1.0,1.0,7/7,72.16%,APPL2;CDC42;PPT1;CLN3;AXL;APPL1;ANKFY1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.25478184622612143,-0.453594323787317,1.0,1.0,1.0,2/10,21.52%,NABP2;BRCA2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.23971899797417046,-0.4522399886766209,1.0,1.0,1.0,1/13,12.49%,NUP54
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.2828459697659488,0.44821472268885193,1.0,1.0,1.0,7/7,71.73%,DHX9;AGO1;AGO2;AGO3;DDX3X;DHX36;AGO4
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.2868912732363208,0.44812930819880276,0.9838709677419355,1.0,1.0,1/6,17.12%,DOT1L
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.2631448227432109,-0.4477719000607582,1.0,1.0,1.0,2/8,19.57%,PTGIS;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.24680994043947396,0.4464842994492656,1.0,1.0,1.0,5/14,25.12%,ATAD5;DDRGK1;GLI1;CUL3;ZNF16
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.271711705109391,0.4433935101587332,0.9824561403508771,1.0,1.0,3/9,27.16%,ADRA1D;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.24416539264528264,-0.4433531801670044,1.0,1.0,1.0,3/11,19.87%,PEX10;PEX13;PEX1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.2615940695935101,-0.4431384903200121,1.0,1.0,1.0,1/11,9.17%,SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.24828756596279888,-0.44222254931366983,1.0,1.0,1.0,4/13,23.12%,PNKP;NABP2;PKIB;MAP3K4
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.2940841870868654,0.4419292118655848,0.9818181818181818,1.0,1.0,3/5,34.52%,PRKN;ITCH;UBE2S
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.26832013945979816,-0.4416763528148252,0.9791666666666666,1.0,1.0,1/5,17.39%,WNT7B
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.2944849722789612,0.4416747942252577,1.0,1.0,1.0,5/5,70.56%,GHRHR;CHD7;SELENOT;GHRL;DRD2
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.26849804599800264,0.44090422539661356,1.0,1.0,1.0,4/10,26.76%,DSTN;WDR1;MICAL1;GSN
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.26391927622853856,-0.43968883531650904,0.9803921568627451,1.0,1.0,1/10,12.38%,ATP1A2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.23971060144343873,-0.43744543287459126,1.0,1.0,1.0,2/10,19.33%,LARS1;SESN2
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.2500437751707232,-0.4253166990954452,1.0,1.0,1.0,7/7,75.01%,ACTN2;EHD2;EIPR1;SORL1;EHD1;ZDHHC2;AKAP5
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.26567059647484537,-0.42526030755268507,0.9795918367346939,1.0,1.0,6/6,73.45%,ADI1;ENOPH1;MRI1;APIP;BHMT2;BHMT
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.26635131080607427,0.42175264268526397,0.9811320754716981,1.0,1.0,3/6,28.49%,CPT1C;BHMT;BHMT2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.25207566795701863,-0.4191074459519723,0.9777777777777777,1.0,1.0,3/7,21.22%,PNP;SLC16A9;PRPS1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.24095189144296544,0.41903303598708597,1.0,1.0,1.0,4/12,34.34%,TFRC;SHLD1;TGFB1;HMCES
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.23468744695056637,0.418546907527467,1.0,1.0,1.0,5/19,26.17%,BRCA1;RPS6KA4;RPS6KA5;ARRB1;MAPK3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.23400269149404784,-0.41416803461799967,1.0,1.0,1.0,2/10,19.33%,LARS1;SESN2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.23400269149404784,-0.41416803461799967,1.0,1.0,1.0,2/10,19.33%,LARS1;SESN2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.2479131399217792,-0.41404961329498036,1.0,1.0,1.0,9/9,75.23%,DDIT3;XBP1;CALR;ATF6B;MBTPS2;ATF6;HSP90B1;MBTPS1;HSPA5
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.27063149293801775,0.41387691821730804,0.96,1.0,1.0,6/6,72.95%,AKAP8L;IWS1;SETD2;SUPT6H;TPR;NSUN2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.27063149293801775,0.41387691821730804,0.96,1.0,1.0,6/6,72.95%,AKAP8L;IWS1;SETD2;SUPT6H;TPR;NSUN2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.22648707269289925,0.41219707145285994,1.0,1.0,1.0,4/15,28.74%,GLE1;IGF1R;OGFOD1;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.276944472744391,0.4117455010152541,0.9830508474576272,1.0,1.0,3/5,24.78%,BFAR;DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.23724205247167351,0.40847337438663467,1.0,1.0,1.0,4/13,28.56%,BFAR;DDRGK1;HSPA5;ABCA7
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.2675538434599897,0.4053670064339692,1.0,1.0,1.0,7/7,73.26%,FLOT1;RIPOR2;EHD1;MAPK14;CFLAR;ADGRB1;EHD2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.22020383182119074,-0.4046030046185428,1.0,1.0,1.0,4/18,23.12%,PNKP;NABP2;PKIB;MAP3K4
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.24000169421942638,0.40202392526716296,1.0,1.0,1.0,2/6,29.94%,MRTFB;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.26174496644295303,-0.40126028933884506,1.0,1.0,1.0,5/5,73.84%,IL34;PTK2;CSF1R;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.2634404250590975,-0.4012045283030258,1.0,1.0,1.0,1/5,19.11%,NR1H2
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.27814414940180904,0.4003392918104647,1.0,1.0,1.0,5/5,72.19%,AP1G1;AP3D1;RAB32;AP1M1;CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.27814414940180904,0.4003392918104647,1.0,1.0,1.0,5/5,72.19%,AP1G1;AP3D1;RAB32;AP1M1;CD63
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.23596661379513012,-0.39972702971878193,0.9782608695652174,1.0,1.0,2/7,20.72%,ENPP3;SPHK2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.24017747679374157,0.39921813030547604,1.0,1.0,1.0,11/11,76.00%,PPP2R2D;CLASP1;UBE2S;EPS8;CHMP7;CHMP4B;CLASP2;SIRT7;SPAST;CHMP2A;CTDP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.2675382280845106,0.3978761635125564,1.0,1.0,1.0,6/6,73.26%,FLOT1;RIPOR2;EHD1;MAPK14;ADGRB1;EHD2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.2543480798412514,0.39774162694192283,1.0,0.999868474791037,1.0,6/6,74.57%,NUP88;XPO1;LTV1;RAN;RPS15;NPM1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.21729320065143498,-0.3959303341337175,1.0,1.0,1.0,4/10,26.15%,RNF8;CTR9;LEO1;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.22564072625372178,-0.3913037548472181,1.0,0.9999919009552061,1.0,11/11,77.46%,GCC2;SAR1B;SLC51B;TMEM30A;SORL1;BRSK2;INSIG1;TM9SF4;CD81;SEC16A;SAR1A
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.2447181043539162,-0.39053984468953823,1.0,0.9994349354985761,1.0,6/6,75.54%,GTF3C6;GTF3C4;GTF3C3;GTF3C2;GTF3C1;GTF3C5
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.24121345261713076,0.3887210726869351,1.0,1.0,1.0,1/9,15.46%,TP53
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.20006221457227297,0.3802798799202403,1.0,1.0,1.0,4/20,23.86%,WAC;UBE2B;UBE2E1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.21330577850736743,0.37463491304902263,1.0,1.0,1.0,3/19,23.06%,TP53;MED24;MED13
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.2434782608695652,-0.37342414988833444,1.0,0.9997680747994288,1.0,5/5,75.67%,DHFR;MTHFS;QDPR;FPGS;GCH1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.23326491095678614,0.35908120010472916,1.0,1.0,1.0,4/10,32.44%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.23326491095678614,0.35908120010472916,1.0,1.0,1.0,4/10,32.44%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2045082924550339,0.3579967252762407,1.0,0.9998280458648732,1.0,16/16,79.57%,TINF2;TNKS2;TNKS;NAF1;TERF2;SMG6;HNRNPA2B1;SMG5;PINX1;POT1;ATM;ERCC4;DHX36;TERF1;PARP1;SLX4
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.21899753856266382,0.34978462043656505,1.0,0.9997162145544095,1.0,1/8,19.88%,FGFR1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.19969645671589514,-0.349495371417669,1.0,0.999761750947269,1.0,9/9,80.05%,UBB;UBA52;TUT4;TUT7;ISG15;UBC;CHFR;DIS3L2;RPS27A
